VAERS Reports 042A21A

VAERS 2726834

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 50,0
Geschlecht: M
Eingang: 22.12.2023
Impfdatum: 10.04.2021
Beginn: 30.09.2023
Tage bis Beginn: 903,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Blood culture negative Blood gases normal Blood potassium decreased Blood pressure increased Brain natriuretic peptide increased COVID-19 pneumonia Cardiac stress test abnormal Chest X-ray abnormal Chest pain Computerised tomogram thorax abnormal Dyspnoea Echocardiogram normal Electrocardiogram ST segment depression Electrocardiogram T wave normal Glycosylated haemoglobin increased Hypervolaemia Hypokalaemia

Symptomtext

Patient is a 53 y.o. male patient of DO with history of HTN, HLD, CAD s/p PCI, OA, fibromyalgia presented to Hospital with chest pain, SOB. Problem based management in the hospital is as follows: Acute Hypoxic Respiratory Failure, resoled COVID-19 virus pneumonia Acute onset chest pain/shortness of breath early a.m. 9/30. O2 sats initially 89% on room air with swift recovery with 4 to 6 L nasal cannula. VBG wnl. CXR with interstitial opacities, edema versus infiltrates. CT PE with no PE, pulmonary edema with bilateral pleural effusions. COVID (+). Suspect AHRF multifactorial due to COVID, slight volume overload. Continued scheduled breathing treatments, prn albuterol S/p 60mg solumedrol in ED, de-escalated Decadron, discharged on taper Received remdesivir x2 days Continue supplemental O2 to maintain sats >90%, now back on room air Blood and sputum cultures NTD Procal negative ID were following Chest Pain, resolved CAD s/p PCI Chronic Angina Elevated Troponin Elevated BNP Known coronary disease and chronic angina with previous left heart cath 7/12/2022 with DES x3 across chronically occluded circumflex artery/obtuse marginal branch. Distally noted to have moderate right coronary disease, and patent stent previously placed in LAD, 30% proximal left main lesion. Has since had an echo 3/23 which was normal. Repeat stress test 3/23 due to ongoing chest pain, that despite being abnormal showed no ischemia. Last follow-up with Dr. 6/7/2023 with recommendation to continue current regimen, continue DAPT for now. In ED, BNP 117, initial trop 85-- >202. ECG with ST depressions I, II, aVl, normal T waves. Imaging with noted pulmonary edema. States current symptoms feel more severe than chronic angina, does not have radiation similar to last time when he had an MI. Given up-trending trop/non-specific ECG abnormalities, initiated on heparin drip, discontinued heparin drip at discharge Gentle IV lasix 20mg x1 Monitored on Tele Continued plavix, ranolazine, imdur HTN tx as below Cardiology consulted, appreciate recs, do not feel respiratory failure secondary to heart failure, no further inpatient work-up recommended. Hypokalemia, resolved K 3.3 on admission, s/p 40mEq KCl HTN BP on arrival 209/133-- >170/84. Suspect elevated trop as above related to acute illness and not indicative of hypertensive emergency from elevated BP. Continued home meds HLD Continued statin T2DM Diabetic Neuropathy Gastroparesis Last A1c 1/20/23 was 8.2. Current home meds include: glipizide 10mgTID, 70/30 30u BID. Lantus 20 units + SSI while admitted, Discharged back on home meds Fibromyalgia Continued prn tramadol Depression Continued sertraline RLS Continued requip BPH Continued flomax OSA Does not tolerate CPAP. Currently being evaluated for Inspire After 2 days of hospital stay, patient was doing well so he was discharged in stable condition. Advised to f/u with PCP and cardiology. All questions and concerns were addressed before discharge.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 1,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2718091

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MN
Alter: 69,0
Geschlecht: F
Eingang: 27.11.2023
Impfdatum: 12.11.2021
Beginn: 23.11.2023
Tage bis Beginn: 741,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Patient expired 11/23/2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Unknown
Vorgeschichte: COPD, AAA, anemia, anxiety disorder, depressive disorder, arthritis, essential hypertension,
Andere Medikamente: Unknown
Allergien: Penicillins, morphine, erythromycin, meloxicam
Vorherige Impfungen: -

VAERS 2708114

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 37,0
Geschlecht: F
Eingang: 01.11.2023
Impfdatum: 08.04.2021
Beginn: 31.10.2023
Tage bis Beginn: 936,0
Dosis: 1
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Anion gap Auscultation Basophil count decreased Basophil percentage decreased Blood calcium normal Blood chloride normal Blood creatinine normal Blood culture Blood glucose normal Blood lactic acid normal Blood potassium normal Blood sodium normal Blood urea decreased Breast abscess Breast feeding Breast mass Breast necrosis Breast pain

Symptomtext

Document Type: History and Physical Document Subject: History & Physical Note Performed By: NP on October 31, 2023 14:12 Verified By: NP on October 31, 2023 14:45 Encounter Info: Hospital, Inpatient, 10/31/23 - * Final Report * Document Contains Addenda History of Present Illness/Subjective This is a 39 year old patient with a past medical history significant for Asthma that presented to Ed on 10/31/2023 from home via POV with c/o a breast wound and is being admitted to inpatient for breast abscess and outpatient treatment failure. This patient was seen and evaluated while still in the ED. She was found to be lying in bed, alert and oriented and in no distress. C/o breast abscess for 1.5 weeks. She was seen in the facility on 10/27/23 and given a Rocephin and a prescription for Bactrim DS. She continues on her Bactrim but in the meantime she has developed fever, chills, nausea, and the abscess has worsened. 3 months postpartum, weaned her infant approx 1 month ago, denies engorgement and feels she is no longer lactating. Afebrile. All other vs stable and wnl. CMP and CBC nonactionable. Review of Systems Constitutional: No fevers, no chills, no sweats Eyes: No changes in vision Ears, Nose, Mouth, Throat: No ear pain, no nasal congestion, no sore throat Respiratory: No shortness of breath, no cough, no wheeze Cardiovascular: No chest pain, no palpitations, no edema Gastrointestinal: No abdominal pain, no nausea, no vomiting, no diarrhea, no constipation Genitourinary: No frequency, no urgency, no dysuria, no hematuria Hematologic/Lymphatic: No bruising, no enlarged lymph nodes Allergic/Immunologic: No hives Endocrine: No cold intolerance, no heat intolerance, no polyuria, no polydipsia Musculoskeletal: No arthralgia, no myalgia Skin: +erythema and blackened area Neurological: No headache, no focal weakness, no numbness Psychiatric: No anxiety, no depression Physical Exam/Objective Vitals & Measurements most recent past 24 hours T: 36.8 ?C (Oral) BP: 112/73 HR: 80 (Monitored) RR: 16 SpO2: 98% Oxygen Therapy: Room air WT: 76.80 kg (WFC) Hemodynamics Neurologic Glasgow Coma Score: 15 Patient Weight Current Daily Weight: 76.8 kg 10/31/23 Patient Height Current Height: 152 cm 10/31/23 Constitutional: No acute distress, well-nourished Eyes: PERRLA, EOMI, normal conjunctiva, no scleral icterus ENMT: Moist oral mucosa Neck: Supple, non-tender, intact range of motion Respiratory: Lungs CTAB Cardiovascular: Regular rate and rhythm Gastrointestinal: Soft, non-tender, non-distended Musculoskeletal: No joint swelling, no deformity, intact ROM Integumentary: see clinical media Neurologic: Alert & Oriented x 3, no cognitive impairment, no focal deficits Psychiatric: Cooperative, appropriate mood and affect Assessment/Plan This is a 39 year old patient with a past medical history significant for Asthma that presented to Ed on 10/31/2023 from home via POV with c/o a breast wound and is being admitted to inpatient for breast abscess and outpatient treatment failure. This is a 39 year old patient with a past medical history significant for Asthma that presented to Ed on 10/31/2023 from home via POV with c/o a breast wound and is being admitted to inpatient for breast abscess and outpatient treatment failure. 1. Breast abscess N61.1 failed outpatient treatment does not meet sepsis criteria IV atbx, blood cx pending surgery following for possible I/D will have oncology consult to r/o breast ca 2. Failure of outpatient treatment Z78.9 treated with one dose of Ceftx and a bactrim script. no improvement see plan above 3. Mastitis N61.0 see plan above 4. Anxiety and depression F41.9 continue lexapro 5. Hashimoto's thyroiditis E06.3 continue levothyroxine 6. Narcolepsy G47.419 noted. 7. Asthma J45.909 not in exacerbation Inpt, medical floor Daily labs - CBC, CMP Daily Regular Diet IV fluids SL Full Code Status VTE Prophylaxis - Heparin Code Status None Recorded Chronic Problem List Abscess of breast Adenoma of colon Advanced maternal age in multigravida Anxiety and depression Attention deficit hyperactivity disorder Colon polyp Family history of colon cancer in mother Family history of hemophilia Family history of secondary malignant neoplasm of large intestine and rectum Hair loss Hashimoto's thyroiditis Irritable bowel syndrome with diarrhea Kidney stones Major depression, recurrent, chronic Migraines Narcolepsy Obesity, Class I, BMI 30-34.9 Panic disorder without agoraphobia Positive screening for depression on 2-item Patient Health Questionnaire (PHQ-2) Seasonal allergies Procedure/Surgical History ?Cystoscopy, Right Ureteroscopy , Laser Lithotripsy, Right Stent placement (08/11/2021) ?Cystoscopy, insert reteral Stent (07/21/2021) ?Kidney stone (07/21/2021) ?Date of last PAP smear (07/06/2021) ?Colonoscopy (01/06/2021) ?cesarean section (08/16/2015) ?Nasal bones, closed fracture.. (2003) ?Wisdom Teeth Removed (2003) Surgical History Internal 08/01/2023 Cesarean Section. MD 08/11/2021 Ureteroscopy. (Right) MD 07/21/2021 Cystoscopy Insert Ureteral Stent or Cath (Right) MD 01/06/2021 Colonscpy Snare Tmr Polyp Lsn MD PhD 08/06/2015 Cesarean Section. MD Medications Home Medications (6) Active acetaminophen 500 mg oral tablet 1,000 mg = 2 Tablet, Orally, Q8H amphetamine-dextroamphetamine 10 mg tablet 20 mg Bactrim DS 800 mg-160 mg oral tablet 1 Tablet, Orally, BID escitalopram 20 mg oral tablet 20 mg = 1 Tablet, Orally, Daily levothyroxine 137 mCg (0.137 mg) oral tablet 137 mCg = 1 Tablet, Orally, Daily, Avoid antacids, calcium, or iron for at least 4 hrs before or 4 hrs afterAs a single daily dose before breakfast Sunosi 150 mg oral tablet Active Scheduled Inpatient Medications piperacillin-tazobactam, Injection, 3.375 GM, IVPB, ONCE, Indication: SSTI - Severe/DFI/Necrotizing Fasciitis, Start: 10/31/23 17:00:00 One-Time Medications Given 10/30/23 00:00:00 TO 10/31/23 14:12:32 ketoROLAC, Injection, 15 mg, IV Push, ONCE, (1 DOSE 10/31/23 12:52:00) ondansetron, Injection, 4 mg, IV Push, ONCE, (1 DOSE 10/31/23 12:52:00) piperacillin-tazobactam, Injection, 4.5 GM, IV Push, ONCE, (1 DOSE 10/31/23 12:52:00) vancomycin, Injection, 1.5 GM, IVPB, ONCE, (1 DOSE 10/31/23 13:12:00) PRN Medications (0600 - 0559) from 10/30 - 10/31 None Reported Allergies Ambien (Hallucinations) HYDROcodone (Itching) Latex (mild itching) Social History Alcohol Current, 1-2 times per month Electronic Cigarette/Vaping E-Cigarette Use Never. Employment/School Employed, Work/School description: LPN-Select Home Health. Highest education level: Some college. Exercise Exercise frequency: Does Not Exercise. Home/Environment FOB: - Relationship since 9/2022, Lives with Significant other, and her daughter. Nutrition/Health Diet: Regular. Caffeine intake amount: <200mg daily. Other ACE: 4 Pt declined HFI Psychosocial Substance Abuse Denies Tobacco Tobacco Use: Never (less than 100 in lifetime). Family History Alcohol abuse: Father. Asthma: Brother. Cancer of colon: Mother. Depression: Mother, Father, Sister and Brother. Hypertension: Mother, Grandfather (P) and Grandmother (M). Thyroid disorder: Aunt, Grandmother (P), Maternal Cousin and Paternal Cousin. Lab Results All Labs Last 24 hours (No Micro or Pathology) Hematology: WBC: 10.8 k/cumm High (10/31/23 12:40:00) RBC: 4.39 million/cumm (10/31/23 12:40:00) Hgb: 13.3 GM/dL (10/31/23 12:40:00) Hct: 39.2 % (10/31/23 12:40:00) MCV: 89 fL (10/31/23 12:40:00) MCH: 30.3 pg (10/31/23 12:40:00) MCHC: 33.9 GM/dL (10/31/23 12:40:00) RDW: 13.7 % (10/31/23 12:40:00) Platelet: 350 k/cumm (10/31/23 12:40:00) MPV: 7.8 fL (10/31/23 12:40:00) Neutrophils %: 74 % (10/31/23 12:40:00) Lymphocytes %: 17 % (10/31/23 12:40:00) Monocytes %: 5 % (10/31/23 12:40:00) Eosinophils %: 3 % (10/31/23 12:40:00) Basophils %: 0 % (10/31/23 12:40:00) Absolute Neutrophil: 8.1 k/cumm High (10/31/23 12:40:00) Absolute Lymphocyte: 1.9 k/cumm (10/31/23 12:40:00) Absolute Monocyte: 0.5 k/cumm (10/31/23 12:40:00) Absolute Eosinophil: 0.3 k/cumm (10/31/23 12:40:00) Absolute Basophil: 0 k/cumm (10/31/23 12:40:00) Chemistry: Sodium SerPl QN: 139 mmol/L (10/31/23 12:40:00) Potassium SerPl QN: 3.5 mmol/L (10/31/23 12:40:00) Chloride SerPl QN: 105 mmol/L (10/31/23 12:40:00) Carbon Dioxide SerPl QN: 27 mmol/L (10/31/23 12:40:00) Anion Gap: 7 mmol/L (10/31/23 12:40:00) BUN SerPl QN: 7 mg/dL (10/31/23 12:40:00) Creatinine SerPl QN: 0.92 mg/dL (10/31/23 12:40:00) Estimated GFR (CKD-EPI, no race): 81 mL/min/1.73m2 (10/31/23 12:40:00) Estimated CRCL (CG): 75 mL/min (10/31/23 12:40:00) Glucose SerPl QN: 86 mg/dL (10/31/23 12:40:00) Calcium Total SerPl QN: 9.3 mg/dL (10/31/23 12:40:00) Lactate Venous Pl QN: 1.1 mmol/L (10/31/23 12:40:00) Diagnostics Radiology Results - Last 24 hours Across Visits No radiology results found in the last 24 hours. Signature Line Electronically Signed on 10/31/23 14:45 ________________________________________________________ NP Addendum by MD on October 31, 2023 18:52:21 (Verified) I saw and evaluated the patient in addition to NP. I provided a substantive portion of the care for this patient. I have reviewed and verified this documentation and it accurately reflects our care. 39-year-old woman admitted to the hospital for left breast redness and pain of 1 week duration. Patient notes that left breast pain and redness started small but has gradually worsened. She reports a high-grade fever at home. Recent history of breast-feeding but last breast-fed 1 month ago. No history of prior breast abscess or engorgement. No recent history of mammogram or breast ultrasound. Currently complains of poor pain control. Vital signs are stable. We will continue current antibiotics. Surgery eval to follow. General: Alert and oriented, No acute distress. Eye: Normal conjunctiva. Cardiovascular: Regular rate, Normal rhythm, No murmur. Respiratory: Lungs are clear to auscultation, Respirations are non-labored. Gastrointestinal: Soft, Non-tender, Non-distended, Normal bowel sounds, No organomegaly. Neurologic: no focal deficits Psychiatric: Cooperative, Appropriate mood & affect. Musculoskeletal: No swelling, Breast exam-necrotic appearing mass on the left outer quadrant of the left breast, with surrounding redness and peau d'orange appearance, very tender to palpation I spent more than 30 minutes in the entire evaluation MD Signature Line Electronically Signed on 10/31/23 18:55 ________________________________________________________ MD

Weitere VAERSDATA-Felder

Praegender Schweregrund: Coma scale
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2708099

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: TX
Alter: 60,0
Geschlecht: M
Eingang: 01.11.2023
Impfdatum: 02.04.2021
Beginn: 15.10.2021
Tage bis Beginn: 196,0
Dosis: 1
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Atrial fibrillation Cardiac arrest Cough Death Haemofiltration Hypotension Pneumonia Vasopressive therapy

Symptomtext

to ED c/o cough, + pneumonia, TX: toci, decadron, req vasopressors for hypotension, CRRT, develops afib, cardiac arrest on 10/26, made DNR 10/27, pt expired 10/28

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: 13,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2657752

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: TX
Alter: 86,0
Geschlecht: M
Eingang: 18.07.2023
Impfdatum: 12.04.2021
Beginn: 11.01.2022
Tage bis Beginn: 274,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19 pneumonia Dyspnoea Hypoxia

Symptomtext

Presented to ED w/SOB, hypoxia; admitted w/ COVID-19 pna and acute hypoxic resp failure; tx w/steroids, abx, O2, Vit C, Remdesivir, zinc; dc'd to rehab w/O2.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 10,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2614781

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 88,0
Geschlecht: F
Eingang: 13.04.2023
Impfdatum: 07.04.2021
Beginn: 18.12.2021
Tage bis Beginn: 255,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute myocardial infarction Diabetic diet Type 2 diabetes mellitus

Symptomtext

ACUTE NON ST ELEVATION MI 10/30/2021 DM 2 CONTROLLED BY DIET

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2613971

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 61,0
Geschlecht: M
Eingang: 12.04.2023
Impfdatum: 05.04.2021
Beginn: 03.06.2021
Tage bis Beginn: 59,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute myocardial infarction Hypertension

Symptomtext

ACUTE ST ELEVATION MI, LEFT ANTERIOR DESCENDING CORONARY ARTERY 6/15/2021 HTN (HYPERTENSION)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2591807

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MI
Alter: 74,0
Geschlecht: M
Eingang: 31.03.2023
Impfdatum: 09.04.2021
Beginn: 20.02.2023
Tage bis Beginn: 682,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Angiogram abnormal Angiogram pulmonary abnormal Anticoagulant therapy Atrial fibrillation Atrial flutter Angiogram Angiogram pulmonary Biopsy lung Biopsy muscle COVID-19 Cardiac disorder Condition aggravated Computerised tomogram abdomen Computerised tomogram pelvis Computerised tomogram thorax Dyspnoea Echocardiogram abnormal Haemoglobin decreased

Symptomtext

HYPOXIA; LYMPHADENOPATHY; PNEUMOTHORAX; TACHYCARDIA; BIOPSY MUSCLE; RIGHT VENTRICULAR DYSFUNCTION; BIOPSY LUNG; RIGHT VENTRICULAR FAILURE; ECHOCARDIOGRAM ABNORMAL; DYSPNOEA; ANGIOGRAM ABNORMAL; PULMONARY HYPERTENSION; HAEMOGLOBIN DECREASED; INGUINAL MASS; THROMBECTOMY; RIGHT VENTRICULAR FAILURE; SARS-COV-2 TEST POSITIVE; RIGHT VENTRICULAR DYSFUNCTION; ECHOCARDIOGRAM ABNORMAL; INGUINAL MASS; MUSCLE MASS; LYMPHADENOPATHY; PELVIC MASS; PELVIC MASS; SINUS ARRHYTHMIA; PULMONARY MASS; BIOPSY LUNG; SINUS ARRHYTHMIA; ANGIOGRAM PULMONARY ABNORMAL; TACHYCARDIA; ANTICOAGULANT THERAPY; MUSCLE MASS; PULMONARY MASS; CARDIAC DISORDER; COVID-19; CONDITION AGGRAVATED; CARDIAC DISORDER; DYSPNOEA; CONDITION AGGRAVATED; ATRIAL FLUTTER; PULMONARY EMBOLISM; PULMONARY EMBOLISM; HAEMOGLOBIN DECREASED; PULMONARY HYPERTENSION; BIOPSY MUSCLE; ATRIAL FIBRILLATION; PNEUMOTHORAX; ANGIOGRAM PULMONARY ABNORMAL; ATRIAL FIBRILLATION; ANTICOAGULANT THERAPY; HYPOXIA; SARS-COV-2 TEST POSITIVE; ANGIOGRAM ABNORMAL; COVID-19; ATRIAL FLUTTER; This spontaneous report received from a health care professional by a Regulatory Authority, Vaccine Adverse Event Reporting System (VAERS) (VAERS ID: 2591807) concerned a 75 year old male of an unspecified race and ethnicity. The patient's height, and weight were not reported. The patient's past medical history included: covid-19, lung mass, acute respiratory failure with hypoxia, soft tissue mass, and pneumothorax after biopsy, and concurrent conditions included: bilateral pulmonary embolism, acute anemia, acute deep vein thrombosis, DVT (deep vein thrombosis) of left lower extremity, and drug allergy (sulfa and had rash), benign prostatic hyperplasia (BPH), non-smoker, and tobacco user, and other pre-existing medical conditions included: The patient had no history of current illness at the time of vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: UNKNOWN) dose was not reported, 1 total was administered on 09-APR-2021 for an unspecified indication. Age at time of vaccination 74 years old. Concomitant medications included amiodarone hydrochloride (Pacerone), apixaban (Eliquis), fish oil, omega-3 fatty acids, and tamsulosin hydrochloride (Flomax). On 20-FEB-2023, the patient experienced unspecified symptoms for COVID-19 which had started about 1 week prior to the hospital admission. On 27-FEB-2023, the patient was presented to the emergency department with severe shortness of breath (dyspnoea), bilateral pulmonary embolism, acute pulmonary embolism with acute cor pulmonale of unspecified pulmonary embolism type (pulmonary embolism), The patient had recently started workup for left gluteal maximus mass (muscle mass) and felt to be liposarcoma. On arrival the patient was significantly tachycardiac (tachycardia) (cardiac disorder) with rates up into the 160s appeared to be atrial flutter. The patient required IV (intravenous) diltiazem and after administration and was spontaneously converted back to normal sinus rhythm (sinus arrhythmia). CTA (Computed Tomography Angiography) of thorax (angiogram pulmonary abnormal) was performed which had shown bilateral PE (pulmonary embolism) with right heart strain and multiple pulmonary masses (pulmonary mass). The patient was started on a heparin drip (anticoagulant therapy) . The patient also had a largest mass in the right upper lobe which was most suspicious for neoplasm. The patient was additionally had COVID-19 positive (sars-cov-2 test positive) (COVID-19). On 28-FEB-2023, the patient had consulted interventional radiologist and completed mechanical thrombectomy which had removed 85-90 percent of clot burden with some improvement in pulmonary hypertension via PA (Pascal) pressures from 40 8 18 to 34 8 16 mmHg (pulmonary hypertension) Echocardiogram (echocardiogram abnormal) was performed prior to thrombectomy with moderate to severe RV (acute right ventricle) dysfunction (right ventricular dysfunction) and moderate dilation with systolic septal flattening consistent with RV (right ventricular) pressure overload (right ventricular failure). MRI (Magnetic Resonance Imaging) of the left hip was attempted to be obtained, but the patient was unable to tolerate for test and examinations were non diagnostic due to motion artifact. The patient continued to intermittently revert back to atrial flutter. The patient had later consulted cardiologist where they had initiated intravenous (IV) amiodarone and later the patient had spontaneously converted back to NSR (Normal sinus rhythm) to maintain his sinus rhythm. The patient was transitioned to oral loading dose 3 4 Hemoglobin (haemoglobin decreased) and noted to trend down after procedures with CTA abdomen (angiogram abnormal) and CTA pelvis obtained to rule out retroperitoneal hemorrhage. This demonstrated no active bleed but had shown enlarging left pelvic (pelvic mass) and inguinal masses (inguinal mass) likely enlarging lymph nodes (lymphadenopathy) as well as a prior nodule in the right lower lobe that had grown significantly in size which was already suspicious for aggressive malignancy. On 03-MAR-2023, the patient had biopsy completed for his right upper lobe mass (biopsy muscle) as well as left gluteal mass (biopsy lung) in order to limit interruption of anticoagulation. The patient had very small right apical pneumothorax after the procedure which had improved with conservative management. The patient was evaluated by pulmonary rehabilitation who recommended home oxygen which only needed with activity Hypoxemia (hypoxia) and it was likely not related to COVID as the patient symptoms onset had occurred around 20-FEB-2023. The patient had not started steroids and had to continue 14-day amiodarone load with 400 mg twice per day and then after 14 days 200 mg daily. Upon follow-up with cardiologist, the patient was started on Eliquis and the patient had to continue this as the starter pack after the discharge. The patient was hospitalized for 6 days and on 05-MAR-2023, the patient was discharged from hospital. The drug latency was reported as 689 days. The patient had a follow up with pulmonologist for biopsy results. The patient need to repeat echo and it was reported that the patient would obtain complete blood count within the next 1 week at the time of reporting and the patient needs oncology referral by PCP (primary care physician) once biopsy results were finalized. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from pulmonary hypertension, atrial fibrillation, hypoxia, pneumothorax, pulmonary embolism, right ventricular dysfunction, right ventricular failure, atrial flutter, covid-19, cardiac disorder, condition aggravated, dyspnoea, inguinal mass, lymphadenopathy, muscle mass, pelvic mass, pulmonary mass, sinus arrhythmia, tachycardia, thrombectomy, anticoagulant therapy, angiogram pulmonary abnormal, angiogram abnormal, haemoglobin decreased, biopsy muscle, biopsy lung, echocardiogram abnormal, and sars-cov-2 test positive. This report was serious (Hospitalization Caused / Prolonged). This case was associated with a product quality complaint 90000275615. The suspected product quality complaint has been confirmed to be the reported allegation was not confirmed and the root cause was determined to be not manufacturing related. Batch and lot tested and found within specifications based on the PQC evaluation/investigation performed. Additional information received from Central Complaint Vigilance department on 29-MAR-2023. The following information was updated and incorporated into the case narrative: Product quality complaint investigation result.; Sender's Comments: V1: This follow up version updates- Product quality complaint investigation result. This updated information does not alter the causality of previously reported events. 20230349252-pulmonary hypertension, atrial fibrillation, hypoxia, pneumothorax, right ventricular dysfunction, right ventricular failure, atrial flutter, cardiac disorder, condition aggravated, dyspnoea, inguinal mass, lymphadenopathy, muscle mass, pelvic mass, pulmonary mass, sinus arrhythmia, tachycardia, , haemoglobin decreased, biopsy muscle, biopsy lung, echocardiogram abnormal, pulmonary embolism, thrombectomy, anticoagulant therapy, angiogram pulmonary abnormal, angiogram abnormal. The event shows an incompatible temporal relationship. Therefore, this event is considered inconsistent with vaccine administration. 20230349252-sars-cov-2 test positive, covid-19. The event is deemed to be scientifically implausible, i.e., there is scientific evidence against a drug/event relationship; AND there is no known class effect. Therefore, this event is considered inconsistent with vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 6,0
Labordaten: Test Date: 20230227; Test Name: SARS-COV-2 TEST; Test Result: Positive ; Test Date: 20230227; Test Name: ANGIOGRAM PULMONARY; Result Unstructured Data: abnormal; Test Date: 20230227; Test Name: HEART RATE; Result Unstructured Data: 160s, tachycardiac; Test Date: 20230227; Test Name: COMPUTED TOMOGRAPHY ANGIOGRAPHY OF THORAX; Result Unstructured Data: bilateral PE (pulmonary embolism) with right heart strain and multiple pulmonary masses; Test Date: 20230228; Test Name: ECHOCARDIOGRAM; Result Unstructured Data: abnormal (moderate to severe RV (acute right ventricle) dysfunction (right ventricular dysfunction) and moderate dilation with systolic septal flattening consistent with RV (right ventricular) pressure overload (right ventricular failure); Test Date: 20230228; Test Name: CTA PELVIS; Result Unstructured Data: to rule out retroperitoneal hemorrhage. no active bleed but did show enlarging left pelvic (pelvic mass) and inguinal masses (inguinal mass) likely enlarging lymph nodes (lymphadenopathy) as well as a prior nodule in the right lower lobe that had grown significantly in size which was already suspicious for aggressive malignancy.; Test Date: 20230228; Test Name: PULMONARY BLOOD PRESSURE; Result Unstructured Data: 40 8 18 to 34 8 16 mmHg; Test Date: 20230228; Test Name: ANGIOGRAM; Result Unstructured Data: abnormal; Test Date: 20230228; Test Name: CTA ABDOMEN; Result Unstructured Data: to rule out retroperitoneal hemorrhage. no active bleed but did show enlarging left pelvic (pelvic mass) and inguinal masses (inguinal mass) likely enlarging lymph nodes (lymphadenopathy) as well as a prior nodule in the right lower lobe that had grown significantly in size which was already suspicious for aggressive malignancy.; Test Date: 20230228; Test Name: HAEMOGLOBIN; Result Unstructured Data: decreased; Test Date: 20230303; Test Name: BIOPSY LUNG; Result Unstructured Data: not reported; Test Date: 20230303; Test Name: BIOPSY MUSCLE; Result Unstructured Data: Not reported
Aktuelle Erkrankungen: Acute anemia; Acute hypoxic respiratory failure; Benign prostatic hyperplasia; Deep vein thrombosis; Drug allergy (sulfa and had rash); DVT of legs; Non-smoker; Pneumothorax; Pulmonary embolism; Tobacco user
Vorgeschichte: Medical History/Concurrent Conditions: COVID-19; Lung mass; Soft tissue mass; Comments: The patient had no history of current illness at the time of vaccination
Andere Medikamente: PACERONE; ELIQUIS; OMEGA-3 FATTY ACIDS; FISH OIL; FLOMAX [TAMSULOSIN HYDROCHLORIDE]; APIXABAN
Allergien: -
Vorherige Impfungen: -

VAERS 2593487

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MI
Alter: 62,0
Geschlecht: F
Eingang: 09.03.2023
Impfdatum: 12.11.2022
Beginn: 20.12.2022
Tage bis Beginn: 38,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Agitation Antiplatelet therapy Anxiety Blood creatinine Blood creatinine increased Blood potassium Blood pressure measurement Blood pressure systolic Blood pressure systolic increased COVID-19 Cerebrovascular accident Computerised tomogram head Computerised tomogram head abnormal Dysphagia Encephalopathy Full blood count Full blood count abnormal Hypertension

Symptomtext

CEREBROVASCULAR ACCIDENT; ENCEPHALOPATHY; HYPOKALAEMIA; MYOCARDIAL INFARCTION; RENAL IMPAIRMENT; METABOLIC ENCEPHALOPATHY; AGITATION; ANTIPLATELET THERAPY; ANXIETY; BLOOD CREATININE INCREASED; BLOOD PRESSURE SYSTOLIC INCREASED; COVID-19; COMPUTERISED TOMOGRAM HEAD ABNORMAL; DYSPHAGIA; FULL BLOOD COUNT ABNORMAL; HYPERTENSION; INTENSIVE CARE; LEUKOCYTOSIS; MAGNETIC RESONANCE IMAGING ABNORMAL; MENTAL STATUS CHANGES; NERVOUS SYSTEM DISORDER; OEDEMA; SARS-COV-2 TEST POSITIVE; TREATMENT NONCOMPLIANCE; This spontaneous report received from a health care professional by a Regulatory Authority VAERS (Vaccine Adverse Event Reporting System, VAERS ID 2577987) concerned a 62 year old female of an unspecified race and ethnicity. The patient's height, and weight were not reported. The patient's past medical history included: cerebrovascular accident (Cerebrovascular accident CVA due to embolism of carotid artery), integumentary tinea capitis, and alopecia, and concurrent conditions included: cardiovascular hypertension (HTN) benign, tobacco use, acute encephalopathy, and hypertensive encephalopathy (poorly controlled hypertension and medical noncompliance). The other pre-existing medical conditions included: The patient had no know allergies. The patient previously received covid-19 vaccine ad26.cov2.s (unspecified manufacturer) (Dose number in series 1) (suspension for injection, route of admin not reported, batch number:1855194, expiry: UNKNOWN) dose was not reported, 1 total, administered on an unspecified date for an unspecified indication. It was unknown whether the patient experienced any adverse events following vaccination with covid-19 vaccine ad26.cov2.s (unspecified manufacturer) (Dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin not reported, batch number: 042A21A expiry: UNKNOWN) dose was not reported, 1 total, administered on 12-NOV-2022 for an unspecified indication. Age at time of vaccination 62 years old. Concomitant medications included aspirin low dose (acetylsalicylic acid), norvasc (amlodipine besilate), lipitor (atorvastatin calcium), and catapres TTS (clonidine) for drug used for unknown indication. On 20-DEC-2022, the patient presented with chief complaint of altered mental status (mental status changes) (Dose number in series 2). On presentation, the patient was noted to be hypertensive systolics (hypertension) (blood pressure systolic increased) in the 240s creatinine (blood creatinine increased), 28 hypokalemic (hypokalaemia), complete blood count notable for leukocytosis (leukocytosis) (full blood count abnormal) (Dose number in series 2). A computerized tomography (CT) was performed and showed nonspecific low attenuation in both cerebral hemispheres (computerised tomogram head abnormal) (Dose number in series 2). The patient was admitted for workup of strokes and altered mental status. The patient initially admitted to the intensive care unit (intensive care) required IV blood pressure medications and transferred to progressive care unit once titrated off of intravenous (IV) medications (Dose number in series 2). The patient continued to be non-compliant (treatment noncompliance) with oral medications throughout her stay requiring IV supplementation to her blood pressure regimen (Dose number in series 2). The patient was tested positive for COVID-19 family (sars-cov-2 PCR test positive), declined remdesivir and she was not requiring oxygen (Dose number in series 2). Initial repeat CT was concerning for acute CVA (cerebrovascular accident) right caudate head lacunar infarct, question microhemorrhage (Dose number in series 2). The initial magnetic resonance imaging (MRI) was a poor study secondary to patient agitation (magnetic resonance imaging abnormal) (Dose number in series 2). The repeat studies were obtained with IV medications for anxiety/sedation. The MRI showed small attenuated acute infarcts right caudate nucleus right lateral ventricle, left temporal lobe (nervous system disorder) (Dose number in series 2). The patient was started on dual anti-platelets (antiplatelet therapy) and seen by neurology (Dose number in series 2). The MRI was obtained without large vessel occlusion or stenosis. The patient required prolonged stay secondary to encephalopathy edema (oedema) secondary to new CVAs, COVID and metabolic encephalopathy (Dose number in series 2). The patient had renal impairment (Dose number in series 2). The renal function was improved following IV fluids. The blood pressure regimen was titrated up former she no longer required IV medications. She was saw by physical therapy (PT) and occupational therapy (OT ) with recommendations for rehab. The family declined wanting to take patient home. The patient will be discharged on 21 day therapy dual anti-platelets followed by aspirin monotherapy. Discharge was delayed secondary to holiday difficulty with coordination of home care. The family chose to pursue home care from primary outpatient. The patient had dysphagia which improved prior to discharge was able to eat normal diet. The patient experienced myocardial infarction (Dose number in series 2). The number of days of hospitalization was 13 days. The latency was 38 days. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from agitation, antiplatelet therapy, anxiety, blood creatinine increased, blood pressure systolic increased, covid-19, cerebrovascular accident, computerised tomogram head abnormal, dysphagia, encephalopathy, full blood count abnormal, hypertension, hypokalaemia, intensive care, leukocytosis, magnetic resonance imaging abnormal, mental status changes, metabolic encephalopathy, myocardial infarction, nervous system disorder, oedema, renal impairment, sars-cov-2 test positive, and treatment noncompliance. This report was serious (Hospitalization Caused / Prolonged). This report was associated with product quality complaint. The suspected product quality complaint has been confirmed to be the reported allegation could not be determined. A manufacturing related root cause could not be identified based on the PQC evaluation/investigation performed. Additional information was received from Complaint department on 06-MAR-2023. The following information was updated and incorporated into the case narrative: Product quality complaint investigation result.; Sender's Comments: V1: This follow up adds information about Product quality complaint investigation result. This does not alter previous causality assessment of the reported events. 20230244617-full blood count abnormal, leukocytosis , intensive care, anxiety, nervous system disorder. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event. Therefore, the WHO Causality is considered indeterminate. The company causality is considered unassessable. 20230244617-cerebrovascular accident, antiplatelet therapy, encephalopathy, agitation, dysphagia, myocardial infarction, metabolic encephalopathy, blood pressure systolic increased, hypertension, mental status changes, magnetic resonance imaging abnormal, computerised tomogram head abnormal, renal impairment, blood creatinine increased, hypokalaemia, oedema. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event. Specifically: MEDICAL HISTORY. Therefore, this event is considered inconsistent with vaccine administration. 20230244617-covid-19, sars-cov-2 test positive. The event is deemed to be scientifically implausible, i.e., there is scientific evidence against a drug/event relationship; AND there is no known class effect. Therefore, this event is considered inconsistent with vaccine administration. 20230244617-treatment noncompliance. The case causality is considered INCONSISTENT. Rationale: Event treatment noncompliance described in context of oral medications for blood pressure and not with vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 13,0
Labordaten: Test Date: 20221220; Test Name: COVID-19 PCR TEST; Test Result: Positive ; Test Date: 20221220; Test Name: BLOOD CREATININE; Result Unstructured Data: increased; Test Date: 20221220; Test Name: BLOOD PRESSURE SYSTOLIC; Result Unstructured Data: increased; Test Date: 20221220; Test Name: CT HEAD; Result Unstructured Data: nonspecific low attenuation in both cerebral hemispheres; Test Date: 20221220; Test Name: FULL BLOOD COUNT; Result Unstructured Data: abnormal; Test Date: 20221220; Test Name: MRI; Result Unstructured Data: poor study secondary to patient agitation; Test Date: 20221220; Test Name: MRI; Result Unstructured Data: showed small attenuated acute infarcts right caudate nucleus right lateral ventricle left temporal lobe; Test Date: 20221220; Test Name: BLOOD PRESSURE; Result Unstructured Data: hypertension; Test Date: 20221222; Test Name: POTASSIUM; Result Unstructured Data: hypokalaemia
Aktuelle Erkrankungen: Encephalopathy acute; Hypertension ((401.1),); Hypertensive encephalopathy; Tobacco user ((305.1))
Vorgeschichte: Medical History/Concurrent Conditions: Alopecia; Cerebrovascular accident (Cerebrovascular accident CVA due to embolism of carotid artery); Tinea capitis); Comments: The patient had no know allergies.
Andere Medikamente: ASPIRIN LOW; NORVASC; LIPITOR; CATAPRESS TTS
Allergien: -
Vorherige Impfungen: -

VAERS 2577987

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MI
Alter: 62,0
Geschlecht: F
Eingang: 08.02.2023
Impfdatum: 12.11.2022
Beginn: 20.12.2022
Tage bis Beginn: 38,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Agitation Antiplatelet therapy Anxiety Blood creatinine increased Blood pressure systolic increased COVID-19 Cerebrovascular accident Computerised tomogram head abnormal Dysphagia Encephalopathy Full blood count abnormal Hypertension Hypokalaemia Intensive care Leukocytosis Magnetic resonance imaging abnormal Mental status changes Metabolic encephalopathy

Symptomtext

Provider d/c note: "63-year-old female past medical history of poorly controlled hypertension and medical noncompliance. She presented on 12/20 for chief complaint of altered mental status. On presentation patient was noted to be hypertensive systolics in the 240s creatinine 2.8 hypokalemic, complete blood count notable for leukocytosis. CT was performed showing nonspecific low attenuation in both cerebral hemispheres. Patient was admitted for workup of strokes and altered mental status. See initially admitted to the intensive care unit requiring IV blood pressure medications transferred to progressive care unit once titrated off of IV medications. Patient continued to be noncompliant with oral medications throughout her stay requiring IV supplementation to her blood pressure regimen. Patient was tested positive for COVID-19, family declined remdesivir and she was not requiring oxygen. Initial repeat CT was concerning for acute CVA right caudate head lacunar infarct, question microhemorrhage. Initial MRI was a poor study secondary to patient agitation. Repeat studies were obtained with IV medications for anxiety/sedation. MRI showed small attenuated acute infarcts right caudate nucleus right lateral ventricle, left temporal lobe. Patient was started on dual antiplatelets and seen by Neurology. MRI was obtained without large vessel occlusion or stenosis. Patient required prolonged stay secondary to encephalopathy edema secondary to new CVAs, COVID, metabolic encephalopathy. Renal function improved following IV fluids. Blood pressure regimen was titrated up former she no longer required IV medications. She was seen by PT and OT with recommendations for rehab. Family declined wanting to take patient home. Patient will be discharged on 21 day therapy dual antiplatelets followed by aspirin monotherapy. Discharge was delayed secondary to holiday difficulty with coordination of home care. Family choosing to pursue home care from primary outpatient. Patient had dysphagia which improved prior to discharge patient was able to eat normal diet."

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 13,0
Labordaten: Covid PCR dectected on 12/20/2022
Aktuelle Erkrankungen: -
Vorgeschichte: Cardiovascular HTN, Benign* (401.1) Cerebrovascular accident (CVA) due to embolism of carotid artery (HCC) Integumentary Tinea capitis (110.0) Alopecia Other DISORDER, TOBACCO USE (305.1) Acute encephalopathy Hypertensive encephalopathy
Andere Medikamente: amLODIPine (NORVASC) 10 mg tablet Take 1 tablet by mouth daily. aspirin (LOW DOSE ASA) 81 mg chewable tablet Take 1 tablet by mouth daily. atorvastatin (LIPITOR) 40 mg tablet Take 1 tablet by mouth nightly. cloNIDine (CATAPRES-TTS-1) 0.
Allergien: No Know Allergies
Vorherige Impfungen: -

VAERS 2561134

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: CT
Alter: 18,0
Geschlecht: M
Eingang: 16.01.2023
Impfdatum: 03.04.2021
Beginn: 12.12.2022
Tage bis Beginn: 618,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Anticoagulant therapy Blood test Computerised tomogram thorax abnormal Fibrin D dimer Pelvic venous thrombosis Pulmonary embolism Scan abdomen abnormal

Symptomtext

12/12/22 diagnosed with unprovoked Pulmonary Embolism and Iliac DVT. survived. On blood thinners for life.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 3,0
Labordaten: D dimer, blood work, CT chest scan, Abdomen scan,
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 2554216

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 58,0
Geschlecht: M
Eingang: 07.01.2023
Impfdatum: 12.04.2021
Beginn: 25.11.2022
Tage bis Beginn: 592,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Cardiac arrest Death

Symptomtext

Narrative: Patient died on 11/25/2022 at hospital after self presenting to ER on 11/25/22 with Diagnosis: cardiac arrest on same day 11/25/2022. Pt had received a covid vaccine (J&J) EUA on 4/12/2021. Vaccine is unrelated to this patient's death. Reporting this since vaccine is EUA status.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2525220

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 76,0
Geschlecht: M
Eingang: 07.12.2022
Impfdatum: 12.05.2021
Beginn: 23.11.2021
Tage bis Beginn: 195,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Intensive care Metastatic neoplasm Multiple organ dysfunction syndrome

Symptomtext

Narrative: Inpatient died during MICU car with consulting palliative care inpatient visit at hospital. Patient died on Nov 23,2022@02:00 while inpatient. Death was caused by: Multiorgan failure due to metastatic cancer Reporting this since pt had received an EUA vaccine for covid-19 vaccine EUA (J&J) on 5/12/2021. THIS DEATH IS NOT RELATED TO THE COVID VACCINE.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2508609

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 83,0
Geschlecht: M
Eingang: 15.11.2022
Impfdatum: 31.08.2021
Beginn: 01.01.2022
Tage bis Beginn: 123,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Chest X-ray abnormal Death Dyspnoea Intensive care Nausea Pneumonia Vomiting

Symptomtext

pt brought to hosp via EMS with increasing SOB; O2 saturation 50% on RA; c/o nausea and vomiting; O2 supplementation; CXR showed bilateral pneumonia; transferred to ICU; given Remdesivir, dexamethasone, baricitinib, zinc, vitamin D, ABX; pt transitioned to DNR and eventually comfort care; pt passed away in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 6,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2500579

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge 042A21A

kritisch

Staat: MI
Alter: 81,0
Geschlecht: M
Eingang: 07.11.2022
Impfdatum: 04.08.2022
Beginn: 24.10.2022
Tage bis Beginn: 81,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Anticoagulant therapy Aortic valve incompetence Atrial fibrillation Atrial flutter Blood pressure decreased COVID-19 COVID-19 pneumonia Chest X-ray abnormal Computerised tomogram thorax abnormal Cough Echocardiogram normal Ejection fraction normal Hypotension Imaging procedure abnormal Intensive care Left atrial volume increased Left ventricular hypertrophy

Symptomtext

Discharge Provider: MD Admission Date: 10/24/2022 Discharge Date: Nov 4, 2022 PRESENTING PROBLEM: Febrile illness [R50.9] Cough, unspecified type [R05.9] COVID-19 [U07.1] COVID [U07.1] HOSPITAL COURSE: Patient is an 81 year-old male with PMH T2DM on insulin, CKD3b, COPD on 2L, Diastolic Heart Failure (EF 61%), Alzheimer's, Squamous cell carcinoma of RLL of lung s/p resection, chemotherapy, and radiation, and recent ICU admission for bacterial pneumonia who presented with fever and cough. On arrival to ED, he was found to be febrile, tachycardic, hypotensive. Pressures did not improve with fluids and vasopressors were started. COVID testing returned positive. Thoracic imaging showed bilateral infiltrates as well as subsegmental PE (no RH strain on echo). He was started on heparin, IV vancomycin and Zosyn, decadron, and remdesivir and admitted to the ICU. MRSA nares was negative so vancomycin was discontinued. He was quickly weaned off pressors and oxygenation improved, transferred to gen med floor 10/25. Able to wean oxygen to room air however patient refuses pulse oximetry as well and is noncompliant with his nasal cannula so unclear if maintaining oxygen saturation. Developed Afib/flutter 10/30 with rates up to 150-160. Improved with IV metoprolol 5 x2 however BP dropped to 80s/60s. Improved with 1L LR. Cardiology recommended Toprol, patient currently on 12.5 2 times a day Septic Shock Present on admission now resolved Suspected superimposed bacterial pneumonia: Multifocal pneumonia greatest involving in right lower lobe noted on CT: CXR concerning for pneumonia with initial shock req pressors Completed 5 day course of Zosyn COVID Pneumonia Acute on chronic respiratory failure COVID+ on 10/24. Recent ICU admission for bacterial pneumonia. CXR shows small bilateral effusions and multifocal infiltrates. - Continue Decadron 6mg once daily for total of 10 days - Completed remdesivir course - CURRENTLY ON ROOM AIR

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 11,0
Labordaten: -
Aktuelle Erkrankungen: Admission from 10/7/2022-10/12/2022 at Hospital Discharge Provider: DO Primary Care Provider at Discharge: None Admission Date: 10/7/2022 Discharge Date: 10/12/2022 PRESENTING PROBLEM: Severe sepsis (HCC) [A41.9, R65.20] SIRS (systemic inflammatory response syndrome) (HCC) [R65.10] Septic shock (HCC) [A41.9, R65.21] Community acquired bacterial pneumonia [J15.9] HOSPITAL COURSE: Patient is an 81 y.o. male h/o O2 dep COPD, lung CA - squamous cell carcinoma RLL, tobacco abuse, monoclonal gammopathy, HTN, dyslipidemia and dementia. Presented from assisted living with tachypnea, tachycardia, and changes to his speech and mentation and also reporting cough. He was noted to be hypotensive and some increasing consolidation in Right lung base. He was admitted to ICU for septic shock however never required pressors. Vanc Zosyn de-escalated to Rocephin - MRSA negative. PT/OT recommended return to ALF. Speech therapy recommended dysphagia diet and ongoing therapy. On 10/10 he was noted to have episode of tachycardia - SVT vs A. Flutter/fib. TTE revealed EF 61%, mild AR, mild LVH, LA volume mildly increased. History reviewed and questionable history of afib in the past. Had planned to discharge patient with Zio however was discharged prior to this being arranged. Would recommended consideration of Zio outpatient to evaluate burden and be able to further discuss stroke risk with patient's family. Discussed with a patient's son/DPOA and would recommend ASA 81. On day of discharge, patient felt well and denied complaint. He completed 5 day course of antibiotics. He is to continue dysphagia diet. Insulin was adjusted (decreased to 16 units) and can be adjusted outpatient. He was discharged back to ALF in improving condition. CBC and BMP recommended in 1 week.
Vorgeschichte: Emphysema of lung (HCC) Obstructive sleep apnea Acute respiratory failure with hypoxia (HCC) Bronchiectasis without complication (HCC) Malignant neoplasm of lower lobe of right lung (HCC) Chronic respiratory failure with hypoxia (HCC) On home oxygen therapy Community acquired bacterial pneumonia Pneumonia due to COVID-19 virus Essential hypertension Systolic murmur Acute pulmonary embolism without acute cor pulmonale (HCC) Chronic diastolic heart failure (HCC) AF (paroxysmal atrial fibrillation) (HCC) Dysphagia Chronic venous stasis dermatitis Left leg weakness Senile nuclear cataract, bilateral Nicotine use disorder Dementia (HCC) Late onset Alzheimer's disease without behavioral disturbance (HCC) Type 2 diabetes mellitus with stage 3b chronic kidney disease, with long-term current use of insulin (HCC) Chronic kidney disease (CKD), stage III (moderate) (HCC) Hyperlipidemia, unspecified hyperlipidemia type Gammopathy, monoclonal Shock (HCC) Restless leg syndrome Cervical stenosis of spinal canal Spinal stenosis of lumbar region without neurogenic claudication Myopia of both eyes Ventral hernia without obstruction or gangrene Abdominal wall mass of right upper quadrant History of lung cancer
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet albuterol (PROVENTIL, VENTOLIN, PROAIR) 108 (90 Base) MCG/ACT inhaler allopurinol (ZYLOPRIM) 100 MG tablet amiodarone (PACERONE) 200 MG tablet amiodarone (PACERONE) 400 MG tablet apixaban starter pack (
Allergien: Simvastatin
Vorherige Impfungen: -

VAERS 2493796

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 78,0
Geschlecht: M
Eingang: 26.10.2022
Impfdatum: 12.04.2021
Beginn: 10.10.2022
Tage bis Beginn: 546,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anaemia Cardiac failure acute Death Osteoarthritis

Symptomtext

Narrative: Patient received a covid vaccine EUA (J&J) on 4/12/2021. Pt died on 10/10/2022. Pt recently had new diagnosis of acute on chronic heart failure (9/23/22) not included in his problem list yet. Pt had the following issues in medical chart problem list: Active Problems ---------------------------- 22 Active Problems PROBLEM LAST MOD PROVIDER Anemia (SCT 271737000) (ICD-10-CM D64.9) 06/15/2022 OA - Osteoarthritis of hip (SCT 239872002) 04/29/2022 (ICD-10-CM M16.9) History of gastrointestinal bleed (SCT 03/15/2022 275551007) (ICD-10-CM Z87.19), Onset 07/00/2016 Lumbar spinal stenosis (SCT 18347007) (ICD-10-CM 04/28/2021 M48.061) Proliferative retinopathy with retinal edema due 11/19/2020 to type 2 diabetes mellitus (SCT 97341000119105) (ICD-10-CM E11.3519) Chronic kidney disease stage 5 (SCT 433146000) (08/21/2020) (ICD-10-CM N18.5) Neck pain (SCT 81680005) (ICD-10-CM M54.12) 09/21/2018 Seen by palliative care service (SCT 441874000) 09/13/2018 (ICD-10-CM Z51.5) History of total knee arthroplasty (SCT 03/18/2019 1211000119105) (ICD-10-CM R69.), Onset 00/00/2016 1. Left 2016 2. Right 3/14/2019 Hyperparathyroidism due to renal insufficiency 08/09/2018 (SCT 19034001) (ICD-10-CM N25.81) Venous insufficiency of leg (SCT 234050002) 05/23/2018 (ICD-10-CM I87.2) Gout (SCT 90560007) (ICD-10-CM M10.9) 03/30/2018 Illicit due use (SCT 307052004) (ICD-10-CM 08/09/2017 R69). Marijuana Osteoarthritis of right knee joint (SCT 06/07/2017 323321000119100) (ICD-10-CM M17.11) H/O: rheumatoid arthritis (SCT 161567008) 06/07/2017 (ICD-10-CM M06.9) Coronary arteriosclerosis (SCT 53741008) 06/17/2017 (ICD-10-CM I25.10) Hyperlipidemia (SCT 55822004) (ICD-10-CM E78.5) 11/17/2016 Cerebral infarction (SCT 432504007) (ICD-10-CM 11/17/2016 Z86.73) (ICD-10-CM N18.4); Chronic kidney disease stage 12/04/2017 4 due to hypertension (SNOMED CT 129151000119102) (ICD-10-CM M19.041); Osteoarthrosis of hand 04/05/2016 (SNOMED CT 22193007) (ICD-10-CM E11.65); Diabetic stage 3 chronic 01/12/2016 renal impairment due to type 2 diabetes mellitus (SNOMED CT 731000119105) (ICD-10-CM I10.); Benign hypertension (SNOMED CT 01/12/2016 10725009) Likely covid vaccine EUA (J&J) is not related to this pt's death given long length of time between date of vaccine & date of death.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2488346

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 89,0
Geschlecht: F
Eingang: 25.10.2022
Impfdatum: 03.05.2021
Beginn: 20.05.2022
Tage bis Beginn: 382,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Death Fracture pain General physical health deterioration Hypophagia Lethargy SARS-CoV-2 test positive Sluggishness

Symptomtext

pt had a positive COVID test on 5/20/22; at Rehab Center; pt declined since diagnosed with COVID; lethargic, sluggish, in pain due to previous fractures; poor oral intake; pt passed away

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: COPD, HLD, DEMENTIAL CARDIAC MURMUR
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2467299

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MI
Alter: 75,0
Geschlecht: M
Eingang: 03.10.2022
Impfdatum: 30.04.2021
Beginn: 23.09.2022
Tage bis Beginn: 511,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Aspiration pleural cavity COVID-19 Cardiac failure acute Chronic obstructive pulmonary disease Condition aggravated Cough Dyspnoea Dyspnoea exertional Gastrointestinal haemorrhage Hypotension Laboratory test abnormal Pleural effusion Polyuria Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive Sputum increased

Symptomtext

Discharge Provider: DO Primary Care Provider: DO Admission Date: 9/23/2022 Discharge Date: 10/3/2022 PRESENTING PROBLEM: Pleural effusion Hypoxia Acute respiratory failure with hypoxia (HCC) Hypotension, unspecified hypotension type Gastrointestinal hemorrhage, unspecified gastrointestinal hemorrhage type COVID-19 HOSPITAL COURSE: Patient is a 76 y.o. male with PMH of coronary artery disease, chronic AFib, COPD, chronic systolic heart failure, ischemic cardiomyopathy, CABG. recurrent right pleural effusions who presented on 9/23 with shortness of breath. A few days before admission he noticed that with exertion he was more winded than usual. He thought he had allergies because he had rhinorrhea, coughing, increased sputum, congestion with no fevers. He usually wears 2L at night, but started needing oxygen during the day as well. COVID test was positive. During admission, he was treated for acute hypoxic respiratory failure secondary to COVID, COPD exacerbation, right pleural effusion, and acute on chronic heart failure. His symptoms dramatically improved with IV diuresis, decadron, remdesivir. Thoracentesis with performed, showing exudative fluid. Additionally, the patient was seen by the wound care team regarding lower extremity wounds. ABI was abnormal. Vascular saw the patient and recommended compression stockings with outpatient follow up. Pt diuresed well throughout his hospital stay, with his oxygen needs returning to baseline. The pt has a new estimated dry weight of 97.5 kg. The pt was previously on Warfarin for a-fib. Consideration was given to transitioning to Eliquis, for which the patient was agreeable. After discussion with pulmonology, who is planning to perform a thoracoscopy on 10/5, the pt was instructed to start this after the procedure. Will hold all anticoagulation per pulmonary recommendations (no warfarin, Eliquis, or ASA) until post procedure. The pt's torsemide was decreased from 20mg BID to 20mg once daily as he continued to have diuresis on day of discharge. His potassium was decreased to once daily. His home losartan was also decreased to 12.5 mg daily, and was continued for the cardioprotective remodeling benefits. Pt discharged to SAR on 10/3 in stable condition.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 10,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: PVD (peripheral vascular disease) with claudication (HCC) Chronic atrial fibrillation (HCC) CAD (coronary artery disease) COPD (chronic obstructive pulmonary disease) (HCC) Ischemic cardiomyopathy Recurrent right-sided pleural effusion Benign prostatic hyperplasia with lower urinary tract symptoms Gastroesophageal reflux disease without esophagitis Hyperlipidemia Venous insufficiency (chronic) (peripheral) Prsnl hx of TIA (TIA), and cereb infrc w/o resid deficits Hypertension Anemia Leg wound, left Dependence on supplemental oxygen Insomnia, unspecified Polyosteoarthritis, unspecified Chronic constipation Other chronic pain Ulcer of left lower leg (HCC) Personal history of nicotine dependence Left-sided low back pain with left-sided sciatica Lumbar discogenic pain syndrome Lumbar spondylolysis Chronic ulcer of left leg with fat layer exposed (HCC)
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler apixaban (ELIQUIS) 5 MG tablet atorvastatin (LIPITOR) 20 MG tablet budesonide/formoterol (SYMBICORT) 160-4.5 MCG/ACT
Allergien: Seasonal
Vorherige Impfungen: -

VAERS 2449621

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MI
Alter: 79,0
Geschlecht: M
Eingang: 17.09.2022
Impfdatum: 06.05.2021
Beginn: 22.07.2022
Tage bis Beginn: 442,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Asthenia Blood creatine phosphokinase Blood creatine phosphokinase increased Blood creatinine Blood creatinine increased Blood sodium Blood sodium increased COVID-19 Cardiac monitoring Cardiac monitoring abnormal Chest X-ray Chest X-ray normal Chronic obstructive pulmonary disease Condition aggravated Hypoxia Pneumonia SARS-CoV-2 test

Symptomtext

PNEUMONIA; ACUTE RESPIRATORY FAILURE; HYPOXIA; COVID-19; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; CONDITION AGGRAVATED; TACHYCARDIA; CHEST X-RAY NORMAL; SARS-COV-2 TEST POSITIVE; CARDIAC MONITORING ABNORMAL; BLOOD SODIUM INCREASED; BLOOD CREATININE INCREASED; BLOOD CREATINE PHOSPHOKINASE INCREASED; ASTHENIA; This spontaneous report received from a health care professional by a Regulatory Authority VAERS (Vaccine Adverse Event Reporting System) concerned a 79 year old male of unspecified race and ethnicity. The patient's height, and weight were not reported. The patient's past medical history included: covid-19, and concurrent conditions included: gammopathy, monoclonal COPD, obstructive sleep apnea, Type 2 diabetes mellitus, stage 3 chronic kidney disease, acute respiratory failure with hypoxia, hypoxia, restless leg syndrome, essential hypertension, hyperlipidemia (unspecified hyperlipidemia type), bronchiectasis without complication, chronic venous stasis dermatitis, left leg weakness, cervical stenosis of spinal canal, spinal stenosis of lumbar region without neurogenic claudication, senile nuclear cataract bilateral, myopia of both eyes, malignant neoplasm of lower lobe of right lung, chronic respiratory failure with hypoxia, systolic murmur, nicotine use disorder, on home oxygen therapy, ventral hernia without obstruction or gangrene, abdominal wall mass of right upper quadrant, dementia, late onset Alzheimer's disease without behavioral disturbance, tobacco use and pneumonia, and other pre-existing medical conditions included: The patient had no current illness at the time of vaccination. The patient experienced myalgia when treated with simvastatin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin was not reported, batch number: 042A21A, expiry: unknown) dose was not reported, 1 total, administered on 06-MAY-2021 for unknown indication. The drug was associated with Batch and lot tested and found within specifications. Age at time of vaccination 79 years old. Latency period was 442 days. Concomitant medications included allopurinol, clobetasol propionate/gentamicin sulfate/miconazole nitrate, colecalciferol, fluticasone propionate, paracetamol, blood glucose monitoring supplement MISC, and salbutamol used for unknown indication. On 22-JUL-2022, the patient experienced pneumonia [J18 9] weakness [R53 1] COPD (chronic obstructive pulmonary disease) exacerbation [J44 1] Acute respiratory failure with hypoxia [J96 01] COVID-19 [U07 1]. He had a dementia who presented after he was found on the floor by daughter. Evaluation in the emergency department revealed the patient was positive for COVID-19 and Chest x-ray was negative. Patient had mild hypoxia on ambulation down to 88 percent and was placed on 2 L of oxygen. He had elevated creatinine, CPK and sodium. He was started on IV fluids and was admitted to hospital on same day for further management. Patient was started on Decadron 6 mg daily. His oxygen was weaned of quickly and creatinine improved back to his baseline chronic kidney disease stage 3. He was evaluated by PT (Physiotherapist) and OT (Occupational therapist) who recommended discharge to subacute rehab. He had a 15 minute episode of tachycardia into the 150s to 160s that reverted back to normal sinus rhythm spontaneously. Cardiac monitoring was continued and he had no further episodes of tachycardia. He was discharged to SAR in stable condition on 2 L supplemental O2 via NC (nasal cannula). He was discharged on 02-AUG-2022. Number of days of hospitalization was 11 days. Laboratory data included: Blood creatine phosphokinase increased, Blood creatinine increased, Blood sodium increased, Cardiac monitoring abnormal, Chest X-ray normal, and SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) test Positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from acute respiratory failure, asthenia, blood creatine phosphokinase increased, blood creatinine increased, blood sodium increased, covid-19, cardiac monitoring abnormal, chest x-ray normal, chronic obstructive pulmonary disease, condition aggravated, hypoxia, pneumonia, sars-cov-2 test positive, and tachycardia. This report was serious (Hospitalization Caused / Prolonged). This report was associated with product quality complaint: 90000247430. The suspected product quality complaint has been confirmed to be batch and lot tested and found within specifications, the reported allegation was not confirmed and the root cause was determined to be not manufacturing related based on the PQC evaluation/investigation performed. Additional information was received from department on 07-SEP-2022. The following information was updated and incorporated in to the case narrative: product quality complaint investigation result.; Sender's Comments: V1:Follow up information in this version updates, product quality complaint investigation result. This updated information does not change the causality of the previously reported events. 20220844562-covid-19 vaccine ad26.cov2.s -Pneumonia, acute respiratory failure, hypoxia, covid-19, chronic obstructive pulmonary disease, condition aggravated, tachycardia, chest x-ray normal, sars-cov-2 test positive, cardiac monitoring abnormal, blood sodium increased, blood creatinine increased, blood creatine phosphokinase increased, asthenia. The event(s) shows an incompatible temporal relationship. Therefore, this event(s) is considered not related.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 11,0
Labordaten: Test Date: 20220722; Test Name: BLOOD CREATINE PHOSPHOKINASE; Result Unstructured Data: increased; Test Date: 20220722; Test Name: BLOOD CREATININE; Result Unstructured Data: increased; Test Date: 20220722; Test Name: SARS-COV-2 TEST; Test Result: Positive ; Test Date: 20220722; Test Name: CARDIAC MONITORING; Result Unstructured Data: abnormal; Test Date: 20220722; Test Name: CHEST X-RAY; Result Unstructured Data: normal; Test Date: 20220722; Test Name: BLOOD SODIUM; Result Unstructured Data: increased
Aktuelle Erkrankungen: Abdominal wall mass; Acute respiratory failure; Alzheimer's disease; Bronchiectasis; Cervical spinal stenosis; Chronic kidney disease; COPD; Dementia; Essential hypertension; Gammopathy; Hyperlipidemia (unspecified hyperlipidemia type); Hypoxia; Hypoxic respiratory failure; Lower extremities weakness of; Lung neoplasm malignant; Myopia; Nicotine addiction; Nuclear senile cataract; Obstructive sleep apnea syndrome; Oxygen therapy; Pneumonia; Restless leg syndrome; Spinal stenosis of lumbar region; Stasis dermatitis; Systolic murmur; Tobacco user; Type II diabetes mellitus; Ventral hernia
Vorgeschichte: Medical History/Concurrent Conditions: COVID-19; Comments: The patient had no current illness at the time of vaccination.
Andere Medikamente: ACETAMINOPHEN; VENTOLIN [SALBUTAMOL]; TYLENOL [PARACETAMOL]; ALBUTEROL [SALBUTAMOL]; PROVENTIL [SALBUTAMOL]; PROAIR [FLUTICASONE PROPIONATE]; MCG; ALLOPURINOL; ZYLOPRIM; CHOLECALCIFEROL; VITAMIN D3; MCG
Allergien: -
Vorherige Impfungen: -

VAERS 2424061

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

kritisch

Staat: MI
Alter: 62,0
Geschlecht: F
Eingang: 30.08.2022
Impfdatum: 20.11.2021
Beginn: 29.08.2022
Tage bis Beginn: 282,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Abdominal distension Acute respiratory failure Body temperature increased COVID-19 Chest pain Cough Dyspnoea Electrocardiogram Fluid intake reduced Nausea Oxygen saturation decreased Productive cough SARS-CoV-2 test positive Tachypnoea Vomiting

Symptomtext

Patient arrives with EMS with a chief complaint of shortness of breath. Patient uses a home air concentrator and her sat at home was 92%. Patient arrives tachypneic. Patient is speaking in full sentences patient says that she has had shortness of breath for 2 days today she has had nausea vomiting and cannot keep water down. She had chest pain, which was worse earlier and now she only rates it as a 6 out of 10. Patient denies diarrhea. Patient has had low-grade temps, she has 99.1 here. Patient has an obviously enlarged abdomen and she attributes this to her hernia. Patient lives with her daughter in a second floor apartment. Patient tested positive for COVID earlier today. Patient has past medical history of COPD, hernia, Panic disorder coronary artery disease peripheral vascular disease CHF dyslipidemia hypertension diabetes seizures. Patient has past surgical history of 5 cardiac stents and a pacemaker, hernia repair Pt is a smoker of tobacco and denies alcohol Associated Symptoms: chest pain, cough, nausea, shortness of breath, sputum, vomiting

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 2,0
Labordaten: o ED Clinical Course EKG shows sinus at 95 1845 hours pt room air sat 989% and she was becoming more labored and we put her on 2 L NC again case DW Dr. and accepted for acute respiratory failure as her oxygen saturation was going down to 89% and she was becoming more labored in breathing as we are trialing her Patient agrees to stay
Aktuelle Erkrankungen: unknown
Vorgeschichte: COPD, PVD, CHF
Andere Medikamente: unknown
Allergien: baclofen, bactrim, tetracycline, erythromycin
Vorherige Impfungen: -

VAERS 2430918

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 76,0
Geschlecht: M
Eingang: 27.08.2022
Impfdatum: 28.04.2021
Beginn: 08.07.2022
Tage bis Beginn: 436,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Frontotemporal dementia

Symptomtext

Narrative: 76yo male died in hospice care with Medical Diagnosis: Other Frontotemporal Dementia on 7/8/2022. Pt had received a covid J&J vaccine EUA on 4/28/2021. Likely this death is not related to the vaccine given hospice care at end of life and lont time between date of vaccine and date of death.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2413538

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 47,0
Geschlecht: M
Eingang: 17.08.2022
Impfdatum: 11.05.2021
Beginn: 01.01.2022
Tage bis Beginn: 235,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute kidney injury Acute respiratory failure COVID-19 Cardiac arrest Cardio-respiratory arrest Chest X-ray abnormal Cough Death Dyspnoea Endotracheal intubation Intensive care Multiple organ dysfunction syndrome Respiratory disorder Resuscitation SARS-CoV-2 test positive

Symptomtext

1/19/22 positive COVID test at a HCF; increasing SOB, fatigue, cough; 1/29/22 pt to hospital; CXR showed possible pulmonary edema or atypical infection; 69% O2 saturation on RA; AHRF; O2 supplementation; Dexamethasone, Remdesivir, Rocephin; transferred to ICU; AKI; intubated; respiratory status worsened; multiorgan failure; code blue called; multiple rounds of CPR; asystole; pt passed away in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 9,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: OBESITY
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2405685

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MI
Alter: 79,0
Geschlecht: M
Eingang: 09.08.2022
Impfdatum: 06.05.2021
Beginn: 22.07.2022
Tage bis Beginn: 442,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Asthenia Blood creatine phosphokinase increased Blood creatinine increased Blood sodium increased COVID-19 Cardiac monitoring abnormal Chest X-ray normal Chronic obstructive pulmonary disease Condition aggravated Hypoxia Pneumonia SARS-CoV-2 test positive Tachycardia

Symptomtext

Discharge Provider: MD Primary Care Provider: DO Admission Date: 7/22/2022 Discharge Date: 8/2/2022 PRESENTING PROBLEM: Pneumonia [J18.9] Weakness [R53.1] COPD exacerbation [J44.1] Acute respiratory failure with hypoxia [J96.01] COVID-19 [U07.1] HOSPITAL COURSE: 81-year-old male past medical history of lung cancer status post resection and chemotherapy, chronic obstructive pulmonary disease with active tobacco use, dementia, who presented after he was found on the floor by daughter. Evaluation in the emergency department revealed the patient was positive for COVID-19. Chest x-ray was negative. Patient had mild hypoxia on ambulation down to 88% and was placed on 2 L of oxygen. He had elevated creatinine, CPK, and sodium. He was started on IV fluids and was admitted for further management. Patient was started on Decadron 6 mg daily. His oxygen was weaned of quickly. His creatinine improved back to his baseline chronic kidney disease stage 3. He was evaluated by PT and OT who recommended discharge to subacute rehab. He had a 15 minute episode of tachycardia into the 150s to 160s that reverted back to normal sinus rhythm spontaneously. Cardiac monitoring was continued and he had no further episodes of tachycardia. He was discharged to SAR in stable condition on 2L supplemental O2 via NC.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 11,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Gammopathy, monoclonal COPD (chronic obstructive pulmonary disease) Obstructive sleep apnea Type 2 diabetes mellitus with stage 3 chronic kidney disease Acute respiratory failure with hypoxia Restless leg syndrome Essential hypertension Hyperlipidemia, unspecified hyperlipidemia type Bronchiectasis without complication Chronic venous stasis dermatitis Left leg weakness Cervical stenosis of spinal canal Spinal stenosis of lumbar region without neurogenic claudication Senile nuclear cataract, bilateral Myopia of both eyes Malignant neoplasm of lower lobe of right lung Chronic respiratory failure with hypoxia Systolic murmur Nicotine use disorder On home oxygen therapy Ventral hernia without obstruction or gangrene Abdominal wall mass of right upper quadrant Dementia Late onset Alzheimer's disease without behavioral disturbance Pneumonia COVID-19
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet albuterol (PROVENTIL, VENTOLIN, PROAIR) 108 (90 Base) MCG/ACT inhaler allopurinol (ZYLOPRIM) 100 MG tablet Blood Glucose Monitoring Suppl MISC cholecalciferol (VITAMIN D3) 25 MCG (1000 UT) tablet C
Allergien: Simvastatin-Myalgia
Vorherige Impfungen: -

VAERS 2399213

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 91,0
Geschlecht: M
Eingang: 02.08.2022
Impfdatum: 01.06.2021
Beginn: 01.01.2022
Tage bis Beginn: 214,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Death General physical health deterioration Respiratory distress SARS-CoV-2 test positive Tachypnoea Use of accessory respiratory muscles

Symptomtext

pt had a positive COVID test on 1/27/22 and was hospitalized at Hospital; pt is a DNR; admitted to Hospice of Care Center, 1/28/22; pt's condition worsened since admission for COVID and respiratory distress; tachypnea; accessory muscle use; comfort care only; pt passed away in hospice

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: ASTHMA, ARF, PTE
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2397690

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: TN
Alter: 69,0
Geschlecht: F
Eingang: 31.07.2022
Impfdatum: 07.04.2021
Beginn: 06.02.2022
Tage bis Beginn: 305,0
Dosis: 1
Route/Site: SYR / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Atrial fibrillation Brain oedema Cardiac failure congestive Chest X-ray abnormal Computerised tomogram head abnormal Death Dyspnoea Fall General physical health deterioration Intracranial mass Lung infiltration Pneumonia

Symptomtext

History of hypertension, diabetes, CDPD, lung cancer with recent finding of METS to the brain presented to Regional hospital on 02/06/2022 with worsening SOB. She was found to be in AFib RVR and was treated with Cardizem. Chest x-ray showed bibasilar interstitial and alveolar infiltrates, CHF versus pneumonia with: small bilateral allusions. She was treated with Lasix, started on Levaquin today. Unfortunately on 2/9 she fell. CT of the head without contrast showed right temporal lobe mass, decreased in size. and decreasing cerebral edema in the right temporal lobe, but no acute findings from the fall. Patient continued to decline and expired on 02/13/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 7,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2379161

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 71,0
Geschlecht: M
Eingang: 22.07.2022
Impfdatum: 01.04.2021
Beginn: 01.09.2021
Tage bis Beginn: 153,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute respiratory failure COVID-19 Death Dyspnoea General physical health deterioration Positive airway pressure therapy SARS-CoV-2 test positive

Symptomtext

pt admitted to hospital with SOB; found to be positive for COVID; acute respiratory failure secondary to COVID; given steroids, zinc, Vitamin C, Remdesivir, ABX; O2 supplementation - BiPAP; pt's condition continued to worsen despite aggressive measures; pt passed away in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: DMT2
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2374667

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: -
Geschlecht: U
Eingang: 20.07.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Alanine aminotransferase increased Aspartate aminotransferase increased Blood creatinine increased Blood lactate dehydrogenase increased Blood lactic acid C-reactive protein increased COVID-19 Chest X-ray normal Cough Dyspnoea Fibrin D dimer normal Hepatic steatosis Inflammatory marker increased Oropharyngeal pain Pain Pneumonia bacterial Procalcitonin

Symptomtext

Pt presented to ED complaining of cough and shortness of breath. Patient's symptoms started on Friday 1/7. His had some fever, generalized body aches, sore throat, shortness of breath. He tested positive for COVID-19 on 01/10/2021. Patient's acute hypoxemic respiratory failure was secondary to COVID-19 and likely superimposed bacterial pneumonia. Patient received 2 days of Remdesivir, 3 days of doxy, 3 days of Rocephin while in the hospital. Due to his bilateral central serous core urine output the patient is to strictly avoid corticosteroids. Patient remained stable on oxygen and was able to go home with it. Although he had elevated inflammatory markers due to covid his D-dimer was within normal limits. Patient was incidentally noted to have bilateral renal cysts and hepatic steatosis. Patient remained hemodynamically stable throughout hospital stay and was discharged in stable condition.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: Labs: Creatinine 2.4, ferritin level 1962 AST 59 ALT 51 troponin was negative lactic acid 1.0 LDH 271 CRP 11 procalcitonin 0.28 D-dimer was 278. COVID-19 was positive. Imaging: Chest x-ray was benign.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2370301

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 73,0
Geschlecht: M
Eingang: 14.07.2022
Impfdatum: 08.04.2021
Beginn: 18.06.2022
Tage bis Beginn: 436,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Cardiac arrest Death

Symptomtext

Narrative: 72yo male patient received a Covid healthcare professional vaccine (J&J) EUA on 4/8/2021. Pt died on 6/18/2022. Patient self-present to community emergency facility Emergency Notification Intake Date Presenting to the Facility: 06/18/2022 Chief Complaint: Cardiac Arrest Primary Diagnosis: Patient Admitted? No. ED/Death Note. Expired 6/18/2022 @ 2315 Appears death is not related to vaccine given long time between vaccine given and date of death from cardiac arrest.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2321481

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MI
Alter: 74,0
Geschlecht: F
Eingang: 16.06.2022
Impfdatum: 14.06.2021
Beginn: 10.04.2022
Tage bis Beginn: 300,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 COVID-19 pneumonia Chemotherapy Condition aggravated Hypoxia Plasma cell myeloma Platelet transfusion SARS-CoV-2 test SARS-CoV-2 test positive Sudden death Thrombocytopenia X-ray

Symptomtext

This spontaneous report received from a health care professional by a Regulatory Authority, Vaccine Adverse Event Reporting System (VAERS Inbound Unit) concerned a 74 year old female of an unspecified race and ethnicity. The patient's height, and weight were not reported. The patient's past medical history included: compression fracture of T12 (twelfth thoracic) vertebra, and deep vein thrombosis (DVT) of lower extremity, and concurrent conditions included: X-Ray showed lytic lesion of bone, malignancy breast, anxiety, depression, B12 deficiency, iron deficiency anemia due to chronic blood loss, anemia in stage 4 chronic kidney disease, lambda light chain myeloma, stage 3b chronic kidney disease, chemotherapy induced thrombocytopenia, leukopenia due to antineoplastic chemotherapy, severe protein calorie malnutrition, vitamin D deficiency, antineoplastic chemotherapy induced pancytopenia, refractory anemia with excess of blasts 1, failure to thrive in adult (FTT) and drug allergy (Flomax). The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: unknown) dose was not reported, single dose, 1 total administered on 14-JUN-2021 for an unspecified indication. Age at time of vaccination 74 years old. The latency was 303 days. Concomitant medications included colecalciferol, dexamethasone, fludrocortisone acetate, folic acid, lenalidomide, omeprazole, and venlafaxine hydrochloride. On 10-APR-2022, the patient had a COVID-19 PCR (polymerase chain reaction) test which detected Covid-19. On 13-APR-2022, the patient was admitted with Covid-19 pneumonia which quickly progressed to the need for HFNC (high flow nasal cannula) despite treatment with steroid. The patient experienced severe thrombocytopenia and was not safe to add anticoagulation despite platelet transfusion. The patient experienced advanced multiple myeloma (coded as plasma cell myeloma) and was on chemotherapy, condition aggravated and was sars-cov-2 (severe acute respiratory syndrome coronavirus 2) test positive. On 13-APR-2022, the patient had a sudden death and died from hypoxia. It was unknown if an autopsy was performed. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient died of sudden death, hypoxia, plasma cell myeloma, Covid-19 pneumonia, thrombocytopenia, Covid-19, condition aggravated, sars-cov-2 test positive, chemotherapy and platelet transfusion on 13-APR-2022. This report was serious (Death). This report was associated with a product quality complaint. The suspected product quality complaint has been confirmed to be the reported allegation was not confirmed and the root cause was determined to be not manufacturing related, batch and lot tested and found within specifications based on the product quality complaint evaluation/investigation performed. Additional information received from Complaint Department on 10-JUN-2022. The following information was updated and incorporated into the case narrative: Product quality complaint number and investigation result. Upon review, the following information was corrected: event level medically confirmed corrected to blank from yes. Sender's Comments: V2 Additional information in this version updates of Product quality complaint number and investigation result. Upon review, the following information was corrected: event level medically confirmed corrected to blank from yes. This updated information does not change the prior causality assessment of reported events. Covid-19 vaccine ad26.cov2.s- Sudden death, Covid-19 pneumonia, Covid-19, condition aggravated, sars-cov-2 test positive, Hypoxia, The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable. Covid-19 vaccine ad26.cov2.s-Plasma cell myeloma, chemotherapy. The event(s) shows an incompatible temporal relationship. Therefore, this event(s) is considered not related. (Additionally patient has medical history of light chain Myeloma). Covid-19 vaccine ad26.cov2.s-Thrombocytopenia, platelet transfusion. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY. Therefore, this event(s) is considered not related.(Also patient has medical history of chemotherapy induced thrombocytopenia); Reported Cause(s) of Death: HYPOXIA.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Sudden death
Hospital-Tage: -
Labordaten: Test Date: 20220410; Test Name: COVID-19 PCR TEST; Result Unstructured Data: Covid; Test Date: 20220413; Test Name: SARS-COV-2 TEST; Test Result: Positive; Test Name: X-RAY; Result Unstructured Data: Lytic lesion of bone.
Aktuelle Erkrankungen: Anxiety; Blood loss of (NOS); Breast tumor malignant; Chronic kidney disease stage 3; Chronic renal failure anemia; Depression; Drug allergy (Flomax); Failure to thrive; Iron deficiency anemia; Leukopenia; Myeloma; Osteolytic lesion (On X-ray); Protein-calorie malnutrition; Refractory anemia with an excess of blasts; Secondary pancytopenia; Secondary thrombocytopenia; Vitamin B12 deficiency; Vitamin D deficiency
Vorgeschichte: Medical History/Concurrent Conditions: Compression of fractured vertebra; Thrombosis of leg deep venous
Andere Medikamente: Florinef; Folic Acid; Revlimid; Prilosec [Omeprazole]; Effexor; Vitamin D3; Decadron [Dexamethasone]
Allergien: -
Vorherige Impfungen: -

VAERS 2320331

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

kritisch

Staat: MI
Alter: 80,0
Geschlecht: F
Eingang: 15.06.2022
Impfdatum: 31.03.2021
Beginn: 27.01.2022
Tage bis Beginn: 302,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Death Extra dose administered SARS-CoV-2 test positive

Symptomtext

Pt. Deceased - Cant confirm in system. Johnson and Johnson Dose 3/31/2021 042a21a

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Positive COVID Test - 1/27/2022
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2320179

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 77,0
Geschlecht: M
Eingang: 15.06.2022
Impfdatum: 25.05.2021
Beginn: 02.06.2022
Tage bis Beginn: 373,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 77 yo male died on 6/2/2022 of unknown cause found at home by lawn care company at his residence. Pt had received a covid EUA vaccine (J&J) on 5/25/21. No info in chart regarding circumstances of pt's death. Past Medical History: Perforation of intestine (SCT 56905009) Colostomy bag changed (SCT 183209007) Renal failure (SCT 42399005) Recurrent urinary tract infection (SCT 197927001) Malnutrition (SCT 2492009) Gastroesophageal reflux disease (SCT 235595009) Cluster headache (SCT 193031009) Tobacco use (SCT 110483000) Anemia (SCT 271737000) Seen by palliative care medicine service (SCT 305824005) Postoperative peritonitis (SCT 427883005Pyelonephritis (SCT 45816000) Neck pain (SCT 81680005) Degeneration of cervical intervertebral disc (SCT 69195002) Mild cognitive disorder (SCT 386805003) Colonoscopy in 2003- normal. (ICD-9-CM 799.9) Osteopenia (ICD-9-CM 733.90) ACQUIRED (ICD-9-CM 727.03) Basal Cell Cancer (ICD-9-CM 173.9) Unspecified disorder of adrenal glands (ICD-9-CM 255.9) Headache (ICD-9-CM 784.0) Basal cell carcinoma - primary (ICD-9-CM 173.9) Benign essential hypertension (SCT 12010Hyperlipidemia (SCT 55822004) GERD (ICD-9-CM 530.81) Degeneration of lumbar intervertebral disc (SCT 26538006) Abdominal aortic aneurysm (SCT 233985008Anxiety reaction (SCT 48694002) Panic disorder without agoraphobia with Vitamin B12 deficiency (non anemic) (SCT 64117007) Chronic cluster headache (SCT 230473009)Kidney stone (SCT 95570007) Active problem list reviewed

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2287410

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: IL
Alter: 63,0
Geschlecht: M
Eingang: 20.05.2022
Impfdatum: 08.08.2021
Beginn: 10.05.2022
Tage bis Beginn: 275,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Acute respiratory failure COVID-19 Cardiomegaly Chest X-ray abnormal Chills Cough Dyspnoea Malaise Nasopharyngitis Nausea SARS-CoV-2 test positive

Symptomtext

Patient received J&J vaccine on 8/18/21. COVID positive on 5/10/22. PResented to ER on 5/11/22. Patient started to get sick last Wednesday with cough, cold, and some chills and on Monday which is 2 days ago he was diagnosed with COVID-19. He comes to the emergency room because of worsening shortness of breath and cough without any chest pain. Mild nausea. No vomiting. No diarrhea. Denies any bleeds or melenic stools. He was found to be quite hypoxemic with a PO2 of only 61 on room air. Chest x-ray did not reveal anything acute except for some mild increased size in the cardiac silhouette. The patient was given Lasix in the ER and then the hospitalist service called for admission. When I saw the patient, I discussed with him that he has acute hypoxemic respiratory failure secondary to COVID-19 and that he would benefit from Decadron, but the patient says he is "allergic to corticosteroids" and he is vehemently denying receiving any Solu-Medrol or any other oral or IV corticosteroids. The patient will be admitted as an inpatient to IMC unit with acute hypoxemic respiratory failure secondary to COVID-19. REceived remdesivir 200 mg x 1 and doxycycline. Discharged on 5/12/22.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 1,0
Labordaten: 5/10/22 COVID19: positive
Aktuelle Erkrankungen: -
Vorgeschichte: History of a dilated cardiomyopathy, mild combined CHF, obstructive sleep apnea, morbid obesity, history of AFib status post ablation x2 on chronic anticoagulation, GERD, osteoarthritis, remote history of alcohol abuse, history of SVT, hypertension, hyperlipidemia, hypothyroidism, COPD, erectile dysfunction, history of pulmonary hypertension, history of GERD, osteoarthritis, fibromyalgia, spinal stenosis, history of colonoscopy, history of lumbar laminectomy.
Andere Medikamente: Albuterol Sulfate 108 (90 Base) MCG/ACT 2 Puffs Inhalation EVERY 4 HOURS PRN Atorvastatin Calcium 40 mg Oral NIGHTLY Carvedilol 12.5 mg Oral 2 TIMES DAILY WITH MEALS Furosemide 40 mg Oral DAILY Glycopyrrolate-Formoterol 9-4.8 MCG/ACT 2
Allergien: predenisone and morphine
Vorherige Impfungen: -

VAERS 2286991

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: IA
Alter: 54,0
Geschlecht: M
Eingang: 20.05.2022
Impfdatum: 12.04.2021
Beginn: 26.11.2021
Tage bis Beginn: 228,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Aspartate aminotransferase increased Blood creatinine increased Blood glucose normal Blood urea increased CD4 lymphocytes decreased COVID-19 COVID-19 pneumonia Chest X-ray abnormal Cough Diarrhoea Dyspnoea Exposure to SARS-CoV-2 Fibrin D dimer increased Lung disorder Nausea Oxygen saturation decreased Pain

Symptomtext

COVID Vaccine Breakthrough CAse J&J Dose 4/12/21 (042A21A) COVID Positive 12/3/21 12/3/21: Patient is a 55-year-old male with a past medical history significant for HIV. The patient presents to the ED today with complaints of slight cough, worsening shortness of breath. Per the patient's medical documentation, his symptoms started 1 week ago. The patient's other accompanying symptoms include body aches, nausea, vomiting, diarrhea. The patient denies any fever, chills, chest pain. The patient had a known exposure to his family with COVID-19. The patient is vaccinated against COVID-19. The patient's oxygen saturation was 74% on room air upon arrival to the ED, the patient was placed on high-flow oxygen which improved patient's O2 saturations. The patient subsequently had an episode of desaturation on oxygen with respiratory distress which required being placed on BiPAP. The patient is currently at 40% FiO2 with a respiration rate of 26, the patient's oxygen saturation is 93%. Upon arrival to ED patient's temperature is 99.6?, heart rate 99, respirations 24, pulse ox 78% on room air, blood pressure 116/87. Chest x-ray revealed bibasilar airspace disease, suspicious for multifocal infection although volume overload can be a similar appearance. Patient's laboratory findings are significant for glucose 122, BUN 27, creatinine 1.67, AST 55, proBNP 221, D-dimer 1.31. Patient received 500 mg IV azithromycin and 6 mg IV Decadron in ED. 12/9/21: Admission diagnosis: Acute hypoxic respiratory failure secondary to COVID-19 pneumonia Rule out superimposed bacterial pneumonia, underlying immunosuppression, AIDS Patient is 55-year-old male with past medical history of HIV/AIDA on HAART, and CKD. He presented to the emergency room with complaint of cough and progressively worsening shortness of breath x 1 week. He had a known exposure to his family with COVID-19. Patient is fully vaccinated for COVID-19.Upon arrival to ED patient's temperature is 99.6?, heart rate 99, respirations 24, pulse ox 78% on room air, blood pressure 116/87. Chest x-ray revealed bibasilar airspace disease, suspicious for multifocal infection although volume overload can be a similar appearance. Patient's laboratory findings are significant for glucose 122, BUN 27, creatinine 1.67, AST 55, proBNP 221, D-dimer 1.31. CT chest with IV contrast was obtained which was negative for pulmonary embolism but revealed bilateral infiltrates. Patient was admitted for further management of acute hypoxic respiratory failure likely secondary to COVID-19 pneumonia with possible superimposed bacterial pneumonia. Patient was started with empiric IV antibiotic treatment. He also started with IV dexamethasone. Initially, remdesivir was held because of elevated creatinine. However, patient is on chronic prophylactic treatment with Bactrim which is known to increase creatinine without affecting kidney function. Kidney function improved with IV hydration. Later,he was started with IV remdesivir. Actemra was deferred as patient has severe M*Modal suppression from underlying AIDS with CD4 count of 78. Case was discussed with ID specialist Dr. Patient's respiratory status progressively improved. On day of discharge, he underwent home oxygen walk test and did require any supplemental oxygen. He is being discharged home with 4 more days of dexamethasone 4 mg p.o. daily. He will follow-up with his PMD in 1 week time. He was instructed to self isolate at home for 7 more days. He is being discharged home with COVID-19 home program.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 7,0
Labordaten: -
Aktuelle Erkrankungen: HIV AIDS insomnia PCP pneumonia
Vorgeschichte: HIV AIDS insomnia PCP pneumonia
Andere Medikamente: albuterol 2 puffs Q6h PRN Odefsey 1 tab PO QD Bactrim DS 1 tab PO QD trazodone 50 mg PO HS
Allergien: NKA
Vorherige Impfungen: -

VAERS 2273054

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MI
Alter: -
Geschlecht: M
Eingang: 12.05.2022
Impfdatum: -
Beginn: 28.05.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Abdominal distension Abdominal pain upper Blood test Gastrointestinal sounds abnormal Pulmonary embolism Ultrasound scan Venous thrombosis Weight increased

Symptomtext

THROMBOSIS OF THE RIGHT FEMORAL VEIN; PULMONARY EMBOLISM; PAIN ON RIGHT SIDE OF UPPER ABDOMEN UNDER RIB CAGE WHICH THEN APPEARED ON LEFT SIDE; STOMACH GROWLING; WEIGHT GAIN ABOUT 10 POUNDS; CONSTANT BLOATING; This spontaneous report received from a consumer concerned a 57 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: alcohol user (On DEC-2019 patient quit but started drinking again when COVID hit), smoker (1.5 pack (around 30) cigarettes per day), and asthma. The patient had no known allergies. The patient had no history of drug abuse or illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: 21-JUN-2021) dose was not reported, 1 total administered on 23-MAY-2021 to left arm for prophylactic vaccination. Concomitant medications included epinephrine (Primatene Mist) for asthma relief, apixaban (Eliquis), fluticasone furoate/umeclidinium bromide/vilanterol trifenatate (Trilegy Ellipta), and lovastatin. On 28-MAY-2021, the patient experienced difficulty breathing, constant bloating and pain on right side of upper abdomen under rib cage which made his stomach hurt much, but that subsided It was also reported that, the patient had pain at the upper right side of his abdomen, under his rib cage, that started going away but then appeared on his left side. On 01-JUN-2021, the patient had gone cold turkey thinking that his breathing problems were due to that fact that he was smoking. On 08-JUN-2021, one to two weeks after quitting to smoke, the patient experienced weight gain of about 10 pounds. On 12-JUN-2021, the patient was taken to the accident and emergency (A&E) department, was hospitalized and was diagnosed for pulmonary embolism after being seen by a cardiologist, pulmonologist and hematologist. The patient was treated with heparin. On 14-JUN-2021, the patient experienced thrombosis of the right femoral vein. Laboratory data included: Ultrasound scan (Doppler) (NR: not provided) thrombosis of right femoral vein (despite no swollen ankles) and no deep vein thrombosis (DVT) of left leg. On an unspecified date, the patient's upper right abdominal pain had gone away but had appeared on the left side. On 15-JUN-2021, the patient was discharged. The patient hospitalized for 3 days. On 24-SEP-2021, Laboratory data included: Blood test ordered by hematologist, showed presence of protein factor V. On an unspecified date in 2021, the patient was put on anti-reflux medication, even though he had no heartburn. On DEC-2021, the patient had stopped taking the anti-reflux medication. On 15-MAR-2022, the patient experienced stomach growling, which people could hear it from about 10 feet away. The patient stated that he would find it easier to breathe when laying down and that his breathing had not gotten any better. The patient further stated that he believed he was ineligible for the vaccine as he had protein factor 5, and also that his physician thought he had COPD (chronic obstructive pulmonary disease) due to him being an ex-smoker. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from stomach growling, constant bloating, and pulmonary embolism, and the outcome of weight gain about 10 pounds, pain on right side of upper abdomen under rib cage which then appeared on left side and thrombosis of the right femoral vein was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20220513847-Covid-19 vaccine ad26.cov2.s-pulmonary embolism, thrombosis of the right femoral vein, pain on right side of upper abdomen under rib cage which then appeared on left side. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 3,0
Labordaten: Test Date: 20210614; Test Name: Ultrasound scan; Result Unstructured Data: thrombosis of right femoral vein; Test Date: 20210924; Test Name: Blood test; Result Unstructured Data: presence of protein factor V
Aktuelle Erkrankungen: Alcohol use (The patient quit drinking in DEC-2019 and started drinking again when COVID hit.); Asthma; Smoker (The patient smoked 1.5 pack (around 30) cigarettes per day at the time of event. On 01-JUN-2021, he stopped smoking)
Vorgeschichte: Comments: The patient had no known allergies. The patient had no history of drug abuse or illicit drug use.
Andere Medikamente: ELIQUIS; TRELEGY ELLIPTA; LOVASTATIN; PRIMATENE MIST
Allergien: -
Vorherige Impfungen: -

VAERS 2241077

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MI
Alter: 74,0
Geschlecht: F
Eingang: 19.04.2022
Impfdatum: 14.06.2021
Beginn: 13.04.2022
Tage bis Beginn: 303,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 COVID-19 pneumonia Chemotherapy Condition aggravated Hypoxia Plasma cell myeloma Platelet transfusion SARS-CoV-2 test positive Sudden death Thrombocytopenia

Symptomtext

Patient with single J+J COVID vaccination 06/14/21 who admitted with COVID complications and died. Provider discharge note below: "75 YO female with advanced multiple myeloma on chemotherapy admitted with covid pneumonia. Quickly progressed to needing HFNC despite treatment with steroid. Due to severe thrombocytopenia, not safe to add anticoagulation (despite platelet transfusion). Patient died suddenly overnight due to hypoxia."

Weitere VAERSDATA-Felder

Praegender Schweregrund: Sudden death
Hospital-Tage: -
Labordaten: COVID detected PCR on 04/10/22.
Aktuelle Erkrankungen: -
Vorgeschichte: Lytic lesion of bone on x-ray HX, PERSONAL, MALIGNANCY, BREAST Anxiety and depression Compression fracture of T12 vertebra (*) B12 deficiency Iron deficiency anemia due to chronic blood loss Anemia in stage 4 chronic kidney disease (*) Lambda light chain myeloma (*) Stage 3b chronic kidney disease (*) Chemotherapy-induced thrombocytopenia Leukopenia due to antineoplastic chemotherapy (*) Severe protein-calorie malnutrition (*) History of DVT of lower extremity Vitamin D deficiency FTT (failure to thrive) in adult Refractory anemia with excess of blasts 1 (*) Antineoplastic chemotherapy induced pancytopenia (*)
Andere Medikamente: Florinef Folic acid Revlimid Prilosec Effexor Vitamin D3 Decadron
Allergien: Flomax
Vorherige Impfungen: -

VAERS 2213689

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 81,0
Geschlecht: M
Eingang: 03.04.2022
Impfdatum: -
Beginn: 16.03.2022
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Intensive care Mechanical ventilation Renal failure

Symptomtext

Narrative: 80yo male patient died on 3/16/2022 at community hospital outside facility after had had presented to community hospital on 3/8/22. Chief compliant: Kidney Failure Pt was admitted and sent to ICU, sedated and on a vent with Palliative Care. On 3/16/2022 patient expired. Cause of death renal failure. Pt received a covid vaccine on 4/8/2021 (J&J). This death is not related to this vaccine given pt's advanced age and cause of death defined as renal failure.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2206594

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: TN
Alter: 89,0
Geschlecht: F
Eingang: 30.03.2022
Impfdatum: 10.08.2021
Beginn: 24.12.2021
Tage bis Beginn: 136,0
Dosis: 1
Route/Site: SYR / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Chest X-ray abnormal Death Hypoxia Malaise Pneumothorax Positive airway pressure therapy SARS-CoV-2 test positive

Symptomtext

Patient started having symptoms of COVID around 8 to 9 days and tested positive for COVID-19 in the facility she was sent to the ER with hypoxia, 70% on room air, patient was started an dexamethasone and remdesivir. Overnight patient developed worsening hypoxia repeat chest x-ray showed collapsed left lung Patient was started on nebs and suction and was placed on BiPAP. We discussed the case with pulmonary . Patient's family stated that patient is DNR and DNI. Patient continues to be hypoxic despite being on Bi PAP. We discussed with family regarding patient's critical condition and overall prognosis and recommended comfort measures. Patient's family was out of state and was allowed to came to see patient. In the meantime patient was continued on Covid specific treatment with addition of baricitinib and continued management for collapsed lung. Once patient's family arrived and saw the patient after discussion with md, they decided to make patient comfort measures only. Patient expired on 12/31/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 7,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Dementia, ETOH
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2201642

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: KY
Alter: 66,0
Geschlecht: M
Eingang: 28.03.2022
Impfdatum: 09.04.2021
Beginn: 08.02.2022
Tage bis Beginn: 305,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Acute respiratory failure Bronchitis Bronchospasm COVID-19 Chest X-ray normal Chest discomfort Chest tube insertion Chest tube removal Chronic obstructive pulmonary disease Condition aggravated Decreased activity Dyspnoea Fatigue Headache Hypoxia Influenza Intensive care Muscle spasms

Symptomtext

Patient presented to ED today with chief complaint of productive cough, worsening dyspnea, and increased oxygen requirements.The patient states that for the past several days, he has been experiencing worsening shortness of breath, cough productive of yellow sputum, and a "spasm" sensation in his chest that causes him to cough. Constitutional: Positive for activity change and fatigue. Negative for chills, fever and unexpected weight change. HENT: Positive for congestion. Negative for ear pain, hearing loss, sinus pressure, sore throat and trouble swallowing. Eyes: Negative for visual disturbance. Respiratory: Positive for cough, shortness of breath and wheezing. Cardiovascular: Negative for chest pain and palpitations. Gastrointestinal: Negative for abdominal pain, blood in stool, constipation, diarrhea, nausea and vomiting. Genitourinary: Negative for decreased urine volume, dysuria and hematuria. Musculoskeletal: Negative for back pain, gait problem, joint swelling and myalgias. Skin: Negative for rash and wound. Neurological: Positive for headaches. Negative for dizziness, syncope, weakness, light-headedness and numbness. Acute hypoxic respiratory failure on chronic nocturnal hypoxemia with OSA COPD bronchitis exacerbation and bronchospasms due to influenza A ?Patient with recent failed partial treatment outpatient with doxycycline and steroids -- > Initially placed on IV Rocephin, azithromycin, transitioned to ceftin which is now complete. Azithromycin to be completed soon. ?Solu-Medrol 60 mg every 12 hours ?Finished Tamiflu course ?DuoNebs scheduled and PRN, Pulmicort nebs BID, Brovana BID, Daliresp, Singulair ?Scheduled cough medication with expectorant --CXR 3/2 unremarkable However, patient had some violent coughing spells that made him decompensate rapidly and was diagnosed to have a pneumothorax. Shifted to ICU where chest tube was inserted with resolution of the same. Subsequently was transferred back to the floor where after clamping trial, the tube was taken out. Patient back at his baseline at discharge Discharge Disposition/Condition Disposition: Home Condition: Stable (s/sx potential problems absent or manageable)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 10,0
Labordaten: COVID PCR confirmed positive on 2/8/22
Aktuelle Erkrankungen: N/A
Vorgeschichte: Past Medical History: Diagnosis Date ? Benign prostatic hyperplasia ? Chronic obstructive pulmonary disease, unspecified (CMS/HCC) ? Gastro-esophageal reflux disease without esophagitis ? Hyperlipidemia ? Hypertension ? Nicotine dependence ? Obesity ? Sleep apnea, obstructive ? Type 2 diabetes mellitus (CMS/HCC) ? Unspecified asthma, uncomplicated
Andere Medikamente: Prior to Admission medications Medication Sig Start Date End Date Taking? Authorizing Provider acetaminophen (Tylenol) 325 MG tablet 3/16/20 Historical Provider, MD albuterol (2.5 MG/3ML) 0.083% nebulizer solution USE 1 VIAL VIA NEBU
Allergien: hydrocodone-acetaminophen oxycodone-acetaminophen
Vorherige Impfungen: -

VAERS 2201642

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge 042A21A

kritisch

Staat: KY
Alter: 66,0
Geschlecht: M
Eingang: 28.03.2022
Impfdatum: 09.04.2021
Beginn: 08.02.2022
Tage bis Beginn: 305,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Acute respiratory failure Bronchitis Bronchospasm COVID-19 Chest X-ray normal Chest discomfort Chest tube insertion Chest tube removal Chronic obstructive pulmonary disease Condition aggravated Decreased activity Dyspnoea Fatigue Headache Hypoxia Influenza Intensive care Muscle spasms

Symptomtext

Patient presented to ED today with chief complaint of productive cough, worsening dyspnea, and increased oxygen requirements.The patient states that for the past several days, he has been experiencing worsening shortness of breath, cough productive of yellow sputum, and a "spasm" sensation in his chest that causes him to cough. Constitutional: Positive for activity change and fatigue. Negative for chills, fever and unexpected weight change. HENT: Positive for congestion. Negative for ear pain, hearing loss, sinus pressure, sore throat and trouble swallowing. Eyes: Negative for visual disturbance. Respiratory: Positive for cough, shortness of breath and wheezing. Cardiovascular: Negative for chest pain and palpitations. Gastrointestinal: Negative for abdominal pain, blood in stool, constipation, diarrhea, nausea and vomiting. Genitourinary: Negative for decreased urine volume, dysuria and hematuria. Musculoskeletal: Negative for back pain, gait problem, joint swelling and myalgias. Skin: Negative for rash and wound. Neurological: Positive for headaches. Negative for dizziness, syncope, weakness, light-headedness and numbness. Acute hypoxic respiratory failure on chronic nocturnal hypoxemia with OSA COPD bronchitis exacerbation and bronchospasms due to influenza A ?Patient with recent failed partial treatment outpatient with doxycycline and steroids -- > Initially placed on IV Rocephin, azithromycin, transitioned to ceftin which is now complete. Azithromycin to be completed soon. ?Solu-Medrol 60 mg every 12 hours ?Finished Tamiflu course ?DuoNebs scheduled and PRN, Pulmicort nebs BID, Brovana BID, Daliresp, Singulair ?Scheduled cough medication with expectorant --CXR 3/2 unremarkable However, patient had some violent coughing spells that made him decompensate rapidly and was diagnosed to have a pneumothorax. Shifted to ICU where chest tube was inserted with resolution of the same. Subsequently was transferred back to the floor where after clamping trial, the tube was taken out. Patient back at his baseline at discharge Discharge Disposition/Condition Disposition: Home Condition: Stable (s/sx potential problems absent or manageable)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 10,0
Labordaten: COVID PCR confirmed positive on 2/8/22
Aktuelle Erkrankungen: N/A
Vorgeschichte: Past Medical History: Diagnosis Date ? Benign prostatic hyperplasia ? Chronic obstructive pulmonary disease, unspecified (CMS/HCC) ? Gastro-esophageal reflux disease without esophagitis ? Hyperlipidemia ? Hypertension ? Nicotine dependence ? Obesity ? Sleep apnea, obstructive ? Type 2 diabetes mellitus (CMS/HCC) ? Unspecified asthma, uncomplicated
Andere Medikamente: Prior to Admission medications Medication Sig Start Date End Date Taking? Authorizing Provider acetaminophen (Tylenol) 325 MG tablet 3/16/20 Historical Provider, MD albuterol (2.5 MG/3ML) 0.083% nebulizer solution USE 1 VIAL VIA NEBU
Allergien: hydrocodone-acetaminophen oxycodone-acetaminophen
Vorherige Impfungen: -

VAERS 2190011

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 53,0
Geschlecht: F
Eingang: 21.03.2022
Impfdatum: 02.06.2021
Beginn: 21.12.2021
Tage bis Beginn: 202,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Atrial fibrillation COVID-19 Cardiac arrest Death Endotracheal intubation General physical health deterioration Life support Positive airway pressure therapy Pulseless electrical activity Pyrexia Resuscitation SARS-CoV-2 test positive Tracheostomy

Symptomtext

pt had a previous hospitalization at Hospital and was diagnosed positive for COVID in their ED; she was intubated in the ED and suffered cardiac arrest; CPR was performed; she was transferred to Medical Center where she was treated with COVID specific therapies; she was extubated but BiPAP dependent; family pursued tracheostomy; pt was reintubated and experienced a perioperative PEA arrest; pt became febrile; ABX were given; pt's condition deteriorated and she suffered A Fib requiring vasopressors; pt's condition worsened and she had PEA arrest, ACLS was performed but was unsuccessful; pt died in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: 18,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: HTN, morbid obesity, acute on chronic systolic heart failure
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2178228

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MT
Alter: 88,0
Geschlecht: F
Eingang: 14.03.2022
Impfdatum: 09.04.2021
Beginn: 10.01.2022
Tage bis Beginn: 276,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure COVID-19 Chest X-ray abnormal Cough Decreased appetite Hypoxia Lung infiltration Respiratory symptom SARS-CoV-2 RNA SARS-CoV-2 test positive

Symptomtext

Case was vaccinated in April 2021 for Covid, then was hospitalized for Covid in January 2022. Hospitalized at: a local health care facility. * Acute respiratory failure due to COVID-19 (HCC) Presented with 6 days of URI symptoms, cough was so severe it was hard for her to eat. She tested positive for covid 1/10/22, was mildly hypoxic, and had bilateral patchy infiltrates on CXR on admission. She received one dose of J&J vaccine in April 2021. She has no history of heart or lung disease but has been on an extended prednisone taper for PMR which may increase risk of severe illness. She was treated with dexamethasone and remdesivir. She received 3 doses of remdesivir before she discharged. She will complete a 10 day course of dexamethasone as an outpatient because she was still requiring supplemental O2 at the time of discharge.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: Ordered Test: FLUABV + SARS-CoV-2 Resp NAA+probe Ordered Test Codes: 95423-0 (LN LOINC)/ Status: Final Accession Number: Specimen Source: SOFT TISSUE SAMPLE Specimen Site: MIDDLE NASAL TURBINATE STRUCTURE(60962000) Specimen Collection Date/Time: 2022-01-10 11:13:00.0 * Resulted Test: SARS-CoV-2 RNA Resp Ql NAA+probe Coded Result: DETECTED Numeric Result: Units: Text Result: Reference Range From: Not Detected Reference Range To: Performing Facility Details: Date/Time: 2022-01-10 12:08:50.0 Performing Facility: Facility ID: Interpretation: Very abnormal Result Method: LAB DEVICE: CEPHEID GENEXPERT DX SYSTEM (7332940001377) Status: Final Test Code: 94500-6 (LN LOINC)/ Result Code: 260373001 (SCT/
Aktuelle Erkrankungen: Cataract ? Crohn disease (HCC) ? Glaucoma ? Macular degeneration ? Polymyalgia rheumatica (HCC)
Vorgeschichte: Cataract ? Crohn disease (HCC) ? Glaucoma ? Macular degeneration ? Polymyalgia rheumatica (HCC)
Andere Medikamente: acetaminophen (TYLENOL) 500 mg tablet Take 1,000 mg by mouth every 4 hours as needed for Pain or Fever (or fever >= 38.6 C (101.5 F)) . ? aspirin 325 mg tablet Take 325 mg by mouth Daily. ? latanoprost (XALATAN) 0.005% ophthalmic so
Allergien: Omperazole
Vorherige Impfungen: -

VAERS 2173940

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 45,0
Geschlecht: F
Eingang: 11.03.2022
Impfdatum: 31.07.2021
Beginn: 04.01.2022
Tage bis Beginn: 157,0
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Abdominal pain Acute kidney injury Acute respiratory failure COVID-19 COVID-19 pneumonia Death Dyspnoea Endotracheal intubation Fatigue Haemoglobin decreased Hepatitis alcoholic Intensive care Jaundice Pancreatitis acute Pneumonia staphylococcal Positive airway pressure therapy Red blood cell transfusion SARS-CoV-2 test positive

Symptomtext

pt brought to hosp with abdominal pain, jaundice, fatigue, SOB; AHRF due to COVID PNA, ETOH hepatitis, acute pancreatitis; positive COVID test; AKI; dexamethasone; increasing O2 requirements; O2 supplementation; pt's stay was complicated by MRSA PNA; ABX; had a drop in hemoglobin without signs of GI bleed; given 1 unit pRBCs, shortly after transfusion pt had an increase in O2 requirements and tachypnea; placed on BIPAP; transferred to MICU; intubated; later transitioned to comfort care and passed away in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 15,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2085299

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: CT
Alter: 42,0
Geschlecht: F
Eingang: 04.03.2022
Impfdatum: 29.11.2021
Beginn: 02.02.2022
Tage bis Beginn: 65,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: unbekannt Erholt: nein

Blood creatine phosphokinase increased Brain oedema Cerebral artery thrombosis Cerebral infarction Decompressive craniectomy Cerebrovascular accident Impaired work ability Intensive care Laboratory test Loss of consciousness Microcytic anaemia Packed red blood cell transfusion Malaise

Symptomtext

She got her vaccine shew as fine. On 2/2/22 she got sick, she didn't go to work and the sent the police to her apartment and found out that she had passed out and was transported to the hospital where they determined that she had a stroke. She still continues to be in the hospital in ICU. She is improving little by little.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 30,0
Labordaten: Multiple while in the hospital.
Aktuelle Erkrankungen: None.
Vorgeschichte: None.
Andere Medikamente: None.
Allergien: None.
Vorherige Impfungen: -

VAERS 2151037

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 91,0
Geschlecht: F
Eingang: 01.03.2022
Impfdatum: 09.04.2021
Beginn: 01.10.2021
Tage bis Beginn: 175,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Arrhythmia COVID-19 Death Dyspnoea General physical health deterioration Hypotension Intensive care

Symptomtext

EMS called to pt's house due to SOB; pt admitted to hosp; 2 dys prior to hospitalization, pt was diagnosed with COVID along with other members of the family; required O2 support; given dexamethasone, antibiotics, remdesivir; NRB; transferred to ICU; DNR; pt's condition continued to decline; pt became hypotensive with rhythm changes and passed away in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: DMT2, HTN, CHF
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2129295

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MI
Alter: 72,0
Geschlecht: M
Eingang: 21.02.2022
Impfdatum: 07.04.2021
Beginn: 18.02.2022
Tage bis Beginn: 317,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 pneumonia Cough Dyspnoea

Symptomtext

Pt has had worsening dyspnea and cough since 2/11/2022. Pt admitted for acute hypoxic respiratory failure and COVID-19 viral pneumonia.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1814715

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 70,0
Geschlecht: M
Eingang: 15.02.2022
Impfdatum: 04.08.2021
Beginn: 01.09.2021
Tage bis Beginn: 28,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute kidney injury Acute respiratory distress syndrome Condition aggravated Coronary artery disease Death COVID-19 Vaccine breakthrough infection Dyspnoea Hypertensive heart disease Pneumonia Post-acute COVID-19 syndrome

Symptomtext

pt admitted to hosp after being dc'd from another hospital for ARF with bilateral pneumonia, pt left AMA; pt called his doctor when he started having increasing SOB after going home, was told to go to ER; seen in ER and placed on O2 supplement of 11 L/in with O2 sats in the 90s; bedridden after a tractor accident several years ago; given remedesivir; pt's condition improved and he was dc'd to home; per death certificate pt died in the home with the causes being: COVID-SARS 19, long hauler, adult respiratory distress syndrome secondary to COVID-SARS 19, Coronary Artery Disease, Hypertensive Cardiovascular Disease

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 9,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: obesity, osteoarthritis, CAD, HTN, DM, COPD, CVA
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1814715

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 70,0
Geschlecht: M
Eingang: 15.02.2022
Impfdatum: 04.08.2021
Beginn: 01.09.2021
Tage bis Beginn: 28,0
Dosis: 1
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute kidney injury Acute respiratory distress syndrome Condition aggravated Coronary artery disease Death COVID-19 Vaccine breakthrough infection Dyspnoea Hypertensive heart disease Pneumonia Post-acute COVID-19 syndrome

Symptomtext

pt admitted to hosp after being dc'd from another hospital for ARF with bilateral pneumonia, pt left AMA; pt called his doctor when he started having increasing SOB after going home, was told to go to ER; seen in ER and placed on O2 supplement of 11 L/in with O2 sats in the 90s; bedridden after a tractor accident several years ago; given remedesivir; pt's condition improved and he was dc'd to home; per death certificate pt died in the home with the causes being: COVID-SARS 19, long hauler, adult respiratory distress syndrome secondary to COVID-SARS 19, Coronary Artery Disease, Hypertensive Cardiovascular Disease

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 9,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: obesity, osteoarthritis, CAD, HTN, DM, COPD, CVA
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1298827

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: AL
Alter: 52,0
Geschlecht: M
Eingang: 09.02.2022
Impfdatum: 01.04.2021
Beginn: 13.04.2021
Tage bis Beginn: 12,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Aphasia Cerebrovascular accident Craniotomy Decreased appetite Dizziness Immobile Movement disorder Fatigue Hemiplegia Influenza like illness Intensive care Nausea Pyrexia Unresponsive to stimuli Vomiting

Symptomtext

Day after receiving injection patient experienced flulike symptoms for 13 days. Fatigue, nasuea, vomiting, fever, dizziness, lack of appetite. April 25 approximately 530 am he experienced first stroke Discovered in home unresposive by his son Ambulance called admitted to Medical Center. April 28 he experienced second stroke while hospitalized. Transfered to a step down unit on April 28 a few hours later nurse discovered patient nonresponsive He had experienced a second stroke and had to have emergency craniotomy and attendant surgeries ICU for several days following surgery. Remained for 72 days. July 6 he was transferred where he remains today. Total right side paralysis. Unable to speak.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 72,0
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1298827

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

kritisch

Staat: AL
Alter: 52,0
Geschlecht: M
Eingang: 09.02.2022
Impfdatum: 01.04.2021
Beginn: 13.04.2021
Tage bis Beginn: 12,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Aphasia Cerebrovascular accident Craniotomy Decreased appetite Dizziness Immobile Movement disorder Fatigue Hemiplegia Influenza like illness Intensive care Nausea Pyrexia Unresponsive to stimuli Vomiting

Symptomtext

Day after receiving injection patient experienced flulike symptoms for 13 days. Fatigue, nasuea, vomiting, fever, dizziness, lack of appetite. April 25 approximately 530 am he experienced first stroke Discovered in home unresposive by his son Ambulance called admitted to Medical Center. April 28 he experienced second stroke while hospitalized. Transfered to a step down unit on April 28 a few hours later nurse discovered patient nonresponsive He had experienced a second stroke and had to have emergency craniotomy and attendant surgeries ICU for several days following surgery. Remained for 72 days. July 6 he was transferred where he remains today. Total right side paralysis. Unable to speak.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 72,0
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 2082436

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: SD
Alter: 82,0
Geschlecht: M
Eingang: 02.02.2022
Impfdatum: 05.04.2021
Beginn: 16.01.2022
Tage bis Beginn: 286,0
Dosis: 1
Route/Site: SYR / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

COVID-19 Death Dyspnoea SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

This is an instance of breakthrough COVID-19 disease after which death occurred. The individual was vaccinated with the Jansen product on 04/05/2021. Symptom onset is not specifically known, but the individual presented to emergency department with shortness of breath on 01/16/2022 and tested positive for COVID-19 via PCR test on 01/16/2021. They were hospitalized from 01/16/2022 to 01/22/2022, when they were discharged to home hospice. They died on 01/23/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 6,0
Labordaten: Positive COVID-19 PCR test on 01/16/2022 despite being vaccinated.
Aktuelle Erkrankungen: -
Vorgeschichte: Type II Diabetes, hypertension, multi-vessel coronary artery disease, hyperlipidemia, non-ST elevated myocardial infarction, stage 4 chronic kidney disease
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1247937

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: IL
Alter: 51,0
Geschlecht: M
Eingang: 27.01.2022
Impfdatum: 04.04.2021
Beginn: 11.04.2021
Tage bis Beginn: 7,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: unbekannt Erholt: nein

Acute disseminated encephalomyelitis Alanine aminotransferase increased Anti-ganglioside antibody negative Antineutrophil cytoplasmic antibody negative Antinuclear antibody negative Balance disorder CSF test abnormal Cerebral infarction Computerised tomogram normal Bickerstaff's encephalitis Blood test Brain oedema Encephalitis autoimmune Arrhythmia Aspartate aminotransferase increased Aspergillus test negative Asthenia Autonomic nervous system imbalance

Symptomtext

Developed headache within one week of vaccine, then within 2 weeks of vaccine developed flu-like symptoms, fever, neck stiffness, imbalance and rapidly progressive encephalopathy. Required intubation and critical care, complicated by papilledema and communicating hydrocephalus. Evaluation for infection, meningitis was negative. Treated with IVIg and steroids with partial recovery. After extensive subsequent workup and evaluation, he has been diagnosed with ADEM/encephalomyeloradiculitis. 9 months later, he has persistent imbalance and numbness/tingling over face. he remains on prednisone 30 mg daly as symptoms worsened when steroids were tapered further. MRI spine 5/2/21: Suspected abnormal cord signal at the C5-C6 and T11-L1 levels. There is thickening and enhancement of multiple thoracic spinal nerve roots and diffuse thickening and enhancement of the cauda equina nerve roots. Findings may relate to inflammatory or infectious process in keeping with the findings in the MRI brain. Flow cytometry results:CSF Flow cytometric immunophenotyping performed on the cerebrospinal fluid reveals a small polytypic B-cell population and a T-cell population (see comment). Comment: Given the limited nature of this sample the analysis was mainly limited to the B-cells. The T-cell markers include CD3, CD5 and CD7 that show a subset of T-cells lack CD7 expression. CT c/a/p 5/2021: normal. EMG 11/10/2021, SUMMARY OF FINDINGS: Extensive electrodiagnostic evaluation of the right and left upper extremities and right lower extremity demonstrates the following: Normal sensory responses of the right and left median, right ulnar, right radial, right sural and right superficial peroneal nerves. Abnormal motor response of the right median nerve with prolonged onset latency and prolonged conduction velocity. Prolonged F wave of the right median nerve. Normal motor response of the left median, right ulnar, right peroneal, and right tibial nerves. Abnormal needle electromyography of selected muscles of the right upper extremity as tabulated above. CONCLUSION: This study shows evidence of a mild demyelinating lesion of the right median nerve between the wrist and elbow with prolonged F-wave. Such findings could be seen with an acquired demyelinating neurology in the appropriate clinical context, but given a single nerve segment slowing, these findings are not consistent a chronic demyelinating process. There is no evidence of an ulnar or radial neuropathy affecting the right upper extremity. There is no evidence of a cervical motor radiculopathy affecting the right upper extremity.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Near death experience
Hospital-Tage: 21,0
Labordaten: MRI Brain 4/19/21: restricted diffusion within areas of cortical FLAIR hyperintensity suggests multiple tiny infarcts with likely underlying ADEM, vasculitis or viral encephalitis.
Aktuelle Erkrankungen: none
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2551047

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 74,0
Geschlecht: M
Eingang: 06.01.2022
Impfdatum: 06.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Fall

Symptomtext

Narrative: Patient received the vaccine on 4/6/21 and subsequently had a fall on 4/9/21 that required 911 to be called and taken to ER where they administered a tetanus shot and sent him home. On 4/10/21 the patient passed. The patient had several comorbid conditions which included to but not limited to diabetes, carcinoma of the bladder, Stage 4 chronic kidney disease, pacemaker, atrial fibrillation, COPD, hypertension, and amputation above the knee of one leg.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2501694

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 72,0
Geschlecht: M
Eingang: 02.01.2022
Impfdatum: 22.05.2021
Beginn: 05.06.2021
Tage bis Beginn: 14,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative:

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2501617

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 99,0
Geschlecht: M
Eingang: 02.01.2022
Impfdatum: 01.04.2021
Beginn: 23.05.2021
Tage bis Beginn: 52,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Asthenia Bradycardia Cardiac arrest Cardio-respiratory arrest Cardioversion Death Decreased appetite Dehydration Hypotension Pneumonia bacterial Septic shock Tachycardia

Symptomtext

Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for tobacco use, aortic aneurysm, chronic obstructive lung disease, advanced age. Pt presented to ED on 5/21/21 with a chief complaint of generalized weakness and lost of appetite. Was found to have bacterial pneumonia without respiratory failure, suspected dehydration. On 5/23 patient was hypotensive, tachycardia, and in septic shock. Went bradycardic and asystole, when code blue called. The code was called off by family. Pt was defibrillated two times.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2500241

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 63,0
Geschlecht: M
Eingang: 02.01.2022
Impfdatum: 11.04.2021
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: Patient received one dose of J&J vaccine. No details recorded in chart as cause of death. Reporting per facility instructions.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1988196

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MI
Alter: 61,0
Geschlecht: F
Eingang: 29.12.2021
Impfdatum: 19.05.2021
Beginn: 02.12.2021
Tage bis Beginn: 197,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure C-reactive protein COVID-19 COVID-19 pneumonia Cardiomegaly Chest X-ray Chest X-ray abnormal Chest pain Chills Cough Dyspnoea Exposure to SARS-CoV-2 Fatigue Fibrin D dimer Foot deformity Full blood count Hyperhidrosis Liver function test

Symptomtext

This spontaneous report received from a health care professional via Regulatory Authority ( ID: 1937008) was received on 17-DEC-2021 concerned a 61-year-old female. The patient's height, and weight were not reported. The patient's past medical history included: mixed stress and urge urinary incontinence, and microscopic hematuria, and concurrent conditions included: COPD (chronic obstructive pulmonary disease), hypoxia/nocturnal hypoxia, tobacco abuse CODP, chronic pain syndrome, recurrent major depression, acute hypoxemic respiratory failure due to covid-19, osteoarthritis of lumbar spine, DDD (degenerative disc disease), lumbar rotator cuff tear, lumbar radiculopathy, cervical spinal stenosis, cervical radiculopathy, insomnia, chronic prescription opiate, osteoarthritis of right knee, mixed hyperlipidemia, allergy to iodine, and allergy to demerol ivp dye. The patient received covid-19 vaccine (Janssen series 1, suspension for injection, route of admin not reported, batch number: 042A21A expiry: UNKNOWN) dose was not reported, 1 total administered on 19-MAY-2021 for a prophylactic vaccination. Concomitant medications included acetylsalicylic acid, duloxetine hydrochloride, hydrocodone bitartrate/paracetamol, salbutamol, and salbutamol sulfate. On 02-DEC-2021, the patient experienced shortness of breath (dyspnoea), cough, nausea, chills, fevers, and chest pain. The patient had more shortness of breath than normal. Patient had been using her home inhalers without much relief. The patient required more oxygen than her baseline which was 2 litre. On 06-DEC-2021, the patient had detected covid-19 by COVID-19 PCR (polymerase chain reaction) test and admitted to medicine-severe COVID pneumonia, acute on chronic hypoxemic respiratory failure. The patient underwent chest x-ray examination which showed cardiomegaly and mild prominence of the pulmonary vascularity (pulmonary edema). Patient was tachycardic and tachypnoeic. During exam, patient was diaphoretic and tired. Patient was wheezy but not using increased respiratory effort. The patient started treatment with remdesivir and daily renal and liver function monitoring for kidney and liver toxicity due to remdesivir. The patient was wheezing, therefore received 125 mg Solu-Medrol (methylprednisolone sodium succinate) in the emergency department and will continue Solu-Medrol 40 mg for every 6 hours. The patient was on albuterol inhaler and on daily trends laboratory tests which included C-reactive protein (CRP) (NR: not provided) not reported, Complete blood count (NR: not provided) not reported, comprehensive metabolic panel (NR: not provided) not reported, Fibrin D dimer (NR: not provided) not reported, Liver function test (NR: not provided) not reported, Pulse oximetry (NR: not provided) not reported, Renal function test (NR: not provided) not reported, and Spirometry (NR: not provided) not reported and Foot overpronation (NR: not provided) not reported. The patient stated that under no circumstances want to live with the respirator. Number of days of hospitalization was 3. The patient visited emergency room. The action taken with covid-19 vaccine was not applicable. The patient had not recovered from acute respiratory failure, c-reactive protein, covid-19, covid-19 pneumonia, cardiomegaly, chest x-ray abnormal, chest pain, chills, cough, dyspnoea, exposure to sars-cov-2, fatigue, fibrin d dimer, full blood count, hyperhidrosis, liver function test, metabolic function test, nausea, pulmonary oedema, pulmonary vasculitis, pyrexia, renal function test, respiratory failure, sars-cov-2 test positive, tachycardia, tachypnoea, and wheezing, and the outcome of confirmed clinical vaccination failure was not reported. This report was serious (Hospitalization Caused / Prolonged). This report was associated with product quality complaint 90000207907. The suspected product quality complaint has been confirmed to be the reported allegation could not be confirmed. A manufacturing related root cause could not be identified based on the PQC evaluation/investigation performed. Additional information received from Regulatory Authority on 22-DEC-2021. The following information was updated and incorporated into the case narrative: Product quality complaint investigation result and product indication.; Sender's Comments: V1: The following information was updated and incorporated into the case narrative: Product quality complaint investigation result and product indication. This added information does not alter the causality of previous reported events. 20211240789-COVID-19 VACCINE Acute respiratory failure, COVID-19 pneumonia, Pulmonary vasculitis, Pulmonary oedema, Respiratory failure, Cardiomegaly, COVID-19, Chest pain, Exposure to SARS-CoV-2, Tachycardia, Tachypnoea, Hyperhidrosis, Cough, Dyspnoea, C-reactive protein, Chest X-ray abnormal, Liver function test, Metabolic function test, Fibrin D dimer, Full blood count, Renal function test, SARS-CoV-2 test positive, Wheezing, Chills, Fatigue, Pyrexia, Nausea. These events are considered unassessable. The events have a compatible/suggestive temporal relationship, are unlabeled, and have unknown scientific plausibility. There is no information on any other factors potentially associated with the events. 20211240789-COVID-19 VACCINE Confirmed clinical vaccination failure. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: Test Date: 20211206; Test Name: Chest X-ray; Result Unstructured Data: Cardiomegaly and prominence; Test Date: 20211206; Test Name: COVID-19 PCR test; Result Unstructured Data: Detected; Test Date: 20211206; Test Name: C-reactive protein; Result Unstructured Data: not reported; Test Date: 20211206; Test Name: Comprehensive metabolic panel; Result Unstructured Data: not reported; Test Date: 20211206; Test Name: Complete blood count; Result Unstructured Data: not reported; Test Date: 20211206; Test Name: Liver function test; Result Unstructured Data: not reported; Test Date: 20211206; Test Name: Pulse oximetry; Result Unstructured Data: not reported; Test Date: 20211206; Test Name: Spirometry; Result Unstructured Data: not reported; Test Date: 20211206; Test Name: Fibrin D dimer; Result Unstructured Data: not reported; Test Date: 20211206; Test Name: Renal function test; Result Unstructured Data: not reported; Test Name: Foot overpronation; Result Unstructured Data: not reported.
Aktuelle Erkrankungen: Acute hypoxic respiratory failure; Cervical radiculopathy; Cervical spinal stenosis; Chronic pain (Severe); Contrast media allergy; COPD (Severe); Hypoxia; Insomnia; Iodine allergy; Knee osteoarthritis; Lumbar disc degeneration; Lumbar radiculopathy; Major depression (Moderate); Mixed hyperlipidemia; Opiate analgesic supportive therapy (for nocturnal hypoxia); Osteoarthritis of lumbar spine; Rotator cuff tear; Tobacco abuse
Vorgeschichte: Medical History/Concurrent Conditions: Microscopic hematuria; Stress urinary incontinence.
Andere Medikamente: PROVENTIL [SALBUTAMOL]; PROVENTIL HFA [SALBUTAMOL SULFATE]; VENTOLIN HFA; PROAIR HFA; ASPRIN; CYMBALTA; HYDROCODONE/ACETAMINOPHEN
Allergien: -
Vorherige Impfungen: -

VAERS 1982116

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MI
Alter: 74,0
Geschlecht: F
Eingang: 27.12.2021
Impfdatum: 26.07.2021
Beginn: 20.12.2021
Tage bis Beginn: 147,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19 COVID-19 pneumonia Chest X-ray abnormal Cough Decreased appetite Dyspnoea Endotracheal intubation Exposure to SARS-CoV-2 Fatigue Fibrin D dimer increased Intensive care Lung disorder Lung opacity Oxygen saturation decreased Respiratory distress Respiratory failure SARS-CoV-2 test positive

Symptomtext

Hospitalized 12/20/2021-still admitted currently; COVID-19 positive 12/20/2021; fully vaccinated ASSESSMENT / PLAN: Patient is a 74-year-old female with past medical history significant for nonischemic cardiomyopathy last known ejection fraction 42%, diabetes (poorly controlled last known A1c of 9) pulmonary embolism and hypertension who is listed as being vaccinated with J and J on July 26th presented to an outside emergency department with extreme exhaustion, cough, fatigue of approximately 2 weeks duration. That has been associated with a poor appetite and weight loss approximately 12 lb. In the emergency department she was found to be COVID positive with an oxygen saturation of 84% on room air. Chest x-ray showed patchy areas of opacification consistent with COVID-19 pneumonia and received 6 mg of IV dexamethasone. She was admitted to hospital approximately 24 hours ago and continued on high-flow nasal cannula with combination of non-rebreather mask. Overnight she has had increasing respiratory distress with tachypnea and progressive desaturation. A repeat chest x-ray approximately 24 hours after the emergency department evaluation looked essentially unchanged with continued moderate airspace disease. Given the patient's respiratory failure, increased work of breathing she has been transferred to the intensive care unit. Assessment and Plan Acute hypoxemic respiratory failure Possibly multifactorial, however most likely secondary to COVID-19 pneumonia -given 1 dose of furosemide prior to transfer -will update chest x-ray -had discussed care at length with patient, daughter updated by hospitalist team, if desires to be full code likely should undergo intubation mechanical ventilation. Told her at length she is at high risk for mortality, complications, tracheostomy. COVID-19 Vaccinated with Johnson & Johnson in July of this year. Multiple family members have been ill with it. -had symptoms approximately 7-10 days before presentation -would not be a candidate for remdesivir -did receive Decadron -steroids have been increased to 50 mg of IV Solu-Medrol 2 times a day, approximately 1 mg per kg body weight -rising D-dimer, possible history of pulmonary embolism past, will check upper and lower extremity Dopplers -if undergoes endotracheal intubation, will likely obtain CT angiogram of thorax pending clinical stability. 12/27/2021 notes: Patient currently still intubated and in ICU * COVID-19 Infection, noted 12/20/21. Assessment & Plan Vaccinated with Johnson & Johnson in 7/26/21. Multiple family members tested positive for Covid. Symptom onset: 7-10 days prior to admission, ~ 12/12. Test positive: 12/20 Admission: 12/20 Intubation: 12/22/21 Remdesivir: not candidate, outside window Steroids: decadron 6mg daily (12/20-12/21), solu-medrol 50mg IV BD (12/22- - management of acute hypoxic respiratory failure as above - continue steroids for minimum 10 days then re-evaluate - continue prophylactic anticoagulation, trend d-dimer - continue antibiotics and follow-up secondary infection work-up

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 7,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Non-ischemic cardiomyopathy Obesity, Class III, BMI 40-49.9 (morbid obesity) Low cardiac output syndrome Type 2 diabetes mellitus without complication, without long-term current use of insulin Hx of pulmonary embolus, noted 4/2017. ICD (implantable cardioverter-defibrillator) in place COVID-19 Infection, noted 12/20/21. Acute hypoxemic respiratory failure Hyperglycemia Shock Eye drainage, with right eye periorbital cellulitis GERD without esophagitis Hypothyroidism (acquired) Lumbago Hypertension associated with diabetes LBBB Hyperlipidemia associated with type 2 diabetes mellitus Chronic combined systolic and diastolic heart failure
Andere Medikamente: aspirin 81 MG tablet Blood Glucose Monitoring Suppl MISC Blood Glucose Monitoring Suppl MISC Blood Glucose Monitoring Suppl MISC calcium carbonate (TUMS) 500 MG chewable tablet carvedilol (COREG) 6.25 MG tablet levothyroxine (SYNTHROID) 150
Allergien: Penicillins
Vorherige Impfungen: -

VAERS 2538821

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 67,0
Geschlecht: M
Eingang: 19.12.2021
Impfdatum: 20.05.2021
Beginn: 10.12.2021
Tage bis Beginn: 204,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Intensive care

Symptomtext

Narrative: 67y.o. M with a h/o idiopathic pulmonary fibrosis on 4L O2 at home, CAD s/p stents, pAfib, DM2, GERD, OA, and adjustment disorder was discharged from long inpatient ICU admission to home hospice on 11/12/2021. Pt then died at home in home hospice on 12/10/2021. Pt had received one covid vaccine on 5/20/21 (J&J). This death is not related to vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2491005

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

kritisch

Staat: -
Alter: 56,0
Geschlecht: M
Eingang: 19.12.2021
Impfdatum: 09.04.2021
Beginn: 05.11.2021
Tage bis Beginn: 210,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Pulmonary embolism

Symptomtext

Employee advises that he was diagnosed with a Pulmonary Embolism the first week of November Narrative:

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1955758

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: TX
Alter: 48,0
Geschlecht: M
Eingang: 16.12.2021
Impfdatum: 03.04.2021
Beginn: 30.10.2021
Tage bis Beginn: 210,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Computerised tomogram thorax abnormal Deep vein thrombosis Intensive care Pulmonary embolism Pulmonary thrombosis Ultrasound scan

Symptomtext

Deep Vein Thrombosis resulting in massive blood clotting in lung - pulmonary embolism

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 7,0
Labordaten: CT scan showing clotting on 11/07 in ER Many other ultrasounds and CT scans in ICU
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: Vitamin D, Esomeprazonle, Rosuvastin
Allergien: none
Vorherige Impfungen: -

VAERS 1946649

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MI
Alter: 73,0
Geschlecht: M
Eingang: 14.12.2021
Impfdatum: 07.06.2021
Beginn: 07.09.2021
Tage bis Beginn: 92,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Alanine aminotransferase Alanine aminotransferase increased Angiogram cerebral Angiogram cerebral abnormal Anion gap Anion gap normal Anticoagulant therapy Anxiety Aspartate aminotransferase Aspartate aminotransferase increased Atrioventricular block first degree Bell's palsy Blood albumin Blood albumin decreased Blood alkaline phosphatase Blood alkaline phosphatase normal Blood bicarbonate Blood bicarbonate normal

Symptomtext

ALANINE AMINOTRANSFERASE INCREASED; ANION GAP NORMAL; BLOOD ALBUMIN DECREASED; BLOOD ALKALINE PHOSPHATASE NORMAL; BLOOD BICARBONATE NORMAL; BLOOD BILIRUBIN NORMAL; BLOOD CALCIUM DECREASED; BLOOD CHLORIDE NORMAL; BLOOD CREATININE NORMAL; BLOOD GLUCOSE INCREASED; BLOOD POTASSIUM NORMAL; BLOOD SODIUM NORMAL; BLOOD UREA NORMAL; ASPARTATE AMINOTRANSFERASE INCREASED; CREATININE RENAL CLEARANCE DECREASED; MEAN CELL HAEMOGLOBIN CONCENTRATION NORMAL; MEAN CELL HAEMOGLOBIN NORMAL; MEAN CELL VOLUME NORMAL; MEAN PLATELET VOLUME INCREASED; METABOLIC FUNCTION TEST; METABOLIC FUNCTION TEST ABNORMAL; FULL BLOOD COUNT ABNORMAL; GLOMERULAR FILTRATION RATE NORMAL; HAEMATOCRIT DECREASED; HAEMOGLOBIN DECREASED; PLATELET COUNT ABNORMAL; PROTEIN TOTAL NORMAL; RED BLOOD CELL COUNT DECREASED; RED BLOOD CELL NUCLEATED MORPHOLOGY; RED CELL DISTRIBUTION WIDTH NORMAL; WHITE BLOOD CELL COUNT DECREASED; HYPOAESTHESIA; SCAN WITH CONTRAST ABNORMAL; SWALLOW STUDY; MAGNETIC RESONANCE IMAGING HEAD NORMAL; NIH STROKE SCALE SCORE INCREASED; NEUROLOGICAL EXAMINATION; ECHOCARDIOGRAM ABNORMAL; ATRIOVENTRICULAR BLOCK FIRST DEGREE; ELECTROCARDIOGRAM PR PROLONGATION; ELECTROCARDIOGRAM QRS COMPLEX; ELECTROCARDIOGRAM QT INTERVAL; ELECTROCARDIOGRAM ABNORMAL; CARDIAC TELEMETRY; COMPUTERISED TOMOGRAM HEAD NORMAL; EXPOSURE TO SARS-COV-2; ANTICOAGULANT THERAPY; DEPRESSION; MUCOSAL HYPERTROPHY; CONDITION AGGRAVATED; ANGIOGRAM CEREBRAL ABNORMAL; CEREBRAL ARTERY STENOSIS; VERTEBRAL ARTERY ARTERIOSCLEROSIS; CAROTID ARTERIOSCLEROSIS; CARDIO-RESPIRATORY ARREST; TRANSIENT ISCHAEMIC ATTACK; BELL'S PALSY; CEREBRAL ATROPHY; CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE; FACIAL PARALYSIS; TYPE 2 DIABETES MELLITUS; BUNDLE BRANCH BLOCK LEFT; SINUS BRADYCARDIA; WHITE MATTER LESION; CHEST PAIN; COVID-19; CONFIRMED CLINICAL VACCINATION FAILURE; SARS-COV-2 TEST POSITIVE; ANXIETY; THROMBOCYTOPENIA; EJECTION FRACTION DECREASED; This spontaneous report received from a health care professional via a Regulatory Authority concerned a 73 year old male. The patient's height, and weight were not reported. The patient's past medical history included: watchman left atrial appendage closure device, transient ischemic attack, and motor vehicle accident, and concurrent conditions included: roator cuff tear, ankylosing spondylitis, elevated liver enzymes, post-concussion syndrome, venous insufficiency of both lower extremities, chronic obstructive pulmonary disease, iron deficiency, calcification of abdominal aorta (Without abdominal aortic aneurysm), asthma, morbid obesity with body mass index of 50 or higher, diabetes mellitus type ii, nonischemic cardiomyopathy, left bundle branch block, chronic combined systolic and diastolic congestive heart failure, coronary artery disease with angina pectoris, bell's palsy, obstructive sleep apnea (on CPAP(Continuous positive airway pressure therapy)), hyperlipidemia, fatty liver, hypertension, and strawberry allergy (anaphylaxis and hives). The patient experienced drug allergy and renal failure when treated with sulfa drugs, and drug allergy, nausea and vomiting when treated with morphine, and drug allergy and leg cramps when treated with atorvastatin, and drug allergy and dyspnea when treated with duloxetine hydrochloride, drug allergy and insomnia when treated with dexamethasone, and drug allergy and throat swelling when treated with citalopram hydrobromide. The patient received covid-19 vaccine ad26.cov2.s (series 1) (suspension for injection, intramuscular, batch number: 042A21A expiry: UNKNOWN) dose was not reported, 1 total, administered on 07-JUN-2021 for an unspecified indication. Concomitant medications included acetylsalicylic acid for coronary artery disease, sertraline hydrochloride for depression, venlafaxine hydrochloride for depression, ezetimibe for hyperlipidaemia, rosuvastatin calcium for hyperlipidaemia, heparin for hyperlipidemia, lisinopril for hypertension, metoprolol for hypertension, insulin for type 2 diabetes mellitus, amiodarone hydrochloride, ascorbic acid, colecalciferol, docusate sodium, ferrous sulfate, salbutamol, and warfarin sodium. On 07-SEP-2021, the patient experienced ejection fraction decreased. Laboratory data included: Echocardiogram (NR: not provided) abnormal, congestive heart failure (CHF): Systolic and diastolic: ejection fraction (EF): 45%. On 12-NOV-2021, the patient experienced thrombocytopenia and chest pain. On the same day, the patient was tested positive for COVID due to family members with COVID symptoms (covid-19, confirmed clinical vaccination failure, sars-cov-2 test positive). He has been very anxious since he tested positive. The patient is fully vaccinated. Laboratory data included: SARS-CoV-2 test (NR: not provided) positive. On 13-NOV-2021 08:21, Laboratory data included: Electrocardiogram (NR: not provided) not reported. On 15-NOV-2021, the patient presented to the emergency department after developing sudden onset of right facial droop (facial paralysis) and right facial numbness and left-sided facial numbness (hypoaesthesia). Someone thought he might have facial weakness but by the time he was seen in the emergency department no facial weakness was noted. Full neurological exam was normal (neurological examination), RA stroke scale was 1 (RA stroke scale score increased), computerised tomography (CT) of the head and magnetic resonance imaging (MRI) brain were negative for stroke (computerised tomogram head normal and magnetic resonance imaging head normal). Symptoms thought to be likely due to his Bell's palsy or anxiety. On the same day, the patient also experienced vertebral artery arteriosclerosis, type 2 diabetes mellitus, transient ischaemic attack, cerebral small vessel ischaemic disease, cerebral atrophy, cerebral artery stenosis, carotid arteriosclerosis, cardio-respiratory arrest, bell's palsy, depression, angiogram cerebral abnormal, exposure to sars-cov-2, anticoagulant therapy, atrioventricular block first degree, bundle branch block left, cardiac telemetry, condition aggravated, echocardiogram abnormal, electrocardiogram PR prolongation, electrocardiogram QRS complex, electrocardiogram QT interval, electrocardiogram abnormal, mucosal hypertrophy, scan with contrast abnormal, sinus bradycardia, swallow study, and white matter lesion. Laboratory data included: Swallow study (NR: not provided) Not reported. On 15-NOV-2021 13:14, Laboratory data included: Computerised tomogram head (NR: not provided) Approximately 50% short segment narrowing of the intracranial right internal carotid artery just above the skull base unchanged since 2020, 2 Approximately 50% atherosclerotic narrowing of the mid portion of the supraclinoid right internal carotid artery also unchanged 3 Severe short segment narrowing of the intracranial left internal carotid artery just above the skull base approximately 80% which is new since the prior exam in 2020 This may be due to age indeterminant dissection atherosclerosis or a combination of these 4 Approximately 50% atherosclerotic narrowing of the supraclinoid left internal carotid artery 5 Approximately 50% short segment atherosclerotic narrowing of the proximal intracranial left vertebral artery (normal); On 15-NOV-2021 13:42, Laboratory data included: Electrocardiogram (NR: not provided) Diagnosis Sinus bradycardia with 1st degree AV block Left bundle branch block (Abnormal). On 15-NOV-2021 18:05, Laboratory data included: Magnetic resonance imaging head (NR: not provided) No acute infarct 2 Chronic findings including intracranial volume loss and mild-to-moderate chronic small vessel ischemic changes (normal). On 16-NOV-2021, the patient experienced anion gap normal, alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase normal, blood bicarbonate normal, blood bilirubin normal, blood calcium decreased, blood chloride normal, blood creatinine normal, blood glucose increased, blood potassium normal, blood sodium normal, blood urea normal, creatinine renal clearance decreased, full blood count abnormal, glomerular filtration rate normal, haematocrit decreased, haemoglobin decreased, mean cell haemoglobin concentration normal, mean cell haemoglobin normal, mean cell volume normal, mean platelet volume increased, metabolic function test. On 16-NOV-2021, the patient experienced metabolic function test abnormal, platelet count abnormal, protein total normal, red blood cell count decreased, red blood cell nucleated morphology, red cell distribution width normal, white blood cell count decreased. On 16-NOV-2021 06:26, Laboratory data included: Laboratory data included: Anion gap 10 mmol/L, Alanine aminotransferase 60 IU/L, Alkaline phosphatase 93 IU/L, Aspartate aminotransferase 36 IU/L, Blood albumin 3.2 g/dL, Blood bicarbonate 26 mmol/L, Blood bilirubin 0.6 mg/dL, Blood calcium 8.6 mg/dL, Blood chloride 100 mmol/L, Blood creatinine 0.89 mg/dL, Blood glucose 139 mg/dL, Blood potassium 3.8 mmol/L, Blood sodium 136 mmol/L, Blood urea 12 mg/dL, and Glomerular filtration rate normal. On 16-NOV-2021 12:45, Laboratory data included: Full blood count (NR: not provided) abnormal. On 16-NOV-2021 14:06, Laboratory data included: Haematocrit 36.9 %, Haemoglobin 12.5 g/dL, Mean cell haemoglobin 30.2 pg, Mean cell haemoglobin concentration 33.9 g/dL, Mean cell volume 89.1 fL, Mean platelet volume 12.7 fL, Metabolic function test Abnormal, Platelet count abnormal, Protein total 6.4 g/dL, Red blood cell count 4.14 10*6/uL, Red cell distribution width 12.9 %, and White blood cell count 3.73 10*3/uL. On the same day, the patient was scheduled for rotator cuff repair full tear but was cancelled due to COVID. The patient did receive monoclonal antibody for his COVID infection. The patient was hospitalized for 2 days due to the events (admission and discharge dates unspecified). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from vertebral artery arteriosclerosis, type 2 diabetes mellitus, transient ischaemic attack, cerebral small vessel ischaemic disease, thrombocytopenia, cerebral atrophy, cerebral artery stenosis, carotid arteriosclerosis, cardio-respiratory arrest, bell's palsy, facial paralysis, chest pain, covid-19, anxiety, depression, alanine aminotransferase increased, angiogram cerebral abnormal, anion gap normal, exposure to sars-cov-2, anticoagulant therapy, aspartate aminotransferase increased, atrioventricular block first degree, blood albumin decreased, blood alkaline phosphatase normal, blood bicarbonate normal, blood bilirubin normal, blood calcium decreased, blood chloride normal, blood creatinine normal, blood glucose increased, blood potassium normal, blood sodium normal, blood urea normal, bundle branch block left, cardiac telemetry, computerised tomogram head normal, condition aggravated, creatinine renal clearance decreased, echocardiogram abnormal, ejection fraction decreased, electrocardiogram PR prolongation, electrocardiogram QRS complex, electrocardiogram QT interval, electrocardiogram abnormal, full blood count abnormal, glomerular filtration rate normal, haematocrit decreased, haemoglobin decreased, hypoaesthesia, magnetic resonance imaging head normal, mean cell haemoglobin concentration normal, mean cell haemoglobin normal, mean cell volume normal, mean platelet volume increased, metabolic function test, metabolic function test abnormal, mucosal hypertrophy, RA stroke scale score increased, neurological examination, platelet count abnormal, protein total normal, red blood cell count decreased, red blood cell nucleated morphology, red cell distribution width normal, sars-cov-2 test positive, scan with contrast abnormal, sinus bradycardia, swallow study, white blood cell count decreased, and white matter lesion, and the outcome of confirmed clinical vaccination failure was not reported. This report was serious (Hospitalization Caused / Prolonged). This report was associated with a product quality complaint: 90000205232. The suspected product quality complaint has been confirmed to be not voided. The reported allegation could not be confirmed. A manufacturing related root cause could not be identified based on the RI evaluation/investigation performed. Additional information received from RA department on 09-DEC-2021. The following information was updated and incorporated into the case narrative: Product quality complaint investigation result added.; Sender's Comments: RA:This version updates RA report, causality retained as in Version 0 . 20211202158-covid19 vaccine-Type2DM,TIA,bell's palsy,block 1st degree,LBBB,ALT increased,AST increased,Alb decreased,blood glucose increased.This event considered not related Event has a compatible/suggestive temporal relationship,unlabeled,unknown scientific plausibility,There are other factors more likely to be associated with event than drug SpecificallyMEDICAL HISTORY Vertebral artery arteriosclerosis,cerebral small vessel ischaemic disease,thrombocytopenia,cerebral artery stenosis,carotid arteriosclerosis,Anxiety,depression,cerebral atrophy,CR arrest,facial paralysis,covid19,chest pain,condition aggravated,mucosal hypertrophy,sars-cov2 positive,sinus bradycardia,angio cerebral abnormal,anion gap normal,exposure to sars-cov2,anticoagulant therapy,ALP normal,HCO3 normal,bili normal,Ca decreased,Cl normal,Cr normal,K normal,Na normal,BU normal,cardiac telemetry,CT head normal,Cr renal clearance decreased,ECG abnormal,EF decreased,PR prolongation,QRS complex,QT interval,FBC abnormal,GFR normal,HCT decreased,HB decreased,MRI head normal,MCHC normal,MCH normal,MCV normal,MPV increased,metabolic function test,metabolic function test abnormal,RA stroke score increased,neurological examination,platelet count abnormal,protein total normal,RBC decreased,RBC nucleated morphology,RDW normal,scan contrast abnormal,swallow study,WBC decreased,white matter lesion.This event considered unassessable,compatible/suggestive temporal relationship,unlabeled,unknown scientific plausibility,There is no information on other factors potentially associated with event Confirmed clinical Vaccination failure.This event is considered not related Event has compatible/suggestive temporal relationship,unlabeled,unknown scientific plausibility There are other factors more likely to be associated with event than drug.Specifically:SPECIAL SITUATIONS Hypoesthesia:This event is labeled per RA is considered potentially related.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardio-respiratory arrest
Hospital-Tage: 2,0
Labordaten: Test Date: 20210907; Test Name: Echocardiogram; Result Unstructured Data: abnormal; Test Date: 20211112; Test Name: SARS-CoV-2 test; Result Unstructured Data: positive; Test Date: 202111130821; Test Name: Electrocardiogram; Result Unstructured Data: not reported; Test Date: 20211115; Test Name: Scan with contrast; Result Unstructured Data: abnormal; Test Date: 20211115; Test Name: Neurological examination; Result Unstructured Data: normal; Test Date: 20211115; Test Name: Angiogram cerebral; Result Unstructured Data: abnormal; Test Date: 20211115; Test Name: Swallow study; Result Unstructured Data: Not reported; Test Date: 20211115; Test Name: RA stroke scale; Result Unstructured Data: 1 (increased); Test Date: 202111151314; Test Name: Computerised tomogram head; Result Unstructured Data: normal; Test Date: 202111151342; Test Name: Electrocardiogram; Result Unstructured Data: Abnormal; Test Date: 202111151805; Test Name: Magnetic resonance imaging head; Result Unstructured Data: normal; Test Date: 202111160626; Test Name: Blood urea; Result Unstructured Data: 12 mg/dL, normal; Test Date: 202111160626; Test Name: Glomerular filtration rate; Result Unstructured Data: normal; Test Date: 202111160626; Test Name: Blood sodium; Result Unstructured Data: 136 mmol/L, normal; Test Date: 202111160626; Test Name: Blood potassium; Result Unstructured Data: 3.8 mmol/L, normal; Test Date: 202111160626; Test Name: Blood glucose; Result Unstructured Data: 139 mg/dL, High; Test Date: 202111160626; Test Name: Blood creatinine; Result Unstructured Data: 0.89 mg/dL, normal; Test Date: 202111160626; Test Name: Blood chloride; Result Unstructured Data: 100 mmol/L, normal; Test Date: 202111160626; Test Name: Blood calcium; Result Unstructured Data: 8.6 mg/dL, low; Test Date: 202111160626; Test Name: Blood bilirubin; Result Unstructured Data: 0.6 mg/dL, normal; Test Date: 202111160626; Test Name: Blood bicarbonate; Result Unstructured Data: 26 mmol/L, Normal; Test Date: 202111160626; Test Name: Alkaline phosphatase; Result Unstructured Data: 93 IU/L, normal; Test Date: 202111160626; Test Name: Blood albumin; Result Unstructured Data: 3.2 g/dL, low; Test Date: 202111160626; Test Name: Alanine aminotransferase; Result Unstructured Data: 60 IU/L, high; Test Date: 202111160626; Test Name: Aspartate aminotransferase; Result Unstructured Data: 36 IU/L, increased; Test Date: 202111160626; Test Name: Anion gap; Result Unstructured Data: 10 mmol/L, normal; Test Date: 202111161245; Test Name: Full blood count; Result Unstructured Data: ABNORMAL; Test Date: 202111161406; Test Name: Platelet count; Result Unstructured Data: abnormal; Test Date: 202111161406; Test Name: Protein total; Result Unstructured Data: 6.4 g/dL, normal; Test Date: 202111161406; Test Name: Red blood cell count; Result Unstructured Data: 4.14 10*6/uL, decreased; Test Date: 202111161406; Test Name: Red cell distribution width; Result Unstructured Data: 12.9 %, NORMAL; Test Date: 202111161406; Test Name: Mean cell volume; Result Unstructured Data: 89.1 fL, normal; Test Date: 202111161406; Test Name: Mean cell haemoglobin concentration; Result Unstructured Data: 33.9 g/dL, normal; Test Date: 202111161406; Test Name: White blood cell count; Result Unstructured Data: 3.73 10*3/uL, Decreased; Test Date: 202111161406; Test Name: Haemoglobin; Result Unstructured Data: 12.5 g/dL, decreased; Test Date: 202111161406; Test Name: Haematocrit; Result Unstructured Data: 36.9 %, decreased; Test Date: 202111161406; Test Name: Mean platelet volume; Result Unstructured Data: 12.7 fL, increased; Test Date: 202111161406; Test Name: Metabolic function test; Result Unstructured Data: Abnormal; Test Date: 202111161406; Test Name: Mean cell haemoglobin; Result Unstructured Data: 30.2 pg, NORMAL
Aktuelle Erkrankungen: Ankylosing spondylitis; Aortic calcification (Without abdominal aortic aneurysm); Asthma; Bell's palsy; Chronic obstructive pulmonary disease (Stable Continue home inhalers Not needing oxygen); Complete rupture of rotator cuff (scheduled for rotator cuff repair full tear for 16/Nov/2021, cancelled due to COVID); Congestive heart failure; Coronary artery disease; Elevated liver enzymes; Fatty liver; Hyperlipidemia; Hypertension; Iron deficiency (De novo after the addition of coumadin); Left bundle branch block; Morbid obesity; Non-ischemic cardiomyopathy; Obstructive sleep apnea syndrome (on CPAP(Continuous positive airway pressure therapy)); Post concussion syndrome; Type II diabetes mellitus; Venous insufficiency
Vorgeschichte: Medical History/Concurrent Conditions: Cardiac assistance device user; Food allergy (anaphylaxis and hives); Motor vehicle accident; Transient ischemic attack
Andere Medikamente: COUMADIN; ASA; INSULIN; AMIODARONE; ZOLOFT; EFFEXOR; METOPROLOL; LISINOPRIL; ZETIA; CRESTOR; ALBUTEROL [SALBUTAMOL]; ASCORBIC ACID; CHOLECALCIFEROL; DOCUSATE SODIUM; EZETIMIBE; FERROUS SULFATE; HEPARIN
Allergien: -
Vorherige Impfungen: -

VAERS 1937008

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MI
Alter: 61,0
Geschlecht: F
Eingang: 09.12.2021
Impfdatum: 19.05.2021
Beginn: 06.12.2021
Tage bis Beginn: 201,0
Dosis: 1
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure C-reactive protein COVID-19 COVID-19 pneumonia Cardiomegaly Chest X-ray abnormal Chest pain Chills Cough Dyspnoea Exposure to SARS-CoV-2 Fatigue Fibrin D dimer Full blood count Hyperhidrosis Liver function test Metabolic function test Nausea

Symptomtext

Currently inpatient admission at (3) days. Admit to medicine-severe COVID pneumonia, acute on chronic hypoxemic respiratory failure Symptom day #4, patient did receive Johnson & Johnson vaccine, initiate remdesivir they Daily renal and liver function monitoring for kidney and liver toxicity due to Remdesvir is required Patient is wheezy, received 125 mg Solu-Medrol in the emergency department Will continue Solu-Medrol 40 mg q.6 hours, scheduled albuterol inhaler Trend daily CRP, CMP, complete blood count, D-dimer, continuous pulse oximetry Encourage incentive spirometry and pronation, p.r.n. Tessalon Perles a 61 y.o. female with a history of severe oxygen dependent chronic obstructive pulmonary disease and chronic pain who presents today with shortness of breath, cough, nausea, and chest pain. She says that her symptoms initially started but 4 days ago. She has had chills, fevers, cough, nausea, and chest pain. She notes that she is more short of breath than normal. She has been using her home inhalers without much relief. She has been vaccinated against COVID-19. On arrival, she test positive for COVID-19. She requires more oxygen than her baseline which is 2 L. she was tachycardic and tachypneic. On exam, she is diaphoretic and tired. She is wheezy but not using increased respiratory effort. Plans are discussed for admission and she is agreeable. She states that under no circumstances would she want have to live with the respirator, and as such she wants to be listed as DNR/DNI code status.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: DR CHEST SINGLE VIEW [356928432] Resulted: 12/06/21 2045 Order Status: Completed Updated: 12/06/21 2048 Narrative: EXAMINATION: Single View Chest EXAM DATE: 12/6/2021 8:20 PM TECHNIQUE: Single view chest INDICATION: Shortness of breath cough covid-19 exposure COMPARISON: 11/17/2021 ENCOUNTER: Not applicable _________________________ FINDINGS: Heart is mildly enlarged. There is mild prominence of pulmonary vascularity. There is minimal edema. There are no focal areas of consolidation. _________________________ Impression: Cardiomegaly and mild prominence of the pulmonary vascularity Collected: 12/06/21 2028 Order Status: Completed Specimen: Swabbed Collection from Nasopharynx Updated: 12/06/21 2043 COVID-19 PCR Detected
Aktuelle Erkrankungen: 4/7/21- COPD, Severe; Hypoxia
Vorgeschichte: Tobacco abuse COPD, severe Chronic pain syndrome Moderate recurrent major depression Mixed stress and urge incontinence Acute hypoxemic respiratory failure due to COVID-19 Osteoarthritis of lumbar spine DDD (degenerative disc disease), lumbar Rotator cuff tear Lumbar radiculopathy Microscopic hematuria Cervical spinal stenosis Cervical radiculopathy Insomnia Chronic prescription opiate use Nocturnal hypoxia Hypoxia Osteoarthritis of right knee Mixed hyperlipidemia
Andere Medikamente: albuterol (PROVENTIL) (2.5 MG/3ML) 0.083% nebulization albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler aspirin 325 MG tablet DULoxetine (CYMBALTA) 60 MG delayed release capsule HYDROcodone-acetaminophen
Allergien: Demerol Ivp Dye, Iodine Containing
Vorherige Impfungen: -

VAERS 2565478

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 54,0
Geschlecht: M
Eingang: 04.12.2021
Impfdatum: 06.04.2021
Beginn: 14.04.2021
Tage bis Beginn: 8,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 53yo M died on 4/14/2021 of unknown causes. His problem list included anxiety, depression & knee pain. His med list only included gabapentin, trazodone & prn ibuprofen. Pt mentioned to his provider that he is going to get some medication off the street for his anxiety, depression, & insomnia. Pt had received a covid vaccine (J&J) on 4/6/2021. There is no information available about the circumstances of pt's death. Not able to assess if death related to the vaccine, however events occurred with the week of each other, but pt with mental health issues and self admitted access to "street medications".

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1920812

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 69,0
Geschlecht: F
Eingang: 03.12.2021
Impfdatum: 05.04.2021
Beginn: 05.10.2021
Tage bis Beginn: 183,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt

Asthenia COVID-19 Cardiac arrest Cyanosis Death Dyspnoea Fatigue Gait inability Hyperglycaemia Hyperhidrosis Hypotension Hypoxia Respiratory failure Resuscitation SARS-CoV-2 test positive Sepsis Tachycardia

Symptomtext

pt to ED c/o weakness, fatigue, dyspnea, unable to ambulate, hyperglycemia, diaphoretic, hypoxemic, cyanotic, tachycardia, hypotensive, COVID positive, sepsis, respiratory failure; treated with Levophed, Baricitinib, remdesivir, dexamethasone; pt experienced cardiac arrest; CPR performed but pt died in the ED

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1943179

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 70,0
Geschlecht: M
Eingang: 30.11.2021
Impfdatum: 09.04.2021
Beginn: 01.09.2021
Tage bis Beginn: 145,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure COVID-19 pneumonia SARS-CoV-2 test positive

Symptomtext

Narrative: 69yr patient received J&J COVID vaccine 4/2021. Admitted to medical facility (9/1 to 9/10) secondary to COVID + PNA and acute hypoxic respiratory failure. Pertinent history: COPD, ESRD on HD, obesity, HTN, HFpEF, and DM2. Patient received dexamethasone 6mg daily along with ceftriaxone and azithryomycin.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1905809

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MO
Alter: 57,0
Geschlecht: M
Eingang: 29.11.2021
Impfdatum: 08.09.2021
Beginn: 10.11.2021
Tage bis Beginn: 63,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19 COVID-19 pneumonia Death Endotracheal intubation Intensive care Malaise Mechanical ventilation Paralysis SARS-CoV-2 test positive

Symptomtext

Onset of COVID symptoms 11/8, tested positive for COVID 11/10/21. admitted from the floor earlier today for acute hypoxic respiratory failure secondary to Covid PNA. Patient was initially a transfer from a hospital on 11/13. Admitted after he needed NIPPV. Intubated 11/17 and paralyzed and proned 11/17. Deceased 11/28/21.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 15,0
Labordaten: COVID PCR+11/10/21
Aktuelle Erkrankungen: -
Vorgeschichte: papillary thyroid carcinoma s/p thyroidectomy, now in acquired hypothyroidism, HTN, gout, and anxiety
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1905053

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: OH
Alter: 62,0
Geschlecht: M
Eingang: 29.11.2021
Impfdatum: 04.05.2021
Beginn: 01.11.2021
Tage bis Beginn: 181,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure COVID-19 COVID-19 pneumonia SARS-CoV-2 test positive

Symptomtext

Covid vaccine monitoring documentation. PT with positive Covid who was vaccinated. PT was not tested here, patient tested at hospital and positive 111/21. Admission 11/1/21 ? 11/6/21. PT vaccinated with Janssen Lot 042A21A on 5/4/21. Primary diagnosis documented as Acute hypoxic respiratory failure, COVID-19 pneumonia.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 6,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1893764

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MI
Alter: 73,0
Geschlecht: M
Eingang: 23.11.2021
Impfdatum: 07.06.2021
Beginn: 15.11.2021
Tage bis Beginn: 161,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Alanine aminotransferase increased Angiogram cerebral abnormal Anion gap normal Anticoagulant therapy Anxiety Aspartate aminotransferase increased Atrioventricular block first degree Bell's palsy Blood albumin decreased Blood alkaline phosphatase normal Blood bicarbonate normal Blood bilirubin normal Blood calcium decreased Blood chloride normal Blood creatinine normal Blood glucose increased Blood potassium normal Blood sodium normal

Symptomtext

Hospitalized /Observation status (11.15.21 - 11/16/21); COVID-19 positive (11.12.21); Fully vaccinated Pre-Existing Active Problems Diagnosis Date Noted POA ? Presence of Watchman left atrial appendage closure device 07/12/2019 Unknown ? Ankylosing spondylitis (HCC) 02/03/2020 Unknown ? History of transient ischemic attack (TIA) 10/30/2019 Unknown ? Elevated liver enzymes Unknown ? Post concussion syndrome 06/26/2019 Unknown ? Venous insufficiency of both lower extremities Unknown ? History of motor vehicle accident - 10/29/18 10/29/2018 Unknown ? COPD (chronic obstructive pulmonary disease) (HCC) 06/06/2018 Unknown ? Iron deficiency - De novo after the addition of coumadin 11/05/2017 Unknown ? Calcification of abdominal aorta - without AAA - (HCC) 11/03/2017 Unknown ? Asthma Unknown ? Morbid obesity with body mass index of 50 or higher (HCC) Unknown ? Diabetes mellitus, type II (HCC) Unknown ? Nonischemic cardiomyopathy (HCC) Unknown ? Left bundle branch block Unknown ? Chronic combined systolic and diastolic congestive heart failure (HCC) Unknown ? Coronary artery disease with angina pectoris (HCC) Unknown ? Hx of Bell's palsy Unknown ? OSA on CPAP Unknown ? Hyperlipidemia Unknown ? Fatty liver Unknown ? HTN (hypertension) Unknown Assessment/Plan ASSESSMENT / PLAN: 1. Right facial numbness: resolved ? Bells palsy ? TIA ? Anxiety NIH Stroke scale is 1. MRI brain - No infarct Lipid levels and A1C Pending. Neurology following Neuro checks q4hours Admit as obs. On asa and statin. 2. COVID 19 Infection: On room air. Symptom onset 3 days ago. Tested positive 11/12/2021 Fully vaccinated. D/W Monoclonal antibody team - patient will be a candidate. He is consented and MAB is ordered. 3. COPD: Stable. Continue home inhalers. Not needing oxygen. 4. Type 2 Diabetes Mellitus: 24 hour corrective insulin and await a1c. 5. H/o Atrial Fibrillation: s/p cardioversion in the past. Has a watchman device. On amiodarone and asa. 6. H/o Coronary Artery Disease: On asa, betablocker and acei. Stable. 7. H/o CHF: Systolic and diastolic: EF: 45% on a recent echo in 9/2021. On asa, betablocker and acei. Stable. Compensated. 8. Depression: On Zoloft and Effexor. 9.h/o Hypertension: On metoprolol and lisinopril. 10: h/o PFO 11. H/o Hyperlipidemia: On Zetia and Crestor. Continue. Full code Heparin Sub q Diabetic Diet. Likely could be discharged tomorrow morning if stable. Hospital Course Patient is a 74 y.o. male patient who originally presented to the hospital on 11/15/2021 with history of type 2 diabetes, TIA, triple agent, Bell's palsy, chronic obstructive pulmonary disease. Presented with left-sided facial numbness. He also has been recently tested for COVID due to family members with COVID symptoms. Patient tested positive on 11/12. He has been very anxious since he tested positive. The patient is fully vaccinated. Patient came to emergency department with hand left-sided facial numbness. Someone thought he might have facial weakness but by the time he was seen in the emergency department, no facial weakness was noted. Full neurological exam was normal. NIH stroke scale was 1. CT of the head and MRI brain were negative for stroke. Symptoms thought to be likely due to his Bell's palsy or anxiety. Patient did received monoclonal antibody for his COVID infection. He will be discharged to home today as he is back to his baseline. Consultations During Hospital Stay: Neurology REASON FOR CONSULT: Signs and symptoms of acute stroke ASSESSMENT/PLAN: Patient is a 74 y.o. male with a history of Afib s/p Watchman device, HTN, HLD, T2DM, OSA on CPAP, Bell's Palsy with residual left facial droop, CHF, Asthma, Anemia, COPD and TIA who was recently diagnosed with COVID-19 on 11/12/2021. He presents to the ED on 11/15/2021 after developing sudden onset right facial droop and right facial numbness. LKW 11:00am, initial NIHSS 1. Transient right facial droop Transient right facial numbness Symptoms completely resolved shortly after arrival to the ED. Given hypercoagulable state in the setting of COVID-19 infection, TIA is of high concern. Known Afib with watchman in place. With Echo completed within the past 3 months (9/7/2021), no need to repeat at this time. Plan: - MRI Brain without contrast - Daily NIHSS until stroke ruled out with MRI - Lipid Panel and A1c pending - Cardiac telemetry - q4hr Neuro checks - NPO until Bedside Swallow - PT/OT/SLP The above information was discussed with my attending physician. Please see their attestation for further information.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardio-respiratory arrest
Hospital-Tage: 2,0
Labordaten: Electrocardiogram, Complete Collected: 11/15/21 1342 Order Status: Completed Updated: 11/16/21 2146 Narrative: Ventricular Rate 59 BPM Atrial Rate 59 BPM P-R Interval 224 ms QRS Duration 180 ms Q-T Interval 522 ms QTC Calculation(Bazett) 516 ms Calculated P Axis 77 degrees Calculated R Axis 31 degrees Calculated T Axis 108 degrees Diagnosis Sinus bradycardia with 1st degree AV block Left bundle branch block Abnormal ECG When compared with ECG of 13-NOV-2021 08:21, No significant change was found MRI BRAIN WITHOUT CONTRAST Resulted: 11/15/21 1809 Order Status: Completed Updated: 11/15/21 1812 Narrative: EXAMINATION: MRI BRAIN WITHOUT CONTRAST EXAM DATE: 11/15/2021 6:05 PM TECHNIQUE: Routine protocol MR imaging of the brain was performed without intravenous contrast. INDICATION: 74-year-old with right facial droop. COMPARISON: CT brain dated November 15, 2021; MR brain dated February 11, 2020 HAND DOMINANCE: Right ENCOUNTER: Not applicable _________________________ FINDINGS: There is mild intracranial volume loss. There is no midline shift or hydrocephalus. The basal cisterns are intact. There is no acute intracranial hemorrhage or pathologic extra-axial fluid collection. T2/flair hyperintensities within the periventricular and subcortical white matter likely represent mild-to-moderate chronic small vessel ischemic change. No restricted diffusion is present to suggest acute infarct. The flow voids for the proximal intracranial arteries and dural sinuses are preserved. The marrow signal is within normal limits. There is mild mucosal thickening in the paranasal sinuses. _________________________ Impression: 1. No acute infarct. 2. Chronic findings including intracranial volume loss and mild-to-moderate chronic small vessel ischemic changes. CT ANGIO HEAD NECK WITH IV CONTRAST STROKE CODE Resulted: 11/15/21 1348 Order Status: Completed Updated: 11/15/21 1350 Narrative: EXAMINATION: CT Angio Head and neck EXAM DATE: 11/15/2021 1:14 PM TECHNIQUE: Multiple axial images were obtained from the upper chest through the skull vertex during the dynamic administration of intravenous Isovue 370. Contrast dose is documented in the electronic medical record. Multiplanar maximum intensity projection(MIP) images were created. PQRI documentation: All internal carotid artery percent stenoses are calculated using the distal internal carotid artery diameter as the denominator (NASCET criteria). INDICATION: Neuro deficit, acute, stroke suspected. COMPARISON: CT angiogram of 2/10/2020 ENCOUNTER: Initial HAND DOMINANCE: Right. _____________________ FINDINGS: Head: Right Anterior Circulation: There is approximately 50% short segment narrowing of the intracranial right internal carotid artery just above the skull base. The remainder of the right petrous internal carotid artery is patent without stenosis. The right cavernous internal carotid artery is patent without stenosis. There is approximately 50% atherosclerotic narrowing of the midportion of the supraclinoid right internal carotid artery. The A1 and A2 segments of the right anterior cerebral artery are patent without stenosis. The M1 and M2 segments of the right middle cerebral artery are patent without stenosis. Left Anterior Circulation: There is severe short segment narrowing of the intracranial left internal carotid artery just above the skull base (approximately 80%) which is new since the prior exam in 2020. This may be due to dissection, atherosclerosis, or a combination of these. The left cavernous internal carotid artery is patent without stenosis. There is approximately 50% atherosclerotic narrowing of the supraclinoid left internal carotid artery. The A1 and A2 segments of the left anterior cerebral artery are patent without stenosis. The M1 and M2 segments of the left middle cerebral artery are patent without stenosis. Posterior Circulation: There is approximately 50% short segment atherosclerotic narrowing of the proximal intracranial left vertebral artery. The basilar artery is patent without stenosis. The P1 and P2 segments of the posterior cerebral arteries are patent without stenosis. Aneurysm/Vascular Malformation: There is no evidence of intracranial aneurysm or other vascular lesion. Dural Venous Sinuses: The visualized dural venous sinuses are patent without evidence of dural venous sinus thrombosis. Neck: The aortic arch is normal in caliber. The innominate and bilateral subclavian arteries are widely patent. Right Carotid: The right common carotid artery is patent without stenosis. There is moderate right carotid bifurcation atherosclerosis, causing less than 50% carotid bulb stenosis. Left Carotid: The left common carotid artery is patent without stenosis. There is moderate left carotid bulb atherosclerosis, causing less than 50% stenosis. Right Vertebral: There is approximately 50% atherosclerotic narrowing of the right vertebral artery origin. The remainder of the right vertebral artery is widely patent through the neck. Left Vertebral: The left cervical vertebral artery is patent without stenosis. _________________________ Impression: 1. Approximately 50% short segment narrowing of the intracranial right internal carotid artery just above the skull base, unchanged since 2020. 2. Approximately 50% atherosclerotic narrowing of the midportion of the supraclinoid right internal carotid artery, also unchanged. 3. Severe short segment narrowing of the intracranial left internal carotid artery just above the skull base (approximately 80%) which is new since the prior exam in 2020. This may be due to (age indeterminant) dissection, atherosclerosis, or a combination of these. 4. Approximately 50% atherosclerotic narrowing of the supraclinoid left internal carotid artery. 5. Approximately 50% short segment atherosclerotic narrowing of the proximal intracranial left vertebral artery. Complete Blood Count without Differential (Abnormal) Collected: 11/16/21 1245 Order Status: Completed Specimen: Blood, Venous Updated: 11/16/21 1406 White Blood Cell 3.73 Low 4.00 - 10.80 x10*3/uL Red Blood Cell 4.14 Low 4.60 - 6.00 x10*6/uL Hemoglobin 12.5 Low 14.0 - 18.0 g/dL Hematocrit 36.9 Low 42.0 - 52.0 % Mean Cell Volume 89.1 80.0 - 100.0 fL Mean Cell Hemoglobin 30.2 27.0 - 33.0 pg NRBC Absolute Count 0.00 0.00 - 0.01 x10*3/uL NRBC Automated 0.0 0.0 - 0.1 %WBC Mean Cell Hemoglobin Concentration 33.9 32.0 - 37.0 g/dL Red Cell Diameter Width 12.9 11.0 - 16.0 % Platelet -- Comment: Automated platelet count is at least 91 x 10*3/uL. Platelet clumps noted on smear. Suggest redraw for accurate platelet count. Mean Platelet Volume 12.7 High 7.4 - 11 fL Comprehensive Metabolic Panel (CMP) (Abnormal) Collected: 11/16/21 0626 Order Status: Completed Specimen: Blood, Venous Updated: 11/16/21 0726 Sodium Level 136 134 - 146 mmol/L Potassium Level 3.8 3.4 - 5.0 mmol/L Chloride 100 98 - 112 mmol/L HCO3 26 21 - 29 mmol/L Anion Gap 10 9 - 18 mmol/L Glucose Level 139 High 70 - 99 mg/dL Blood Urea Nitrogen 12 8 - 20 mg/dL Creatinine 0.89 0.60 - 1.30 mg/dL MDRD eGFR >60 >=60 mL/min/1.73 m2 CG eCrCl 66 mL/min/1.73 m2 Calcium Level Total 8.6 8.6 - 10.4 mg/dL Protein Total 6.4 6.0 - 8.0 g/dL Albumin Level 3.2 Low 3.5 - 5.0 g/dL Bilirubin Total 0.6 0.2 - 1.0 mg/dL Alkaline Phosphatase 93 40 - 129 IU/L Alanine Aminotransferase 60 High 10 - 40 IU/L Aspartate Aminotransferase 36 10 - 40 IU/L
Aktuelle Erkrankungen: 11/12 - ED for COVID/chest pain/thrombocytopenia scheduled for rotator cuff repair (full tear) for 11/16 - cancelled d/t COVID + status
Vorgeschichte: Pre-Existing Active Problems Diagnosis Date Noted POA ? Presence of Watchman left atrial appendage closure device 07/12/2019 Unknown ? Ankylosing spondylitis (HCC) 02/03/2020 Unknown ? History of transient ischemic attack (TIA) 10/30/2019 Unknown ? Elevated liver enzymes Unknown ? Post concussion syndrome 06/26/2019 Unknown ? Venous insufficiency of both lower extremities Unknown ? History of motor vehicle accident - 10/29/18 10/29/2018 Unknown ? COPD (chronic obstructive pulmonary disease) (HCC) 06/06/2018 Unknown ? Iron deficiency - De novo after the addition of coumadin 11/05/2017 Unknown ? Calcification of abdominal aorta - without AAA - (HCC) 11/03/2017 Unknown ? Asthma Unknown ? Morbid obesity with body mass index of 50 or higher (HCC) Unknown ? Diabetes mellitus, type II (HCC) Unknown ? Nonischemic cardiomyopathy (HCC) Unknown ? Left bundle branch block Unknown ? Chronic combined systolic and diastolic congestive heart failure (HCC) Unknown ? Coronary artery disease with angina pectoris (HCC) Unknown ? Hx of Bell's palsy Unknown ? OSA on CPAP Unknown ? Hyperlipidemia Unknown ? Fatty liver Unknown ? HTN (hypertension) Unknown
Andere Medikamente: albuterol 108 MCG/act 2 puffs q 4 hrs prn amiodarone HCL 200 mg daily ascorbic acid 500 mg daily ASA 81 mg daily cholecalciferol 1000 units daily docusate sodium 100 mg BID ezetimibe 10 mg daily ferrous sulfate 325 mg every other day lispr
Allergien: celexa -throat swelling strawberry - anaphylaxis, hives cymbalta - dyspnea decadron - insomnia atorvastatin - leg cramps morphine - N/V sulfa drugs - renal failure
Vorherige Impfungen: -

VAERS 1889896

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MI
Alter: 85,0
Geschlecht: M
Eingang: 22.11.2021
Impfdatum: 09.06.2021
Beginn: 11.11.2021
Tage bis Beginn: 155,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Anticoagulant therapy COVID-19 COVID-19 pneumonia Chest X-ray normal Hypoxia Procalcitonin normal SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Hospitalized (11.9.21); COVID-19 positive (11.11.21); fully vaccinated Admission Date: 11/9/2021 Discharge Date: 11/18/2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypoxia Pneumonia due to COVID-19 virus COVID-19 HOSPITAL COURSE: Patient is a 85 y.o. male who presented with acute respiratory failure with hypoxemia secondary to COVID pneumonia. Patient had J and J vaccine breakthrough case COVID-19. He had Improved throughout hospitalization completed remdesivir and continued on initially IV followed by oral dexamethasone. Given furosemide 40 mg x 1 11/15/2021. Chest x-ray negative. Procalcitonin negative. Patient discharged back to extended care facility. Medically stable at this time. Awaiting results of COVID-19 test prior to discharge. Continue Decadron 6 mg orally q.day x3 days. Consult PT for evaluation and treatment when returns to Hospital. * Pneumonia due to COVID-19 virus Assessment & Plan Patient has weaned from 10 L down to 5L at this time. Overall Improving. COVID +: 11/8/2021 - tested at ECF. Patient is vaccinated with J&J. Day 9. PO Decadron. Completed remdesivir on November 15th. Continue VTE prophylaxis with enoxaparin.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 10,0
Labordaten: -
Aktuelle Erkrankungen: NA
Vorgeschichte: Diabetes mellitus type 2 in obese Essential hypertension, benign Mixed hyperlipidemia Depression Urge incontinence Dementia Pneumonia of left lower lobe due to infectious organism Sepsis Weakness
Andere Medikamente: acetaminophen (TYLENOL) 325 MG tablet aspirin 81 MG EC tablet benazepril (LOTENSIN) 40 MG tablet citalopram (CELEXA) 20 MG tablet dexamethasone (DECADRON) 6 MG tablet esomeprazole (NEXIUM) 20 MG delayed release capsule Insulin Glargine (TOU
Allergien: Ambien [Zolpidem] Aricept [Donepezil Hcl] Nasal Relief Spray [Oxymetazoline]
Vorherige Impfungen: -

VAERS 1873817

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21A

kritisch

Staat: MI
Alter: 21,0
Geschlecht: F
Eingang: 16.11.2021
Impfdatum: 30.03.2021
Beginn: 19.09.2021
Tage bis Beginn: 173,0
Dosis: 1
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein

Cerebrovascular accident Magnetic resonance imaging head abnormal

Symptomtext

My son had a stroke in the posterior occipital lobe. He was young and healthy without currrent health issues

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 5,0
Labordaten: MRI
Aktuelle Erkrankungen: -
Vorgeschichte: None
Andere Medikamente: No
Allergien: Penicillin and sulfa
Vorherige Impfungen: -

VAERS 1722860

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 87,0
Geschlecht: F
Eingang: 15.11.2021
Impfdatum: 09.04.2021
Beginn: 10.08.2021
Tage bis Beginn: 123,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Atrial fibrillation COVID-19 COVID-19 pneumonia Condition aggravated Asthenia Cardiac failure congestive Death Dyspnoea Dementia Diabetes mellitus Gait disturbance Hypophagia Influenza A virus test Influenza B virus test Left ventricular failure Lethargy Muscular weakness

Symptomtext

pt admitted to Hospital 8/7 - 8/19/21 and diagnosed with COVID pneumonia, started on dexamethasone; caregivers have COVID @ home and are unable to care for pt @ this time; pt admitted to Hospital 8/10/21 for physical therapy and worsening dyspnea and generalized weakness; treated with antibiotics, Lasix (CHF secondary to COVID pneumonia), breathing treatments; O2 OptiFlow and NRB with O2 sats in the 80s; condition continued to worsen and family put pt on comfort care measures only; pt died in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 12,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1722860

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 87,0
Geschlecht: F
Eingang: 15.11.2021
Impfdatum: 09.04.2021
Beginn: 10.08.2021
Tage bis Beginn: 123,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Atrial fibrillation COVID-19 COVID-19 pneumonia Condition aggravated Asthenia Cardiac failure congestive Death Dyspnoea Dementia Diabetes mellitus Gait disturbance Hypophagia Influenza A virus test Influenza B virus test Left ventricular failure Lethargy Muscular weakness

Symptomtext

pt admitted to Hospital 8/7 - 8/19/21 and diagnosed with COVID pneumonia, started on dexamethasone; caregivers have COVID @ home and are unable to care for pt @ this time; pt admitted to Hospital 8/10/21 for physical therapy and worsening dyspnea and generalized weakness; treated with antibiotics, Lasix (CHF secondary to COVID pneumonia), breathing treatments; O2 OptiFlow and NRB with O2 sats in the 80s; condition continued to worsen and family put pt on comfort care measures only; pt died in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 12,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1718935

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: NJ
Alter: -
Geschlecht: F
Eingang: 12.11.2021
Impfdatum: -
Beginn: 20.09.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Angiogram pulmonary abnormal Aortic dilatation Atrial fibrillation COVID-19 Cerebral small vessel ischaemic disease Angiogram pulmonary Computerised tomogram head Computerised tomogram head abnormal Condition aggravated Fatigue Hypoxia Lacunar infarction Heart rate increased Lung infiltration Mental status changes Myocardial strain imaging Pain Pleural effusion

Symptomtext

Pulmonary embolism; Cerebral small vessel ischaemic disease; Atrial fibrillation; Hypoxia; Lacunar infarction; Aortic dilatation; COVID-19; Condition aggravated; Fatigue; Lung infiltration; Mental status changes; Pain; Pleural effusion; Computerised tomogram head abnormal; Myocardial strain imaging; Angiogram pulmonary abnormal; SARS-CoV-2 antibody test positive; SARS-CoV-2 test positive; SUSPECTED CLINICAL VACCINATION FAILURE; This spontaneous report received from a health care professional via a Regulatory Authority Vaccine Adverse Event Reporting System (VAERS) (VAER reference number 1718935) concerned a 91 year old female of unknown race and ethnicity. Initial information received on 01-OCT-2021 was processed with additional information received on 06-OCT-2021. The patient's height, and weight were not reported. The patient's height, and weight were not reported. The patient's past medical history included: hyperkeratosis lenticularis perstans (HLP), paroxysmal atrial fibrillation, colon cancer remotely post RT and chemotherapy, and colon resection, and concurrent conditions included: hypertension (HTN), Chronic obstructive pulmonary disease (COPD), dementia, and arteriosclerotic heart disease (ASHD), and former smoker, and other pre-existing medical conditions included: The patient had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 042A21A expiry: unknown) dose was not reported, 1 total, administered on 08-APR-2021 for an unspecified indication. Concomitant medications included amlodipine 10 mg tablet, one tablet oral daily, metoprolol tartrate 25 mg tablet, one tablet oral every twelve hours, and simvastatin 20 mg tablet, 1 tablet oral daily at bedtime. On 20-SEP-2021, patient was brought into the hospital for worsening mental status fatigue and body aches in the emergency department patient was found to be in atrial fibrillation, rapid ventricular rate (RVR) was 120s. She was afebrile but was hypoxic on room air (Oxygen saturation) 88 percent. Patient tested positive for covid. Computed tomography angiography (CTA) positive for bilateral infiltrates r greater than L with bilateral effusions and noted to have a small non occlusive embolus of subsegmental branch of right lower lobe with no right heart strain and ascending aortic dilatation no dissection and computed tomography (CT) head shows remote lacunar infarcts and age related small vessel changes. the patient experienced cerebral small vessel ischaemic disease, lung infiltration, pleural effusion, pulmonary embolism, condition aggravated and suspected clinical vaccination failure. It was unspecified if an autopsy was performed. Laboratory data on the same day included: Angiogram pulmonary (NR: not provided) abnormal, Computerised tomogram head (NR: not provided) abnormal, Myocardial strain (NR: not provided) not reported, and SARS-CoV-2 antibody test (NR: not provided) IgM 0 07 and IgG 0 03. Laboratory data (dates unspecified) included: SARS-CoV-2 test (NR: not provided) Positive. On 20-SEP-2021, the patient died from pulmonary embolism, cerebral small vessel ischaemic disease, atrial fibrillation, hypoxia, lacunar infarction, aortic dilatation, covid-19, condition aggravated, fatigue, lung infiltration, mental status changes, pain, pleural effusion, computerised tomogram head abnormal, myocardial strain imaging, sars-cov-2 antibody test positive, angiogram pulmonary abnormal, and sars-cov-2 test positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the suspected clinical vaccination failure was not reported. This report was serious (Death, and Other Medically Important Condition). This report was associated with product quality complaint: 90000196325. The suspected product quality complaint has been confirmed to be the reported allegation could not be confirmed. A manufacturing related root cause could not be identified based on the PQC evaluation/investigation performed. Additional information received from Central Complaint Vigilance department on 09-NOV-2021. The following information was updated and incorporated into the case narrative: Product quality complaint investigation result.; Sender's Comments: V2: Additional information in this version updates: Product quality complaint investigation result. This updated information does not alter the causality of previously reported events. 20211009613-COVID-19 VACCINE AD26.COV2.S- pulmonary embolism, cerebral small vessel ischaemic disease, atrial fibrillation, hypoxia, lacunar infarction, aortic dilatation, covid-19, condition aggravated, fatigue, lung infiltration, mental status changes, pain, pleural effusion, computerised tomogram head abnormal, myocardial strain imaging, sars-cov-2 antibody test positive, angiogram pulmonary abnormal, and sars-cov-2 test positive. These events are considered unassessable. The events have a compatible/suggestive temporal relationship, are unlabeled, and have unknown scientific plausibility. There is no information on any other factors potentially associated with the events. V0 20211009613-COVID-19 VACCINE AD26.COV2.S-Suspected clinical vaccination failure. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS.; Reported Cause(s) of Death: CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE; ATRIAL FIBRILLATION; HYPOXIA; PULMONARY EMBOLISM; LACUNAR INFARCTION; AORTIC DILATATION; COVID-19; CONDITION AGGRAVATED; FATIGUE; LUNG INFILTRATION; MENTAL STATUS CHANGES; PAIN; PLEURAL EFFUSION; COMPUTERISED

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: Test Date: 20210920; Test Name: Myocardial strain imaging; Result Unstructured Data: not reported; Test Date: 20210920; Test Name: SARS-CoV-2 antibody test; Result Unstructured Data: IgM 0 07 and IgG 0 03; Test Date: 20210920; Test Name: Angiogram pulmonary; Result Unstructured Data: ABNORMAL; Test Date: 20210920; Test Name: Heart rate high; Result Unstructured Data: 120; Comments: 120s; Test Date: 20210920; Test Name: Computerised tomogram head; Result Unstructured Data: ABNORMAL; Test Date: 20210920; Test Name: Oxygen saturation; Result Unstructured Data: 88 %; Test Name: SARS-CoV-2 test; Result Unstructured Data: Positive
Aktuelle Erkrankungen: Arteriosclerotic heart disease; COPD; Dementia; Ex-smoker; Hypertension
Vorgeschichte: Medical History/Concurrent Conditions: Colectomy partial; Colon cancer; Hyperkeratosis lenticularis perstans; Paroxysmal atrial fibrillation; Comments: The patient had no known drug allergies.
Andere Medikamente: AMLODIPINE 10 MG; metoprolol tartrate 25 mg; SIMVASTATIN 20 MG
Allergien: -
Vorherige Impfungen: -

VAERS 1708967

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MI
Alter: 68,0
Geschlecht: M
Eingang: 12.11.2021
Impfdatum: -
Beginn: 01.08.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Angiogram Arteriosclerosis Arteriosclerosis coronary artery Asthenia Atelectasis C-reactive protein increased COVID-19 Cerebellar infarction Blood glucose Blood pressure measurement C-reactive protein Cardiomegaly Cerebral small vessel ischaemic disease Cerebrovascular accident Chest scan Computerised tomogram head Computerised tomogram head abnormal Condition aggravated

Symptomtext

DYSARTHRIA; SOMNOLENCE; HEMIPLEGIA; ISCHAEMIC STROKE; EMBOLIC STROKE; TRANSIENT ISCHAEMIC ATTACK; HYPERCOAGULATION; OROPHARYNGEAL PAIN; RHINORRHOEA; MALAISE; SARS-COV-2 TEST POSITIVE; SPINAL NERVE STIMULATOR IMPLANTATION; LYMPHOCYTE COUNT DECREASED; C-REACTIVE PROTEIN INCREASED; NIH STROKE SCALE; PROCALCITONIN; SERUM FERRITIN; ECHOCARDIOGRAM NORMAL; FIBRIN D DIMER; ENDOTRACHEAL INTUBATION; PNEUMONIA ASPIRATION; INTENSIVE CARE; COMPUTERISED TOMOGRAM HEAD ABNORMAL; FACIAL PARALYSIS; ARTERIOSCLEROSIS CORONARY ARTERY; CEREBELLAR INFARCTION; CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE; LACUNAR INFARCTION; HYPOVENTILATION; ARTERIOSCLEROSIS; MUCOSAL HYPERTROPHY; WHITE MATTER LESION; COMPUTERISED TOMOGRAM NECK; SCAN WITH CONTRAST; ANGIOGRAM; BLOOD GLUCOSE NORMAL; NEUROLOGICAL EXAMINATION ABNORMAL; COUGH; MOVEMENT DISORDER; EMPHYSEMA; SINUS CONGESTION; PYREXIA; ASTHENIA; ATELECTASIS; SPINAL OSTEOARTHRITIS; RIB FRACTURE; HYPOPERFUSION; COVID-19; CARDIOMEGALY; UNRESPONSIVE TO STIMULI; CONFIRMED CLINICAL VACCINATION FAILURE; CEREBROVASCULAR ACCIDENT; CONDITION AGGRAVATED; This spontaneous report received from a health care professional via a Regulatory Authority VAERS (Vaccine Adverse Event Reporting System)(VAERS ID: 1708967 and 1716357) concerned a 68 year old male. Initial information was processed with the additional information received on 06-OCT-2021. The patient's height, and weight were not reported. The patient's past medical history included: dysphagia, hip pain, low back pain, pain in limb, pressure injury of right ankle stage 2, pressure injury of sacral region stage 2, COVID-19, and hospital(hospitalization), and concurrent conditions included: essential hypertension benign, chronic obstructive pulmonary disease, acute ischemic stroke, chronic kidney disease stage 3, avoidant personality disorder, schizoaffective disorder, dyslipidemia, arthritis chronic pain disorder, lumbar spondylosis, urinary tract infection, indwelling urethral catheter, penicillin anaphylaxis allergy (throat swelling and was given Antihistamines), generalized weakness, urinary retention, aspiration pneumonia of left lower lobe, peanut/peanut oil allergy, sulfa allergy, and micronized NSAIDs/ NSAID allergy. The patient experienced confusion when treated with duloxetine hydrochloride, and tramadol for drug used for unknown indication, and drug allergy when treated with diphenhydramine, ibuprofen for drug used for unknown indication, and rash when treated with codeine for drug used for unknown indication. Laboratory data included: Glomerular filtration rate (NR: not provided) 30-59 ml min. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 042A21A) dose was not reported, 1 total, administered on right arm on 04-JUN-2021 for an unknown indication. Concomitant medications included acetylsalicylic acid for drug used for unknown indication, amlodipine besilate for drug used for unknown indication, ascorbic acid for drug used for unknown indication, atorvastatin calcium for drug used for unknown indication, calcium/colecalciferol for drug used for unknown indication, clozapine for drug used for unknown indication, and paracetamol for drug used for unknown indication. The patient was admitted with aspiration pneumonia left lower lob on 26-AUG-2021 (pneumonia aspiration) and was discharged back to AFC (adult foster care) home and unfortunately required more assistance than they could provide and required 2-3 personal assistant (condition aggravated). On 07-SEP-2021, the patient had COVID symptoms reported. The COVID testing was negative on 08-SEP-2021.The patient was negative two days ago and was fully vaccinated per report. Laboratory data included: SARS-CoV-2 test (NR: not provided) Negative. On 09-SEP-2021, the patient was presented to emergency room to hospital admission as patient experienced significant weakness (asthenia) for the past couple days. The patient was admitted for evaluation by physical therapy-occupational therapy (PT OT) for recommendations for rehab placement. He had complaints of cough, sinus congestion, nasal drainage (rhinorrhoea), and sore throat (oropharyngeal pain).Patient developed a fever (pyrexia) on presentation as well. The COVID testing was repeated on admission on 09-SEP-2021, which was positive COVID-19 PCR (polymerase chain reaction) test (NR: not provided) positive and confirmed clinical vaccination failure), however, he remained stable on room air with plans for monoclonal antibody treatment. The patient had malaise, could not lift right upper or lower extremity (movement disorder). It was reported that the patient had cerebrovascular accident, emphysema, hypoperfusion, hypoventilation, and was unresponsive to stimuli. The patient underwent several laboratory examinations which included blood glucose normal (NR: not provided) 102, blood pressure (NR: not provided) 142/67, Neurological examination (NR: not provided) abnormal, and Chest scan (NR: not provided) which (indicated streaky left basilar opacities favored to represent atelectasis. No new focal airspace opacity. No pneumothorax or pulmonary edema. There was unchanged mild cardiomegaly, chronic bilateral rib fractures. Degenerative changes of the spine are present, intrathecal stimulator lead with tip in the mid thoracic spine (spinal osteoarthritis) and small left pleural effusion was unchanged). On 10-SEP-2021, the patient was hospitalized. The chief complaint reason for admission was Acute ischemic stroke (embolic stroke) status post tissue plasminogen activator (TPA). As per neurology, the patient had acute ischemic stroke status post tissue plasminogen activator, suspect embolic atherosclerosis (arteriosclerosis) versus hypercoagulable state (hypercoagulation) in the setting of COVID plus transient ischemic attack(TIA). On 10-SEP-2021, the patient underwent computerized tomogram angiogram of head with IV contrast stroke which indicated (flow was identified within the basilar artery and proximal PCAs. There was a fetal origin of the right PCA (posterior cerebral artery) and no evidence of stenosis), computerized tomogram angiogram of neck with IV contrast which indicated (aortic arch: conventional three vessel anatomy, moderate calcified plaque, right common and internal carotid arteries: Common carotid artery was patent without significant stenosis. There was moderate largely calcified plaque at the proximal internal carotid artery which produces at least mild and potentially moderate stenosis (arteriosclerosis coronary artery), not definitively flow-limiting, left common and internal carotid arteries: scattered plaque along the common carotid artery course without flow-limiting stenosis. Calcified plaque at the bifurcation and carotid bulb with no evidence of more than mild proximal ICA (internal carotid artery) narrowing, vertebral arteries: Left vertebral artery was developmentally dominant. No more than mild narrowing of the left vertebral artery origin and no evidence of significant right ostial stenosis), computerized tomogram of head without IV contrast which indicated (small chronic infarction in the right cerebellum (Cerebellar infarction) and there appeared an interval new small infarct at the upper left cerebellum (lacunar infarct at left thalamus and small left cerebellar infarct), patchy low attenuation in the periventricular and other supra tentorial white matter compatible (white matter lesion), with at least moderate chronic small vessel ischemic disease (cerebral small vessel ischaemic disease) and probable superimposed tiny chronic lacunar infarctions. Congenital abnormality of the tentorium, calcified atherosclerotic plaque noted and posterior calvarial defect again noted. The orbital contents were intact. There was ethmoidal mucosal thickening (mucosal hypertrophy) and clear mastoid cells. No acute cranial hemorrhage, mass effect, or evidence of large acute territorial infarct) and computerized Tomogram perfusion of brain with IV contrast (No CT perfusion evidence of infarct core or ischemic tissue at risk). The case was discussed with neurologist, and if there were no evidence of acute bleed recommended TPA (tissue plasminogen activator) and if there were no large vessel occlusion, then would plan for transfer to stroke ICU (intensive care unit). On the evening of 16-SEP-2021, he was last known well (LKW). At 22:30 hours, upon reevaluation he had acute onset right facial droop (facial paralysis), right upper extremity and right lower extremity (RUE and RLE) plegia (hemiplegia) and then dysarthria(was unable to answer questions) at 00:44 hours of 17-SEP-2021. A stroke code was initiated. The blood pressure was 142/67 mmHg. A head computerized tomogram (CT) was negative for acute hemorrhage yet revealed a new acute subacute lacunar infarct at the left thalamus and small left cerebellar infarct (computerised tomogram head abnormal, cerebellar infarction, lacunar infarction). The computed tomography angiography (CTA) was significantly degraded by motion vessels visualized were negative for large vessel occlusion (LVO), Computed Tomography Perfusion (CTP)with no hypoperfusion or core. Accordingly, Tissue plasminogen activator (TPA) was administered at 02:17 and the patient was transferred to Intensive Care Unit (intensive care)for further evaluation. Upon arrival to the ICU, he was drowsy (somnolence) and dysarthric and followed simple commands. His strength appeared generalized and minimally worse on right. The lacunar workup would be completed and his COVID for potential respiratory compromise would be followed. A review of systems (ROS)was difficult secondary to dysarthria. He denied chest pain, abdominal pain and was unable to obtain complaints due to dysarthria. From 16-SEP-2021, the assessment plan was given as acute ischemic stroke, stable CT head showed acute subacute lacunar infarct at the left thalamus and a small left cerebellar infarction. The tissue plasminogen activator (tPA) given with no complications with some improvement of symptoms. They were unable to perform magnetic resonance imaging (MRI) brain due to implanted low back stimulator (spinal nerve stimulator implantation). Repeat computed tomography head(CTH) had been stable with no evidence of bleed or new infarcts. The echocardiogram (ECHO) was normal. The patient was continued on statin. The physical therapy, occupational therapy (PT OT), speech?language pathologist (SLP) consulted and was recommended sub-acute rehab (SAR) and dysphagia diet. The normal BP goal was given. The discharge planned to subacute rehab. The COVID-19 Assessment Plan was given as improving Current oxygen requirement: SpO2: 92 percentage, oxygen flow Rate per minute: 2 liters min, Lymphocyte count: 0.75 (lymphocyte count decreased), C-reactive protein: 28.5 (C-reactive protein increased), fibrin D-dimer and serum ferritin: No results provided, Procalcitonin: 0.07 and dexamethasone 6 mg per day was given. On day 6, the Venous thromboembolism (VTE) prophylaxis with enoxaparin and escalating oxygen support up to and including intubation (endotracheal intubation). In SEP-2021, Laboratory data included: NIH (National Institutes of Health)stroke scale (NR: not provided) Not reported, Oxygen saturation (NR: not provided) 92 percentage, and Procalcitonin (NR: not provided) 0.07. On 17-SEP-2021, Laboratory data included: Blood pressure (NR: not provided) 142/67 mmHg, CT angiography (NR: not provided) Negative, Angiogram (NR: not provided) no evidence of stenosis Computerised tomogram neck (NR: not provided) without significant stenosis, and Scan with contrast (NR: not provided) no perfusion evidence, no evidence of stenosis, computerised tomogram head (NR: not provided) Abnormal. Treatment medications (dates unspecified) included: dexamethasone and enoxaparin. The number of days hospitalized was reported as 8 days for events transient ischaemic attack, spinal nerve stimulator implantation, serum ferritin, somnolence, pneumonia aspiration, procalcitonin, rhinorrhoea, lymphocyte count decreased, malaise, NIH (National Institutes of Health )stroke scale, hypercoagulation, ischaemic stroke, fibrin D dimer, hemiplegia, echocardiogram normal, embolic stroke, endotracheal intubation, dysarthria and c-reactive protein increased and 11 days of hospitalization was reported for arteriosclerosis, asthenia, covid-19, cerebellar infarction, computerised tomogram head abnormal, condition aggravated, cough, facial paralysis, intensive care, lacunar infarction, oropharyngeal pain sars-cov-2 test positive, angiogram, arteriosclerosis coronary artery, atelectasis, blood glucose normal, cardiomegaly, cerebral small vessel ischaemic disease, cerebrovascular accident, computerised tomogram neck, emphysema, hypoperfusion, hypoventilation, movement disorder, mucosal hypertrophy, neurological examination abnormal, pyrexia, rib fracture, scan with contrast, sinus congestion, spinal osteoarthritis, unresponsive to stimuli and white matter lesion. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from arteriosclerosis, asthenia, c-reactive protein increased, covid-19, cerebellar infarction, computerised tomogram head abnormal, condition aggravated, cough, dysarthria, echocardiogram normal, embolic stroke, endotracheal intubation, facial paralysis, fibrin d dimer, hemiplegia, hypercoagulation, intensive care, ischaemic stroke, lacunar infarction, lymphocyte count decreased, malaise, NIH (National Institutes of Health)stroke scale, oropharyngeal pain, pneumonia aspiration, procalcitonin, rhinorrhoea, sars-cov-2 test positive, serum ferritin, somnolence, spinal nerve stimulator implantation, and transient ischaemic attack, and the outcome of confirmed clinical vaccination failure, angiogram, arteriosclerosis coronary artery, atelectasis, blood glucose normal, cardiomegaly, cerebral small vessel ischaemic disease, cerebrovascular accident, computerised tomogram neck, emphysema, hypoperfusion, hypoventilation, movement disorder, mucosal hypertrophy, neurological examination abnormal, pyrexia, rib fracture, scan with contrast, sinus congestion, spinal osteoarthritis, unresponsive to stimuli and white matter lesion was not reported. This report was associated with product quality complaint: 90000196324 and 90000197039 This report was serious (Hospitalization Caused / Prolonged). This case is a duplicate of 20211008977. Additional information was received on 03-NOV-2021. It was determined that Manufacturer Case Number (20211008977) was a duplicate of this case. All relevant information regarding this case(20211008977) will be submitted under Manufacturer Case Number (20211009378).; Sender's Comments: V1: Additional information updated in this version include: It was determined that Manufacturer Case Number (20211008977) was a duplicate of this case. All relevant information regarding this case(20211008977) will be submitted under Manufacturer Case Number (20211009378). This updated information does not alter the causality of previously reported events. 20211009378-covid-19 vaccine ad26.cov2.s -cerebellar infarction, embolic stroke, facial paralysis, hemiplegia, ischaemic stroke, lacunar infarct, transient ischaemic attack, arteriosclerosis, dysarthria. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY 20211009378-covid-19 vaccine ad26.cov2.s -Suspected clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS 20211009378-covid-19 vaccine ad26.cov2.s -pneumonia aspiration, COVID-19, Cough, malaise, asthenia, condition aggravated, hypercoagulation, C reactive protein increased, Oropharyngeal pain, Rhinorrhoea, SARS CoV-2 test positive, Serum ferritin, lymphocyte count decreased, Echocardiogram normal, Somnolence, endotracheal intubation, fibrin d dimer, procalcitonin, intensive care, spinal nerve stimulator implantation, NIH stroke scale, computerised tomogram head abnormal. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 8,0
Labordaten: Test Date: 202109; Test Name: Procalcitonin; Result Unstructured Data: 0.07; Test Date: 202109; Test Name: NIH stroke scale; Result Unstructured Data: Not reported; Test Date: 202109; Test Name: Fibrin D dimer; Result Unstructured Data: unspecified; Test Date: 202109; Test Name: C-reactive protein; Result Unstructured Data: 28.5, increased; Test Date: 202109; Test Name: Ferritin; Result Unstructured Data: unspecified; Test Date: 202109; Test Name: Echocardiogram; Result Unstructured Data: normal; Test Date: 202109; Test Name: Oxygen saturation; Result Unstructured Data: 92 %; Test Date: 202109; Test Name: Lymphocyte count; Result Unstructured Data: 0.75 decreased; Test Date: 20210907; Test Name: COVID-19 virus test; Result Unstructured Data: negative; Test Date: 20210908; Test Name: SARS-CoV-2 test; Result Unstructured Data: Negative; Test Date: 20210909; Test Name: SARS-CoV-2 test; Result Unstructured Data: positive; Test Date: 20210909; Test Name: Chest scan; Result Unstructured Data: left plural effusion unchanged; Test Date: 20210909; Test Name: Blood pressure; Result Unstructured Data: 142/67 mmHg; Test Date: 20210909; Test Name: COVID-19 PCR test; Result Unstructured Data: positive; Test Date: 20210909; Test Name: Neurological examination; Result Unstructured Data: abnormal; Test Date: 20210909; Test Name: Blood glucose; Result Unstructured Data: 102; Test Date: 20210910; Test Name: Computerised tomogram neck; Result Unstructured Data: without significant stenosis; Test Date: 20210910; Test Name: Computerised tomogram head; Result Unstructured Data: no acute intracranial hemorrhage; Test Date: 20210910; Test Name: Scan with contrast; Result Unstructured Data: no evidence of stenosis; Test Date: 20210910; Test Name: Angiogram; Result Unstructured Data: no evidence of stenosis; Test Date: 20210910; Test Name: Scan with contrast; Result Unstructured Data: no perfusion evidence; Test Date: 20210917; Test Name: CT angiography; Result Unstructured Data: Negative; Test Date: 20210917; Test Name: Computerised tomogram head; Result Unstructured Data: Abnormal; Test Date: 20210917; Test Name: Blood pressure; Result Unstructured Data: 142/67 mmHg; Test Name: Glomerular filtration rate; Result Unstructured Data: 30-59 ml min
Aktuelle Erkrankungen: Allergic reaction to antibiotics (rash); Anaphylactic reaction to drug (Throat swelling and was given Antihistamines); Arthritic pains; Aspiration pneumonia (unspecified aspiration pneumonia type); Avoidant personality disorder; Chronic kidney disease stage 3 (Glomerular filtration rate 30-59 ml per minute); Chronic obstructive pulmonary disease; Drug allergy (rash); Dyslipidemia; Essential hypertension; Ischemic stroke; Lumbar spondylosis; Peanut allergy (anaphylaxis); Schizoaffective disorder; Urethral catheterisation; Urinary retention; Urinary tract infection; Weakness generalized
Vorgeschichte: Medical History/Concurrent Conditions: Ankle injury; COVID-19; Dysphagia; Hospitalization; Low back pain; Pain in hip; Pain in limb; Soft tissue injury
Andere Medikamente: VITAMIN C [ASCORBIC ACID]; NORVASC; ASPRIN; LIPITOR; CALCIUM VITAMIN D; CLOZARIL; TYLENOL
Allergien: -
Vorherige Impfungen: -

VAERS 1785490

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: TX
Alter: 66,0
Geschlecht: M
Eingang: 06.11.2021
Impfdatum: -
Beginn: 01.10.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Angiogram abnormal COVID-19 Cardiac disorder Carotid artery occlusion Cerebrovascular accident Chest X-ray normal Computerised tomogram abnormal Death Embolism venous Endotracheal intubation Computerised tomogram Haemodynamic instability Haemoglobin Haemoglobin normal Hemiparesis Hypoxia Nucleic acid test Pulseless electrical activity

Symptomtext

DEATH; PULSELESS ELECTRICAL ACTIVITY; HAEMODYNAMIC INSTABILITY; HAEMOGLOBIN NORMAL; NUCLEIC ACID TEST; SARS-COV-2 TEST POSITIVE; THROMBECTOMY; TROPONIN INCREASED; ULTRASOUND DOPPLER; WHITE BLOOD CELL COUNT INCREASED; CONFIRMED CLINICAL VACCINATION FAILURE; COVID-19; ANGIOGRAM ABNORMAL; CARDIAC DISORDER; CHEST X-RAY NORMAL; COMPUTERISED TOMOGRAM ABNORMAL; ENDOTRACHEAL INTUBATION; CAROTID ARTERY OCCLUSION; CEREBROVASCULAR ACCIDENT; EMBOLISM VENOUS; HEMIPARESIS; HYPOXIA; SEPSIS; This spontaneous report received from a health care professional via the Regulatory Authority VAERS (Vaccine Adverse Event Reporting System) (VAERS ID: 1785490) concerned a 66 year old male of unknown race and ethnicity. The patient's past medical history included: acute otitis media, anxiety, and vitamin D deficiency, and concurrent conditions included: CAD (coronary artery disease), cataracts, CHF (congestive heart failure), chronic kidney disease, COPD (chronic obstructive pulmonary disease), DM (diabetes mellitus), enlarged thyroid, hypertension, and sleep apnea, and other pre-existing medical conditions included: The patient had no known drug allergy. The patient received covid-19 vaccine (suspension for injection, intramuscular, batch number: 042A21A expiry: unknown) dose was not reported, 1 total was administered to right arm on 11-APR-2021 for prophylactic vaccination. Concomitant medications included hydroxyzine for anxiety, carvedilol for drug used for unknown indication, escitalopram for drug used for unknown indication, furosemide for drug used for unknown indication, glipizide for drug used for unknown indication, isophane insulin for drug used for unknown indication, potassium chloride for drug used for unknown indication, salbutamol for drug used for unknown indication, and simvastatin for drug used for unknown indication. On 01-OCT-2021, patient presented to medical center with a chief complaint of cerebrovascular accident. The symptom onset was overnight and the patient woke up with complaints of left sided weakness (hemiparesis). The patient was seen by teleneurology and CTA (computed tomography angiography) showed occlusion at the right ICA (internal carotid artery) (carotid artery occlusion) origin CT (computed tomography) perfusion scan revealed at risk tissue that was felt to be amenable to reperfusion so patient was transferred to hospital (hospitalized for 11 days) emergently for cerebral thrombectomy. The patient was intubated (endotracheal intubation), the patient was covid-19 positive (confirmed clinical vaccination failure). The patient was extubated after procedure on 01-OCT-2021. On 01-OCT-2021, White blood cells were acutely elevated, Chest X-ray was stable (normal), LE (lower extremity) Doppler (ultrasound Doppler), troponin was increased (0.14 more than 0.15), heamoglobin was stable (normal). The patient was reintubated on 07-OCT-2021. On 11-OCT-2021, the patient developed acute hemodynamic instability and worsening of hypoxemia. It was reported that the patient's etiology was unclear, acute sepsis vs venous thrombolic disease (embolism venous). The patient was progressed to PEA (pulseless electrical activity) arrest (cardiac disorder) and did not have ROSC (return of spontaneous circulation) despite ACLS (advanced cardiovascular life support). On 11-OCT-2021, the patient passed away (died) from covid-19, cardiac disorder, carotid artery occlusion, cerebrovascular accident, embolism venous, heamodynamic instability, hemiparesis, hypoxia, pulseless electrical activity, and sepsis. It was unknown if autopsy was performed. The action taken with covid-19 vaccine was not applicable. The patient died of death, angiogram abnormal, chest x-ray normal, computerised tomogram abnormal, endotracheal intubation, heamoglobin normal, nucleic acid test, sars-cov-2 test positive, thrombectomy, troponin increased, ultrasound doppler and white blood cell count increased on 11-OCT-2021, and the outcome of confirmed clinical vaccination failure was not reported. This report was serious (Death, Hospitalization Caused / Prolonged). This report was associated with product quality complaint: 90000199301. The suspected product quality complaint has been confirmed to be the reported allegation could not be confirmed. A manufacturing related root cause could not be identified based on the PQC evaluation/investigation performed. Additional information received from Central Complaint Vigilance department on 02-Nov-2021. The following information was updated and incorporated into the case narrative: Product quality complaint investigation result.; Sender's Comments: V2: This version is created to update the information regarding Product quality complaint investigation result, this does not change the causality of the previously reported events. 20211046214-COVID-19 VACCINE Death, carotid artery occlusion, cerebrovascular accident, embolism venous, hemiparesis, hypoxia, sepsis, pulseless electrical activity, covid-19, angiogram abnormal, cardiac disorder, chest x-ray normal, computerised tomogram abnormal, endotracheal intubation, haemodynamic instability, haemoglobin normal, nucleic acid test, sars-cov-2 test positive, thrombectomy, troponin increased, ultrasound Doppler, white blood cell count increased. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20211046214-COVID-19 VACCINE Confirmed clinical vaccination failure. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS; Reported Cause(s) of Death: COVID-19; CARDIAC DISORDER; CAROTID ARTERY OCCLUSION; CEREBROVASCULAR ACCIDENT; EMBOLISM VENOUS; HAEMODYNAMIC INSTABILITY; HEMIPARESIS; HYPOXIA; PULSELESS ELECTRICAL ACTIVITY; SEPSIS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 11,0
Labordaten: Test Date: 20211001; Test Name: COVID-19 PCR test; Result Unstructured Data: Positive; Test Date: 20211001; Test Name: Computerised tomogram; Result Unstructured Data: Abnormal; Test Date: 20211001; Test Name: WBC; Result Unstructured Data: Increased; Test Date: 20211001; Test Name: Troponin; Result Unstructured Data: Increased; Test Date: 20211001; Test Name: Ultrasound Doppler; Result Unstructured Data: Unknown; Test Date: 20211001; Test Name: Haemoglobin; Result Unstructured Data: Normal
Aktuelle Erkrankungen: Cataracts; Chronic kidney disease; Congestive heart failure; COPD; Coronary artery disease; Diabetes mellitus; Enlarged thyroid; Hypertension; Sleep apnea
Vorgeschichte: Medical History/Concurrent Conditions: Anxiety; Otitis media acute; Vitamin D deficiency; Comments: The patient had no known drug allergy.
Andere Medikamente: SIMVASTATIN; ALBUTEROL [SALBUTAMOL]; CARVEDILOL; ESCITALOPRAM; FUROSEMIDE; GLIPIZIDE; HYDROXYZINE; NPH INSULIN; POTASSIUM CHLORIDE
Allergien: -
Vorherige Impfungen: -

VAERS 2580134

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 82,0
Geschlecht: M
Eingang: 05.11.2021
Impfdatum: 09.04.2021
Beginn: 17.09.2021
Tage bis Beginn: 161,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Abscess drainage Computerised tomogram abdomen abnormal Death Drain placement Dysphagia Infection Malaise Malnutrition Nausea Oesophageal candidiasis Oesophageal stenosis Oesophagogastroduodenoscopy abnormal Perinephric abscess Psoas abscess Systemic inflammatory response syndrome Urinary tract infection Urine analysis abnormal White blood cell count increased

Symptomtext

Narrative: Patient is an 82 yo male with PMHx COPD, HLD, HTN, GERD with hx of esophageal stricture s/p dilation 2009), anemia, chronic venous htn, and RA who presented to MC ED 9/7/21 c/o difficulty swallowing food, nausea, and general malaise x several months, steadily worsening. SIRS 2/4, WBC 24.4 and HR 114 OA. CT a/p concerning for psoas abscess; surgery consulted and recommended IR. UA with infectious signs, air in the nephric space concerning for complicated UTI vs translocative infection in the setting of psoas abscess, started on vanc/cefepime. Patient was admitted for further work up and treatment. IR performed CT guided abscess drainage yesterday 9/9/2021 with successful placement of drain into left lower quadrant to drain the lateral inferior abscess, and successful placement of drain through the left flank to drain the perinephric abscess. GI performed EGD yesterday 9/9/21 and found intrinsic 8 mm stricture that was 5 cm long and appeared at 35 cm; dilated to 10mm. Additional findings suggestive of candidal esophagitis. Hospice and palliative medicine consulted for Goals of care. Patient is known to palliative medicine service from prior admission May 2021. Patient was transitioned to comfort care in inpatient hospice unit 9/15/21. Pt then died on 9/17/2021 at hospital during inpatient hospice admission. Per MD death note, "Death was caused by: Severe Protein-Calorie Malnutrition" Pt had received one covid vaccine on 4/9/2021. Death is not related to covid vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2577055

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 72,0
Geschlecht: M
Eingang: 05.11.2021
Impfdatum: 28.04.2021
Beginn: 27.10.2021
Tage bis Beginn: 182,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Haemorrhagic stroke

Symptomtext

Narrative: 71yo mlae patient with Malignant neoplasm of larynx went to community ER on 10/20/21 with diagnosis of hemorragic stroke. Pt admitted to hospital and died at this hospital on 10/27/2021. Pt had received covid vaccine on 4/28/21 (J&J). This death is likely not related to the vaccinations due to comorbidities, age, and length of time from vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2597341

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 73,0
Geschlecht: M
Eingang: 02.11.2021
Impfdatum: 11.05.2021
Beginn: 23.08.2021
Tage bis Beginn: 104,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure COVID-19 Chest X-ray abnormal Chronic obstructive pulmonary disease Clostridium difficile infection Condition aggravated Death Dyspnoea Lung disorder Pneumonia SARS-CoV-2 test positive

Symptomtext

Narrative: Admission Date: Sep 23,2021 Discharge: Sep 8,2021 Condition of patient at discharge: deceased Acute hypoxic respiratory failure secondary to COVID-19 complicated by COPD on home O2. 73 year old male PMHx of COPD (on 3.5-4L NC baseline), HFpEF, saddle pulmonary embolism (s/p IVC filter), OSA, HTN, gout, and hyperlipidemia, presented to the Emergency Dept with dyspnea, found to be COVID+ (8/23) and worsening acute hypoxic respiratory failure despite being vaccinated with Janssen (J&J) vaccine on 5/11/2021. Patient treated for Covid (see treatment meds), pneumonia (vancomycin and Zosyn) and C. difficile (oral vancomycin) while hospitalized. Continued to require high flow nasal cannula and unable to wean off. Discussions had with family and patient for comfort care only with morphine for air hunger. Patient unfortunately passed away on 9/8/21.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: Specimen Collection Date: Aug 23, 2021@10:30 COVID-19 DETECTED H* Exam Date/Time 08/23/2021 10:33 Procedure Name CHEST-1 VIEW (AP/PA) Reason for Study dyspnea Impression Right greater left lower lung parenchymal disease, concerning for infection to include covid. Report Findings: Single portable view of the chest with comparison from one week prior demonstrates interval patchy right greater than left lower lung parenchymal disease. There is no larger pleural effusion. There is no pneumothorax. Cardiomediastinal silhouette is unchanged. No acute osseous abnormality is identified.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2600543

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A;

kritisch

Staat: -
Alter: 67,0
Geschlecht: M
Eingang: 01.11.2021
Impfdatum: 28.04.2021
Beginn: 31.08.2021
Tage bis Beginn: 125,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: 66yo with hx of htn, etoh abuse, tobacco use, hbp, & hearing loss who had not been seen in his promary care for last 4 years was found deceased in his apartment by property manager on 8/31/2021. No information about pt's death available. Pt had received one covid (j&J0 vaccine on 4/28/21, likely not related to pt's death given length of time btwn vaccine & pt's date of death.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2600529

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 67,0
Geschlecht: M
Eingang: 01.11.2021
Impfdatum: 09.04.2021
Beginn: 13.09.2021
Tage bis Beginn: 157,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Angiogram pulmonary abnormal Blood gases abnormal COVID-19 pneumonia Dyspnoea Dyspnoea exertional Lung infiltration PO2 decreased Pneumonia bacterial Scan with contrast abnormal Superinfection

Symptomtext

Narrative: Admission Date: September 13, 2021 Discharge Date: September 15, 2021 Discharge Type: Regular PRINCIPAL DIAGNOSIS: 1. Acute hypoxic respiratory failure ADDITIONAL DIAGNOSES: 1. Acute SARS-CoV-2 pneumonia. 2. Superimposed bacterial pneumonia 3. Prediabetes 4. History of pulmonary embolism and infarction 5. History of tuberculosis 6. History of tobacco use 7. Chronic sinusitis 8. Chronic post-traumatic stress disorder 9. Chronic insomnia PROCEDURES: 09/13/2021 CT angiogram of chest with contrast: Impression: 1) No radiographic evidence of pulmonary emboli. 2) Extensive interstitial infiltrates along with volume loss involving the right lung. HISTORY OF PRESENT ILLNESS: PATIENT is a 67 year-old male with a history of prediabetes, h/o PE with infarction, h/o TB, h/o tobacco use, chronic sinusitis, PTSD, and insomnia, who presented to the emergency department on 09/13/21 with complaint of persistent shortness of breath since being discharged from outside Hospital one week prior. He said the shortness of breath was mainly during exertion. He denied any fever, chills, increase in cough, abdominal symptoms, or urinary symptoms. He had tested positive for COVID-19 virus on 08/20/21, and was admitted to outside Hospital from 08/23-09/06/21. He received REGEN-COV (casirivimab & imdevimab monoclonal antibodies) on 08/23/21. He also received 5 days of IV remdesivir therapy from 08/24-08/28/21. He was discharged on 4 liters oxygen for home use. Of note, he had received one dose of Janssen COVID-19 vaccination on 04/09/21. In the ED on 09/13/21, a CT angiogram of the chest showed extensive right lung interstitial infiltrates, but no evidence of any pulmonary emboli. On ABG, pO2 was 73.9 on 4 liters oxygen. HOSPITAL COURSE: PATIENT was admitted to the Medical Step Down Unit on 09/13/21 for treatment of acute hypoxic respiratory failure, acute COVID-19 pneumonia with presumed superimposed bacterial pneumonia. He was placed on 6 liters of oxygen, and started on cefepime IV antibiotic. He was also treated with IV methylprednisolone, prn albuterol inhaler, and prn tylenol. His symptoms improved, and he was transferred to the general medical floor on 09/14/21. That day, he was successfully weaned to 4 liters, which was his home prescription. PATIENT was medically stable for discharge home on 09/15/21.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: 09/13/2021 CT angiogram of chest with contrast: Impression: 1) No radiographic evidence of pulmonary emboli. 2) extensive interstitial infiltrates along with volume loss involving the right lung.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2638776

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 91,0
Geschlecht: M
Eingang: 31.10.2021
Impfdatum: 13.08.2021
Beginn: 24.08.2021
Tage bis Beginn: 11,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Agitation Angiogram pulmonary abnormal Blood bicarbonate normal Blood gases abnormal Blood lactic acid Blood pH increased Brain natriuretic peptide increased COVID-19 COVID-19 pneumonia Chest X-ray abnormal Confusional state Death Fatigue Fibrin D dimer International normalised ratio increased Lung consolidation Lung opacity

Symptomtext

Narrative: COVID infection following COVID vaccine series 08/24 pt cc: fatigue exposure: unknown 08/31 Janssen, dose #1 09/05 CTA PE impression: 1. Negative for central PE. 2. Severe multifocal consolidation compatible, greatest at the lower lobes compatible with history of COVID pneumonia. 09/05 CXR impression: 1. Multifocal patchy interstitial and airspace opacities in the mid to lower lung zones, which may represent COVID-19 pneumonia given the history. Superimposed bacterial pneumonia remains a possibility. 2. Possible small bilateral pleural effusions. 09/05 COVID swab, result: detected 09/05 pt admit to medcine cc: confused, agitated, dx: Severe COVID-19 Pneumonia, Acute Hypoxic Respiratory Failure LOS: 2 days 09/05 TROPONIN I: 0.391 09/05 ABG: ABG: i-pH 7.52, i-PCO2 27.9, i-P02 54, i-HCO3 23.0 09/05 DDIMER: 67.14 09/05 LACTIC ACID: 2.18 09/05 PT/INR 14.6/32.3 09/05 BNP: 128.0 09/05 PROCALCITONIN: 0.22 09/05 SARS-COV-2 Variant Sequencing result: pending 09/15 pt deceased

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: 09/05 CTA PE impression: 1. Negative for central PE. 2. Severe multifocal consolidation compatible, greatest at the lower lobes compatible with history of COVID pneumonia. 09/05 CXR impression: 1. Multifocal patchy interstitial and airspace opacities in the mid to lower lung zones, which may represent COVID-19 pneumonia given the history. Superimposed bacterial pneumonia remains a possibility. 2. Possible small bilateral pleural effusions. 09/05 COVID swab, result: detected 09/05 TROPONIN I: 0.391 09/05 ABG: ABG: i-pH 7.52, i-PCO2 27.9, i-P02 54, i-HCO3 23.0 09/05 DDIMER: 67.14 09/05 LACTIC ACID: 2.18 09/05 PT/INR 14.6/32.3 09/05 BNP: 128.0 09/05 PROCALCITONIN: 0.22 09/05 SARS-COV-2 Variant Sequencing result: pending
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1829223

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 83,0
Geschlecht: F
Eingang: 29.10.2021
Impfdatum: 04.06.2021
Beginn: 23.08.2021
Tage bis Beginn: 80,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Respiratory arrest Respiratory failure SARS-CoV-2 test positive Sepsis

Symptomtext

pt admitted to hosp with hypoxic respiratory failure and sepsis due to positive for COVID 19; treated with antibiotics, steroids, breathing treatments; remdesivir, Baracitinib; overall condition and oxygenation worsened; pt experienced respiratory arrest in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Respiratory arrest
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1825164

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: ME
Alter: 36,0
Geschlecht: F
Eingang: 28.10.2021
Impfdatum: 30.07.2021
Beginn: 19.10.2021
Tage bis Beginn: 81,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Adenovirus test Anxiety Asthma Atelectasis Bordetella test negative COVID-19 Chest pain Chlamydia test negative Computerised tomogram thorax Condition aggravated Coronavirus test negative Cough Essential hypertension Exposure to SARS-CoV-2 Formication Human metapneumovirus test Human rhinovirus test

Symptomtext

Acute hypoxic respiratory insufficiency: Due to Atelectasis and Asthma exacerbation No actual pna / Infiltrate on CTA Tobacco use Hx of DVT / PT Factor 5 Leiden heterozygous Super Morbid Obesity Covid symptoms began on 10/15. Hospitalized 10/19. Patient reluctant to start solumedrol since it makes her incredibly anxious and she doesn't tolerate it. She is agreeable to decadron. Will schedule albuterol inh 4 puffs q 4 hours + q 2 hours prn. Try to avoid aerosolizing nebulizers if able. Monitor covid labs. Encourage tobacco cessation Continue home xarelto CTA thorax done on admission with no PE (atelectasis - no infiltrate) Essential HTN: DM2: Hold home metformin - Start low dose corrective (likely will need inc. Given steroid use). Vte prophy: Cont home Xarelto Diet: General per pt preference Code: Full HISTORY OF PRESENT ILLNESS: Patient is a 37 y.o. female who presents today with covid-19 symptoms and exertional hypoxia. She lives with a friend and she has covid also. She was vaccinated against Covid (in July - J&J). She has been feeling unwell for at least 5 days since 10/15/21. She has been checking her temp and having fevers up to 102.7 last night which was the highest. She has been taking tylenol and ibuprofen. She feels sore all over. She has chest pain that she describes as achy or sore. She has been having a dry cough. She hasn't brought up phlegm. She has had poor po intake. She has hx of DM on metformin. She has a history of asthma. was last hospitalized with asthma a few months ago. She has noticed wheezing in the past few days as well. She is reluctant to try any solumedrol since it makes her really anxious and crawling out of her skin. She has a hx of DVT and PE and takes Xarelto for that (factor 5 leiden hetero). She had nausea and vomiting 2 days ago - that was bilious but no N/V since then. She hasn't had any diarrhea.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 9,0
Labordaten: Procedure Component Value Ref Range Date/Time CT ANGIO THORAX WITH IV CONTRAST [347775223] Resulted: 10/19/21 1907 Order Status: Completed Updated: 10/19/21 1910 Narrative: EXAMINATION: CT Angiography of the Thorax EXAM DATE: 10/19/2021 6:25 PM TECHNIQUE: Standard protocol CT angiogram images were obtained through the chest following the administration of intravenous contrast. Coronal and sagittal MIP 3-D reformations were performed. CONTRAST: The amount and type of contrast are recorded in the medical record. QPP DOCUMENTATION: At least one of the following dose reduction techniques was utilized: Iterative reconstruction, and/or Automatic Exposure Control, and/or mA/kV adjustment based on body size. INDICATION: PE suspected, high prob, acute dypsnea, hx PE/dvt, recent COVID. COMPARISON: 5/10/2021 ENCOUNTER: Not applicable ____________________ FINDINGS: Base of Neck & Axillae: There is no lymph node enlargement. Mediastinum & Hila: There is no mediastinal or hilar lymph node enlargement. There is a mild 1 cm short axis right hilar lymph node. Nonspecific. Cardiovascular: The heart has a normal size. There is no pericardial effusion. The thoracic aorta is not aneurysmal and there is no dissection. There is no evidence for right heart strain. Pulmonary Arteries: Pulmonary arteries are not well opacified. Limited evaluation for pulmonary embolus. Is also limitations with respiratory motion artifact. There is no evidence of large or central pulmonary embolus. Lungs & Airways: Platelike atelectasis in the anterior right upper lobe near the junction of the right middle lobe. There is respiratory motion artifact somewhat limiting evaluation. No definite infiltrate. Pleural Space: There are no pleural effusions. There is no pneumothorax. Upper Abdomen: Included portions of the upper abdomen are unremarkable. Chest Wall & Musculoskeletal: No significant abnormality. ____________________ Impression: 1. No central large pulmonary embolus. There are limitations with respiratory motion artifact and limited opacification. 2. Platelike atelectasis anterior right upper lobe. Procedure Component Value Ref Range Date/Time Respiratory Pathogens by Film Array [347816505] (Abnormal) Collected: 10/20/21 0900 Order Status: Completed Specimen: Swabbed Collection from Nasopharynx Updated: 10/20/21 1417 Adenovirus PCR Film Array Not Detected Not Detected Coronavirus 229E PCR Film Array Not Detected Not Detected Coronavirus HKU1 PCR Film Array Not Detected Not Detected Coronavirus NL63 PCR Film Array Not Detected Not Detected Coronavirus OC43 PCR Film Array Not Detected Not Detected COVID-19 PCR Detected Abnormal Not Detected Comment: COVID-19 (SARS-CoV-2) test is positive. Clinical correlation with patient history and other diagnostic information is necessary to determine infection status. This test has received Emergency Use Authorization (EUA) by the FDA, but performance has not been evaluated for asymptomatic patients. Testing was performed using a nucleic acid amplification method. The specimen source may have been changed from the original order per patient situation or symptoms. See http://lab.spectrumhealth.org for additional information. Metapneumovirus PCR Film Array Not Detected Not Detected Rhinovirus-Enterovirus PCR Film Array Not Detected Not Detected Influenza A PCR Film Array Not Detected Not Detected Influenza A H3 PCR Film Array Not Detected Not Detected Influenza A H1 PCR Film Array Not Detected Not Detected Influenza A 2009 H1 PCR Film Array Not Detected Not Detected Influenza B PCR Film Array Not Detected Not Detected Parainfluenza 1 PCR Film Array Not Detected Not Detected Parainfluenza 2 PCR Film Array Not Detected Not Detected Parainfluenza 3 PCR Film Array Not Detected Not Detected Parainfluenza 4 PCR Film Array Not Detected Not Detected Respiratory Syncytial Virus PCR Film Array Not Detected Not Detected Bordetella pertussis PCR Not Detected Not Detected Bordetella parapertussis PCR Not Detected Not Detected Chlamydia pneumoniae PCR Not Detected Not Detected Mycoplasma pneumoniae PCR Not Detected Not Detected
Aktuelle Erkrankungen: Shortness of breath Hypoxia COPD exacerbation
Vorgeschichte: Non-Hospital hx of DVT Bipolar disorder (HCC) Depression Factor 5 Leiden mutation, heterozygous (HCC) hx of heroin abuse GERD (gastroesophageal reflux disease) Hypertension Tobacco abuse Anxiety Morbid obesity (HCC) Pulmonary embolism (HCC) Obstructive sleep apnea syndrome Moderate persistent asthma with exacerbation Microscopic hematuria Asthma exacerbation attacks Opioid use disorder, severe, dependence (HCC) Benzodiazepine abuse (HCC) Chronic hepatitis C without hepatic coma (HCC) Pulmonary emboli (HCC) Hematuria Morbid obesity (HCC) with BMI of 72.6 Acute asthma exacerbation Steroid-induced hyperglycemia Type 2 diabetes mellitus, without long-term current use of insulin (HCC)
Andere Medikamente: Outpatient Medications albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler busPIRone (BUSPAR) 10 MG tablet desvenlafaxine (PRISTIQ) 100 MG 24 hr tablet hydrOXYzine (VISTARIL) 50 MG capsule liraglutide (VICT
Allergien: Haldol [Haloperidol]Anxiety Methylprednisolone
Vorherige Impfungen: -

VAERS 1818646

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: IN
Alter: 40,0
Geschlecht: F
Eingang: 26.10.2021
Impfdatum: 10.04.2021
Beginn: 01.08.2021
Tage bis Beginn: 113,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Computerised tomogram Pulmonary embolism Upper respiratory tract infection

Symptomtext

I was diagnosed with pulmonary embolism on 08/27/2021. One week prior I had an upper respiratory infection. I saw the doctor and they gave me some medication. I went in again on 08/24/2021 and they gave me more medication and they thought I was having an asthmatic reaction to my respiratory infection. On 08/27/2021 I went again and they did a CT scan. It showed I had 2 blood clots in my lower left lung and that is when I was diagnosed with pulmonary embolism.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: 08/27/2021 CT scan- 2 blood clots in lower left lung , diagnosed with pulmonary embolism
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1808213

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MI
Alter: 40,0
Geschlecht: F
Eingang: 22.10.2021
Impfdatum: 18.08.2021
Beginn: 18.10.2021
Tage bis Beginn: 61,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Angiogram cerebral abnormal Arteriogram carotid abnormal Brain oedema COVID-19 Cerebellar artery occlusion Cerebral artery stenosis Cerebral haemorrhage Cerebral infarction Cerebral thrombosis Computerised tomogram head abnormal Condition aggravated Cough Decreased appetite Dizziness Fall Fatigue Haematocrit decreased Headache

Symptomtext

Hospitalized 10/18/2021; COVID-19 positive 10/18/2021; fully vaccinated Patient is a 41 y.o. female with past medical history of polysubstance abuse, ETOH abuse, non-ischemic cardiomyopathy with HVAD implant 12/22/2019 on ASA 325 mg and INR goal of 2.5-3.0 due to evidence of LV recovery, with LVEF 50% on echo 8/2021. Also with hx MVA due to ETOH abuse 8/2020 with SAH and right hip dislocation requiring surgical intervention, infected now on lifelong antibiotics. Patient states she fell about 2 weeks ago without injury, did not hit her head. States she tripped over her dog, but denies injury. About 1 week ago, developed significant headache that has been constant since, state headache better now but still there. Also has been feeling lightheaded and dizzy at times, so decided to come get checked out. Went to ED, CTH showed multiple areas intraparenchymal bleed and SAH. Also complained of dry cough for about a week, intermittent nausea and fatigue with poor oral intake over the last week. Taking in fluids ok, but hasn?t been eating much. Denies fever/chills, shortness of breath, orthopnea, abdominal pain, drainage from driveline. States has had some dried blood on driveline dressing changes, but no active bleeding. Denies vision changes, gait disturbances, slurred speech, unilateral weakness or other complaints at this time. ASSESSMENT / PLAN Recent Fall without head injury Headache with evidence of Multiple acute right cerebral hemisphere intraparenchymal hemorrhages, as well as mild SAH. - per CT from hospital - INR 2.9 at Mercy, given 2.5 mg vitamin K and 2 units of FFP. - hold coumadin and ASA for now, until cleared to restart from neurosurgery. - consult neurosurgery. Per ED, talked to neurosurgery who stated no acute needs at this time with no neurological changes. Will likely need follow-up CT head. - neuro checks, monitor for changes. Hx Non-ischemic Cardiomyopathy/Cardiogenic shock s/p HVAD implant 12/22/19 - previously on ASA 325 mg and coumadin (goal INR 2.5-3 due to LV recovery). Will hold for now with brain bleed. - last echo 8/16/21: LVEF 50%, RV normal. - await recommendation from neurosurgery on when ok to resume OAC. - multiple low flow alarms - consistent with LV recovery/suction events. Previously decreased HCT on pump to decrease alarms. Will give IVF resuscitation due to decrease oral intake. - continue BB and Entresto. Monitor BP. - monitor INR and LDH. COVID 19 + - patient with cough and poor appetite, no other symptoms. Symptoms started about 1 week prior. - O2 sats stable on RA. Defer treatment at this time. Monitor for progression of symptoms. 10/22/2021 note: ASSESSMENT / PLAN Plan for today: -supra therapeutic INR s/p vitamin K 2.5 mg po & 2 units FFP -Neurosurgery recommended 10 day hold of ASA & Coumadin. Coumadin was restarted at 3mg on 10/20 with goal to keep INR <1.5 for 7-10 days post bleed - appreciate neurosurgery comments/recommendations- plan to repeat head CT 10/22 afternoon and if stable- will start low intensity heparin with NO initial or subsequent boluses- then once therapeutic for 24 hours follow up CT head -stroke neurology team consulted per Neurosurg recs Multiple acute right cerebral hemisphere intraparenchymal hemorrhages, as well as mild SAH 10/18/21 Headache for 1 week prior to admit -recent fall without head injury PTA, only complaint is of HA x 1 wk, maybe intermittent blurry vision but no focal weakness - per CT from hospital - INR 2.9 at hospital, given 2.5 mg vitamin K and 2 units of FFP->INR on 10/19 am=1.5 - Coumadin 3 mg HS since 10/20 for new INR goal 2-2.5, but will keep < 1.5 for 7-10 days post bleed - Neurosurgery team appreciated -10/18 CTA Head/Neck with right M1/M2 near occlusive, stenosis likely subacute thrombosis -10/18 am CT Head with right MCA cortical & SAH with surrounding edema, favored hemorrhagic conversion of subacute infarct -repeat CT Head 10/18 early afternoon as recommended by NeuroSurg=no acute change - neuro checks q 4hr COVID 19 + - patient with mild cough and poor appetite, no other symptoms. Symptoms started about 1 week prior - O2 sats stable on RA. Defer treatment at this time. Monitor for progression of symptoms. - she was given Janssen vaccine 8/18/21

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Chronic interstitial cystitis Chronic pelvic pain in female Cyst of ovary Endometriosis Right ventricular dysfunction Long term current use of anticoagulant therapy Antiplatelet or antithrombotic long-term use History of depression History of cocaine use Complication involving left ventricular assist device (LVAD) History of subarachnoid hemorrhage Polysubstance abuse Chronic combined systolic and diastolic heart failure NICM (nonischemic cardiomyopathy) Left ventricular assist device present, placed 12/22/19 Intraparenchymal hematoma of brain COVID-19 Brain bleed
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet ascorbic acid (VITAMIN C) 100 MG tablet aspirin 325 MG tablet busPIRone (BUSPAR) 15 MG tablet digoxin (LANOXIN) 125 MCG tablet doxycycline (VIBRAMYCIN) 100 MG capsule ferrous sulfate 325 (65 Fe) MG dela
Allergien: NKA
Vorherige Impfungen: -

VAERS 1804809

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: SD
Alter: 42,0
Geschlecht: M
Eingang: 21.10.2021
Impfdatum: 02.04.2021
Beginn: 24.04.2021
Tage bis Beginn: 22,0
Dosis: 1
Route/Site: UN / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asymptomatic COVID-19 Cardiac arrest Death Fatigue SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

This is a breakthrough case who died, but the causality is not clear. There are unusual circumstances, in that the positive test was done post-mortem since the patient was an organ donor, thus the delay in identifying this as a breakthrough case. The patient was vaccinated on 04/02/2021. On 04/24/2021, he suffered a presumed cardiac arrest while exercising at home, and he subsequently passed away on the same day. Per policy, the organ/tissue donation facility ran a routine COVID-19 test on a sample taken on 04/25/2021 which came back PCR-positive on 04/27/2021. Per follow-up with the surviving spouse, the patient had been experiencing fatigue in the week prior to death, but no other possible COVID-19 symptoms that they were aware of. The case had also previously been COVID-19 positive in October 2020.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: PCR positive COVID-19 test despite being fully vaccinated (breakthrough case)
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1689428

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MD
Alter: 97,0
Geschlecht: F
Eingang: 15.10.2021
Impfdatum: 30.03.2021
Beginn: 28.08.2021
Tage bis Beginn: 151,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute myocardial infarction Asthenia COVID-19 Cough Death Chills Dyspnoea Hypoxia Pyrexia SARS-CoV-2 test positive Peripheral swelling Pneumonia Respiratory failure Suspected COVID-19

Symptomtext

Patient presented to the ED with fever, chills, cough, shortness of breath and bilateral leg swelling. She was found to have pneumonia of both lungs, suspected COVID-19 infection, hypoxia and respiratory failure. She was admitted for further management. Patient passed away after 4 days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1737483

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: TX
Alter: 52,0
Geschlecht: M
Eingang: 27.09.2021
Impfdatum: 11.04.2021
Beginn: 22.04.2021
Tage bis Beginn: 11,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein

Cerebrovascular accident Disability Impaired work ability Speech disorder

Symptomtext

4/22/2021 suffered a stroke, hospitalized on 4/23/2021 for 3 days! affected right side ,speech was affected. been off work since,Still currently off work disabilty 9/27/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 3,0
Labordaten: 4/22/2021 suffered a stroke, hospitalized on 4/23/2021 for 3 days! affected right side ,speech was affected. been off work since,Still currently off work disabilty 9/27/2021
Aktuelle Erkrankungen: high blood pressure,diebeted,
Vorgeschichte: high blood pressure,diebeted,
Andere Medikamente: metformin 500 mg ,simvastatin 20 mg , gabapentin 300 mg ,amlodipine 10 mg ,aspirin 325 mg
Allergien: none
Vorherige Impfungen: -

VAERS 1727441

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MI
Alter: 81,0
Geschlecht: M
Eingang: 23.09.2021
Impfdatum: 02.04.2021
Beginn: 15.09.2021
Tage bis Beginn: 166,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute kidney injury Acute respiratory failure Asthenia COVID-19 Chest X-ray abnormal Condition aggravated Cough Dementia Diarrhoea Dyspnoea Hyperglycaemia Hypophagia Mechanical ventilation Mental status changes Pneumonia aspiration Pulmonary congestion SARS-CoV-2 test positive Wheelchair user

Symptomtext

Hospitalized (9.15.21); COVID-19 positive (9.15.21); Fully Vaccinated Discharge Provider: Primary Care Provider at Discharge: Admission Date: 9/15/2021 Discharge Date: 9/23/2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Weakness [R53.1] AKI (acute kidney injury) (HCC) [N17.9] Acute respiratory failure with hypoxia (HCC) [J96.01] Aspiration pneumonia, unspecified aspiration pneumonia type, unspecified laterality, unspecified part of lung (HCC) [J69.0] COVID-19 [U07.1] HOSPITAL COURSE: he patient is an 81-year-old gentleman with presented to the hospital with acute respiratory insufficiency. He was noted to have COVID-19. Number has a past medical history significant for dementia, diabetes mellitus type 2, hypertension, dyslipidemia, CKD 3 and prior DVT for which he is on Xarelto. Apparently the patient became increasingly weak over the past 2-3 days prior to admission. He is normally able to ambulate around the home with use of walker but he was so weak on the day admission that a wheelchair was needed. His also had a cough, diarrhea and reduced oral intake. The patient has dementia at baseline but his mental status has even worsened. Denies any fevers chest pain abdominal pain or vomiting. The patient has a history of having aspiration pneumonia in the past. The patient does have a history of vaccination for COVID in the past. Upon evaluation in the emergency department the patient noted to be hypoxic. He was requiring 2 L of supplemental oxygen. Also found to have AKI on CKD positive for COVID PCR. X-ray chest demonstrated mild pulmonary vascular congestion. Was started on remdesivir and dexamethasone. He is on vent to the conservative management. And was subsequently taken off oxygen. Shortness of breath and cough also resolved. He did have significant hyperglycemia while he was on steroids. The sister was subsequently discontinued. Doing fine off oxygen.Plan is for home with OT/PT.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 9,0
Labordaten: -
Aktuelle Erkrankungen: NA
Vorgeschichte: Non-Hospital Urinary retention with incomplete bladder emptying Hematochezia Hospital History of DVT (deep vein thrombosis) 3/16/2016 Pneumonia due to COVID-19 virus Aspiration pneumonia (HCC) Dementia (HCC) OSA (obstructive sleep apnea) Prolonged Q-T interval on ECG Complete left bundle branch block Type 2 diabetes mellitus (HCC) Hyperlipidemia Hypertension Morbid obesity (HCC) CKD (chronic kidney disease) stage 3, GFR 30-59 ml/min with superimposed AKI Acute kidney injury (HCC) Acute respiratory insufficiency
Andere Medikamente: Outpatient Medications atorvastatin (LIPITOR) 20 MG tablet bumetanide (BUMEX) 2 MG tablet glimepiride (AMARYL) 2 MG tablet metformin (GLUCOPHAGE) 1000 MG tablet metOLazone (ZAROXOLYN) 2.5 MG tablet metoprolol succinate-XL (TOPROL-XL) 50 MG
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1726456

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

kritisch

Staat: FL
Alter: 57,0
Geschlecht: M
Eingang: 23.09.2021
Impfdatum: 17.05.2021
Beginn: 08.06.2021
Tage bis Beginn: 22,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cerebrovascular accident

Symptomtext

on 6/8/21 he had a stroke drs have not been able to link the stroke to the covid vax

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: trazadone seriquil clonodine metoptropnal
Allergien: -
Vorherige Impfungen: -

VAERS 1696342

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MI
Alter: 67,0
Geschlecht: F
Eingang: 14.09.2021
Impfdatum: 07.07.2021
Beginn: 26.08.2021
Tage bis Beginn: 50,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Abdominal pain Acute respiratory failure Azotaemia Barium swallow abnormal Bladder hypertrophy Blood potassium decreased COVID-19 Chest X-ray abnormal Computerised tomogram abdomen abnormal Computerised tomogram head normal Confusional state Cystitis Encephalopathy Escherichia infection Haematuria Hypertension Infection Mental status changes

Symptomtext

Hospitalized; COVID-19 positive (8.26.21 / 9.7.21); fully vaccinated Admission Date: 9/7/2021 Discharge Date: 09/13/2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute cystitis with hematuria Acute encephalopathy Altered mental status, unspecified altered mental status type HOSPITAL COURSE: Patient is a 68-year-old female with past medical history significant for end-stage renal disease on dialysis, diabetes, hypertension and chronic debility, resides in a nursing home over the last 4 months, presents to the hospital from dialysis as she became confused and started yelling that her legs hurt, complain of abdominal pain and had only finished about 75% of her dialysis run. Patient was also tested positive for COVID-19 on 08/26 and was started on Decadron on 08/30. She was noted to be mildly tachypneic, hypertensive 199/73 and needed 4 L nasal cannula. Urinalysis also was indicative of infection. Chest x-ray showed moderate pulmonary vascular congestion. Patient was admitted for further workup. Patient was noted to have E coli urinary tract infection and upon further evaluation with a CT showed possible ascending urinary tract infection. Urology consultation was obtained however felt that changes noted on CT were noted previously and this is likely related to low flow state given her dialysis state. No further urological interventions were felt to be needed. 7 day antibiotic course was completed. COVID-19: Patient was diagnosed to have COVID-19 on 08/26 and was started on dexamethasone 8/30 which she completed 10 day course. Respiratory status improved to her baseline. Acute hypoxic respiratory failure: Likely related to a combination of COVID-19 and volume status given her dialysis. This returned back to her baseline with supportive treatment, negative fluid balance to dialysis and ongoing treatment of COVID-19 End-stage renal disease: Nephrology assisted in management of dialysis. Patient was noted to be on Lokelma 4 days per week but was also noted to have low normal to low potassium levels and hence ir Lokelma dose was reduced to just 2 days per week. Hypertension: Even though she was noted to be hypertensive at admit, patient actually needed of her home dosing both Lopressor and losartan and maintained normal blood pressures. Encephalopathy: Likely related to toxic/metabolic encephalopathy related urinary tract infection, uremia and COVID-19. Over the hospital stay her mental status slowly improved. Goals of care discussion: Spoke to multiple times with son but attempts to call husband were unsuccessful. Did speak further about code status but per my conversation with patient, wishes are consistent with full resuscitation Consultations: Nephrology Neurology Gastroenterology Procedures: CT of the head negative Lower extremity bilateral ultrasound negative for DVT Barium swallow esophagogram suspicious for esophageal stricture, presbyesophagus CT of the abdomen and pelvis with IV contrast--bilateral urothelial/bladder wall thickening and hyper enhancement concerning for ascending urinary tract infection. Similar to changes noted on previous CT in April. Patchy ground-glass attenuation interlobular septal thickening has peripheral solid nodularity related to pulmonary edema versus COVID-19 infection Bilateral upper extremity ultrasound negative for DVT

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 7,0
Labordaten: -
Aktuelle Erkrankungen: NA COVID-19 positive 8.26.21 / 9.7.21
Vorgeschichte: DM (diabetes mellitus), type 2 with ophthalmic complications Generalized abdominal pain ESRD (end stage renal disease) on dialysis Chronic diarrhea HTN (hypertension) Arthritis Restless legs syndrome Multiple-type hyperlipidemia Unspecified severe protein-calorie malnutrition Multiple rib fractures Advanced care planning/counseling discussion Weakness Iron deficiency anemia, unspecified Chronic back pain Bipolar affective disorder Anemia of chronic disease Anemia in chronic kidney disease
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler CRANBERRY PO D-Mannose 500 MG CAPS Dextrose, Diabetic Use, (GLUCOSE PO) doxazosin (CARDURA) 4 MG tablet fiber supple
Allergien: Percocet [Oxycodone-acetaminophen] Itching Tramadol Other
Vorherige Impfungen: -

VAERS 1689182

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: OH
Alter: 59,0
Geschlecht: M
Eingang: 10.09.2021
Impfdatum: 18.05.2021
Beginn: 29.05.2021
Tage bis Beginn: 11,0
Dosis: 1
Route/Site: SYR / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Loss of consciousness Posturing Seizure

Symptomtext

Patient was sleeping, rolled over siezed up body postured with arms drawn. Called 911.Patient was unconscious and appeared to take his last breath as medics arrived. Medics and sheriffs arrived. I verified patient did not hit his head, fall or have any injury. They worked on the patient and transferred him to the hospital. Patient was pronounced Dead at the hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: blood pressure - sometimes acid reflux
Andere Medikamente: Lisinopril 10 MG
Allergien: none
Vorherige Impfungen: -

VAERS 1658405

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: OH
Alter: 58,0
Geschlecht: M
Eingang: 31.08.2021
Impfdatum: 25.05.2021
Beginn: 17.08.2021
Tage bis Beginn: 84,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Angiogram pulmonary abnormal Deep vein thrombosis Echocardiogram Pulmonary embolism Ultrasound Doppler abnormal

Symptomtext

New onset of multiple pulmonary embolisms and DVTs.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 3,0
Labordaten: Venous Duplex Scans, Chest CTA, CTD Echo
Aktuelle Erkrankungen: None
Vorgeschichte: Type 2 DM, Hyperlipidemia, Hypertension, seasonal allergies
Andere Medikamente: Albuterol, Amlodipine-Atorvastatin, Ascorbic acid, Aspirin, Cetirizine, Glimepiride, Janumet, Lisinopril, Multivitamin, zinc
Allergien: None
Vorherige Impfungen: -

VAERS 1591430

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: CT
Alter: 60,0
Geschlecht: M
Eingang: 26.08.2021
Impfdatum: -
Beginn: 22.04.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bundle branch block left Cardiac stress test normal Catheterisation cardiac Echocardiogram Ejection fraction decreased Echocardiogram abnormal Electrocardiogram abnormal Electrocardiogram Myocardial infarction Physical examination Left ventricular dysfunction Scan Ventricular hypokinesia

Symptomtext

FIXED INFERIOR INFEROSEPTAL AND APICAL WALLS CONSISTENT WITH PRIOR INFARCT; LOW EJECTION FRACTION; LEFT BUNDLE BRANCH BLOCK; This spontaneous report received from a health care professional concerned a 60 year old white and non Hispanic/Latino male. The patient's height, and weight were not reported. The patient's concurrent conditions included: the patient was only taking vitamins at the time of vaccine administration and other pre-existing medical conditions included: the patient had no known drug allergies, no known chronic illnesses prior to receiving the vaccine, no known previous medical conditions and no previous medication use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: 21-JUN-2021) dose was not reported, 1 total, administered on 31-MAR-2021 for prophylactic vaccination to left arm. Concomitant medications included carvedilol, losartan and Vitamins. The patient's medical examinations were provided by the nurse during the call. On 22-APR-2021, the patient went for annual physical and was found to have low ejection fraction of 29% and EKG showed a left bundle branch block,. On MAY-2021, the patient readings for ejection fraction was 30-35% via echocardiogram. On 22-JUL-2021, the patient's lexiscan (Cardiac stress test) failed and showed fixed inferior inferoseptal and apical walls consistent with prior infarct (event coded) myoglobal hypokinesis with moderate hypokinesis of the apex and left ventricular function is moderately to severely reduced with left ventricular ejection fraction (LVES) at 29%. On 17-AUG-2021, the patient cardiac catheterisation doctor gave verbal report of no blockages but, the patient is waiting for written confirmation from cardiologist. The patient was not hospitalized and did not require a visit to the emergency room. The patient also mentioned that if cardiologist can not figure out what was going on then patient had to seek tertiary help in the form of support from perhaps a University. The nurse also mentioned that had reported to VAERS on 20-AUG-2021 and provided a temporary e-report number of 619535. The nurse said the patient may follow up with additional information on now received patient's complaint and when probed for more details patient stated that patient will follow up with details after receiving VAERS report from health department of vaccination facility. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from low ejection fraction, and left bundle branch block, and the outcome of fixed inferior inferoseptal and apical walls consistent with prior infarct was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20210642793.; Sender's Comments: V0: 20210843055-covid-19 vaccine ad26.cov2.s- fixed inferior inferoseptal and apical walls consistent with prior infarct, low ejection fraction, left bundle branch block This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: -
Labordaten: Test Date: 20210422; Test Name: Electrocardiogram; Result Unstructured Data: Left bundle branch block; Test Date: 20210422; Test Name: Physical examination; Result Unstructured Data: Found low ejection fraction of 29%; Test Date: 202105; Test Name: Echocardiogram; Result Unstructured Data: Ejection fraction 30-35%; Test Date: 20210722; Test Name: Cardiac stress test normal; Result Unstructured Data: Failed and showed fixed inferior inferoseptal and apical wall consists; Test Date: 20210817; Test Name: Cardiac catheterisation; Result Unstructured Data: No blockages; Comments: doctor verbally reported no blockages to patient. Patient is awaiting.
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient had no known drug allergies, no known chronic illnesses prior to receiving the vaccine, no known previous medical conditions and no previous medication use. The patient was only taking vitamins at the time of vaccine administration.
Andere Medikamente: Losartan; Carvedilol; Vitamins Nos
Allergien: -
Vorherige Impfungen: -

VAERS 1591430

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: CT
Alter: 60,0
Geschlecht: M
Eingang: 26.08.2021
Impfdatum: -
Beginn: 22.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bundle branch block left Cardiac stress test normal Catheterisation cardiac Echocardiogram Ejection fraction decreased Echocardiogram abnormal Electrocardiogram abnormal Electrocardiogram Myocardial infarction Physical examination Left ventricular dysfunction Scan Ventricular hypokinesia

Symptomtext

FIXED INFERIOR INFEROSEPTAL AND APICAL WALLS CONSISTENT WITH PRIOR INFARCT; LOW EJECTION FRACTION; LEFT BUNDLE BRANCH BLOCK; This spontaneous report received from a health care professional concerned a 60 year old white and non Hispanic/Latino male. The patient's height, and weight were not reported. The patient's concurrent conditions included: the patient was only taking vitamins at the time of vaccine administration and other pre-existing medical conditions included: the patient had no known drug allergies, no known chronic illnesses prior to receiving the vaccine, no known previous medical conditions and no previous medication use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: 21-JUN-2021) dose was not reported, 1 total, administered on 31-MAR-2021 for prophylactic vaccination to left arm. Concomitant medications included carvedilol, losartan and Vitamins. The patient's medical examinations were provided by the nurse during the call. On 22-APR-2021, the patient went for annual physical and was found to have low ejection fraction of 29% and EKG showed a left bundle branch block,. On MAY-2021, the patient readings for ejection fraction was 30-35% via echocardiogram. On 22-JUL-2021, the patient's lexiscan (Cardiac stress test) failed and showed fixed inferior inferoseptal and apical walls consistent with prior infarct (event coded) myoglobal hypokinesis with moderate hypokinesis of the apex and left ventricular function is moderately to severely reduced with left ventricular ejection fraction (LVES) at 29%. On 17-AUG-2021, the patient cardiac catheterisation doctor gave verbal report of no blockages but, the patient is waiting for written confirmation from cardiologist. The patient was not hospitalized and did not require a visit to the emergency room. The patient also mentioned that if cardiologist can not figure out what was going on then patient had to seek tertiary help in the form of support from perhaps a University. The nurse also mentioned that had reported to VAERS on 20-AUG-2021 and provided a temporary e-report number of 619535. The nurse said the patient may follow up with additional information on now received patient's complaint and when probed for more details patient stated that patient will follow up with details after receiving VAERS report from health department of vaccination facility. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from low ejection fraction, and left bundle branch block, and the outcome of fixed inferior inferoseptal and apical walls consistent with prior infarct was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20210642793.; Sender's Comments: V0: 20210843055-covid-19 vaccine ad26.cov2.s- fixed inferior inferoseptal and apical walls consistent with prior infarct, low ejection fraction, left bundle branch block This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: -
Labordaten: Test Date: 20210422; Test Name: Electrocardiogram; Result Unstructured Data: Left bundle branch block; Test Date: 20210422; Test Name: Physical examination; Result Unstructured Data: Found low ejection fraction of 29%; Test Date: 202105; Test Name: Echocardiogram; Result Unstructured Data: Ejection fraction 30-35%; Test Date: 20210722; Test Name: Cardiac stress test normal; Result Unstructured Data: Failed and showed fixed inferior inferoseptal and apical wall consists; Test Date: 20210817; Test Name: Cardiac catheterisation; Result Unstructured Data: No blockages; Comments: doctor verbally reported no blockages to patient. Patient is awaiting.
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient had no known drug allergies, no known chronic illnesses prior to receiving the vaccine, no known previous medical conditions and no previous medication use. The patient was only taking vitamins at the time of vaccine administration.
Andere Medikamente: Losartan; Carvedilol; Vitamins Nos
Allergien: -
Vorherige Impfungen: -

VAERS 1633980

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MI
Alter: 61,0
Geschlecht: M
Eingang: 25.08.2021
Impfdatum: 01.04.2021
Beginn: 21.08.2021
Tage bis Beginn: 142,0
Dosis: 1
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Pulmonary embolism

Symptomtext

Patient admitted to hospital with PE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1602597

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MI
Alter: 65,0
Geschlecht: F
Eingang: 21.08.2021
Impfdatum: 27.04.2021
Beginn: 05.06.2021
Tage bis Beginn: 39,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood test Cerebrovascular accident Computerised tomogram Gait disturbance Grip strength decreased Hypoaesthesia Hypotonia Magnetic resonance imaging Musculoskeletal disorder SARS-CoV-2 test

Symptomtext

I had a mild stroke. I was typing on my laptop and all of a sudden my fingers were not working. They weren't pressing the keys. I thought maybe all the gardening I did that day my be contributing, plus I stayed up later after taking my insomnia medicine; so I went to sleep. Next morning, I could not hold my coffee cup and knew something was wrong. Plus I my left side arm & hand could not be used. It just flopped on the table; and left side of face & ear was numb and left leg was walking wonky. I went to the emergency room at the closest hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 12,0
Labordaten: Blood work, Covid test, Cat scan , and MRI was done. It was determined I had had a mild stroke located in the around the top middle of my head to the left.
Aktuelle Erkrankungen: None
Vorgeschichte: Insomnia. Foot Pain, situational depression
Andere Medikamente: Prestique, Serequel and Lamotrogine.
Allergien: Codine relate. Aloe.
Vorherige Impfungen: -

VAERS 1459756

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MO
Alter: 55,0
Geschlecht: F
Eingang: 21.08.2021
Impfdatum: -
Beginn: 01.04.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute kidney injury Alanine aminotransferase Amphetamines Analgesic drug level Angiogram Anion gap Anti-cyclic citrullinated peptide antibody Antibody test Antimicrobial susceptibility test resistant Antineutrophil cytoplasmic antibody Antinuclear antibody Antinuclear antibody negative Apolipoprotein Apolipoprotein A-I Aspartate aminotransferase Asthenia Chest pain Death

Symptomtext

ACUTE RENAL FAILURE; SEPTIC SHOCK; PERICARDITIS; VASCULITIS; STAPHYLOCOCCUS AUREUS INFECTION; SEPSIS; PERICARDIAL EFFUSION; POSSIBLE EPSTEIN BARR INFECTION; DEATH; AUTOPSY; HISTOLOGY; This spontaneous report received from a health care professional via a Regulatory Authority (VAERS ID: 1459756) concerned a 55 year old white female of unspecified ethnic origin. The patient's weight was 212 pounds, and height was 69 inches. The patient's concurrent conditions included: diabetes, hypertension, dyslipidemia, obesity, and tobacco abuser. The patient had no allergies to medications, food, or other products. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 042A21A, and expiry: Unknown) dose was not reported, with frequency 1 total administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 21-APR-2021, after vaccination, the patient admitted to the hospital with complaints of sharp pain which started one week prior to the admission and it was worse with deep breath. The patient also had no appetite and chills. On certain tests such as d-dimer, computed tomography of chest, it was diagnosed the patient had probable aortitis. The cause of aortitis was not clear during the admission period. The patient tested also identified with inflammatory response of the great vessels. No pulmonary embolism was identified. The patient was discharged from the hospital on 24-APR-2021 with steroid medication (prednisone 20 mg). The patient also diagnosed with pericarditis, possible staphylococcus aureus infection, uncontrolled type 2 diabetes mellitus with hyperglycemia, and possible Epstein Barr infection. Laboratory data included: ECG (NR: not provided) sinus rhythm, inferior infract, acute anteroseptal infract., Fibrin D dimer (NR: not provided) elevated, and Gram stain (NR: not provided) clusters of gram positive cocci. CT scan (NR: not provided) and results came as Heart: trace pericardial fluid thickening. calcification is present within the visualized coronary arteries. size is normal and position. Mediastinum: moderate to marked increased attenuation in the area around the great vessel origins and the descending aorta to the mid arch. This extends superiorly to the superior mediastinum along the course of the right brachiocephalic artery and to a lesser extend to the left common carotid artery. Nonspecific lymph nodes are present in the adjacent superior mediastinum. Nonspecific lymph nodes present also in the aorticopulmonary window. Thyroid: Nonspecific areas of decreased attenuation unable to be further characterized in the thyroid left greater than right. Largest measure approximately 1.5 cm. Vasculature, aorta: The thoracic aorta demonstrates no evidence of aneurysm or rupture as visualized. Minimal vascular calcification. Pulmonary arteries: No evidence of pulmonary embolus is demonstrated in the central or pulmonary arteries. Lymph nodes: no pathologically enlarged lymph nodes. On 21-APR-2021 14:49, Laboratory data included: Anion gap (NR: not provided) 9, Creatinine clearance (NR: not provided) 59.5, Glucose (NR: 74 - 106) 306 mg/dL, and Troponin (NR: 0.00 - 0.040) less than 0.006 ng/ml. On 21-APR-2021 15:49, Laboratory data included: GFR (NR: not provided) greater than 60 ml/min, Hematocrit (NR: 35 - 45) 49.4 %, Hemoglobin (NR: 12.0 - 16.0) 16.6 g/dL, Lymphocytes (NR: not provided) 10 %, MCH (NR: 27 - 31) 29.8 pg, MCHC (NR: 31 - 36.5) 33.6 g/dL, MCV 89 fL, Monocytes (NR: not provided) 10 %, Neutrophils (NR: 2 - 8.1) 14.6 10*3/uL, Platelet count (NR: 150 - 400) 224 10*3/uL, Red blood cell count (NR: 4.20 - 5.40) 5.57 10*6/uL, Red blood cell sedimentation rate (NR: 0 - 20) 28 mm/h, and WBC (NR: 4 - 10.8) 17.0 10*3/uL. On 21-APR-2021 16:09, Laboratory data included: Fibrin D dimer (NR: 215 - 500) 814 ng/mL, INR (NR: not provided) 1.15 (units unspecified), and Prothrombin time (NR: 9.4 - 12.5) 13.1 sec. On 21-APR-2021 17:54, Laboratory data included: Blood culture (NR: not provided) positive for staphylococcus aureus. On 21-APR-2021 20:09, Laboratory data included: Anti-cyclic citrullinated peptide antibody, HIV antibody, Hepatitis A antibody, Hepatitis B antibody and Hepatitis C antibody as Negative, non-reactive. On 21-APR-2021 20:46, Laboratory data included: Urine culture (NR: not provided) positive for staphylococcus aureus. On 21-APR-2021 22:26, Laboratory data included: Glucose (NR: 60 - 69) 204 mg/dL. On 22-APR-2021, Laboratory data included: Anti-SCL 70 (NR: not provided) less than 1.2 RLU, Antinuclear antibody (NR: not provided) positive, Double stranded DNA antibody (NR: not provided) Negative, Jo-1 antibody negative (NR: not provided) less than 2.2 RLU, Ribonucleoprotein antibody (NR: not provided) less than 3.5 RLU, and SM antibody (NR: not provided) less than 3.3 RLU. On 22-APR-2021 06:17, Laboratory data included: Glucose 131 mg/dL. On 22-APR-2021 09:42, Laboratory data included: MRI angiography (NR: not provided): Patent aorta and proximal branches. No stenosis identified. The significant surrounding inflammation of the proximal thoracic great vessels and aortic arch better demonstrated on the prior day CT. Findings remain concerning for large vessel vasculitis versus infectious etiology. On 22-APR-2021 10:55, Laboratory data included: Glucose 149 mg/dL. On 22-APR-2021 15:19, Laboratory data included: Anti-cyclic citrullinated peptide antibody (NR: not provided) less than16 units, Immunoglobulin G (NR: not provided) reported, and Rheumatoid factor (NR: not provided) positive. On 22-APR-2021 16:00, Laboratory data included: Troponin less than 0.006. On 22-APR-2021 18:36, Laboratory data included: Glucose 292 mg/dL. On 22-APR-2021 20:21, Laboratory data included: Glucose 302 mg/dL. On 23-APR-2021 04:17, Laboratory data included: Anion gap (NR: not provided) 8, Bicarbonate 23 mmol/L, Calcium 9.3 mg/dL, Chloride 108 mmol/L, Creatinine clearance (NR: not provided) 72.3, GFR (NR: not provided) greater than 60 ml/min, Glucose 104 mg/dL, Hematocrit 46.8 %, Hemoglobin 15.5 g/dL, Platelet count 234 10*3/uL, Potassium 3.9 mmol/L, Sodium 139 mmol/L, Troponin less than 0.006 ng/ml, and WBC 15.4 10*3/uL. On 23-APR-2021 06:07, Laboratory data included: Glucose 115 mg/dL. On 23-APR-2021 10:58, Laboratory data included: Glucose 228 mg/dL. Other laboratory data (dates unspecified) included: Creatinine (NR: not provided) 0.96, and GFR (NR: not provided) 60. On 1-MAY-2021, the patient again admitted to the hospital with complaints of chest pain, sepsis with septic shock and acute renal failure. On admission the patient admitted to emergency room covered in feces. The patient also had multiple scratches and excoriations covered entire body as a part of different stages of healing (the patient had 10 cats). On first day of admission, the patient was in shock and she had taken to intensive care unit (ICU) and on two vasopressors(unspecified). The patient's respiratory failure worsened at night and kept her on intubation and was later placed on ventilator. The patient also had profound metabolic acidosis which was unresponsive to medical therapy. The patient was presented with a pH of 7.2 and she was placed on bicarb drip with additional pushes and her pH continued to deteriorate. From nephrology she had instructed to start dialysis. The patient consulted with vascular surgery foe placement of a dialysis catheter. The patient also consulted with pulmonary critical care and infectious disease. The patient had large pericardial effusion. The patient had mild thrombocytosis and platelets were normal in morphology without significant platelet anisocytosis. Thrombocytosis might have accompanied along with reactive neutrophilia that are secondary to acute stress. Laboratory data included: Chest X-ray revealed cardiomegaly, Upper limb X-ray (NR: not provided) No acute bony abnormality identified in the right forearm, and pH (NR: not provided) 7.2. On 01-MAY-2021 04:49, Laboratory data included: Arterial blood gases (NR: not provided) pH art: 7.03 (normal- 7.35-7.45), pCO2 art: 33 mmHg(35-45), pO2 art: 77 mmHg(80-102 ), HCO3 art: 9mmol/l(22-26), O2Hb%:88%(95-100), % saturation, arterial: 90%(95-100), base excess art:-21.1mmol/l(-2-2), O2 cont. art: 16.4 vol. % (16-20), Hemoglobin art: 13.1 gm/dl(12-18), carboxy hemoglobin: 0.6%(0.0-0.2), met HB, arterial:0.7%(0.0-3.0), reduced HB: 10.4(2.5-9.3), NA level-art: 132mmol/l(135-145), K level: 5.8mmol/l(3.5-5.0), Cl level-art: 99mmol/l(98-106), Ion Ca level-art: 0.87mmol/l(1.05-1.30), arterial lactate: 1.6mmol/l(0.3-1.3), arterial glucose:373mg/dl(60-99), FIO2-arterial:90. On 01-MAY-2021 06:37, Laboratory data included: Albumin 2.2 g/dL, Alkaline phosphatase 185 U/L, Anion gap (NR: not provided) 22, BUN 115 mg/dL, Bicarbonate 10 mmol/L, Bilirubin total less than 0.2 mg/dl, Blood alcohol (NR: not provided) less than 12 mg/dl, C-reactive protein (NR: not provided) greater than 30.4 mg/dl, CK MB (NR: not provided) 1.71 ng/mL, CPK (NR: 34 - 145) 199 U/L, Calcium 7.5 mg/dL, Chloride 98 mmol/L, Creatinine 5.48 mg/dL, GFR (NR: not provided) 8 mL/min, Glucose 126 mg/dL, Hemoglobin 12.7 g/dL, Magnesium (NR: 1.6 - 2.6) 2.4 mg/dL, Phosphate (NR: 2.4 - 5.1) 12.5 mg/dL, Platelet count 477 10*3/uL, Potassium 5.3 mmol/L, Red blood cell sedimentation rate 69 mm/h, Sodium 130 mmol/L, and WBC 35.2 10*3/uL. On 01-MAY-2021 07:00, Laboratory data included: COVID-19 virus test (NR: not provided) Presumptive negative. On 01-MAY-2021 08:10, Laboratory data included: Antimicrobial susceptibility test resistant, Candida test, Cryptococcus test, Enterococcus test, Klebsiella test, Listeria test, Streptococcus test and Salmonella test as not detected, Staphylococcus test and staphylococcus aureus were detected. On 01-MAY-2021 09:17, Laboratory data included: Glucose (NR: 60 - 99) 464 mg/mL. On 01-MAY-2021 12:22, Laboratory data included: Epstein-Barr virus antibody (NR: not provided) less than 36 units/ml, 729 U/mL, and Epstein-Barr virus test (NR: not provided) greater than 600 units/ml. On 01-MAY-2021 13:15, Laboratory data included: Arterial blood gases (NR: not provided) pH art: 7.07 (normal- 7.35-7.45), pCO2 art: 23 mmHg(35-45), pO2 art: 62 mmHg(80-102 ), HCO3 art: 6mmol/l(22-26), O2Hb%:79%(95-100), % saturation, arterial: 80%(95-100), base excess art:-23.4mmol/l(-2-2), O2 cont. art: 15.2 vol. % (16-20), Hemoglobin art: 13.7 gm/dl(12-18), carboxy hemoglobin: -0.2%(0.0-0.2), met HB, arterial:1%(0.0-3.0), reduced HB: 20(2.5-9.3), NA level-art: 131mmol/l(135-145), K level: 5.6mmol/l(3.5-5.0), Cl level-art: 105mmol/l(98-106), Ion Ca level-art: 0.96mmol/l(1.05-1.30), arterial lactate: 1.4mmol/l(0.3-1.3), arterial glucose:185mg/dl(60-99),. On 01-MAY-2021 14:46, Laboratory data included: Glucose 318 mg/mL. On 01-MAY-2021 16:14, Laboratory data included: Glucose 226 mg/mL. On 01-MAY-2021 17:13, Laboratory data included: Arterial blood gases (NR: not provided) pH art: 7.09 (normal- 7.35-7.45), pCO2 art: 21 mmHg(35-45), pO2 art: 108 mmHg(80-102 ), HCO3 art: 6mmol/l(22-26), O2Hb%:96%(95-100), % saturation, arterial: 96%(95-100), base excess art:-21.8mmol/l(-2-2), O2 cont. art: 18 vol%(16-20), Hemoglobin art: 13.3 gm/dl(12-18), carboxy hemoglobin: 0.3%(0.0-0.2), met HB, arterial:0.5%(0.0-3.0), reduced HB: 3.7(2.5-9.3), NA level-art: 132mmol/l(135-145), K level: 5.6mmol/l(3.5-5.0), Cl level-art: 104mmol/l(98-106), Ion Ca level-art: 0.82mmol/l(1.05-1.30), arterial lactate: 1.6mmol/l(0.3-1.3), arterial glucose:241mg/dl(60-99), FIO2-arterial:70. On 01-MAY-2021 20:08, Laboratory data included: Amphetamines, Barbiturates, Benzodiazepine, Opiates, and Cannabinoids drug level as negative. Chlamydia test, Polymerase chain reaction were not detected, Legionella test and Streptococcus test was negative. On 02-MAY-2021 04:26, Laboratory data included: Antimicrobial susceptibility test resistant (NR: not provided) Amoxicillin/clavulanate, cefazolin, Clindamycin, erythromycin, gentamycin, levofloxacin, tetracycline, oxacillin, and trimethoprim/sulfa -susceptible, ampicillin and penicillin- resistant. On 02-MAY-2021 04:28, Laboratory data included: BUN 124 mg/dL, Bicarbonate less than 10 mmol/l, Calcium 6.5 mg/dL, Chloride 99 mmol/L, Creatinine 5.39 mg/dL, Creatinine clearance (NR: not provided) 10.6, GFR (NR: not provided) 8 mL/min, Glucose 395 mg/dL, Hematocrit 36.5 %, Hemoglobin 12 g/dL, MCH 29.9 pg, MCHC 32.9 g/dL, MCV 91 fL, Platelet count 476 10*3/uL, Potassium 5.5 mmol/L, Red blood cell count 4.02 10*6/uL, Red cell distribution width 15.3 %, Sodium 134 mmol/L, and WBC 34.8 10*3/uL. On 02-MAY-2021 04:56, Laboratory data included: Chest X-ray revealed cardiomegaly CHF and increasing pulmonary edema. On 02-MAY-2021 08:11, Laboratory data included: Echocardiogram (NR: not provided) Normal left ventricular systolic function. LV ejection fraction was 74%. The left ventricular ejection fraction was an estimation. mild left ventricular hypertrophy. Moderate to large pericardial effusion. The pericardial effusion was circumferential to the heart. No echocardiographic evidence to suggest cardiac tamponade. On 02-MAY-2021 10:56, Laboratory data included: Acetaminophen (NR: 10 - 20) less than 4 mcg/ml, Hepatitis B antibody, Hepatitis B antigen, and Hepatitis C antibody as non-reactive, and Salicylate (NR: 2.8 - 20) less than 3 mg/ml. On 02-MAY-2021 11:30, Laboratory data included: Apo A1 (NR: 0.2 - 0.3) 0.8 g/dL, Apo lipoprotein (NR: 0.5 - 0.9) 1.2 g/dL, Beta 2 globulin (NR: 0.2 - 0.5) 0.4 g/dL, Beta globulin (NR:.4 - 0.6) 0.4 g/dL, Complement factor C3 (NR: 83 - 193) 146 mg/dL, Complement factor C4 (NR: 15 - 57) 20 mg/dL, Gamma globulin (NR: 0.8 - 1.7) 0.7 g/dL, Serum protein electrophoresis (NR: 3.8 - 4.8) 1.7 g/dL, and Serum total protein 5.2 g/dL. On 02-MAY-2021 12:22, Laboratory data included: Beta-2 glycoprotein antibody (NR: not provided) less than 1, Brucella serology (NR: not provided) 0.58, 0.08, CMV IgG antibody (NR: not provided) less than 0.6 unit/ml, CMV IgM antibody (NR: not provided) less than 30, Ehrlichia serology (NR: not provided) less than 1:20, less than 1:64, Parvovirus B19 serology (NR: not provided) 7.8, 0.2, and Tuberculosis test (NR: not provided) indeterminate. On 02-MAY-2021 15:06, Laboratory data included: Albumin 2.2 g/dL, Alkaline phosphatase 328 U/L, Anion gap (NR: not provided) 25, BUN 97 mg/dL, Bicarbonate 17 mmol/L, Bilirubin total 0.5 mg/dL, Calcium 8.6 mg/dL, Chloride 95 mmol/L, Creatinine 4.26 mg/dL, Creatinine clearance (NR: not provided) 13.4, GFR (NR: not provided) 11 mL/min, Glucose 283 mg/dL, Potassium 5.8 mmol/L, SGOT (NR: not provided) 2655 U/L, SGPT 1204 U/L, Serum total protein 5.8 g/dL, and Sodium 137 mmol/L. On 02-MAY-2021 15:13, Laboratory data included: ECG (NR: not provided) atrial fibrillation. On 02-MAY-2021 16:11, Laboratory data included: Arterial blood gases (NR: not provided) pH art: 7.12 (normal- 7.35-7.45), pCO2 art: 27 mmHg (35-45), pO2 art: 64mmHg (80-102), HCO3 art: 9mmol/l(22-26), O2Hb%:81%(95-100), % saturation, arterial: 82%(95-100), base excess art:-19.3mmol/l(-2-2), O2 cont. art: 10.6 vol. % (16-20), Hemoglobin art: 9.2 gm/dl(12-18), carboxy hemoglobin: 0.2%(0.0-0.2), met HB, arterial:1%(0.0-3.0), reduced HB: 17.6(2.5-9.3), NA level-art: 137mmol/l(135-145), K level: 4.6mmol/l(3.5-5.0), Cl level-art: 103mmol/l(98-106), Ion Ca level-art: 0.93mmol/l(1.05-1.30), arterial lactate: 11.8mmol/l(0.3-1.3), arterial glucose:230mg/dl(60-99), FIO2-arterial:100. On 02-MAY-2021, the patient died from sepsis, pericarditis, large vessel vasculitis, and staphylococcus aureus infection as per the autopsy report. On 03-MAY-2021, Laboratory data included during autopsy: Blood urea nitrogen (NR: not provided) 107 mg/dL, Chloride (NR: not provided) 105 mmol/L, Creatinine (NR: not provided) 3.5 mg/dL, Ethanol (NR: not provided) negative, Glucose (NR: not provided) 161 mg/dL, Isopropanol (NR: not provided) negative, Methanol (NR: not provided) Negative, Potassium (NR: not provided) 11.2 mmol/L, and Sodium (NR: not provided) 141 mmol/L. Laboratory data (dates unspecified) included: ANA (NR: not provided) positive 1:1280, ANCA (NR: not provided) Negative, Anti-cyclic citrullinated peptide antibody (NR: not provided) Negative and GFR (NR: not provided) 60. Treatment medications (dates unspecified) included: metformin hydrochloride/sitagliptin phosphate monohydrate, trazodone, vitamin b complex, sodium bicarbonate, diltiazem, buspirone, venlafaxine hydrochloride, canagliflozin, prednisone, atorvastatin, ascorbic acid/beta carotene/biotin/calcium/calcium pantothenate/chromium amino acid chelate/colecalciferol/copper amino acid chelate/cyanocobalamin/folic acid/magnesium citrate/magnesium oxide/manganese amino acid chelate/mecobalamin/molybdenum amino acid chelate/nicotinamide/phytomenadione/potassium iodide/pyridoxine hydrochloride/retinol palmitate/riboflavin/selenium amino acid chelate/thiamine mononitrate/tocopheryl acetate/zinc amino acid chelate, colecalciferol, losartan, momordica charantia, glipizide, fish oil/omega-3 fatty acids, and insulin detemir. On 03-MAY-2021, Laboratory data included: Acetone, Amphetamines, Barbiturates, Benzodiazepine drug level, cannabinoids, muscle relaxants, opioid analgesics and stimulants levels were negative. An autopsy performed on 3-MAY-2021 08:00, which revealed pericarditis with large vessel vasculitis and a fibrinous exudate coating the epicardial surface of the heart. Ascending and descending aorta grossly and histologically remarkable. A gram stain performed on tissue from the brachiocephalic and left common carotid arteries revealed numerous clusters of gram positive cocci. The radial artery histologically showed fibrinoid material with associated inflammatory cells in a vessel wall within the adventitia but no inflammation of the vessel walls. Lungs with diffuse alveolar damage and centrilobular necrosis of the liver and acute tubular necrosis of the kidneys. The heart was enlarged (cardiomegaly, 500 grams) and exhibited moderate to severe calcific coronary artery disease with up to 80% occlusion of the left anterior descending coronary artery. ventral hernia. Multiple right sided rib fractures were noted, which were likely secondary to resuscitative efforts. remote cholecystectomy and bilateral tubal ligation. Vitreous electrolytes were significant for renal failure. It was unclear vaccination played a direct role in death. Based on the circumstances surrounding the death and the findings at autopsy, the patient died as a result of sepsis with pericarditis and large vessel vasculitis due to staphylococcus aureus bacterial infection. The manner of death was natural. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died of death, autopsy, vasculitis, septic shock, histology and staphylococcus aureus infection on 02-MAY-2021, and the outcome of possible Epstein Barr infection, pericardial effusion, acute renal failure was not reported. This report was serious (Death, Hospitalization Caused / Prolonged, and Other Medically Important Condition). Additional information was received via company representative on 06-AUG-2021, 07-AUG-2021 and 9-AUG-2021. The following information was updated and incorporated into the case narrative: Patient's demographics added (DOB, height, weight, race), patient history added (hypertension, obesity, dyslipidemia, tobacco abuse), cause of death updated (sepsis, pericarditis, large vessel vasculitis, staphylococcal aureus infection, Date of autopsy updated, events added (septic shock, sepsis, staphylococcal aureus infection, acute renal failure, possible Epstein Barr infection), seriousness criteria added (pericarditis, vasculitis and septic shock-Hospitalization caused/prolonged), hospital address added, lab data added (from data 3 to data 302), Reporter added and narrative updated. The narrative has been abstracted to comply with E2B data limitations. Sender's Comments: V1: Follow up information received in the current version is regarding patient demographics, medical history, autopsy findings, new events with clinical course and laboratory details. 20210751395-Covid-19 vaccine ad26.cov2.s-sepsis, pericarditis, vasculitis, staphylococcus aureus infection, septic shock, death, autopsy, histology, pericardial effusion, acute renal failure. Follow-up received regarding Clinical Details. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY; Reported Cause(s) of Death: SEPSIS; PERICARDITIS; LARGE VESSEL VASCULITIS; STAPHYLOCOCCUS AUREUS INFECTION.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 3,0
Labordaten: Test Date: 202104; Test Name: Physical examination; Result Unstructured Data: Reported; Comments: General: Alert, oriented and no acute distress. Head: Atraumatic, Eyes: PERRLA EOMI. Mouth: Moist mucus membrane. No pharyngeal erythema. Neck: soft and supple. No lymphadenopathy. Heart: regular rate and rhythm without murmur. Lungs: clear to auscultation bilaterally in all lung fields. Abdomen: No guarding or rebound. non tender and non distended, positive normoactive bowel sounds, no mass or hepatosplenomegaly, no bruits heard. Extremities: No clubbing, cyanosis or edema.; Test Date: 20210421; Test Name: ECG; Result Unstructured Data: sinus rhythm, inferior infract, acute anteroseptal infract.; Test Date: 20210421; Test Name: Gram stain; Result Unstructured Data: clusters of gram positive cocci; Test Date: 20210421; Test Name: Fibrin D dimer; Result Unstructured Data: elevated; Test Date: 202104211449; Test Name: SGOT; Result Unstructured Data: less than 15 u/l; Test Date: 202104211449; Test Name: Creatinine clearance; Result Unstructured Data: 59.5; Test Date: 202104211449; Test Name: Creatinine; Result Unstructured Data: 0.96 mg/dL; Test Date: 202104211449; Test Name: BUN; Result Unstructured Data: 12 mg/dL; Test Date: 202104211449; Test Name: Glucose; Result Unstructured Data: 306 mg/dL; Test Date: 202104211449; Test Name: Bicarbonate; Result Unstructured Data: 23 mmol/L; Test Date: 202104211449; Test Name: Chloride; Result Unstructured Data: 102 mmol/L; Test Date: 202104211449; Test Name: Potassium; Result Unstructured Data: 4.0 mmol/L; Test Date: 202104211449; Test Name: Sodium; Result Unstructured Data: 134 mmol/L; Test Date: 202104211449; Test Name: Troponin; Result Unstructured Data: less than 0.006 ng/ml; Test Date: 202104211449; Test Name: Calcium; Result Unstructured Data: 9.5 mg/dL; Test Date: 202104211449; Test Name: Anion gap; Result Unstructured Data: 9; Test Date: 202104211449; Test Name: Serum total protein; Result Unstructured Data: 8 g/dL; Test Date: 202104211449; Test Name: Bilirubin total; Result Unstructured Data: 0.7 mg/dL; Test Date: 202104211449; Test Name: Albumin; Result Unstructured Data: 3.9 g/dL; Test Date: 202104211449; Test Name: SGPT; Result Unstructured Data: 12 U/L; Test Date: 202104211449; Test Name: Alkaline phosphatase; Result Unstructured Data: 123 U/L; Test Date: 202104211549; Test Name: GFR; Result Unstructured Data: greater than 60 ml/min; Test Date: 202104211549; Test Name: Basophils; Result Unstructured Data: 0.0 10*3/uL; Test Date: 202104211549; Test Name: Red blood cell morphology; Result Unstructured Data: Normal; Test Date: 202104211549; Test Name: Red blood cell sedimentation rate; Result Unstructured Data: 28 mm/h; Test Date: 202104211549; Test Name: Eosinophils; Result Unstructured Data: 0.0 10*3/uL; Test Date: 202104211549; Test Name: Monocytes; Result Unstructured Data: 0.7 10*3/uL; Test Date: 202104211549; Test Name: Lymphocytes; Result Unstructured Data: 1.7 10*3/uL; Test Date: 202104211549; Test Name: Neutrophils; Result Unstructured Data: 14.6 10*3/uL; Test Date: 202104211549; Test Name: Basophils; Result Unstructured Data: 0 %; Test Date: 202104211549; Test Name: Eosinophils; Result Unstructured Data: 0 %; Test Date: 202104211549; Test Name: Monocytes; Result Unstructured Data: 10 %; Test Date: 202104211549; Test Name: Lymphocytes; Result Unstructured Data: 10 %; Test Date: 202104211549; Test Name: Platelet count; Result Unstructured Data: 224 10*3/uL; Test Date: 202104211549; Test Name: Red cell distribution width; Result Unstructured Data: 13.7 %; Test Date: 202104211549; Test Name: MCHC; Result Unstructured Data: 33.6 g/dL; Test Date: 202104211549; Test Name: MCH; Result Unstructured Data: 29.8 pg; Test Date: 202104211549; Test Name: MCV; Result Unstructured Data: 89 fL; Test Date: 202104211549; Test Name: WBC; Result Unstructured Data: 17.0 10*3/uL; Test Date: 202104211549; Test Name: Red blood cell count; Result Unstructured Data: 5.57 10*6/uL; Test Date: 202104211549; Test Name: Hemoglobin; Result Unstructured Data: 16.6 g/dL; Test Date: 202104211549; Test Name: Hematocrit; Result Unstructured Data: 49.4 %; Test Date: 202104211609; Test Name: Fibrin D dimer; Result Unstructured Data: 814 ng/mL; Test Date: 202104211609; Test Name: Prothrombin time; Result Unstructured Data: 13.1 sec; Test Date: 202104211609; Test Name: INR; Result Unstructured Data: 1.15; Test Date: 202104211729; Test Name: CT scan; Result Unstructured Data: Reported; Comments: Lungs: Bibasilar interlobular thickening with minimal interstitial accentuation. Minimal patchy opacification bilaterally , left greater than right. Heart: trace pericardial fluid thickening. calcification is present within the visualized coronary arteries. size is normal and position mediastinum: moderate to marked increased attenuation in the area around the great vessel origins and the descending aorta to the mid arch. This extends superiorly to the superior mediastinum along the course of the right brachiocephalic artery and to a lesser extend to the left common carotid artery. Non specific lymph nodes are present in the adjacent superior mediastinum. Non specific lymph nodes present also in the aorticopulmonary window. Thyroid: Non specific areas of decreased attenuation unable to be further characterized in the thyroid left grater than right. Largest measure approximately 1.5 cm. Bones/joints: No definite acute findings. Soft tissues: No definite acute findings. Vasculature: aorta: The thoracic aorta demonstrates no evidence of aneurysm or rupture as visualized. Minimal vascular calcification. Pulmonary arteries: No evidence of pulmonary embolus is demonstrated in the central or pulmonary arteries. Lymph nodes: no pathologically enlarged lymph nodes. Upper abdomen: The upper abdominal structures demonstrate no acute abnormalities as visualized.; Test Date: 202104211754; Test Name: Blood culture; Result Unstructured Data: positive for staphylococcus aureus; Test Date: 202104212002; Test Name: Urine analysis; Result Unstructured Data: Reported; Comments: color: straw (yellow-normal), appearance: clear (normal-clear), PH: 5.0 (normal- 7.0), Urine specific gravity: 1.024 (normal-1.015), urine protein: Negative(normal-negative), urine glucose: more than 3(normal-negative),urine ketones: trace(normal-negative), urine bilirubin: negative(normal-negative), urine blood: negative(normal-negative), urine urobilinogen: normal (normal), urine nitrite: negative(negative), urine LE-Test :negative (negative). urine RBC: 0-2(normal-absent), urine WBC: 0-5 (normal- 0-5), urine mucus: rare(normal-absent), urine yeast: rare (normal- absent), urine granular cast: none seen, Urine hyal cast: none seen (normal0-2), Urine RBC casts: none seen, urine waxy casts: none seen, urine WBC casts: none seen, urine epi casts: none seen.; Test Date: 202104212009; Test Name: Hepatitis C antibody; Result Unstructured Data: Negative, non reactive; Test Date: 202104212009; Test Name: HIV antibody; Result Unstructured Data: Negative, non reactive; Test Date: 202104212009; Test Name: Antibody test; Result Unstructured Data: Negative, non reactive; Test Date: 202104212009; Test Name: Anti-cyclic citrullinated peptide antibody; Result Unstructured Data: negative; Test Date: 202104212009; Test Name: Hepatitis B antibody; Result Unstructured Data: non reactive; Test Date: 202104212009; Test Name: Hepatitis A antibody; Result Unstructured Data: non reactive; Test Date: 202104212046; Test Name: Urine culture; Result Unstructured Data: positive for staphylococcus aureus; Test Date: 202104212226; Test Name: Glucose; Result Unstructured Data: 204 mg/dL; Test Date: 20210422; Test Name: Antinuclear antibody; Result Unstructured Data: positive; Comments: FANA titer: 1:1280, FANA pattern: speckled; Test Date: 20210422; Test Name: Anti-SCL 70; Result Unstructured Data: less than 1.2 RLU; Test Date: 20210422; Test Name: Jo-1 antibody negative; Result Unstructured Data: less than 2.2 RLU; Test Date: 20210422; Test Name: Double stranded DNA antibody; Result Unstructured Data: Negative; Test Date: 20210422; Test Name: SM antibody; Result Unstructured Data: less than 3.3 RLU; Test Date: 20210422; Test Name: Ribonucleoprotein antibody; Result Unstructured Data: less than 3.5 RLU; Test Date: 202104220350; Test Name: Anion gap; Result Unstructured Data: 9; Test Date: 202104220350; Test Name: Glucose; Result Unstructured Data: 95 mg/dL; Test Date: 202104220350; Test Name: BUN; Result Unstructured Data: 11 mg/dL; Test Date: 202104220350; Test Name: Creatinine; Result Unstructured Data: 0.77 mg/dL; Test Date: 202104220350; Test Name: Creatinine clearance; Result Unstructured Data: 74.2; Test Date: 202104220350; Test Name: GFR; Result Unstructured Data: greater than 60 ml/min; Test Date: 202104220350; Test Name: Bicarbonate; Result Unstructured Data: 22 mmol/L; Test Date: 202104220350; Test Name: Chloride; Result Unstructured Data: 107 mmol/L; Test Date: 202104220350; Test Name: Potassium; Result Unstructured Data: 3.4 mmol/L; Test Date: 202104220350; Test Name: Sodium; Result Unstructured Data: 138 mmol/L; Test Date: 202104220350; Test Name: Calcium; Result Unstructured Data: 9.2 mg/dL; Test Date: 202104220350; Test Name: Red blood cell morphology; Result Unstructured Data: Normal; Test Date: 202104220350; Test Name: Eosinophils; Result Unstructured Data: 0.15 10*3/uL; Test Date: 202104220350; Test Name: Basophils; Result Unstructured Data: 0.07 10*3/uL; Test Date: 202104220350; Test Name: Monocytes; Result Unstructured Data: 1.26 10*3/uL; Test Date: 202104220350; Test Name: Lymphocytes; Result Unstructured Data: 2.6 10*3/uL; Test Date: 202104220350; Test Name: Neutrophils; Result Unstructured Data: 12.25 10*3/uL; Test Date: 202104220350; Test Name: Basophils; Result Unstructured Data: 0 %; Test Date: 202104220350; Test Name: Eosinophils; Result Unstructured Data: 1 %; Test Date: 202104220350; Test Name: WBC; Result Unstructured Data: 16.4 10*3/uL; Test Date: 202104220350; Test Name: Red blood cell count; Result Unstructured Data: 5.18 10*6/uL; Test Date: 202104220350; Test Name: Hemoglobin; Result Unstructured Data: 15.5 g/dL; Test Date: 202104220350; Test Name: Hematocrit; Result Unstructured Data: 45.8 %; Test Date: 202104220350; Test Name: MCV; Result Unstructured Data: 88 fL; Test Date: 202104220350; Test Name: MCH; Result Unstructured Data: 29.9 pg; Test Date: 202104220350; Test Name: MCHC; Result Unstructured Data: 33.8 g/dL; Test Date: 202104220350; Test Name: Red cell distribution width; Result Unstructured Data: 13.5 %; Test Date: 202104220350; Test Name: Platelet count; Result Unstructured Data: 218 10*6/uL; Test Date: 202104220350; Test Name: Lymphocytes; Result Unstructured Data: 16 %; Test Date: 202104220350; Test Name: Monocytes; Result Unstructured Data: 8 %; Test Date: 202104220617; Test Name: Glucose; Result Unstructured Data: 131 mg/dL; Test Date: 202104220942; Test Name: MRI angiography; Result Unstructured Data: Reported; Comments: Normal course and caliber of the thoracic and abdominal aorta. There is mild atheromatous plaque of the lower descending thoracic aorta and abdominal aorta. Common origin of the brachiocephalic and left common carotid arteries, a normal variant. Patient flow is seen in the celiac, SMA, and bilateral renal arteries. No evidence of central pulmonary embolism. The previously demonstrated formation along the aortic arch and proximal great vessels is better demonstrated on prior day CT. No evidence of abscess or radiation or enlarged mediastinal adenopathy. Partially imaged abdomen does not show acute findings. Cholecystectomy. No stenosis are identified.; Test Date: 202104221055; Test Name: Glucose; Result Unstructured Data: 149 mg/dL; Test Date: 202104221519; Test Name: Rheumatoid factor; Result Unstructured Data: positive; Test Date: 202104221519; Test Name: Immunoglobulin G; Result Unstructured Data: reported; Comments: IGGS1-531mg/dl (382-921), IGGS2-226 mg/dl (271-700), IGGS3- 21mg/dl(22-178), IGGS4-10.9 mg/dl(4-86), IMMGG-913mg/dl(600-1640); Test Date: 202104221519; Test Name: Anti-cyclic citrullinated peptide antibody; Result Unstructured Data: less than16 units; Test Date: 202104221600; Test Name: Troponin; Result Unstructured Data: less than 0.006; Test Date: 202104221836; Test Name: Glucose; Result Unstructured Data: 292 mg/dL; Test Date: 202104222021; Test Name: Glucose; Result Unstructured Data: 302 mg/dL; Test Date: 202104230417; Test Name: Monocytes; Result Unstructured Data: 1.01 10*3/uL; Test Date: 202104230417; Test Name: Red blood cell morphology; Result Unstructured Data: Normal; Test Date: 202104230417; Test Name: Anion gap; Result Unstructured Data: 8; Test Date: 202104230417; Test Name: Calcium; Result Unstructured Data: 9.3 mg/dL; Test Date: 202104230417; Test Name: Troponin; Result Unstructured Data: less than 0.006 ng/ml; Test Date: 202104230417; Test Name: Sodium; Result Unstructured Data: 139 mmol/L; Test Date: 202104230417; Test Name: Potassium; Result Unstructured Data: 3.9 mmol/L; Test Date: 202104230417; Test Name: Chloride; Result Unstructured Data: 108 mmol/L; Test Date: 202104230417; Test Name: Bicarbonate; Result Unstructured Data: 23 mmol/L; Test Date: 202104230417; Test Name: Glucose; Result Unstructured Data: 104 mg/dL; Test Date: 202104230417; Test Name: BUN; Result Unstructured Data: 13 mg/dL; Test Date: 202104230417; Test Name: Creatinine; Result Unstructured Data: 0.79 mg/dL; Test Date: 202104230417; Test Name: Creatinine clearance; Result Unstructured Data: 72.3; Test Date: 202104230417; Test Name: GFR; Result Unstructured Data: greater than 60 ml/min; Test Date: 202104230417; Test Name: Eosinophils; Result Unstructured Data: 0.19 10*3/uL; Test Date: 202104230417; Test Name: Basophils; Result Unstructured Data: 0.06 10*3/uL; Test Date: 202104230417; Test Name: Lymphocytes; Result Unstructured Data: 1.79 10*3/uL; Test Date: 202104230417; Test Name: WBC; Result Unstructured Data: 15.4 10*3/uL; Test Date: 202104230417; Test Name: Red blood cell count; Result Unstructured Data: 5.16 10*6/uL; Test Date: 202104230417; Test Name: Hemoglobin; Result Unstructured Data: 15.5 g/dL; Test Date: 202104230417; Test Name: Hematocrit; Result Unstructured Data: 46.8 %; Test Date: 202104230417; Test Name: MCV; Result Unstructured Data: 91 fL; Test Date: 202104230417; Test Name: MCH; Result Unstructured Data: 30 pg; Test Date: 202104230417; Test Name: MCHC; Result Unstructured Data: 33.1 g/dL; Test Date: 202104230417; Test Name: Red cell distribution width; Result Unstructured Data: 13.4 %; Test Date: 202104230417; Test Name: Platelet count; Result Unstructured Data: 234 10*3/uL; Test Date: 202104230417; Test Name: Lymphocytes; Result Unstructured Data: 12 %; Test Date: 202104230417; Test Name: Monocytes; Result Unstructured Data: 7 %; Test Date: 202104230417; Test Name: Eosinophils; Result Unstructured Data: 1 %; Test Date: 202104230417; Test Name: Basophils; Result Unstructured Data: 0 %; Test Date: 202104230417; Test Name: Neutrophils; Result Unstructured Data: 12.29 10*3/uL; Test Date: 202104230607; Test Name: Glucose; Result Unstructured Data: 115 mg/dL; Test Date: 202104231058; Test Name: Glucose; Result Unstructured Data: 228 mg/dL; Test Date: 20210501; Test Name: Chest X-ray; Result Unstructured Data: cardiomegaly with significant increased in heart size; Comments: Mild CHF with central pulmonary vascular congestion. There are scattered areas of mainly interstitial opacity in the mid to lower portions of both lungs most likely representing sub segmental atelectasis. There is no pneumothorax.; Test Date: 20210501; Test Name: Upper limb X-ray; Result Unstructured Data: No acute bony abnormality identified in the right forearm; Comments: Normal right humerus radiographs.; Test Date: 20210501; Test Name: pH; Result Unstructured Data: 7.2; Test Date: 202105010449; Test Name: Arterial blood gases; Result Unstructured Data: reported; Comments: pH art: 7.03 (normal- 7.35-7.45), pCO2 art: 33 mmHg(35-45), pO2 art: 77 mmHg(80-102 ), HCO3 art: 9mmol/l(22-26), O2Hb%:88%(95-100), % saturation, arterial: 90%(95-100), base excess art:-21.1mmol/l(-2-2), O2 cont. art: 16.4 vol%(16-20), Hemoglobin art: 13.1 gm/dl(12-18), carboxy hemoglobin: 0.6%(0.0-0.2), met Hb, arterial:0.7%(0.0-3.0), reduced Hb: 10.4(2.5-9.3), NA level-art: 132mmol/l(135-145), K level: 5.8mmol/l(3.5-5.0), Cl level-art: 99mmol/l(98-106), Ion Ca level-art: 0.87mmol/l(1.05-1.30), arterial lactate: 1.6mmol/l(0.3-1.3), arterial glucose:373mg/dl(60-99), FIO2-arterial:90.; Test Date: 202105010637; Test Name: WBC; Result Unstructured Data: 35.2 10*3/uL; Test Date: 202105010637; Test Name: Red blood cell count; Result Unstructured Data: 4.26 10*6/uL; Test Date: 202105010637; Test Name: Hemoglobin; Result Unstructured Data: 12.7 g/dL; Test Date: 202105010637; Test Name: Hematocrit; Result Unstructured Data: 37.3 %; Test Date: 202105010637; Test Name: MCV; Result Unstructured Data: 88 fL; Test Date: 202105010637; Test Name: MCH; Result Unstructured Data: 29.8 pg; Test Date: 202105010637; Test Name: MCV; Result Unstructured Data: 88 fL; Test Date: 202105010637; Test Name: MCHC; Result Unstructured Data: 34 g/dL; Test Date: 202105010637; Test Name: Red cell distribution width; Result Unstructured Data: 14.6 %; Test Date: 202105010637; Test Name: Platelet count; Result Unstructured Data: 477 10*3/uL; Test Date: 202105010637; Test Name: Lymphocytes; Result Unstructured Data: 6 %; Test Date: 202105010637; Test Name: Monocytes; Result Unstructured Data: 2 %; Test Date: 202105010637; Test Name: Eosinophils; Result Unstructured Data: 0 %; Test Date: 202105010637; Test Name: Basophils; Result Unstructured Data: 0 %; Test Date: 202105010637; Test Name: Neutrophils; Result Unstructured Data: 30.3 10*3/uL; Test Date: 202105010637; Test Name: Lymphocytes; Result Unstructured Data: 2.1 10*3/uL; Test Date: 202105010637; Test Name: Monocytes; Result Unstructured Data: 0.7 10*3/uL; Test Date: 202105010637; Test Name: Eosinophils; Result Unstructured Data: 0.0 10*3/uL; Test Date: 202105010637; Test Name: Basophils; Result Unstructured Data: 0.0 10*3/uL; Test Date: 202105010637; Test Name: Red blood cell morphology; Result Unstructured Data: Normal; Test Date: 202105010637; Test Name: Red blood cell sedimentation rate; Result Unstructured Data: 69 mm/h; Test Date: 202105010637; Test Name: Serum total protein; Result Unstructured Data: 7 g/dL; Test Date: 202105010637; Test Name: Albumin; Result Unstructured Data: 2.2 g/dL; Test Date: 202105010637; Test Name: Calcium; Result Unstructured Data: 7.5 mg/dL; Test Date: 202105010637; Test Name: Bilirubin total; Result Unstructured Data: less than 0.2 mg/dl; Test Date: 202105010637; Test Name: Alkaline phosphatase; Result Unstructured Data: 185 U/L; Test Date: 202105010637; Test Name: Sodium; Result Unstructured Data: 130 mmol/L; Test Date: 202105010637; Test Name: Potassium; Result Unstructured Data: 5.3 mmol/L; Test Date: 202105010637; Test Name: Chloride; Result Unstructured Data: 98 mmol/L; Test Date: 202105010637; Test Name: Bicarbonate; Result Unstructured Data: 10 mmol/L; Test Date: 202105010637; Test Name: Anion gap; Result Unstructured Data: 22; Test Date: 202105010637; Test Name: Glucose; Result Unstructured Data: 126 mg/dL; Test Date: 202105010637; Test Name: BUN; Result Unstructured Data: 115 mg/dL; Test Date: 202105010637; Test Name: Creatinine; Result Unstructured Data: 5.48 mg/dL; Test Date: 202105010637; Test Name: GFR; Result Unstructured Data: 8 mL/min; Test Date: 202105010637; Test Name: SGPT; Result Unstructured Data: 39 U/L; Test Date: 202105010637; Test Name: SGOT; Result Unstructured Data: 43 U/L; Test Date: 202105010637; Test Name: Magnesium; Result Unstructured Data: 2.4 mg/dL; Test Date: 202105010637; Test Name: CPK; Result Unstructured Data: 199 U/L; Test Date: 202105010637; Test Name: CK MB; Result Unstructured Data: 1.71 ng/mL; Test Date: 202105010637; Test Name: Blood alcohol; Result Unstructured Data: less than 12 mg/dl; Test Date: 202105010637; Test Name: C-reactive protein; Result Unstructured Data: greater than 30.4 mg/dl; Test Date: 202105010637; Test Name: Phosphate; Result Unstructured Data: 12.5 mg/dL; Test Date: 202105010643; Test Name: Arterial blood gases; Result Unstructured Data: reported; Comments: pH art: 7.16 (normal- 7.35-7.45), pCO2 art: 25 mmHg(35-45), pO2 art:59 mmHg(80-102 ), HCO3 art:9mmol/l(22-26), O2Hb%:81%(95-100), % saturation, arterial: 83%(95-100), base excess art:-18.4mmol/l(-2-2), O2 cont. art: 15.1 vol. % (16-20), Hemoglobin art: 13.2 gm/dl(12-18), carboxy hemoglobin: 1%(0.0-0.2), met HB, arterial:0.8%(0.0-3.0), reduced HB: 17 (2.5-9.3), NA level-art: 131mmol/l(135-145), K level: 5.1mmol/l(3.5-5.0), Cl level-art: 102mmol/l(98-106), Ion Ca level-art: 0.92mmol/l(1.05-1.30), arterial lactate: 1.6mmol/l(0.3-1.3), arterial glucose:128mg/dl(60-99),FIO2-arterial:21.; Test Date: 202105010700; Test Name: COVID-19 virus test; Result Unstructured Data: Presumptive negative; Test Date: 202105010713; Test Name: Arterial blood gases; Result Unstructured Data: reported; Comments: pH art: 6.98 (normal- 7.35-7.45), pCO2 art: 43 mmHg(35-45), pO2 art: 54 mmHg(80-102 ), HCO3 art: 10mmol/l(22-26), O2Hb%:71%(95-100), % saturation, arterial: 72%(95-100), base excess art:-22.0mmol/l(-2-2), O2 cont. art: 12.5 vol % (16-20), Hemoglobin art: 12.5 gm/dl(12-18), carboxy hemoglobin: -0.1%(0.0-0.2), met HB, arterial:1%(0.0-3.0), reduced HB: 27.0(2.5-9.3), NA level-art: 130mmol/l(135-145), K level: 6.1mmol/l(3.5-5.0), Cl level-art: 99mmol/l(98-106), Ion Ca level-art: 0.9mmol/l(1.05-1.30), arterial lactate: 1.9mmol/l(0.3-1.3), arterial glucose:478mg/dl(60-99), FIO2-arterial:100.; Test Date: 202105010810; Test Name: Salmonella test; Result Unstructured Data: not detected; Test Date: 202105010810; Test Name: Cryptococcus test; Result Unstructured Data: not detected; Test Date: 202105010810; Test Name: Candida test; Result Unstructured Data: Not detected; Test Date: 202105010810; Test Name: Klebsiella test; Result Unstructured Data: not detected; Test Date: 202105010810; Test Name: Streptococcus test; Result Unstructured Data: not detected; Test Date: 202105010810; Test Name: Staphylococcus test; Result Unstructured Data: detected and staphylococcus aureus detected; Test Date: 202105010810; Test Name: Listeria test; Result Unstructured Data: Not detected; Test Date: 202105010810; Test Name: Enterococcus test; Result Unstructured Data: not detected; Test Date: 202105010810; Test Name: Antimicrobial susceptibility test resistant; Result Unstructured Data: reported; Comments: IMP(carbapenem)- Not applicable, KPC(carbapenem)- Not applicable, OXA-48-like(carbapenem)- Not applicable, NDM(carbapenem)- Not applicable, VIM(carbapenem)- Not applicable, mcr-1 colistin -Not applicable, CTX-M(ESBL)-Not applicable, mecA-Methicillin-Not applicable, mecA/C and MREJ(MRSA)(Methicillin)-Not detected, can A/B(vancomycin)-not detected; Test Date: 202105010917; Test Name: Glucose; Result Unstructured Data: 464 mg/mL; Test Date: 202105011222; Test Name: Epstein-Barr virus antibody; Result Unstructured Data: 729 U/mL; Test Date: 202105011222; Test Name: Epstein-Barr virus test; Result Unstructured Data: grater than 600 units/ml; Test Date: 202105011222; Test Name: Epstein-Barr virus antibody; Result Unstructured Data: less than 36 units/ml; Test Date: 202105011243; Test Name: Glucose; Result Unstructured Data: 462 mg/mL; Test Date: 202105011315; Test Name: Arterial blood gases; Result Unstructured Data: reported; Comments: pH art: 7.07 (normal- 7.35-7.45), pCO2 art: 23 mmHg(35-45), pO2 art: 62 mmHg(80-102 ), HCO3 art: 6mmol/l(22-26), O2Hb%:79%(95-100), % saturation, arterial: 80%(95-100), base excess art:-23.4mmol/l(-2-2), O2 cont art: 15.2 vol % (16-20), Hemoglobin art: 13.7 gm/dl(12-18), carboxy hemoglobin: -0.2%(0.0-0.2), met HB, arterial:1%(0.0-3.0), reduced HB: 20(2.5-9.3), NA level-art: 131mmol/l(135-145), K level: 5.6mmol/l(3.5-5.0), Cl level-art: 105mmol/l(98-106), Ion Ca level-art: 0.96mmol/l(1.05-1.30), arterial lactate: 1.4mmol/l(0.3-1.3), arterial glucose:185mg/dl(60-99),; Test Date: 202105011346; Test Name: Glucose; Result Unstructured Data: 415 mg/mL; Test Date: 202105011446; Test Name: Glucose; Result Unstructured Data: 318 mg/mL; Test Date: 202105011614; Test Name: Glucose; Result Unstructured Data: 226 mg/mL; Test Date: 202105011713; Test Name: Arterial blood gases; Result Unstructured Data: reported; Comments: pH art: 7.09 (normal- 7.35-7.45), pCO2 art: 21 mmHg(35-45), pO2 art: 108 mmHg(80-102 ), HCO3 art: 6mmol/l(22-26), O2Hb%:96%(95-100), % saturation, arterial: 96%(95-100), base excess art:-21.8mmol/l(-2-2), O2 cont art: 18 vol % (16-20), Hemoglobin art: 13.3 gm/dl(12-18), carboxy hemoglobin: 0.3%(0.0-0.2), met HB, arterial:0.5%(0.0-3.0), reduced HB: 3.7(2.5-9.3), NA level-art: 132mmol/l(135-145), K level: 5.6mmol/l(3.5-5.0), Cl level-art: 104mmol/l(98-106), Ion Ca level-art: 0.82mmol/l(1.05-1.30), arterial lactate: 1.6mmol/l(0.3-1.3), arterial glucose:241mg/dl(60-99), FIO2-arterial:70.; Test Date: 202105012008; Test Name: Legionella test; Result Unstructured Data: Negative; Test Date: 202105012008; Test Name: Streptococcus test; Result Unstructured Data: negative; Test Date: 202105012008; Test Name: Chlamydia test; Result Unstructured Data: not detected; Test Date: 202105012008; Test Name: Polymerase chain reaction; Result Unstructured Data: Not detected; Test Date: 202105012008; Test Name: Drug screen; Result Unstructured Data: Positive; Test Date: 202105012008; Test Name: Opiates; Result Unstructured Data: Negative; Test Date: 202105012008; Test Name: Urine analysis; Result Unstructured Data: Reported; Comments: color: amber (yellow-normal), appearance: 2 plus (normal-clear), PH: 5.0 (normal- 7.0), Urine specific gravity: 1.025 (normal-1.015), urine protein: 2 plus(normal-negative), urine glucose: more than 2(normal-negative),urine ketones: negative(normal-negative), urine bilirubin: negative(normal-negative), urine blood: more than 3(normal-negative), urine urobilinogen: increased (normal), urine nitrite: negative(negative), urine LE-Test :trace (negative), urine RBC: packed(normal-absent), urine WBC-packed (normal-0-5), urine mucus: more than 1(normal-absent), urine yeast: rare (normal- absent), urine granular cast: none seen, Urine hyal cast: none seen (normal0-2), Urine RBC casts: none seen, urine waxy casts: none seen, urine WBC casts: none seen, urine epi casts: none seen, urine epithelial cells:6-10(normal-0-5), urine non squamous epithelial cells: 0-5(normal-0-5), urine bacteria: rare(normal-absent), urine creatinine: 137.8 mg/ml, urine chloride: 31mmol/l, urine osmolality: 348mOsM/kg (normal- 390-1090), urine potassium: 22.8 mmol/l, Urine protein: 331mg/dl, urine sodium: 30mmol/l, urine urea: 215 mg/dl, urine CP/TR ratio-random: 2.40 (less than or equal to 0.2).; Test Date: 202105012008; Test Name: Cannabinoids; Result Unstructured Data: Negative; Test Date: 202105012008; Test Name: Benzodiazepine drug level; Result Unstructured Data: negative; Test Date: 202105012008; Test Name: Barbiturates; Result Unstructured Data: negative; Test Date: 202105012008; Test Name: Amphetamines; Result Unstructured Data: negative; Test Date: 202105012055; Test Name: Arterial blood gases; Result Unstructured Data: reported; Comments: pH art: 7.18 (normal- 7.35-7.45), pCO2 art: 22 mmHg(35-45), pO2 art: 74 mmHg(80-102 ), HCO3 art: 8mmol/l(22-26), O2Hb%:89%(95-100), % saturation, arterial: 90%(95-100), base excess art:-19.4mmol/l(-2-2), O2 cont art: 16.1 vol%(16-20), Hemoglobin art: 12.8 gm/dl(12-18), carboxy hemoglobin: 0.0%(0.0-0.2), metHb, arterial:1.1%(0.0-3.0), reduced Hb: 9.7(2.5-9.3), NA level-art: 134mmol/l(135-145), K level: 5.4mmol/l(3.5-5.0), Cl level-art: 103mmol/l(98-106), IonCa level-art: 0.88mmol/l(1.05-1.30), arterial lactate: 1.7mmol/l(0.3-1.3), arterial glucose:275mg/dl(60-99), FIO2-arterial:70.; Test Date: 20210502; Test Name: Histology; Result Unstructured Data: Not reported; Test Date: 20210502; Test Name: Autopsy; Result Unstructured Data: Not reported; Test Date: 202105020426; Test Name: Antimicrobial susceptibility test resistant; Result Unstructured Data: reported; Comments: Amoxicillin/clavulanate-susceptible, ampicillin-resistant, cefazolin- susceptible, Clindamycin-susceptible, erythromycin-susceptible, gentamycin-susceptible, levofloxacin-susceptible, oxacillin-susceptible, penicillin- resistant, tetracycline-susceptible, trimethoprim/sulfa-susceptible.; Test Date: 202105020428; Test Name: Hemoglobin; Result Unstructured Data: 12 g/dL; Test Date: 202105020428; Test Name: Hematocrit; Result Unstructured Data: 36.5 %; Test Date: 202105020428; Test Name: MCV; Result Unstructured Data: 91 fL; Test Date: 202105020428; Test Name: MCH; Result Unstructured Data: 29.9 pg; Test Date: 202105020428; Test Name: MCHC; Result Unstructured Data: 32.9 g/dL; Test Date: 202105020428; Test Name: Red cell distribution width; Result Unstructured Data: 15.3 %; Test Date: 202105020428; Test Name: Platelet count; Result Unstructured Data: 476 10*3/uL; Test Date: 202105020428; Test Name: GFR; Result Unstructured Data: 8 mL/min; Test Date: 202105020428; Test Name: Creatinine clearance; Result Unstructured Data: 10.6; Test Date: 202105020428; Test Name: Calcium; Result Unstructured Data: 6.5 mg/dL; Test Date: 202105020428; Test Name: Sodium; Result Unstructured Data: 134 mmol/L; Test Date: 202105020428; Test Name: Potassium; Result Unstructured Data: 5.5 mmol/L; Test Date: 202105020428; Test Name: Chloride; Result Unstructured Data: 99 mmol/L; Test Date: 202105020428; Test Name: Bicarbonate; Result Unstructured Data: less than 10 mmol/l; Test Date: 202105020428; Test Name: Glucose; Result Unstructured Data: 395 mg/dL; Test Date: 202105020428; Test Name: BUN; Result Unstructured Data: 124 mg/dL; Test Date: 202105020428; Test Name: Creatinine; Result Unstructured Data: 5.39 mg/dL; Test Date: 202105020428; Test Name: WBC; Result Unstructured Data: 34.8 10*3/uL; Test Date: 202105020428; Test Name: Red blood cell count; Result Unstructured Data: 4.02 10*6/uL; Test Date: 202105020456; Test Name: Chest X-ray; Result Unstructured Data: cardiomegaly CHF and increasing pulmonary edema; Comments: There is increased and scattered areas of alveolar opacity throughout both lungs which may represent superimposed pneumonia, there is no pneumothorax.; Test Date: 202105020811; Test Name: Echocardiogram; Result Unstructured Data: Reported; Comments: Normal left ventricular systolic function. LV ejection fraction was 74%. The left ventricular ejection fraction was an estimation. mild left ventricular hypertrophy. Moderate to large pericardial effusion. The pericardial effusion was circumferential to the heart. No echocardiographic evidence to suggest cardiac tamponade; Test Date: 202105021056; Test Name: Salicylate; Result Unstructured Data: less than 3 mg/ml; Test Date: 202105021056; Test Name: Hepatitis B antibody; Result Unstructured Data: Non reactive; Test Date: 202105021056; Test Name: Hepatitis B antigen; Result Unstructured Data: non reactive; Test Date: 202105021056; Test Name: Hepatitis C antibody; Result Unstructured Data: non reactive; Test Date: 202105021056; Test Name: Acetaminophen; Result Unstructured Data: less than 4 mcg/ml; Test Date: 202105021130; Test Name: Complement factor C3; Result Unstructured Data: 146 mg/dL; Test Date: 202105021130; Test Name: Complement factor C4; Result Unstructured Data: 20 mg/dL; Test Date: 202105021130; Test Name: Serum protein electrophoresis; Result Unstructured Data: 1.7 g/dL; Test Date: 202105021130; Test Name: Apo A1; Result Unstructured Data: 0.8 g/dL; Test Date: 202105021130; Test Name: Apolipoprotein; Result Unstructured Data: 1.2 g/dL; Test Date: 202105021130; Test Name: Beta globulin; Result Unstructured Data: 0.4 g/dL; Test Date: 202105021130; Test Name: Beta 2 globulin; Result Unstructured Data: 0.4 g/dL; Test Date: 202105021130; Test Name
Aktuelle Erkrankungen: Diabetes; Dyslipidemia; Hypertension; Obesity; Tobacco abuse.
Vorgeschichte: Comments: The patient had no allergies to medications, food, or other products.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1459756

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MO
Alter: 55,0
Geschlecht: F
Eingang: 21.08.2021
Impfdatum: -
Beginn: 01.04.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute kidney injury Alanine aminotransferase Amphetamines Analgesic drug level Angiogram Anion gap Anti-cyclic citrullinated peptide antibody Antibody test Antimicrobial susceptibility test resistant Antineutrophil cytoplasmic antibody Antinuclear antibody Antinuclear antibody negative Apolipoprotein Apolipoprotein A-I Aspartate aminotransferase Asthenia Chest pain Death

Symptomtext

ACUTE RENAL FAILURE; SEPTIC SHOCK; PERICARDITIS; VASCULITIS; STAPHYLOCOCCUS AUREUS INFECTION; SEPSIS; PERICARDIAL EFFUSION; POSSIBLE EPSTEIN BARR INFECTION; DEATH; AUTOPSY; HISTOLOGY; This spontaneous report received from a health care professional via a Regulatory Authority (VAERS ID: 1459756) concerned a 55 year old white female of unspecified ethnic origin. The patient's weight was 212 pounds, and height was 69 inches. The patient's concurrent conditions included: diabetes, hypertension, dyslipidemia, obesity, and tobacco abuser. The patient had no allergies to medications, food, or other products. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 042A21A, and expiry: Unknown) dose was not reported, with frequency 1 total administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 21-APR-2021, after vaccination, the patient admitted to the hospital with complaints of sharp pain which started one week prior to the admission and it was worse with deep breath. The patient also had no appetite and chills. On certain tests such as d-dimer, computed tomography of chest, it was diagnosed the patient had probable aortitis. The cause of aortitis was not clear during the admission period. The patient tested also identified with inflammatory response of the great vessels. No pulmonary embolism was identified. The patient was discharged from the hospital on 24-APR-2021 with steroid medication (prednisone 20 mg). The patient also diagnosed with pericarditis, possible staphylococcus aureus infection, uncontrolled type 2 diabetes mellitus with hyperglycemia, and possible Epstein Barr infection. Laboratory data included: ECG (NR: not provided) sinus rhythm, inferior infract, acute anteroseptal infract., Fibrin D dimer (NR: not provided) elevated, and Gram stain (NR: not provided) clusters of gram positive cocci. CT scan (NR: not provided) and results came as Heart: trace pericardial fluid thickening. calcification is present within the visualized coronary arteries. size is normal and position. Mediastinum: moderate to marked increased attenuation in the area around the great vessel origins and the descending aorta to the mid arch. This extends superiorly to the superior mediastinum along the course of the right brachiocephalic artery and to a lesser extend to the left common carotid artery. Nonspecific lymph nodes are present in the adjacent superior mediastinum. Nonspecific lymph nodes present also in the aorticopulmonary window. Thyroid: Nonspecific areas of decreased attenuation unable to be further characterized in the thyroid left greater than right. Largest measure approximately 1.5 cm. Vasculature, aorta: The thoracic aorta demonstrates no evidence of aneurysm or rupture as visualized. Minimal vascular calcification. Pulmonary arteries: No evidence of pulmonary embolus is demonstrated in the central or pulmonary arteries. Lymph nodes: no pathologically enlarged lymph nodes. On 21-APR-2021 14:49, Laboratory data included: Anion gap (NR: not provided) 9, Creatinine clearance (NR: not provided) 59.5, Glucose (NR: 74 - 106) 306 mg/dL, and Troponin (NR: 0.00 - 0.040) less than 0.006 ng/ml. On 21-APR-2021 15:49, Laboratory data included: GFR (NR: not provided) greater than 60 ml/min, Hematocrit (NR: 35 - 45) 49.4 %, Hemoglobin (NR: 12.0 - 16.0) 16.6 g/dL, Lymphocytes (NR: not provided) 10 %, MCH (NR: 27 - 31) 29.8 pg, MCHC (NR: 31 - 36.5) 33.6 g/dL, MCV 89 fL, Monocytes (NR: not provided) 10 %, Neutrophils (NR: 2 - 8.1) 14.6 10*3/uL, Platelet count (NR: 150 - 400) 224 10*3/uL, Red blood cell count (NR: 4.20 - 5.40) 5.57 10*6/uL, Red blood cell sedimentation rate (NR: 0 - 20) 28 mm/h, and WBC (NR: 4 - 10.8) 17.0 10*3/uL. On 21-APR-2021 16:09, Laboratory data included: Fibrin D dimer (NR: 215 - 500) 814 ng/mL, INR (NR: not provided) 1.15 (units unspecified), and Prothrombin time (NR: 9.4 - 12.5) 13.1 sec. On 21-APR-2021 17:54, Laboratory data included: Blood culture (NR: not provided) positive for staphylococcus aureus. On 21-APR-2021 20:09, Laboratory data included: Anti-cyclic citrullinated peptide antibody, HIV antibody, Hepatitis A antibody, Hepatitis B antibody and Hepatitis C antibody as Negative, non-reactive. On 21-APR-2021 20:46, Laboratory data included: Urine culture (NR: not provided) positive for staphylococcus aureus. On 21-APR-2021 22:26, Laboratory data included: Glucose (NR: 60 - 69) 204 mg/dL. On 22-APR-2021, Laboratory data included: Anti-SCL 70 (NR: not provided) less than 1.2 RLU, Antinuclear antibody (NR: not provided) positive, Double stranded DNA antibody (NR: not provided) Negative, Jo-1 antibody negative (NR: not provided) less than 2.2 RLU, Ribonucleoprotein antibody (NR: not provided) less than 3.5 RLU, and SM antibody (NR: not provided) less than 3.3 RLU. On 22-APR-2021 06:17, Laboratory data included: Glucose 131 mg/dL. On 22-APR-2021 09:42, Laboratory data included: MRI angiography (NR: not provided): Patent aorta and proximal branches. No stenosis identified. The significant surrounding inflammation of the proximal thoracic great vessels and aortic arch better demonstrated on the prior day CT. Findings remain concerning for large vessel vasculitis versus infectious etiology. On 22-APR-2021 10:55, Laboratory data included: Glucose 149 mg/dL. On 22-APR-2021 15:19, Laboratory data included: Anti-cyclic citrullinated peptide antibody (NR: not provided) less than16 units, Immunoglobulin G (NR: not provided) reported, and Rheumatoid factor (NR: not provided) positive. On 22-APR-2021 16:00, Laboratory data included: Troponin less than 0.006. On 22-APR-2021 18:36, Laboratory data included: Glucose 292 mg/dL. On 22-APR-2021 20:21, Laboratory data included: Glucose 302 mg/dL. On 23-APR-2021 04:17, Laboratory data included: Anion gap (NR: not provided) 8, Bicarbonate 23 mmol/L, Calcium 9.3 mg/dL, Chloride 108 mmol/L, Creatinine clearance (NR: not provided) 72.3, GFR (NR: not provided) greater than 60 ml/min, Glucose 104 mg/dL, Hematocrit 46.8 %, Hemoglobin 15.5 g/dL, Platelet count 234 10*3/uL, Potassium 3.9 mmol/L, Sodium 139 mmol/L, Troponin less than 0.006 ng/ml, and WBC 15.4 10*3/uL. On 23-APR-2021 06:07, Laboratory data included: Glucose 115 mg/dL. On 23-APR-2021 10:58, Laboratory data included: Glucose 228 mg/dL. Other laboratory data (dates unspecified) included: Creatinine (NR: not provided) 0.96, and GFR (NR: not provided) 60. On 1-MAY-2021, the patient again admitted to the hospital with complaints of chest pain, sepsis with septic shock and acute renal failure. On admission the patient admitted to emergency room covered in feces. The patient also had multiple scratches and excoriations covered entire body as a part of different stages of healing (the patient had 10 cats). On first day of admission, the patient was in shock and she had taken to intensive care unit (ICU) and on two vasopressors(unspecified). The patient's respiratory failure worsened at night and kept her on intubation and was later placed on ventilator. The patient also had profound metabolic acidosis which was unresponsive to medical therapy. The patient was presented with a pH of 7.2 and she was placed on bicarb drip with additional pushes and her pH continued to deteriorate. From nephrology she had instructed to start dialysis. The patient consulted with vascular surgery foe placement of a dialysis catheter. The patient also consulted with pulmonary critical care and infectious disease. The patient had large pericardial effusion. The patient had mild thrombocytosis and platelets were normal in morphology without significant platelet anisocytosis. Thrombocytosis might have accompanied along with reactive neutrophilia that are secondary to acute stress. Laboratory data included: Chest X-ray revealed cardiomegaly, Upper limb X-ray (NR: not provided) No acute bony abnormality identified in the right forearm, and pH (NR: not provided) 7.2. On 01-MAY-2021 04:49, Laboratory data included: Arterial blood gases (NR: not provided) pH art: 7.03 (normal- 7.35-7.45), pCO2 art: 33 mmHg(35-45), pO2 art: 77 mmHg(80-102 ), HCO3 art: 9mmol/l(22-26), O2Hb%:88%(95-100), % saturation, arterial: 90%(95-100), base excess art:-21.1mmol/l(-2-2), O2 cont. art: 16.4 vol. % (16-20), Hemoglobin art: 13.1 gm/dl(12-18), carboxy hemoglobin: 0.6%(0.0-0.2), met HB, arterial:0.7%(0.0-3.0), reduced HB: 10.4(2.5-9.3), NA level-art: 132mmol/l(135-145), K level: 5.8mmol/l(3.5-5.0), Cl level-art: 99mmol/l(98-106), Ion Ca level-art: 0.87mmol/l(1.05-1.30), arterial lactate: 1.6mmol/l(0.3-1.3), arterial glucose:373mg/dl(60-99), FIO2-arterial:90. On 01-MAY-2021 06:37, Laboratory data included: Albumin 2.2 g/dL, Alkaline phosphatase 185 U/L, Anion gap (NR: not provided) 22, BUN 115 mg/dL, Bicarbonate 10 mmol/L, Bilirubin total less than 0.2 mg/dl, Blood alcohol (NR: not provided) less than 12 mg/dl, C-reactive protein (NR: not provided) greater than 30.4 mg/dl, CK MB (NR: not provided) 1.71 ng/mL, CPK (NR: 34 - 145) 199 U/L, Calcium 7.5 mg/dL, Chloride 98 mmol/L, Creatinine 5.48 mg/dL, GFR (NR: not provided) 8 mL/min, Glucose 126 mg/dL, Hemoglobin 12.7 g/dL, Magnesium (NR: 1.6 - 2.6) 2.4 mg/dL, Phosphate (NR: 2.4 - 5.1) 12.5 mg/dL, Platelet count 477 10*3/uL, Potassium 5.3 mmol/L, Red blood cell sedimentation rate 69 mm/h, Sodium 130 mmol/L, and WBC 35.2 10*3/uL. On 01-MAY-2021 07:00, Laboratory data included: COVID-19 virus test (NR: not provided) Presumptive negative. On 01-MAY-2021 08:10, Laboratory data included: Antimicrobial susceptibility test resistant, Candida test, Cryptococcus test, Enterococcus test, Klebsiella test, Listeria test, Streptococcus test and Salmonella test as not detected, Staphylococcus test and staphylococcus aureus were detected. On 01-MAY-2021 09:17, Laboratory data included: Glucose (NR: 60 - 99) 464 mg/mL. On 01-MAY-2021 12:22, Laboratory data included: Epstein-Barr virus antibody (NR: not provided) less than 36 units/ml, 729 U/mL, and Epstein-Barr virus test (NR: not provided) greater than 600 units/ml. On 01-MAY-2021 13:15, Laboratory data included: Arterial blood gases (NR: not provided) pH art: 7.07 (normal- 7.35-7.45), pCO2 art: 23 mmHg(35-45), pO2 art: 62 mmHg(80-102 ), HCO3 art: 6mmol/l(22-26), O2Hb%:79%(95-100), % saturation, arterial: 80%(95-100), base excess art:-23.4mmol/l(-2-2), O2 cont. art: 15.2 vol. % (16-20), Hemoglobin art: 13.7 gm/dl(12-18), carboxy hemoglobin: -0.2%(0.0-0.2), met HB, arterial:1%(0.0-3.0), reduced HB: 20(2.5-9.3), NA level-art: 131mmol/l(135-145), K level: 5.6mmol/l(3.5-5.0), Cl level-art: 105mmol/l(98-106), Ion Ca level-art: 0.96mmol/l(1.05-1.30), arterial lactate: 1.4mmol/l(0.3-1.3), arterial glucose:185mg/dl(60-99),. On 01-MAY-2021 14:46, Laboratory data included: Glucose 318 mg/mL. On 01-MAY-2021 16:14, Laboratory data included: Glucose 226 mg/mL. On 01-MAY-2021 17:13, Laboratory data included: Arterial blood gases (NR: not provided) pH art: 7.09 (normal- 7.35-7.45), pCO2 art: 21 mmHg(35-45), pO2 art: 108 mmHg(80-102 ), HCO3 art: 6mmol/l(22-26), O2Hb%:96%(95-100), % saturation, arterial: 96%(95-100), base excess art:-21.8mmol/l(-2-2), O2 cont. art: 18 vol%(16-20), Hemoglobin art: 13.3 gm/dl(12-18), carboxy hemoglobin: 0.3%(0.0-0.2), met HB, arterial:0.5%(0.0-3.0), reduced HB: 3.7(2.5-9.3), NA level-art: 132mmol/l(135-145), K level: 5.6mmol/l(3.5-5.0), Cl level-art: 104mmol/l(98-106), Ion Ca level-art: 0.82mmol/l(1.05-1.30), arterial lactate: 1.6mmol/l(0.3-1.3), arterial glucose:241mg/dl(60-99), FIO2-arterial:70. On 01-MAY-2021 20:08, Laboratory data included: Amphetamines, Barbiturates, Benzodiazepine, Opiates, and Cannabinoids drug level as negative. Chlamydia test, Polymerase chain reaction were not detected, Legionella test and Streptococcus test was negative. On 02-MAY-2021 04:26, Laboratory data included: Antimicrobial susceptibility test resistant (NR: not provided) Amoxicillin/clavulanate, cefazolin, Clindamycin, erythromycin, gentamycin, levofloxacin, tetracycline, oxacillin, and trimethoprim/sulfa -susceptible, ampicillin and penicillin- resistant. On 02-MAY-2021 04:28, Laboratory data included: BUN 124 mg/dL, Bicarbonate less than 10 mmol/l, Calcium 6.5 mg/dL, Chloride 99 mmol/L, Creatinine 5.39 mg/dL, Creatinine clearance (NR: not provided) 10.6, GFR (NR: not provided) 8 mL/min, Glucose 395 mg/dL, Hematocrit 36.5 %, Hemoglobin 12 g/dL, MCH 29.9 pg, MCHC 32.9 g/dL, MCV 91 fL, Platelet count 476 10*3/uL, Potassium 5.5 mmol/L, Red blood cell count 4.02 10*6/uL, Red cell distribution width 15.3 %, Sodium 134 mmol/L, and WBC 34.8 10*3/uL. On 02-MAY-2021 04:56, Laboratory data included: Chest X-ray revealed cardiomegaly CHF and increasing pulmonary edema. On 02-MAY-2021 08:11, Laboratory data included: Echocardiogram (NR: not provided) Normal left ventricular systolic function. LV ejection fraction was 74%. The left ventricular ejection fraction was an estimation. mild left ventricular hypertrophy. Moderate to large pericardial effusion. The pericardial effusion was circumferential to the heart. No echocardiographic evidence to suggest cardiac tamponade. On 02-MAY-2021 10:56, Laboratory data included: Acetaminophen (NR: 10 - 20) less than 4 mcg/ml, Hepatitis B antibody, Hepatitis B antigen, and Hepatitis C antibody as non-reactive, and Salicylate (NR: 2.8 - 20) less than 3 mg/ml. On 02-MAY-2021 11:30, Laboratory data included: Apo A1 (NR: 0.2 - 0.3) 0.8 g/dL, Apo lipoprotein (NR: 0.5 - 0.9) 1.2 g/dL, Beta 2 globulin (NR: 0.2 - 0.5) 0.4 g/dL, Beta globulin (NR:.4 - 0.6) 0.4 g/dL, Complement factor C3 (NR: 83 - 193) 146 mg/dL, Complement factor C4 (NR: 15 - 57) 20 mg/dL, Gamma globulin (NR: 0.8 - 1.7) 0.7 g/dL, Serum protein electrophoresis (NR: 3.8 - 4.8) 1.7 g/dL, and Serum total protein 5.2 g/dL. On 02-MAY-2021 12:22, Laboratory data included: Beta-2 glycoprotein antibody (NR: not provided) less than 1, Brucella serology (NR: not provided) 0.58, 0.08, CMV IgG antibody (NR: not provided) less than 0.6 unit/ml, CMV IgM antibody (NR: not provided) less than 30, Ehrlichia serology (NR: not provided) less than 1:20, less than 1:64, Parvovirus B19 serology (NR: not provided) 7.8, 0.2, and Tuberculosis test (NR: not provided) indeterminate. On 02-MAY-2021 15:06, Laboratory data included: Albumin 2.2 g/dL, Alkaline phosphatase 328 U/L, Anion gap (NR: not provided) 25, BUN 97 mg/dL, Bicarbonate 17 mmol/L, Bilirubin total 0.5 mg/dL, Calcium 8.6 mg/dL, Chloride 95 mmol/L, Creatinine 4.26 mg/dL, Creatinine clearance (NR: not provided) 13.4, GFR (NR: not provided) 11 mL/min, Glucose 283 mg/dL, Potassium 5.8 mmol/L, SGOT (NR: not provided) 2655 U/L, SGPT 1204 U/L, Serum total protein 5.8 g/dL, and Sodium 137 mmol/L. On 02-MAY-2021 15:13, Laboratory data included: ECG (NR: not provided) atrial fibrillation. On 02-MAY-2021 16:11, Laboratory data included: Arterial blood gases (NR: not provided) pH art: 7.12 (normal- 7.35-7.45), pCO2 art: 27 mmHg (35-45), pO2 art: 64mmHg (80-102), HCO3 art: 9mmol/l(22-26), O2Hb%:81%(95-100), % saturation, arterial: 82%(95-100), base excess art:-19.3mmol/l(-2-2), O2 cont. art: 10.6 vol. % (16-20), Hemoglobin art: 9.2 gm/dl(12-18), carboxy hemoglobin: 0.2%(0.0-0.2), met HB, arterial:1%(0.0-3.0), reduced HB: 17.6(2.5-9.3), NA level-art: 137mmol/l(135-145), K level: 4.6mmol/l(3.5-5.0), Cl level-art: 103mmol/l(98-106), Ion Ca level-art: 0.93mmol/l(1.05-1.30), arterial lactate: 11.8mmol/l(0.3-1.3), arterial glucose:230mg/dl(60-99), FIO2-arterial:100. On 02-MAY-2021, the patient died from sepsis, pericarditis, large vessel vasculitis, and staphylococcus aureus infection as per the autopsy report. On 03-MAY-2021, Laboratory data included during autopsy: Blood urea nitrogen (NR: not provided) 107 mg/dL, Chloride (NR: not provided) 105 mmol/L, Creatinine (NR: not provided) 3.5 mg/dL, Ethanol (NR: not provided) negative, Glucose (NR: not provided) 161 mg/dL, Isopropanol (NR: not provided) negative, Methanol (NR: not provided) Negative, Potassium (NR: not provided) 11.2 mmol/L, and Sodium (NR: not provided) 141 mmol/L. Laboratory data (dates unspecified) included: ANA (NR: not provided) positive 1:1280, ANCA (NR: not provided) Negative, Anti-cyclic citrullinated peptide antibody (NR: not provided) Negative and GFR (NR: not provided) 60. Treatment medications (dates unspecified) included: metformin hydrochloride/sitagliptin phosphate monohydrate, trazodone, vitamin b complex, sodium bicarbonate, diltiazem, buspirone, venlafaxine hydrochloride, canagliflozin, prednisone, atorvastatin, ascorbic acid/beta carotene/biotin/calcium/calcium pantothenate/chromium amino acid chelate/colecalciferol/copper amino acid chelate/cyanocobalamin/folic acid/magnesium citrate/magnesium oxide/manganese amino acid chelate/mecobalamin/molybdenum amino acid chelate/nicotinamide/phytomenadione/potassium iodide/pyridoxine hydrochloride/retinol palmitate/riboflavin/selenium amino acid chelate/thiamine mononitrate/tocopheryl acetate/zinc amino acid chelate, colecalciferol, losartan, momordica charantia, glipizide, fish oil/omega-3 fatty acids, and insulin detemir. On 03-MAY-2021, Laboratory data included: Acetone, Amphetamines, Barbiturates, Benzodiazepine drug level, cannabinoids, muscle relaxants, opioid analgesics and stimulants levels were negative. An autopsy performed on 3-MAY-2021 08:00, which revealed pericarditis with large vessel vasculitis and a fibrinous exudate coating the epicardial surface of the heart. Ascending and descending aorta grossly and histologically remarkable. A gram stain performed on tissue from the brachiocephalic and left common carotid arteries revealed numerous clusters of gram positive cocci. The radial artery histologically showed fibrinoid material with associated inflammatory cells in a vessel wall within the adventitia but no inflammation of the vessel walls. Lungs with diffuse alveolar damage and centrilobular necrosis of the liver and acute tubular necrosis of the kidneys. The heart was enlarged (cardiomegaly, 500 grams) and exhibited moderate to severe calcific coronary artery disease with up to 80% occlusion of the left anterior descending coronary artery. ventral hernia. Multiple right sided rib fractures were noted, which were likely secondary to resuscitative efforts. remote cholecystectomy and bilateral tubal ligation. Vitreous electrolytes were significant for renal failure. It was unclear vaccination played a direct role in death. Based on the circumstances surrounding the death and the findings at autopsy, the patient died as a result of sepsis with pericarditis and large vessel vasculitis due to staphylococcus aureus bacterial infection. The manner of death was natural. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died of death, autopsy, vasculitis, septic shock, histology and staphylococcus aureus infection on 02-MAY-2021, and the outcome of possible Epstein Barr infection, pericardial effusion, acute renal failure was not reported. This report was serious (Death, Hospitalization Caused / Prolonged, and Other Medically Important Condition). Additional information was received via company representative on 06-AUG-2021, 07-AUG-2021 and 9-AUG-2021. The following information was updated and incorporated into the case narrative: Patient's demographics added (DOB, height, weight, race), patient history added (hypertension, obesity, dyslipidemia, tobacco abuse), cause of death updated (sepsis, pericarditis, large vessel vasculitis, staphylococcal aureus infection, Date of autopsy updated, events added (septic shock, sepsis, staphylococcal aureus infection, acute renal failure, possible Epstein Barr infection), seriousness criteria added (pericarditis, vasculitis and septic shock-Hospitalization caused/prolonged), hospital address added, lab data added (from data 3 to data 302), Reporter added and narrative updated. The narrative has been abstracted to comply with E2B data limitations. Sender's Comments: V1: Follow up information received in the current version is regarding patient demographics, medical history, autopsy findings, new events with clinical course and laboratory details. 20210751395-Covid-19 vaccine ad26.cov2.s-sepsis, pericarditis, vasculitis, staphylococcus aureus infection, septic shock, death, autopsy, histology, pericardial effusion, acute renal failure. Follow-up received regarding Clinical Details. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY; Reported Cause(s) of Death: SEPSIS; PERICARDITIS; LARGE VESSEL VASCULITIS; STAPHYLOCOCCUS AUREUS INFECTION.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 3,0
Labordaten: Test Date: 202104; Test Name: Physical examination; Result Unstructured Data: Reported; Comments: General: Alert, oriented and no acute distress. Head: Atraumatic, Eyes: PERRLA EOMI. Mouth: Moist mucus membrane. No pharyngeal erythema. Neck: soft and supple. No lymphadenopathy. Heart: regular rate and rhythm without murmur. Lungs: clear to auscultation bilaterally in all lung fields. Abdomen: No guarding or rebound. non tender and non distended, positive normoactive bowel sounds, no mass or hepatosplenomegaly, no bruits heard. Extremities: No clubbing, cyanosis or edema.; Test Date: 20210421; Test Name: ECG; Result Unstructured Data: sinus rhythm, inferior infract, acute anteroseptal infract.; Test Date: 20210421; Test Name: Gram stain; Result Unstructured Data: clusters of gram positive cocci; Test Date: 20210421; Test Name: Fibrin D dimer; Result Unstructured Data: elevated; Test Date: 202104211449; Test Name: SGOT; Result Unstructured Data: less than 15 u/l; Test Date: 202104211449; Test Name: Creatinine clearance; Result Unstructured Data: 59.5; Test Date: 202104211449; Test Name: Creatinine; Result Unstructured Data: 0.96 mg/dL; Test Date: 202104211449; Test Name: BUN; Result Unstructured Data: 12 mg/dL; Test Date: 202104211449; Test Name: Glucose; Result Unstructured Data: 306 mg/dL; Test Date: 202104211449; Test Name: Bicarbonate; Result Unstructured Data: 23 mmol/L; Test Date: 202104211449; Test Name: Chloride; Result Unstructured Data: 102 mmol/L; Test Date: 202104211449; Test Name: Potassium; Result Unstructured Data: 4.0 mmol/L; Test Date: 202104211449; Test Name: Sodium; Result Unstructured Data: 134 mmol/L; Test Date: 202104211449; Test Name: Troponin; Result Unstructured Data: less than 0.006 ng/ml; Test Date: 202104211449; Test Name: Calcium; Result Unstructured Data: 9.5 mg/dL; Test Date: 202104211449; Test Name: Anion gap; Result Unstructured Data: 9; Test Date: 202104211449; Test Name: Serum total protein; Result Unstructured Data: 8 g/dL; Test Date: 202104211449; Test Name: Bilirubin total; Result Unstructured Data: 0.7 mg/dL; Test Date: 202104211449; Test Name: Albumin; Result Unstructured Data: 3.9 g/dL; Test Date: 202104211449; Test Name: SGPT; Result Unstructured Data: 12 U/L; Test Date: 202104211449; Test Name: Alkaline phosphatase; Result Unstructured Data: 123 U/L; Test Date: 202104211549; Test Name: GFR; Result Unstructured Data: greater than 60 ml/min; Test Date: 202104211549; Test Name: Basophils; Result Unstructured Data: 0.0 10*3/uL; Test Date: 202104211549; Test Name: Red blood cell morphology; Result Unstructured Data: Normal; Test Date: 202104211549; Test Name: Red blood cell sedimentation rate; Result Unstructured Data: 28 mm/h; Test Date: 202104211549; Test Name: Eosinophils; Result Unstructured Data: 0.0 10*3/uL; Test Date: 202104211549; Test Name: Monocytes; Result Unstructured Data: 0.7 10*3/uL; Test Date: 202104211549; Test Name: Lymphocytes; Result Unstructured Data: 1.7 10*3/uL; Test Date: 202104211549; Test Name: Neutrophils; Result Unstructured Data: 14.6 10*3/uL; Test Date: 202104211549; Test Name: Basophils; Result Unstructured Data: 0 %; Test Date: 202104211549; Test Name: Eosinophils; Result Unstructured Data: 0 %; Test Date: 202104211549; Test Name: Monocytes; Result Unstructured Data: 10 %; Test Date: 202104211549; Test Name: Lymphocytes; Result Unstructured Data: 10 %; Test Date: 202104211549; Test Name: Platelet count; Result Unstructured Data: 224 10*3/uL; Test Date: 202104211549; Test Name: Red cell distribution width; Result Unstructured Data: 13.7 %; Test Date: 202104211549; Test Name: MCHC; Result Unstructured Data: 33.6 g/dL; Test Date: 202104211549; Test Name: MCH; Result Unstructured Data: 29.8 pg; Test Date: 202104211549; Test Name: MCV; Result Unstructured Data: 89 fL; Test Date: 202104211549; Test Name: WBC; Result Unstructured Data: 17.0 10*3/uL; Test Date: 202104211549; Test Name: Red blood cell count; Result Unstructured Data: 5.57 10*6/uL; Test Date: 202104211549; Test Name: Hemoglobin; Result Unstructured Data: 16.6 g/dL; Test Date: 202104211549; Test Name: Hematocrit; Result Unstructured Data: 49.4 %; Test Date: 202104211609; Test Name: Fibrin D dimer; Result Unstructured Data: 814 ng/mL; Test Date: 202104211609; Test Name: Prothrombin time; Result Unstructured Data: 13.1 sec; Test Date: 202104211609; Test Name: INR; Result Unstructured Data: 1.15; Test Date: 202104211729; Test Name: CT scan; Result Unstructured Data: Reported; Comments: Lungs: Bibasilar interlobular thickening with minimal interstitial accentuation. Minimal patchy opacification bilaterally , left greater than right. Heart: trace pericardial fluid thickening. calcification is present within the visualized coronary arteries. size is normal and position mediastinum: moderate to marked increased attenuation in the area around the great vessel origins and the descending aorta to the mid arch. This extends superiorly to the superior mediastinum along the course of the right brachiocephalic artery and to a lesser extend to the left common carotid artery. Non specific lymph nodes are present in the adjacent superior mediastinum. Non specific lymph nodes present also in the aorticopulmonary window. Thyroid: Non specific areas of decreased attenuation unable to be further characterized in the thyroid left grater than right. Largest measure approximately 1.5 cm. Bones/joints: No definite acute findings. Soft tissues: No definite acute findings. Vasculature: aorta: The thoracic aorta demonstrates no evidence of aneurysm or rupture as visualized. Minimal vascular calcification. Pulmonary arteries: No evidence of pulmonary embolus is demonstrated in the central or pulmonary arteries. Lymph nodes: no pathologically enlarged lymph nodes. Upper abdomen: The upper abdominal structures demonstrate no acute abnormalities as visualized.; Test Date: 202104211754; Test Name: Blood culture; Result Unstructured Data: positive for staphylococcus aureus; Test Date: 202104212002; Test Name: Urine analysis; Result Unstructured Data: Reported; Comments: color: straw (yellow-normal), appearance: clear (normal-clear), PH: 5.0 (normal- 7.0), Urine specific gravity: 1.024 (normal-1.015), urine protein: Negative(normal-negative), urine glucose: more than 3(normal-negative),urine ketones: trace(normal-negative), urine bilirubin: negative(normal-negative), urine blood: negative(normal-negative), urine urobilinogen: normal (normal), urine nitrite: negative(negative), urine LE-Test :negative (negative). urine RBC: 0-2(normal-absent), urine WBC: 0-5 (normal- 0-5), urine mucus: rare(normal-absent), urine yeast: rare (normal- absent), urine granular cast: none seen, Urine hyal cast: none seen (normal0-2), Urine RBC casts: none seen, urine waxy casts: none seen, urine WBC casts: none seen, urine epi casts: none seen.; Test Date: 202104212009; Test Name: Hepatitis C antibody; Result Unstructured Data: Negative, non reactive; Test Date: 202104212009; Test Name: HIV antibody; Result Unstructured Data: Negative, non reactive; Test Date: 202104212009; Test Name: Antibody test; Result Unstructured Data: Negative, non reactive; Test Date: 202104212009; Test Name: Anti-cyclic citrullinated peptide antibody; Result Unstructured Data: negative; Test Date: 202104212009; Test Name: Hepatitis B antibody; Result Unstructured Data: non reactive; Test Date: 202104212009; Test Name: Hepatitis A antibody; Result Unstructured Data: non reactive; Test Date: 202104212046; Test Name: Urine culture; Result Unstructured Data: positive for staphylococcus aureus; Test Date: 202104212226; Test Name: Glucose; Result Unstructured Data: 204 mg/dL; Test Date: 20210422; Test Name: Antinuclear antibody; Result Unstructured Data: positive; Comments: FANA titer: 1:1280, FANA pattern: speckled; Test Date: 20210422; Test Name: Anti-SCL 70; Result Unstructured Data: less than 1.2 RLU; Test Date: 20210422; Test Name: Jo-1 antibody negative; Result Unstructured Data: less than 2.2 RLU; Test Date: 20210422; Test Name: Double stranded DNA antibody; Result Unstructured Data: Negative; Test Date: 20210422; Test Name: SM antibody; Result Unstructured Data: less than 3.3 RLU; Test Date: 20210422; Test Name: Ribonucleoprotein antibody; Result Unstructured Data: less than 3.5 RLU; Test Date: 202104220350; Test Name: Anion gap; Result Unstructured Data: 9; Test Date: 202104220350; Test Name: Glucose; Result Unstructured Data: 95 mg/dL; Test Date: 202104220350; Test Name: BUN; Result Unstructured Data: 11 mg/dL; Test Date: 202104220350; Test Name: Creatinine; Result Unstructured Data: 0.77 mg/dL; Test Date: 202104220350; Test Name: Creatinine clearance; Result Unstructured Data: 74.2; Test Date: 202104220350; Test Name: GFR; Result Unstructured Data: greater than 60 ml/min; Test Date: 202104220350; Test Name: Bicarbonate; Result Unstructured Data: 22 mmol/L; Test Date: 202104220350; Test Name: Chloride; Result Unstructured Data: 107 mmol/L; Test Date: 202104220350; Test Name: Potassium; Result Unstructured Data: 3.4 mmol/L; Test Date: 202104220350; Test Name: Sodium; Result Unstructured Data: 138 mmol/L; Test Date: 202104220350; Test Name: Calcium; Result Unstructured Data: 9.2 mg/dL; Test Date: 202104220350; Test Name: Red blood cell morphology; Result Unstructured Data: Normal; Test Date: 202104220350; Test Name: Eosinophils; Result Unstructured Data: 0.15 10*3/uL; Test Date: 202104220350; Test Name: Basophils; Result Unstructured Data: 0.07 10*3/uL; Test Date: 202104220350; Test Name: Monocytes; Result Unstructured Data: 1.26 10*3/uL; Test Date: 202104220350; Test Name: Lymphocytes; Result Unstructured Data: 2.6 10*3/uL; Test Date: 202104220350; Test Name: Neutrophils; Result Unstructured Data: 12.25 10*3/uL; Test Date: 202104220350; Test Name: Basophils; Result Unstructured Data: 0 %; Test Date: 202104220350; Test Name: Eosinophils; Result Unstructured Data: 1 %; Test Date: 202104220350; Test Name: WBC; Result Unstructured Data: 16.4 10*3/uL; Test Date: 202104220350; Test Name: Red blood cell count; Result Unstructured Data: 5.18 10*6/uL; Test Date: 202104220350; Test Name: Hemoglobin; Result Unstructured Data: 15.5 g/dL; Test Date: 202104220350; Test Name: Hematocrit; Result Unstructured Data: 45.8 %; Test Date: 202104220350; Test Name: MCV; Result Unstructured Data: 88 fL; Test Date: 202104220350; Test Name: MCH; Result Unstructured Data: 29.9 pg; Test Date: 202104220350; Test Name: MCHC; Result Unstructured Data: 33.8 g/dL; Test Date: 202104220350; Test Name: Red cell distribution width; Result Unstructured Data: 13.5 %; Test Date: 202104220350; Test Name: Platelet count; Result Unstructured Data: 218 10*6/uL; Test Date: 202104220350; Test Name: Lymphocytes; Result Unstructured Data: 16 %; Test Date: 202104220350; Test Name: Monocytes; Result Unstructured Data: 8 %; Test Date: 202104220617; Test Name: Glucose; Result Unstructured Data: 131 mg/dL; Test Date: 202104220942; Test Name: MRI angiography; Result Unstructured Data: Reported; Comments: Normal course and caliber of the thoracic and abdominal aorta. There is mild atheromatous plaque of the lower descending thoracic aorta and abdominal aorta. Common origin of the brachiocephalic and left common carotid arteries, a normal variant. Patient flow is seen in the celiac, SMA, and bilateral renal arteries. No evidence of central pulmonary embolism. The previously demonstrated formation along the aortic arch and proximal great vessels is better demonstrated on prior day CT. No evidence of abscess or radiation or enlarged mediastinal adenopathy. Partially imaged abdomen does not show acute findings. Cholecystectomy. No stenosis are identified.; Test Date: 202104221055; Test Name: Glucose; Result Unstructured Data: 149 mg/dL; Test Date: 202104221519; Test Name: Rheumatoid factor; Result Unstructured Data: positive; Test Date: 202104221519; Test Name: Immunoglobulin G; Result Unstructured Data: reported; Comments: IGGS1-531mg/dl (382-921), IGGS2-226 mg/dl (271-700), IGGS3- 21mg/dl(22-178), IGGS4-10.9 mg/dl(4-86), IMMGG-913mg/dl(600-1640); Test Date: 202104221519; Test Name: Anti-cyclic citrullinated peptide antibody; Result Unstructured Data: less than16 units; Test Date: 202104221600; Test Name: Troponin; Result Unstructured Data: less than 0.006; Test Date: 202104221836; Test Name: Glucose; Result Unstructured Data: 292 mg/dL; Test Date: 202104222021; Test Name: Glucose; Result Unstructured Data: 302 mg/dL; Test Date: 202104230417; Test Name: Monocytes; Result Unstructured Data: 1.01 10*3/uL; Test Date: 202104230417; Test Name: Red blood cell morphology; Result Unstructured Data: Normal; Test Date: 202104230417; Test Name: Anion gap; Result Unstructured Data: 8; Test Date: 202104230417; Test Name: Calcium; Result Unstructured Data: 9.3 mg/dL; Test Date: 202104230417; Test Name: Troponin; Result Unstructured Data: less than 0.006 ng/ml; Test Date: 202104230417; Test Name: Sodium; Result Unstructured Data: 139 mmol/L; Test Date: 202104230417; Test Name: Potassium; Result Unstructured Data: 3.9 mmol/L; Test Date: 202104230417; Test Name: Chloride; Result Unstructured Data: 108 mmol/L; Test Date: 202104230417; Test Name: Bicarbonate; Result Unstructured Data: 23 mmol/L; Test Date: 202104230417; Test Name: Glucose; Result Unstructured Data: 104 mg/dL; Test Date: 202104230417; Test Name: BUN; Result Unstructured Data: 13 mg/dL; Test Date: 202104230417; Test Name: Creatinine; Result Unstructured Data: 0.79 mg/dL; Test Date: 202104230417; Test Name: Creatinine clearance; Result Unstructured Data: 72.3; Test Date: 202104230417; Test Name: GFR; Result Unstructured Data: greater than 60 ml/min; Test Date: 202104230417; Test Name: Eosinophils; Result Unstructured Data: 0.19 10*3/uL; Test Date: 202104230417; Test Name: Basophils; Result Unstructured Data: 0.06 10*3/uL; Test Date: 202104230417; Test Name: Lymphocytes; Result Unstructured Data: 1.79 10*3/uL; Test Date: 202104230417; Test Name: WBC; Result Unstructured Data: 15.4 10*3/uL; Test Date: 202104230417; Test Name: Red blood cell count; Result Unstructured Data: 5.16 10*6/uL; Test Date: 202104230417; Test Name: Hemoglobin; Result Unstructured Data: 15.5 g/dL; Test Date: 202104230417; Test Name: Hematocrit; Result Unstructured Data: 46.8 %; Test Date: 202104230417; Test Name: MCV; Result Unstructured Data: 91 fL; Test Date: 202104230417; Test Name: MCH; Result Unstructured Data: 30 pg; Test Date: 202104230417; Test Name: MCHC; Result Unstructured Data: 33.1 g/dL; Test Date: 202104230417; Test Name: Red cell distribution width; Result Unstructured Data: 13.4 %; Test Date: 202104230417; Test Name: Platelet count; Result Unstructured Data: 234 10*3/uL; Test Date: 202104230417; Test Name: Lymphocytes; Result Unstructured Data: 12 %; Test Date: 202104230417; Test Name: Monocytes; Result Unstructured Data: 7 %; Test Date: 202104230417; Test Name: Eosinophils; Result Unstructured Data: 1 %; Test Date: 202104230417; Test Name: Basophils; Result Unstructured Data: 0 %; Test Date: 202104230417; Test Name: Neutrophils; Result Unstructured Data: 12.29 10*3/uL; Test Date: 202104230607; Test Name: Glucose; Result Unstructured Data: 115 mg/dL; Test Date: 202104231058; Test Name: Glucose; Result Unstructured Data: 228 mg/dL; Test Date: 20210501; Test Name: Chest X-ray; Result Unstructured Data: cardiomegaly with significant increased in heart size; Comments: Mild CHF with central pulmonary vascular congestion. There are scattered areas of mainly interstitial opacity in the mid to lower portions of both lungs most likely representing sub segmental atelectasis. There is no pneumothorax.; Test Date: 20210501; Test Name: Upper limb X-ray; Result Unstructured Data: No acute bony abnormality identified in the right forearm; Comments: Normal right humerus radiographs.; Test Date: 20210501; Test Name: pH; Result Unstructured Data: 7.2; Test Date: 202105010449; Test Name: Arterial blood gases; Result Unstructured Data: reported; Comments: pH art: 7.03 (normal- 7.35-7.45), pCO2 art: 33 mmHg(35-45), pO2 art: 77 mmHg(80-102 ), HCO3 art: 9mmol/l(22-26), O2Hb%:88%(95-100), % saturation, arterial: 90%(95-100), base excess art:-21.1mmol/l(-2-2), O2 cont. art: 16.4 vol%(16-20), Hemoglobin art: 13.1 gm/dl(12-18), carboxy hemoglobin: 0.6%(0.0-0.2), met Hb, arterial:0.7%(0.0-3.0), reduced Hb: 10.4(2.5-9.3), NA level-art: 132mmol/l(135-145), K level: 5.8mmol/l(3.5-5.0), Cl level-art: 99mmol/l(98-106), Ion Ca level-art: 0.87mmol/l(1.05-1.30), arterial lactate: 1.6mmol/l(0.3-1.3), arterial glucose:373mg/dl(60-99), FIO2-arterial:90.; Test Date: 202105010637; Test Name: WBC; Result Unstructured Data: 35.2 10*3/uL; Test Date: 202105010637; Test Name: Red blood cell count; Result Unstructured Data: 4.26 10*6/uL; Test Date: 202105010637; Test Name: Hemoglobin; Result Unstructured Data: 12.7 g/dL; Test Date: 202105010637; Test Name: Hematocrit; Result Unstructured Data: 37.3 %; Test Date: 202105010637; Test Name: MCV; Result Unstructured Data: 88 fL; Test Date: 202105010637; Test Name: MCH; Result Unstructured Data: 29.8 pg; Test Date: 202105010637; Test Name: MCV; Result Unstructured Data: 88 fL; Test Date: 202105010637; Test Name: MCHC; Result Unstructured Data: 34 g/dL; Test Date: 202105010637; Test Name: Red cell distribution width; Result Unstructured Data: 14.6 %; Test Date: 202105010637; Test Name: Platelet count; Result Unstructured Data: 477 10*3/uL; Test Date: 202105010637; Test Name: Lymphocytes; Result Unstructured Data: 6 %; Test Date: 202105010637; Test Name: Monocytes; Result Unstructured Data: 2 %; Test Date: 202105010637; Test Name: Eosinophils; Result Unstructured Data: 0 %; Test Date: 202105010637; Test Name: Basophils; Result Unstructured Data: 0 %; Test Date: 202105010637; Test Name: Neutrophils; Result Unstructured Data: 30.3 10*3/uL; Test Date: 202105010637; Test Name: Lymphocytes; Result Unstructured Data: 2.1 10*3/uL; Test Date: 202105010637; Test Name: Monocytes; Result Unstructured Data: 0.7 10*3/uL; Test Date: 202105010637; Test Name: Eosinophils; Result Unstructured Data: 0.0 10*3/uL; Test Date: 202105010637; Test Name: Basophils; Result Unstructured Data: 0.0 10*3/uL; Test Date: 202105010637; Test Name: Red blood cell morphology; Result Unstructured Data: Normal; Test Date: 202105010637; Test Name: Red blood cell sedimentation rate; Result Unstructured Data: 69 mm/h; Test Date: 202105010637; Test Name: Serum total protein; Result Unstructured Data: 7 g/dL; Test Date: 202105010637; Test Name: Albumin; Result Unstructured Data: 2.2 g/dL; Test Date: 202105010637; Test Name: Calcium; Result Unstructured Data: 7.5 mg/dL; Test Date: 202105010637; Test Name: Bilirubin total; Result Unstructured Data: less than 0.2 mg/dl; Test Date: 202105010637; Test Name: Alkaline phosphatase; Result Unstructured Data: 185 U/L; Test Date: 202105010637; Test Name: Sodium; Result Unstructured Data: 130 mmol/L; Test Date: 202105010637; Test Name: Potassium; Result Unstructured Data: 5.3 mmol/L; Test Date: 202105010637; Test Name: Chloride; Result Unstructured Data: 98 mmol/L; Test Date: 202105010637; Test Name: Bicarbonate; Result Unstructured Data: 10 mmol/L; Test Date: 202105010637; Test Name: Anion gap; Result Unstructured Data: 22; Test Date: 202105010637; Test Name: Glucose; Result Unstructured Data: 126 mg/dL; Test Date: 202105010637; Test Name: BUN; Result Unstructured Data: 115 mg/dL; Test Date: 202105010637; Test Name: Creatinine; Result Unstructured Data: 5.48 mg/dL; Test Date: 202105010637; Test Name: GFR; Result Unstructured Data: 8 mL/min; Test Date: 202105010637; Test Name: SGPT; Result Unstructured Data: 39 U/L; Test Date: 202105010637; Test Name: SGOT; Result Unstructured Data: 43 U/L; Test Date: 202105010637; Test Name: Magnesium; Result Unstructured Data: 2.4 mg/dL; Test Date: 202105010637; Test Name: CPK; Result Unstructured Data: 199 U/L; Test Date: 202105010637; Test Name: CK MB; Result Unstructured Data: 1.71 ng/mL; Test Date: 202105010637; Test Name: Blood alcohol; Result Unstructured Data: less than 12 mg/dl; Test Date: 202105010637; Test Name: C-reactive protein; Result Unstructured Data: greater than 30.4 mg/dl; Test Date: 202105010637; Test Name: Phosphate; Result Unstructured Data: 12.5 mg/dL; Test Date: 202105010643; Test Name: Arterial blood gases; Result Unstructured Data: reported; Comments: pH art: 7.16 (normal- 7.35-7.45), pCO2 art: 25 mmHg(35-45), pO2 art:59 mmHg(80-102 ), HCO3 art:9mmol/l(22-26), O2Hb%:81%(95-100), % saturation, arterial: 83%(95-100), base excess art:-18.4mmol/l(-2-2), O2 cont. art: 15.1 vol. % (16-20), Hemoglobin art: 13.2 gm/dl(12-18), carboxy hemoglobin: 1%(0.0-0.2), met HB, arterial:0.8%(0.0-3.0), reduced HB: 17 (2.5-9.3), NA level-art: 131mmol/l(135-145), K level: 5.1mmol/l(3.5-5.0), Cl level-art: 102mmol/l(98-106), Ion Ca level-art: 0.92mmol/l(1.05-1.30), arterial lactate: 1.6mmol/l(0.3-1.3), arterial glucose:128mg/dl(60-99),FIO2-arterial:21.; Test Date: 202105010700; Test Name: COVID-19 virus test; Result Unstructured Data: Presumptive negative; Test Date: 202105010713; Test Name: Arterial blood gases; Result Unstructured Data: reported; Comments: pH art: 6.98 (normal- 7.35-7.45), pCO2 art: 43 mmHg(35-45), pO2 art: 54 mmHg(80-102 ), HCO3 art: 10mmol/l(22-26), O2Hb%:71%(95-100), % saturation, arterial: 72%(95-100), base excess art:-22.0mmol/l(-2-2), O2 cont. art: 12.5 vol % (16-20), Hemoglobin art: 12.5 gm/dl(12-18), carboxy hemoglobin: -0.1%(0.0-0.2), met HB, arterial:1%(0.0-3.0), reduced HB: 27.0(2.5-9.3), NA level-art: 130mmol/l(135-145), K level: 6.1mmol/l(3.5-5.0), Cl level-art: 99mmol/l(98-106), Ion Ca level-art: 0.9mmol/l(1.05-1.30), arterial lactate: 1.9mmol/l(0.3-1.3), arterial glucose:478mg/dl(60-99), FIO2-arterial:100.; Test Date: 202105010810; Test Name: Salmonella test; Result Unstructured Data: not detected; Test Date: 202105010810; Test Name: Cryptococcus test; Result Unstructured Data: not detected; Test Date: 202105010810; Test Name: Candida test; Result Unstructured Data: Not detected; Test Date: 202105010810; Test Name: Klebsiella test; Result Unstructured Data: not detected; Test Date: 202105010810; Test Name: Streptococcus test; Result Unstructured Data: not detected; Test Date: 202105010810; Test Name: Staphylococcus test; Result Unstructured Data: detected and staphylococcus aureus detected; Test Date: 202105010810; Test Name: Listeria test; Result Unstructured Data: Not detected; Test Date: 202105010810; Test Name: Enterococcus test; Result Unstructured Data: not detected; Test Date: 202105010810; Test Name: Antimicrobial susceptibility test resistant; Result Unstructured Data: reported; Comments: IMP(carbapenem)- Not applicable, KPC(carbapenem)- Not applicable, OXA-48-like(carbapenem)- Not applicable, NDM(carbapenem)- Not applicable, VIM(carbapenem)- Not applicable, mcr-1 colistin -Not applicable, CTX-M(ESBL)-Not applicable, mecA-Methicillin-Not applicable, mecA/C and MREJ(MRSA)(Methicillin)-Not detected, can A/B(vancomycin)-not detected; Test Date: 202105010917; Test Name: Glucose; Result Unstructured Data: 464 mg/mL; Test Date: 202105011222; Test Name: Epstein-Barr virus antibody; Result Unstructured Data: 729 U/mL; Test Date: 202105011222; Test Name: Epstein-Barr virus test; Result Unstructured Data: grater than 600 units/ml; Test Date: 202105011222; Test Name: Epstein-Barr virus antibody; Result Unstructured Data: less than 36 units/ml; Test Date: 202105011243; Test Name: Glucose; Result Unstructured Data: 462 mg/mL; Test Date: 202105011315; Test Name: Arterial blood gases; Result Unstructured Data: reported; Comments: pH art: 7.07 (normal- 7.35-7.45), pCO2 art: 23 mmHg(35-45), pO2 art: 62 mmHg(80-102 ), HCO3 art: 6mmol/l(22-26), O2Hb%:79%(95-100), % saturation, arterial: 80%(95-100), base excess art:-23.4mmol/l(-2-2), O2 cont art: 15.2 vol % (16-20), Hemoglobin art: 13.7 gm/dl(12-18), carboxy hemoglobin: -0.2%(0.0-0.2), met HB, arterial:1%(0.0-3.0), reduced HB: 20(2.5-9.3), NA level-art: 131mmol/l(135-145), K level: 5.6mmol/l(3.5-5.0), Cl level-art: 105mmol/l(98-106), Ion Ca level-art: 0.96mmol/l(1.05-1.30), arterial lactate: 1.4mmol/l(0.3-1.3), arterial glucose:185mg/dl(60-99),; Test Date: 202105011346; Test Name: Glucose; Result Unstructured Data: 415 mg/mL; Test Date: 202105011446; Test Name: Glucose; Result Unstructured Data: 318 mg/mL; Test Date: 202105011614; Test Name: Glucose; Result Unstructured Data: 226 mg/mL; Test Date: 202105011713; Test Name: Arterial blood gases; Result Unstructured Data: reported; Comments: pH art: 7.09 (normal- 7.35-7.45), pCO2 art: 21 mmHg(35-45), pO2 art: 108 mmHg(80-102 ), HCO3 art: 6mmol/l(22-26), O2Hb%:96%(95-100), % saturation, arterial: 96%(95-100), base excess art:-21.8mmol/l(-2-2), O2 cont art: 18 vol % (16-20), Hemoglobin art: 13.3 gm/dl(12-18), carboxy hemoglobin: 0.3%(0.0-0.2), met HB, arterial:0.5%(0.0-3.0), reduced HB: 3.7(2.5-9.3), NA level-art: 132mmol/l(135-145), K level: 5.6mmol/l(3.5-5.0), Cl level-art: 104mmol/l(98-106), Ion Ca level-art: 0.82mmol/l(1.05-1.30), arterial lactate: 1.6mmol/l(0.3-1.3), arterial glucose:241mg/dl(60-99), FIO2-arterial:70.; Test Date: 202105012008; Test Name: Legionella test; Result Unstructured Data: Negative; Test Date: 202105012008; Test Name: Streptococcus test; Result Unstructured Data: negative; Test Date: 202105012008; Test Name: Chlamydia test; Result Unstructured Data: not detected; Test Date: 202105012008; Test Name: Polymerase chain reaction; Result Unstructured Data: Not detected; Test Date: 202105012008; Test Name: Drug screen; Result Unstructured Data: Positive; Test Date: 202105012008; Test Name: Opiates; Result Unstructured Data: Negative; Test Date: 202105012008; Test Name: Urine analysis; Result Unstructured Data: Reported; Comments: color: amber (yellow-normal), appearance: 2 plus (normal-clear), PH: 5.0 (normal- 7.0), Urine specific gravity: 1.025 (normal-1.015), urine protein: 2 plus(normal-negative), urine glucose: more than 2(normal-negative),urine ketones: negative(normal-negative), urine bilirubin: negative(normal-negative), urine blood: more than 3(normal-negative), urine urobilinogen: increased (normal), urine nitrite: negative(negative), urine LE-Test :trace (negative), urine RBC: packed(normal-absent), urine WBC-packed (normal-0-5), urine mucus: more than 1(normal-absent), urine yeast: rare (normal- absent), urine granular cast: none seen, Urine hyal cast: none seen (normal0-2), Urine RBC casts: none seen, urine waxy casts: none seen, urine WBC casts: none seen, urine epi casts: none seen, urine epithelial cells:6-10(normal-0-5), urine non squamous epithelial cells: 0-5(normal-0-5), urine bacteria: rare(normal-absent), urine creatinine: 137.8 mg/ml, urine chloride: 31mmol/l, urine osmolality: 348mOsM/kg (normal- 390-1090), urine potassium: 22.8 mmol/l, Urine protein: 331mg/dl, urine sodium: 30mmol/l, urine urea: 215 mg/dl, urine CP/TR ratio-random: 2.40 (less than or equal to 0.2).; Test Date: 202105012008; Test Name: Cannabinoids; Result Unstructured Data: Negative; Test Date: 202105012008; Test Name: Benzodiazepine drug level; Result Unstructured Data: negative; Test Date: 202105012008; Test Name: Barbiturates; Result Unstructured Data: negative; Test Date: 202105012008; Test Name: Amphetamines; Result Unstructured Data: negative; Test Date: 202105012055; Test Name: Arterial blood gases; Result Unstructured Data: reported; Comments: pH art: 7.18 (normal- 7.35-7.45), pCO2 art: 22 mmHg(35-45), pO2 art: 74 mmHg(80-102 ), HCO3 art: 8mmol/l(22-26), O2Hb%:89%(95-100), % saturation, arterial: 90%(95-100), base excess art:-19.4mmol/l(-2-2), O2 cont art: 16.1 vol%(16-20), Hemoglobin art: 12.8 gm/dl(12-18), carboxy hemoglobin: 0.0%(0.0-0.2), metHb, arterial:1.1%(0.0-3.0), reduced Hb: 9.7(2.5-9.3), NA level-art: 134mmol/l(135-145), K level: 5.4mmol/l(3.5-5.0), Cl level-art: 103mmol/l(98-106), IonCa level-art: 0.88mmol/l(1.05-1.30), arterial lactate: 1.7mmol/l(0.3-1.3), arterial glucose:275mg/dl(60-99), FIO2-arterial:70.; Test Date: 20210502; Test Name: Histology; Result Unstructured Data: Not reported; Test Date: 20210502; Test Name: Autopsy; Result Unstructured Data: Not reported; Test Date: 202105020426; Test Name: Antimicrobial susceptibility test resistant; Result Unstructured Data: reported; Comments: Amoxicillin/clavulanate-susceptible, ampicillin-resistant, cefazolin- susceptible, Clindamycin-susceptible, erythromycin-susceptible, gentamycin-susceptible, levofloxacin-susceptible, oxacillin-susceptible, penicillin- resistant, tetracycline-susceptible, trimethoprim/sulfa-susceptible.; Test Date: 202105020428; Test Name: Hemoglobin; Result Unstructured Data: 12 g/dL; Test Date: 202105020428; Test Name: Hematocrit; Result Unstructured Data: 36.5 %; Test Date: 202105020428; Test Name: MCV; Result Unstructured Data: 91 fL; Test Date: 202105020428; Test Name: MCH; Result Unstructured Data: 29.9 pg; Test Date: 202105020428; Test Name: MCHC; Result Unstructured Data: 32.9 g/dL; Test Date: 202105020428; Test Name: Red cell distribution width; Result Unstructured Data: 15.3 %; Test Date: 202105020428; Test Name: Platelet count; Result Unstructured Data: 476 10*3/uL; Test Date: 202105020428; Test Name: GFR; Result Unstructured Data: 8 mL/min; Test Date: 202105020428; Test Name: Creatinine clearance; Result Unstructured Data: 10.6; Test Date: 202105020428; Test Name: Calcium; Result Unstructured Data: 6.5 mg/dL; Test Date: 202105020428; Test Name: Sodium; Result Unstructured Data: 134 mmol/L; Test Date: 202105020428; Test Name: Potassium; Result Unstructured Data: 5.5 mmol/L; Test Date: 202105020428; Test Name: Chloride; Result Unstructured Data: 99 mmol/L; Test Date: 202105020428; Test Name: Bicarbonate; Result Unstructured Data: less than 10 mmol/l; Test Date: 202105020428; Test Name: Glucose; Result Unstructured Data: 395 mg/dL; Test Date: 202105020428; Test Name: BUN; Result Unstructured Data: 124 mg/dL; Test Date: 202105020428; Test Name: Creatinine; Result Unstructured Data: 5.39 mg/dL; Test Date: 202105020428; Test Name: WBC; Result Unstructured Data: 34.8 10*3/uL; Test Date: 202105020428; Test Name: Red blood cell count; Result Unstructured Data: 4.02 10*6/uL; Test Date: 202105020456; Test Name: Chest X-ray; Result Unstructured Data: cardiomegaly CHF and increasing pulmonary edema; Comments: There is increased and scattered areas of alveolar opacity throughout both lungs which may represent superimposed pneumonia, there is no pneumothorax.; Test Date: 202105020811; Test Name: Echocardiogram; Result Unstructured Data: Reported; Comments: Normal left ventricular systolic function. LV ejection fraction was 74%. The left ventricular ejection fraction was an estimation. mild left ventricular hypertrophy. Moderate to large pericardial effusion. The pericardial effusion was circumferential to the heart. No echocardiographic evidence to suggest cardiac tamponade; Test Date: 202105021056; Test Name: Salicylate; Result Unstructured Data: less than 3 mg/ml; Test Date: 202105021056; Test Name: Hepatitis B antibody; Result Unstructured Data: Non reactive; Test Date: 202105021056; Test Name: Hepatitis B antigen; Result Unstructured Data: non reactive; Test Date: 202105021056; Test Name: Hepatitis C antibody; Result Unstructured Data: non reactive; Test Date: 202105021056; Test Name: Acetaminophen; Result Unstructured Data: less than 4 mcg/ml; Test Date: 202105021130; Test Name: Complement factor C3; Result Unstructured Data: 146 mg/dL; Test Date: 202105021130; Test Name: Complement factor C4; Result Unstructured Data: 20 mg/dL; Test Date: 202105021130; Test Name: Serum protein electrophoresis; Result Unstructured Data: 1.7 g/dL; Test Date: 202105021130; Test Name: Apo A1; Result Unstructured Data: 0.8 g/dL; Test Date: 202105021130; Test Name: Apolipoprotein; Result Unstructured Data: 1.2 g/dL; Test Date: 202105021130; Test Name: Beta globulin; Result Unstructured Data: 0.4 g/dL; Test Date: 202105021130; Test Name: Beta 2 globulin; Result Unstructured Data: 0.4 g/dL; Test Date: 202105021130; Test Name
Aktuelle Erkrankungen: Diabetes; Dyslipidemia; Hypertension; Obesity; Tobacco abuse.
Vorgeschichte: Comments: The patient had no allergies to medications, food, or other products.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1459756

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MO
Alter: 55,0
Geschlecht: F
Eingang: 21.08.2021
Impfdatum: -
Beginn: 01.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute kidney injury Alanine aminotransferase Amphetamines Analgesic drug level Angiogram Anion gap Anti-cyclic citrullinated peptide antibody Antibody test Antimicrobial susceptibility test resistant Antineutrophil cytoplasmic antibody Antinuclear antibody Antinuclear antibody negative Apolipoprotein Apolipoprotein A-I Aspartate aminotransferase Asthenia Chest pain Death

Symptomtext

ACUTE RENAL FAILURE; SEPTIC SHOCK; PERICARDITIS; VASCULITIS; STAPHYLOCOCCUS AUREUS INFECTION; SEPSIS; PERICARDIAL EFFUSION; POSSIBLE EPSTEIN BARR INFECTION; DEATH; AUTOPSY; HISTOLOGY; This spontaneous report received from a health care professional via a Regulatory Authority (VAERS ID: 1459756) concerned a 55 year old white female of unspecified ethnic origin. The patient's weight was 212 pounds, and height was 69 inches. The patient's concurrent conditions included: diabetes, hypertension, dyslipidemia, obesity, and tobacco abuser. The patient had no allergies to medications, food, or other products. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 042A21A, and expiry: Unknown) dose was not reported, with frequency 1 total administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 21-APR-2021, after vaccination, the patient admitted to the hospital with complaints of sharp pain which started one week prior to the admission and it was worse with deep breath. The patient also had no appetite and chills. On certain tests such as d-dimer, computed tomography of chest, it was diagnosed the patient had probable aortitis. The cause of aortitis was not clear during the admission period. The patient tested also identified with inflammatory response of the great vessels. No pulmonary embolism was identified. The patient was discharged from the hospital on 24-APR-2021 with steroid medication (prednisone 20 mg). The patient also diagnosed with pericarditis, possible staphylococcus aureus infection, uncontrolled type 2 diabetes mellitus with hyperglycemia, and possible Epstein Barr infection. Laboratory data included: ECG (NR: not provided) sinus rhythm, inferior infract, acute anteroseptal infract., Fibrin D dimer (NR: not provided) elevated, and Gram stain (NR: not provided) clusters of gram positive cocci. CT scan (NR: not provided) and results came as Heart: trace pericardial fluid thickening. calcification is present within the visualized coronary arteries. size is normal and position. Mediastinum: moderate to marked increased attenuation in the area around the great vessel origins and the descending aorta to the mid arch. This extends superiorly to the superior mediastinum along the course of the right brachiocephalic artery and to a lesser extend to the left common carotid artery. Nonspecific lymph nodes are present in the adjacent superior mediastinum. Nonspecific lymph nodes present also in the aorticopulmonary window. Thyroid: Nonspecific areas of decreased attenuation unable to be further characterized in the thyroid left greater than right. Largest measure approximately 1.5 cm. Vasculature, aorta: The thoracic aorta demonstrates no evidence of aneurysm or rupture as visualized. Minimal vascular calcification. Pulmonary arteries: No evidence of pulmonary embolus is demonstrated in the central or pulmonary arteries. Lymph nodes: no pathologically enlarged lymph nodes. On 21-APR-2021 14:49, Laboratory data included: Anion gap (NR: not provided) 9, Creatinine clearance (NR: not provided) 59.5, Glucose (NR: 74 - 106) 306 mg/dL, and Troponin (NR: 0.00 - 0.040) less than 0.006 ng/ml. On 21-APR-2021 15:49, Laboratory data included: GFR (NR: not provided) greater than 60 ml/min, Hematocrit (NR: 35 - 45) 49.4 %, Hemoglobin (NR: 12.0 - 16.0) 16.6 g/dL, Lymphocytes (NR: not provided) 10 %, MCH (NR: 27 - 31) 29.8 pg, MCHC (NR: 31 - 36.5) 33.6 g/dL, MCV 89 fL, Monocytes (NR: not provided) 10 %, Neutrophils (NR: 2 - 8.1) 14.6 10*3/uL, Platelet count (NR: 150 - 400) 224 10*3/uL, Red blood cell count (NR: 4.20 - 5.40) 5.57 10*6/uL, Red blood cell sedimentation rate (NR: 0 - 20) 28 mm/h, and WBC (NR: 4 - 10.8) 17.0 10*3/uL. On 21-APR-2021 16:09, Laboratory data included: Fibrin D dimer (NR: 215 - 500) 814 ng/mL, INR (NR: not provided) 1.15 (units unspecified), and Prothrombin time (NR: 9.4 - 12.5) 13.1 sec. On 21-APR-2021 17:54, Laboratory data included: Blood culture (NR: not provided) positive for staphylococcus aureus. On 21-APR-2021 20:09, Laboratory data included: Anti-cyclic citrullinated peptide antibody, HIV antibody, Hepatitis A antibody, Hepatitis B antibody and Hepatitis C antibody as Negative, non-reactive. On 21-APR-2021 20:46, Laboratory data included: Urine culture (NR: not provided) positive for staphylococcus aureus. On 21-APR-2021 22:26, Laboratory data included: Glucose (NR: 60 - 69) 204 mg/dL. On 22-APR-2021, Laboratory data included: Anti-SCL 70 (NR: not provided) less than 1.2 RLU, Antinuclear antibody (NR: not provided) positive, Double stranded DNA antibody (NR: not provided) Negative, Jo-1 antibody negative (NR: not provided) less than 2.2 RLU, Ribonucleoprotein antibody (NR: not provided) less than 3.5 RLU, and SM antibody (NR: not provided) less than 3.3 RLU. On 22-APR-2021 06:17, Laboratory data included: Glucose 131 mg/dL. On 22-APR-2021 09:42, Laboratory data included: MRI angiography (NR: not provided): Patent aorta and proximal branches. No stenosis identified. The significant surrounding inflammation of the proximal thoracic great vessels and aortic arch better demonstrated on the prior day CT. Findings remain concerning for large vessel vasculitis versus infectious etiology. On 22-APR-2021 10:55, Laboratory data included: Glucose 149 mg/dL. On 22-APR-2021 15:19, Laboratory data included: Anti-cyclic citrullinated peptide antibody (NR: not provided) less than16 units, Immunoglobulin G (NR: not provided) reported, and Rheumatoid factor (NR: not provided) positive. On 22-APR-2021 16:00, Laboratory data included: Troponin less than 0.006. On 22-APR-2021 18:36, Laboratory data included: Glucose 292 mg/dL. On 22-APR-2021 20:21, Laboratory data included: Glucose 302 mg/dL. On 23-APR-2021 04:17, Laboratory data included: Anion gap (NR: not provided) 8, Bicarbonate 23 mmol/L, Calcium 9.3 mg/dL, Chloride 108 mmol/L, Creatinine clearance (NR: not provided) 72.3, GFR (NR: not provided) greater than 60 ml/min, Glucose 104 mg/dL, Hematocrit 46.8 %, Hemoglobin 15.5 g/dL, Platelet count 234 10*3/uL, Potassium 3.9 mmol/L, Sodium 139 mmol/L, Troponin less than 0.006 ng/ml, and WBC 15.4 10*3/uL. On 23-APR-2021 06:07, Laboratory data included: Glucose 115 mg/dL. On 23-APR-2021 10:58, Laboratory data included: Glucose 228 mg/dL. Other laboratory data (dates unspecified) included: Creatinine (NR: not provided) 0.96, and GFR (NR: not provided) 60. On 1-MAY-2021, the patient again admitted to the hospital with complaints of chest pain, sepsis with septic shock and acute renal failure. On admission the patient admitted to emergency room covered in feces. The patient also had multiple scratches and excoriations covered entire body as a part of different stages of healing (the patient had 10 cats). On first day of admission, the patient was in shock and she had taken to intensive care unit (ICU) and on two vasopressors(unspecified). The patient's respiratory failure worsened at night and kept her on intubation and was later placed on ventilator. The patient also had profound metabolic acidosis which was unresponsive to medical therapy. The patient was presented with a pH of 7.2 and she was placed on bicarb drip with additional pushes and her pH continued to deteriorate. From nephrology she had instructed to start dialysis. The patient consulted with vascular surgery foe placement of a dialysis catheter. The patient also consulted with pulmonary critical care and infectious disease. The patient had large pericardial effusion. The patient had mild thrombocytosis and platelets were normal in morphology without significant platelet anisocytosis. Thrombocytosis might have accompanied along with reactive neutrophilia that are secondary to acute stress. Laboratory data included: Chest X-ray revealed cardiomegaly, Upper limb X-ray (NR: not provided) No acute bony abnormality identified in the right forearm, and pH (NR: not provided) 7.2. On 01-MAY-2021 04:49, Laboratory data included: Arterial blood gases (NR: not provided) pH art: 7.03 (normal- 7.35-7.45), pCO2 art: 33 mmHg(35-45), pO2 art: 77 mmHg(80-102 ), HCO3 art: 9mmol/l(22-26), O2Hb%:88%(95-100), % saturation, arterial: 90%(95-100), base excess art:-21.1mmol/l(-2-2), O2 cont. art: 16.4 vol. % (16-20), Hemoglobin art: 13.1 gm/dl(12-18), carboxy hemoglobin: 0.6%(0.0-0.2), met HB, arterial:0.7%(0.0-3.0), reduced HB: 10.4(2.5-9.3), NA level-art: 132mmol/l(135-145), K level: 5.8mmol/l(3.5-5.0), Cl level-art: 99mmol/l(98-106), Ion Ca level-art: 0.87mmol/l(1.05-1.30), arterial lactate: 1.6mmol/l(0.3-1.3), arterial glucose:373mg/dl(60-99), FIO2-arterial:90. On 01-MAY-2021 06:37, Laboratory data included: Albumin 2.2 g/dL, Alkaline phosphatase 185 U/L, Anion gap (NR: not provided) 22, BUN 115 mg/dL, Bicarbonate 10 mmol/L, Bilirubin total less than 0.2 mg/dl, Blood alcohol (NR: not provided) less than 12 mg/dl, C-reactive protein (NR: not provided) greater than 30.4 mg/dl, CK MB (NR: not provided) 1.71 ng/mL, CPK (NR: 34 - 145) 199 U/L, Calcium 7.5 mg/dL, Chloride 98 mmol/L, Creatinine 5.48 mg/dL, GFR (NR: not provided) 8 mL/min, Glucose 126 mg/dL, Hemoglobin 12.7 g/dL, Magnesium (NR: 1.6 - 2.6) 2.4 mg/dL, Phosphate (NR: 2.4 - 5.1) 12.5 mg/dL, Platelet count 477 10*3/uL, Potassium 5.3 mmol/L, Red blood cell sedimentation rate 69 mm/h, Sodium 130 mmol/L, and WBC 35.2 10*3/uL. On 01-MAY-2021 07:00, Laboratory data included: COVID-19 virus test (NR: not provided) Presumptive negative. On 01-MAY-2021 08:10, Laboratory data included: Antimicrobial susceptibility test resistant, Candida test, Cryptococcus test, Enterococcus test, Klebsiella test, Listeria test, Streptococcus test and Salmonella test as not detected, Staphylococcus test and staphylococcus aureus were detected. On 01-MAY-2021 09:17, Laboratory data included: Glucose (NR: 60 - 99) 464 mg/mL. On 01-MAY-2021 12:22, Laboratory data included: Epstein-Barr virus antibody (NR: not provided) less than 36 units/ml, 729 U/mL, and Epstein-Barr virus test (NR: not provided) greater than 600 units/ml. On 01-MAY-2021 13:15, Laboratory data included: Arterial blood gases (NR: not provided) pH art: 7.07 (normal- 7.35-7.45), pCO2 art: 23 mmHg(35-45), pO2 art: 62 mmHg(80-102 ), HCO3 art: 6mmol/l(22-26), O2Hb%:79%(95-100), % saturation, arterial: 80%(95-100), base excess art:-23.4mmol/l(-2-2), O2 cont. art: 15.2 vol. % (16-20), Hemoglobin art: 13.7 gm/dl(12-18), carboxy hemoglobin: -0.2%(0.0-0.2), met HB, arterial:1%(0.0-3.0), reduced HB: 20(2.5-9.3), NA level-art: 131mmol/l(135-145), K level: 5.6mmol/l(3.5-5.0), Cl level-art: 105mmol/l(98-106), Ion Ca level-art: 0.96mmol/l(1.05-1.30), arterial lactate: 1.4mmol/l(0.3-1.3), arterial glucose:185mg/dl(60-99),. On 01-MAY-2021 14:46, Laboratory data included: Glucose 318 mg/mL. On 01-MAY-2021 16:14, Laboratory data included: Glucose 226 mg/mL. On 01-MAY-2021 17:13, Laboratory data included: Arterial blood gases (NR: not provided) pH art: 7.09 (normal- 7.35-7.45), pCO2 art: 21 mmHg(35-45), pO2 art: 108 mmHg(80-102 ), HCO3 art: 6mmol/l(22-26), O2Hb%:96%(95-100), % saturation, arterial: 96%(95-100), base excess art:-21.8mmol/l(-2-2), O2 cont. art: 18 vol%(16-20), Hemoglobin art: 13.3 gm/dl(12-18), carboxy hemoglobin: 0.3%(0.0-0.2), met HB, arterial:0.5%(0.0-3.0), reduced HB: 3.7(2.5-9.3), NA level-art: 132mmol/l(135-145), K level: 5.6mmol/l(3.5-5.0), Cl level-art: 104mmol/l(98-106), Ion Ca level-art: 0.82mmol/l(1.05-1.30), arterial lactate: 1.6mmol/l(0.3-1.3), arterial glucose:241mg/dl(60-99), FIO2-arterial:70. On 01-MAY-2021 20:08, Laboratory data included: Amphetamines, Barbiturates, Benzodiazepine, Opiates, and Cannabinoids drug level as negative. Chlamydia test, Polymerase chain reaction were not detected, Legionella test and Streptococcus test was negative. On 02-MAY-2021 04:26, Laboratory data included: Antimicrobial susceptibility test resistant (NR: not provided) Amoxicillin/clavulanate, cefazolin, Clindamycin, erythromycin, gentamycin, levofloxacin, tetracycline, oxacillin, and trimethoprim/sulfa -susceptible, ampicillin and penicillin- resistant. On 02-MAY-2021 04:28, Laboratory data included: BUN 124 mg/dL, Bicarbonate less than 10 mmol/l, Calcium 6.5 mg/dL, Chloride 99 mmol/L, Creatinine 5.39 mg/dL, Creatinine clearance (NR: not provided) 10.6, GFR (NR: not provided) 8 mL/min, Glucose 395 mg/dL, Hematocrit 36.5 %, Hemoglobin 12 g/dL, MCH 29.9 pg, MCHC 32.9 g/dL, MCV 91 fL, Platelet count 476 10*3/uL, Potassium 5.5 mmol/L, Red blood cell count 4.02 10*6/uL, Red cell distribution width 15.3 %, Sodium 134 mmol/L, and WBC 34.8 10*3/uL. On 02-MAY-2021 04:56, Laboratory data included: Chest X-ray revealed cardiomegaly CHF and increasing pulmonary edema. On 02-MAY-2021 08:11, Laboratory data included: Echocardiogram (NR: not provided) Normal left ventricular systolic function. LV ejection fraction was 74%. The left ventricular ejection fraction was an estimation. mild left ventricular hypertrophy. Moderate to large pericardial effusion. The pericardial effusion was circumferential to the heart. No echocardiographic evidence to suggest cardiac tamponade. On 02-MAY-2021 10:56, Laboratory data included: Acetaminophen (NR: 10 - 20) less than 4 mcg/ml, Hepatitis B antibody, Hepatitis B antigen, and Hepatitis C antibody as non-reactive, and Salicylate (NR: 2.8 - 20) less than 3 mg/ml. On 02-MAY-2021 11:30, Laboratory data included: Apo A1 (NR: 0.2 - 0.3) 0.8 g/dL, Apo lipoprotein (NR: 0.5 - 0.9) 1.2 g/dL, Beta 2 globulin (NR: 0.2 - 0.5) 0.4 g/dL, Beta globulin (NR:.4 - 0.6) 0.4 g/dL, Complement factor C3 (NR: 83 - 193) 146 mg/dL, Complement factor C4 (NR: 15 - 57) 20 mg/dL, Gamma globulin (NR: 0.8 - 1.7) 0.7 g/dL, Serum protein electrophoresis (NR: 3.8 - 4.8) 1.7 g/dL, and Serum total protein 5.2 g/dL. On 02-MAY-2021 12:22, Laboratory data included: Beta-2 glycoprotein antibody (NR: not provided) less than 1, Brucella serology (NR: not provided) 0.58, 0.08, CMV IgG antibody (NR: not provided) less than 0.6 unit/ml, CMV IgM antibody (NR: not provided) less than 30, Ehrlichia serology (NR: not provided) less than 1:20, less than 1:64, Parvovirus B19 serology (NR: not provided) 7.8, 0.2, and Tuberculosis test (NR: not provided) indeterminate. On 02-MAY-2021 15:06, Laboratory data included: Albumin 2.2 g/dL, Alkaline phosphatase 328 U/L, Anion gap (NR: not provided) 25, BUN 97 mg/dL, Bicarbonate 17 mmol/L, Bilirubin total 0.5 mg/dL, Calcium 8.6 mg/dL, Chloride 95 mmol/L, Creatinine 4.26 mg/dL, Creatinine clearance (NR: not provided) 13.4, GFR (NR: not provided) 11 mL/min, Glucose 283 mg/dL, Potassium 5.8 mmol/L, SGOT (NR: not provided) 2655 U/L, SGPT 1204 U/L, Serum total protein 5.8 g/dL, and Sodium 137 mmol/L. On 02-MAY-2021 15:13, Laboratory data included: ECG (NR: not provided) atrial fibrillation. On 02-MAY-2021 16:11, Laboratory data included: Arterial blood gases (NR: not provided) pH art: 7.12 (normal- 7.35-7.45), pCO2 art: 27 mmHg (35-45), pO2 art: 64mmHg (80-102), HCO3 art: 9mmol/l(22-26), O2Hb%:81%(95-100), % saturation, arterial: 82%(95-100), base excess art:-19.3mmol/l(-2-2), O2 cont. art: 10.6 vol. % (16-20), Hemoglobin art: 9.2 gm/dl(12-18), carboxy hemoglobin: 0.2%(0.0-0.2), met HB, arterial:1%(0.0-3.0), reduced HB: 17.6(2.5-9.3), NA level-art: 137mmol/l(135-145), K level: 4.6mmol/l(3.5-5.0), Cl level-art: 103mmol/l(98-106), Ion Ca level-art: 0.93mmol/l(1.05-1.30), arterial lactate: 11.8mmol/l(0.3-1.3), arterial glucose:230mg/dl(60-99), FIO2-arterial:100. On 02-MAY-2021, the patient died from sepsis, pericarditis, large vessel vasculitis, and staphylococcus aureus infection as per the autopsy report. On 03-MAY-2021, Laboratory data included during autopsy: Blood urea nitrogen (NR: not provided) 107 mg/dL, Chloride (NR: not provided) 105 mmol/L, Creatinine (NR: not provided) 3.5 mg/dL, Ethanol (NR: not provided) negative, Glucose (NR: not provided) 161 mg/dL, Isopropanol (NR: not provided) negative, Methanol (NR: not provided) Negative, Potassium (NR: not provided) 11.2 mmol/L, and Sodium (NR: not provided) 141 mmol/L. Laboratory data (dates unspecified) included: ANA (NR: not provided) positive 1:1280, ANCA (NR: not provided) Negative, Anti-cyclic citrullinated peptide antibody (NR: not provided) Negative and GFR (NR: not provided) 60. Treatment medications (dates unspecified) included: metformin hydrochloride/sitagliptin phosphate monohydrate, trazodone, vitamin b complex, sodium bicarbonate, diltiazem, buspirone, venlafaxine hydrochloride, canagliflozin, prednisone, atorvastatin, ascorbic acid/beta carotene/biotin/calcium/calcium pantothenate/chromium amino acid chelate/colecalciferol/copper amino acid chelate/cyanocobalamin/folic acid/magnesium citrate/magnesium oxide/manganese amino acid chelate/mecobalamin/molybdenum amino acid chelate/nicotinamide/phytomenadione/potassium iodide/pyridoxine hydrochloride/retinol palmitate/riboflavin/selenium amino acid chelate/thiamine mononitrate/tocopheryl acetate/zinc amino acid chelate, colecalciferol, losartan, momordica charantia, glipizide, fish oil/omega-3 fatty acids, and insulin detemir. On 03-MAY-2021, Laboratory data included: Acetone, Amphetamines, Barbiturates, Benzodiazepine drug level, cannabinoids, muscle relaxants, opioid analgesics and stimulants levels were negative. An autopsy performed on 3-MAY-2021 08:00, which revealed pericarditis with large vessel vasculitis and a fibrinous exudate coating the epicardial surface of the heart. Ascending and descending aorta grossly and histologically remarkable. A gram stain performed on tissue from the brachiocephalic and left common carotid arteries revealed numerous clusters of gram positive cocci. The radial artery histologically showed fibrinoid material with associated inflammatory cells in a vessel wall within the adventitia but no inflammation of the vessel walls. Lungs with diffuse alveolar damage and centrilobular necrosis of the liver and acute tubular necrosis of the kidneys. The heart was enlarged (cardiomegaly, 500 grams) and exhibited moderate to severe calcific coronary artery disease with up to 80% occlusion of the left anterior descending coronary artery. ventral hernia. Multiple right sided rib fractures were noted, which were likely secondary to resuscitative efforts. remote cholecystectomy and bilateral tubal ligation. Vitreous electrolytes were significant for renal failure. It was unclear vaccination played a direct role in death. Based on the circumstances surrounding the death and the findings at autopsy, the patient died as a result of sepsis with pericarditis and large vessel vasculitis due to staphylococcus aureus bacterial infection. The manner of death was natural. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died of death, autopsy, vasculitis, septic shock, histology and staphylococcus aureus infection on 02-MAY-2021, and the outcome of possible Epstein Barr infection, pericardial effusion, acute renal failure was not reported. This report was serious (Death, Hospitalization Caused / Prolonged, and Other Medically Important Condition). Additional information was received via company representative on 06-AUG-2021, 07-AUG-2021 and 9-AUG-2021. The following information was updated and incorporated into the case narrative: Patient's demographics added (DOB, height, weight, race), patient history added (hypertension, obesity, dyslipidemia, tobacco abuse), cause of death updated (sepsis, pericarditis, large vessel vasculitis, staphylococcal aureus infection, Date of autopsy updated, events added (septic shock, sepsis, staphylococcal aureus infection, acute renal failure, possible Epstein Barr infection), seriousness criteria added (pericarditis, vasculitis and septic shock-Hospitalization caused/prolonged), hospital address added, lab data added (from data 3 to data 302), Reporter added and narrative updated. The narrative has been abstracted to comply with E2B data limitations. Sender's Comments: V1: Follow up information received in the current version is regarding patient demographics, medical history, autopsy findings, new events with clinical course and laboratory details. 20210751395-Covid-19 vaccine ad26.cov2.s-sepsis, pericarditis, vasculitis, staphylococcus aureus infection, septic shock, death, autopsy, histology, pericardial effusion, acute renal failure. Follow-up received regarding Clinical Details. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY; Reported Cause(s) of Death: SEPSIS; PERICARDITIS; LARGE VESSEL VASCULITIS; STAPHYLOCOCCUS AUREUS INFECTION.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 3,0
Labordaten: Test Date: 202104; Test Name: Physical examination; Result Unstructured Data: Reported; Comments: General: Alert, oriented and no acute distress. Head: Atraumatic, Eyes: PERRLA EOMI. Mouth: Moist mucus membrane. No pharyngeal erythema. Neck: soft and supple. No lymphadenopathy. Heart: regular rate and rhythm without murmur. Lungs: clear to auscultation bilaterally in all lung fields. Abdomen: No guarding or rebound. non tender and non distended, positive normoactive bowel sounds, no mass or hepatosplenomegaly, no bruits heard. Extremities: No clubbing, cyanosis or edema.; Test Date: 20210421; Test Name: ECG; Result Unstructured Data: sinus rhythm, inferior infract, acute anteroseptal infract.; Test Date: 20210421; Test Name: Gram stain; Result Unstructured Data: clusters of gram positive cocci; Test Date: 20210421; Test Name: Fibrin D dimer; Result Unstructured Data: elevated; Test Date: 202104211449; Test Name: SGOT; Result Unstructured Data: less than 15 u/l; Test Date: 202104211449; Test Name: Creatinine clearance; Result Unstructured Data: 59.5; Test Date: 202104211449; Test Name: Creatinine; Result Unstructured Data: 0.96 mg/dL; Test Date: 202104211449; Test Name: BUN; Result Unstructured Data: 12 mg/dL; Test Date: 202104211449; Test Name: Glucose; Result Unstructured Data: 306 mg/dL; Test Date: 202104211449; Test Name: Bicarbonate; Result Unstructured Data: 23 mmol/L; Test Date: 202104211449; Test Name: Chloride; Result Unstructured Data: 102 mmol/L; Test Date: 202104211449; Test Name: Potassium; Result Unstructured Data: 4.0 mmol/L; Test Date: 202104211449; Test Name: Sodium; Result Unstructured Data: 134 mmol/L; Test Date: 202104211449; Test Name: Troponin; Result Unstructured Data: less than 0.006 ng/ml; Test Date: 202104211449; Test Name: Calcium; Result Unstructured Data: 9.5 mg/dL; Test Date: 202104211449; Test Name: Anion gap; Result Unstructured Data: 9; Test Date: 202104211449; Test Name: Serum total protein; Result Unstructured Data: 8 g/dL; Test Date: 202104211449; Test Name: Bilirubin total; Result Unstructured Data: 0.7 mg/dL; Test Date: 202104211449; Test Name: Albumin; Result Unstructured Data: 3.9 g/dL; Test Date: 202104211449; Test Name: SGPT; Result Unstructured Data: 12 U/L; Test Date: 202104211449; Test Name: Alkaline phosphatase; Result Unstructured Data: 123 U/L; Test Date: 202104211549; Test Name: GFR; Result Unstructured Data: greater than 60 ml/min; Test Date: 202104211549; Test Name: Basophils; Result Unstructured Data: 0.0 10*3/uL; Test Date: 202104211549; Test Name: Red blood cell morphology; Result Unstructured Data: Normal; Test Date: 202104211549; Test Name: Red blood cell sedimentation rate; Result Unstructured Data: 28 mm/h; Test Date: 202104211549; Test Name: Eosinophils; Result Unstructured Data: 0.0 10*3/uL; Test Date: 202104211549; Test Name: Monocytes; Result Unstructured Data: 0.7 10*3/uL; Test Date: 202104211549; Test Name: Lymphocytes; Result Unstructured Data: 1.7 10*3/uL; Test Date: 202104211549; Test Name: Neutrophils; Result Unstructured Data: 14.6 10*3/uL; Test Date: 202104211549; Test Name: Basophils; Result Unstructured Data: 0 %; Test Date: 202104211549; Test Name: Eosinophils; Result Unstructured Data: 0 %; Test Date: 202104211549; Test Name: Monocytes; Result Unstructured Data: 10 %; Test Date: 202104211549; Test Name: Lymphocytes; Result Unstructured Data: 10 %; Test Date: 202104211549; Test Name: Platelet count; Result Unstructured Data: 224 10*3/uL; Test Date: 202104211549; Test Name: Red cell distribution width; Result Unstructured Data: 13.7 %; Test Date: 202104211549; Test Name: MCHC; Result Unstructured Data: 33.6 g/dL; Test Date: 202104211549; Test Name: MCH; Result Unstructured Data: 29.8 pg; Test Date: 202104211549; Test Name: MCV; Result Unstructured Data: 89 fL; Test Date: 202104211549; Test Name: WBC; Result Unstructured Data: 17.0 10*3/uL; Test Date: 202104211549; Test Name: Red blood cell count; Result Unstructured Data: 5.57 10*6/uL; Test Date: 202104211549; Test Name: Hemoglobin; Result Unstructured Data: 16.6 g/dL; Test Date: 202104211549; Test Name: Hematocrit; Result Unstructured Data: 49.4 %; Test Date: 202104211609; Test Name: Fibrin D dimer; Result Unstructured Data: 814 ng/mL; Test Date: 202104211609; Test Name: Prothrombin time; Result Unstructured Data: 13.1 sec; Test Date: 202104211609; Test Name: INR; Result Unstructured Data: 1.15; Test Date: 202104211729; Test Name: CT scan; Result Unstructured Data: Reported; Comments: Lungs: Bibasilar interlobular thickening with minimal interstitial accentuation. Minimal patchy opacification bilaterally , left greater than right. Heart: trace pericardial fluid thickening. calcification is present within the visualized coronary arteries. size is normal and position mediastinum: moderate to marked increased attenuation in the area around the great vessel origins and the descending aorta to the mid arch. This extends superiorly to the superior mediastinum along the course of the right brachiocephalic artery and to a lesser extend to the left common carotid artery. Non specific lymph nodes are present in the adjacent superior mediastinum. Non specific lymph nodes present also in the aorticopulmonary window. Thyroid: Non specific areas of decreased attenuation unable to be further characterized in the thyroid left grater than right. Largest measure approximately 1.5 cm. Bones/joints: No definite acute findings. Soft tissues: No definite acute findings. Vasculature: aorta: The thoracic aorta demonstrates no evidence of aneurysm or rupture as visualized. Minimal vascular calcification. Pulmonary arteries: No evidence of pulmonary embolus is demonstrated in the central or pulmonary arteries. Lymph nodes: no pathologically enlarged lymph nodes. Upper abdomen: The upper abdominal structures demonstrate no acute abnormalities as visualized.; Test Date: 202104211754; Test Name: Blood culture; Result Unstructured Data: positive for staphylococcus aureus; Test Date: 202104212002; Test Name: Urine analysis; Result Unstructured Data: Reported; Comments: color: straw (yellow-normal), appearance: clear (normal-clear), PH: 5.0 (normal- 7.0), Urine specific gravity: 1.024 (normal-1.015), urine protein: Negative(normal-negative), urine glucose: more than 3(normal-negative),urine ketones: trace(normal-negative), urine bilirubin: negative(normal-negative), urine blood: negative(normal-negative), urine urobilinogen: normal (normal), urine nitrite: negative(negative), urine LE-Test :negative (negative). urine RBC: 0-2(normal-absent), urine WBC: 0-5 (normal- 0-5), urine mucus: rare(normal-absent), urine yeast: rare (normal- absent), urine granular cast: none seen, Urine hyal cast: none seen (normal0-2), Urine RBC casts: none seen, urine waxy casts: none seen, urine WBC casts: none seen, urine epi casts: none seen.; Test Date: 202104212009; Test Name: Hepatitis C antibody; Result Unstructured Data: Negative, non reactive; Test Date: 202104212009; Test Name: HIV antibody; Result Unstructured Data: Negative, non reactive; Test Date: 202104212009; Test Name: Antibody test; Result Unstructured Data: Negative, non reactive; Test Date: 202104212009; Test Name: Anti-cyclic citrullinated peptide antibody; Result Unstructured Data: negative; Test Date: 202104212009; Test Name: Hepatitis B antibody; Result Unstructured Data: non reactive; Test Date: 202104212009; Test Name: Hepatitis A antibody; Result Unstructured Data: non reactive; Test Date: 202104212046; Test Name: Urine culture; Result Unstructured Data: positive for staphylococcus aureus; Test Date: 202104212226; Test Name: Glucose; Result Unstructured Data: 204 mg/dL; Test Date: 20210422; Test Name: Antinuclear antibody; Result Unstructured Data: positive; Comments: FANA titer: 1:1280, FANA pattern: speckled; Test Date: 20210422; Test Name: Anti-SCL 70; Result Unstructured Data: less than 1.2 RLU; Test Date: 20210422; Test Name: Jo-1 antibody negative; Result Unstructured Data: less than 2.2 RLU; Test Date: 20210422; Test Name: Double stranded DNA antibody; Result Unstructured Data: Negative; Test Date: 20210422; Test Name: SM antibody; Result Unstructured Data: less than 3.3 RLU; Test Date: 20210422; Test Name: Ribonucleoprotein antibody; Result Unstructured Data: less than 3.5 RLU; Test Date: 202104220350; Test Name: Anion gap; Result Unstructured Data: 9; Test Date: 202104220350; Test Name: Glucose; Result Unstructured Data: 95 mg/dL; Test Date: 202104220350; Test Name: BUN; Result Unstructured Data: 11 mg/dL; Test Date: 202104220350; Test Name: Creatinine; Result Unstructured Data: 0.77 mg/dL; Test Date: 202104220350; Test Name: Creatinine clearance; Result Unstructured Data: 74.2; Test Date: 202104220350; Test Name: GFR; Result Unstructured Data: greater than 60 ml/min; Test Date: 202104220350; Test Name: Bicarbonate; Result Unstructured Data: 22 mmol/L; Test Date: 202104220350; Test Name: Chloride; Result Unstructured Data: 107 mmol/L; Test Date: 202104220350; Test Name: Potassium; Result Unstructured Data: 3.4 mmol/L; Test Date: 202104220350; Test Name: Sodium; Result Unstructured Data: 138 mmol/L; Test Date: 202104220350; Test Name: Calcium; Result Unstructured Data: 9.2 mg/dL; Test Date: 202104220350; Test Name: Red blood cell morphology; Result Unstructured Data: Normal; Test Date: 202104220350; Test Name: Eosinophils; Result Unstructured Data: 0.15 10*3/uL; Test Date: 202104220350; Test Name: Basophils; Result Unstructured Data: 0.07 10*3/uL; Test Date: 202104220350; Test Name: Monocytes; Result Unstructured Data: 1.26 10*3/uL; Test Date: 202104220350; Test Name: Lymphocytes; Result Unstructured Data: 2.6 10*3/uL; Test Date: 202104220350; Test Name: Neutrophils; Result Unstructured Data: 12.25 10*3/uL; Test Date: 202104220350; Test Name: Basophils; Result Unstructured Data: 0 %; Test Date: 202104220350; Test Name: Eosinophils; Result Unstructured Data: 1 %; Test Date: 202104220350; Test Name: WBC; Result Unstructured Data: 16.4 10*3/uL; Test Date: 202104220350; Test Name: Red blood cell count; Result Unstructured Data: 5.18 10*6/uL; Test Date: 202104220350; Test Name: Hemoglobin; Result Unstructured Data: 15.5 g/dL; Test Date: 202104220350; Test Name: Hematocrit; Result Unstructured Data: 45.8 %; Test Date: 202104220350; Test Name: MCV; Result Unstructured Data: 88 fL; Test Date: 202104220350; Test Name: MCH; Result Unstructured Data: 29.9 pg; Test Date: 202104220350; Test Name: MCHC; Result Unstructured Data: 33.8 g/dL; Test Date: 202104220350; Test Name: Red cell distribution width; Result Unstructured Data: 13.5 %; Test Date: 202104220350; Test Name: Platelet count; Result Unstructured Data: 218 10*6/uL; Test Date: 202104220350; Test Name: Lymphocytes; Result Unstructured Data: 16 %; Test Date: 202104220350; Test Name: Monocytes; Result Unstructured Data: 8 %; Test Date: 202104220617; Test Name: Glucose; Result Unstructured Data: 131 mg/dL; Test Date: 202104220942; Test Name: MRI angiography; Result Unstructured Data: Reported; Comments: Normal course and caliber of the thoracic and abdominal aorta. There is mild atheromatous plaque of the lower descending thoracic aorta and abdominal aorta. Common origin of the brachiocephalic and left common carotid arteries, a normal variant. Patient flow is seen in the celiac, SMA, and bilateral renal arteries. No evidence of central pulmonary embolism. The previously demonstrated formation along the aortic arch and proximal great vessels is better demonstrated on prior day CT. No evidence of abscess or radiation or enlarged mediastinal adenopathy. Partially imaged abdomen does not show acute findings. Cholecystectomy. No stenosis are identified.; Test Date: 202104221055; Test Name: Glucose; Result Unstructured Data: 149 mg/dL; Test Date: 202104221519; Test Name: Rheumatoid factor; Result Unstructured Data: positive; Test Date: 202104221519; Test Name: Immunoglobulin G; Result Unstructured Data: reported; Comments: IGGS1-531mg/dl (382-921), IGGS2-226 mg/dl (271-700), IGGS3- 21mg/dl(22-178), IGGS4-10.9 mg/dl(4-86), IMMGG-913mg/dl(600-1640); Test Date: 202104221519; Test Name: Anti-cyclic citrullinated peptide antibody; Result Unstructured Data: less than16 units; Test Date: 202104221600; Test Name: Troponin; Result Unstructured Data: less than 0.006; Test Date: 202104221836; Test Name: Glucose; Result Unstructured Data: 292 mg/dL; Test Date: 202104222021; Test Name: Glucose; Result Unstructured Data: 302 mg/dL; Test Date: 202104230417; Test Name: Monocytes; Result Unstructured Data: 1.01 10*3/uL; Test Date: 202104230417; Test Name: Red blood cell morphology; Result Unstructured Data: Normal; Test Date: 202104230417; Test Name: Anion gap; Result Unstructured Data: 8; Test Date: 202104230417; Test Name: Calcium; Result Unstructured Data: 9.3 mg/dL; Test Date: 202104230417; Test Name: Troponin; Result Unstructured Data: less than 0.006 ng/ml; Test Date: 202104230417; Test Name: Sodium; Result Unstructured Data: 139 mmol/L; Test Date: 202104230417; Test Name: Potassium; Result Unstructured Data: 3.9 mmol/L; Test Date: 202104230417; Test Name: Chloride; Result Unstructured Data: 108 mmol/L; Test Date: 202104230417; Test Name: Bicarbonate; Result Unstructured Data: 23 mmol/L; Test Date: 202104230417; Test Name: Glucose; Result Unstructured Data: 104 mg/dL; Test Date: 202104230417; Test Name: BUN; Result Unstructured Data: 13 mg/dL; Test Date: 202104230417; Test Name: Creatinine; Result Unstructured Data: 0.79 mg/dL; Test Date: 202104230417; Test Name: Creatinine clearance; Result Unstructured Data: 72.3; Test Date: 202104230417; Test Name: GFR; Result Unstructured Data: greater than 60 ml/min; Test Date: 202104230417; Test Name: Eosinophils; Result Unstructured Data: 0.19 10*3/uL; Test Date: 202104230417; Test Name: Basophils; Result Unstructured Data: 0.06 10*3/uL; Test Date: 202104230417; Test Name: Lymphocytes; Result Unstructured Data: 1.79 10*3/uL; Test Date: 202104230417; Test Name: WBC; Result Unstructured Data: 15.4 10*3/uL; Test Date: 202104230417; Test Name: Red blood cell count; Result Unstructured Data: 5.16 10*6/uL; Test Date: 202104230417; Test Name: Hemoglobin; Result Unstructured Data: 15.5 g/dL; Test Date: 202104230417; Test Name: Hematocrit; Result Unstructured Data: 46.8 %; Test Date: 202104230417; Test Name: MCV; Result Unstructured Data: 91 fL; Test Date: 202104230417; Test Name: MCH; Result Unstructured Data: 30 pg; Test Date: 202104230417; Test Name: MCHC; Result Unstructured Data: 33.1 g/dL; Test Date: 202104230417; Test Name: Red cell distribution width; Result Unstructured Data: 13.4 %; Test Date: 202104230417; Test Name: Platelet count; Result Unstructured Data: 234 10*3/uL; Test Date: 202104230417; Test Name: Lymphocytes; Result Unstructured Data: 12 %; Test Date: 202104230417; Test Name: Monocytes; Result Unstructured Data: 7 %; Test Date: 202104230417; Test Name: Eosinophils; Result Unstructured Data: 1 %; Test Date: 202104230417; Test Name: Basophils; Result Unstructured Data: 0 %; Test Date: 202104230417; Test Name: Neutrophils; Result Unstructured Data: 12.29 10*3/uL; Test Date: 202104230607; Test Name: Glucose; Result Unstructured Data: 115 mg/dL; Test Date: 202104231058; Test Name: Glucose; Result Unstructured Data: 228 mg/dL; Test Date: 20210501; Test Name: Chest X-ray; Result Unstructured Data: cardiomegaly with significant increased in heart size; Comments: Mild CHF with central pulmonary vascular congestion. There are scattered areas of mainly interstitial opacity in the mid to lower portions of both lungs most likely representing sub segmental atelectasis. There is no pneumothorax.; Test Date: 20210501; Test Name: Upper limb X-ray; Result Unstructured Data: No acute bony abnormality identified in the right forearm; Comments: Normal right humerus radiographs.; Test Date: 20210501; Test Name: pH; Result Unstructured Data: 7.2; Test Date: 202105010449; Test Name: Arterial blood gases; Result Unstructured Data: reported; Comments: pH art: 7.03 (normal- 7.35-7.45), pCO2 art: 33 mmHg(35-45), pO2 art: 77 mmHg(80-102 ), HCO3 art: 9mmol/l(22-26), O2Hb%:88%(95-100), % saturation, arterial: 90%(95-100), base excess art:-21.1mmol/l(-2-2), O2 cont. art: 16.4 vol%(16-20), Hemoglobin art: 13.1 gm/dl(12-18), carboxy hemoglobin: 0.6%(0.0-0.2), met Hb, arterial:0.7%(0.0-3.0), reduced Hb: 10.4(2.5-9.3), NA level-art: 132mmol/l(135-145), K level: 5.8mmol/l(3.5-5.0), Cl level-art: 99mmol/l(98-106), Ion Ca level-art: 0.87mmol/l(1.05-1.30), arterial lactate: 1.6mmol/l(0.3-1.3), arterial glucose:373mg/dl(60-99), FIO2-arterial:90.; Test Date: 202105010637; Test Name: WBC; Result Unstructured Data: 35.2 10*3/uL; Test Date: 202105010637; Test Name: Red blood cell count; Result Unstructured Data: 4.26 10*6/uL; Test Date: 202105010637; Test Name: Hemoglobin; Result Unstructured Data: 12.7 g/dL; Test Date: 202105010637; Test Name: Hematocrit; Result Unstructured Data: 37.3 %; Test Date: 202105010637; Test Name: MCV; Result Unstructured Data: 88 fL; Test Date: 202105010637; Test Name: MCH; Result Unstructured Data: 29.8 pg; Test Date: 202105010637; Test Name: MCV; Result Unstructured Data: 88 fL; Test Date: 202105010637; Test Name: MCHC; Result Unstructured Data: 34 g/dL; Test Date: 202105010637; Test Name: Red cell distribution width; Result Unstructured Data: 14.6 %; Test Date: 202105010637; Test Name: Platelet count; Result Unstructured Data: 477 10*3/uL; Test Date: 202105010637; Test Name: Lymphocytes; Result Unstructured Data: 6 %; Test Date: 202105010637; Test Name: Monocytes; Result Unstructured Data: 2 %; Test Date: 202105010637; Test Name: Eosinophils; Result Unstructured Data: 0 %; Test Date: 202105010637; Test Name: Basophils; Result Unstructured Data: 0 %; Test Date: 202105010637; Test Name: Neutrophils; Result Unstructured Data: 30.3 10*3/uL; Test Date: 202105010637; Test Name: Lymphocytes; Result Unstructured Data: 2.1 10*3/uL; Test Date: 202105010637; Test Name: Monocytes; Result Unstructured Data: 0.7 10*3/uL; Test Date: 202105010637; Test Name: Eosinophils; Result Unstructured Data: 0.0 10*3/uL; Test Date: 202105010637; Test Name: Basophils; Result Unstructured Data: 0.0 10*3/uL; Test Date: 202105010637; Test Name: Red blood cell morphology; Result Unstructured Data: Normal; Test Date: 202105010637; Test Name: Red blood cell sedimentation rate; Result Unstructured Data: 69 mm/h; Test Date: 202105010637; Test Name: Serum total protein; Result Unstructured Data: 7 g/dL; Test Date: 202105010637; Test Name: Albumin; Result Unstructured Data: 2.2 g/dL; Test Date: 202105010637; Test Name: Calcium; Result Unstructured Data: 7.5 mg/dL; Test Date: 202105010637; Test Name: Bilirubin total; Result Unstructured Data: less than 0.2 mg/dl; Test Date: 202105010637; Test Name: Alkaline phosphatase; Result Unstructured Data: 185 U/L; Test Date: 202105010637; Test Name: Sodium; Result Unstructured Data: 130 mmol/L; Test Date: 202105010637; Test Name: Potassium; Result Unstructured Data: 5.3 mmol/L; Test Date: 202105010637; Test Name: Chloride; Result Unstructured Data: 98 mmol/L; Test Date: 202105010637; Test Name: Bicarbonate; Result Unstructured Data: 10 mmol/L; Test Date: 202105010637; Test Name: Anion gap; Result Unstructured Data: 22; Test Date: 202105010637; Test Name: Glucose; Result Unstructured Data: 126 mg/dL; Test Date: 202105010637; Test Name: BUN; Result Unstructured Data: 115 mg/dL; Test Date: 202105010637; Test Name: Creatinine; Result Unstructured Data: 5.48 mg/dL; Test Date: 202105010637; Test Name: GFR; Result Unstructured Data: 8 mL/min; Test Date: 202105010637; Test Name: SGPT; Result Unstructured Data: 39 U/L; Test Date: 202105010637; Test Name: SGOT; Result Unstructured Data: 43 U/L; Test Date: 202105010637; Test Name: Magnesium; Result Unstructured Data: 2.4 mg/dL; Test Date: 202105010637; Test Name: CPK; Result Unstructured Data: 199 U/L; Test Date: 202105010637; Test Name: CK MB; Result Unstructured Data: 1.71 ng/mL; Test Date: 202105010637; Test Name: Blood alcohol; Result Unstructured Data: less than 12 mg/dl; Test Date: 202105010637; Test Name: C-reactive protein; Result Unstructured Data: greater than 30.4 mg/dl; Test Date: 202105010637; Test Name: Phosphate; Result Unstructured Data: 12.5 mg/dL; Test Date: 202105010643; Test Name: Arterial blood gases; Result Unstructured Data: reported; Comments: pH art: 7.16 (normal- 7.35-7.45), pCO2 art: 25 mmHg(35-45), pO2 art:59 mmHg(80-102 ), HCO3 art:9mmol/l(22-26), O2Hb%:81%(95-100), % saturation, arterial: 83%(95-100), base excess art:-18.4mmol/l(-2-2), O2 cont. art: 15.1 vol. % (16-20), Hemoglobin art: 13.2 gm/dl(12-18), carboxy hemoglobin: 1%(0.0-0.2), met HB, arterial:0.8%(0.0-3.0), reduced HB: 17 (2.5-9.3), NA level-art: 131mmol/l(135-145), K level: 5.1mmol/l(3.5-5.0), Cl level-art: 102mmol/l(98-106), Ion Ca level-art: 0.92mmol/l(1.05-1.30), arterial lactate: 1.6mmol/l(0.3-1.3), arterial glucose:128mg/dl(60-99),FIO2-arterial:21.; Test Date: 202105010700; Test Name: COVID-19 virus test; Result Unstructured Data: Presumptive negative; Test Date: 202105010713; Test Name: Arterial blood gases; Result Unstructured Data: reported; Comments: pH art: 6.98 (normal- 7.35-7.45), pCO2 art: 43 mmHg(35-45), pO2 art: 54 mmHg(80-102 ), HCO3 art: 10mmol/l(22-26), O2Hb%:71%(95-100), % saturation, arterial: 72%(95-100), base excess art:-22.0mmol/l(-2-2), O2 cont. art: 12.5 vol % (16-20), Hemoglobin art: 12.5 gm/dl(12-18), carboxy hemoglobin: -0.1%(0.0-0.2), met HB, arterial:1%(0.0-3.0), reduced HB: 27.0(2.5-9.3), NA level-art: 130mmol/l(135-145), K level: 6.1mmol/l(3.5-5.0), Cl level-art: 99mmol/l(98-106), Ion Ca level-art: 0.9mmol/l(1.05-1.30), arterial lactate: 1.9mmol/l(0.3-1.3), arterial glucose:478mg/dl(60-99), FIO2-arterial:100.; Test Date: 202105010810; Test Name: Salmonella test; Result Unstructured Data: not detected; Test Date: 202105010810; Test Name: Cryptococcus test; Result Unstructured Data: not detected; Test Date: 202105010810; Test Name: Candida test; Result Unstructured Data: Not detected; Test Date: 202105010810; Test Name: Klebsiella test; Result Unstructured Data: not detected; Test Date: 202105010810; Test Name: Streptococcus test; Result Unstructured Data: not detected; Test Date: 202105010810; Test Name: Staphylococcus test; Result Unstructured Data: detected and staphylococcus aureus detected; Test Date: 202105010810; Test Name: Listeria test; Result Unstructured Data: Not detected; Test Date: 202105010810; Test Name: Enterococcus test; Result Unstructured Data: not detected; Test Date: 202105010810; Test Name: Antimicrobial susceptibility test resistant; Result Unstructured Data: reported; Comments: IMP(carbapenem)- Not applicable, KPC(carbapenem)- Not applicable, OXA-48-like(carbapenem)- Not applicable, NDM(carbapenem)- Not applicable, VIM(carbapenem)- Not applicable, mcr-1 colistin -Not applicable, CTX-M(ESBL)-Not applicable, mecA-Methicillin-Not applicable, mecA/C and MREJ(MRSA)(Methicillin)-Not detected, can A/B(vancomycin)-not detected; Test Date: 202105010917; Test Name: Glucose; Result Unstructured Data: 464 mg/mL; Test Date: 202105011222; Test Name: Epstein-Barr virus antibody; Result Unstructured Data: 729 U/mL; Test Date: 202105011222; Test Name: Epstein-Barr virus test; Result Unstructured Data: grater than 600 units/ml; Test Date: 202105011222; Test Name: Epstein-Barr virus antibody; Result Unstructured Data: less than 36 units/ml; Test Date: 202105011243; Test Name: Glucose; Result Unstructured Data: 462 mg/mL; Test Date: 202105011315; Test Name: Arterial blood gases; Result Unstructured Data: reported; Comments: pH art: 7.07 (normal- 7.35-7.45), pCO2 art: 23 mmHg(35-45), pO2 art: 62 mmHg(80-102 ), HCO3 art: 6mmol/l(22-26), O2Hb%:79%(95-100), % saturation, arterial: 80%(95-100), base excess art:-23.4mmol/l(-2-2), O2 cont art: 15.2 vol % (16-20), Hemoglobin art: 13.7 gm/dl(12-18), carboxy hemoglobin: -0.2%(0.0-0.2), met HB, arterial:1%(0.0-3.0), reduced HB: 20(2.5-9.3), NA level-art: 131mmol/l(135-145), K level: 5.6mmol/l(3.5-5.0), Cl level-art: 105mmol/l(98-106), Ion Ca level-art: 0.96mmol/l(1.05-1.30), arterial lactate: 1.4mmol/l(0.3-1.3), arterial glucose:185mg/dl(60-99),; Test Date: 202105011346; Test Name: Glucose; Result Unstructured Data: 415 mg/mL; Test Date: 202105011446; Test Name: Glucose; Result Unstructured Data: 318 mg/mL; Test Date: 202105011614; Test Name: Glucose; Result Unstructured Data: 226 mg/mL; Test Date: 202105011713; Test Name: Arterial blood gases; Result Unstructured Data: reported; Comments: pH art: 7.09 (normal- 7.35-7.45), pCO2 art: 21 mmHg(35-45), pO2 art: 108 mmHg(80-102 ), HCO3 art: 6mmol/l(22-26), O2Hb%:96%(95-100), % saturation, arterial: 96%(95-100), base excess art:-21.8mmol/l(-2-2), O2 cont art: 18 vol % (16-20), Hemoglobin art: 13.3 gm/dl(12-18), carboxy hemoglobin: 0.3%(0.0-0.2), met HB, arterial:0.5%(0.0-3.0), reduced HB: 3.7(2.5-9.3), NA level-art: 132mmol/l(135-145), K level: 5.6mmol/l(3.5-5.0), Cl level-art: 104mmol/l(98-106), Ion Ca level-art: 0.82mmol/l(1.05-1.30), arterial lactate: 1.6mmol/l(0.3-1.3), arterial glucose:241mg/dl(60-99), FIO2-arterial:70.; Test Date: 202105012008; Test Name: Legionella test; Result Unstructured Data: Negative; Test Date: 202105012008; Test Name: Streptococcus test; Result Unstructured Data: negative; Test Date: 202105012008; Test Name: Chlamydia test; Result Unstructured Data: not detected; Test Date: 202105012008; Test Name: Polymerase chain reaction; Result Unstructured Data: Not detected; Test Date: 202105012008; Test Name: Drug screen; Result Unstructured Data: Positive; Test Date: 202105012008; Test Name: Opiates; Result Unstructured Data: Negative; Test Date: 202105012008; Test Name: Urine analysis; Result Unstructured Data: Reported; Comments: color: amber (yellow-normal), appearance: 2 plus (normal-clear), PH: 5.0 (normal- 7.0), Urine specific gravity: 1.025 (normal-1.015), urine protein: 2 plus(normal-negative), urine glucose: more than 2(normal-negative),urine ketones: negative(normal-negative), urine bilirubin: negative(normal-negative), urine blood: more than 3(normal-negative), urine urobilinogen: increased (normal), urine nitrite: negative(negative), urine LE-Test :trace (negative), urine RBC: packed(normal-absent), urine WBC-packed (normal-0-5), urine mucus: more than 1(normal-absent), urine yeast: rare (normal- absent), urine granular cast: none seen, Urine hyal cast: none seen (normal0-2), Urine RBC casts: none seen, urine waxy casts: none seen, urine WBC casts: none seen, urine epi casts: none seen, urine epithelial cells:6-10(normal-0-5), urine non squamous epithelial cells: 0-5(normal-0-5), urine bacteria: rare(normal-absent), urine creatinine: 137.8 mg/ml, urine chloride: 31mmol/l, urine osmolality: 348mOsM/kg (normal- 390-1090), urine potassium: 22.8 mmol/l, Urine protein: 331mg/dl, urine sodium: 30mmol/l, urine urea: 215 mg/dl, urine CP/TR ratio-random: 2.40 (less than or equal to 0.2).; Test Date: 202105012008; Test Name: Cannabinoids; Result Unstructured Data: Negative; Test Date: 202105012008; Test Name: Benzodiazepine drug level; Result Unstructured Data: negative; Test Date: 202105012008; Test Name: Barbiturates; Result Unstructured Data: negative; Test Date: 202105012008; Test Name: Amphetamines; Result Unstructured Data: negative; Test Date: 202105012055; Test Name: Arterial blood gases; Result Unstructured Data: reported; Comments: pH art: 7.18 (normal- 7.35-7.45), pCO2 art: 22 mmHg(35-45), pO2 art: 74 mmHg(80-102 ), HCO3 art: 8mmol/l(22-26), O2Hb%:89%(95-100), % saturation, arterial: 90%(95-100), base excess art:-19.4mmol/l(-2-2), O2 cont art: 16.1 vol%(16-20), Hemoglobin art: 12.8 gm/dl(12-18), carboxy hemoglobin: 0.0%(0.0-0.2), metHb, arterial:1.1%(0.0-3.0), reduced Hb: 9.7(2.5-9.3), NA level-art: 134mmol/l(135-145), K level: 5.4mmol/l(3.5-5.0), Cl level-art: 103mmol/l(98-106), IonCa level-art: 0.88mmol/l(1.05-1.30), arterial lactate: 1.7mmol/l(0.3-1.3), arterial glucose:275mg/dl(60-99), FIO2-arterial:70.; Test Date: 20210502; Test Name: Histology; Result Unstructured Data: Not reported; Test Date: 20210502; Test Name: Autopsy; Result Unstructured Data: Not reported; Test Date: 202105020426; Test Name: Antimicrobial susceptibility test resistant; Result Unstructured Data: reported; Comments: Amoxicillin/clavulanate-susceptible, ampicillin-resistant, cefazolin- susceptible, Clindamycin-susceptible, erythromycin-susceptible, gentamycin-susceptible, levofloxacin-susceptible, oxacillin-susceptible, penicillin- resistant, tetracycline-susceptible, trimethoprim/sulfa-susceptible.; Test Date: 202105020428; Test Name: Hemoglobin; Result Unstructured Data: 12 g/dL; Test Date: 202105020428; Test Name: Hematocrit; Result Unstructured Data: 36.5 %; Test Date: 202105020428; Test Name: MCV; Result Unstructured Data: 91 fL; Test Date: 202105020428; Test Name: MCH; Result Unstructured Data: 29.9 pg; Test Date: 202105020428; Test Name: MCHC; Result Unstructured Data: 32.9 g/dL; Test Date: 202105020428; Test Name: Red cell distribution width; Result Unstructured Data: 15.3 %; Test Date: 202105020428; Test Name: Platelet count; Result Unstructured Data: 476 10*3/uL; Test Date: 202105020428; Test Name: GFR; Result Unstructured Data: 8 mL/min; Test Date: 202105020428; Test Name: Creatinine clearance; Result Unstructured Data: 10.6; Test Date: 202105020428; Test Name: Calcium; Result Unstructured Data: 6.5 mg/dL; Test Date: 202105020428; Test Name: Sodium; Result Unstructured Data: 134 mmol/L; Test Date: 202105020428; Test Name: Potassium; Result Unstructured Data: 5.5 mmol/L; Test Date: 202105020428; Test Name: Chloride; Result Unstructured Data: 99 mmol/L; Test Date: 202105020428; Test Name: Bicarbonate; Result Unstructured Data: less than 10 mmol/l; Test Date: 202105020428; Test Name: Glucose; Result Unstructured Data: 395 mg/dL; Test Date: 202105020428; Test Name: BUN; Result Unstructured Data: 124 mg/dL; Test Date: 202105020428; Test Name: Creatinine; Result Unstructured Data: 5.39 mg/dL; Test Date: 202105020428; Test Name: WBC; Result Unstructured Data: 34.8 10*3/uL; Test Date: 202105020428; Test Name: Red blood cell count; Result Unstructured Data: 4.02 10*6/uL; Test Date: 202105020456; Test Name: Chest X-ray; Result Unstructured Data: cardiomegaly CHF and increasing pulmonary edema; Comments: There is increased and scattered areas of alveolar opacity throughout both lungs which may represent superimposed pneumonia, there is no pneumothorax.; Test Date: 202105020811; Test Name: Echocardiogram; Result Unstructured Data: Reported; Comments: Normal left ventricular systolic function. LV ejection fraction was 74%. The left ventricular ejection fraction was an estimation. mild left ventricular hypertrophy. Moderate to large pericardial effusion. The pericardial effusion was circumferential to the heart. No echocardiographic evidence to suggest cardiac tamponade; Test Date: 202105021056; Test Name: Salicylate; Result Unstructured Data: less than 3 mg/ml; Test Date: 202105021056; Test Name: Hepatitis B antibody; Result Unstructured Data: Non reactive; Test Date: 202105021056; Test Name: Hepatitis B antigen; Result Unstructured Data: non reactive; Test Date: 202105021056; Test Name: Hepatitis C antibody; Result Unstructured Data: non reactive; Test Date: 202105021056; Test Name: Acetaminophen; Result Unstructured Data: less than 4 mcg/ml; Test Date: 202105021130; Test Name: Complement factor C3; Result Unstructured Data: 146 mg/dL; Test Date: 202105021130; Test Name: Complement factor C4; Result Unstructured Data: 20 mg/dL; Test Date: 202105021130; Test Name: Serum protein electrophoresis; Result Unstructured Data: 1.7 g/dL; Test Date: 202105021130; Test Name: Apo A1; Result Unstructured Data: 0.8 g/dL; Test Date: 202105021130; Test Name: Apolipoprotein; Result Unstructured Data: 1.2 g/dL; Test Date: 202105021130; Test Name: Beta globulin; Result Unstructured Data: 0.4 g/dL; Test Date: 202105021130; Test Name: Beta 2 globulin; Result Unstructured Data: 0.4 g/dL; Test Date: 202105021130; Test Name
Aktuelle Erkrankungen: Diabetes; Dyslipidemia; Hypertension; Obesity; Tobacco abuse.
Vorgeschichte: Comments: The patient had no allergies to medications, food, or other products.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1267408

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MA
Alter: -
Geschlecht: M
Eingang: 21.08.2021
Impfdatum: -
Beginn: 22.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Electromyogram Guillain-Barre syndrome Hypoaesthesia Inflammation Back pain Cerebral haemorrhage Loss of personal independence in daily activities Lumbar puncture Magnetic resonance imaging SARS-CoV-2 test

Symptomtext

WEAKNESS; UNABLE TO FUNCTION; NUMBNESS IN HANDS AND FEET; MIDSECTION (WAIST) WAS NUMB; LINGERING INFLAMMATION; GUILLAIN BARRE SYNDROME; Initial information was processed with additional information received on 16-AUG-2021 from the patient via a telephone communication log (TCL). This spontaneous report received from a patient concerned a 58 year old white male. The patient's height, and weight were not reported. The patient's concurrent conditions included: alcohol use (once daily), non-smoker (occasional once a year, cigar celebration), and occasional cannabis edible consumption. He had a previously active lifestyle (exercise, played sports). Patient did not had any known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: 19-SEP-2021) on 03-APR-2021 11:00 into left arm, for prophylactic vaccination. No concomitant medications were reported. Patient reported that on 22-APR-2021, he developed Guillain Barre Syndrome (GBS) two weeks post-vaccination, and was hospitalized. His symptoms included numb mid-section of torso ("felt like wearing a tick and wide belt"), fingertip numbness, aching feeling all over the torso and legs, "ants under skin" feeling, and facial palsy. The symptoms gradually spread and worsened over time with bilateral weakness and urinary urgency. COVID-19 virus test on an unspecified date was negative. Patient went to the medical center to figure out the symptoms he was experiencing. He was admitted on 22-APR-2021. Did all the tests, magnetic resonance imaging (MRI) and lumbar puncture. Patient was diagnosed with Guillain Barre Syndrome (GBS). Patient was treated with 5 rounds of intravenous immunoglobulin (IV Ig) (fresh antibodies). Patient was discharged to rehabilitation hospital on 01-MAY-2021 for rehab and recovery. Patient was discharged to home on 15-MAY-2021. Patient developed weakness and unable to function again. Patient was sent back to medical center on 09-JUN-2021, and did another lumbar puncture with elevated proteins. Patient was admitted again and treated with plasmapheresis (transfusion of plasma for fresh antibodies to get immune system to stop attacking his peripheral nervous system). Patient was there for 10 days and discharged again to rehabilitation hospital. Patient went through physical and occupational therapy for 10 days. Patient developed weakness again, and transferred back to medical center and did an electromyogram (EMG) test (to see extent of prevalent damage in his left leg). Patient developed a lot of numbness in hands and feet. Mid-section (waist) was numb, felt like wearing a "wrestling belt". Patient required assistance of walker. Patient was admitted once again to medical center on 19-JUN-2021, treated with intravenous (IV) steroids then oral prednisone, which he continued to be on. This was intended to knock down the lingering inflammation and allow him to regain the strength to the rehab once again. Patient was transferred again to rehabilitation hospital, on 29-JUN-2021. Patient returned to medical center on 01-JUL-2021 for another intravenous (IV) steroid and second electromyogram (EMG) test, then back to rehabilitation hospital on 03-JUL-2021. Finally patient was discharged to home on 13-JUL-2021 and continued with physical and occupational therapy home visits since. After successfully completing rehab work at rehabilitation hospital, and has been convalescing ever since. At the time of this report, patient continued to improve but was taking a long time. Patient body was regenerating and repairing the damage to the myelin sheath surrounding his axon nerves. Patient understands it will take time for him to improve, and still walks with assistance of walker and goes through physical and occupational therapy to regain balance. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from Guillain Barre syndrome, weakness, numbness in hands and feet, unable to function, lingering inflammation, and midsection (waist) was numb. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: This spontaneous report received from a patient concerned a 58-year-old white male who experienced Guillain Barre syndrome (GBS) 2 weeks after vaccine. No significant past medical history was reported. No concomitant medications were reported. Patient developed GBS two weeks post-vaccination and was hospitalized. His symptoms included numb mid-section of torso, fingertip numbness, aching feeling all over the torso and legs, "ants under skin" feeling, and facial palsy. The symptoms gradually spread and worsened over time with bilateral weakness and urinary urgency. COVID-19 virus test on an unspecified date was negative. Patient was admitted and underwent magnetic resonance imaging (MRI) and lumbar puncture and was diagnosed with GBS. Patient was treated with 5 rounds of intravenous immunoglobulin (IVIG). Patient was discharged to rehabilitation hospital on day 28 and discharged home on day 42. Patient developed weakness and was readmitted days 67-77, with another lumbar puncture with elevated proteins. Patient was treated with plasmapheresis and discharged to rehab. Patient developed weakness again, underwent electromyogram (EMG). Patient was admitted once again days 77-87, treated with intravenous (IV) steroids then oral prednisone, then returned to rehab. Patient returned to medical center on day 89 for another intravenous (IV) steroid and second electromyogram (EMG) test, then back to rehab on day 91. Finally, patient was discharged to home on day 101 and continued with physical and occupational therapy home visits since. At the time of this report, patient continued to improve, but slowly. Information regarding other potential etiologies was insufficient, and the occurrence of GBS could represent background incidence of such events in the general population. Considering the temporal relationship, the event is assessed to have an indeterminate relationship with vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: -
Labordaten: Test Name: Magnetic resonance imaging; Result Unstructured Data: diagnosed with Guillain-Barre syndrome; Test Name: Lumbar puncture; Result Unstructured Data: diagnosed with Guillain-Barre syndrome; Test Name: COVID-19 virus test; Result Unstructured Data: negative; Test Name: EMG; Result Unstructured Data: not reported; Comments: to see extent of prevalent damage in his left leg; Test Name: EMG; Result Unstructured Data: not reported; Test Name: Lumbar puncture; Result Unstructured Data: elevated proteins
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Alcohol use (once daily); Cannabis abuse, unspecified use (occasional); Non-smoker (occasionally (once a year, cigar celebration)); Comments: No known drug allergies, previously active lifestyle (exercise, played sports)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1574000

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: NY
Alter: 39,0
Geschlecht: F
Eingang: 16.08.2021
Impfdatum: 09.04.2021
Beginn: 02.05.2021
Tage bis Beginn: 23,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Angiogram pulmonary abnormal Back pain Dyspnoea exertional Fibrin D dimer increased Pain Pulmonary embolism Scan with contrast abnormal

Symptomtext

On 5/2/21 I started experiencing pain in my upper back when walking. 5/3/21 I noticed I was short of breath going up the stairs 5/4/21 My shortness of breath got worse, when walking from room to room. I went to urgent care which sent me to the hospital. After tests were run it was found that I had: Bilateral acute pulmonary emboli involving the main pulmonary arteries and extending to all main lobar, segmental and some segmental arteries. This was right at the 3 week mark of receiving my Johnson and Johnson Vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 3,0
Labordaten: D Dimer was ran, my results were: 3,047 (5/4/21) CT Angio Chest/w contrast (5/4/2021)
Aktuelle Erkrankungen: Sinus Infection 3/3/2021
Vorgeschichte: -
Andere Medikamente: Prenatal Vitamins, Vitamin D, Vitamin C, Zinc, Tumeric
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 1531611

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: NE
Alter: 39,0
Geschlecht: F
Eingang: 06.08.2021
Impfdatum: 15.07.2021
Beginn: 29.07.2021
Tage bis Beginn: 14,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Angiogram abnormal Arthralgia Chest X-ray abnormal Cough Deep vein thrombosis Fibrin D dimer increased Haemoptysis Musculoskeletal chest pain Pulmonary embolism Ultrasound Doppler abnormal Ultrasound chest

Symptomtext

She had a L knee injury on 7/8/21 and was seeking medical care for that. She presented to this clinic for evaluation of L knee pain and was given Covid vaccine at that visit per her request. She was observed for 30 minutes after due to allergy history without incident. Pt presented to ER on 7/31/21 with complaints of cough, bloody sputum, L sided rib pain. She was diagnosed with L popliteal DVT, positive D-dimer with suspected PE.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 7,0
Labordaten: positive D-dimer 7/31/21, CT ANGIO CHEST 7/31/21, VENOUS DUPLEX LEGS BILATERAL 8/1/21, XR CHEST AND CHEST US 8/3/21, XR CHEST 8/4/21
Aktuelle Erkrankungen: LUPUS
Vorgeschichte: LUPUS, ASTHMA,
Andere Medikamente: HYDROXYCHLOROQUINE SULFATE, DULOXETINE, PEG, ALBUTEROL, CARBOXYMETHYLCELLULOSE NA OP SOLN, CLOBETASOL PROPIONATE CREAM,
Allergien: GABAPENTIN, VARENICLINE, PCN, BEE STINGS, ZOLMITRIPTAN, CONTRAST MEDIA, ESCITALOPRAM
Vorherige Impfungen: -

VAERS 1528618

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: KY
Alter: 87,0
Geschlecht: F
Eingang: 05.08.2021
Impfdatum: 05.04.2021
Beginn: 03.05.2021
Tage bis Beginn: 28,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Condition aggravated Death Exposure to SARS-CoV-2 Functional gastrointestinal disorder General physical health deterioration Pneumonia SARS-CoV-2 test positive

Symptomtext

This case was hospitalized 4/6 due to bowel issues. Exposed and developed symptoms in hospital. Eventual transfer to hospice d/t decline in part d/t pneumonia symptoms. COVID Positive PCR - 5/3/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: COVID Positive PCR - 5/3/2021
Aktuelle Erkrankungen: Bowel issues
Vorgeschichte: -
Andere Medikamente: -
Allergien: Amoxicillin, Azithromycin, Bactrim (sulfamethoxazole-trimethoprim) Clarithromycin, Codeine, Doxycycline, Levofloxacin, Levothyroxine, Loratadine, OxyContin, Penicillin, Pneumococcal Vaccine
Vorherige Impfungen: Pneumococcal Vaccine

VAERS 1523303

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MO
Alter: 65,0
Geschlecht: M
Eingang: 03.08.2021
Impfdatum: 17.06.2021
Beginn: 23.07.2021
Tage bis Beginn: 36,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19 Cough Diarrhoea Dyspnoea Headache Myalgia Pneumonia Pyrexia SARS-CoV-2 test positive

Symptomtext

7/23/21 Postive RT-PCR at Admitted to Hospital on 7/31/21 for SOB, Headache, Cough, Myalgia, Diarrhea, Fever, Acute Respiratory Failure, Pneumonia. Discharged home from hospital on 8/2/21

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: RT-PCR Positive via nasopharyngeal swab 7/23/2021
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1519752

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MO
Alter: 75,0
Geschlecht: M
Eingang: 02.08.2021
Impfdatum: 04.05.2021
Beginn: 20.07.2021
Tage bis Beginn: 77,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Amyloidosis COVID-19 Endotracheal intubation Exposure to SARS-CoV-2 Pulmonary mass

Symptomtext

Pt was seen in ER on 7/18/21 and tested positive for Covid-19 after a previous exposure to another positive person. Pt was discharged with a script for Ivermectin at that time. Pt returned to the ER on 7/20/2021 with worsening symptoms and was admitted with acute hypoxic respiratory failure secondary to Covid with PNA. Pt gradually started requiring more and more oxygen and was intubated on 7/24/21 and transferred out of our facility.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: Multivitamin
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1505319

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: FL
Alter: 84,0
Geschlecht: M
Eingang: 27.07.2021
Impfdatum: 06.05.2021
Beginn: 01.05.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anxiety Death Dementia Neuropsychiatric symptoms

Symptomtext

Cause of death not documented. Significant comorbidities include dementia with neuropsychiatric behaviors including anxiety.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Urinary tract infection, Dementia
Vorgeschichte: Arrhythmia, Benign prostatic hypertrophy, hyperlipidemia, hypertension
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1498405

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

kritisch

Staat: WA
Alter: 75,0
Geschlecht: M
Eingang: 23.07.2021
Impfdatum: 04.05.2021
Beginn: 04.07.2021
Tage bis Beginn: 61,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Cerebrovascular accident

Symptomtext

According to the patient. He received his dose on May 4th and had a stroke on July 4th.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: -
Allergien: none
Vorherige Impfungen: -

VAERS 1469614

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

kritisch

Staat: OH
Alter: 41,0
Geschlecht: F
Eingang: 14.07.2021
Impfdatum: -
Beginn: 07.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Chest X-ray Feeling abnormal Nasopharyngitis Nausea Pulmonary embolism Scan with contrast

Symptomtext

NAUSEOUS; PULMONARY EMBOLISM; FELT LIKE TRYING TO GET SICK; FELT LIKE COMING DOWN WITH A COLD; This spontaneous report received from a patient concerned a 41 year old African American, not Hispanic or Latino female. The patient's height, and weight were not reported. The patient's concurrent conditions included high blood pressure and the patient did not have any history of previous clots and no medical condition reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 042A21A expiry: 05-AUG-2021) dose was not reported, 1 total administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 07-APR-2021, after vaccination, the patient felt like she was trying to get sick, and felt like she was coming down with a cold but did not really get sick. On 30-MAY-2021, the patient was working and ended up getting admitted in the hospital on 17-JUN-2021 night at 7 PM. On an unspecified date in JUN-2021, laboratory data included: chest X-ray (NR: not provided) multiple clots in both the lungs, and scan with contrast (NR: not provided) multiple clots in both the lungs and was diagnosed with pulmonary embolism. The physician were not sure if it was because of the vaccine. The patient was hospitalized until 28-JUN-2021 or 29-JUN-2021. The duration of hospitalization was 12 days. On an unspecified date, the patient felt like there was something sitting on her chest, was nauseous so she thought she had food poisoning. The patient had been a little short of breath, thought it was because she just started working out but it was not much noticeable. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pulmonary embolism, and the outcome of felt like coming down with a cold, nauseous and felt like trying to get sick was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20210713153-COVID-19 VACCINE AD26.COV2.S-Pulmonary Embolism. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20210713153-COVID-19 VACCINE AD26.COV2.S-Nauseous. This event(s) is labeled and is therefore considered potentially related.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 12,0
Labordaten: Test Date: 202106; Test Name: Scan with contrast; Result Unstructured Data: multiple clots in both the lungs; Test Date: 202106; Test Name: Chest X-ray; Result Unstructured Data: multiple clots in both the lungs
Aktuelle Erkrankungen: Blood pressure high
Vorgeschichte: Comments: The patient did not have any history of previous clots and no medical condition reported.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1454652

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: CO
Alter: 62,0
Geschlecht: M
Eingang: 07.07.2021
Impfdatum: 06.07.2021
Beginn: 07.07.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anticoagulant therapy Pulmonary embolism

Symptomtext

Pulmonary embolism treated with heparin

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Hyponatremia, COPD, hypothyroidism, depression, pneumonia, hematuria, malnutrition, sinus tachycardia, leukocytosis, constipation, fracture, iron deficiency anemia, tobacco use disorder, osteoporosis
Vorgeschichte: COPD, depression, hypothyroidism
Andere Medikamente: Symbicort, cefepime, Synthroid, Tamsulosin, vancomycin, Tylenol, nicoderm
Allergien: Fish containing products
Vorherige Impfungen: -

VAERS 1446661

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: IN
Alter: 84,0
Geschlecht: M
Eingang: 04.07.2021
Impfdatum: 10.04.2021
Beginn: 11.04.2021
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Cerebrovascular accident Chest X-ray Computerised tomogram Condition aggravated Dysarthria Facial paralysis Magnetic resonance imaging Therapy change Visual impairment X-ray with contrast

Symptomtext

Apr 10, 2021 ? Jan and I both received Covid-19 Immunization at The Event Center using Janssen (J&J) 042A21A Apr 11, 2021 ? Awoke with slurred speech. Left side of face a little droopy. Vision partly blocked by what I thought was droopy eyebrow. April 12, 2021 ? Made appt to see Dr. After initial checkout and some discussion she sent me directly to ER. Arrived and was checked in and admitted; IV installed, CT Scan, chest ray, MRI and many other tests were administered. One was X_RAY recording me as I drank barium water. I was diagnosed as having had a Stroke by Drs as well as resident Physician. My dosage of (Imdur) Atorvastatin was increased to 80 MG per day. Other meds remain the same. @ Dr: 226.4#, 95% ox, 56hr, 120/72 bp hospital has complete records.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 2,0
Labordaten: IV installed, CT Scan, chest ray, MRI and many other tests were administered. 4/11 & 4/12
Aktuelle Erkrankungen: None
Vorgeschichte: I have had six heart attacks, one TIA and tis last stroke
Andere Medikamente: Allopurinol 400 MG, Aspirin 81 MG, B-Complex 300 MG, Fishoil 1000 MG Flomax 0.4 MG, Imdur 60 MG (Isosorbide), Klor-Con M10 (Potassium) Lasix 40 Mg (Furosemide), Lipitor (Astorvastatin) 10 MG, Plavix (Clopidogrel) 75 MG Carvedilol (Coreg
Allergien: I am allergic to Ivory Soap, Benicar, butter, Norvasc, Pravachol, Rhinocort and Capoten & (All ACE Inhibitors.) I was told to add Latex to this list.
Vorherige Impfungen: -

VAERS 2614201

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: IA
Alter: 83,0
Geschlecht: M
Eingang: 30.06.2021
Impfdatum: 11.05.2021
Beginn: 12.05.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / OT

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Terminal state

Symptomtext

Pt expired Pt was on hospice for end of life cares and death was anticipated Pt was in long term care facility so vaccine was administered due to congregate living environment

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: metastatic lung cancer
Vorgeschichte: DM, HTN, HLD, spinal cord compression due to malignancy
Andere Medikamente: Fentanyl, zofran, lorazepam, morphine
Allergien: NKA
Vorherige Impfungen: -

VAERS 1430874

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: NC
Alter: 64,0
Geschlecht: M
Eingang: 28.06.2021
Impfdatum: 14.06.2021
Beginn: 20.06.2021
Tage bis Beginn: 6,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Death

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: ALS/Respiratory Failure
Vorgeschichte: -
Andere Medikamente: -
Allergien: Cyclobenzaprine
Vorherige Impfungen: -

VAERS 1331122

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: CT
Alter: 61,0
Geschlecht: M
Eingang: 26.06.2021
Impfdatum: -
Beginn: 19.04.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death SARS-CoV-2 test SARS-CoV-2 test positive

Symptomtext

DEATH; COVID-19 INFECTION; This spontaneous report received from a health care professional concerned a 61 year old White and Not Hispanic or Latino male. The patient's height, and weight were not reported. The patient's past medical history included health issues The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: unknown) dose was not reported, one total administered on right arm on 31-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 19-APR-2021, the patient experienced covid-19 infection, he was tested positive for Covid-19 using PCR. On 08-MAY-2021, the patient died from unknown cause of death, it was unknown whether autopsy was performed or not. He was not a home bound patient. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died of death on 08-MAY-2021, and the outcome of covid-19 infection was not reported. This case was associated with product quality complaint number : 90000183355. The suspected product quality complaint has been confirmed to be confirmed no PQC was identified within the reported complaint reported. complaint is approved for void. Void:y. based on the PQC evaluation/investigation performed. This report was serious (Death). Additional information was received from Central Complaint Vigilance on 21-JUN-2021. The following information was updated and incorporated into the case narrative: Product complaint investigation result updated.; Sender's Comments: V0: 20210642793-covid-19 vaccine ad26.cov2.s -Death. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Test Date: 20210419; Test Name: COVID-19 virus test; Result Unstructured Data: Positive
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: General physical condition abnormal
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1331122

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: CT
Alter: 61,0
Geschlecht: M
Eingang: 26.06.2021
Impfdatum: -
Beginn: 19.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death SARS-CoV-2 test SARS-CoV-2 test positive

Symptomtext

DEATH; COVID-19 INFECTION; This spontaneous report received from a health care professional concerned a 61 year old White and Not Hispanic or Latino male. The patient's height, and weight were not reported. The patient's past medical history included health issues The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: unknown) dose was not reported, one total administered on right arm on 31-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 19-APR-2021, the patient experienced covid-19 infection, he was tested positive for Covid-19 using PCR. On 08-MAY-2021, the patient died from unknown cause of death, it was unknown whether autopsy was performed or not. He was not a home bound patient. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died of death on 08-MAY-2021, and the outcome of covid-19 infection was not reported. This case was associated with product quality complaint number : 90000183355. The suspected product quality complaint has been confirmed to be confirmed no PQC was identified within the reported complaint reported. complaint is approved for void. Void:y. based on the PQC evaluation/investigation performed. This report was serious (Death). Additional information was received from Central Complaint Vigilance on 21-JUN-2021. The following information was updated and incorporated into the case narrative: Product complaint investigation result updated.; Sender's Comments: V0: 20210642793-covid-19 vaccine ad26.cov2.s -Death. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Test Date: 20210419; Test Name: COVID-19 virus test; Result Unstructured Data: Positive
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: General physical condition abnormal
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1426477

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: IN
Alter: 77,0
Geschlecht: F
Eingang: 25.06.2021
Impfdatum: 06.04.2021
Beginn: 29.04.2021
Tage bis Beginn: 23,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Atrial fibrillation COVID-19 pneumonia Condition aggravated Death Hypertension Nucleic acid test Obesity Polymerase chain reaction Pulmonary embolism

Symptomtext

Death 5/15/2021 Causes of death listed on death certificate: 1) COVID 19 pneumonia 2) Acute respiratory failure with hypoxia 3) Pulmonary embolism 4) Paroxysmal atrial fibrillation Other: obesity, hypertension

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: RT-PCR or other NAAT test
Aktuelle Erkrankungen: COVID 19 pneumonia
Vorgeschichte: Paroxysmal atrial fibrillation obesity hypertension
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1424409

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: FL
Alter: 81,0
Geschlecht: F
Eingang: 24.06.2021
Impfdatum: 07.04.2021
Beginn: 17.06.2021
Tage bis Beginn: 71,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Angiogram Balance disorder Blood test Cerebrovascular accident Chest X-ray Computerised tomogram head Echocardiogram Electrocardiogram Facial paralysis Hypoaesthesia Magnetic resonance imaging head Malaise Perfusion brain scan

Symptomtext

My mom had a stroke on 6/17/2021 and was hospitalized. A week or so before the stroke, my mom lost feeling in the fingers of her right hand and didn?t feel well...but she didn?t feel sick, just not her normal self. The stroke spidered out over both sides of her brain. Mom is off balance, her mouth droops on the right and that side of her face is numb. The doctors in hospital could see what happened to my mom but were puzzled why because she?s so healthy with no prior issues which would cause a stroke. We saw mom?s primary care doctor after release from hospital. She was very surprised that mom had a stroke as nothing in blood work, her health or family history would indicate that this would happen. Doctor said it was probably the COVID-19 vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 4,0
Labordaten: Blood panel CT Head w/o contrast CT Brain perfusion add-on CTA Head CTA Neck XR chest MRI head w/o contrast EKG 12-lead Carotid duplex bilat Echo complete with bubble
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Metoprolol tar 25mg 1 tab 2x daily Amlodipine 2.5mg 1 tab in morning Atorvastatin 10mg 1 tab at bedtime Vitamin D3 Vitamin B-12
Allergien: Sulfur Codeine
Vorherige Impfungen: -

VAERS 1274367

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: CT
Alter: 100,0
Geschlecht: F
Eingang: 23.06.2021
Impfdatum: -
Beginn: 27.04.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Decreased appetite Tremor

Symptomtext

PASSED AWAY; This spontaneous report received from a health care professional (reported as nurse) concerned a 100 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included home bound, and health issues. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: unknown) dose was not reported, 1 total was administered on left arm on 06-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 27-APR-2021, the patient passed away from unknown cause of death. It was unspecified if an autopsy was performed. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The outcome of passed away was fatal. This report was serious (Death).; Sender's Comments: V0: 20210642648- JANSSEN COVID-19 VACCINE Ad26.COV2.S- DEATH. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: General physical condition abnormal; Homebound
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1274367

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: CT
Alter: 100,0
Geschlecht: F
Eingang: 23.06.2021
Impfdatum: -
Beginn: 27.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Decreased appetite Tremor

Symptomtext

PASSED AWAY; This spontaneous report received from a health care professional (reported as nurse) concerned a 100 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included home bound, and health issues. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: unknown) dose was not reported, 1 total was administered on left arm on 06-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 27-APR-2021, the patient passed away from unknown cause of death. It was unspecified if an autopsy was performed. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The outcome of passed away was fatal. This report was serious (Death).; Sender's Comments: V0: 20210642648- JANSSEN COVID-19 VACCINE Ad26.COV2.S- DEATH. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: General physical condition abnormal; Homebound
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1395132

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: AZ
Alter: 63,0
Geschlecht: M
Eingang: 22.06.2021
Impfdatum: 02.06.2021
Beginn: 06.06.2021
Tage bis Beginn: 4,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Cerebrovascular accident

Symptomtext

Stroke

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: Psoriasis Type 2 diabetes
Vorgeschichte: Mechanical heart value
Andere Medikamente: Warferin Atenolol Fenofibrate Glimepiride Hydrochlorothizide
Allergien: None.
Vorherige Impfungen: -

VAERS 1415252

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: IN
Alter: 73,0
Geschlecht: M
Eingang: 21.06.2021
Impfdatum: 17.06.2021
Beginn: 20.06.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Patient died 06/20/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: n/a
Vorgeschichte: Bullous Pemphigold, A fib, Type II Diabetes
Andere Medikamente: n/a
Allergien: Amoxicillin, Spirolactone, Actos, Ace Inhibitors, PCN
Vorherige Impfungen: -

VAERS 1410704

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: CA
Alter: 38,0
Geschlecht: M
Eingang: 18.06.2021
Impfdatum: 07.04.2021
Beginn: 17.05.2021
Tage bis Beginn: 40,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Cerebrovascular accident Computerised tomogram Influenza like illness Magnetic resonance imaging Pain

Symptomtext

didn't have any at the time. had flu-like symptoms and area hurt then had a stroke about a month later

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 4,0
Labordaten: had a stroke on 5/17/21. had c scan and MRI done
Aktuelle Erkrankungen: none
Vorgeschichte: hypertension
Andere Medikamente: amlodipine, lisinopril, aspirin
Allergien: none
Vorherige Impfungen: -

VAERS 1406893

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: IN
Alter: 60,0
Geschlecht: F
Eingang: 17.06.2021
Impfdatum: 10.04.2021
Beginn: 07.05.2021
Tage bis Beginn: 27,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Cerebral haemorrhage Cerebrovascular accident Computerised tomogram head abnormal Dialysis Dizziness postural Headache Hemiparesis Renal disorder

Symptomtext

Patient became dizzy upon standing and experience left sided weakness. Ambulance was called and patient transported to hospital. Upon exam it was determined the patient had a bleed on the ride side of the brain. After 4 or 5 days she was transferred to Rehab. She was then sent back to hospital after complications. Patient began having kidney problems and was undergoing dialysis. 06/16/2021 patient began having bad headaches, CT scan showed multiple previous strokes(clots). Patient currently still in hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: chronic back pain; pain pump located in back
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1403374

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: AL
Alter: 69,0
Geschlecht: F
Eingang: 16.06.2021
Impfdatum: 07.04.2021
Beginn: 01.06.2021
Tage bis Beginn: 55,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Cardiac imaging procedure abnormal Hypotension Myocardial strain Pulmonary embolism Troponin increased

Symptomtext

Patient seen in clinic on 6-14 and admitted to observation in the hospital setting. Patient was transferred to Medical Center for higher level of care due to hypotension and elevated troponins on 6/15

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 3,0
Labordaten: 6-15-21 "large left pulmonary artery embolus with right heart strain" noted on CT
Aktuelle Erkrankungen: unknown
Vorgeschichte: malignant neoplasm of upper outer quadrant of breast (estrogen receptor pos) GERD Hypercholestremia
Andere Medikamente: maxzide 75/50 potassium chloride 20meq tamoxifen 20mg
Allergien: epinephrine
Vorherige Impfungen: -

VAERS 1389178

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

kritisch

Staat: CA
Alter: 49,0
Geschlecht: M
Eingang: 16.06.2021
Impfdatum: 05.04.2021
Beginn: 15.05.2021
Tage bis Beginn: 40,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Computerised tomogram abnormal Deep vein thrombosis Pulmonary embolism Ultrasound Doppler

Symptomtext

DVT/PE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: venous ultrasound CT chest
Aktuelle Erkrankungen: n/a
Vorgeschichte: GERD, vitamin b12 def, Depression, ADHD
Andere Medikamente: n/a
Allergien: penicillin
Vorherige Impfungen: -

VAERS 1399936

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: NY
Alter: 47,0
Geschlecht: F
Eingang: 15.06.2021
Impfdatum: 02.04.2021
Beginn: 09.06.2021
Tage bis Beginn: 68,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Anticoagulant therapy Bell's palsy Blood test Catheter directed thrombolysis Computerised tomogram thorax abnormal Echocardiogram Pulmonary embolism

Symptomtext

Bells Palsy diagnosed on 5/31/2021. Steroid and antiviral medication. Pulmonary embolism on 6/9/2021. EKOS procedure on 6/10/2021. Heparin IV for 3 days. Oral medication eliquis prescribed.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 4,0
Labordaten: Ekos procedure CT scan Ecocardiogram Multiple blood tests
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Junel Fe
Allergien: None
Vorherige Impfungen: -

VAERS 1399175

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: PA
Alter: 86,0
Geschlecht: M
Eingang: 15.06.2021
Impfdatum: 18.05.2021
Beginn: 01.06.2021
Tage bis Beginn: 14,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Anticoagulant therapy Deep vein thrombosis Full blood count normal Metabolic function test normal Pelvic venous thrombosis Peripheral swelling Pulmonary embolism Ultrasound Doppler abnormal

Symptomtext

Biliateral Pulmonary Emboli, Rt leg DVT up to iliac vein. Treated with Eliquis po. -- sent to hospital for further treatment Remains in hospital at this time Symptoms were swelling of Rt foot, normally SOB, no increase in baseline

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 5,0
Labordaten: Doppler, CBC, CMP Doppler + CBC, CMP within normal limits
Aktuelle Erkrankungen: none
Vorgeschichte: HLD, OSA chronic pain, arthritis, glaucoma, MI, CABG, Dementia, alzheimers, lyme disease, Electronic stimulator for lumbar canal stenosis., spondyloses, mild facial pain, indigestion. Positive for covid 19 1/8/2021.
Andere Medikamente: Vit. D3, Vit. B12, Rosuvastatin, Refresh eye drops, Nitroglycerine PRN, Lisinopril, Latanoprost eye drops, Glucosamine Chond. , fluticasone nose spray, Docusate sodium, Carvedilol, aspirin, aspercream lido patch, tums, L-Lysine, Mag., miri
Allergien: Rhopressa, Codiene
Vorherige Impfungen: -

VAERS 1382543

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: NV
Alter: 68,0
Geschlecht: F
Eingang: 08.06.2021
Impfdatum: 13.05.2021
Beginn: 17.05.2021
Tage bis Beginn: 4,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cardiac disorder Cerebrovascular accident Computerised tomogram abnormal Loss of consciousness Magnetic resonance imaging abnormal Muscular weakness

Symptomtext

Stroke occurred 4 days after shot administered. Blacked out, right arm limp and of no use. 2 pm 5/17/21. 911 called transported to hospital and then transported/admitted to another hospital. CAT scan and MRI test done. Test show right side of head had stroke, and heart has damage.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: CAT and MRI scans done between 3/18 and 3/20.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Amlodipine Besylate 10mg tab Calcium Citrate with d3 Fish Oil 1000 mg with Omega-3 300mg Multivitamin
Allergien: Iodine Penicillin
Vorherige Impfungen: -

VAERS 1365527

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: CA
Alter: 58,0
Geschlecht: F
Eingang: 08.06.2021
Impfdatum: -
Beginn: 09.04.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Angiogram Asthenia Blood test Carotid artery stenosis Chest X-ray Blood chloride Blood lactate dehydrogenase Cerebrovascular accident Chest discomfort Choking Dizziness Dysarthria Dysphagia Echocardiogram Computerised tomogram Dehydration Haematemesis Malaise

Symptomtext

THROWING UP BLOOD; FEELING LIKE BEING CHOKED; HEAVY FEELING IN CHEST; FELT SHAKY; FELT SICK; STROKE-LIKE SYMPTOMS; PAIN IN BASE OF SPINE; LEFT TORSO AND BOTH ARMS ITCHING; DEHYDRATION; This spontaneous report received from a patient concerned a 58 year old female. Initial information was processed along with additional information on 04-JUN-2021. The patient's height, and weight were not reported. The patient's past medical history included vertebral dissection of right vertebral artery in 2000, hiatal hernia, chemotherapy, radiation, vertebral tear, 5 years of cancer drugs and stroke-like symptoms, and concurrent conditions included 2 times breast cancer survivor, non-smoker, and sulfa drug allergy cause night time swells in mouth and tongue. The patient experienced pain in base of spine when treated with pegfilgrastim for breast cancer. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: UNKNOWN) dose was not reported, 1 in total administered at left arm on 09-APR-2021 for prophylactic vaccination. Concomitant medications included acetylsalicylic acid, and pravastatin. On an unspecified date in 2021, the patient had elevated lactate level of 2.5 (unit unspecified) and was 1.5 (unit unspecified) on repeat and also had elevated chloride level was 110 (unit unspecified). The patient was dehydrated. On 09-APR-2021, the patient had left torso and both arms itching for 4 hours, started within half hour after received vaccine. On 10-APR-2021, the patient experienced pain in base of spine, which was exactly the same as when she received Neulasta during a previous cancer treatment regimen and patient experienced headache for 3 days. On 21-APR-2021, the patient woke up with left side numbness from head to toes, feeling like being choked as if like an allergy, felt heaviness in chest, within one hour patient felt shaky and like she was going to faint, felt dizziness/lightheaded and laid down for 2 days, later felt like her eyes were going to pop out of her head, was putting Refresh eye drops in her eyes and was having problems focusing her eyes (vision disturbances). The patient was only able to stay up for 2 hours, then had lie down because felt sick and weakness and had sever fatigue. All like stroke-like symptoms. The symptoms started on 21-APR-2021. The patient went to emergency room on 24-APR-2021 and discharged on same day. On 28-APR-2021, the patient had computed tomography scan and showed occluded right Vertebral artery. The patient had a computed tomography scan one year ago and there was no occlusion. They did a computed tomography scan that showed a same occlusion as on 28-APR-2021. On 28-APR-2021, the patient had stenosis of right carotid artery. The patient went back to emergency room on 15-MAY-2021 because she was throwing up blood and dizzy and she was told to go to emergency room. On 11-JUN-2021, she was going to see a stroke neurologist specialist a neurosurgeon 16-JUN-2021. On 15-MAY-2021, the patient went to emergency room and they re-performed a computed tomography scan and it showed an occluded right vertebral artery just as first scan did. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from left torso and both arms itching on 09-APR-2021, had not recovered from pain in base of spine, and stroke-like symptoms, and the outcome of heavy feeling in chest, feeling like being choked, felt shaky, felt sick, dehydration and throwing up blood was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: This spontaneous report received from a patient concerned a 58-year-old female who experienced stroke-like symptoms and occluded vertebral artery 15 days after vaccine. Past medical history included vertebral dissection of right vertebral artery in 2000, hiatal hernia, chemotherapy, radiation, vertebral tear, 5 years of cancer drugs and stroke-like symptoms, and concurrent conditions included 2 times breast cancer survivor. Concomitant medications included acetylsalicylic acid, and pravastatin. On day 12 after vaccine, the patient woke up with left side stroke-like symptoms. The patient went to emergency room on day 15 and discharged on same day. On day 19, the patient had computed tomography scan and showed occluded right Vertebral artery. The patient had a computed tomography scan one year ago and there was no occlusion. She was discharged and evaluated by stroke neurologist. There is no report of thrombocytopenia to suggest thrombosis with thrombocytopenia syndrome. Given the pre-existing history of vertebral artery dissection, there is a plausible alternative explanation for the event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: Test Date: 2021; Test Name: Lactate dehydrogenase; Result Unstructured Data: 2.5 (unit not reported); Test Date: 2021; Test Name: Chloride; Result Unstructured Data: 110 (unit not reported); Test Date: 2021; Test Name: Lactate dehydrogenase; Result Unstructured Data: 1.5 (unit not reported); Test Date: 20210428; Test Name: CT scan; Result Unstructured Data: showed a same occlusion; Test Date: 20210428; Test Name: CT scan; Result Unstructured Data: Occluded Right Vertebral Artery; Test Date: 20210515; Test Name: CT scan; Result Unstructured Data: showed an occluded right vertebral artery; Comments: occluded right vertebral artery and 70% stenosis of right carotid artery
Aktuelle Erkrankungen: Breast cancer (Patient is two time breast cancer survivor. Patient is on cancer drug for 5 year.); Non-smoker; Sulfonamide allergy (CAUSE NIGHT TIME SWELLS IN MOUTH AND TONGUE)
Vorgeschichte: Medical History/Concurrent Conditions: Chemotherapy; Hiatal hernia; Intervertebral disc annular tear; Radiation therapy; Stroke; Vertebral artery dissection
Andere Medikamente: PRAVASTATIN; ASA
Allergien: -
Vorherige Impfungen: -

VAERS 1365527

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: CA
Alter: 58,0
Geschlecht: F
Eingang: 08.06.2021
Impfdatum: -
Beginn: 09.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Angiogram Asthenia Blood test Carotid artery stenosis Chest X-ray Blood chloride Blood lactate dehydrogenase Cerebrovascular accident Chest discomfort Choking Dizziness Dysarthria Dysphagia Echocardiogram Computerised tomogram Dehydration Haematemesis Malaise

Symptomtext

THROWING UP BLOOD; FEELING LIKE BEING CHOKED; HEAVY FEELING IN CHEST; FELT SHAKY; FELT SICK; STROKE-LIKE SYMPTOMS; PAIN IN BASE OF SPINE; LEFT TORSO AND BOTH ARMS ITCHING; DEHYDRATION; This spontaneous report received from a patient concerned a 58 year old female. Initial information was processed along with additional information on 04-JUN-2021. The patient's height, and weight were not reported. The patient's past medical history included vertebral dissection of right vertebral artery in 2000, hiatal hernia, chemotherapy, radiation, vertebral tear, 5 years of cancer drugs and stroke-like symptoms, and concurrent conditions included 2 times breast cancer survivor, non-smoker, and sulfa drug allergy cause night time swells in mouth and tongue. The patient experienced pain in base of spine when treated with pegfilgrastim for breast cancer. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: UNKNOWN) dose was not reported, 1 in total administered at left arm on 09-APR-2021 for prophylactic vaccination. Concomitant medications included acetylsalicylic acid, and pravastatin. On an unspecified date in 2021, the patient had elevated lactate level of 2.5 (unit unspecified) and was 1.5 (unit unspecified) on repeat and also had elevated chloride level was 110 (unit unspecified). The patient was dehydrated. On 09-APR-2021, the patient had left torso and both arms itching for 4 hours, started within half hour after received vaccine. On 10-APR-2021, the patient experienced pain in base of spine, which was exactly the same as when she received Neulasta during a previous cancer treatment regimen and patient experienced headache for 3 days. On 21-APR-2021, the patient woke up with left side numbness from head to toes, feeling like being choked as if like an allergy, felt heaviness in chest, within one hour patient felt shaky and like she was going to faint, felt dizziness/lightheaded and laid down for 2 days, later felt like her eyes were going to pop out of her head, was putting Refresh eye drops in her eyes and was having problems focusing her eyes (vision disturbances). The patient was only able to stay up for 2 hours, then had lie down because felt sick and weakness and had sever fatigue. All like stroke-like symptoms. The symptoms started on 21-APR-2021. The patient went to emergency room on 24-APR-2021 and discharged on same day. On 28-APR-2021, the patient had computed tomography scan and showed occluded right Vertebral artery. The patient had a computed tomography scan one year ago and there was no occlusion. They did a computed tomography scan that showed a same occlusion as on 28-APR-2021. On 28-APR-2021, the patient had stenosis of right carotid artery. The patient went back to emergency room on 15-MAY-2021 because she was throwing up blood and dizzy and she was told to go to emergency room. On 11-JUN-2021, she was going to see a stroke neurologist specialist a neurosurgeon 16-JUN-2021. On 15-MAY-2021, the patient went to emergency room and they re-performed a computed tomography scan and it showed an occluded right vertebral artery just as first scan did. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from left torso and both arms itching on 09-APR-2021, had not recovered from pain in base of spine, and stroke-like symptoms, and the outcome of heavy feeling in chest, feeling like being choked, felt shaky, felt sick, dehydration and throwing up blood was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: This spontaneous report received from a patient concerned a 58-year-old female who experienced stroke-like symptoms and occluded vertebral artery 15 days after vaccine. Past medical history included vertebral dissection of right vertebral artery in 2000, hiatal hernia, chemotherapy, radiation, vertebral tear, 5 years of cancer drugs and stroke-like symptoms, and concurrent conditions included 2 times breast cancer survivor. Concomitant medications included acetylsalicylic acid, and pravastatin. On day 12 after vaccine, the patient woke up with left side stroke-like symptoms. The patient went to emergency room on day 15 and discharged on same day. On day 19, the patient had computed tomography scan and showed occluded right Vertebral artery. The patient had a computed tomography scan one year ago and there was no occlusion. She was discharged and evaluated by stroke neurologist. There is no report of thrombocytopenia to suggest thrombosis with thrombocytopenia syndrome. Given the pre-existing history of vertebral artery dissection, there is a plausible alternative explanation for the event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: Test Date: 2021; Test Name: Lactate dehydrogenase; Result Unstructured Data: 2.5 (unit not reported); Test Date: 2021; Test Name: Chloride; Result Unstructured Data: 110 (unit not reported); Test Date: 2021; Test Name: Lactate dehydrogenase; Result Unstructured Data: 1.5 (unit not reported); Test Date: 20210428; Test Name: CT scan; Result Unstructured Data: showed a same occlusion; Test Date: 20210428; Test Name: CT scan; Result Unstructured Data: Occluded Right Vertebral Artery; Test Date: 20210515; Test Name: CT scan; Result Unstructured Data: showed an occluded right vertebral artery; Comments: occluded right vertebral artery and 70% stenosis of right carotid artery
Aktuelle Erkrankungen: Breast cancer (Patient is two time breast cancer survivor. Patient is on cancer drug for 5 year.); Non-smoker; Sulfonamide allergy (CAUSE NIGHT TIME SWELLS IN MOUTH AND TONGUE)
Vorgeschichte: Medical History/Concurrent Conditions: Chemotherapy; Hiatal hernia; Intervertebral disc annular tear; Radiation therapy; Stroke; Vertebral artery dissection
Andere Medikamente: PRAVASTATIN; ASA
Allergien: -
Vorherige Impfungen: -

VAERS 1249208

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: IL
Alter: 71,0
Geschlecht: F
Eingang: 03.06.2021
Impfdatum: 06.04.2021
Beginn: 06.04.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood glucose abnormal Blood glucose increased Gastrointestinal haemorrhage Death

Symptomtext

We were at my Hair Stylist and the Pharamist came over and asked if anyone if they needed a Covid 19 shot and I said to the patient ) there's your shot, we walked next door and she got it in her left arm . I drove her home right after this she seemed fine then. We went back to pick her up to take her to a Primary Dr. for a follow up so she establbblishd a Primary in the area, She did not answer the door, we banged on the door and no one answered 3-4 days she was dead.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Diabetic / nothing else that we know of
Vorgeschichte: Just Diabetic
Andere Medikamente: Metformin is one, don't know any others
Allergien: none
Vorherige Impfungen: -

VAERS 1368374

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MA
Alter: 39,0
Geschlecht: M
Eingang: 02.06.2021
Impfdatum: 08.04.2021
Beginn: 29.05.2021
Tage bis Beginn: 51,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Computerised tomogram thorax abnormal Deep vein thrombosis Pulmonary embolism Ultrasound Doppler abnormal

Symptomtext

This patient developed DVT's and P.E's.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 2,0
Labordaten: ultrasounds, cat scans, 5/29 and 5/30 respectively
Aktuelle Erkrankungen: hypertension Psychotic disorder NOS
Vorgeschichte: Hypertension
Andere Medikamente: Risperdal, Zyprexa, Lisinopril, Vistaril, Gabapentin, Prozac, Famotidine, Subutex, Tylenol
Allergien: Phenobarbital
Vorherige Impfungen: -

VAERS 1366333

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: NV
Alter: 37,0
Geschlecht: M
Eingang: 01.06.2021
Impfdatum: 21.04.2021
Beginn: 04.05.2021
Tage bis Beginn: 13,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Death

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Call the Coroners office
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1354740

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: NC
Alter: 70,0
Geschlecht: M
Eingang: 27.05.2021
Impfdatum: 24.05.2021
Beginn: 25.05.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Death

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: hip fracture, metastatic prostate cancer
Vorgeschichte: COPD, A Fib, HTN, DM
Andere Medikamente: oxycodone
Allergien: No known Allergies
Vorherige Impfungen: -

VAERS 2623729

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MD
Alter: 51,0
Geschlecht: F
Eingang: 26.05.2021
Impfdatum: 07.04.2021
Beginn: 23.04.2021
Tage bis Beginn: 16,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Anticoagulant therapy Blood test Chest pain Chest scan abnormal Fibrin D dimer Haematology test normal Paraesthesia Platelet count decreased Pleurisy Pulmonary embolism Pulmonary thrombosis Scan normal Ultrasound Doppler normal

Symptomtext

No symptoms for first two weeks post-vaccine. After ~16 days, I began having chest pain on the left side (later determined pleurisy denoting something underlying). I waited 24 hours and was still having chest pain, so went to the ER. After several tests/scans, they determined I had multiple PEs (pulmonary embolisms/blood clots in both lungs). I was hospitalized for two nights/three days while they gave me blood thinners through IV (argatroban). To note, no shortness-of-breath, oxygen at 99-100% throughout this experience. I was released on Day 3 with direction to take Eliquis/blood thinner pills (5mg 2x/day) and follow up with a hematologist, who recommended a blood coagulation work-up to determine if I had something underlying aside from the vaccine which may have caused the clots. My chest pain/pleurisy went away within a week after hospitalization. After seeing the hematologist (three weeks post-hospitalization,) all tests showed negative (no underlying trait causing clots,) so doctor recommending thinners for six months, then will re-evaluate. I will also add that I have had one other experience with blood clots ~ 15 years ago when I took birth control pills (multiple PEs that time, too.) I was put on blood thinners at that time as well for nine months, and was simply told I could not/should not take birth control pills thereafter, and I have not had any clotting issues since then until this vaccine experience. (I now also have tingling feet/ankles which began in the hospital, so not sure if this is due to the vaccine or the blood thinners. This occurs on and off throughout every day now. I plan to inquire with a PCP soon if it persists.)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 3,0
Labordaten: Multiple blood tests including: (4/24/21) - D-Dimer: 1.30 mcg/mL FEU - Platelet: 147 x10(3)/mcL Head scan - negative (4/24/21) Chest scan - multiple PEs in both lungs (4/24/21) Leg ultrasound - negative (4/26/21)
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: OTC multi-vitamin (1x/day)
Allergien: Amoxicillin
Vorherige Impfungen: -

VAERS 1350433

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MI
Alter: 50,0
Geschlecht: F
Eingang: 26.05.2021
Impfdatum: 08.04.2021
Beginn: 08.05.2021
Tage bis Beginn: 30,0
Dosis: 1
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Anticoagulant therapy Bacterial infection Bilevel positive airway pressure Blood culture positive COVID-19 Cardiac arrest Catheter placement Condition aggravated Cough Death Diarrhoea Disseminated intravascular coagulation Dyspnoea Endotracheal intubation Fibrin D dimer increased Fluid replacement General physical health deterioration

Symptomtext

Presented 5/13 to Hospital. Presented to Hospital on 5/13 with one week of symptoms including cough, dyspnea, diarrhea. COVID-19 testing was positive on 5/8. Treatments prior to arrival included remdesivir and dexamethasone, started 5/13. She was also placed on pulse dose steroids 1000 mg/day methylprednisolone given her history of ground glass lung opacities in 2018. Progressed to high-flow nasal cannula, then BiPAP on 5/14, and was intubated on 5/17. Paralysis and proning initiated. Transferred to another hospital for possible VV ecmo candidacy. Patient with severe acute respiratory failure d/t covid who has failed treatment with the ventilator despite paralysis and proning. CTS asked to place patient on VV ECMO. 5/20/21 1135am initiated ECMO Patient is a 50yr old female with past medical history of hypertension, asthma, OSA and obesity BMI 41.5 who presented to hospital on 5/13 with progressive cough and shortness of breath for about a week. Of note, patient also has a history of respiratory failure presenting with ground glass opacities on CT scan in 2018 with unclear etiology despite bronchoscopy and serologic studies which resolved with high dose corticosteroids. Patient recently tested positive for COVID on 5/8 and received johnson and johnson vaccine in April. Patient was admitted on 5/13 and treated with decadron, remdesivir and tocilizumab. Course complicated by progressive respiratory failure requiring HFNC followed by Bipap and ultimately intubation on 5/17. Due to elevated d-dimer, lower extremity dopplers were obtained which were negative, however a heparin gtt was initiated. Course further complicated by cold left lower extremity; arterial duplex demonstrated distal popliteal artery thormbus extending into the peroneal, anterior tibial and dorsalis pedis arteries. therefore heparin was switched to argatroban and a HIT panel was sent. On 5/19 patient continued to decline despite paralytic and pronning. Patient transferred to ICU for further level of care and VV ECMO evaluation. On arrival patient was started on veletri; however due to continued respiratory decline a shock call was placed for VV ECMO and patient cannulated for VV @ 1200. Cannulation was difficult and patient was felt to have an IVC thrombus as clot was seen going into the ECMO circuit during cannulation. Post cannulation she developed worsening septic shock and DIC. She received 2uprbc, 1unit cryo, 1 platelet, 2 FFP, 5 liters crystalloid and 1L albumin. Blood cultures positive for GPC in clusters. Escalating vasopressors (Epi/NE/vaso) and ongoing hypoxia family opted to change code status to DNR. Patient then continue to have worsening hemodynamic instability and went into PEA and ultimately asystole. She was pronounced deceased at 1815. Family was en route already due to her instability thus will be notified of her passing once they arrive. Dr. was notified of patients death.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 7,0
Labordaten: D-dimer was normal on 5/13 and elevated to 32400 on 5/18. Dopplers negative. CT angio not done due to clinical instability. Treated initially with heparin and changed empirically to argatroban when it was concerning that she had developed arterial thrombus on heparin.
Aktuelle Erkrankungen: -
Vorgeschichte: Respiratory Acute respiratory failure with hypoxemia (HCC) Pneumonia due to COVID-19 virus Circulatory Arterial embolism and thrombosis of lower extremity (HCC) Hematologic Elevated d-dimer Endocrine/Metabolic Electrolyte imbalance
Andere Medikamente: albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler ALPRAZolam (XANAX) 0.5 MG tablet Aromatic Inhalants (VICKS BABYRUB EXT) atorvastatin (LIPITOR) 40 MG tablet cetirizine (ZYRTEC) 10 MG tablet citalopram (C
Allergien: No Known Allergies
Vorherige Impfungen: -

VAERS 1343832

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: NV
Alter: 65,0
Geschlecht: U
Eingang: 24.05.2021
Impfdatum: 15.04.2021
Beginn: 24.04.2021
Tage bis Beginn: 9,0
Dosis: UNK
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Cerebrovascular accident

Symptomtext

Stroke

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: Hospital overnight and 10 Days in Rehab clinic. Apri; 26th thru May 7
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1334698

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: CA
Alter: 57,0
Geschlecht: M
Eingang: 20.05.2021
Impfdatum: 12.04.2021
Beginn: 10.05.2021
Tage bis Beginn: 28,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Cerebrovascular accident

Symptomtext

Acute stroke requiring hospitalization.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 3,0
Labordaten: May 11
Aktuelle Erkrankungen: None
Vorgeschichte: Gastro Reflux
Andere Medikamente: Lansaprozel
Allergien: Penecilin
Vorherige Impfungen: -

VAERS 1334628

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

kritisch

Staat: ID
Alter: 20,0
Geschlecht: F
Eingang: 20.05.2021
Impfdatum: 19.05.2021
Beginn: 19.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Loss of consciousness Posture abnormal Presyncope Respiratory arrest Seizure Syncope

Symptomtext

Patient had a vasovagal response and fainted a few minutes after her injection. She was unconscious, not breathing for a few seconds as her head fell to her chest, but resumed breathing when we opened her airways. Her body seized upon taking in air and 911 was called. She regained consciousness before the paramedics arrived and her vitals were within normal limits when they checked her. Pt went home on her own with mom.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Respiratory arrest
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: -
Allergien: No
Vorherige Impfungen: -

VAERS 1333900

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: VA
Alter: 63,0
Geschlecht: M
Eingang: 20.05.2021
Impfdatum: 01.04.2021
Beginn: 16.05.2021
Tage bis Beginn: 45,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Angiogram pulmonary abnormal Immunology test Platelet factor 4 Pulmonary embolism

Symptomtext

Acute Pulmonary embolus

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 5,0
Labordaten: 1. CTA. 2. PF4 ELISA Ab
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1322184

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: SC
Alter: 59,0
Geschlecht: F
Eingang: 16.05.2021
Impfdatum: 10.04.2021
Beginn: 13.04.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Catheterisation cardiac Coronary arterial stent insertion Intracardiac thrombus Myocardial infarction

Symptomtext

Patient reported heart attack due to blood clot. Patient report catheterization with stent placement.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: 1,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Major Depressive Disorder Hypertension Diabetes Hypothyroidism Obesity Acquired Nystagmus
Andere Medikamente: Triamterene/HCTZ 75/50 mg Lamotrigine 100mg Metformin 1000mg Levothyroxine 100mcg Omeprazole 40mg Famotidine 20mg Hydroxyzine HCL 10mg Pepto Tums GasX
Allergien: Tetracycline Lisinopril Neurontin
Vorherige Impfungen: -

VAERS 1204671

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: CO
Alter: 40,0
Geschlecht: F
Eingang: 15.05.2021
Impfdatum: -
Beginn: 06.04.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Activated partial thromboplastin time shortened Alanine aminotransferase increased Angiogram pulmonary abnormal Aspartate aminotransferase increased Blood alkaline phosphatase decreased Activated partial thromboplastin time Activated partial thromboplastin time prolonged Alanine aminotransferase Angiogram Angiogram pulmonary Aspartate aminotransferase Blood alkaline phosphatase Blood electrolytes Blood electrolytes normal Blood fibrinogen Cerebral venous sinus thrombosis Dizziness Haptoglobin normal

Symptomtext

Cerebral venous sinus thrombosis; Pulmonary embolism; PLATELET COUNT DECREASED; Activated partial thromboplastin time shortened; Rash erythematous; Dizziness; Headache; ALANINE AMINOTRANSFERASE INCREASED; ANGIOGRAM PULMONARY ABNORMAL; ASPARTATE AMINOTRANSFERASE INCREASED; BLOOD ALKALINE PHOSPHATASE DECREASED; BLOOD ELECTROLYTES NORMAL; HAPTOGLOBIN NORMAL; THROMBIN TIME PROLONGED; ULTRASOUND SCAN NORMAL; VENOGRAM ABNORMAL; This spontaneous report received from a patient, concerned a 40-year-old. This case was described in a literature article, reference: outcomes of bivalirudin therapy for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination: The patient's height, and weight were not reported. The patient's concurrent conditions included tonsil exudate, seasonal allergies, strain of cervical portion of right trapezius muscle, and migraine headaches. There was no history of thrombosis, clotting disorders, inflammatory bowel disease, collagen vascular disorders or cancers. The patient was not pregnant at the time of reporting, was not using estrogen-containing medications or tobacco and had no recent surgical history. On 01-APR-2021, the patient received covid-19 vaccine (suspension for injection, intramuscular, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, once total administered on left arm for prophylactic vaccination. Concomitant medications included cyanocobalamin, menatetrenone, and paracetamol. On post-vaccination day 5, 06-APR-2021, the patient developed a headache, sinus pressure, myalgias and sore throat with tonsillar exudate. On day 8, she presented to urgent care and was prescribed amoxicillin/clavulanate potassium, a methyl-prednisolone taper and methocarbamol. No laboratory evaluation was performed. She continued to have worsening headaches (different to her normal headaches), especially with movement, associated photophobia and intermittent dizziness prompting her presentation at the Emergency Department on post-vaccination day 12, 13-APR-2021. She denied fever, weakness, numbness, vision changes, speech difficulty, gait instability, seizure. Her initial vital signs were within normal limits, except blood pressure was 141/96 mmHg. Physical examination revealed small areas of petechiae on her chest and right cheek of the face and mild tonsillar exudate without cervical lymphadenopathy. A detailed neurological examination was normal, and she had no leg swelling or pain. She was admitted to the hospital for further testing and management. The patient was found to have thrombocytopenia, an elevated D-dimer, normal fibrinogen, and mild elevation of the serum transaminases. Laboratory data on 13-APR-2021 included: alanine aminotransferase was 87 U/L, aspartate aminotransferase was 65 U/L, blood alkaline phosphatase was 25 U/L, other blood electrolytes were normal, haptoglobin was 208 mg/dL, partial thromboplastin time prolonged was 26.4 sec, platelet count was 20x10*9/L, and thrombin time was 14.9 sec, D-dimer was 27,150 to 47,570 FEU. Peripheral smear did not reveal schistocytes or other evidence of hemolysis. The patient's nasopharyngeal swab tested negative for SARS-CoV-2 RNA by reverse-transcriptase?polymerase-chain-reaction assay. An initial heparin induced thrombocytopenia antibody test, HIT IGG PF4, (HemosIL LIA assay) was negative. A confirmatory HIT PF4 ELISA resulted positive. While the patient did show a transient drop in hemoglobin (nadir of 12.3 g/dL on 15-APR-2021), there was no clinical evidence of bleeding. Mild transaminitis was present on time of admission; investigation for causes such as autoimmune hepatitis did not reveal an etiology. A CT angiogram of the chest showed a mild burden of acute pulmonary embolism with subsegmental filling defects in the right lower lobe. No right heart strain or lung infarct. A CT venography of the head/brain showed occlusive dural venous sinus thrombosis involving the left transverse and sigmoid sinuses extending into the left internal jugular vein. There is no associated infarct. There was possible additional nonocclusive thrombus in the right internal jugular vein. A lower extremity ultrasound was negative for DVT. A right upper quadrant ultrasound confirmed no portal vein thrombosis. The patient was treated with bivalirudin, a direct thrombin inhibitor with a short half-life. Infusion was started at 0.15 mg/kg/hr with titration parameters to target a PTT goal of 50-80 seconds. Additional pharmacologic interventions to aid in platelet recovery included intravenous globulin 1 g/kg/day for 12 days and prednisone 1 mg/kg daily. The patient demonstrated steady improvement until discharge on hospital day 6 and continued to show improvement. Platelet count was 115 x 10^9/L (at discharge on hospital day 6/post-vaccination day 18) and was 182 x 10^9/L (during outpatient follow-up on post-vaccination day 21). The patient did not demonstrate any sequelae of thrombosis. The patient was recovering well from the events of cerebral venous sinus thrombosis, pulmonary embolism, low platelet count, activated partial thromboplastin time shortened, dizziness, and rash erythematous, and vision changes was not reported. The event of headache resolved on an unspecified date. This report was serious (Hospitalization Caused / Prolonged). This case, from the same reporter is linked. Additional information was received from traditional media and the literature via a company representative on 07-MAY-2021. The following information was updated and incorporated into the case narrative: Literature citation, author details, company representative added as reporter, patient race, medical history, platelet count, clinical progression, lab data, corrective treatment, and outcome.; Sender's Comments: V2: Follow up from literature provided clinical details; company assessment remains the same. This case initially obtained concerns a 40-year-old White female who was hospitalized for cerebral venous sinus thrombosis, pulmonary embolism (PE) and thrombocytopenia 12 days after receiving covid-19 vaccine. Medical history included migraine headaches. There was no history of thrombosis, clotting disorders, inflammatory bowel disease, collagen vascular disorders or cancers. She was not pregnant, was not using estrogen-containing medications or tobacco, & had no recent surgical history. Concomitant medications included cyanocobalamin, menatetrenone, & paracetamol. Post-vaccination day 5 (PVD5), she developed a headache, sinus pressure, myalgias & sore throat with tonsillar exudate. PVD8, she went to urgent care & was prescribed amoxicillin/clavulanate, methylprednisolone taper & methocarbamol. PVD12, headaches worsened, prompting Emergency Department visit. She was hospitalized for further testing and management. Labs showed: Platelets (PLT) 20k/uL, peripheral smear without schistocytes or hemolysis, d-dimer 47K, normal fibrinogen, negative Covid-19 PCR swab, positive HIT PF4 ELISA. CTV of brain showed occlusive dural venous sinus thrombosis involving left transverse & sigmoid sinuses extending into left internal jugular vein. CTA showed PE in right lobe. Ultrasound did not show deep vein thrombosis of lower extremity or portal vein. Treatment included bivalirudin, IVIG, & prednisone. Patient improved and was discharged on PVD18 with PLT 115; PLT 182 on PVD21. She was recovering without sequelae of thrombosis. Based on evolving knowledge of Thrombosis with Thrombocytopenia Syndrome (TTS, per definition from Brighton Collaboration-BC), the low platelet count and temporal relationship to vaccination (BC Criteria level 1), the events are assessed to have a plausible relationship with vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: Test Date: 20210415; Test Name: Hemoglobin; Result Unstructured Data: 12.3 g/dL; Test Name: Aspartate aminotransferase; Result Unstructured Data: 65 U/L, increased; Test Name: Blood alkaline phosphatase; Result Unstructured Data: 25 U/L, decreased; Test Name: Blood electrolytes; Result Unstructured Data: normal; Test Name: Haptoglobin; Result Unstructured Data: 208 mg/dL, normal; Test Name: Platelet count; Result Unstructured Data: 20 10*9/L, decreased; Test Name: Thrombin time; Result Unstructured Data: 14.9 sec, prolonged; Test Name: Venogram; Result Unstructured Data: ABNORMAL; Comments: occlusive dural venous sinus thrombosis involving the left transverse and sigmoid sinuses. There is no associated infarct; Possible additional nonocclusive thrombus in the right internal jugular vein Lower extremity ultrasound: negative for DVT D-dimer: 27,150 FEU; Test Name: Blood pressure; Result Unstructured Data: 141/96 mmHg; Test Name: CT angiography; Result Unstructured Data: acute pulmonary embolism; Comments: mild burden of acute pulmonary embolism with subsegmental filling defects in the right lower lobe. No right heart strain or lung infarct; Test Name: Partial thromboplastin time prolonged; Result Unstructured Data: 26.4 sec; Test Name: Platelet count; Result Unstructured Data: 115 10*9/L; Comments: at discharge on day 6; Test Name: Platelet count; Result Unstructured Data: 182 10*9/L; Comments: outpatient follow-up day 9; Test Name: Ultrasound scan; Result Unstructured Data: lower extremity: no DVT; Test Name: Activated partial thromboplastin time; Result Unstructured Data: shortened; Test Name: Platelet factor 4; Result Unstructured Data: HemosIL LIA assay: negative; Test Name: ELISA; Result Unstructured Data: positive; Test Name: Transaminases increased; Result Unstructured Data: elevated; Test Name: Fibrinogen; Result Unstructured Data: normal; Test Name: Blood test; Result Unstructured Data: peripheral blood smear; Test Name: COVID-19 virus test negative; Result Unstructured Data: negative for SARS-CoV-2 RNA by Reverse-transcriptase PCR assay; Test Name: Fibrin D dimer; Result Unstructured Data: confirmation HIT PF4ELISA was positive; Test Name: Ultrasound scan; Result Unstructured Data: RUQ: no portal vein thrombosis; Test Name: Blood pressure; Result Unstructured Data: 141/96 mmHg; Test Name: Fibrin D dimer; Result Unstructured Data: 27150 to 47570 FEU; Test Name: Partial thromboplastin time prolonged; Result Unstructured Data: 26.4 sec; Test Name: Alanine aminotransferase; Result Unstructured Data: 87 U/L, Increased; Test Name: Angiogram pulmonary; Result Unstructured Data: abnormal
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Migraine; Seasonal allergy; Strain; Tonsillar exudate; Comments: No history of thrombosis, clotting disorders, inflammatory bowel disease, collagen vascular disorders or cancers. The patient was not pregnant at the time of reporting, was not using estrogen-containing medications or tobacco and no recent surgical history
Andere Medikamente: ACETAMINOPHEN; VITAMIN B12; VITAMIN K2
Allergien: -
Vorherige Impfungen: -

VAERS 1204671

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: CO
Alter: 40,0
Geschlecht: F
Eingang: 15.05.2021
Impfdatum: -
Beginn: 06.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Activated partial thromboplastin time shortened Alanine aminotransferase increased Angiogram pulmonary abnormal Aspartate aminotransferase increased Blood alkaline phosphatase decreased Activated partial thromboplastin time Activated partial thromboplastin time prolonged Alanine aminotransferase Angiogram Angiogram pulmonary Aspartate aminotransferase Blood alkaline phosphatase Blood electrolytes Blood electrolytes normal Blood fibrinogen Cerebral venous sinus thrombosis Dizziness Haptoglobin normal

Symptomtext

Cerebral venous sinus thrombosis; Pulmonary embolism; PLATELET COUNT DECREASED; Activated partial thromboplastin time shortened; Rash erythematous; Dizziness; Headache; ALANINE AMINOTRANSFERASE INCREASED; ANGIOGRAM PULMONARY ABNORMAL; ASPARTATE AMINOTRANSFERASE INCREASED; BLOOD ALKALINE PHOSPHATASE DECREASED; BLOOD ELECTROLYTES NORMAL; HAPTOGLOBIN NORMAL; THROMBIN TIME PROLONGED; ULTRASOUND SCAN NORMAL; VENOGRAM ABNORMAL; This spontaneous report received from a patient, concerned a 40-year-old. This case was described in a literature article, reference: outcomes of bivalirudin therapy for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination: The patient's height, and weight were not reported. The patient's concurrent conditions included tonsil exudate, seasonal allergies, strain of cervical portion of right trapezius muscle, and migraine headaches. There was no history of thrombosis, clotting disorders, inflammatory bowel disease, collagen vascular disorders or cancers. The patient was not pregnant at the time of reporting, was not using estrogen-containing medications or tobacco and had no recent surgical history. On 01-APR-2021, the patient received covid-19 vaccine (suspension for injection, intramuscular, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, once total administered on left arm for prophylactic vaccination. Concomitant medications included cyanocobalamin, menatetrenone, and paracetamol. On post-vaccination day 5, 06-APR-2021, the patient developed a headache, sinus pressure, myalgias and sore throat with tonsillar exudate. On day 8, she presented to urgent care and was prescribed amoxicillin/clavulanate potassium, a methyl-prednisolone taper and methocarbamol. No laboratory evaluation was performed. She continued to have worsening headaches (different to her normal headaches), especially with movement, associated photophobia and intermittent dizziness prompting her presentation at the Emergency Department on post-vaccination day 12, 13-APR-2021. She denied fever, weakness, numbness, vision changes, speech difficulty, gait instability, seizure. Her initial vital signs were within normal limits, except blood pressure was 141/96 mmHg. Physical examination revealed small areas of petechiae on her chest and right cheek of the face and mild tonsillar exudate without cervical lymphadenopathy. A detailed neurological examination was normal, and she had no leg swelling or pain. She was admitted to the hospital for further testing and management. The patient was found to have thrombocytopenia, an elevated D-dimer, normal fibrinogen, and mild elevation of the serum transaminases. Laboratory data on 13-APR-2021 included: alanine aminotransferase was 87 U/L, aspartate aminotransferase was 65 U/L, blood alkaline phosphatase was 25 U/L, other blood electrolytes were normal, haptoglobin was 208 mg/dL, partial thromboplastin time prolonged was 26.4 sec, platelet count was 20x10*9/L, and thrombin time was 14.9 sec, D-dimer was 27,150 to 47,570 FEU. Peripheral smear did not reveal schistocytes or other evidence of hemolysis. The patient's nasopharyngeal swab tested negative for SARS-CoV-2 RNA by reverse-transcriptase?polymerase-chain-reaction assay. An initial heparin induced thrombocytopenia antibody test, HIT IGG PF4, (HemosIL LIA assay) was negative. A confirmatory HIT PF4 ELISA resulted positive. While the patient did show a transient drop in hemoglobin (nadir of 12.3 g/dL on 15-APR-2021), there was no clinical evidence of bleeding. Mild transaminitis was present on time of admission; investigation for causes such as autoimmune hepatitis did not reveal an etiology. A CT angiogram of the chest showed a mild burden of acute pulmonary embolism with subsegmental filling defects in the right lower lobe. No right heart strain or lung infarct. A CT venography of the head/brain showed occlusive dural venous sinus thrombosis involving the left transverse and sigmoid sinuses extending into the left internal jugular vein. There is no associated infarct. There was possible additional nonocclusive thrombus in the right internal jugular vein. A lower extremity ultrasound was negative for DVT. A right upper quadrant ultrasound confirmed no portal vein thrombosis. The patient was treated with bivalirudin, a direct thrombin inhibitor with a short half-life. Infusion was started at 0.15 mg/kg/hr with titration parameters to target a PTT goal of 50-80 seconds. Additional pharmacologic interventions to aid in platelet recovery included intravenous globulin 1 g/kg/day for 12 days and prednisone 1 mg/kg daily. The patient demonstrated steady improvement until discharge on hospital day 6 and continued to show improvement. Platelet count was 115 x 10^9/L (at discharge on hospital day 6/post-vaccination day 18) and was 182 x 10^9/L (during outpatient follow-up on post-vaccination day 21). The patient did not demonstrate any sequelae of thrombosis. The patient was recovering well from the events of cerebral venous sinus thrombosis, pulmonary embolism, low platelet count, activated partial thromboplastin time shortened, dizziness, and rash erythematous, and vision changes was not reported. The event of headache resolved on an unspecified date. This report was serious (Hospitalization Caused / Prolonged). This case, from the same reporter is linked. Additional information was received from traditional media and the literature via a company representative on 07-MAY-2021. The following information was updated and incorporated into the case narrative: Literature citation, author details, company representative added as reporter, patient race, medical history, platelet count, clinical progression, lab data, corrective treatment, and outcome.; Sender's Comments: V2: Follow up from literature provided clinical details; company assessment remains the same. This case initially obtained concerns a 40-year-old White female who was hospitalized for cerebral venous sinus thrombosis, pulmonary embolism (PE) and thrombocytopenia 12 days after receiving covid-19 vaccine. Medical history included migraine headaches. There was no history of thrombosis, clotting disorders, inflammatory bowel disease, collagen vascular disorders or cancers. She was not pregnant, was not using estrogen-containing medications or tobacco, & had no recent surgical history. Concomitant medications included cyanocobalamin, menatetrenone, & paracetamol. Post-vaccination day 5 (PVD5), she developed a headache, sinus pressure, myalgias & sore throat with tonsillar exudate. PVD8, she went to urgent care & was prescribed amoxicillin/clavulanate, methylprednisolone taper & methocarbamol. PVD12, headaches worsened, prompting Emergency Department visit. She was hospitalized for further testing and management. Labs showed: Platelets (PLT) 20k/uL, peripheral smear without schistocytes or hemolysis, d-dimer 47K, normal fibrinogen, negative Covid-19 PCR swab, positive HIT PF4 ELISA. CTV of brain showed occlusive dural venous sinus thrombosis involving left transverse & sigmoid sinuses extending into left internal jugular vein. CTA showed PE in right lobe. Ultrasound did not show deep vein thrombosis of lower extremity or portal vein. Treatment included bivalirudin, IVIG, & prednisone. Patient improved and was discharged on PVD18 with PLT 115; PLT 182 on PVD21. She was recovering without sequelae of thrombosis. Based on evolving knowledge of Thrombosis with Thrombocytopenia Syndrome (TTS, per definition from Brighton Collaboration-BC), the low platelet count and temporal relationship to vaccination (BC Criteria level 1), the events are assessed to have a plausible relationship with vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: Test Date: 20210415; Test Name: Hemoglobin; Result Unstructured Data: 12.3 g/dL; Test Name: Aspartate aminotransferase; Result Unstructured Data: 65 U/L, increased; Test Name: Blood alkaline phosphatase; Result Unstructured Data: 25 U/L, decreased; Test Name: Blood electrolytes; Result Unstructured Data: normal; Test Name: Haptoglobin; Result Unstructured Data: 208 mg/dL, normal; Test Name: Platelet count; Result Unstructured Data: 20 10*9/L, decreased; Test Name: Thrombin time; Result Unstructured Data: 14.9 sec, prolonged; Test Name: Venogram; Result Unstructured Data: ABNORMAL; Comments: occlusive dural venous sinus thrombosis involving the left transverse and sigmoid sinuses. There is no associated infarct; Possible additional nonocclusive thrombus in the right internal jugular vein Lower extremity ultrasound: negative for DVT D-dimer: 27,150 FEU; Test Name: Blood pressure; Result Unstructured Data: 141/96 mmHg; Test Name: CT angiography; Result Unstructured Data: acute pulmonary embolism; Comments: mild burden of acute pulmonary embolism with subsegmental filling defects in the right lower lobe. No right heart strain or lung infarct; Test Name: Partial thromboplastin time prolonged; Result Unstructured Data: 26.4 sec; Test Name: Platelet count; Result Unstructured Data: 115 10*9/L; Comments: at discharge on day 6; Test Name: Platelet count; Result Unstructured Data: 182 10*9/L; Comments: outpatient follow-up day 9; Test Name: Ultrasound scan; Result Unstructured Data: lower extremity: no DVT; Test Name: Activated partial thromboplastin time; Result Unstructured Data: shortened; Test Name: Platelet factor 4; Result Unstructured Data: HemosIL LIA assay: negative; Test Name: ELISA; Result Unstructured Data: positive; Test Name: Transaminases increased; Result Unstructured Data: elevated; Test Name: Fibrinogen; Result Unstructured Data: normal; Test Name: Blood test; Result Unstructured Data: peripheral blood smear; Test Name: COVID-19 virus test negative; Result Unstructured Data: negative for SARS-CoV-2 RNA by Reverse-transcriptase PCR assay; Test Name: Fibrin D dimer; Result Unstructured Data: confirmation HIT PF4ELISA was positive; Test Name: Ultrasound scan; Result Unstructured Data: RUQ: no portal vein thrombosis; Test Name: Blood pressure; Result Unstructured Data: 141/96 mmHg; Test Name: Fibrin D dimer; Result Unstructured Data: 27150 to 47570 FEU; Test Name: Partial thromboplastin time prolonged; Result Unstructured Data: 26.4 sec; Test Name: Alanine aminotransferase; Result Unstructured Data: 87 U/L, Increased; Test Name: Angiogram pulmonary; Result Unstructured Data: abnormal
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Migraine; Seasonal allergy; Strain; Tonsillar exudate; Comments: No history of thrombosis, clotting disorders, inflammatory bowel disease, collagen vascular disorders or cancers. The patient was not pregnant at the time of reporting, was not using estrogen-containing medications or tobacco and no recent surgical history
Andere Medikamente: ACETAMINOPHEN; VITAMIN B12; VITAMIN K2
Allergien: -
Vorherige Impfungen: -

VAERS 1317507

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MD
Alter: 37,0
Geschlecht: F
Eingang: 14.05.2021
Impfdatum: 07.04.2021
Beginn: 22.04.2021
Tage bis Beginn: 15,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abortion spontaneous Exposure during pregnancy Foetal death Intermenstrual bleeding Nausea Pyrexia Ultrasound scan Vomiting

Symptomtext

On 05.11.2021 I went in for an ultrasound due to spotting. I should have been 13 weeks pregnant. The fetus was measuring 9 weeks 4 days which means the fetus died on 4.22.2021. 4.7.21 - received vaccine shot 4.8.21-4.9.21 - fever (used tylonel), nausea, vomiting I had significant nausea and vomiting the week of 4.11.21 - particularly the end of the week. 4.15.21 - ultrasound (baby measuring 8 weeks, 4 day; HR -176) I continued to vomit, though I was able to hold more food down. 4.22.21 the fetus would have been 9.4 days which is when the fetus stopped developing 5.11.21 - Ultrasound discovering missed miscarriage Doctor recommended reporting due to the timing with the vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Foetal death
Hospital-Tage: -
Labordaten: 4.15.21 - ultrasound (baby measuring 8 weeks, 4 day; HR -176 5.11.21 - Ultrasound discovering missed miscarriage at 9 weeks 4 days
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Prenatal vitamin
Allergien: codeine
Vorherige Impfungen: -

VAERS 1281336

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 32,0
Geschlecht: F
Eingang: 12.05.2021
Impfdatum: 08.04.2021
Beginn: 29.04.2021
Tage bis Beginn: 21,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Activated partial thromboplastin time Anticoagulant therapy Chest pain Computerised tomogram Dyspnoea Pulmonary embolism Fatigue Pain in extremity Pulmonary thrombosis Ultrasound scan

Symptomtext

pulmonary embolus

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: CT with PE
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1307274

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: IN
Alter: 82,0
Geschlecht: M
Eingang: 11.05.2021
Impfdatum: 02.04.2021
Beginn: 29.04.2021
Tage bis Beginn: 27,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Computerised tomogram thorax abnormal Haemoptysis Infusion International normalised ratio increased Pulmonary embolism

Symptomtext

We admitted patient to the hospital DOB 08/30/1938 MR#46977 FIN#98705621120 on 04.30.21 through our ER to Med/Surg for new right middle lobe PE. Pt received the Johnson and Johnson (Janssen) COVID vaccine on 04.02.21 at the Pharmacy (lot# 042A21A). The pt was on warfarin prior to admission for diagnosis afib and therapeutic (INR 2.2) at time of admission so he was placed on heparin high intensity infusion. Pt subsequently developed hemoptysis so heparin infusion was held and pt was transferred to the hospital for hematology/pulmonology/oncology consult. At accepting facility heparin was held on admission and was restarted on 05.02.21.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: Chest CT showed pulmonary embolism on 4/30/21
Aktuelle Erkrankungen: coughing up blood
Vorgeschichte: Afib COPD Emphysema Hyperlipidemia Hypertension Pneumonia
Andere Medikamente: Albuterol/Ipratropium 2.5mg-0.5mg/3mL Albuterol 90mcg/inh HFA allopurinol alprazolam symbicort diltiazem lisinopril loratadine ropinirole zoloft terazosin warfarin
Allergien: Allergies: Penicillin, zocor, biaxin, keflex, tape
Vorherige Impfungen: -

VAERS 1223644

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: TX
Alter: 75,0
Geschlecht: M
Eingang: 11.05.2021
Impfdatum: 02.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 7,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain upper Death Fatigue Malaise

Symptomtext

Patient passed away one week after receiving the vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: Patient had a medical history with issues involving his heart. All and other health issues would need to be confirmed with doctors
Andere Medikamente: hydrocodone-APAP 7.5-325mg Ipratropium-albuterol 0.5-2.5mg montelukast 10mg tab Eliquis 2.5mg Potassium Chloride 20meQ Esomeprazole 20mg Toresemide 20mg Metoprolol 25mg Tartrate Duloxetine DR 30mg
Allergien: No known drug allergies
Vorherige Impfungen: -

VAERS 1223644

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: TX
Alter: 75,0
Geschlecht: M
Eingang: 11.05.2021
Impfdatum: 02.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 7,0
Dosis: 1
Route/Site: SYR / AR

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain upper Death Fatigue Malaise

Symptomtext

Patient passed away one week after receiving the vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: Patient had a medical history with issues involving his heart. All and other health issues would need to be confirmed with doctors
Andere Medikamente: hydrocodone-APAP 7.5-325mg Ipratropium-albuterol 0.5-2.5mg montelukast 10mg tab Eliquis 2.5mg Potassium Chloride 20meQ Esomeprazole 20mg Toresemide 20mg Metoprolol 25mg Tartrate Duloxetine DR 30mg
Allergien: No known drug allergies
Vorherige Impfungen: -

VAERS 1417404

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: NJ
Alter: 64,0
Geschlecht: F
Eingang: 09.05.2021
Impfdatum: 07.04.2021
Beginn: 11.04.2021
Tage bis Beginn: 4,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Acute myocardial infarction Chest pain Electrocardiogram repolarisation abnormality Hypertension Myocardial necrosis marker increased Sleep disorder

Symptomtext

chest pains- nocturnal awakening: high BP 210/94 Diagnosis: NSTEMI (non-ST elevation myocardial infarction)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 1,0
Labordaten: elevated cardiac enzymes abn. EKG-non Specific repolarization > 4/11/2021 and 4/12/2021 disturbance
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: SULFA
Vorherige Impfungen: -

VAERS 1289959

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: FL
Alter: 63,0
Geschlecht: M
Eingang: 05.05.2021
Impfdatum: 01.04.2021
Beginn: 28.04.2021
Tage bis Beginn: 27,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: unbekannt Erholt: nein

Angiogram pulmonary abnormal Intensive care Pulmonary embolism SARS-CoV-2 test positive Thrombectomy

Symptomtext

Developed Covid 19 infection 28 days after Johnson and Johnson vaccination. This was further complicated by bilateral pulmonary embolism requiring mechanical thrombectomy and ICU admission.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 8,0
Labordaten: Covid 19 PCR- 4/28- positive CTA- 4.28- confirmed presence of lareg extensive bilateral pulmonary emboli
Aktuelle Erkrankungen: -
Vorgeschichte: Hypertension, previous DVT, COPD
Andere Medikamente: Eliquis, insulin, diltiazem
Allergien: None
Vorherige Impfungen: -

VAERS 1284655

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: NY
Alter: -
Geschlecht: U
Eingang: 04.05.2021
Impfdatum: -
Beginn: 06.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Anaphylactic shock Idiopathic intracranial hypertension

Symptomtext

RECURRENT ANAPHYLACTIC SHOCK; IDIOPATHIC INTRACRANIAL HYPERTENSION; This spontaneous report received via company representative from a patient concerned a patient of unspecified age and sex. The patients weight, height, and medical history were not reported. The patient received COVID-19 VACCINE AD26.COV2.S (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: UNKNOWN)dose was not reported, 1 total administered on 06-Apr-2021;11:54 for prophylactic vaccination. No concomitant medications were reported. On 06-APR-2021 at 12:10pm the patient was reacting to the vaccine and was hospitalized and received treatment for extreme Anaphylactic Shock ( had 3 bounceback reactions over the course of the next 24 hours. Patient was treated with Epinephrine (iv drip), Steroids and multiple Nebulizer treatments. Patient was in the ICU for 3days and a regular room for e additional days. Hospitalized from 6Apr through 11Apr.I was home for several days and was again hospitalized 19Apr through 22Apr for a severe headache, ringing in ears, numbness in left arm, leg, an leg. Also for blurry/double vision in right eye. On 19-APR-2021, the patient was again hospitalized for a severe headache, ringing in ears, numbness in left arm, and leg, blurry/double vision in right eye. It was determined to be Idiopathic Intracranial Hypertension and still being treated for it and will be attending Occupational and Physical therapy to get vision, arm and leg to work properly again. Patient was hospitalized for 3 days. The action taken with COVID-19 VACCINE AD26.COV2.S was not applicable. The patient had not recovered from idiopathic intracranial hypertension, and the outcome of recurrent anaphylactic shock was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: 20210452704-Covid-19 vaccine ad26.cov2.s-Idiopathic intracranial hypertension. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20210452704-Covid-19 vaccine ad26.cov2.s-Anaphylactic reaction. This event(s) is considered related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and is scientifically plausible. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic shock
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1237092

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MI
Alter: 32,0
Geschlecht: M
Eingang: 04.05.2021
Impfdatum: 10.04.2021
Beginn: 12.04.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Autopsy Breath sounds abnormal Cardiac arrest Confusional state Cyanosis Death Diarrhoea Dyspnoea Electrocardiogram Endotracheal intubation Livedo reticularis Musculoskeletal discomfort Pulmonary embolism Pulseless electrical activity Pupil fixed Resuscitation Seizure Syncope

Symptomtext

Shortness of breath. Passed away on 4/19/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: Unknown
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Lisinopril and Tramadol
Allergien: None
Vorherige Impfungen: -

VAERS 1237092

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MI
Alter: 32,0
Geschlecht: M
Eingang: 04.05.2021
Impfdatum: 10.04.2021
Beginn: 12.04.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: SYR / AR

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Autopsy Breath sounds abnormal Cardiac arrest Confusional state Cyanosis Death Diarrhoea Dyspnoea Electrocardiogram Endotracheal intubation Livedo reticularis Musculoskeletal discomfort Pulmonary embolism Pulseless electrical activity Pupil fixed Resuscitation Seizure Syncope

Symptomtext

Shortness of breath. Passed away on 4/19/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: Unknown
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Lisinopril and Tramadol
Allergien: None
Vorherige Impfungen: -

VAERS 1277679

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MI
Alter: 42,0
Geschlecht: M
Eingang: 01.05.2021
Impfdatum: 09.04.2021
Beginn: 30.04.2021
Tage bis Beginn: 21,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Death on 04/30/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Cardiac, lung problems, history of blood clots, back and leg pain
Andere Medikamente: Protonix, Folic Acid, K-Dur,
Allergien: -
Vorherige Impfungen: -

VAERS 1276519

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MD
Alter: 64,0
Geschlecht: F
Eingang: 01.05.2021
Impfdatum: -
Beginn: 23.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Computerised tomogram thorax Platelet count Pulmonary embolism SARS-CoV-2 test

Symptomtext

PULMONARY EMBOLISM/RIGHT SIDED MID BACK PAIN; This spontaneous report received from a health care professional concerned a 64 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included Crohn's disease. The patient was previously treated with infliximab for Crohn's disease. The patient experienced drug allergy when treated with infliximab (Remicade). The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 042A21A, expiry: unknown) dose was not reported, 1 total administered on 31-MAR-2021 to left arm for prophylactic vaccination. Concomitant medications included vitamins nos, azathioprine, dicycloverine, and mesalazine for drug used for unknown indication. On 22-APR-2021 by evening, the patient experienced right-sided mid-back pain and shortness of breath and was presented to ED (emergency department) on 23-APR-2021. The patient's pain was sharp and worsened with coughing and deep inspiration; she felt that she was taking shallow breaths. Upon ED (emergency department) presentation, there was no shortness of breath, chest pain, dizziness, fevers, dysuria, or abdominal pain. The patient had reproducible pain on her right mid-back area. There was some mild diffuse tenderness in her abdomen, but it was reported that she always had a tender abdomen due to Crohn's disease. The patient had no peritoneal signs and had no recent travel history. On 23-APR-2021, the CTA (Computed tomography angiography) of chest was done with and without contrast and found out central and peripheral pulmonary emboli in the right lower lobe. The patient had no CT (computerized tomography) evidence of right heart strain. The patient's ground glass opacities within the right lower lobe was somewhat band like in appearance and concerned for early pulmonary infarcts. It was reported that this might also relate to sub segmental atelectasis or less likely an inflammatory/infectious process. The patient had also small right pleural effusion; no acute inflammatory process in the abdomen or pelvis. On 23-APR-2021, the patient's platelet count was 252 k/mcL and was tested negative for covid test. The patient was diagnosed with pulmonary embolism; she consulted hematology/oncology specialist and recommended with initiation of argatroban for treatment of pulmonary embolism. The patient was admitted to inpatient on 23-APR-2021. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of pulmonary embolism/right sided mid back pain was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0;-covid-19 vaccine ad26.cov2.s-Pulmonary Embolism. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: Test Date: 20210423; Test Name: CT pulmonary angiogram; Result Unstructured Data: Central and peripheral pulmonary emboli in the right lower lobe; Test Date: 20210423; Test Name: COVID-19 virus test; Result Unstructured Data: negative; Test Date: 20210423; Test Name: Platelet count; Result Unstructured Data: 252 k/mcL
Aktuelle Erkrankungen: Crohn's disease; Drug allergy (Remicade allergy)
Vorgeschichte: Comments: The patent was on multi vitamins
Andere Medikamente: MESALAMINE; AZATHIOPRINE; DICYCLOMINE [DICYCLOVERINE]; MULTIVITAMINS [VITAMINS NOS]
Allergien: -
Vorherige Impfungen: -

VAERS 1201912

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MS
Alter: 43,0
Geschlecht: M
Eingang: 30.04.2021
Impfdatum: 06.04.2021
Beginn: 06.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: unbekannt Erholt: nein

Cerebral infarction Computerised tomogram head Hemiplegia Magnetic resonance imaging head Cerebrovascular accident Ischaemic stroke

Symptomtext

Ischemic Stroke

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension
Andere Medikamente: Lisinopril & Propranolol
Allergien: None
Vorherige Impfungen: -

VAERS 1201912

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MS
Alter: 43,0
Geschlecht: M
Eingang: 30.04.2021
Impfdatum: 06.04.2021
Beginn: 06.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: unbekannt Erholt: nein

Cerebral infarction Computerised tomogram head Hemiplegia Magnetic resonance imaging head Cerebrovascular accident Ischaemic stroke

Symptomtext

Ischemic Stroke

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension
Andere Medikamente: Lisinopril & Propranolol
Allergien: None
Vorherige Impfungen: -

VAERS 1258458

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MD
Alter: 64,0
Geschlecht: F
Eingang: 26.04.2021
Impfdatum: 31.03.2021
Beginn: 22.04.2021
Tage bis Beginn: 22,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Abdominal pain Abdominal tenderness Angiogram pulmonary abnormal Anticoagulant therapy Atelectasis Back pain Chest pain Computerised tomogram thorax abnormal Cough Dizziness Dyspnoea Dysuria Hypopnoea Lung opacity Painful respiration Peripheral embolism Platelet count normal Pleural effusion

Symptomtext

2021-04-23 Patient presents to the ED with right-sided mid-back pain and shortness of breath starting 2021-04-22 evening. Pain is sharp and worsens with coughing and deep inspiration; she feels that she is taking shallow breaths. On ED presentation, no shortness of breath, chest pain, dizziness, fevers, dysuria, or abdominal pain. She does have reproducible pain on her right mid-back area. There is some mild diffuse tenderness in her abdomen, but reports that she always has a tender abdomen due to Crohn's disease. No peritoneal signs. No recent travel. Patient was found to have pulmonary embolism. Hematology/Oncology specialist was consulted and recommended initiation of argatroban for treatment of pulmonary embolism. Patient was admitted to inpatient.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: 2021-04-23 CTA chest w/ and w/out contrast: Central and peripheral pulmonary emboli in the right lower lobe. No CT evidence of right heart strain. Groundglass opacities within theright lower lobe which are somewhat bandlike in appearance and concerning for early pulmonary infarcts. Alternatively this may relate to subsegmental atelectasis or less likely an inflammatory/infectious process. Small right pleural effusion. No acute inflammatory process in the abdomen or pelvis. 2021-04-23 platelets 252k/mcL 2021-04-23 COVID test - negative
Aktuelle Erkrankungen: unknown
Vorgeschichte: Crohn's disease
Andere Medikamente: mesalamine, azathioprine, dicyclomine, multivitamin
Allergien: Remicade
Vorherige Impfungen: -

VAERS 1219878

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MI
Alter: 42,0
Geschlecht: F
Eingang: 26.04.2021
Impfdatum: 05.04.2021
Beginn: 15.04.2021
Tage bis Beginn: 10,0
Dosis: UNK
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain Agitation Angiogram cerebral abnormal Aphasia Areflexia Arterial rupture Full blood count Headache Platelet count normal Arterial angioplasty Blood culture Blood sodium increased Brain death Brain herniation Brain oedema Brain stem syndrome CSF culture Cardiac index

Symptomtext

4/16/2021: 42-year-old female with hypertension presented to hospital with complaints of a headache. The patient presented with the worst headache of her life beginning suddenly at 1800 on 4/15. She described her head as feeling like it was going to explode. She had associated photophobia and phonophobia. -CT head consistent with subarachnoid hemorrhage; CT angiography demonstrates complex anterior communicating artery aneurysm -Hypertensive; requiring IV nicardipine -New mode of pain and scalp are administered -Patient transferred to hospital -Underwent successful cerebral angiography for coiling culprit aneurysm -Mental status abnormal after procedure -Concern for bifrontal ischemic stroke noted -Episodes nonsustained sinus bradycardia; nimodipine administered 30 mg every 2 hours -Eventually underwent placement of EVD for persistently altered mental status 4/17/2021: -Mental status improved some overnight -ICP ranging between 1 and 7 since placement of EVD -Continuous EEG monitoring ongoing -Awaiting formal interpretation of this morning's TCD -Patient nods in response to questions and follows commands, but remains aphasic; she is able to write legible notes; she wants to go home but was able to express understanding of the need for very close observation for potentially more than 2 weeks 4/18/2021: -Mental status unchanged -EVD in place; ICP 0-2 -Daily TCD's, no evidence for vasospasm 4/19/21: - ICPs 2-6 - TCD this morning shows no evidence of vasospasm. 4/20/21 - ICPs 0-6 -Awaiting formal interpretation of this morning's TCD -no major events reported overnight 4/21/2021: -Seems attentive, but answers no questions and follows no commands -Febrile, white count 7.9; blood cultures, CSF culture and urinalysis pending -TCD today demonstrates persistently elevated velocities in the left middle cerebral artery and basilar artery similar to study yesterday -ICP range between 0 and 5 so far today 4/22/2021: - TCDs normal today -pt having increased abdominal pain this afternoon -pt got extra 25 mcg of fentanyl 4/23/2021: : -Neurosurgery raised EVD to 5 -pt more agitated this morning -no vasospasm on TCD -pt had repeat head CT per neurosurgery -Underwent formal cerebral angiogram that showed significant vasospasm in the posterior circulation as well as RIGHT MCA and ACA, all treated with chemical angioplasty. Suspected hypercoagulable state per IR due to repeat clotting off procedural catheters. Vasc NSx added daily rectal ASA. -Extubated following procedure, transferred back to ICU setting, but not protecting airway, required emergent reintubation by anesthesia. -Hemodynamic parameters adjusted per Vascular NSx MAP 90-110 and cardiac index 4.1 or more, phenylephrine and dobutamine added -Developed blown LEFT pupil, ICP remains <10, repeat CTH cont to show diffuse edema overall unchanged, hypertonic saline initiated following 3% bolus -EVD dropped to -5cm 4/24/2021: Repeat CTH early AM showing new, multifocal areas of infarct RIGHT frontal lobe, increased mass effect and impending vs ongoing herniation -Received 23.4% bullet after CTH findings -Increased velocities bilateral MCA on AM TCD -Developed increased ICPs in the mid to late morning 20-30s, sustained then progressed to 50s, NSx aware -Refractory intracranial hypertension, no further recommendations per Neurosciences, grave overall prognosis -Family notified of sig worsening, came to bedside and updated by Neurosurgery, Neuro IR and ICU -Further private conversations to be held with family, no further decisions regarding direction of care at this time -Family ultimately decided to update CODE STATUS to DNR, no escalation of support and reconvene on 4/25 -Patient with marked hemodynamic and ICP changes in the late afternoon/early evening, with loss of all brainstem reflexes, high suspicion for brain herniation, family aware and gift of life notified 4/25/2021: In the early a.m., patient developed high UOP, suspicious for central diabetes insipidus subsequent increase in sodium -DDAVP administered and D5 water infusion initiated -After electrolyte/acid-base derangements improved, clinical brain death testing performed with ICU and neurology services, family present at bedside -Pronounced deceased by neurologic criteria at 11:47 Discharge Condition: Pronounced deceased by neurological criteria on 4/25 at 1147.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Brain death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: HTN
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1203337

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: KS
Alter: -
Geschlecht: M
Eingang: 24.04.2021
Impfdatum: -
Beginn: 01.04.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Cardio-respiratory arrest Coagulation test Dyspnoea Foaming at mouth Heparin-induced thrombocytopenia test Death Full blood count HIV test Haemoglobin decreased Loss of consciousness Malaise Metabolic function test Platelet count decreased Sputum discoloured Platelet count Pulmonary embolism Thrombocytopenia

Symptomtext

PATIENT CODED; SHORTNESS OF BREATH; FOAMING AT MOUTH; PINK SPUTUM; This spontaneous report received from a health care professional (registered nurse) concerned a 66 year old male. Initial information was processed with additional information received from a healthcare professional on 13-APR-2021. The reporter reported to VAERS (no reference number provided). The patient's height, and weight were not reported. The patient's medical history included cancer (not further specified). The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, 1 total, administered to right deltoid on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. An unspecified amount of time after vaccination, the patient was experiencing shortness of breath, and foaming at mouth. It was reported the patient "coded" at home (captured as cardiopulmonary arrest) and was brought in unresponsive with pink sputum to the emergency department around 1:00 am on 13-APR-2021. Platelets were 129 (normal range and units not reported). Additional tests heparin-PF4 antibody test, extra lab work, clotting tests were performed but results were not reported. On 13-APR-2021 at 2:06 am the patient was pronounced dead. An autopsy was planned. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient outcome for cardiopulmonary arrest was fatal and for shortness of breath, foaming at mouth, pink sputum was not reported. This report was serious (Death, and Other Medically Important Condition).; Sender's Comments: V0 This report concerns a 66-year-old male patient who died (coded) a day after receiving Jansen COVID-19 vaccine. At an unspecified time, the patient experienced SOB and foaming at mouth. On 13-APR-2021 (one day after vaccination), the patient was "coded" at home and was brought in unresponsive with pink sputum to the ER around 1:00 am. At 2:06 am the patient was pronounced dead. The platelet was 129 (unit unspecified), heparin-PF4 antibody test, extra lab work, clotting tests were performed but results were not reported. This case has insufficient information to make a meaningful medical assessment. Additional information has been requested including autopsy findings.; Reported Cause(s) of Death: CARDIOPULMONARY ARREST

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardio-respiratory arrest
Hospital-Tage: -
Labordaten: Test Date: 202104; Test Name: Heparin-induced thrombocytopenia test; Result Unstructured Data: not reported; Test Date: 202104; Test Name: Coagulation test; Result Unstructured Data: not reported; Test Date: 20210413; Test Name: Platelet count; Result Unstructured Data: 129
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Cancer (not further specified)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1203337

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: KS
Alter: -
Geschlecht: M
Eingang: 24.04.2021
Impfdatum: -
Beginn: 01.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Cardio-respiratory arrest Coagulation test Dyspnoea Foaming at mouth Heparin-induced thrombocytopenia test Death Full blood count HIV test Haemoglobin decreased Loss of consciousness Malaise Metabolic function test Platelet count decreased Sputum discoloured Platelet count Pulmonary embolism Thrombocytopenia

Symptomtext

PATIENT CODED; SHORTNESS OF BREATH; FOAMING AT MOUTH; PINK SPUTUM; This spontaneous report received from a health care professional (registered nurse) concerned a 66 year old male. Initial information was processed with additional information received from a healthcare professional on 13-APR-2021. The reporter reported to VAERS (no reference number provided). The patient's height, and weight were not reported. The patient's medical history included cancer (not further specified). The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, 1 total, administered to right deltoid on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. An unspecified amount of time after vaccination, the patient was experiencing shortness of breath, and foaming at mouth. It was reported the patient "coded" at home (captured as cardiopulmonary arrest) and was brought in unresponsive with pink sputum to the emergency department around 1:00 am on 13-APR-2021. Platelets were 129 (normal range and units not reported). Additional tests heparin-PF4 antibody test, extra lab work, clotting tests were performed but results were not reported. On 13-APR-2021 at 2:06 am the patient was pronounced dead. An autopsy was planned. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient outcome for cardiopulmonary arrest was fatal and for shortness of breath, foaming at mouth, pink sputum was not reported. This report was serious (Death, and Other Medically Important Condition).; Sender's Comments: V0 This report concerns a 66-year-old male patient who died (coded) a day after receiving Jansen COVID-19 vaccine. At an unspecified time, the patient experienced SOB and foaming at mouth. On 13-APR-2021 (one day after vaccination), the patient was "coded" at home and was brought in unresponsive with pink sputum to the ER around 1:00 am. At 2:06 am the patient was pronounced dead. The platelet was 129 (unit unspecified), heparin-PF4 antibody test, extra lab work, clotting tests were performed but results were not reported. This case has insufficient information to make a meaningful medical assessment. Additional information has been requested including autopsy findings.; Reported Cause(s) of Death: CARDIOPULMONARY ARREST

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardio-respiratory arrest
Hospital-Tage: -
Labordaten: Test Date: 202104; Test Name: Heparin-induced thrombocytopenia test; Result Unstructured Data: not reported; Test Date: 202104; Test Name: Coagulation test; Result Unstructured Data: not reported; Test Date: 20210413; Test Name: Platelet count; Result Unstructured Data: 129
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Cancer (not further specified)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1201378

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: CA
Alter: -
Geschlecht: F
Eingang: 23.04.2021
Impfdatum: -
Beginn: 01.04.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Argininosuccinate lyase deficiency Computerised tomogram head Ischaemic stroke Magnetic resonance imaging Muscular weakness Blood test Computerised tomogram Electrocardiogram Cerebral thrombosis Chills Injection site pain Cerebrovascular accident Computerised tomogram head normal Discomfort Dizziness Fatigue Feeling abnormal Gait disturbance

Symptomtext

ACUTE ISCHEMIC STROKE; BLOOD CLOT IN LEFT FRONTAL LOBE; CHILLS; INJECTION SITE PAIN; This spontaneous report received from a patient concerned a white, not hispanic female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: unknown) dose was not reported, 1 total administered on 08-APR-2021 on left arm for prophylactic vaccination. No concomitant medications were reported. On an unspecified date in APR-2021 the patient's laboratory data included: CT scan (computed tomography scan), EKG (electrocardiography), MRI (magnetic resonance imaging) (NR: not provided) resulted in stroke/blood clot in the left frontal lobe. The patient experienced acute ischemic stroke on 08-APR-2021 and experienced blood clot in left frontal lobe on an unspecified date in APR-2021. On 08-APR-2021, the patient experienced injection site pain at first and felt ok until she went to sleep. In the middle of the night on 08-APR-2021, the patient experienced headache, chills, nausea and then on 09-APR-2021 and 10-APR-2021, the patient experienced brain fog and a headache. On 11-APR-2021, the patient had no change and sat down to have coffee, when she stood up she was dizzy and had no strength in her right leg and right side of the body. She could not walk and called her healthcare professional and went to the emergency room. The patient was hospitalized on 11-Apr-2021 and was discharged on 12-Apr-2021. The patient was hospitalized for 1 day. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from blood clot in left frontal lobe, and acute ischemic stroke, and the outcome of chills and injection site pain was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: This is a female patient, unspecified age, unspecified ethnicity, who experienced headache and brain fog 2 days after receiving the Janssen COVID-19. Medical, smoking, and alcohol history and concomitant medications were not reported. Height and weight were not reported. Almost 1 day after receiving the vaccine, the patient experienced headache, chills and nausea. The condition progressed the following day to having brain fog and headache. 3rd day after receiving the vaccine, patient experienced dizziness when standing up, feeling weakness on the right side of the body and right leg. She sought consult with HCP and went to the ER, where EKG, MRI and CT Scan (actual results not provided) done revealed blood clot in the left frontal lobe suggestive of acute ischemic stroke. Based on the available information, this is assessed as indterminate per WHO causality classification of adverse events following immunization. Additional information requested.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 1,0
Labordaten: Test Date: 202104; Test Name: EKG; Result Unstructured Data: stroke/blood clot in the left frontal lobe; Test Date: 202104; Test Name: CT scan; Result Unstructured Data: stroke/blood clot in the left frontal lobe; Test Date: 202104; Test Name: MRI; Result Unstructured Data: stroke/blood clot in the left frontal lobe
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1201378

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: CA
Alter: -
Geschlecht: F
Eingang: 23.04.2021
Impfdatum: -
Beginn: 01.04.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Argininosuccinate lyase deficiency Computerised tomogram head Ischaemic stroke Magnetic resonance imaging Muscular weakness Blood test Computerised tomogram Electrocardiogram Cerebral thrombosis Chills Injection site pain Cerebrovascular accident Computerised tomogram head normal Discomfort Dizziness Fatigue Feeling abnormal Gait disturbance

Symptomtext

ACUTE ISCHEMIC STROKE; BLOOD CLOT IN LEFT FRONTAL LOBE; CHILLS; INJECTION SITE PAIN; This spontaneous report received from a patient concerned a white, not hispanic female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: unknown) dose was not reported, 1 total administered on 08-APR-2021 on left arm for prophylactic vaccination. No concomitant medications were reported. On an unspecified date in APR-2021 the patient's laboratory data included: CT scan (computed tomography scan), EKG (electrocardiography), MRI (magnetic resonance imaging) (NR: not provided) resulted in stroke/blood clot in the left frontal lobe. The patient experienced acute ischemic stroke on 08-APR-2021 and experienced blood clot in left frontal lobe on an unspecified date in APR-2021. On 08-APR-2021, the patient experienced injection site pain at first and felt ok until she went to sleep. In the middle of the night on 08-APR-2021, the patient experienced headache, chills, nausea and then on 09-APR-2021 and 10-APR-2021, the patient experienced brain fog and a headache. On 11-APR-2021, the patient had no change and sat down to have coffee, when she stood up she was dizzy and had no strength in her right leg and right side of the body. She could not walk and called her healthcare professional and went to the emergency room. The patient was hospitalized on 11-Apr-2021 and was discharged on 12-Apr-2021. The patient was hospitalized for 1 day. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from blood clot in left frontal lobe, and acute ischemic stroke, and the outcome of chills and injection site pain was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: This is a female patient, unspecified age, unspecified ethnicity, who experienced headache and brain fog 2 days after receiving the Janssen COVID-19. Medical, smoking, and alcohol history and concomitant medications were not reported. Height and weight were not reported. Almost 1 day after receiving the vaccine, the patient experienced headache, chills and nausea. The condition progressed the following day to having brain fog and headache. 3rd day after receiving the vaccine, patient experienced dizziness when standing up, feeling weakness on the right side of the body and right leg. She sought consult with HCP and went to the ER, where EKG, MRI and CT Scan (actual results not provided) done revealed blood clot in the left frontal lobe suggestive of acute ischemic stroke. Based on the available information, this is assessed as indterminate per WHO causality classification of adverse events following immunization. Additional information requested.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 1,0
Labordaten: Test Date: 202104; Test Name: EKG; Result Unstructured Data: stroke/blood clot in the left frontal lobe; Test Date: 202104; Test Name: CT scan; Result Unstructured Data: stroke/blood clot in the left frontal lobe; Test Date: 202104; Test Name: MRI; Result Unstructured Data: stroke/blood clot in the left frontal lobe
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1201378

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: CA
Alter: -
Geschlecht: F
Eingang: 23.04.2021
Impfdatum: -
Beginn: 01.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Argininosuccinate lyase deficiency Computerised tomogram head Ischaemic stroke Magnetic resonance imaging Muscular weakness Blood test Computerised tomogram Electrocardiogram Cerebral thrombosis Chills Injection site pain Cerebrovascular accident Computerised tomogram head normal Discomfort Dizziness Fatigue Feeling abnormal Gait disturbance

Symptomtext

ACUTE ISCHEMIC STROKE; BLOOD CLOT IN LEFT FRONTAL LOBE; CHILLS; INJECTION SITE PAIN; This spontaneous report received from a patient concerned a white, not hispanic female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: unknown) dose was not reported, 1 total administered on 08-APR-2021 on left arm for prophylactic vaccination. No concomitant medications were reported. On an unspecified date in APR-2021 the patient's laboratory data included: CT scan (computed tomography scan), EKG (electrocardiography), MRI (magnetic resonance imaging) (NR: not provided) resulted in stroke/blood clot in the left frontal lobe. The patient experienced acute ischemic stroke on 08-APR-2021 and experienced blood clot in left frontal lobe on an unspecified date in APR-2021. On 08-APR-2021, the patient experienced injection site pain at first and felt ok until she went to sleep. In the middle of the night on 08-APR-2021, the patient experienced headache, chills, nausea and then on 09-APR-2021 and 10-APR-2021, the patient experienced brain fog and a headache. On 11-APR-2021, the patient had no change and sat down to have coffee, when she stood up she was dizzy and had no strength in her right leg and right side of the body. She could not walk and called her healthcare professional and went to the emergency room. The patient was hospitalized on 11-Apr-2021 and was discharged on 12-Apr-2021. The patient was hospitalized for 1 day. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from blood clot in left frontal lobe, and acute ischemic stroke, and the outcome of chills and injection site pain was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: This is a female patient, unspecified age, unspecified ethnicity, who experienced headache and brain fog 2 days after receiving the Janssen COVID-19. Medical, smoking, and alcohol history and concomitant medications were not reported. Height and weight were not reported. Almost 1 day after receiving the vaccine, the patient experienced headache, chills and nausea. The condition progressed the following day to having brain fog and headache. 3rd day after receiving the vaccine, patient experienced dizziness when standing up, feeling weakness on the right side of the body and right leg. She sought consult with HCP and went to the ER, where EKG, MRI and CT Scan (actual results not provided) done revealed blood clot in the left frontal lobe suggestive of acute ischemic stroke. Based on the available information, this is assessed as indterminate per WHO causality classification of adverse events following immunization. Additional information requested.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 1,0
Labordaten: Test Date: 202104; Test Name: EKG; Result Unstructured Data: stroke/blood clot in the left frontal lobe; Test Date: 202104; Test Name: CT scan; Result Unstructured Data: stroke/blood clot in the left frontal lobe; Test Date: 202104; Test Name: MRI; Result Unstructured Data: stroke/blood clot in the left frontal lobe
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1245230

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: WA
Alter: 46,0
Geschlecht: F
Eingang: 22.04.2021
Impfdatum: 09.04.2021
Beginn: 22.04.2021
Tage bis Beginn: 13,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Anticoagulant therapy Condition aggravated Cor pulmonale Deep vein thrombosis Embolism venous Myocardial strain Platelet count normal Pulmonary embolism

Symptomtext

Patient received J&J COVID vaccine on 4/9/21 at pharmacy . Today (4/22/21), patient is admitted to our facility with VTE, submassive, unprovoked, with bilateral high-burden PE and LLE DVT, and right heart strain / acute cor pulmonale; in patient with H/o R PE, provoked 2014 after transcontinental flight, s/p Warfarin x 6 months, reportedly negative hypercoagulable panel; with strong family history of venous thrombosis in mother and sister. Heparin drip started, plan to start DOAC tomorrow. Anticipate hospital admission for at least 2 nights.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: Plt 280 (4/22/21)
Aktuelle Erkrankungen: -
Vorgeschichte: 1. H/o R PE, provoked 2014 after transcontinental flight, s/p Warfarin x 6 months, reportedly negative hypercoagulable panel; with strong family history of venous thrombosis in mother and sister (+ hypercoagulable state, specific type unrecalled to patient) 2. OSA with morbid obesity, nocturnal hypoxemia; on CPAP 3. Asthma, mild intermittent 4. Hypertension 5. Depression, Panic disorder, IBS 6. Allergic rhinitis 7. Intermittent migraine headaches 8. Endometriosis, Ovarian cyst
Andere Medikamente: Acetaminophen PRN, aripiprazole 1mg qday, buproprion XL 150mg qday, duloxetine 60mg qday, Flonase nasal 2 sp qday, ibuprofen PRN, naproxen PRN, propranolol LA 160mg qday
Allergien: Codeine
Vorherige Impfungen: -

VAERS 1243300

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: AL
Alter: 66,0
Geschlecht: M
Eingang: 22.04.2021
Impfdatum: 06.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: SYR / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Fatigue Feeling abnormal Impaired work ability Unresponsive to stimuli Weight decreased

Symptomtext

Started feeling bad two=three days after shot, became fatigued, lost 15 pounds and could not go to work. On morning of 4/21 was found unresponsive and rushed to hospital where he died 2 hours later

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None known
Vorgeschichte: Smoker
Andere Medikamente: None known
Allergien: None Known
Vorherige Impfungen: -

VAERS 1215401

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MS
Alter: 69,0
Geschlecht: M
Eingang: 22.04.2021
Impfdatum: -
Beginn: 15.04.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Glycosylated haemoglobin Myocardial infarction

Symptomtext

DEATH; POSSIBLE HEART ATTACK; This spontaneous report received from a consumer and concerned a 69 year old male. Initial information was received on 16-APR-2021 from patient's sister, with additional information received on 20-APR-2021 from primary care physician. The patient's height and weight were not reported. The patient's concurrent conditions included hypertension, hypercholesterolemia, diabetes mellitus, and morbid obesity (Body mass index of 45.9). He had no history of heart attacks, strokes or blood clots. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: 042A21A, expiry: Unknown) frequency one total, dose was not reported, administered on 05-APR-2021 (also reported as 04-APR-2021) for prophylactic vaccination. Concomitant medications included amlodipine besilate, atorvastatin, bumetanide, glipizide/metformin, lisinopril and pioglitazone. The consumer reported that the patient did not have any problems after he got Janssen Covid-19 vaccine (shot). The most recent Glycosylated hemoglobin (Hgb A1C) was 9.6 (units not provided). On 15-APR-2021, the patient passed away in his sleep. The reporter believed the cause of death was possible heart attack. The patient died due to unspecified cause. An autopsy was not performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died on 15-APR-2021. This report was serious (Death and Other Medically Important Condition).; Sender's Comments: V0: This case concerns a 69 year-old male with medical history significant for hypertension, poorly controlled diabetes mellitus (HgbA1c 9.6), morbid obesity (BMI 45.9), and hypercholesterolemia who died of unknown causes 10 days after receiving the Janssen Covid-19 vaccine. He had no history of heart attacks, strokes, or blood clots. Concomitant medications included amlodipine besilate, atorvastatin, bumetanide, glipizide/metformin, lisinopril and pioglitazone. No adverse events were experienced on the days immediately following vaccination. Ten days after vaccination, he died while sleeping. The cause is unknown but the patient's sister believes it was a possible heart attack. An autopsy is not planned. While the cause of death is unknown, the patient had multiple strong risk factors for myocardial infarction. The death and possible heart attack are considered to have an inconsistent relationship to vaccine.; Reported Cause(s) of Death: DEATH; POSSIBLE HEART ATTACK

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Test Name: Glycosylated hemoglobin; Result Unstructured Data: 9.6, units not provided
Aktuelle Erkrankungen: Diabetes mellitus; Hypercholesterolemia; Hypertension; Morbid obesity (BMI 45.9)
Vorgeschichte: Comments: Unknown
Andere Medikamente: ATORVASTATIN; NORVASC; GLIPIZIDE;METFORMIN; BUMEX; LISINOPRIL; PIOGLITAZONE
Allergien: -
Vorherige Impfungen: -

VAERS 1215401

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MS
Alter: 69,0
Geschlecht: M
Eingang: 22.04.2021
Impfdatum: -
Beginn: 15.04.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Glycosylated haemoglobin Myocardial infarction

Symptomtext

DEATH; POSSIBLE HEART ATTACK; This spontaneous report received from a consumer and concerned a 69 year old male. Initial information was received on 16-APR-2021 from patient's sister, with additional information received on 20-APR-2021 from primary care physician. The patient's height and weight were not reported. The patient's concurrent conditions included hypertension, hypercholesterolemia, diabetes mellitus, and morbid obesity (Body mass index of 45.9). He had no history of heart attacks, strokes or blood clots. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: 042A21A, expiry: Unknown) frequency one total, dose was not reported, administered on 05-APR-2021 (also reported as 04-APR-2021) for prophylactic vaccination. Concomitant medications included amlodipine besilate, atorvastatin, bumetanide, glipizide/metformin, lisinopril and pioglitazone. The consumer reported that the patient did not have any problems after he got Janssen Covid-19 vaccine (shot). The most recent Glycosylated hemoglobin (Hgb A1C) was 9.6 (units not provided). On 15-APR-2021, the patient passed away in his sleep. The reporter believed the cause of death was possible heart attack. The patient died due to unspecified cause. An autopsy was not performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died on 15-APR-2021. This report was serious (Death and Other Medically Important Condition).; Sender's Comments: V0: This case concerns a 69 year-old male with medical history significant for hypertension, poorly controlled diabetes mellitus (HgbA1c 9.6), morbid obesity (BMI 45.9), and hypercholesterolemia who died of unknown causes 10 days after receiving the Janssen Covid-19 vaccine. He had no history of heart attacks, strokes, or blood clots. Concomitant medications included amlodipine besilate, atorvastatin, bumetanide, glipizide/metformin, lisinopril and pioglitazone. No adverse events were experienced on the days immediately following vaccination. Ten days after vaccination, he died while sleeping. The cause is unknown but the patient's sister believes it was a possible heart attack. An autopsy is not planned. While the cause of death is unknown, the patient had multiple strong risk factors for myocardial infarction. The death and possible heart attack are considered to have an inconsistent relationship to vaccine.; Reported Cause(s) of Death: DEATH; POSSIBLE HEART ATTACK

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Test Name: Glycosylated hemoglobin; Result Unstructured Data: 9.6, units not provided
Aktuelle Erkrankungen: Diabetes mellitus; Hypercholesterolemia; Hypertension; Morbid obesity (BMI 45.9)
Vorgeschichte: Comments: Unknown
Andere Medikamente: ATORVASTATIN; NORVASC; GLIPIZIDE;METFORMIN; BUMEX; LISINOPRIL; PIOGLITAZONE
Allergien: -
Vorherige Impfungen: -

VAERS 1215401

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MS
Alter: 69,0
Geschlecht: M
Eingang: 22.04.2021
Impfdatum: -
Beginn: 15.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Glycosylated haemoglobin Myocardial infarction

Symptomtext

DEATH; POSSIBLE HEART ATTACK; This spontaneous report received from a consumer and concerned a 69 year old male. Initial information was received on 16-APR-2021 from patient's sister, with additional information received on 20-APR-2021 from primary care physician. The patient's height and weight were not reported. The patient's concurrent conditions included hypertension, hypercholesterolemia, diabetes mellitus, and morbid obesity (Body mass index of 45.9). He had no history of heart attacks, strokes or blood clots. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: 042A21A, expiry: Unknown) frequency one total, dose was not reported, administered on 05-APR-2021 (also reported as 04-APR-2021) for prophylactic vaccination. Concomitant medications included amlodipine besilate, atorvastatin, bumetanide, glipizide/metformin, lisinopril and pioglitazone. The consumer reported that the patient did not have any problems after he got Janssen Covid-19 vaccine (shot). The most recent Glycosylated hemoglobin (Hgb A1C) was 9.6 (units not provided). On 15-APR-2021, the patient passed away in his sleep. The reporter believed the cause of death was possible heart attack. The patient died due to unspecified cause. An autopsy was not performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died on 15-APR-2021. This report was serious (Death and Other Medically Important Condition).; Sender's Comments: V0: This case concerns a 69 year-old male with medical history significant for hypertension, poorly controlled diabetes mellitus (HgbA1c 9.6), morbid obesity (BMI 45.9), and hypercholesterolemia who died of unknown causes 10 days after receiving the Janssen Covid-19 vaccine. He had no history of heart attacks, strokes, or blood clots. Concomitant medications included amlodipine besilate, atorvastatin, bumetanide, glipizide/metformin, lisinopril and pioglitazone. No adverse events were experienced on the days immediately following vaccination. Ten days after vaccination, he died while sleeping. The cause is unknown but the patient's sister believes it was a possible heart attack. An autopsy is not planned. While the cause of death is unknown, the patient had multiple strong risk factors for myocardial infarction. The death and possible heart attack are considered to have an inconsistent relationship to vaccine.; Reported Cause(s) of Death: DEATH; POSSIBLE HEART ATTACK

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Test Name: Glycosylated hemoglobin; Result Unstructured Data: 9.6, units not provided
Aktuelle Erkrankungen: Diabetes mellitus; Hypercholesterolemia; Hypertension; Morbid obesity (BMI 45.9)
Vorgeschichte: Comments: Unknown
Andere Medikamente: ATORVASTATIN; NORVASC; GLIPIZIDE;METFORMIN; BUMEX; LISINOPRIL; PIOGLITAZONE
Allergien: -
Vorherige Impfungen: -

VAERS 1209415

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: -
Geschlecht: F
Eingang: 22.04.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Cerebral haemorrhage Computerised tomogram head abnormal Endotracheal intubation Headache Hypertension Computerised tomogram Intracranial aneurysm Nausea Influenza like illness Pain Unresponsive to stimuli Vomiting

Symptomtext

BRAIN ANEURYSM; SHE STARTED FEELING NAUSEOUS; This spontaneous report received from a consumer via a news report by a company representative concerned a female of unspecified age and ethnicity. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, Expiry: Unknown) dose was not reported, administered on 30-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. The patient started feeling nauseous and was found on the floor unresponsive, and on 01-APR-2021, she was admitted to an area hospital. The reporter stated that the doctor couldn't figure out what was going on, a CT scan was performed and they found bleeding on the brain. It was reported to be massive, and at first that it was thought it was actually two aneurysms, but it was only one. On 09-APR-2021, it was reported that the patient died from brain aneurysm. It is unknown if an autopsy was done. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died on 09-APR-2021, and the outcome of she started feeling nauseous was not reported. This report was serious (Death, and Hospitalization Caused / Prolonged).; Sender's Comments: V0 This report concerns an elderly female patient who died due to brain aneurysm, 10 days after receiving Jansen COVID-19 vaccine. Two days after vaccination, the patient started nauseous. She was found on the floor unresponsive and was admitted to the hospital. A CT scan found bleeding on the brain. It was reported "at first that it was thought it was actually two aneurysms, but it was only one." The patient died due to brain aneurysm 10 days after vaccination. Due to the nature of the event (slow development process) and lack of the biological plausibility, the event is considered not related to the COVID-19 vaccine. Additional information has been requested.; Reported Cause(s) of Death: BRAIN ANEURYSM

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: -
Labordaten: Test Name: CT scan; Result Unstructured Data: one big brain aneurysm; Comments: bleeding on the brain, it was It was so massive one big brain aneurysm
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1238784

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: IL
Alter: 52,0
Geschlecht: F
Eingang: 21.04.2021
Impfdatum: 10.04.2021
Beginn: 20.04.2021
Tage bis Beginn: 10,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Angiogram pulmonary abnormal Computerised tomogram thorax abnormal Pulmonary embolism

Symptomtext

Pulmonary Embolus

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 3,0
Labordaten: CTA chest
Aktuelle Erkrankungen: None
Vorgeschichte: CAD s/p CABG, Asthma
Andere Medikamente: Buspar, fenofibrate, ferrous sulfate, liothyronine, losartan, norethindrone, omeprazole, paroxetine, albuterol, Pulmicort, singular, vitamin C
Allergien: None
Vorherige Impfungen: -

VAERS 1237478

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: TX
Alter: 64,0
Geschlecht: F
Eingang: 21.04.2021
Impfdatum: 06.04.2021
Beginn: 06.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Dyspnoea Fatigue Headache

Symptomtext

6-8 hours following the vaccine, the patient developed a severe head ache, SOB and fatigue. Patient took an unknown OTC medication, this did not help her symptoms. Her headache receded on 04/08, and her symptoms improved, but never fully resolved (per patient's son).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: About two months before death, the patient presented to clinic, where she was diagnosed with anemia (hemoglobin 7.0, received two blood transfusions).
Vorgeschichte: History of asthma and seasonal allergies
Andere Medikamente: Singulair
Allergien: -
Vorherige Impfungen: -

VAERS 1195069

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MA
Alter: 43,0
Geschlecht: F
Eingang: 21.04.2021
Impfdatum: 06.04.2021
Beginn: 21.04.2021
Tage bis Beginn: 15,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Angiogram pulmonary abnormal Dyspnoea Headache Peripheral swelling Pulmonary embolism Blood pressure increased Dizziness Heart rate increased Blood test abnormal Computerised tomogram Hot flush Myalgia Swelling face Tachycardia

Symptomtext

04/14/2021: Patient currently being seen in ER for ? of reaction to Janssen COVID-19 vaccine. She reports SOB, dizziness, tachycardia that started the day before. She is awaiting results of CT scan and blood work. Will follow-up with her at a later time. 04/15/2021: call made to Patient. She is presently in the hospital, was admitted yesterday afternoon after work-up revealed pulmonary emboli.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 2,0
Labordaten: unknown
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: none
Vorherige Impfungen: -

VAERS 1195069

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MA
Alter: 43,0
Geschlecht: F
Eingang: 21.04.2021
Impfdatum: 06.04.2021
Beginn: 21.04.2021
Tage bis Beginn: 15,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Angiogram pulmonary abnormal Dyspnoea Headache Peripheral swelling Pulmonary embolism Blood pressure increased Dizziness Heart rate increased Blood test abnormal Computerised tomogram Hot flush Myalgia Swelling face Tachycardia

Symptomtext

04/14/2021: Patient currently being seen in ER for ? of reaction to Janssen COVID-19 vaccine. She reports SOB, dizziness, tachycardia that started the day before. She is awaiting results of CT scan and blood work. Will follow-up with her at a later time. 04/15/2021: call made to Patient. She is presently in the hospital, was admitted yesterday afternoon after work-up revealed pulmonary emboli.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 2,0
Labordaten: unknown
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: none
Vorherige Impfungen: -

VAERS 1226242

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: NC
Alter: 59,0
Geschlecht: F
Eingang: 20.04.2021
Impfdatum: 10.04.2021
Beginn: 16.04.2021
Tage bis Beginn: 6,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Angiogram cerebral abnormal Angiogram pulmonary abnormal Cerebrovascular accident Chest X-ray abnormal Computerised tomogram head Angiogram Dyspnoea Pulmonary embolism Computerised tomogram thorax Echocardiogram Fatigue Headache Magnetic resonance imaging head Scan with contrast abnormal Thrombosis Ultrasound Doppler Ultrasound Doppler normal Visual impairment

Symptomtext

Patient presented to the ED 4/16- 6 days after receiving Johnson & Johnson Covid vaccine. Found to have acute CVA & bilateral PE?s. Approx 1 week after vaccine flew to another country. Experienced extreme SOB in the airport prior to flight to another country requiring wheelchair transport through the airport. Husband cut trip short leaving early. Pt came straight to the ED from the airport. During admission Neuro, Hem/Onc, & Pulm consulted. Pulm note states concern for relation to J&J vaccine. Plan to repeat CTA chest in 2-3 months.4/19. Pt d/c home to self care. On room air. New rx Eliquis.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1229262

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: NC
Alter: 82,0
Geschlecht: F
Eingang: 19.04.2021
Impfdatum: 02.04.2021
Beginn: 16.04.2021
Tage bis Beginn: 14,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Chest pain Dyspnoea Pulmonary embolism Computerised tomogram thorax abnormal Fibrin D dimer Full blood count International normalised ratio Prothrombin time

Symptomtext

Patient stated to hospital staff that she had shortness of breath starting 4/16/21 and chest pain while working in her garden moving bags of mulch on 4/18. Patient was diagnosed with bilateral pulmonary embolism

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: Hospital staff has completed a VAERS report
Aktuelle Erkrankungen: none listed on vaccine consent form
Vorgeschichte: none listed on vaccine consent form
Andere Medikamente: not known
Allergien: none listed of vaccine consent form
Vorherige Impfungen: -

VAERS 1229262

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: NC
Alter: 82,0
Geschlecht: F
Eingang: 19.04.2021
Impfdatum: 02.04.2021
Beginn: 16.04.2021
Tage bis Beginn: 14,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Chest pain Dyspnoea Pulmonary embolism Computerised tomogram thorax abnormal Fibrin D dimer Full blood count International normalised ratio Prothrombin time

Symptomtext

Patient stated to hospital staff that she had shortness of breath starting 4/16/21 and chest pain while working in her garden moving bags of mulch on 4/18. Patient was diagnosed with bilateral pulmonary embolism

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: Hospital staff has completed a VAERS report
Aktuelle Erkrankungen: none listed on vaccine consent form
Vorgeschichte: none listed on vaccine consent form
Andere Medikamente: not known
Allergien: none listed of vaccine consent form
Vorherige Impfungen: -

VAERS 1228903

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: CA
Alter: 75,0
Geschlecht: M
Eingang: 19.04.2021
Impfdatum: 06.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Angiogram cerebral Cerebral haemorrhage Cerebral venous sinus thrombosis Computerised tomogram head Magnetic resonance imaging head

Symptomtext

patient had massive intracerebral hemorrhage 3 days after vaccination. family claims patient was doing well until vaccination. there is a suspicion that patient might have had sinus venous thrombosis that lead to the the ICH.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: 1,0
Labordaten: ct and cta head 4/9/21 mri brain 4/9/21
Aktuelle Erkrankungen: covid19
Vorgeschichte: rheumatoid arthritis gibleed afib hx cva hx recurrent uti
Andere Medikamente: albuterol amiodarone asa digoxin diltiazem esomeprazole heparin sq ipratropium lactulose ativan metoprolol seroquel
Allergien: none
Vorherige Impfungen: -

VAERS 1228756

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MO
Alter: 58,0
Geschlecht: M
Eingang: 19.04.2021
Impfdatum: 10.04.2021
Beginn: 17.04.2021
Tage bis Beginn: 7,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: unbekannt Erholt: nein

Cerebrovascular accident Computerised tomogram head abnormal Laboratory test

Symptomtext

CVA, hospitalized

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 2,0
Labordaten: CT head, labs
Aktuelle Erkrankungen: Diabetes, hypertension
Vorgeschichte: Diabetes, hypertension
Andere Medikamente: Metformin, lisinopril/HCTZ, Glipizide, gabapentin
Allergien: Ultram, hydrocodone
Vorherige Impfungen: -

VAERS 1219249

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: NY
Alter: 47,0
Geschlecht: M
Eingang: 16.04.2021
Impfdatum: 05.04.2021
Beginn: 07.04.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood test abnormal Computerised tomogram thorax abnormal Deep vein thrombosis Pulmonary embolism Ultrasound Doppler abnormal

Symptomtext

2 days after receiving the vaccine I have been diagnosed with Deep vein thrombosis and pulmonary embolisms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 2,0
Labordaten: Blood tests, ultrasound of deep veins in leg and chest ct scans
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1211915

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: UT
Alter: 45,0
Geschlecht: M
Eingang: 16.04.2021
Impfdatum: 05.04.2021
Beginn: 13.04.2021
Tage bis Beginn: 8,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Chest pain Computerised tomogram Fibrin D dimer Full blood count Metabolic function test Coagulopathy Computerised tomogram thorax Electrocardiogram Faeces discoloured Lipase Pain Pulmonary embolism Troponin Troponin I

Symptomtext

I had unexplained pain in left side (possibly left lung). I went to urgent care and they drew blood and were worried about blood clots, so they sent me to emergency room. Emergency room gave me CT scan and found blood clots in my right lung and put me on blood thinner. My last two bowel movements have been black, so I am worried about internal bleeding. Diagnosis: Other acute pulmonary embolism without acute cor pulmonale (HCC). Medicines given: Alum & Mag Hydroxide-Simeth (Maalox Max) Last given at 8:14 PM; Fentanyl citrate Last given at 8:45 PM; Isovue-370 (Lopamidol) Last given at 8:35 PM; lidocaine viscous (XYLOCAINE) Last given at 8:14 PM.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: Lab tests: CBC With Plt Count And Auto Diff; Comprehensive Metabolic Panel; Lipase, Serum Or Plasma; Troponin I. Imaging tests: 12 Lead ECG; CT Chest W Cont Pulmonary Arteries for PE
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1215945

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: AZ
Alter: 85,0
Geschlecht: M
Eingang: 15.04.2021
Impfdatum: 07.04.2021
Beginn: 15.04.2021
Tage bis Beginn: 8,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Computerised tomogram thorax abnormal Fibrin D dimer increased Pulmonary embolism

Symptomtext

Bilateral Pulmonary Emboli

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: Elevated D Dimer 4/15/2021 Chest CT/PE protocol 4/15/2021
Aktuelle Erkrankungen: none
Vorgeschichte: DM, HTN, BPH, HLD
Andere Medikamente: metoprolol, Norvasc, metformin, atorvastatin
Allergien: nkda
Vorherige Impfungen: -

VAERS 1212470

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 29,0
Geschlecht: M
Eingang: 15.04.2021
Impfdatum: 01.04.2021
Beginn: 14.04.2021
Tage bis Beginn: 13,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Pleuritic pain Pulmonary embolism

Symptomtext

29yom with no significant medical history was diagnosed by CT with acute pulmonary embolism involving the branch vessel in the right lower lobe 14 days after receiving Johnson & Johnson vaccine. Symptoms of right pleuritic pain began 4 days prior to the diagnosis. Initiated therapy on oral anticoagulants.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: no
Vorgeschichte: none
Andere Medikamente: sertraline
Allergien: NKA
Vorherige Impfungen: -

VAERS 1209724

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

kritisch

Staat: PA
Alter: 74,0
Geschlecht: M
Eingang: 14.04.2021
Impfdatum: 09.04.2021
Beginn: 12.04.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Hospice patient received Janssen vaccine on Friday and passed away peacefully on Monday. We don't think the death is related to the vaccine but reporting it since it happened less than a week after receiving vaccine

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Patient was a hospice patient
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1203342

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: PA
Alter: 69,0
Geschlecht: M
Eingang: 13.04.2021
Impfdatum: 03.04.2021
Beginn: 07.04.2021
Tage bis Beginn: 4,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Cerebrovascular accident Fall

Symptomtext

Patient's daughter called phamacy today 4/13/21 to report that her father suffered a fall at his home on 4/4/21, the following day after patient received Janssen covid vaccine at pharmacy. Patient's daughter stated on phone that she took her father to hospital after she learned that he fell on 4/7/21 to be examined. Patient's daughter stated that he was diagnosed at hospital with having a stroke and discharged to return home on 4/8/21.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none listed by patient at time of immunization.
Andere Medikamente: duloxetine, clonazepam, carvedilol,
Allergien: no known allergies and no allergies listed by patient.
Vorherige Impfungen: -

VAERS 1202969

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: -
Alter: 95,0
Geschlecht: M
Eingang: 13.04.2021
Impfdatum: 06.04.2021
Beginn: 11.04.2021
Tage bis Beginn: 5,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death Fall Musculoskeletal chest pain

Symptomtext

death Narrative: Patient with consistent decline over the last year; March 2021- increased confusion related to dementia, falls, hospitalizations wt loss. Enrolled in home hospice on 3/26 family's goal was to keep patient home and comfortable. Patient received J&J vaccine in the home through agency on 4/6/2021, Patient had a fall on 4/7/2021, Patient with rib pain after the fall no other injury noted. Patient passed away on home hospice on 4/11/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1202290

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: MO
Alter: 19,0
Geschlecht: F
Eingang: 13.04.2021
Impfdatum: 05.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 4,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: unbekannt Erholt: ja

Angiogram cerebral abnormal Arteriosclerosis Blood cholesterol normal Blood triglycerides increased Cardiolipin antibody Cerebral artery occlusion Cerebrovascular accident Embolism Hemiparesis High density lipoprotein decreased Low density lipoprotein increased Magnetic resonance imaging head abnormal Non-high-density lipoprotein cholesterol increased Platelet count normal Thrombectomy

Symptomtext

Patient presented to hospital on 4/9/21 - 4 days post vaccination - with new onset left sided weakness. Brain CTA showed a M1 branch occlusion. Patient was given TPA and transferred to Medical Center for further management and mechanical thrombectomy. Successful thrombectomy done. Etiology of stroke cryptogenic but suspect emoblic event. Questionable moyamoya disease - notes state "if moyamoya suspect, patietn will get neurosurgery survice on board/appreciate neuro recommendations"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 4,0
Labordaten: Brain CTA - large M1 branch occlusion Angiogram - bilateral chronic atheroschlerotic disease MRI brain - shows acute and old strokes. Patient's parents stated patient did NOT have a known history of strokes. Platelets - range from 192 on admission to 306 Anti-cardiolipin IgG/IgM antibody - pending Total cholesterol - 181 Triglycerides - 134 LDL - 112 Non-HDL 139 HDL - 42
Aktuelle Erkrankungen: unknown
Vorgeschichte: Down syndrome Autism Deaf
Andere Medikamente: Budesonide 3 mg EC capsules - 1 capsule PO every other day Simpesse (norethindrone/ethinyl estradiol) - 1 tablet PO daily Ditropan 5 mg tablets - 1 tablet PO BID Montelukast 10 mg - 1 tablet daily
Allergien: Cefaclor - unknown reaction Sulfamethoxazole/trimethoprim - unknown reaction
Vorherige Impfungen: -

VAERS 1198540

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

kritisch

Staat: CA
Alter: 21,0
Geschlecht: M
Eingang: 12.04.2021
Impfdatum: 01.04.2021
Beginn: 11.04.2021
Tage bis Beginn: 10,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Endotracheal intubation Respiratory arrest Resuscitation Unresponsive to stimuli

Symptomtext

Unknown if the vaccine has any correlation to event. Patient was found unresponsive and not breathing on 4/11/21 @ approximately 3:45 PM outside on the grounds of the campus. A rented scoter was next to him. There was no sign of trauma. 9-1-1 was called and CPR initiated by passerby (there were no witnesses). He remained unresponsive and was intubated when the paramedics arrived. He was transported to hospital where he was pronounced dead.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: unknown what was done at hospital.
Aktuelle Erkrankungen: none known
Vorgeschichte: none known
Andere Medikamente: none known
Allergien: reported none on medical screening
Vorherige Impfungen: -

VAERS 1195038

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

kritisch

Staat: NC
Alter: 69,0
Geschlecht: M
Eingang: 11.04.2021
Impfdatum: 04.04.2021
Beginn: 05.04.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Balance disorder Cerebrovascular accident Dysarthria Gait disturbance Hypoaesthesia

Symptomtext

PT had no reactions post administration. About 36 hours after administration, the patient had a CVA. Pt experienced numbness in his left arm and shortly after proceed to have slurred speech and loss of balance and gait. Patient take to Emergency Room where he received the diagnosis. the patient was hospitalized. After several days, patient was discharge and was recovering.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: none
Vorgeschichte: cardiomyopathy and congestive heart failure
Andere Medikamente: Pt has cardiomyopathy and congestive heart failure.
Allergien: sulfa drugs
Vorherige Impfungen: -

VAERS 2583415

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: WI
Alter: 64,0
Geschlecht: M
Eingang: 17.02.2023
Impfdatum: 01.04.2021
Beginn: 14.01.2023
Tage bis Beginn: 653,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Computerised tomogram Deep vein thrombosis Laboratory test

Symptomtext

Received the Johnson and Johnson vaccine April 2021. I experienced a DVT (blood clot) the full length of my leg in January 2023. I have no other risk factors and doctors have been unable to determine the cause of my incident. J & J vaccines have had incidents of blood clots raising my suspicion for possible vaccine injury.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: 6,0
Labordaten: CT and labs done throughout hospitalization January 14 - 19, 2023
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Blood pressure
Allergien: NKA
Vorherige Impfungen: -

VAERS 2579916

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MI
Alter: 52,0
Geschlecht: M
Eingang: 11.02.2023
Impfdatum: 25.05.2021
Beginn: 28.09.2022
Tage bis Beginn: 491,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute kidney injury Aggression Blood creatinine Blood creatinine increased Blood glucose Blood glucose increased Blood potassium Blood potassium increased COVID-19 Chest X-ray Chest X-ray abnormal Condition aggravated Deep vein thrombosis Fall Glucose tolerance test Glycosylated haemoglobin Glycosylated haemoglobin increased Haematocrit

Symptomtext

ACUTE KIDNEY INJURY; POLYNEUROPATHY; CHEST X-RAY ABNORMAL; HYPERKALAEMIA; BLOOD CREATININE INCREASED; DEEP VEIN THROMBOSIS; FALL; LUNG OPACITY; BLOOD GLUCOSE INCREASED; AGGRESSION; POLYNEUROPATHY; COVID-19; AGGRESSION; CONDITION AGGRAVATED; FALL; HYPERGLYCAEMIA; HYPERGLYCAEMIA; VITAMIN B12 DEFICIENCY; NASAL CONGESTION; BLOOD POTASSIUM INCREASED; VITAMIN B12 DEFICIENCY; WHITE BLOOD CELL COUNT NORMAL; BLOOD CREATININE INCREASED; HYPERKALAEMIA; BLOOD GLUCOSE INCREASED; DEEP VEIN THROMBOSIS; BLOOD POTASSIUM INCREASED; LUNG OPACITY; CHEST X-RAY ABNORMAL; COVID-19; GLYCOSYLATED HAEMOGLOBIN INCREASED; NASAL CONGESTION; SARS-COV-2 TEST POSITIVE; GLYCOSYLATED HAEMOGLOBIN INCREASED; ULTRASOUND DOPPLER ABNORMAL; VITAMIN B12 DECREASED; WHITE BLOOD CELL COUNT NORMAL; TREATMENT NONCOMPLIANCE; TREATMENT NONCOMPLIANCE; SARS-COV-2 TEST POSITIVE; This spontaneous report received from a health care professional by a Regulatory Authority VAERS (Vaccine Adverse Event Reporting System, VAERS ID: Unknown) concerned a 52 year old male of an unspecified race and ethnic origin. The patient's height, and weight were not reported. The patient's concurrent conditions included: psychiatric disorder NOS, and other pre-existing medical conditions included: The patient had past medical history (PMH) significant for type 2 insulin-dependent diabetes mellitus (T2IDDM), deep vein thrombosis/pulmonary embolism (DVT/PE) and polyneuropathy. The patient was previously treated with lithium and bupropion for psychiatric disorder NOS (patient stated he did not like the side effects and did not take them. He did not want to restart those medications. Psychiatry was consulted, no new medication was advised). The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: UNKNOWN) dose was not reported, 01 total, administered on 25-MAY-2021 for an unspecified indication. Age at time of vaccination 52 years old. No concomitant medications were reported. On 28-SEP-2022 (491 days after vaccination), the patient was hospitalized for deep vein thrombosis/pulmonary embolism (DVT/PE) and polyneuropathy. Patient presented hospital with fall, found to be hyperglycemic (hyperglycaemia) by EMS (emergency medical service) (aggression, condition aggravated). On the same day, the patient's blood glucose was increased (891 without anion gap or acidosis), hematocrit (HCT) was done which showed no acute process, chest x-ray (CXR) was abnormal showed right lower lobe (RLL) lung opacity. Patient also had ultrasound doppler abnormal. Patient was given IV (intravenous infusion), started on insulin infusion, and received doxycycline/ceftriaxone for possible community-acquired pneumonia (CAP). It was reported as concern for CAP was low as patient was afebrile with normal white blood cells (WBC) and differential throughout admission, empiric antibiotics were discontinued. Patient had reportedly been out of his medications including insulin for one month. Patient's glycosylated hemoglobin (HbA1c) was increased (13.0). It was further reported that, endocrinology was consulted and Insulin glucose tolerance test (GTT) was changed to subcutaneous insulin. Diabetes was difficult to manage due to dietary indiscretions. Patient had prerenal acute kidney injury (AKI) on admission with increased creatinine (blood creatinine increased) to 1.45 and hyperkalemia to 5.3 (blood potassium increased). It was resolved with intravenous infusion (IV) and glycemic control. Patient was also found to have significant vitamin B12 deficiency with vitamin B12 less than 146 (vitamin B12 decreased), likely contributing to polyneuropathy and frequent mechanical falls. Patient had intramuscular (IM) vitamin B12 1000 mcg daily and patient was ready to be discharged with prescription for oral vitamin B12. Patient had DVT/PE, was off anticoagulation for months. It was reported that, LEVD (left ventricular assist device) ordered and demonstrated chronic RLE (right lower extremity) proximal DVTs and acute left peroneal vein DVT. Patient was not an ideal candidate for anticoagulation due to falls, noncompliance (treatment noncompliance). Hematology/oncology was consulted and recommended lifelong Eliquis at a prophylactic dose (2.5 mg two times a day) to decrease risk of bleeding, and advised repeat LEVD in 2 weeks. On an unspecified date (the morning of discharge), patient complained of nasal congestion, he denied other respiratory symptoms, was afebrile. Patient had covid-19 test. Further psychiatry evaluated patient and cleared for discharge. Given frequent falls, PT/OT (Physical therapy/ occupational therapy) consulted. Physical therapist made several attempts to work with patient, had difficulties evaluating patient due patient's refusal. Physical therapist referred to occupational therapy (note from 30-SEP-2022) who recommended home with supervision. Patient had rolling walker (RW) and shower chair ordered. Covid-19 test resulted positive after discharge on an unspecified date (sars-cov-2 test positive by qualitative nucleic acid amplification (NAA) (micro detected). Number of days of hospitalization was not reported. Doctor explained to consumer that his father had no respiratory symptoms or complaints when he reevaluated him, and efforts were made to discharge as per his request. Infectious disease specialist recommended monoclonal antibody (mAb) or antiviral treatment if patient want to get treatment for covid-19, would avoid paxlovid and given eliquis. Also stated that readmission for remdesivir was not necessary, but if patient elects to return to the hospital, doctors decide to prescribe remdesivir. Consumer was informed and recommended for urgent care near patient's home where mAb can be administered (get well urgent care). Doctor called patient to follow up on decision of re treatment, patient stated he was not having nasal congestion, sore throat, cough. Consumer stated he will see how his father feels and will call urgent care next day, he was not sure about treatment and possible side effects since his father had no symptoms. ED (emergency department) notified of possible readmission for remdesivir. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from acute kidney injury, deep vein thrombosis, aggression, covid-19, condition aggravated, fall, hyperglycaemia, hyperkalaemia, lung opacity, nasal congestion, polyneuropathy, treatment noncompliance, vitamin B12 deficiency, blood creatinine increased, blood glucose increased, blood potassium increased, chest x-ray abnormal, glycosylated haemoglobin increased, sars-cov-2 test positive, ultrasound doppler abnormal, vitamin B12 decreased, and white blood cell count normal. This report was serious (Hospitalization Caused / Prolonged). This report was associated with product quality complaint: Unknown. The suspected product quality complaint has been confirmed to be batch and lot tested and found within specifications. The reported allegation was not confirmed and the root cause was determined to be not manufacturing related based on the PQC evaluation/investigation performed. Additional information received from Central Complaint department on 08-FEB-2023. The following information was updated and incorporated into the case narrative: Product quality complaint investigation result.; Sender's Comments: V1: Additional information received updates Product Quality complaint investigation result. This updated information does not alter prior causality assessment of reported events Acute kidney injury, polyneuropathy, hyperkalaemia, deep vein thrombosis, lung opacity, aggression, condition aggravated, fall, hyperglycaemia, Vitamin b12 deficiency, blood creatinine increased, blood glucose increased, blood potassium increased, chest x-ray abnormal, glycosylated haemoglobin increased, ultrasound doppler abnormal, vitamin B12 decreased, white blood cell count normal, treatment noncompliance. The event shows an incompatible temporal relationship. Therefore, this event is considered inconsistent with vaccine administration. V0: 20230101157- Nasal congestion, Covid 19, Sars Cov 2 test positive- The event is deemed to be scientifically implausible, i.e., there is scientific evidence against a drug/event relationship; AND there is no known class effect. Therefore, this event is considered inconsistent with vaccine administration..

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: -
Labordaten: Test Date: 20220928; Test Name: BLOOD CREATININE; Result Unstructured Data: Increased (1.45); Test Date: 20220928; Test Name: BLOOD GLUCOSE; Result Unstructured Data: increased (891 without anion gap or acidosis); Test Date: 20220928; Test Name: BLOOD POTASSIUM; Result Unstructured Data: increased (5.3); Test Date: 20220928; Test Name: CHEST X-RAY; Result Unstructured Data: abnormal (Right lower lobe (RLL) lung opacity); Test Date: 20220928; Test Name: GLYCOSYLATED HAEMOGLOBIN; Result Unstructured Data: increased (13.0); Test Date: 20220928; Test Name: VITAMIN B12; Result Unstructured Data: deficiency (less than 146); Test Date: 20220928; Test Name: ULTRASOUND DOPPLER; Result Unstructured Data: abnormal; Test Date: 20220928; Test Name: VITAMIN B12; Result Unstructured Data: decreased; Test Date: 20220928; Test Name: WHITE BLOOD CELL COUNT; Result Unstructured Data: normal; Test Date: 20220928; Test Name: HEMATOCRIT; Result Unstructured Data: showed no acute process; Test Date: 20220928; Test Name: GLUCOSE TOLERANCE TEST; Result Unstructured Data: Not reported; Test Date: 20220928; Test Name: SARS-COV-2 TEST; Test Result: Positive
Aktuelle Erkrankungen: Psychiatric disorder NOS
Vorgeschichte: Comments: The patient had past medical history (PMH) significant for type 2 insulin-dependent diabetes mellitus (T2IDDM), deep vein thrombosis/pulmonary embolism (DVT/PE) and polyneuropathy.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2605750

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: -
Alter: 79,0
Geschlecht: M
Eingang: 10.01.2023
Impfdatum: 02.11.2021
Beginn: 10.06.2022
Tage bis Beginn: 220,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Atrial fibrillation COVID-19 Dyspnoea Dyspnoea exertional Fatigue Haemoptysis Intensive care Pleural effusion Pneumothorax Productive cough SARS-CoV-2 test positive Sinus rhythm

Symptomtext

Narrative: 77 year old MALE with PMH of metastatic adenocarcinoma of the rectum (stage IV) on chemotherapy, peripheral neuropathy, and COPD. Pt presented to ED on 06/09/22 w/ 2 days worsening hemoptysis in setting of persistent right-sided pleural effusion and pneumothorax. Pt reports shortness of breath has been going on for several months, however progressively worsened approximately 2 days ago. Pt w/ increasing fatigue, dyspnea on minimal exertion and increasing productive cough with noted blood-tinged sputum. Pt admitted to hospital on 06/09. Pt tested negative for COVID 19 on 06/09. Pt tested positive for COVID 19 on 06/10 and transferred to ICU due to Afib RVR. Pt received remdesivir (06/13-06/16). Pt converted back to SR on 06/13. Pt stable and discharged to home w/ hospice on 06/16.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: -
Labordaten: 06/10/2022 COVID 19 positive
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2539059

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MI
Alter: 50,0
Geschlecht: M
Eingang: 21.12.2022
Impfdatum: 25.05.2021
Beginn: 28.09.2022
Tage bis Beginn: 491,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute kidney injury Aggression Blood creatinine increased Blood glucose increased Blood potassium increased COVID-19 Chest X-ray abnormal Condition aggravated Deep vein thrombosis Fall Glycosylated haemoglobin increased Hyperglycaemia Hyperkalaemia Lung opacity Nasal congestion Polyneuropathy SARS-CoV-2 test positive Treatment noncompliance

Symptomtext

52-year-old male with PMH significant for T2IDDM, DVT/PE, and polyneuropathy who presented to hospital on 09/28/2022 from home with chief complaint of fall, found to be hyperglycemic by EMS. On presentation the patient's blood glucose was 891 without anion gap or acidosis. HCT was done showing no acute process. CXR showed RLL opacity. He was given IVF, started on insulin infusion, and received doxycycline/ceftriaxone for possible CAP. Concern for CAP was low as patient was afebrile with normal WBC and differential throughout admission. Empiric antibiotics were discontinued. Patient had reportedly been out of his medications including insulin for one month. HbA1c was 13.0. Endocrinology was consulted and Insulin gtt was changed to subcutaneous insulin. Diabetes was difficult to manage due to dietary indiscretions. Per dispense report in 6/2022 he was prescribed lithium and bupropion by psychiatry, patient states he did not like the side effects and did not take them. Does not want to be restarted on these medication. Psychiatry was consulted, no new medication advised. Patient used innapropriate language towards staff, he was presented Safety and respect contract and agreed with the contract. Prerenal AKI was present on admission with creatinine to 1.45 and hyperkalemia to 5.3. Resolved with IVF and glycemic control. Patient was also found to have significant vitamin B12 deficiency with vitamin B12 < 146, likely contributing to polyneuropathy and frequent mechanical falls. IM vitamin B12 1000 mcg QD was initiated, and patient will be discharged with prescription for oral vitamin B12. Patient has h/o DVT/PE, was off anticoagulation for months. LEVD ordered and demonstrated chronic RLE proximal DVTs and acute left peroneal vein DVT. Patient is not an ideal candidate for anticoagulation due to falls, noncompliance. Hematology/oncology was consulted and recommended lifelong Eliquis at a prophylactic dose (2.5 mg BID) to decrease risk of bleeding, and advised repeat LEVD in 2 weeks. The morning of discharge patient complained of nasal congestion, he denied other respiratory symptoms, was afebrile. Covid test ordered per patient request. Psychiatry evaluated patient and cleared for discharge. Given frequent falls, PT/OTconsulted. PT made several attempts to work with patient, had difficulties evaluating patient due patient's refusal. PT referred to OT note from 9/30 who recommended home with supervision. Patient states he has a roommate who will be able to help. RW and shower chair ordered Patient repeatedly asked for discharge. He was stable for discharge and CC contacted and assisted with discharge and DMEs. Skilled care, home PT,OT, visiting nurse and dietitian ordered. Covid test resulted positive after discharge. Patinet had Janssen vaccine on 5/25/21. Dr notified son of result, son was upset and wanted to speak with attending. I called son and discussed test result, he was frustrated and angry, used abusive language, asked to have hospital administrator call him. Explained that his father had no respiratory symptoms or complaints in the afternoon when I reevaluated him, and efforts were made to discharge him yesterday per his request. At the end of the conversation son apologized for language used and would appreciate a call from hospital administration. Discussed with hospital administrator Dr and with infectious disease specialist who recommended monoclonal antibody or antiviral tx if patient elects to get treatment for Covid 19. Would avoid paxlovid given eliquis. Readmission for remdesivir is not necessary, but if patient elects to return to the hospital will prescribe remdesivir. Provided son with these recommendations and gave information re urgent care near patient's home where mAb can be administered (Get well urgent care). I called patient to follow up on decision re treatment, patient states he does not have nasal congestion, sore throat, cough but if he can have a ride would come to the hospital if he has a private room. Called son, son states he will see how his father feels and will call urgent care tomorrow, he is not sure about treatment and possible side effects since his father has no symptoms. ED notified of possible readmission for remdesivir.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: -
Labordaten: 10/4 SARS-CoV-2 -COVID-19 by NAA, Micro -- detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1267674

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NJ
Alter: -
Geschlecht: F
Eingang: 04.11.2022
Impfdatum: 12.04.2021
Beginn: 01.04.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bell's palsy Blood test Computerised tomogram Dysarthria Electrocardiogram Eye disorder Eye ulcer Facial paralysis Speech disorder Vision blurred

Symptomtext

HAVE BEEN TREATED FOR EYE MANY TIMES; BELL'S PALSY; This spontaneous report received from a patient via a company representative concerned a female patient of unspecified age, race and ethnicity. Initial information was processed along with additional information received on 28-OCT-2022. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: UNKNOWN) dose was not reported, 1 total, administered on 12-APR-2021 for covid-19 prophylaxis. No concomitant medications were reported. On an unspecified date in APR-2021, the patient experienced Bell's palsy. On an unspecified date, the patient had been treated for eye many times and the treatment was still continued. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from have been treated for eye many times, and the outcome of Bell's palsy was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20221059137- Bell's palsy- The event has an unknown/unclear temporal relationship, and is labeled. There is no information on any other factors potentially associated with the event. Therefore, this event is considered consistent with vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1267674

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NJ
Alter: -
Geschlecht: F
Eingang: 04.11.2022
Impfdatum: 12.04.2021
Beginn: 01.04.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bell's palsy Blood test Computerised tomogram Dysarthria Electrocardiogram Eye disorder Eye ulcer Facial paralysis Speech disorder Vision blurred

Symptomtext

HAVE BEEN TREATED FOR EYE MANY TIMES; BELL'S PALSY; This spontaneous report received from a patient via a company representative concerned a female patient of unspecified age, race and ethnicity. Initial information was processed along with additional information received on 28-OCT-2022. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: UNKNOWN) dose was not reported, 1 total, administered on 12-APR-2021 for covid-19 prophylaxis. No concomitant medications were reported. On an unspecified date in APR-2021, the patient experienced Bell's palsy. On an unspecified date, the patient had been treated for eye many times and the treatment was still continued. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from have been treated for eye many times, and the outcome of Bell's palsy was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20221059137- Bell's palsy- The event has an unknown/unclear temporal relationship, and is labeled. There is no information on any other factors potentially associated with the event. Therefore, this event is considered consistent with vaccine administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2433307

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: KY
Alter: 20,0
Geschlecht: F
Eingang: 08.09.2022
Impfdatum: 31.03.2021
Beginn: 12.08.2022
Tage bis Beginn: 499,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Abdominal pain Asthma COVID-19 Cough Diarrhoea Dyspnoea Full blood count Haematocrit decreased Haemoglobin decreased Hypophagia Mean cell haemoglobin concentration normal Mean cell haemoglobin decreased Mean cell volume decreased Mean platelet volume normal Pain Platelet count normal Red blood cell count normal Red cell distribution width increased

Symptomtext

Patient ID: 21 y.o. Admit Date: 8/12/2022 Discharge Date: 8/14/2022 Final Diagnoses: Patient Active Problem List Diagnosis ? Asthmatic bronchitis ? COVID-19 Problem Respiratory Distress (Resolved) Review of hospital course: See H&P for HPI. Started on ivf,iv rocephin,iv solumedrol,albuteorl neb and bromfed dm.has improved remarkably well since meds were started.sob and bad frequent congested cough has resolved,no fever,occ body aches and abdominal cramping and occ diarrhea.resting,eating and drinking fair after saline bolus on the second HD,with good urine output.feeling a lot better. Condition at discharge: Patient is resting comfortably ,has not vomited.,decreased but adequate po intake. Exam: Wt Readings from Last 1 Encounters: 08/12/22 (!) 143.3 kg (316 lb) Recorded Vitals 08/13/22 1533 08/13/22 1836 08/13/22 2000 08/14/22 0000 BP: 144/89 137/82 Pulse: 88 86 96 99 Resp: 16 16 18 18 Temp: 97.5 ?F (36.4 ?C) 98.5 ?F (36.9 ?C) TempSrc: Oral Oral SpO2: 98% 98% 100% General:well-appearing, well-hydrated, in no apparent distress Heart: S1, S2 normal, no murmur, click, rub or gallop, regular rate and rhythm Lungs: occ rhonchi and exp wheezes over both lung fields,no retractions,good a/e Abdomen:Normal bowel sounds, soft, nondistended, no mass, no organomegaly. Skin no rashes,good cap refill HEENT tm/tp normal,moist oral mucosa,no sunken eyeballs,no alar flare, Watery nasal d/c,suppleneck,no supraclavicular retracitons Labs: CBC: Lab Results Component Value Date/Time WBC 9.5 08/12/2022 2101 RBC 4.80 08/12/2022 2101 HGB 11.7 08/12/2022 2101 HCT 36.0 08/12/2022 2101 MCV 75.0 08/12/2022 2101 MCH 24.3 08/12/2022 2101 MCHC 32.5 08/12/2022 2101 RDW 15.1 08/12/2022 2101 MPV 8.0 08/12/2022 2101 PLATELETCNT 382 08/12/2022 2101 Consults: None Significant Diagnostic Studies: labs: Unresulted Labs: Disposition: Home,f/up in 2 days,albuterol neb qid,bromfed dm 1 tsp q 6 hr,cont zpak,prednisone 40 mg bid Discharge Condition: good

Weitere VAERSDATA-Felder

Praegender Schweregrund: Respiratory distress
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2427107

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: WA
Alter: 64,0
Geschlecht: M
Eingang: 01.09.2022
Impfdatum: 01.04.2021
Beginn: 10.09.2021
Tage bis Beginn: 162,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: unbekannt

Abdominal pain Acute kidney injury Acute myeloid leukaemia Arthralgia Aspiration joint Atypical pneumonia Biopsy bone marrow Blood test Chemotherapy Chest pain Clostridium difficile infection Fluid retention Haemoglobin Hypervolaemia Joint swelling Laboratory test Leukopenia Nephrolithiasis

Symptomtext

June 28, 2021 - pt. was diagnosed with Walking Pneumonia. Aug 6, 2021 - seen in local ED for chest pain. Sep 9, 2021 - seen in local ED for severe right lateral abdominal pain. Sep 10, 2021 - diagnosed with Leukopenia, acute kidney injury. Sep 14, 2021 - Dr. indicates dropping White Cell Count, Red Cell Count, Hemoglobin, Neutrophil. Sep 17, 2021 - 2nd Dr. saw him for rt knee pain/swelling. Sep 18, 2021 - Medical team sent him to hospital for lt knee pain/swelling and neutropenia. Knee was aspirated. Oncology drs felt he could go home. Sep 21, 2021 - 3rd Dr. did a procedure for kidney stone (RIGHT ESWL). Sep 29, 2021 - 1st Dr. admitted pt. for chemotherapy for Acute Myeloid Leukemia Bone Marrow Biopsy was done. He was discharged on Oct 2, 2021. He was admitted on Oct 9 2021 and discharged on Nov 2, 2021. 1st Dr. retired from Oncology and pt.'s care is now under the direction of a 4th Dr. Since this visit, pt. has been making 2 visits a week, or more, to the hospital for blood draws and infusions/shots. He would be readmitted every six weeks or so for more chemo therapy. He never achieved remission. During his May 29 - June 25, 2022 admission, he developed multiple blood clots in both legs (right leg had 5, left leg had 3). He also developed an infection called c. diff and fluid retention overload. He almost died in this visit. He has received more chemotherapy in an outpatient setting and is being set up for a stem cell transplant.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: 100,0
Labordaten: Bone marrow biopsies, lab draws, infusions, injections re rebuild him.
Aktuelle Erkrankungen: None
Vorgeschichte: Kidney stones, melanoma check-ups
Andere Medikamente: Tylenol, Vit C, CoQ10, Vit B12, Advil, Garlic, Flomax, Testost
Allergien: Honey bee venom, Latex
Vorherige Impfungen: -

VAERS 2402933

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MI
Alter: 60,0
Geschlecht: M
Eingang: 05.08.2022
Impfdatum: 17.08.2021
Beginn: 02.08.2022
Tage bis Beginn: 350,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Influenza Pyrexia SARS-CoV-2 test positive Seizure

Symptomtext

Pt admitted on 7/26 post seizure. Pt has a history of a right MCA stroke. Was found to have influenza A. Tested positive for COVID-19 on 8/2 after having fevers the day prior.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2377303

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CA
Alter: 60,0
Geschlecht: M
Eingang: 21.07.2022
Impfdatum: 03.04.2021
Beginn: 30.11.2021
Tage bis Beginn: 241,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: unbekannt Erholt: nein

Blindness Laboratory test Ophthalmic artery thrombosis

Symptomtext

Event: Blood clot in right eye causing loss of vision Treatment: I have been told by 3 doctors that there is no treatment Outcome: Loss of vision in right eye

Weitere VAERSDATA-Felder

Praegender Schweregrund: Ophthalmic artery thrombosis
Hospital-Tage: 2,0
Labordaten: Every imaginable test by my Doctor
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: Aleve
Vorherige Impfungen: -

VAERS 2370042

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: OR
Alter: 53,0
Geschlecht: F
Eingang: 15.07.2022
Impfdatum: 05.04.2021
Beginn: 24.08.2021
Tage bis Beginn: 141,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Haemorrhagic stroke Hypertension

Symptomtext

HEMORRHAGIC STROKE; HIGH BLOOD PRESSURE; This spontaneous report received from a patient concerned a 53 year old female. Initial information was processed along with the additional information received on 13-JUL-2022. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: 16-FEB-2022) dose was not reported, 01 total administered on 05-APR-2021 for prophylactic vaccination. Age at time of vaccination 53 years old. No concomitant medications were reported. On 24-AUG-2021, the patient experienced hemorrhagic stroke from high blood pressure. The reporter reported that the stroke had nothing to do with blood clots. The patient additionally received covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1855194, expiry: 06-SEP-2022) dose was not reported, 01 total administered on 29-NOV-2021 to the upper left arm for prophylactic vaccination. It was unknown if patient had any adverse events following vaccination with covid-19 vaccine ad26.cov2.s (dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the hemorrhagic stroke and high blood pressure was not reported. This report was serious (Other Medically Important Condition). This report was associated with a product quality complaint number 90000241924. The suspected product quality complaint has been confirmed to be voided (did not meet pqc criteria) based on the PQC evaluation/investigation performed. This case, from the same reporter is linked to 20220724260.; Sender's Comments: V0: 20220724456- COVID-19 VACCINE AD26.COV2.S-hemorrhagic stroke, high blood pressure. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Haemorrhagic stroke
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2290979

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: -
Alter: 51,0
Geschlecht: F
Eingang: 23.05.2022
Impfdatum: 01.04.2021
Beginn: 01.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Autoimmune thyroiditis Bone pain Cardiac monitoring Cardiac stress test Chest X-ray Chest discomfort Chest pain Chills Condition aggravated Dizziness Echocardiogram abnormal Electrocardiogram Fatigue Feeling abnormal Headache Pain Palpitations Pericardial effusion

Symptomtext

I have Hashimoto's, an autoimmune thyroid disease. The symptoms of it started two months after receiving several vaccines before traveling in 2004. My immune system is reactive to a lot of things. The first couple days after the COVID-19 vaccine, I was very sick. I had a 102 fever, body and bone aches, chills, severe headache, etc. Then I was extremely fatigued for three weeks. Then I had an autoimmune flare-up, which I hadn't had in a few years. I started to feel speedy, which is common with a Hashimoto's flareup. What was unusual is that I continued to feel speedy for weeks, to the point that I cut out my thyroid medication (levothyroxine) for two full weeks. I was speedy, light-headed, heart palpitations, etc. Every time I tried to take my thyroid medication again, I?d feel super speedy and have to stop. It took a year to recalibrate my thyroid medication. In conjunction with that, last year, a couple months after the vaccine, I started to have pressure in my chest. I have since had multiple appointments and labs with a cardiologist and pulmonologist, and am about to see a rheumatologist. The cardiologist diagnosed a Pericardial Effusion. It is not responding to standard drugs. It is looking like it is pericarditis. I have constant pressure, achiness and constriction in my chest.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: -
Labordaten: Too many tests to list. Full workups from cardiologist and pulmonologist. They include: chest x-ray, VQ scan, bloodwork, heart monitor, EKG, heart stress test, pulmonary function test, echocardiogram. Results: two echocardiograms show a pericardial effusion.
Aktuelle Erkrankungen: -
Vorgeschichte: Hashimoto's thyroiditis (diagnosed in 2006)
Andere Medikamente: levothyroxine
Allergien: penicillin
Vorherige Impfungen: As mentioned, the Hashimoto's Thyroiditis symptoms started two months after receiving multiple vaccines prior to traveling in 20

VAERS 2271083

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: -
Alter: 19,0
Geschlecht: F
Eingang: 11.05.2022
Impfdatum: 24.05.2021
Beginn: 10.02.2022
Tage bis Beginn: 262,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Seizure like phenomena

Symptomtext

02/12/22 presents to ED as a transfer for "recurrent seizure activity" "COVID Infection". PMHx of "cerebral palsy, epilepsy, hydrocephalus status post VP shunt"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure like phenomena
Hospital-Tage: -
Labordaten: 02/12/22 SARS-CoV-2 (COVID-19) by NAA not detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2254715

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MI
Alter: 80,0
Geschlecht: F
Eingang: 27.04.2022
Impfdatum: 17.06.2021
Beginn: 05.04.2022
Tage bis Beginn: 292,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute kidney injury Anticoagulant therapy COVID-19 Cough Dyspnoea Fibrin D dimer Mental status changes Platelet count decreased Pneumonia bacterial Positive airway pressure therapy Respiratory distress SARS-CoV-2 test positive Troponin

Symptomtext

Patient is fully vaccinated and boosted 11/18/2021.COVID + 4/5/2022 81-year-old female who presents to the hospital secondary to difficulty in breathing. History is extremely limited as patient is in severe respiratory distress with altered mentation. Patient was found to have an oxygen saturation at the nursing home at 79%.Patient stated that she was having difficulty in breathing and cough for the past several days. Patient was placed on BiPAP with improvement of oxygenation to 96%. Troponin .29; PLTS 103; D dimer 6,444. Medications: remdesivir, dexamethason, antibiotics (for bacterial pneumonia), heparin. Acute kidney injury. Discharged back to nursing home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Respiratory distress
Hospital-Tage: 10,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2118423

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: PA
Alter: 67,0
Geschlecht: U
Eingang: 17.02.2022
Impfdatum: -
Beginn: 13.04.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Thrombosis

Symptomtext

BLOOD CLOTS AFTER BLOWING NOSE; This spontaneous report received from a patient concerned a 67 year old white and non hispanic or latino patient of unspecified sex. The patient's height, and weight were not reported. The patient's concurrent conditions included: rheumatoid arthritis, non-smoker, and non alcohol consumer, and other pre-existing medical conditions included: the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: UNKNOWN) dose was not reported, 1 total administered on 06-APR-2021 on right arm for prophylactic vaccination. No concomitant medications were reported. On 13-APR-2021, the patient experienced blood clots after blowing nose. About 4 out of 7 times, when the patient blew the nose, the patient got a lot of blood clot. It always happened in the morning and the patient had not a runny nose at those times. There were also no nosebleeds. The patient discussed it with rheumatologist, but they did not say much about it. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from blood clots after blowing nose. This report was serious (Other Medically Important Condition). Sender's Comments: V0.20220236868- covid-19 vaccine ad26.cov2.s - Blood clots after blowing nose. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Abstains from alcohol; Non-smoker; Rheumatoid arthritis.
Vorgeschichte: Comments: The patient had no known allergies.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1192656

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: WA
Alter: -
Geschlecht: F
Eingang: 03.02.2022
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cold sweat Hyperhidrosis Loss of consciousness Pallor Syncope Vital signs measurement

Symptomtext

Patient passed out for a couple minutes while seated. She was pale, sweaty, clammy after. Paramedics checked on her.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1186078

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: IN
Alter: 57,0
Geschlecht: F
Eingang: 03.02.2022
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Dysstasia Feeling abnormal Hypoaesthesia Loss of consciousness Dizziness

Symptomtext

Shooting numbness in arm Dizzyness, felt like Blacking out

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2039181

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CA
Alter: 60,0
Geschlecht: M
Eingang: 17.01.2022
Impfdatum: 27.07.2021
Beginn: 30.12.2021
Tage bis Beginn: 156,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test Chest X-ray Chest pain Computerised tomogram abnormal Dysphagia Dyspnoea Heart rate increased Pulmonary thrombosis

Symptomtext

Pt. states that after receiving the 1st dose of J&J 07/27/2021, started experiencing symptoms 07/27/2021 (8hrs after) possible throat swelling (difficulty swallowing) lasting estimated 2hrs before subsiding. Started experiencing symptoms 12/30/2021 of shortness of breath with chest pain and rapid heart-beat. Emergency Room visit 12/30/2021 resulting in Blood Work, Chest X-Ray, and Cat-Scan, located a blood-clot in the Left Lung Lobe. Recommendations of Follow-Up with Primary and treatment of Long-Term Blood Thinners.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary thrombosis
Hospital-Tage: -
Labordaten: Blood Work 12/30/2021 Cat-Scan 12/30/2021 Chest X-Ray 12/30/2021
Aktuelle Erkrankungen: N/A
Vorgeschichte: Chronic Pain, Headaches, High Cholesterol
Andere Medikamente: Gabapentin, Atorvastatin
Allergien: N/A
Vorherige Impfungen: -

VAERS 2038023

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MI
Alter: 56,0
Geschlecht: M
Eingang: 15.01.2022
Impfdatum: 27.08.2021
Beginn: 21.11.2021
Tage bis Beginn: 86,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anticoagulant therapy Haematology test Laboratory test Thrombosis Ultrasound Doppler abnormal

Symptomtext

I experienced a blood clot in my calf 22 days following the J&J shot. I have never had anything like this before. I am a 57 year old healthy male who exercises 3-4x/week.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: laboratory tests- hematology, general, chemistry and diagnostic peripheral vascular lab test - ultra sound that detected blood clot in my calf. I was prescribed a blood thinner Eliquis with starting 4 tabs/day for 2 weeks and then continue until at least the end of February.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2659145

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: -
Alter: 45,0
Geschlecht: M
Eingang: 06.01.2022
Impfdatum: 08.04.2021
Beginn: 08.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Confusional state Disorientation Dizziness Echocardiogram Electrocardiogram abnormal Feeling hot Flushing Hypotension Loss of consciousness Myocardial necrosis marker normal Sinus bradycardia Sinus rhythm Tunnel vision

Symptomtext

Narrative: Patient is a 43 year old male who presented to COVID-19 vaccine clinic for administration of the Johnson&Johnson COVID-19 vaccine. Past medical history significant for bilateral tinnitus and vitamin D deficiency. Patient was not on any prescribed or OTC medications and allergies include pollen and dust. Vaccine history includes Tdap vaccine in 02/05/2018. Patient reported feeling hot and flushed while sitting 3-4 minutes following administration of the J&J vaccine. He then stood up to drink water from the drinking fountain and developed tunnel vision as well as lightheadedness. A rapid response was called when patient passed out. Upon waking, the patient endorsed some confusion and disorientation that resolved quickly . Blood pressure was notable for 67/47 and subsequent readings were 87/57 and 103/68. In the ED, pulse was 56 and EKG showed sinus bradycardia. One liter of normal saline was administered which resolved the bradycardia and hypotension. The patient was admitted for further evaluation for any cardiac etiology. ECG and cardiac enzymes were negative. Cardiac enzymes were trended and remained negative. He was noted to be bradycardic into the 40s, but patient stated this is a known issue for him. Overnight, he remained in normal sinus rhythm with a regular rate. TTE was unremarkable. Patient was then discharged in stable condition.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Vitals: 16:05- BP: 67/47; 40bpm 16:08- BP: 87/57; 67bpm 16:11- BP: 103/68; 67bpm
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2010285

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MI
Alter: 94,0
Geschlecht: F
Eingang: 06.01.2022
Impfdatum: 23.07.2021
Beginn: 22.12.2021
Tage bis Beginn: 152,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Confusional state Loss of consciousness SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

COVID Breakthrough- 94y.o. female who presented to the hospital on 12/22/2021 with loss of consciousness, found down by her home care nurse. EMS brought her to ED. She was awake but confused. Incidentally found to be COVID positive. Denies cough or SOB, on Room air.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: 9,0
Labordaten: COVID+ by PCR on 12/22/21
Aktuelle Erkrankungen: -
Vorgeschichte: Hypertension
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2532990

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: -
Alter: 83,0
Geschlecht: M
Eingang: 04.01.2022
Impfdatum: 10.04.2021
Beginn: 27.04.2021
Tage bis Beginn: 17,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Bladder cancer Chemotherapy Deep vein thrombosis Thrombocytopenia

Symptomtext

Narrative: Patient experienced RLE DVT within3 weeks of receiving the Janssen COVID-19 vaccine. Patient also with thrombocytopenia at time of diagnosis. Of note patient with bladder carcinoma on chemo. DVT possibly cancer associated vs vaccine-related and the thrombocytopenia is common with chemo (gemcitabine + carboplatin). Patient was started on apixaban therapy for DVT.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2502910

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: -
Alter: 46,0
Geschlecht: F
Eingang: 01.01.2022
Impfdatum: 28.04.2021
Beginn: 27.04.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Hypertension Pericarditis

Symptomtext

Narrative: Pericarditis. On steroid orally. Had Covid 19 about 1 month prior to vaccine and had fully recovered to getting J&J vaccine. HYPERtension Pericarditis

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1995994

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: AK
Alter: 42,0
Geschlecht: F
Eingang: 31.12.2021
Impfdatum: 06.04.2021
Beginn: 27.11.2021
Tage bis Beginn: 235,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anticoagulant therapy Deep vein thrombosis

Symptomtext

DVT in left leg. Treating with Xarelto.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: -
Labordaten: Ultrasound Dec 3 2021
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Nuvaring
Allergien: PCN
Vorherige Impfungen: -

VAERS 1955664

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NJ
Alter: 64,0
Geschlecht: F
Eingang: 16.12.2021
Impfdatum: 12.04.2021
Beginn: 28.06.2021
Tage bis Beginn: 77,0
Dosis: 1
Route/Site: UN / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Abnormal clotting factor Anticoagulant therapy Blood test abnormal Cardiac monitoring normal Chest X-ray abnormal Dizziness Dyspnoea Dyspnoea exertional Echocardiogram normal Impaired driving ability Muscle spasms Pain in extremity Pulmonary thrombosis Respiration abnormal Scan with contrast abnormal Thrombosis Ultrasound Doppler abnormal

Symptomtext

Got the vaccine in April,. 2021. I don't have any underlying conditions at time of vaccine. On or around June 25 I experienced a very severe dizzy spell while driving the likes of which I have NEVER experienced. It managed to clear up with continual heavy breathing and just trying to get 02 in my body and specifically my head. Also experienced gradual shortness of breath just walking around which I thought was unusual on June 26-27. On the night of June 28th I experienced lower leg cramps in calf and foot area like I have never felt before. On the morning I woke up and couldn't breath properly. Off to hospital. Blood clots both lungs and left leg. Surprise.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary thrombosis
Hospital-Tage: 5,0
Labordaten: Cardio monitoring, echo cardiogram, doppler of left leg. chest x ray with contrast in emergency room. Cardio and echo were fine. Doppler indicated I had a clot behind my left knee, I think I had one in my right leg judging from the terrible cramps and pain but I think it went to my lung before I got to the hospital. I had lots of bloodwork that the Dr. will have record of. Put on Heparin drip for three days then Eliquis 10 mg x 2 thereafter. My blood does not have a tendency to clot abnormally according to the blood tests and Dr. The ONLY thing I could come up with regarding this unprovoked episode is the Covid vaccine.
Aktuelle Erkrankungen: None
Vorgeschichte: Just blood pressure which has been under control for some time same with cholesterol.
Andere Medikamente: Liprinosil 40 mg x 1 Buproprion 150 mg x 1 Previstatin 40mg x 1 Levothyroxine 50 Mcg x 1
Allergien: None
Vorherige Impfungen: -

VAERS 1935356

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MI
Alter: 34,0
Geschlecht: F
Eingang: 09.12.2021
Impfdatum: 08.04.2021
Beginn: 08.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Body temperature Chills Fatigue Injection site mass Nausea Pain Paraesthesia Peripheral swelling Pyrexia Superficial vein thrombosis Tremor Ultrasound Doppler Ultrasound Doppler abnormal

Symptomtext

ULTRASOUND DOPPLER ABNORMAL; ARTHRALGIA; CHILLS; PARAESTHESIA; FATIGUE; NAUSEA; PYREXIA; SUPERFICIAL VEIN THROMBOSIS; TREMOR; PERIPHERAL SWELLING; INJECTION SITE MASS; PAIN; This spontaneous report received from a health care professional via a Regulatory Authority VAERS (Vaccine Adverse Event Reporting System) concerned a 34-year-old female. The patient's height, and weight were not reported. The patient's past medical history included: breastfeeding. The patient received covid-19 vaccine ad26.cov2.s (Janssen series 1, suspension for injection, route of admin not reported, batch number: 042a21a expiry: UNKNOWN) dose was not reported, 1 total, administered on 08-APR-2021 for an unknown indication. Vaccine was given about 1.5 cm below the acromion process per doctor measurement. No concomitant medications were reported. On 08-APR-2021, the patient experienced a small lump at injection site within 15 minutes of vaccination. That night patient had 'pins and needles' (paraesthesia) down her left arm. The patient experienced hand tremors, chills, fever 102.3, nausea, body aches, fatigue and shoulder pain (arthralgia). On 09-APR-2021, The patient took ibuprofen at 4 AM. On 10-APR-2021 patient noticed a lump on her left forearm. On 14-APR-2021, The patient had an Ultrasound Doppler done on her left arm and a supraficial venous thrombosis in the cephalic vein of the left forearm was found. Patient was told to start aspirin 81 mg. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the arthralgia, chills, fatigue, injection site mass, nausea, pain, paraesthesia, peripheral swelling, pyrexia, superficial vein thrombosis, tremor and ultrasound doppler abnormal was not reported. This report was serious (Other Medically Important Condition). Version created to amend previously reported information on 30-NOV-2021. Upon review following information was amended: seriousness of event superficial vein thrombosis updated to serious (other medically important).; Sender's Comments: V1. This follow up version was created to update the following information: seriousness of event superficial vein thrombosis updated to serious (other medically important). 20211201391-covid-19 vaccine ad26.cov2.s -superficial vein thrombosis . This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Superficial vein thrombosis
Hospital-Tage: -
Labordaten: Test Date: 20210408; Test Name: Body temperature; Result Unstructured Data: 102.3; Test Date: 20210414; Test Name: Ultrasound Doppler; Result Unstructured Data: venous thrombosis
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Breast feeding
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1868296

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: IN
Alter: 36,0
Geschlecht: F
Eingang: 14.11.2021
Impfdatum: 25.04.2021
Beginn: 24.06.2021
Tage bis Beginn: 60,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Blood test Contusion Heavy menstrual bleeding Petechiae Platelet count normal Thrombosis

Symptomtext

During the beginning of my period in June, I had heavier bleeding than usual, including a blood clot the size of the palm of my hand, including two other additional blood clots slightly smaller. This all happened in one day at the beginning of my period. Around this time I also had more bruising and having petechiae. These things have never happened to me before. This only happened for my June period, the following months I have not had blood clots as large as these. I started taking aspirin and K2 again to try and help the bruising and petechiae, as a protective measure.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: I saw my doctor and gynecologist at the beginning of August. By this time the symptoms had subsided. Neither doctor seemed concerned about these unusually large clots. However, when I also told about the bruising and petechiae with the clots, my obgyn ordered a blood test to make sure my blood platelets were in order, they came back normal.
Aktuelle Erkrankungen: -
Vorgeschichte: Have a history of IBS, interstitial cystitis, and vulvodynia. Irregular period - not heavy, but lasting ten days, spotting, short cycle. Had a hysteroscopy in Jan 2021 for suspected polyps, they ended up not existing, but a biopsy was taken and showed excess estrogen.
Andere Medikamente: Stopped taking any supplements prior to vaccination as a precaution. But within the weeks prior or a few weeks afterwards had taken things such as aspirin, K2 (mk4), niacinamide, progesterone (monthly during luteal phase), cascara sagrada.
Allergien: None known
Vorherige Impfungen: -

VAERS 1865074

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CO
Alter: 59,0
Geschlecht: F
Eingang: 12.11.2021
Impfdatum: 02.04.2021
Beginn: 03.04.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Chest pain Concussion Head injury Hip arthroplasty Joint injury Loss of consciousness

Symptomtext

I experienced chest pain after my vaccine. I received the vaccine on 04/02/2021 and passed out the next day, 17 hours later. I passed out, hit my head and tweaked my right hip. The result was got a concussion. I went to ER, and I had a hip replacement. It was very hard to know what the symptom of hitting my head and hitting my hip.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Underwent- Right Hip Replacement
Aktuelle Erkrankungen: None reported
Vorgeschichte: None reported
Andere Medikamente: None reported
Allergien: None reported
Vorherige Impfungen: -

VAERS 1860107

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CA
Alter: -
Geschlecht: M
Eingang: 11.11.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Deep vein thrombosis

Symptomtext

DEEP VEIN THROMBOSIS; This spontaneous report received from a physician concerned a 62 year old male of unspecified race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: 19-SEP-2021) dose, 1 total, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, 3 to 4 weeks post vaccination, the patient experienced edema in legs and deep vein thrombosis. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the deep vein thrombosis was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20211118921- COVID-19 VACCINE AD26.COV2.S- Deep vein thrombosis. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1856603

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CA
Alter: 62,0
Geschlecht: F
Eingang: 10.11.2021
Impfdatum: -
Beginn: 02.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Cardiovascular disorder Dizziness Paraesthesia Physiotherapy Syncope

Symptomtext

DIZZINESS; CIRCULATION PROBLEMS WITH FEET, HANDS AND KNEES; INCREASING NEED FOR PHYSIOTHERAPY; JOINT PAINS; FINGERS TINGLING; FAINTED ON THE INJECTION DAY; This spontaneous report received from a patient concerned a 62 year old adult female. The patient's height, and weight were not reported. The patient's concurrent conditions included: lupus. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: 042A21A expiry: unknown) dose was not reported, 01 total administered in left arm on 02-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 02-APR-2021, the patient fainted on the injection day. On an unspecified date, the patient had dizziness, circulation problems with feet, hands and knees, increasing need for physiotherapy, joint pains, and fingers tingling. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the dizziness, circulation problems with feet, hands and knees, fingers tingling, joint pains, increasing need for physiotherapy and fainted on the injection day was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20211116539-COVID-19 VACCINE AD26.COV2.S-fainted on the injection day. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Lupus erythematosus
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1846760

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: MN
Alter: 56,0
Geschlecht: F
Eingang: 05.11.2021
Impfdatum: 01.09.2021
Beginn: 17.09.2021
Tage bis Beginn: 16,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Differential white blood cell count normal Erythema Full blood count normal Haemoglobin normal Pain in extremity Peripheral swelling Platelet count normal Red blood cell count normal Skin warm Sleep disorder Superficial vein thrombosis Ultrasound Doppler White blood cell count normal

Symptomtext

16 days post vaccination, PT awoke with left calf pain, swelling, warmth, and redness. She was evaluated at the Emergency Department. She was diagnosed with : Thrombophlebitis of superficial veins of left lower extremity I80.02. She was instructed to

Weitere VAERSDATA-Felder

Praegender Schweregrund: Superficial vein thrombosis
Hospital-Tage: -
Labordaten: 9/17/21: Venous Ultrasound of left leg. CBC with Differential: WNL (WBC 5.9, RBC 4.96, HGB 14.4, PLT 284)
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2486761

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: -
Alter: 63,0
Geschlecht: M
Eingang: 02.11.2021
Impfdatum: 10.05.2021
Beginn: 07.06.2021
Tage bis Beginn: 28,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood creatinine normal Blood culture Body temperature increased Brain natriuretic peptide normal COVID-19 COVID-19 pneumonia Chest X-ray abnormal Dyspnoea Endotracheal intubation Haemoglobin decreased Incentive spirometry Intensive care Laboratory test normal Lung infiltration Platelet count decreased SARS-CoV-2 test positive White blood cell count normal

Symptomtext

Narrative: 62 year old male patient with past medical history of mixed restrictive/obstructive lung disease, PE (on Eliquis), tobacco use disorder, alcohol use disorder, obesity, osteoarthritis, T2DM, BPH, and poor health literacy and poor medication compliance presenting with COVID pneumonia. He denies fever, chills, shortness of breath, chest pain, n/v/c/d. When asked why he came to the hospital before he knew he had COVID, he states that he was drinking like he usually does, and EMS found him and brought him here. He also states that his last drink was yesterday, and he states that he drinks hard liquor. Denies drug use. He states that he smokes too much but cannot further quantify. Per ED documentation, he presented to ED 6/7/2021 with dyspnea. Temp 100.4, HDS, SpO2 mid 90s on ROOM AIR. WBC 5K, Hb 13.7, Plt 142, Cr 1.1, BNP <100, cardiac markers negative. Blood cx drawn. CXR consistent with multifocal pneumonia. He was given albuterol nebulizer, azithromycin and ceftriaxone x1. Found to be COVID positive admitted. Admitted to floor 6/8, transferred to MICU 6/9 and intubated for increased oxygen requirements, extubated 6/16. Received tocilizumab 6/9, Dexamethasone (6/9 - 6/18), Remdesivir (6/8 - 6/18). Transferred to the floor 6/21 on 2L NC and weaned to room air on 6/23. Remained stable on room air for remainder of hospital course. Continued incentive spirometry. COVID IgG positive 6/19. Patient was discharged 6/25/2021 to Rehab facility but has had ongoing SOB ever since.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: -
Labordaten: Specimen Collection Date: Jun 07, 2021@23:30 COVID-19_(XPRESS PCR) DETECTED H* Chest x-ray 6/7/2021: 1. Alveolar and interstitial infiltrates involving the right upper and lower lobes, along with the lateral portion of the left upper lobe and posterior segment of the left lower lobe. These findings most likely represent multifocal pneumonia. 2. No cardiomegaly or significant pleural effusion.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1814720

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MI
Alter: 73,0
Geschlecht: M
Eingang: 25.10.2021
Impfdatum: 30.03.2021
Beginn: 20.10.2021
Tage bis Beginn: 204,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Atrial fibrillation Cardiac resynchronisation therapy Catheterisation cardiac abnormal Chest X-ray abnormal Chills Coronary arterial stent insertion Cough Decreased appetite Dyspnoea Dyspnoea exertional Heart rate abnormal Hypoxia Illness Ischaemic cardiomyopathy Pyrexia Respiratory disorder Respiratory distress Respiratory tract congestion

Symptomtext

his is a 74-year-old male with significant past medical history of CAD, hypertension, congestive heart failure, combined diastolic and systolic, ischemic cardiomyopathy status post ICD placement who presented to the hospital chief complaint of progressively worsening dyspnea over the past several days. The patient recently had a cardiac catheterization on 9/30 and received a stent to the LAD, he was found to have ischemic cardiomyopathy and he had delayed placement of ICD on 10/7. Patient states he was doing pretty well up until about a weekago when he started develop upper respiratory illness. He was having a cough, congestion, fevers, chills and poor appetite. The patient states he was still drinking fluids but he wasn't eating very much. The patient denied any chest pain, palpitations, lightheadedness or dizziness. Patient notes he started to get more short of breath over the last several days and he was having more difficulty getting around his house without feeling very short of breath. Patient has had fevers and chills. The patient did come to the hospital on October 18 and was sent home as he was not hypoxemic, with the instruction to come back if he got any worse. He was sent home with azithromycin, albuterol and prednisone. In the emergency room, the patient was found to be in A. fib with RVR, he was given a dose of IV and oral Cardizem without improvement in his heart rate, blood pressure was stable. He initially was not hypoxemic he was given 2 L of IV fluids. He was then started on a Cardizem drip with subsequent improvement of heart rate but then he went to respiratory distress and hypoxemic. He was titrated up rapidly to a nonrebreather mask. Chest x-ray did look like Covid. Pressure still stable, heart rate improving, he is tachypneic but no distress.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Respiratory distress
Hospital-Tage: 6,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Persistent A-Fib PTSD Gout HTN CHF CAD
Andere Medikamente: Current Home Medications 1. allopurinol 100 mg oral tablet : 2 tab(s) orally once a day 2. Aspir 81 oral delayed release tablet : 1 tab(s) orally once a day 3. atorvastatin 20 mg oral tablet : 0.5 tab(s) orally once a day 4. buPROPion 150 m
Allergien: none known
Vorherige Impfungen: -

VAERS 1797895

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MI
Alter: 47,0
Geschlecht: M
Eingang: 19.10.2021
Impfdatum: 31.08.2021
Beginn: 06.09.2021
Tage bis Beginn: 6,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Angina pectoris Chest X-ray normal Differential white blood cell count normal Echocardiogram normal Ejection fraction decreased Full blood count normal Hypoaesthesia Metabolic function test normal Pain Pericarditis Troponin T increased

Symptomtext

A week after receiving the covid vaccine I started to experience numbness in my left arm that would start in the shoulder and radiate down to my pinky and thumb. This numbness was off and on and still persists today, almost two months after the shot. The second week after the shot I started developing chest pains around the heart that intensified as the days went on. I also had shooting pains in my heart. I ended up visiting the ER on September 22nd as I was concerned I was having some sort of cardiac event. Several tests were run and I was discharged to go home and consult with a cardiologist. I began taking ibuprofen which seemed to offer some relief. I spoke with my primary care doctor and he reviewed my test results and suggested everything was fine. I had pushed for an echo in the ER and they would not do it. So I asked him if he thought it was a value and he ordered one. On October 1st I had an echo cardiogram done and according to my doctor there was no significant findings. I did however have a low EF 50-55% which seems low for a triathlete like myself. My doctor again suggested things were ok and I pushed for a stress test which he agreed to. I did not do the stress test but I set up an appointment with a cardiologist to find out what is going on. I had the appointment on October 18th and after speaking with him and having look over all my test results he determined that I most likely have pericarditis that at the top of the list of causes is the recent covid vaccine. He said the numbness in my arm could also be caused by the inflammation around my heart. He prescribed that I up my dosage of ibuprofen to 1200mg/day and follow up in a month. I am a healthy active adult who trains and races in triathlons. I had no health issues leading up to the covid vaccine. Since getting the covid vaccine I have been dealing with chest pain around the heart and numbness in the left arm that radiates down to my fingers. Taking ibuprofen seems to offer some relief. I am not sure how long these conditions will persist and am concerned about the long term outlook.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: -
Labordaten: On September 22, 2021 I had and EKG done (results normal), Comprehensive Metabolic Panel (results normal) CBC with Differential (results normal), TRoponin T <6, Chest X-Ray (normal) On October 1st Echo Cardiogram (normal outside low normal EF 50-55%)
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1796179

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CO
Alter: 27,0
Geschlecht: F
Eingang: 18.10.2021
Impfdatum: 08.07.2021
Beginn: 01.09.2021
Tage bis Beginn: 55,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Heavy menstrual bleeding Menstruation irregular Muscle spasms Thrombosis

Symptomtext

At the beginning of September, she started a period where she experienced heavy bleeding with clots that continued for about three weeks, which is irregular/unusual for her. She started her next period on 10/10/21 and is having heavy bleeding with cramping. She was encouraged to complete vsafe reporting to the CDC, Counseled on use of over the counter pain medications and use of heating pad for cramping/pain. Patient does not have a regular PCP and was encouraged to visit a local provider or local health care clinic for evaluation and possible treatment. Patient had previously asked for consultation from another pharmacist for irregular bleeding issues but felt she was ignored.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None stated by patient
Vorgeschichte: None stated by patient
Andere Medikamente: None stated by patient. Does have a birth control implant.
Allergien: None stated by patient
Vorherige Impfungen: -

VAERS 1776849

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CA
Alter: 46,0
Geschlecht: F
Eingang: 11.10.2021
Impfdatum: 10.04.2021
Beginn: 10.07.2021
Tage bis Beginn: 91,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Blood pressure decreased Blood test normal Computerised tomogram normal Corrective lens user Dehydration Electrocardiogram normal Eye injury Headache Loss of consciousness Malaise Nausea Pyrexia Suture insertion X-ray normal

Symptomtext

I had been sick for like 3 days. I had a fever, I felt nauseous, and I had a headache that nothing would touch. On 07/10/2021 I passed out. I had to be taken to the emergency room by an ambulance because my blood pressure dropped so low. I wear glasses and I felt forward, and my glasses cut into my eye. I had to have my eyes stitched. They did blood work, EKG, x-rays, and CT scan. They came back normal. I went to the cardiologist, and he thinks it was just dehydration. He did a heart monitor, and everything was normal.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Blood work, EKG, x-rays, and CT scan all normal.
Aktuelle Erkrankungen: None
Vorgeschichte: When I was 14 years old to 22 I had ITP but I got pregnant at 22 so that went away, I was in a serious car accident at 24 and they put me on Zoloft for a head injury.
Andere Medikamente: Allergy pill; calcium; vitamin pill
Allergien: Environmental allergies
Vorherige Impfungen: -

VAERS 1741517

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: DC
Alter: 40,0
Geschlecht: F
Eingang: 28.09.2021
Impfdatum: 02.04.2021
Beginn: 11.04.2021
Tage bis Beginn: 9,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Bell's palsy Facial paralysis Fatigue Gait disturbance Laboratory test Magnetic resonance imaging Muscular weakness Myalgia Paraesthesia

Symptomtext

The symptoms started 9 days after the J&J shot, with very severe muscle pain (worsening during nights) during the first week. This turned into a facial paralysis (17 days after the shot) followed by about 5 months of tingling in fingertips, fatigue and muscle pain/weakness in legs and difficulty to walk properly. I have an appointment with a neurologist in October but this will probably be too late as I felt fully recovered since about three weeks. That is why I wanted to report this to ensure that it is in the systems.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: My primary Doctor ordered several tests of which some were mishandled by the Lab and never yielded any results. The Hospital also took many tests, including an MRI, when I was at their emergency room on April 21, 2021. I do not have access to all the results but left there with medication for Belles Pares, with an unknown cause. This was before the risk of getting Guillain-Barre Syndrome from the J&J vaccine was discovered.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1736808

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: OK
Alter: 83,0
Geschlecht: M
Eingang: 27.09.2021
Impfdatum: 07.04.2021
Beginn: 21.09.2021
Tage bis Beginn: 167,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Atrial fibrillation COVID-19 pneumonia Condition aggravated Haematuria Hypotension Intensive care SARS-CoV-2 test positive

Symptomtext

Patient admitted to ICU for COVID-19 pneumonia on 9/21 due to high oxygen requirements. Still admitted to the ICU at the time of this submission.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: 8,0
Labordaten: 09/21/2021@15:03:34 COVID-19 DETECTED
Aktuelle Erkrankungen: Discharged from the hospital 3/17/2021 for CHF exacerbation (admitted 2/23), asymptomatic hypotension with atrial fibrillation 4/15/2021, and gross hematuria 5/3/2021
Vorgeschichte: CAD, CHF, ICM, AF, COPD, BPH, OA, obesity
Andere Medikamente: Aspirin, apixaban, atorvastatin, digoxin, furosemide, gabapentin, metoprolol, pantoprazole, potassium, tamsulosin, finasteride, budesonide/formoterol
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1726750

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: MN
Alter: 19,0
Geschlecht: M
Eingang: 23.09.2021
Impfdatum: 16.09.2021
Beginn: 16.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dyspnoea Heart rate increased Hyperhidrosis Presyncope Sleep disorder Vision blurred

Symptomtext

Within 5 minutes of the shot: Nearly passing out/blurred vision/intense sweating, went away within a few minutes. Several hours after the vaccine, however, I had a severely increased pulse, as well as a growing inability to breathe overnight, by ~4:30AM I was struggling to breathe the most (nearly bad enough to go to the hospital) and had over a 120 bpm pulse (over double my average). This happened for most of the night (I was not able to sleep), and only mostly went away by the next night.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None known
Vorherige Impfungen: -

VAERS 1719091

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CA
Alter: 19,0
Geschlecht: M
Eingang: 21.09.2021
Impfdatum: 18.09.2021
Beginn: 18.09.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Bradycardia Dizziness Hypotension Presyncope Pyrexia

Symptomtext

Patient became hypotensive and bradycardic after dose of Janssen. Patient felt light-headed and feverish. Near-syncopal episode.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1718538

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NJ
Alter: 23,0
Geschlecht: F
Eingang: 21.09.2021
Impfdatum: 15.05.2021
Beginn: 15.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Movement disorder Pallor Syncope Vomiting projectile

Symptomtext

Pale, projectile vomiting, fainting, inability to pick self off of the ground

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: PCOS and OCD
Andere Medikamente: Zoloft 50mg, Yaz generic birth control
Allergien: Keflex
Vorherige Impfungen: -

VAERS 1709177

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MO
Alter: 31,0
Geschlecht: M
Eingang: 17.09.2021
Impfdatum: 17.09.2021
Beginn: 17.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Loss of consciousness

Symptomtext

about 2 minutes after injection, patient was being observed, mumbled something, patient appeared to lose consciousness, regained awareness with a shout, patient then laid of floor, vitals were taken, patient was stable and observed for 30 minutes, dismissed with his mother.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: None that we were told of
Vorgeschichte: Patient did not give good oral history
Andere Medikamente: None that we were told
Allergien: Patient stated he had previous allergic reaction to an infusion, refused to state the name of the medication.
Vorherige Impfungen: -

VAERS 1700160

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: MN
Alter: -
Geschlecht: M
Eingang: 15.09.2021
Impfdatum: 15.09.2021
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fall Head injury Loss of consciousness Syncope

Symptomtext

Patient fainted. The person with him got my attention very shortly after he got the vaccine. He fell down and hit his head, and ended up in a sitting position. He became conscious and with the help of a stander-by, we were able to gently lower him into a laying position. He felt fine after laying down for a while and got some water. There was no redness around the injection site nor any other indications of an allergic reaction. The 911 operator asked if he wanted someone to come and check on him, but he declined this. After a while he got up and sat in a chair for several minutes, and then they left.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: NA
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1697159

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: GA
Alter: 42,0
Geschlecht: F
Eingang: 14.09.2021
Impfdatum: 09.09.2021
Beginn: 09.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood pressure increased Dysarthria Hypopnoea Loss of consciousness Somnolence

Symptomtext

I had an appointment at the local health dept 9/9/21 to receive the Janssen Vaccine. I went in with a friend, completed the required paperwork, and received the injection, 11:16. We sat in the back of the clinic together. At 11:24 I felt odd and sleepy and immediately fell over, unconscious, into my friend's side. My BP at this time sitting was 182/104 and heart rate 137.- taken by a nurse at the health dept. (My normal is 108/70 and my weight is 105lbs- no history of hypertension, cardiac issues.) My friend said that my speech slurred and then I fell over onto him with him stabilizing me so that I didn't fall into the floor. After they took my BP he moved me to lie on the floor during which time I was conscious but not able to assist much in the movement. He said that I kept saying , " I am sleepy." My heart rate and BP continued to be elevated and my breathing was shallow and rapid. I recall having diffculty staying awake with my friend telling me to keep my eyes open. I would fade off he said and then he would tap me and call my name and I would open my eyes. My body began to shake and I felt like I was very cold. All of this occurred within approximately 15 mins after the injection and continued on for some time, over an hour lying on the health dept floor with them monitoring me. I was unable to stand and every time they sat me up I would increase BP. They called 911 and I went to the ER.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: ER 9/9/21
Aktuelle Erkrankungen: none
Vorgeschichte: SLE
Andere Medikamente: Tylenol
Allergien: Sulfa Environmental
Vorherige Impfungen: mild reaction to flu vaccine

VAERS 1696925

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NY
Alter: 25,0
Geschlecht: F
Eingang: 14.09.2021
Impfdatum: 09.09.2021
Beginn: 09.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Heavy menstrual bleeding Polymenorrhoea Thrombosis

Symptomtext

I started my menstrual cycle on Monday, September 6th. My period consistently lasts 6-7 days. On Thursday, September 9th (4th day of my period), I received my Janssen COVID-19 vaccine in the morning. My menstrual flow ceased the remainder of the day on 9/9. I had no flow on 9/10 or 9/11. On 9/12 (day 6), my period began again, after 4 days of bleeding, and 3 days of no bleeding. It wasn't heavy, just very light. On 9/13 and today 9/14, my period has been so heavy that I am emptying a 30 mL menstrual cup every 50 minutes. It typically takes me 6-12 hours to fill that depending on the day. My period flow consistency right now is extremely abnormal in that it is bright red and watery, with 2-3 quarter sized clots being passed every hour. This is not normal for me. I have had consistently 26-30 day cycles with dark red thick flow for years. Someone has to look into this. Please.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: COVID-19 Infection Tested positive 8/20/21.
Vorgeschichte: None.
Andere Medikamente: Spironolactone 50 mg once daily (have been taking for 3.5 years for acne)
Allergien: N/A
Vorherige Impfungen: -

VAERS 1693153

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MI
Alter: 18,0
Geschlecht: M
Eingang: 11.09.2021
Impfdatum: 07.09.2021
Beginn: 08.09.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Anaphylactic reaction Angioedema Dizziness Dyspnoea Nausea Pharyngeal swelling Scrotal oedema Scrotal pain Scrotal swelling Ultrasound Doppler Urticaria

Symptomtext

scrotal swelling and pain - onset about 12-18 hours after vaccination and then anaphylaxis type symptoms (angioedema, throat swelling, shortness of breath, hives, lightheadedness, nausea) about 24-36 hours after vaccination requiring epinephrine injection; lip swelling improved but not fully resolved but no further anaphylaxis in the ED and sent home with script for Epipen

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: 9/8/21 scrotal US performed and showed scrotal wall edema but otherwise normal.
Aktuelle Erkrankungen: -
Vorgeschichte: history of hemophilia A
Andere Medikamente: -
Allergien: eggshell membrane, tree nuts, polyethylene glycol
Vorherige Impfungen: -

VAERS 1693092

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: WI
Alter: 39,0
Geschlecht: M
Eingang: 11.09.2021
Impfdatum: 11.09.2021
Beginn: 11.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Hyperhidrosis Loss of consciousness Vomiting

Symptomtext

Patient came in looking for a Janssen vaccine. He came in asking if the vaccine can make him vomit because he recently broke his jaw and was worried about vomiting with his mouth wired shut. I informed the patient that it is unlikely, but a possibility and asked the patient if he still felt comfortable getting the vaccine. Because his jaw was wired shut, I asked if he's gotten anything to eat today and described to me he had some yogurt and blend fruit, but that is it. Asked how he is feeling today and he said he "felt good" and isn't sensitive to vaccines in the past. After Administering the J&J vaccine into his right deltoid, I asked him to sit in a chair for 15 minutes to make sure he is feeling okay. As I was helping other customers, the Patient said loudly that he wasn't feeling good. As I walked over he repeatedly said he felt like he was going to faint. 5 seconds later he fainted in the chair. I positioned myself so he wouldnt fall out of the chair. and a technician called 911 right away. The patient was unconscious for roughly 10-15 seconds then woke up and appeared very sweaty. A technician and I stayed by the patient's side until paramedics arrived less than 5 minutes later where the patient appeared wake and oriented to where he was. Paramedics thought the reason for the fainting after the vaccine was due to not having enough food in his system due to recently having his jaw wired shut. Pharmacy provided the patient with Gatorade, Ensure, and applesauce to help. Paramedics were here monitoring the patient for 25 minutes Patient stayed for about 1 hour until a friend came and picked him up.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Paramedics took the patients blood pressure and appeared slightly lower than normal when they first got there, but gradually increased. They also monitored the patient's heart, where he had normal sinus rhythm.
Aktuelle Erkrankungen: Broken Jaw. No other illness
Vorgeschichte: Unknown
Andere Medikamente: Unknown. Does not fill at this Pharmacy.
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1690158

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MN
Alter: 33,0
Geschlecht: M
Eingang: 10.09.2021
Impfdatum: 10.09.2021
Beginn: 10.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Loss of consciousness Mydriasis Nausea Posture abnormal Seizure Unresponsive to stimuli

Symptomtext

Shortly after receiving the vaccine, the patient reported feeling nauseous (he was sitting in the waiting area). I asked if he felt dizzy and he said no. He asked for a bag in case he threw up so I walked back into the pharmacy to get one. When I left he was leaning against the wall and when I came back he was on the ground with his eyes very dilated and a blank stare. He appeared to have slouched down the wall (didn't fall over or hit his head). I started tapping his shoulders and loudly saying his name to try to arouse him. He then began mildly convulsing. I yelled for my technician to call ED and to get the store manager. I tried to move him into a recovery position but was unable to. I kept an eye on his breathing and pulse and after about 1 minute he came to. After the initial shock wore off of me telling him he had a seizure, he said he felt better. We waited for the paramedics to arrive, at which point they took his vitals and did a work up. They determined he did not need to go to the hospital but they were going to go wait in the ambulance with him until someone could come pick him up from the store. At that point the patient and the paramedics departed the pharmacy. As far as I know, he did not go to the doctor or hospital to be evaluated further.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Vitals taken
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: NONE THAT PT REPORTED
Allergien: NONE
Vorherige Impfungen: -

VAERS 1685259

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: MI
Alter: 45,0
Geschlecht: F
Eingang: 09.09.2021
Impfdatum: 11.08.2021
Beginn: 12.08.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Chills Fatigue Headache Pain Pyrexia Syncope

Symptomtext

Started w/ chills, fever (104.2 F), generalized body aches, headache, extreme fatigue, weakness , fainting. All symptoms subsided after 3 days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None that I know of.
Vorherige Impfungen: All flu shots

VAERS 1675551

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: IN
Alter: 21,0
Geschlecht: F
Eingang: 06.09.2021
Impfdatum: 05.09.2021
Beginn: 05.09.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

Patient was given vaccine. Within 5 minutes patient fainted and revived with smelling salts. Patient sat in pharmacy under care for 30 minutes. Patient was ok to leave pharmacy walking by themselves. Patient was checked on 2 hours later and still doing fine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: Patient did not say, just said history of vagal syncope to needles

VAERS 1665969

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: IN
Alter: 56,0
Geschlecht: F
Eingang: 02.09.2021
Impfdatum: 06.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 4,0
Dosis: 1
Route/Site: UN / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Abdominal pain lower Nausea Syncope

Symptomtext

Severe lower abdomen pain, severe nausea, syncope

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1641830

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MI
Alter: 57,0
Geschlecht: M
Eingang: 27.08.2021
Impfdatum: 06.08.2021
Beginn: 06.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Computerised tomogram Intensive care Laboratory test Muscle spasms Vomiting Weight decreased

Symptomtext

Starting having severe leg cramps Lost 26 lbs after vomiting every meal taken by ambulance told his sugar is over 600 never had diabetes or diverticulitis was told he now has two new conditions requires insulin was in ICU told no covid

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: -
Labordaten: Labs and CT
Aktuelle Erkrankungen: -
Vorgeschichte: Neck and back injury surgery lung collapse from trauma heart injury put on blood pressure medication
Andere Medikamente: Lisopril
Allergien: Codeine
Vorherige Impfungen: -

VAERS 1637227

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: MI
Alter: 18,0
Geschlecht: M
Eingang: 26.08.2021
Impfdatum: 26.08.2021
Beginn: 26.08.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Amnesia Blood glucose normal Electrocardiogram normal Eye movement disorder Head injury Mydriasis Seizure Syncope

Symptomtext

2-3 minutes after receiving vaccine pt. sitting up in chair and eyes rolled back in head and pt. started convulsing. Convulsions lasting approximately 10 seconds. Immediately following Dr. entered the room, pt. came to, writer reported dilated pupils bilaterally and the convulsions. Pt. with no recollection of what happened. Pt. with stand by assist to exam table and lying flat on table. Pt. assessed by physician and RN took pt's vital signs: 120/60 HR= 60 Pulse ox 97%. EKG done and read by Dr. to be normal. Pt. observed for 1/2 hour post vaccine in lying position. Pt. sat up and VSS checked 1 minute post sitting= 90/62 P=66 water given. Attempted to take BG x2 and unable to gain reading. A minute after 2nd BG poke, pt. fainted, hit the back of his head, 911 called, placed flat on exam table b/P= 112/56 P=72 pulse ox of 97%. EMS arrived and pt. declined going to ED. Pt. wheelchaired to car with mother driving.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: EKG BG checked with EMS= 80
Aktuelle Erkrankungen: exercise induced asthma
Vorgeschichte: exercise induced asthma Hx of Concussion Pt. felt he may have had COVID in the fall (2020) because his parents lost their sense of taste and smell and he was in close proximity to them.
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1633145

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: OH
Alter: 20,0
Geschlecht: F
Eingang: 25.08.2021
Impfdatum: 25.08.2021
Beginn: 25.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fall Loss of consciousness Syncope

Symptomtext

Within 1 minute of receiving vaccine patient fainted and fell from the chair onto the floor. She regained consciousness within a few seconds. She drank water and had a snack and symptoms quickly improved. Patient left on her own about 30 minutes after vaccine. I spoke with patient approximately 3 hours later and she said she was feeling OK.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: None.
Aktuelle Erkrankungen: None
Vorgeschichte: none
Andere Medikamente: birth control medication
Allergien: None
Vorherige Impfungen: -

VAERS 1631053

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: OK
Alter: 60,0
Geschlecht: M
Eingang: 25.08.2021
Impfdatum: -
Beginn: 03.08.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Coagulation factor V level Dental necrosis Thrombosis Toothache Venous occlusion

Symptomtext

TOOTH WAS NOW DEAD; PAIN ON UPPER MOLAR RIGHT SIDE; ONE VEIN WAS COMPLETELY BLOCKED AND THREE OTHER VEINS PARTIALLY BLOCKED; BLOOD CLOT; This spontaneous report received from a patient concerned a 60 year old white male of unknown ethnicity. The patient's weight was 193 pounds, and height was 73 inches. The patient's concurrent conditions included drinks alcohol, and was non smoker. The patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: 21-JUN-2021) dose was not reported, 1 total administered at left deltoid around 12:00 in noon on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 03-AUG-2021, the patient noticed red marking and pain on the right leg. On 05-AUG-2021, diminished the use of right leg and walk was affected. On 06-AUG-2021, patient went to emergency room and diagnosed with blood clot and one vein was completely blocked and three other veins partially blocked. As of 06-AUG-2021, the patient was started on Eliquis 20 mg per day for 7 days. On 11-AUG-2021, the patient begins to feel pain on upper molar right side, so patient went to dentist on 18-AUG-2021. The patient was informed that the tooth was now dead, may had been micro clot blocking of circulating. At the time of this report the patient was on Eliquis 10 mg daily and regimen will last for six months. On an unspecified date, patient underwent factor 5 genetic marker test which was negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from tooth was now dead, and the outcome of blood clot in vein and one vein was completely blocked and three other veins partially blocked was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210838162- covid-19 vaccine ad26.cov2.s-blood clot, one vein was completely blocked and three other veins partially blocked, tooth was now dead. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: Test Name: Coagulation factor V level; Result Unstructured Data: Negative.
Aktuelle Erkrankungen: Alcohol use (1 glass daily); Non-smoker.
Vorgeschichte: Comments: The patient had no known allergies.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1628560

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: AR
Alter: 42,0
Geschlecht: M
Eingang: 24.08.2021
Impfdatum: 08.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 2,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood test abnormal Electric shock sensation Hypoaesthesia Iron deficiency anaemia Neuropathy peripheral

Symptomtext

Developed symptoms of neuropathy with numbness and electrical shocks in the feet/toes within a few days of immunization, and this has progressively worsened and is still ongoing. This sensation was also ultimately noticed in both arms, but that has since subsided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Electric shock sensation
Hospital-Tage: -
Labordaten: Blood tests secondary to chronic medical conditions and new symptoms post COVID vaccine. Patient believes that his labwork was done in June, 2021. Test results showed an iron deficiency anemia, so patient began a treatment regimen with a Prenatal Vitamin which he ultimately switched to a Once Daily Multivitamin. Patient has not returned to an appointment for further evaluation of his anemia, but is awaiting a referral to neurology for an appointment.
Aktuelle Erkrankungen: Crohn's Disease; Sciatica; Arthritis; Carpal tunnel (both wrists)
Vorgeschichte: Crohn's Disease
Andere Medikamente: Citalopram 10mg - 1/2 tablet twice daily; Alprazolam 1mg - three times daily; Seroquel 200mg - 1/2 tablet once daily at night
Allergien: Gabapentin (anaphylaxis); Darvocet (anaphylaxis)
Vorherige Impfungen: -

VAERS 1617581

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: WA
Alter: 41,0
Geschlecht: F
Eingang: 22.08.2021
Impfdatum: 07.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Blood test normal Heavy menstrual bleeding Thrombosis Ultrasound scan normal

Symptomtext

Extremely heavy period with large blood clots

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: Blood work normal-4/10/21 Ultrasound normal-4/10/21
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: Corn
Vorherige Impfungen: -

VAERS 1592588

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MO
Alter: 50,0
Geschlecht: M
Eingang: 20.08.2021
Impfdatum: 20.08.2021
Beginn: 20.08.2021
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Asthenia Blood glucose normal Disorientation Headache Hyperhidrosis Hypoaesthesia Nausea Pallor Presyncope Sitting disability Vision blurred

Symptomtext

1:10 Received vaccine. Pt. alert, oriented,having no health issues. 1:20 Became weak, diaphoretic, nauseated, near syncope. Placed supine with cold compress to head. B/P 140.80 P- 80 R-20 Sat 97%. FSB:105. Pt. admits has only eaten fruit today and no oral fluids. Water taken in sips. Peanut butter crackers given. Pt. reports his vision is blurred and he has a severe headache. 1 :30 Vital signs unchanged. Pt's color very pale. Denies any improvement. Now noticing numbness of face, chest, neck, and abdoman. Disoriented to time, place, and person. Unable to give any information for contacting family. Unable to sit up under own power. EMS notified. No change in Vital signs. 1:55 EMS evaluated and transferred to Medical Center. Condition unchanged.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: FSBS=105
Aktuelle Erkrankungen: History of Hypertension, ADD, Episodes of Syncope " 3 events in last two years". Also states has not had medical care in last 20 years until recently when placed on current meds. Does not check blood glucoses.
Vorgeschichte: As above stated.
Andere Medikamente: Pt. unable to give full list of medications: Metformin 1,000mg BID, Carvedolol ? dose. States he is on eight medications. Denies taking any blood thinners.
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1591750

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: TN
Alter: 81,0
Geschlecht: M
Eingang: 20.08.2021
Impfdatum: 04.05.2021
Beginn: 15.08.2021
Tage bis Beginn: 103,0
Dosis: 1
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Dyspnoea Respiratory distress SARS-CoV-2 test positive

Symptomtext

PATIENT RECEIVED SINGLE DOSE OF JANSSEN COVID19 VACCINE ON 5/04/2021. ADMITTED TO MEDICAL CENTER ON 08/15/2021 WITH WORSENING SHORTNESS OF BREATH. TESTED POSITIVE FOR COVID19 ON 08/10/2021 AFTER STARTING CHEMOTHERAPY FOR SMALL CELL LUNG CANCER THE WEEK PRIOR. REQUIRED HI FLOW O2 IN ED, STARTED ON DECADRON, REMDESIVIR, CEFTRIAXONE, AND LASIX. PATIENT HAD PROGRESSIVE RESPIRATORY DECLINE. FAMILY ELECTED TO PURSUE COMFORT MEASURES. PATIENT EXPIRED ON 08/18/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Respiratory distress
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: SMALL CELL LUNG CANCER--METASTATIC TO LIVER AND BONE. ON CHEMOTHERAPY. CHRONIC OBSTRUCTIVE PULMONARY DISEASE. CORONARY ARTERY DISEASE.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1313559

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: -
Alter: 70,0
Geschlecht: F
Eingang: 16.08.2021
Impfdatum: 09.04.2021
Beginn: 30.04.2021
Tage bis Beginn: 21,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Areflexia Asthenia Back injury Back pain Blood glucose normal Dialysis Diplegia Dysstasia Endotracheal intubation CSF protein increased Chest discomfort Chest pain Condition aggravated Demyelinating polyneuropathy Dysarthria Fall Gait disturbance Hypoaesthesia

Symptomtext

Paralysis started in feet, hands, legs. Weak, unable to stand on own, speech is off, was diagnosed with Guillian-Barre syndrome , has went through 5 treatments of dialysis, intubated 3 times, and 30 days of therapy.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Guillain-Barre syndrome
Hospital-Tage: 95,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Diabetic.
Andere Medikamente: -
Allergien: None.
Vorherige Impfungen: -

VAERS 1313559

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: -
Alter: 70,0
Geschlecht: F
Eingang: 16.08.2021
Impfdatum: 09.04.2021
Beginn: 30.04.2021
Tage bis Beginn: 21,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Areflexia Asthenia Back injury Back pain Blood glucose normal Dialysis Diplegia Dysstasia Endotracheal intubation CSF protein increased Chest discomfort Chest pain Condition aggravated Demyelinating polyneuropathy Dysarthria Fall Gait disturbance Hypoaesthesia

Symptomtext

Paralysis started in feet, hands, legs. Weak, unable to stand on own, speech is off, was diagnosed with Guillian-Barre syndrome , has went through 5 treatments of dialysis, intubated 3 times, and 30 days of therapy.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Guillain-Barre syndrome
Hospital-Tage: 95,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Diabetic.
Andere Medikamente: -
Allergien: None.
Vorherige Impfungen: -

VAERS 1554298

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: OH
Alter: 27,0
Geschlecht: M
Eingang: 13.08.2021
Impfdatum: 13.08.2021
Beginn: 13.08.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Syncope

Symptomtext

Pt felt dizzy and fainted in chair within 5 minutes of vaccine administration (head tilted back, eyes closed, breathing stopped for 1 sec). Regained consciousness within 1 minute, was given glucose tabs, water, crackers and recovered by 30 minutes waiting.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1545433

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CA
Alter: 18,0
Geschlecht: F
Eingang: 11.08.2021
Impfdatum: 11.08.2021
Beginn: 11.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Immediate post-injection reaction Presyncope

Symptomtext

Client had a vasovagal episode which occurred immediately after receiving Janssen COVID-19 vaccine. (1 minute). Client was out of it for about 5-10 seconds. Client assessed. Vital signs checked and within normal limits and normal to client range. After episode client alert and oriented x 3. Denied pain, dizziness, headache, lightheadedness, or nausea after event. EMS called and responded. Client assessed by EMS and refused transfer to the ER stating "I feel fine".

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1536203

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: KY
Alter: 76,0
Geschlecht: F
Eingang: 09.08.2021
Impfdatum: 02.04.2021
Beginn: 05.08.2021
Tage bis Beginn: 125,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory distress syndrome Angiopathy Blood lactic acid decreased Blood potassium decreased Blood sodium decreased COVID-19 pneumonia Cardiomegaly Chest X-ray abnormal Cough Hypoxia Procalcitonin Pyrexia

Symptomtext

Patient is a 76 y.o. non-smoker with a history of hypertension, hyperlipidemia, and GERD that presents to hospital complaining of fevers and cough. She reports she was diagnosed with COVID 19 about 8/1/21 and she has had progressively worsening symptoms. She states she is unsure how high her temperature was at home. She denies shortness of breath, headache, dizziness, nausea, vomiting, and loss of taste and smell. She called her PCP yesterday to report her worsening symptoms and was sent to the ED for further evaluation. She required 6L supplemental oxygen on arrival to the ED. Work up in the ED revealed Na 130, K+ 3.2, lactate 2.1, and procal 0.30. A chest x-ray showed cardiomegaly and vascular congestion. Patient with acute respiratory distress and hypoxemia secondary to COVID-19 pneumonia. Treating with oxygen, twice daily dexamethasone, and remdesivir.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory distress syndrome
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Anxiety Arthritis Chronic insomnia Depression HLD GERD HTN Osteopenia Recurrent UTI
Andere Medikamente: ASA Cal/Vit D/Vit K Clindamycin Delsym Diazepanm Duloxetine Estradiol vaginal cream Eszopiclone Ezetimibe/simvastatin Fexofenadine Fluconazole HCTZ Losartan Meloxicam Montelukast MVI Nitroglycerin prn Fish oil Omeprazole Ondansetron Raloxif
Allergien: Adhesive tape Ceftin
Vorherige Impfungen: -

VAERS 1526750

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: OH
Alter: 26,0
Geschlecht: M
Eingang: 04.08.2021
Impfdatum: 04.08.2021
Beginn: 04.08.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Fall Haemorrhage Head injury Loss of consciousness

Symptomtext

Patient passed out shortly after shot. He fell off chair and hit head on floor. Had a little blood on top of head. He drank water , OJ and had chips and felt better. He did not want me to call the squad. He was able to stand and was coherent. He wanted to walk/ drive himself home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1519562

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: IN
Alter: 26,0
Geschlecht: M
Eingang: 02.08.2021
Impfdatum: 30.07.2021
Beginn: 30.07.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Cardiovascular function test Computerised tomogram Dyspnoea Endoscopy Endotracheal intubation Epistaxis Hypertension Intensive care Laboratory test Mechanical ventilation Mouth haemorrhage Pruritus Pulmonary haemorrhage Pyrexia Respiration abnormal Resuscitation Unresponsive to stimuli

Symptomtext

My Son took the Johnson&Johnson vaccine on 7/30 at 2:35pm. Then was unresponsive by 8:25pm. His father performed CPR and blood was coming out of his nose and mouth. EMS, fire department came and his dad did enough until help came. He was in the ICU with blood in his lungs, the doctors did not know what was wrong with him. I explained he took the shot and had stated minutes earlier his foot was itching and then he went to sleep with gasps trying to breathe. He is still in the hospital. He knew that it was the vaccine, as soon as he was able to talk that is what he stated, the vaccine almost killed me. These are facts and he is still in the hospital, off the ventilator after two days but his breathing is off. as of today 8/2/21 he is still in the hospital. His Blood pressure is high and he is running a fever. Breathing is erratic still.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: 4,0
Labordaten: CT scan, endoscopy, pulmonary work, Cardiovascular- heart test. Tube down his throat. 7/30-8/1 2021, respiratory therapy.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 1502018

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MO
Alter: 47,0
Geschlecht: F
Eingang: 30.07.2021
Impfdatum: -
Beginn: 26.07.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Back pain Blood pressure measurement Headache Hypotension Loss of consciousness Blood glucose normal Dizziness Mydriasis Nausea Somnolence Tremor Unresponsive to stimuli Vision blurred

Symptomtext

EXTREME LOW BACK PAIN; HYPOTENSION; EXCESSIVE DAYTIME SLEEPINESS; SHAKING; HEADACHE; NAUSEA; LOSS OF CONSCIOUSNESS; This spontaneous report received from a patient concerned a 47 year old female. The patient's height, and weight were not reported. The patient's past medical history included epilepsy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total administered in left arm approximately 10:15 am on 26-JUL-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 26-JUL-2021, the patient woke up with headache, but it was gone. The patient took Tylenol for headache. Treatment medications included: paracetamol. The nurse gave her the vaccine and patient experienced headache and felt like she was going to be sick. Within three minutes after the vaccination patient passed out and slumped over (loss of consciousness). Blood pressure bottomed out, and patient was shaking. Patient experienced hypotension, Laboratory data included: Blood pressure (NR: not provided) 102 (Systolic). Patient experienced excessive daytime sleepiness and she slept off all the day. On the same day patient experienced nausea. On 27-JUL-2021, the patient experienced extreme lower back pain to the point that getting up or walking or bending over was painful. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from loss of consciousness, and shaking on 26-JUL-2021, and excessive daytime sleepiness, headache, and nausea on 27-JUL-2021, had not recovered from extreme low back pain, and the outcome of hypotension was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20210757674.; Sender's Comments: V0 20210757738-covid-19 vaccine ad26.cov2.s-Loss of consciousness. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Test Date: 20210726; Test Name: Blood pressure; Result Unstructured Data: 102 (Systolic)
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Epilepsy
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1333503

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: OH
Alter: -
Geschlecht: M
Eingang: 30.07.2021
Impfdatum: -
Beginn: 12.04.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Abdominal pain upper Asthenia Biopsy heart Biopsy lung Cardiac failure Cardiomyopathy Catheterisation cardiac abnormal Chest discomfort Congestive cardiomyopathy Coronary artery stenosis Catheterisation cardiac Echocardiogram Electrocardiogram Feeling abnormal Heart rate Dizziness Dizziness postural Ejection fraction decreased

Symptomtext

FEELING OFF EXACERBATED WHILE CYCLING; HEART FAILURE POST PACEMAKER INSERTION; MYOCARDITIS; VENTRICULAR TACHYCARDIA; STOMACH PAIN WAS STABBING AND ALARMING; WEAKNESS WITH MOVEMENT FROM SITTING TO STANDING; This spontaneous report received from a patient concerned a 49 year old male. The patient's weight was 204 pounds, and height was 61 inches. The patient's past medical history included kidney stones. Concurrent conditions included alcohol use, non-smoker, and penicillin allergy, and other pre-existing medical conditions included no history of drug abuse or illicit drug use, no previous cardiac history was reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 042A21A, expiry: unknown) dose was not reported, 1 total administered on 08-APR-2021 on left arm for prophylactic vaccination. No concomitant medications were reported. Patient received Janssen COVID 19 vaccine 08-APR-2021. He had no complaints during day of administration. On 09-APR-2021, patient did not felt great. He toughed it out but did not felt good, but thought it was normal flu like illness which was expected following vaccine administration. On 10-APR- 2021, He knew something was off. On 12-APR-2021, he had weakness with movement from sitting to standing. On 24-APR-2021, he had stomach pain which was stabbing and alarmed. He sought medical attention on 15-MAY-2021 or 16-MAY-2021 to Emergency room while returning home after cycling. He could not get his heart rate down. His wife took him to emergency room for assessment. He was admitted to hospital to rule out heart attack. Cardiac investigations were performed. On 16-MAY-2021, he had ventricular tachycardia. He got a pacemaker inserted. Laboratory data included: Electrocardiogram (NR: not provided) Abnormal to Cath Lab. On 17-MAY-2021, the he had myocarditis. Laboratory data included: Cardiac catheterization (NR: not provided) Unknown, and Echocardiogram (NR: not provided) Low ejection fraction irregular findings. On 02-JUN-2021, Laboratory data included: MRI (NR: not provided) Advised to wear Life Vest defibrillator. On 03-JUN-2021, he was hospitalized for 9 days. Laboratory data included: PET scan (NR: not provided) Unknown. On 07-JUN-2021, Laboratory data included: Cardiac biopsy (NR: not provided) Unknown. On 09-JUN-2021, Laboratory data included: Lung biopsy (NR: not provided) Lung biopsy (NR: not provided) Nil sarcoidosis, Nil Giant Cell. On 10-JUN-2021, he had a pacemaker inserted. He was discharged on 12-JUN-2021. On 24-JUN-2021, he had heart failure post pacemaker insertion. On 10-JUL-2021, he had the feeling off exacerbated while cycling. On 24-JUL-2021, he had elevated heart rate greater than 170 while cycling. Laboratory data included: Heart rate (NR: not provided) 170. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from stomach pain was stabbing and alarming on 24-JUL-2021, was recovering from weakness with movement from sitting to standing, myocarditis, and feeling off exacerbated while cycling, and had not recovered from heart failure post pacemaker insertion, and ventricular tachycardia. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20210757581- covid-19 vaccine ad26.cov2.s-Heart failure post pacemaker insertion, myocarditis, Ventricular tachycardia, feeling off exacerbated while cycling. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: 9,0
Labordaten: Test Date: 20210516; Test Name: Electrocardiogram; Result Unstructured Data: Abnormal to Cath Lab; Test Date: 20210517; Test Name: Echocardiogram; Result Unstructured Data: Low ejection fraction irregular findings; Comments: Extremely low ejection fraction irregular findings/beats fluid accummulation- 'swelling to heart'; Test Date: 20210517; Test Name: Cardiac catheterization; Result Unstructured Data: Myocarditis; Comments: Normal coronary arteries, no PCI required. No cardiac disease, Diagnosis: Myocarditis; Test Date: 20210602; Test Name: MRI; Result Unstructured Data: Advised to wear Life Vest defibrillator; Test Date: 20210603; Test Name: PET scan; Result Unstructured Data: Unknown; Test Date: 20210607; Test Name: Cardiac biopsy; Result Unstructured Data: Unknown; Test Date: 20210609; Test Name: Lung biopsy; Result Unstructured Data: Nil sarcoidosis, Nil Giant Cell; Test Date: 20210724; Test Name: Heart rate; Result Unstructured Data: 170
Aktuelle Erkrankungen: Alcohol use (occassionally - approximately twice per month); Non-smoker; Penicillin allergy (told me not to take, childhood reaction, unsure of details)
Vorgeschichte: Medical History/Concurrent Conditions: Kidney stones; Comments: The patient had no history of drug abuse or illicit drug use. No previous cardiac history was reported.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1333503

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: OH
Alter: -
Geschlecht: M
Eingang: 30.07.2021
Impfdatum: -
Beginn: 12.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Abdominal pain upper Asthenia Biopsy heart Biopsy lung Cardiac failure Cardiomyopathy Catheterisation cardiac abnormal Chest discomfort Congestive cardiomyopathy Coronary artery stenosis Catheterisation cardiac Echocardiogram Electrocardiogram Feeling abnormal Heart rate Dizziness Dizziness postural Ejection fraction decreased

Symptomtext

FEELING OFF EXACERBATED WHILE CYCLING; HEART FAILURE POST PACEMAKER INSERTION; MYOCARDITIS; VENTRICULAR TACHYCARDIA; STOMACH PAIN WAS STABBING AND ALARMING; WEAKNESS WITH MOVEMENT FROM SITTING TO STANDING; This spontaneous report received from a patient concerned a 49 year old male. The patient's weight was 204 pounds, and height was 61 inches. The patient's past medical history included kidney stones. Concurrent conditions included alcohol use, non-smoker, and penicillin allergy, and other pre-existing medical conditions included no history of drug abuse or illicit drug use, no previous cardiac history was reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 042A21A, expiry: unknown) dose was not reported, 1 total administered on 08-APR-2021 on left arm for prophylactic vaccination. No concomitant medications were reported. Patient received Janssen COVID 19 vaccine 08-APR-2021. He had no complaints during day of administration. On 09-APR-2021, patient did not felt great. He toughed it out but did not felt good, but thought it was normal flu like illness which was expected following vaccine administration. On 10-APR- 2021, He knew something was off. On 12-APR-2021, he had weakness with movement from sitting to standing. On 24-APR-2021, he had stomach pain which was stabbing and alarmed. He sought medical attention on 15-MAY-2021 or 16-MAY-2021 to Emergency room while returning home after cycling. He could not get his heart rate down. His wife took him to emergency room for assessment. He was admitted to hospital to rule out heart attack. Cardiac investigations were performed. On 16-MAY-2021, he had ventricular tachycardia. He got a pacemaker inserted. Laboratory data included: Electrocardiogram (NR: not provided) Abnormal to Cath Lab. On 17-MAY-2021, the he had myocarditis. Laboratory data included: Cardiac catheterization (NR: not provided) Unknown, and Echocardiogram (NR: not provided) Low ejection fraction irregular findings. On 02-JUN-2021, Laboratory data included: MRI (NR: not provided) Advised to wear Life Vest defibrillator. On 03-JUN-2021, he was hospitalized for 9 days. Laboratory data included: PET scan (NR: not provided) Unknown. On 07-JUN-2021, Laboratory data included: Cardiac biopsy (NR: not provided) Unknown. On 09-JUN-2021, Laboratory data included: Lung biopsy (NR: not provided) Lung biopsy (NR: not provided) Nil sarcoidosis, Nil Giant Cell. On 10-JUN-2021, he had a pacemaker inserted. He was discharged on 12-JUN-2021. On 24-JUN-2021, he had heart failure post pacemaker insertion. On 10-JUL-2021, he had the feeling off exacerbated while cycling. On 24-JUL-2021, he had elevated heart rate greater than 170 while cycling. Laboratory data included: Heart rate (NR: not provided) 170. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from stomach pain was stabbing and alarming on 24-JUL-2021, was recovering from weakness with movement from sitting to standing, myocarditis, and feeling off exacerbated while cycling, and had not recovered from heart failure post pacemaker insertion, and ventricular tachycardia. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20210757581- covid-19 vaccine ad26.cov2.s-Heart failure post pacemaker insertion, myocarditis, Ventricular tachycardia, feeling off exacerbated while cycling. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: 9,0
Labordaten: Test Date: 20210516; Test Name: Electrocardiogram; Result Unstructured Data: Abnormal to Cath Lab; Test Date: 20210517; Test Name: Echocardiogram; Result Unstructured Data: Low ejection fraction irregular findings; Comments: Extremely low ejection fraction irregular findings/beats fluid accummulation- 'swelling to heart'; Test Date: 20210517; Test Name: Cardiac catheterization; Result Unstructured Data: Myocarditis; Comments: Normal coronary arteries, no PCI required. No cardiac disease, Diagnosis: Myocarditis; Test Date: 20210602; Test Name: MRI; Result Unstructured Data: Advised to wear Life Vest defibrillator; Test Date: 20210603; Test Name: PET scan; Result Unstructured Data: Unknown; Test Date: 20210607; Test Name: Cardiac biopsy; Result Unstructured Data: Unknown; Test Date: 20210609; Test Name: Lung biopsy; Result Unstructured Data: Nil sarcoidosis, Nil Giant Cell; Test Date: 20210724; Test Name: Heart rate; Result Unstructured Data: 170
Aktuelle Erkrankungen: Alcohol use (occassionally - approximately twice per month); Non-smoker; Penicillin allergy (told me not to take, childhood reaction, unsure of details)
Vorgeschichte: Medical History/Concurrent Conditions: Kidney stones; Comments: The patient had no history of drug abuse or illicit drug use. No previous cardiac history was reported.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1512717

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: IL
Alter: 28,0
Geschlecht: F
Eingang: 29.07.2021
Impfdatum: 29.07.2021
Beginn: 29.07.2021
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Head injury Immediate post-injection reaction Loss of consciousness

Symptomtext

PATIENT UPON RECEIVING VACCINE IMMEDIATELY PASSED OUT IN CHAIR; SHE SLID AND BUMPED HEAD SLIGHTLY AGAINST WALL. PATIENT WAS OUT FOR ABOUT 30 SECONDS. UPON COMING TO, PATIENT WAS FINE. EMTS WERE CALLED TO EVALUATE PATIENT AND PATIENT WAS DEEMED OK AND LEFT WITH HER MOTHER WHO WAS WITH HER AT THE TIME. SHE HAD NO OTHER COMPLAINTS AND MOTHER HAD STATED PRIOR THAT THIS HAD HAPPENED IN PAST WITH OTHER VACCINES. PATIENT IS OTHERWISE OK AT THIS TIME AND WENT HOME WITH HER MOTHER; SHE IS TO CONTACT US AND MD IF ANY OTHER CONCERNS ARISE.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: NONE; PATIENT WAS EVALUATED BY EMTS HOWEVER AND NOTHING OF NOTE FOUND
Aktuelle Erkrankungen: -
Vorgeschichte: SEIZURES, HISTORY OF OTHER MENTAL HEALTH DISORDERS AS WELL (NOT SPECIFIED)
Andere Medikamente: TRINTELLIX, GABAPENTIN, WELLBUTRIN, BUSPIRONE, ABILIFY, ZIPRASIDONE
Allergien: CEFZIL
Vorherige Impfungen: -

VAERS 1501072

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: AK
Alter: 18,0
Geschlecht: F
Eingang: 24.07.2021
Impfdatum: 23.07.2021
Beginn: 23.07.2021
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Syncope

Symptomtext

PATIENT FAINTED 5 TO 10 MINUTES POST ADMINISTRATION. SHE WAS NOT UNCONSCIOUS FOR ANY MEASURABLE AMOUNT OF TIME. SHE DID REMAIN DIZZY AND LIGHT HEADED FOR APPROXIMATELY 15-20 MINUTES BUT RECOVERED AFTER DRINKING SOME WATER AND ORANGE JUICE.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: NONE
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE (NO RECENT PHYSICALS OR LABWORK)
Andere Medikamente: NONE
Allergien: PENICILLIN
Vorherige Impfungen: -

VAERS 1498602

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MI
Alter: 63,0
Geschlecht: M
Eingang: 23.07.2021
Impfdatum: 06.04.2021
Beginn: 15.04.2021
Tage bis Beginn: 9,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anticoagulant therapy Aphthous ulcer Computerised tomogram abnormal Deep vein thrombosis Iridocyclitis Lymphadenopathy Pharyngitis Rash Scan with contrast Thrombocytopenia Ultrasound Doppler

Symptomtext

Patient had autoimmune appearing reaction with rash, iridocyclitis, DVT right femoral vein, thrombocytopenia, lymphadenopathy, aphthous ulcers, pharynigitis rheaumatology consultation, anticoagulation, ophthalmology care, hematology consultation, ENT consultation

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: -
Labordaten: 4/16/2021 ultrasound venous duplex lower extremity, DVT in the proximal right superficial femoral vein. CT neck with contrast 6/29/21: No abnormal solid as lesion identified within the pharynx or larynx however mucosal based lesions can be occult on CT. Correlation with direct visualization via endoscopy is recommended to exclude mucosal based lesion. Borderline enlarged bilateral cervical lymph nodes measuring up to 11 mm with otherwise several nonenlarged lymph nodes noted within the bilateral jugular digastric chains of uncertain clinical significance. Appropriate clinical correlation recommended. Consider follow-up versus tissue sampling if clinically indicated
Aktuelle Erkrankungen: Pulmonary emphysema (CMS/HCC) ? Current every day smoker ? Hyperlipidemia ? Gastroesophageal reflux disease without esophagitis ? Benign essential hypertension ? Pain in both lower extremities ? Syncope and collapse ? Atherosclerosis of native coronary artery of native heart with angina pectoris (CMS/HCC) ? Thoracic ascending aortic aneurysm (CMS/HCC) ? Dysuria ? Nocturia ? Anterior cervical adenopathy ? Chronic pain of right knee ? Nonrheumatic tricuspid valve regurgitation ? Mitral valve prolapse ? Nonrheumatic pulmonary valve insufficiency ? Sleep apnea ? Calcium pyrophosphate deposition disease ? Pneumonia of left upper lobe due to infectious organism ? COPD exacerbation (CMS/HCC) ? Other microscopic hematuria ? Hyponatremia ? Hypoalbuminemia ? Normocytic anemia ? Pulmonary nodules ? Alkaline phosphatase elevation ? Lumbar spinal stenosis ? S/P lumbar fusion ? Facet arthropathy of spine ? S/P cervical spinal fusion ? Neural foraminal stenosis of cervical spine
Vorgeschichte: Pulmonary emphysema (CMS/HCC) ? Current every day smoker ? Hyperlipidemia ? Gastroesophageal reflux disease without esophagitis ? Benign essential hypertension ? Pain in both lower extremities ? Syncope and collapse ? Atherosclerosis of native coronary artery of native heart with angina pectoris (CMS/HCC) ? Thoracic ascending aortic aneurysm (CMS/HCC) ? Dysuria ? Nocturia ? Anterior cervical adenopathy ? Chronic pain of right knee ? Nonrheumatic tricuspid valve regurgitation ? Mitral valve prolapse ? Nonrheumatic pulmonary valve insufficiency ? Sleep apnea ? Calcium pyrophosphate deposition disease ? Pneumonia of left upper lobe due to infectious organism ? COPD exacerbation (CMS/HCC) ? Other microscopic hematuria ? Hyponatremia ? Hypoalbuminemia ? Normocytic anemia ? Pulmonary nodules ? Alkaline phosphatase elevation ? Lumbar spinal stenosis ? S/P lumbar fusion ? Facet arthropathy of spine ? S/P cervical spinal fusion ? Neural foraminal stenosis of cervical spine
Andere Medikamente: albuterol HFA (PROVENTIL HFA;VENTOLIN HFA;PROAIR HFA) 90 mcg/actuation inhaler Inhale 2 puffs every 4 (four) hours as needed for wheezing or shortness of breath. 8.5 g 11 ? aspirin 81 mg tablet Take 1 tablet (81 mg total) by mouth daily. 90
Allergien: penicillin
Vorherige Impfungen: -

VAERS 1495698

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: IL
Alter: 26,0
Geschlecht: M
Eingang: 22.07.2021
Impfdatum: 22.07.2021
Beginn: 22.07.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Discomfort Dizziness Fall Head injury Immediate post-injection reaction Loss of consciousness

Symptomtext

Patient has a history of dizziness with shots, so they elected to get the Johnson and Johnson shot so that they would only need one shot. Patient received the vaccine in the counseling area, and the shot itself went as usual. About 15-45 seconds after the shot the patient stated that they began to feel dizzy. The patient then tried to lower himself to the floor. As soon as he started, he lost consciousness and fell forward out of his chair. He got some carpet burn in the area surrounding his eye. About a dime sized area above and a quarter sized area below. His head also mildly bumped against the wall. As soon as he passed out, 911 was called as a precaution. He was responsive within the minute, stating he was fine. He lost consciousness soon after for about 30 seconds before becoming responsive again. He was able to hold a conversation upon awakening. Patient states this is normal for him to experience. He has some discomfort with the carpet burns but reported no pain from bumping the top of the head. We offered some Neosporin for the carpet burns but patient stated that medication smells can sometimes make him dizzy, so we did not use any. We did provide him with some bandages for the area. I advised him to wash the area with soap and water at home. We kept him in the pharmacy for a half hour keeping conversation with him to make sure he was all right. He was able to stand on his own without issue after 25 minutes, he did not have any issues with dizziness at this point. After the wait and with patient being back to baseline, they wanted to get home and proceeded to go home. Before they left, I did verify that he was not the one driving home. Ii advised them to seek any medical attention if he has any further such issues. Patient came back after about 45 minutes asking what to use to clean wound. I recommended Neosporin, we did provide patient with both Neosporin and rubbing alcohol.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None per patient
Vorgeschichte: None per paperwork
Andere Medikamente: Unknown at present. Patient is not a regular patient at pharamcy.
Allergien: No known food or drug allergies
Vorherige Impfungen: Patient previously has stated they get dizzy from vaccines, but has not had a vaccine since childhood

VAERS 1479070

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CA
Alter: 29,0
Geschlecht: M
Eingang: 16.07.2021
Impfdatum: 16.07.2021
Beginn: 16.07.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Bradycardia Hypotension Incoherent Loss of consciousness Pallor Unresponsive to stimuli

Symptomtext

Shortly after patient received vaccination, I was flagged by spouse as patient became nonresponsive and experienced acute loss of consciousness. No fall or external trauma. Consciousness regained however patient was A&O x 2/3 with pallor and incoherent speech. EMT was contacted and pt was assessed. Pt declined transport to hospital and was further monitored in pharmacy prior to departure.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: 1st readings: BP: 74/37 (hypotensive) HR: 42 (bradycardia) BG: 90 SPO2: 97% Repeat Vitals prior to discharge: BP: 117/77 HR: 55 SPO2: 98%
Aktuelle Erkrankungen: No other illnesses
Vorgeschichte: Past medical history not significant for any health conditions per patient/spouse Pt/spouse state that they tend to become anxious during medical examinations or when within a medical environment
Andere Medikamente: No OTC, supplements, or herbal remedies taken at time of vaccination
Allergien: NKA
Vorherige Impfungen: Pt describes that they become very nervous within any medical setting and have experienced instances of dizziness shortly after

VAERS 1478365

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MI
Alter: 25,0
Geschlecht: M
Eingang: 16.07.2021
Impfdatum: 28.06.2021
Beginn: 10.07.2021
Tage bis Beginn: 12,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Intensive care Poisoning SARS-CoV-2 test positive

Symptomtext

Fully vaccinated patient admitted to hospital and tested positive for COVID. Admitted for intoxication to ICU. History of unmedicated schizophrenia. No s/s of COVID.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: 6,0
Labordaten: Positive COVID PCR on 07/10/2021
Aktuelle Erkrankungen: None known
Vorgeschichte: Schizophrenia
Andere Medikamente: Non prescribed amphetamines,
Allergien: NKA
Vorherige Impfungen: -

VAERS 1478273

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: IL
Alter: 70,0
Geschlecht: F
Eingang: 16.07.2021
Impfdatum: 07.04.2021
Beginn: 13.07.2021
Tage bis Beginn: 97,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Aphasia Computerised tomogram head abnormal Dysarthria Facial paralysis Facial paresis Haemorrhage Haemorrhage intracranial Hemiparesis Intraventricular haemorrhage Muscular weakness Thalamus haemorrhage

Symptomtext

HPI 70 y.o. female with pmh of HTN presenting w/aphasia and R sided facial and extremity weakness onset 15m prior to EMS activation. Per EMS, pt may be on anticoagulation, unk meds. LKW 15 minutes prior to activation pt began slurring her speech and spoused noted R facial droop and R sided weakness. Patient unable to provide history based aphasia however cannot yes or no to questions. Pt is no longer taking medications for BP. Patient positive of intracranial hemorrhage.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Facial paralysis
Hospital-Tage: -
Labordaten: TECHNIQUE: Contiguous 2.5mm unenhanced axial CT images of the head were obtained with generation of coronal and sagittal reformatted images as per the standard Hospital protocol. The exam was performed with one or more of the following dose reduction techniques: Automated exposure control, adjustment of the mA and/or kv according to patient size and/or iterative reconstruction techniques. FINDINGS: There is an acute parenchymal hemorrhage centered at the level of the left thalamic nucleus measuring 2.3 cm (AP) x 2.4 cm (TV) x 2.3 cm (CC). There is mild distortion of the left lateral ventricle. There is dissection of hemorrhage into the third ventricle. There is a minimal amount of hemorrhage in the atrium of the left lateral ventricle. No hydrocephalus. Cerebral volume is within limits of normal. The gray-white matter differentiation is preserved. The paranasal sinuses are aerated. There are no depressed calvarial fractures. IMPRESSION: Acute parenchymal hemorrhage at the level of the left thalamus with dissection into the third ventricle. The case was discussed with dr at 1020 hrs.
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension
Andere Medikamente: Vitamins C, D, E, zinc, calcium.
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 1478120

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MI
Alter: 78,0
Geschlecht: M
Eingang: 16.07.2021
Impfdatum: 06.07.2021
Beginn: 15.07.2021
Tage bis Beginn: 9,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Deep vein thrombosis Femur fracture Ultrasound Doppler abnormal

Symptomtext

DVT to lower extremity diagnosed 7/15/2021. Also, fractured femur to same side 6/13/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: -
Labordaten: Venous doppler to lower extremities positive for DVT.
Aktuelle Erkrankungen: ACUTE ON CHRONIC DIASTOLIC (CONGESTIVE) HEART FAILURE 6/13/2021 ATHEROSCLEROTIC HEART DISEASE OF NATIVE CORONARY ARTERY WITHOUT ANGINA PECTORIS 6/13/2021 ANEMIA, UNSPECIFIED 6/13/2021 VENOUS INSUFFICIENCY (CHRONIC) (PERIPHERAL) 6/13/2021 UNSPECIFIED TROCHANTERIC FRACTURE OF RIGHT FEMUR, SUBSEQUENT ENCOUNTER FOR CLOSED FRACTURE WITH ROUTINE HEALING 6/22/2021 UNSPECIFIED SEVERE PROTEIN-CALORIE MALNUTRITION 6/17/2021 OTHER SPECIFIED DISORDERS OF BONE DENSITY AND STRUCTURE, LEFT THIGH 6/17/2021
Vorgeschichte: ALZHEIMER'S DISEASE WITH LATE ONSET G30.1, F02.80 DEMENTIA IN OTHER DISEASES CLASSIFIED ELSEWHERE WITHOUT BEHAVIORAL DISTURBANCE HISTORY OF FALLING PERIPHERAL VASCULAR DISEASE, UNSPECIFIED XEROSIS CUTIS TINEA UNGUIUM MUSCLE WEAKNESS (GENERALIZED) DIFFICULTY IN WALKING, NOT ELSEWHERE CLASSIFIED OTHER FATIGUE
Andere Medikamente: Docusate Sodium Capsule 100 MG Give 1 capsule by mouth two times a day for constipation Pharmacy Active 6/17/2021 16:00 6/17/2021 Aspirin Tablet Chewable 81 MG Give 1 tablet by mouth one time a day for CAD Pharmacy Active 6/18/2021 08:00
Allergien: No Known Allergies
Vorherige Impfungen: -

VAERS 1470473

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: DC
Alter: 45,0
Geschlecht: M
Eingang: 14.07.2021
Impfdatum: 09.04.2021
Beginn: 16.04.2021
Tage bis Beginn: 7,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Chest X-ray Electrocardiogram Facial paralysis Headache Panic attack

Symptomtext

After receiving the vaccination I experienced headaches, face drooping on the left side possible Bells Palsy. I also experienced panic attack symptoms as well.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Facial paralysis
Hospital-Tage: -
Labordaten: No labs were done. I did have an ekg and chest x-ray.
Aktuelle Erkrankungen: No other illnesses at the time of vaccination.
Vorgeschichte: No chronic or long standing health conditions
Andere Medikamente: No prescription drugs or other medication were taken at the time of vaccination.
Allergien: No known allergies.
Vorherige Impfungen: Sore arm after Influenza

VAERS 1470193

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MI
Alter: 56,0
Geschlecht: M
Eingang: 14.07.2021
Impfdatum: 07.07.2021
Beginn: 08.07.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Angiogram normal Anticoagulant therapy Antiplatelet therapy Asthenia Condition aggravated Diastolic dysfunction Dizziness Drug abuse Echocardiogram abnormal Ejection fraction Embolic stroke Embolism Gait disturbance Headache Hypoaesthesia Hypokinesia Ischaemic cardiomyopathy Magnetic resonance imaging abnormal

Symptomtext

7.8.21: Patient reported weakness, lightheadedness, fever, possible numbness/tingling (also s/p heart cath) 7.9.21: Presented to ED - fever, headache, myalgia, neck stiffness, weakness in lower legs, difficulty walking, numbness - left AMA 7.9.21: Presented to ED - with generalized weakness - He was discharged on 7/7. He had noted BLE weakness during his admission and noted worsening of his weakness following his discharge. He returned to the ER on 7/8 but left AMA. He presented to ER on 7/9 with right arm and BLE weakness and MRI showed numerous small acute ischemic foci bilaterally. CTA was negative for significant stenosis or occlusion. He was evaluated by Neurology and felt that there was a high likelihood of cardioembolism as the etiology of his strokes vs cocaine. They recommended cardiac monitoring for evidence of afib as well as DAPT x 21 days followed by ASA monotherapy. He was noted to have an elevated troponin on admission and was placed on a Heparin drip. Cardiology did not feel that repeat cardiac cath was warranted. An Echo with bubble study was performed and showed EF 45-50%, diffuse hypokinesia, mild DD and no evidence of shunting. He has been accepted at hospital with plan for transfer there today. Assessment / Plan Multifocal stroke - suspect shower embolism vs r/t cocaine use - Echo - no evidence of shunt - per Neuro - DAPT x 21 days followed by ASA monotherapy - 30-day cardiac monitor at discharge Elevated troponin Recent IWMI CAD Ischemic CM - EF 45-50%, diffuse hypokinesia Cocaine use with possible vasospasm - s/p Heparin drip - no indication for repeat cardiac cath per Cardiology - ASA, Plavix, Metoprolol, Lisinopril, Lipitor - Norvasc - counseled on cocaine cessation

Weitere VAERSDATA-Felder

Praegender Schweregrund: Embolic stroke
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: NSTEMI, s/p CV left heart cardiac catheterization, coronary angiogram (7.7.21)
Vorgeschichte: Type 1 diabetes mellitus with hyperglycemia, bilateral peripheral neuropathy and gastroparesis Tobacco abuse disorder Leukocytosis Hypophosphatemia Hypertension COPD (chronic obstructive pulmonary disease) (HCC) Back pain Depression Depression, major, recurrent (HCC) Syncope Subacute maxillary sinusitis Epigastric pain NSTEMI (non-ST elevated myocardial infarction) (HCC) Polysubstance abuse (HCC) Diabetic ulcer of toe of left foot associated with type 1 diabetes mellitus, with fat layer exposed (HCC) Weakness Coronary artery disease of native artery of native heart with stable angina pectoris (HCC) Ischemic cardiomyopathy Cocaine use
Andere Medikamente: Outpatient Medications albuterol (PROVENTIL) (2.5 MG/3ML) 0.083% nebulization albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler amLODIPine (NORVASC) 5 MG tablet aspirin 81 MG chewable tablet atorvastatin
Allergien: Shellfish, bee, Jardiance, seafood, sulfa drugs
Vorherige Impfungen: -

VAERS 1214259

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: FL
Alter: 64,0
Geschlecht: M
Eingang: 14.07.2021
Impfdatum: 05.04.2021
Beginn: 12.04.2021
Tage bis Beginn: 7,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dizziness Hypoaesthesia Loss of consciousness Fatigue Muscular weakness

Symptomtext

Patient's wife reported today 7/14/21 that patient has experienced weakness in legs and fatigue beginning week or so after vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Patient did see his Dr. shortly after , patient's wife relayed to me
Aktuelle Erkrankungen: no
Vorgeschichte: N/A
Andere Medikamente: -
Allergien: no known
Vorherige Impfungen: -

VAERS 1214259

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: FL
Alter: 64,0
Geschlecht: M
Eingang: 14.07.2021
Impfdatum: 05.04.2021
Beginn: 12.04.2021
Tage bis Beginn: 7,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dizziness Hypoaesthesia Loss of consciousness Fatigue Muscular weakness

Symptomtext

Patient's wife reported today 7/14/21 that patient has experienced weakness in legs and fatigue beginning week or so after vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Patient did see his Dr. shortly after , patient's wife relayed to me
Aktuelle Erkrankungen: no
Vorgeschichte: N/A
Andere Medikamente: -
Allergien: no known
Vorherige Impfungen: -

VAERS 1467088

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MO
Alter: 61,0
Geschlecht: M
Eingang: 13.07.2021
Impfdatum: 01.04.2021
Beginn: 01.06.2021
Tage bis Beginn: 61,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test normal Computerised tomogram normal Facial paralysis Fatigue Feeling abnormal Impaired work ability Magnetic resonance imaging normal Oedema Speech disorder Trismus

Symptomtext

Pt claims to have lockjaw and has visible edema. Claims this has been going on for three weeks. He also claimed he had serious fatigue and fell asleep doing daily tasks. He states this is interfering with his ability to work as he is "always in a daze." Patient also has had trouble speaking and had visible facial paralysis (but not bilateral facial paralysis).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Facial paralysis
Hospital-Tage: -
Labordaten: Hospital confirmed no abnormal results during his three previous trips to the ER where they performed full bloodwork, CT scan, and MRI. No abnormal test results. No dates provided to this facility.
Aktuelle Erkrankungen: n/a
Vorgeschichte: hypertension
Andere Medikamente: bisprolol/hctz
Allergien: no allergies
Vorherige Impfungen: -

VAERS 1314915

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: AK
Alter: 42,0
Geschlecht: F
Eingang: 13.07.2021
Impfdatum: 10.04.2021
Beginn: 11.04.2021
Tage bis Beginn: 1,0
Dosis: N/A
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Fall Guillain-Barre syndrome Muscular weakness

Symptomtext

Recipient's mother reported that patient fell down the stairs at home on Sunday, April 11, 2021. Was taken to the ER and several tests performed to rule out any injury.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Guillain-Barre syndrome
Hospital-Tage: -
Labordaten: Unknown as to all tests
Aktuelle Erkrankungen: None
Vorgeschichte: None listed
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 1464743

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NV
Alter: 59,0
Geschlecht: F
Eingang: 12.07.2021
Impfdatum: 08.04.2021
Beginn: 12.06.2021
Tage bis Beginn: 65,0
Dosis: N/A
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Ageusia Anosmia Asthenia Blood test COVID-19 Dehydration Electrocardiogram Feeling abnormal Headache Nasal congestion Nausea Pyrexia SARS-CoV-2 test positive Syncope Throat irritation White blood cell count decreased

Symptomtext

I had itchy, scratchy throat on the 12th in afternoon. Sunday, I woke up fully congested. I went to the pharmacy to get decongestant and I ended up going into the clinic, 13th, to get checked. There, they looked in my nose and she said it was stuffy and goopy. She wasn't convinced it was an infection so told me to wait until. On Monday, Tuesday and Wednesday, I worked all day and was exhausted when I went home and on Wed, 16th, I started taking the antibiotic, I just felt bad and felt really stuffy. Got a low-grade fever, was taking Tylenol. I felt went really bad and I went as a walk-in to my primary care doctor. She said to let whatever it was to take its course. I had a little bout of nausea that would come here and there (she said that was from the drip in the back of my throat). Thursday night, I got dehydrated because I wasn't drinking enough or eating enough, nothing sounded good, though. I had a really bad headache and I passed out, woke up very quickly though. I woke up and felt nauseated. Husband took me to ER. They did an EKG and other testing including COVID test, positive result. Zinc; vitamin D, I started taking it every day instead of three days a week and added vitamin C and the elderberry gummies with immune support. I drank 7-8 bottles of water with electrolytes in it a day. I was in bed for three days without getting up. I got a pulse oximeter (as instructed by nurse at ER), never got below 90. The virus never went into my chest of my lungs and I never had to use my inhaler one time. I have about 90% of taste back now; I have some of my smell back. I didn't go back to work until 29th of June and I was just working short days as I was still very, very tired. About 3PM the tiredness would hit. Into this week, I'm not as tired anymore. I don't have 100% of energy back for exercising back.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: 17th, Hospital ER, EKG; IV fluids (no antibiotic); drew some blood. A nurse did a COVID test on me. Doctor said the reason they needed a COVID test was because my white blood count was low, although everything else was a normal result from testing. Tested positive for COVID. After that, I lost my sense of smell and maybe 70% of my taste.
Aktuelle Erkrankungen: No.
Vorgeschichte: Thyroid, Grave's Disease; Asthma.
Andere Medikamente: Synthroid; Triamterene HCTZ; Lovastatin; Liothyronine; Estradiol Patch; Biotin; Women's Multivitamin; Vitamin D; Gingko Biloba.
Allergien: Shellfish; Pumpkin Seeds.
Vorherige Impfungen: -

VAERS 1450709

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: FL
Alter: 55,0
Geschlecht: M
Eingang: 06.07.2021
Impfdatum: 06.04.2021
Beginn: 01.05.2021
Tage bis Beginn: 25,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Anticoagulant therapy Arthralgia Blood test Chest pain Dyspnoea Echocardiogram Electrocardiogram Food intolerance Hypoaesthesia Pain Pain in extremity Temperature intolerance Thrombosis Ultrasound Doppler abnormal

Symptomtext

I started to suffer from a numbness in my left hand that radiated into a deep pain and increasingly became intense. That pain radiated up to my shoulder and into the left quadrant of my chest. I started experiencing shortness of breath and a hypersensitivity to the heat. I went to Hospital ER and they ran a bunch of tests. I was diagnosed with a blood clot in my arm. I was given Eliquis. I was on that medication for about 2 weeks and after my second week of being on Eliquis, I started to suffer from the same symptoms. I decided to go to the Hospital. When I went there they admitted me and ran through blood tests to check for a heart attack or stroke or anything relating to the pain I was experiencing. Now I am back home and I am still taking Eliquis. As of today, I am still experiencing the symptoms. The symptoms are mild, but it's still scary. I would like to add that I have had an increase in dietary intolerance.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: 1,0
Labordaten: I have had multiple tests completed. There was a lot of blood work drawn, an EKG, an echocardiogram and an ultrasound. It was found that I have a blood clot in my arm and that is why I have been prescribed Eliquis.
Aktuelle Erkrankungen: I did not have any other illnesses.
Vorgeschichte: I had a spinal injury in 1986 that has made me disabled.
Andere Medikamente: I was taking vitamin C, hipprex, baclofen, magnesium and mirilax.
Allergien: I have an allergy to a probiotic, but I cannot remember the name.
Vorherige Impfungen: -

VAERS 1440857

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MI
Alter: 51,0
Geschlecht: M
Eingang: 01.07.2021
Impfdatum: 30.06.2021
Beginn: 30.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Head injury Injection site haemorrhage Loss of consciousness

Symptomtext

Approximately 3 minutes after he received J&J vaccine he passed out while sitting in a chair. He hit his head on the wall next to the chair. Staff immediately supported him and he stayed in the chair. He regained consciousness within a few seconds. A cot was brought to him, he was assisted by staff and laid on the cot, cool cloth applied to his forehead. Within 8 minutes he was feeling better, sitting up on the cot, drinking water. He did report that he has previously passed out at the sight of blood, and there was a small amount of blood at the injection site. We observed him for another 25 minutes and he returned to baseline, stated he was feeling fine. He went home with his step Dad, who had given him a ride to the clinic. I called the patient 2 hours later to check on him. Step Dad reported he was outside and unavailable, but that he has been feeling fine since leaving the clinic.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1433836

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: GA
Alter: 18,0
Geschlecht: M
Eingang: 30.06.2021
Impfdatum: 29.06.2021
Beginn: 29.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Headache Joint contracture Loss of consciousness Nausea Immediate post-injection reaction Paraesthesia Pyrexia Unresponsive to stimuli

Symptomtext

2 mins after receiving the vaccine he became dizzy and nauseous. Then later loss conscious, hands were clenched and was unresponsive for 45 seconds. Fever and slight headache currently.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: none
Vorherige Impfungen: -

VAERS 1432781

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: KY
Alter: 34,0
Geschlecht: F
Eingang: 29.06.2021
Impfdatum: -
Beginn: 07.06.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Capillary fragility Gait inability Soft tissue necrosis Thrombosis

Symptomtext

BLOOD CLOT; TISSUES NECROSIS; UNABLE TO WALK; CAPILLARIES EXPLODED; This spontaneous report received from a 35 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: UNKNOWN) frequency one total, dose was not reported, administered on 07-APR-2021 in left arm for prophylactic vaccination. No concomitant medications were reported. The patient reported about 3 weeks after vaccination his health problems started. He had been to numerous ERs, to primary neurologist, finally at 3rd hospital visit he was admitted and was in the ICU for 5 days. On 07-JUN-2021, they concluded a blood clot had formed in leg and traveled down to feet in toes where all capillaries exploded and tissues in toes necroded and died. The patient was unable to walk by self. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the blood clot, tissue necrosis, unable to walk and capillaries exploded was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0:20210648314-covid-19 vaccine ad26.cov2.s-blood clot, tissue necrosis, unable to walk, capillaries exploded. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1430234

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: MI
Alter: 34,0
Geschlecht: F
Eingang: 27.06.2021
Impfdatum: -
Beginn: 08.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Arthralgia Chills Fatigue Injection site mass Nausea Pain Paraesthesia Peripheral swelling Pyrexia Superficial vein thrombosis Tremor Ultrasound Doppler abnormal

Symptomtext

[Johnson and Johnson Covid 19 vaccine ] treatment under Emergency Use Authorization(EUA): Patient received JJ vaccine on 4/8/21. Vaccine was given about 1.5 cm below the acromion process per doctor measurement. Patient noticed a small lump at injection site within 15 minutes. That night patient had 'pins and needles' down her left arm, arm/hand tremors, chills/fever (102.3), nausea, body aches, fatigue and shoulder pain. Patient took ibuprofen at 4am 4/9. Saturday (4/10) patient noticed a lump on her left forearm. Patient had an ultrasound done (4/14) on her left arm and a supraficial, venous thrombosis in the cephalic vein of the left forearm was found. Patient was told to start aspirin 81mg on 4/15. venous thrombosis in cephalic vein of left forearm found

Weitere VAERSDATA-Felder

Praegender Schweregrund: Superficial vein thrombosis
Hospital-Tage: -
Labordaten: ULTRASOUND - 14-Apr-2021 - venous thrombosis in cephalic vein of left forearm
Aktuelle Erkrankungen: -
Vorgeschichte: breastfeeding
Andere Medikamente: ibuprofen
Allergien: -
Vorherige Impfungen: -

VAERS 1429579

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: IA
Alter: 18,0
Geschlecht: M
Eingang: 26.06.2021
Impfdatum: 25.06.2021
Beginn: 25.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Fall Head injury Syncope Tongue injury

Symptomtext

Patient was sitting on a chair in the recovery area after receiving the vaccine and slumped over and fell off the chair (seeming to have fainted) He hit his head when he fell off the chair and bit his tongue. He regained consciousness immediately and was talking and coherent. We monitored pulse and breathing and kept him talking. We called an ambulance immediately and his parents. Ambulance personnel came and evaluated the patient and released him to his parents with the recommendation to monitor the patients and have him further evaluated if necessary.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1428094

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: IN
Alter: 18,0
Geschlecht: M
Eingang: 25.06.2021
Impfdatum: 25.06.2021
Beginn: 25.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Abdominal discomfort Condition aggravated Loss of consciousness Syncope Vision blurred

Symptomtext

Patient had slight queasiness/stomach discomfort and slight blurry vision before administration of vaccine. Both intensified within a couple minutes after vaccination, and 5 minutes after administration patient fainted/lost consciousness. He regained consciousness 10 seconds later and was ambulatory afterwards. Patient exhibited no difficulty of breath or cognitive impairment. Pharmacist had patient sit and drink water for a half-hour afterwards with observation. Patient left store on own ability and left afterwards.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: None at this time.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1428009

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: NC
Alter: 59,0
Geschlecht: M
Eingang: 25.06.2021
Impfdatum: 25.06.2021
Beginn: 25.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

Convulsive syncope approximately 5 minutes after receiving injection. No treatment given and patient came out of it on his own after approximately 30-60 seconds.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1424065

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NV
Alter: 47,0
Geschlecht: F
Eingang: 24.06.2021
Impfdatum: 05.04.2021
Beginn: 05.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bell's palsy Facial discomfort

Symptomtext

Bells Palsy on left side of face on side of injection. I still have sensations on that side of my face, but there is no obvious signs.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: Premarin 0.625mg Claritin Multivitamins low dose aspirin
Allergien: none
Vorherige Impfungen: -

VAERS 1401097

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CA
Alter: 52,0
Geschlecht: F
Eingang: 24.06.2021
Impfdatum: 10.05.2021
Beginn: 17.05.2021
Tage bis Beginn: 7,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Abdominal pain Acute hepatic failure Biopsy liver abnormal Condition aggravated HBV-DNA polymerase increased Autoimmune hepatitis Hepatitis B reactivation Biopsy liver Blood test Chills Chromaturia Feeding disorder Headache Hepatic enzyme increased Hepatitis B Hepatitis B core antibody positive Hepatitis D antibody negative Hepatitis B DNA increased

Symptomtext

pt with acute liver injury - hospitalized. LFTs abnormal 1-2 weeks after receiving vaccine. Initially thought due to reactivation of hepatitis B vs autoimmune hepatitis. Ultimately required liver transplant for acute liver failure, received 6/20 at

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: 9,0
Labordaten: liver biopsy 6/1, 6/14, liver transplant 6/20
Aktuelle Erkrankungen: None
Vorgeschichte: Hepatitis B, chronic. Rheumatoid Arthritis. Asthma.
Andere Medikamente: vitamin D, voltaren gel, plaquenil, ibuprofen, singulair
Allergien: tegaderm, ampicillin (nausea), aspirin (stomach ache), chlorhexidine (itching)
Vorherige Impfungen: -

VAERS 1175740

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MA
Alter: 60,0
Geschlecht: M
Eingang: 21.06.2021
Impfdatum: 01.04.2021
Beginn: 01.04.2021
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood glucose Blood pressure measurement Electrocardiogram Loss of consciousness Syncope Cardiac monitoring Concussion Heart rate decreased Heart rate irregular Intensive care Retinal tear Seizure

Symptomtext

Fainting at site, 10 minutes after shot administered (while sitting on side after vaccine administered - was fine immediately following receipt of vaccine). Went to hospital, no definitive reason confirmed for fainting (possible dehydration). Two months later, fainted in bathroom (was sleeping, got up to urinate), resulted in concussion. Transported to ER - heart rate dropped three times below 30, hospitalized at hospital. Heart rate dropped 12 hours later, 7 second pause in heart rate. Released with Heart monitor the next day. One week later heart rate dropped three times (fainted again multiple times) at eye doctor, while being checked for retina tear (confirmed retina tear), transported again to hospital. Still no confirmed diagnosis as to why heart rate is continuing to drop resulting in fainting. Continuing followups at this time to determine cause.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: 2,0
Labordaten: Only confirmed medical test out of ordinary is previous Lyme disease. Doctors indicated Lyme disease doesn't typically cause this particular issue with the heart, although that hasn't been totally ruled out. Could this be myocarditis? That hasn't been ruled out either as far as we know.
Aktuelle Erkrankungen: Crohn's disease
Vorgeschichte: Crohn's Disease
Andere Medikamente: Centrum vitamin
Allergien: -
Vorherige Impfungen: -

VAERS 1175740

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MA
Alter: 60,0
Geschlecht: M
Eingang: 21.06.2021
Impfdatum: 01.04.2021
Beginn: 01.04.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood glucose Blood pressure measurement Electrocardiogram Loss of consciousness Syncope Cardiac monitoring Concussion Heart rate decreased Heart rate irregular Intensive care Retinal tear Seizure

Symptomtext

Fainting at site, 10 minutes after shot administered (while sitting on side after vaccine administered - was fine immediately following receipt of vaccine). Went to hospital, no definitive reason confirmed for fainting (possible dehydration). Two months later, fainted in bathroom (was sleeping, got up to urinate), resulted in concussion. Transported to ER - heart rate dropped three times below 30, hospitalized at hospital. Heart rate dropped 12 hours later, 7 second pause in heart rate. Released with Heart monitor the next day. One week later heart rate dropped three times (fainted again multiple times) at eye doctor, while being checked for retina tear (confirmed retina tear), transported again to hospital. Still no confirmed diagnosis as to why heart rate is continuing to drop resulting in fainting. Continuing followups at this time to determine cause.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: 2,0
Labordaten: Only confirmed medical test out of ordinary is previous Lyme disease. Doctors indicated Lyme disease doesn't typically cause this particular issue with the heart, although that hasn't been totally ruled out. Could this be myocarditis? That hasn't been ruled out either as far as we know.
Aktuelle Erkrankungen: Crohn's disease
Vorgeschichte: Crohn's Disease
Andere Medikamente: Centrum vitamin
Allergien: -
Vorherige Impfungen: -

VAERS 1175740

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MA
Alter: 60,0
Geschlecht: M
Eingang: 21.06.2021
Impfdatum: 01.04.2021
Beginn: 01.04.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood glucose Blood pressure measurement Electrocardiogram Loss of consciousness Syncope Cardiac monitoring Concussion Heart rate decreased Heart rate irregular Intensive care Retinal tear Seizure

Symptomtext

Fainting at site, 10 minutes after shot administered (while sitting on side after vaccine administered - was fine immediately following receipt of vaccine). Went to hospital, no definitive reason confirmed for fainting (possible dehydration). Two months later, fainted in bathroom (was sleeping, got up to urinate), resulted in concussion. Transported to ER - heart rate dropped three times below 30, hospitalized at hospital. Heart rate dropped 12 hours later, 7 second pause in heart rate. Released with Heart monitor the next day. One week later heart rate dropped three times (fainted again multiple times) at eye doctor, while being checked for retina tear (confirmed retina tear), transported again to hospital. Still no confirmed diagnosis as to why heart rate is continuing to drop resulting in fainting. Continuing followups at this time to determine cause.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: 2,0
Labordaten: Only confirmed medical test out of ordinary is previous Lyme disease. Doctors indicated Lyme disease doesn't typically cause this particular issue with the heart, although that hasn't been totally ruled out. Could this be myocarditis? That hasn't been ruled out either as far as we know.
Aktuelle Erkrankungen: Crohn's disease
Vorgeschichte: Crohn's Disease
Andere Medikamente: Centrum vitamin
Allergien: -
Vorherige Impfungen: -

VAERS 1413336

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MN
Alter: 43,0
Geschlecht: F
Eingang: 20.06.2021
Impfdatum: 31.03.2021
Beginn: 02.04.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood sodium decreased Blood test normal Bradycardia Chest X-ray normal Chest pain Computerised tomogram thorax normal Dyskinesia Dyspnoea Electrocardiogram normal Fibrin D dimer increased Full blood count normal Gastrooesophageal reflux disease Guillain-Barre syndrome Head discomfort Heart rate increased Hypoaesthesia Immunoglobulin therapy Lumbar puncture

Symptomtext

After receiving the vaccine on 3/31, experienced typical side effects noted such as sore arm, body aches, etc. - however two days after felt numbness and tingling in feet and hands which went away a few days later. On 4/14, the tingling in feet returned. Went to ER on 4/16 as tingling/numbness getting worse and progressing upward to legs; evaluated and sent home. Returned to ER on 4/22 as numbness/tingling continued to progress upward, evaluated and sent home. On 4/25, in addition to constant numbness/tingling, started experiencing tachycardia. Resting heart rate as well as heart rate doing simple tasks was high. Also began experiencing difficulty getting a full breath. Woke up 4/27 to worsening breathing and tachycardia, as well as new feelings of adrenaline rushes and Internal tremors throughout the body. PCP ordered Troponin and D Dimer and D Dimer elevated. Back to ER that day - negative Covid test - CT of chest showed no blood clots; sent home. That evening, resting heart rate was high and elevated even while lying down (90-110 bpm). The next day, 4/28, all symptoms continued and worsened as day progressed. Returned to ER and in the way experienced a pre syncope episode - upon arrival to ER blood pressure was 70/30; stabilized and sent home. Continued tachycardia and another pre-syncope episode that evening. Was referred to neurology and had appointment 4/29; all symptoms remained and were increasingly debilitating. Neurologist determined more testing needed, and was admitted to the hospital for observation/testing. Diagnosed with Guillain Barre Syndrome after head/neck/spine MRI and lumbar puncture, which showed elevated protein. Hospitalized for 5 day course of IVIG and discharged 5/4. Started feeling better for a few weeks, although numbness/tingling in legs/feet never went away. The week of 5/17 started feeling burning in throat/nose/chest and returning tachycardia; returned to ER 5/23, was admitted for observation as D Dimer high again - checked for DVT, all clear; testing and suspicion of Postural Orthostatic Tachycardia Syndrome (POTS); discharged 5/25. On evening of 5/30, experienced new concerning neurological tremors and sudden involuntary movements, as well as stiff neck/head. Returned to ER 5/31; evaluated and released. Have continued to experience autonomic nervous system dysfunction, POTS symptoms, tachycardia and bradycardia, constant numbness and tingling in extremities and occasional tingling/numbness in other areas in the body, pressure in head, internal tremors, adrenaline rushes, feelings of burning in throat/chest, suspected reflux; upcoming appointments with an Electrophysiologist and Neuromuscular Doctor for further evaluation. Note - also reported this using v-safe up until the weekly check ins were over

Weitere VAERSDATA-Felder

Praegender Schweregrund: Guillain-Barre syndrome
Hospital-Tage: 8,0
Labordaten: 4/16 - CBC and metabolic panel; nothing notable, slightly low sodium 4/19 - spine X-ray - unremarkable; numerous blood tests, all normal, sodium back in range 4/22 - metabolic panel, normal; spinal MRI NORMAL 4/26 - EKG; numerous blood tests, all normal 4/27 - troponin normal; d dimer 866; Covid test negative; CT for pulmonary embolism negative 4/28 - CBC, troponin, metabolic panel, EKG all normal or close to range 4/29 - MRI head, cervical spine, and thoracic spine ; all came back no adverse findings 4/30 - lumbar puncture - tested for many things , but protein came back elevated ; led to GBS diagnosis 5/23 - many blood tests - d dimer elevated again at 1546; ultrasound for DVT negative for clots 5/24 - d dimer 1693; no other symptoms of PE so Ct/ VQ scan not recommended; orthostatics tested and showed increase of 30+ bpm upon standing 5/28 - numerous blood tests ; d dimer going down but still elevated at 1496 5/31 - numerous blood tests - normal or close to for all 6/14 - numerous blood tests all normal or close to 6/17 - chest X-ray normal
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Multivitamin, probiotic, occasional over the counter pain relief as needed (Tylenol, ibuprofen)
Allergien: Delayed skin reaction to CT contrast dye
Vorherige Impfungen: -

VAERS 1413153

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: CA
Alter: 33,0
Geschlecht: M
Eingang: 19.06.2021
Impfdatum: 18.06.2021
Beginn: 18.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Blood pressure normal Eye movement disorder Hyperhidrosis Pallor Seizure Syncope Unresponsive to stimuli

Symptomtext

After 5 mins of getting the vaccine, pt had a syncope and/or seizure episode. Pt's eyes started to roll back and was only showing the white. His hands were flinching into fist and pt was unresponsive. This lasted about 20-30 secs. We called ED and got the operator on the phone. When we started to give the operator information, pt starts waking up. Pt's mom didn't want the ambulance to come since pt is now awake so we told the operator everything is fine now and hung up. Pt's forehead was sweaty and facial color was very pale. We gave pt some water to drink and asked pt to continue to sit there and relax. Pt has no idea of what happened he said he just remember one moment talking to his mom and the next moment she was holding him up. Pt sat there for a total of about 1 hour and he said he was fine so they left. We informed mom and pt to please go the UC or ER for follow up but they declined. They said they will have him rest and hopefully things will be OK soon. I checked his Blood pressure x 2 and both times they were good at around 128/87. Gave mom my pharmacy business card to call with any further questions or concerns

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: BP check was normal
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: NONE
Allergien: NO KNOWN ALLERGY
Vorherige Impfungen: -

VAERS 1409968

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: -
Alter: 54,0
Geschlecht: F
Eingang: 18.06.2021
Impfdatum: 16.06.2021
Beginn: 16.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt

Anxiety Dizziness Feeling abnormal Nausea Presyncope Vomiting

Symptomtext

She states she did not eat breakfast but this is normal for her and had coffee this morning, nothing else out of the ordinary. Was very anxious feeling before the vaccine. Pt to ER for dizziness after she received covid vaccine About 5 minutes afterwards she began feeling more anxious, as well as dizzy and lightheaded, vomiting once. No LOC noted. At this point feeling a little "foggy" which has persisted. She has been ambulatory and has no focal weakness or other problems. No history of reactions to other vaccines in the past. Lightheadedness Vasovagal episode . Nausea,Vomiting. ED visit,Monitoring at vaccine site

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1402892

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MI
Alter: 61,0
Geschlecht: M
Eingang: 16.06.2021
Impfdatum: 15.06.2021
Beginn: 15.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Blood glucose normal Dizziness Eye movement disorder Hyperhidrosis Immediate post-injection reaction Loss of consciousness Pain in extremity Respiration abnormal

Symptomtext

Patient denied history of fainting. Patient received Janssen vaccine at 11:49. Immediately after receiving vaccination patient was complaining of arm pain. Patient was asked by charge RN to stay seated at table instead of moving to observation area. Patient started complaining of feeling dizzy at 11:53 am. RN asked patient to lie down. Patient wanted to remain seated. Patient asked if he was diabetic. Patient confirmed he had type 2 diabetes and was unsure of last time he ate and blood sugar. Snack and cold water was obtained for patient. Patient became diaphoretic and was breathing fast. Blood presssure obtained and read 195/177. Blood glucose was obtained and read 132. RN asked for assistance lowering patient to ground. Patient's eyes rolled back while lowering patient. Patient was unconscious for approximately 60 seconds. EMS was called by bystander. Patient came back to consciousness and was alert and oriented. Patient's Blood pressure was obtained adnd read 156/80. HR was 58. EMS arrived and obtained vitals. Patient refused further treatment by EMS. Patient had ride pick him up at 12: 40. Patient was alert and oriented and no other symptoms upon leaving vaccination site.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Blood glucose at 1155-132 Blood Pressure 1155- 195/177 Blood pressure 1200- 156/80, HR 58
Aktuelle Erkrankungen: Patient stated being hospitalized for a month for COVID . Per patient he was discharged June 4. Patient also has history of type 2 diabetes.
Vorgeschichte: Type 2 Diabetes
Andere Medikamente: patient unsure
Allergien: patient stated no allergies
Vorherige Impfungen: -

VAERS 1399963

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NM
Alter: 38,0
Geschlecht: F
Eingang: 15.06.2021
Impfdatum: 06.04.2021
Beginn: 06.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Angiogram cerebral abnormal Anticoagulant therapy Cerebral thrombosis Headache Impaired work ability Magnetic resonance imaging head Pain Paraesthesia Ultrasound Doppler normal Venogram Vomiting

Symptomtext

On April 06,2021 I took the Johnson and Johnson vaccine the next day I threw up and my leg would fall asleep I advised my doctor she sent me to the emergency room I went to the hospital. They did a ultrasound they didn?t find and blood clots I also advised them that I had been having headaches and they told me take over the counter pills. The head aches continued I was with the pain for a month in half my doctor sent me for a MRI and to a neurologist. The headaches still continue finally my neurologist sent me to the hospital. They conducted MRI MRV MRA I was admitted to the hospital for 14 days I haven?t been able to return to work I am not 100% I am on blood thinners. They ended up finding a blood clot on the right side of my head I am still not able to return to work still having headaches and still having to go to follow ups.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral thrombosis
Hospital-Tage: 14,0
Labordaten: I was in the hospital may 17-30 during those day they did mri mrv mra
Aktuelle Erkrankungen: Diabetic High blood pressure
Vorgeschichte: None
Andere Medikamente: None
Allergien: Shellfish
Vorherige Impfungen: -

VAERS 1396453

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: WA
Alter: 41,0
Geschlecht: M
Eingang: 14.06.2021
Impfdatum: 06.04.2021
Beginn: 14.04.2021
Tage bis Beginn: 8,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Thrombosis Ultrasound scan abnormal

Symptomtext

Blood clot in right leg - 6.5?

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: Ultrasound
Aktuelle Erkrankungen: None
Vorgeschichte: Low testosterone Chronic pain in lower back & left hip, knee, ankle Anxiety
Andere Medikamente: Methadone Propranolol Lithium Carbonate Lorazepam
Allergien: NKA
Vorherige Impfungen: -

VAERS 1395447

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: ME
Alter: 26,0
Geschlecht: M
Eingang: 14.06.2021
Impfdatum: 13.06.2021
Beginn: 13.06.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Electrocardiogram Loss of consciousness

Symptomtext

Within about 30-60 seconds of vaccine administration, patient became lightheaded and experienced loss of consciousness. He was sitting in a chair at the time and was prevented from falling. He was moved into the supine position on a cot with feet elevated and rapidly regained consciousness. Over the course of several minutes, his condition improved and he experienced a complete recovery.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: 12 lead EKG was done by one site EMS with unremarkable results.
Aktuelle Erkrankungen: none known
Vorgeschichte: none known
Andere Medikamente: none known
Allergien: none known
Vorherige Impfungen: -

VAERS 1388559

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: WA
Alter: 47,0
Geschlecht: M
Eingang: 10.06.2021
Impfdatum: 26.05.2021
Beginn: 02.06.2021
Tage bis Beginn: 7,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bell's palsy

Symptomtext

Bell's palsy 6 days after vaccine, mild to moderate, unresolved at this time

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1385005

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: IL
Alter: 43,0
Geschlecht: F
Eingang: 09.06.2021
Impfdatum: 09.04.2021
Beginn: 15.05.2021
Tage bis Beginn: 36,0
Dosis: 1
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cough Dizziness Dyspnoea Headache Syncope

Symptomtext

Cough, dizzy, faint, short of breath, headaches at onset. These are the symptoms since May 22nd through today, June 9th. Cough still persists, along w/ headaches and dizzy. Still short of breath...

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: Test (1) - Negative, May 25th. Test (2) - June 8th, Positive.
Aktuelle Erkrankungen: NO
Vorgeschichte: NO
Andere Medikamente: NO
Allergien: NO
Vorherige Impfungen: -

VAERS 1378479

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: IL
Alter: 58,0
Geschlecht: F
Eingang: 07.06.2021
Impfdatum: 10.04.2021
Beginn: 20.04.2021
Tage bis Beginn: 10,0
Dosis: N/A
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein

Angiogram Aphasia Arthralgia Balance disorder CSF protein increased Central venous catheterisation Feeding disorder Guillain-Barre syndrome Hypoaesthesia Immunoglobulin therapy Intensive care Lumbar puncture abnormal Magnetic resonance imaging normal Musculoskeletal disorder Neck pain Pain Pain in extremity Paraesthesia

Symptomtext

Radiating pain from the right neck, shoulder and arm that spread to the left side. Tingling sensation in fingers, along with pain. Taken to ED, labs and imaging were done that were inconclusive. Tingling and numbness spreading to feet and legs, but however patient was discharged even in worsening condition with no answers, and told to make an appointment with a neurologist the following week. After being brought home, the numbness spread and patient could not support her weight and would lose balance. Ambulance called and taken back to the same facility. Admitted under observation initially, the following day, a lumbar puncture was completed, at the request from our daughter (who is a nurse) to the doctors, that showed elevated protein in the CSF. It was concluded that patient showed clinical signs of Guillian-Barre Syndrome and was subsequently started on IVIG therapy. Her condition worsened and she was upgraded to progressive care and then the neuro ICU when numbness had spread to her face. A central line was placed and patient was started on plasmapheresis. Patient showed loss of feeling and function in her arms and legs, swelling in her face that did not allow her to speak or eat properly. 3 more rounds of IVIG were done after plasmapheresis was completed. Patient was stabilized and transferred to the rehabilitation hospital for rehab and therapy.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Guillain-Barre syndrome
Hospital-Tage: 13,0
Labordaten: April 21, 2021 - CT w/Angio and MRI completed - unremarkable April 24, 2021 - Lumbar Puncture showed elevated protein levels in CSF
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1376351

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: TX
Alter: 58,0
Geschlecht: M
Eingang: 06.06.2021
Impfdatum: 24.05.2021
Beginn: 24.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

Patient reported fainting while working, probably due to vaccine because he's not aware that anything else could have caused it. He was in the store manager's office when I was paged to come. He didn't report other symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1373240

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MA
Alter: -
Geschlecht: M
Eingang: 04.06.2021
Impfdatum: -
Beginn: 25.05.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Pain in extremity Thrombosis Ultrasound scan

Symptomtext

TWO BLOOD CLOTS; LEFT CALF PAIN FOR A COUPLE OF DAYS/FELT LIKE MUSCLE STRAIN; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: unknown) dose was not reported, 1 total, administered on 03-APR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported. On 25-MAY-2021, the patient experienced left calf pain for a couple of days which the patient believed that it was a muscle strain and was increasingly painful. On 28-MAY-2021, the patient was sent to the hospital to do an ultrasound and the HCP (health care professional) suggested for the patient to go to the emergency room visit because the patient had two blood clots. On 28-MAY-2021, the patient was hospitalized and was discharged on 28-MAY-2021. The patient was hospitalized for 1 day. Laboratory data included: Diagnostic ultrasound (NR: not provided) 2 blood clots. On the day of reporting, it was informed that the patient was taking treatment medications (dates unspecified) which included: Eliquis (apixaban) for blood clots. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from two blood clot, and the outcome of left calf pain for a couple of days/felt like muscle strain was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20210601553-covid-19 vaccine ad26.cov2.s - two blood clots in patient. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: 1,0
Labordaten: Test Date: 20210528; Test Name: Diagnostic ultrasound; Result Unstructured Data: 2 blood clots
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1184767

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NH
Alter: -
Geschlecht: M
Eingang: 04.06.2021
Impfdatum: -
Beginn: 09.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fatigue Hyperhidrosis Loss of consciousness Tremor Urinary incontinence Seizure like phenomena

Symptomtext

PASSED OUT; URINATED ON SELF; SHAKING; SWEATY; TIREDNESS; This spontaneous report received from a consumer concerned a 38-year-old white, Not Hispanic/Latino male. The patient's height, and weight were not reported. The patient's past medical history included seizures, and concurrent conditions included sleep apnea, and other pre-existing medical conditions included no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the patient experienced passed out, urinated on self, shaking. sweaty and tiredness. The reporter mentions that the patient had passed out, had been shaking and had urinated on himself in about 1 and 1/2 minutes after vaccination The personnel at the vaccination facility had laid him on floor. The patient was sweaty and seemed to have a seizure but the hospital did not call it a seizure. He had regained consciousness in about 1 minute of passing out. He had been taken to the hospital and was discharged on the same day. He had been feeling tired after returning from hospital but all the other events had been resolved. The patient had been feeling normal since the next day that is 10-April-2021 The action taken with covid-19 vaccine ad26.cov2.s was not reported. The patient recovered from passed out, urinated on self, shaking, and sweaty on 09-APR-2021, and tiredness on 09-APR-2021. This report was serious (Other Medically Important Condition).; Sender's Comments: V0 20210604938-covid-19 vaccine ad26.cov2.s-Loss of Consciousness. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Sleep apnea
Vorgeschichte: Medical History/Concurrent Conditions: Seizures (He had seizures as a child but have not had any seizures as an adult.); Comments: No known drug allergies.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1184767

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NH
Alter: -
Geschlecht: M
Eingang: 04.06.2021
Impfdatum: -
Beginn: 09.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fatigue Hyperhidrosis Loss of consciousness Tremor Urinary incontinence Seizure like phenomena

Symptomtext

PASSED OUT; URINATED ON SELF; SHAKING; SWEATY; TIREDNESS; This spontaneous report received from a consumer concerned a 38-year-old white, Not Hispanic/Latino male. The patient's height, and weight were not reported. The patient's past medical history included seizures, and concurrent conditions included sleep apnea, and other pre-existing medical conditions included no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the patient experienced passed out, urinated on self, shaking. sweaty and tiredness. The reporter mentions that the patient had passed out, had been shaking and had urinated on himself in about 1 and 1/2 minutes after vaccination The personnel at the vaccination facility had laid him on floor. The patient was sweaty and seemed to have a seizure but the hospital did not call it a seizure. He had regained consciousness in about 1 minute of passing out. He had been taken to the hospital and was discharged on the same day. He had been feeling tired after returning from hospital but all the other events had been resolved. The patient had been feeling normal since the next day that is 10-April-2021 The action taken with covid-19 vaccine ad26.cov2.s was not reported. The patient recovered from passed out, urinated on self, shaking, and sweaty on 09-APR-2021, and tiredness on 09-APR-2021. This report was serious (Other Medically Important Condition).; Sender's Comments: V0 20210604938-covid-19 vaccine ad26.cov2.s-Loss of Consciousness. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Sleep apnea
Vorgeschichte: Medical History/Concurrent Conditions: Seizures (He had seizures as a child but have not had any seizures as an adult.); Comments: No known drug allergies.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1369341

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CA
Alter: 28,0
Geschlecht: F
Eingang: 02.06.2021
Impfdatum: 09.04.2021
Beginn: 18.04.2021
Tage bis Beginn: 9,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Erythema Headache Pain in extremity Swelling Thrombosis Ultrasound Doppler Ultrasound scan abnormal

Symptomtext

Review of ED notes show she received IV infusion of normal saline, and IV push of benadryl and compazine after going to the ER for severe headache on 04/17/2021. She first noticed pain when streching the arm shortly after the IV infusion but didn't pay attention to it, then 5 day later she noticed localized swelling and redness. Patient was sent for US doppler which left cephalic vein thrombus detected on duplex US. Was treated with aspirin and had follow up doppler of UE for follow up on LUE cephalic vein thrombosis-negative 5/13/21.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: Duplex ultrasounds
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: none
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1362323

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: PA
Alter: 23,0
Geschlecht: M
Eingang: 31.05.2021
Impfdatum: 31.05.2021
Beginn: 31.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Feeling of body temperature change Injection site pain Musculoskeletal stiffness Presyncope Syncope Tremor

Symptomtext

Patient became extremely faint immediately after the injection. Patient began to shake, got really hot, then really cold and felt as if he were going to pass out. Also said that his arm hurt & felt stiff at the injection site. This feeling he described lasted about 15 minutes, then he began to start feeling a little bit better. We gave him some water and had him sit for as long as he needed. Patient sat for total of 30 minutes, then left of his on accord.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1357950

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MI
Alter: 78,0
Geschlecht: F
Eingang: 28.05.2021
Impfdatum: 21.05.2021
Beginn: 21.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein

Angiogram Computerised tomogram Diplopia Eye patch application Magnetic resonance imaging head abnormal Scan with contrast VIth nerve paralysis

Symptomtext

Double vision - diagnosed as 6th nerve palsy in right eye. Could take up to 6 months for normal vision if then. Have seen eye doctor and neurologist. Have to wear eye patch.

Weitere VAERSDATA-Felder

Praegender Schweregrund: VIth nerve paralysis
Hospital-Tage: 2,0
Labordaten: MRI, MRA, Cat scan with contrast. Taken a Hospital on May 21, 2021. No blood clots.
Aktuelle Erkrankungen: None
Vorgeschichte: Ocular Migraines, fibroidmalia,
Andere Medikamente: none
Allergien: Codeine
Vorherige Impfungen: -

VAERS 1309751

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NV
Alter: 55,0
Geschlecht: M
Eingang: 28.05.2021
Impfdatum: 01.04.2021
Beginn: 01.05.2021
Tage bis Beginn: 30,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Abdominal pain upper Arthralgia Back pain Computerised tomogram Dizziness Computerised tomogram thorax abnormal Deep vein thrombosis Dyspnoea Influenza like illness Peripheral swelling Pulmonary thrombosis Thrombosis Ultrasound scan Pleuritic pain Ultrasound Doppler abnormal

Symptomtext

Flu like symptoms x 5-10 days, back/pleuritic pain the following 5 days, SOB x 3 days later, finally went to ER dx with DVT, and PE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary thrombosis
Hospital-Tage: -
Labordaten: + PE on chest CT and + DVT on venous US of lower leg
Aktuelle Erkrankungen: N/a
Vorgeschichte: hypothyroidism
Andere Medikamente: Armour
Allergien: Vicodin
Vorherige Impfungen: -

VAERS 1351080

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: CA
Alter: 24,0
Geschlecht: F
Eingang: 26.05.2021
Impfdatum: 01.05.2021
Beginn: 01.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Dizziness Syncope Unresponsive to stimuli

Symptomtext

Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1192974

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: WI
Alter: 23,0
Geschlecht: F
Eingang: 26.05.2021
Impfdatum: 10.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Abdominal pain Asthenia Dizziness Hyperventilation Nausea Blood potassium decreased Clostridium difficile colitis Computerised tomogram abdomen Diarrhoea Electrocardiogram Feeling abnormal Laboratory test Loss of consciousness Pain Pyrexia Urine analysis Vomiting Syncope

Symptomtext

The day I got the vaccine I had been having health problems. I had been having withdrawal from one of my medications and I had lost weight. Right away after the shot I passed out and when I came to, I threw up a couple of times. I was taken to the ER and I had low potassium levels were low, but all other tests were normal. I had some aches pains and feverishness for a couple of days. Five days after the vaccine I had bad diarrhea several times a day. I was nauseous and feeling bad. I had an appointment with my GI doctor a week later but I had to go to the ER before that. They did not find anything in most tests. The next day I tested positive for CDIFF. I was prescribed antibiotics. I went back to the ER a third time because the Vancomycin prescription had caused severe nausea. I am still feeling bad after six weeks but it has gotten better.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: EKG Labs, Blood Work Urinalysis CT Abdomen
Aktuelle Erkrankungen: -
Vorgeschichte: GI Problems Heart Arrhythmia
Andere Medikamente: Prilosec 20mg twice daily Zofran Gabapentin Mirtazapine Lorazepam Hydroxyzine
Allergien: penicillin Sulfa Zithromax Peanuts Fruits and vegetables
Vorherige Impfungen: -

VAERS 1348284

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: NJ
Alter: 18,0
Geschlecht: M
Eingang: 25.05.2021
Impfdatum: 25.05.2021
Beginn: 25.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Fall Loss of consciousness Nervousness Syncope

Symptomtext

After vaccination, patient fainted and by the time got over to him he was alert. He was able to sit up and then was able to get into the chair. While in the chair he appeared to faint again ( looked like he was asleep in chair) and 911 was called. Patient states he had not eaten today and this was late afternoon. He also said he was nervous. EMS arrived and he agreed to go get checked out.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1345753

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MI
Alter: 43,0
Geschlecht: M
Eingang: 25.05.2021
Impfdatum: -
Beginn: 01.05.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain upper Angina pectoris Arthralgia Chills Dyspnoea Erythema Hyperhidrosis Hyperventilation Hypoaesthesia Loss of consciousness Migraine Muscle spasms Nausea Pain Pyrexia

Symptomtext

PAIN IN STOMACH; SWEATS; REDNESS ON BODY LOOKS LIKE SKIN IS DISCOLORED; CHILLS; FEVER; NAUSEA; BODY PAIN; MIGRAINE; EVERY BEAT OF HEART HURTS; HYPERVENTILATION; COULD NOT GET A FULL BREATH; PASSED OUT'; FINGERS WENT NUMB; GOT A CHARLIE HORSE ON LEG; EVERY SINGLE JOINT AND ANKLES HURTS FOR NO REASON; This spontaneous report received from a patient concerned a 43 year old male. The patient's weight was 135 pounds, and height was 66 inches. No past medical history or concurrent conditions were reported. The patient's concurrent conditions included migraine The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered, 1 total to right deltoid on 19-MAY-2021 around 10 am for prophylactic vaccination. No concomitant medications were reported. On 19-MAY-2021, around 7 pm patient started experiencing side effects. After 1 hour of shot patient had his heart hurt at every beats, hyperventilation. It lasted for 1 -2 hours. The patient also had fever, chills, nausea, sweats and had not taken any medication, as he was afraid of another side effects, had redness on his body which looked like skin was discolored and was like hives. The patient also had body pain appeared suddenly. The patient also had pain in stomach which felt like nastiest gas cramp patient had ever and it was continuous like a rock blocking in stomach, he did not know if it is pain or gas but was hurting. Patient had migraine which lasted long time and was continuous than he ever had. The patient was fine as he was speaking at the time of reporting. On MAY-2021 (dates unspecified) the patient experienced Charlie on his leg (muscle spasm) for which he stood up and didn't do anything on leg, he was passed out and fingers went numb, felt every single joint and ankle hurt with sharp pain like a stuffed knife (intermittent pain for 3-5 minutes).He could not get a full breath of air, and was breathing really fast. Then patient tried to slow down breathing as he didn't want to be hyperventilated but it happened. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from body pain, hyperventilation, migraine, pain in stomach, chills, fever, nausea, and sweats, and the outcome of passed out, could not get a full breath, redness on body looks like skin is discolored, got a charlie horse on leg, every single joint and ankles hurts for no reason, fingers went numb and every beat of heart hurts was not reported. This report was serious (Other Medically Important Condition); Sender's Comments: V0: 20210540430-COVID-19 VACCINE AD26.COV2.S --Every beat of heart hurts, Passed out. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Migraine
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1272388

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: TX
Alter: 54,0
Geschlecht: M
Eingang: 25.05.2021
Impfdatum: -
Beginn: 01.04.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Feeling abnormal Joint swelling Muscle spasms Pain Insomnia Swelling Thrombosis Peripheral swelling Ultrasound Doppler

Symptomtext

FEELING HORRIBLE; BLOOD CLOT; BODY ACHES; JOINT PAIN; SPAMS ALL OVER BODY; TOE SWELLING; KNEE SWELLING/ ANKLE SWELLING; This spontaneous report received from a patient concerned a 54 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: unknown) dose was not reported, 1 in total administered on 03-APR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported. After getting the vaccine, the patient had immediate joint pain and body aches. He had spasms since day one. After two weeks, he developed swollen toe looked like a bunyon, then it moved up to the ankle then it moved up to the knee being swollen. The patient was sent to the imagining center. He had following imaging tests done, bilateral Lower extremity Doppler Exam. On 30-APR-2021, he was recommended to go to the emergency room (ER) and was admitted. He was diagnosed with blood clot and stayed overnight. He was prescribed on Xarelto (rivaroxaban) 15 mg twice a day (BID), titrating to 20 mg once a day. The patient was hospitalised for 2 days. He got another follow up on 14-MAY-2021, gave him another prescription for blood thinner to be on for two months. On 18-MAY-2021, he was given tramadol 7 pills for spams which had helped with his pain and currently patient was feeling horrible. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from joint pain, body aches, toe swelling, knee swelling/ ankle swelling, spams all over body, and blood clot, and the outcome of feeling horrible was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20210540030- Covid-19 vaccine ad26.cov2.s- A 54 yearold male presents with Blood clot, Body aches, Toe swelling, Knee swellng /Ankle swelling, Spasms all over body, feeling horrible. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20210540030- Covid-19 vaccine ad26.cov2.s-Joint pain. This event(s) is labeled per RSI and is therefore considered potentially related.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: 2,0
Labordaten: Test Date: 20210430; Test Name: Doppler scan; Result Unstructured Data: Not provided
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1272388

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: TX
Alter: 54,0
Geschlecht: M
Eingang: 25.05.2021
Impfdatum: -
Beginn: 01.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Feeling abnormal Joint swelling Muscle spasms Pain Insomnia Swelling Thrombosis Peripheral swelling Ultrasound Doppler

Symptomtext

FEELING HORRIBLE; BLOOD CLOT; BODY ACHES; JOINT PAIN; SPAMS ALL OVER BODY; TOE SWELLING; KNEE SWELLING/ ANKLE SWELLING; This spontaneous report received from a patient concerned a 54 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: unknown) dose was not reported, 1 in total administered on 03-APR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported. After getting the vaccine, the patient had immediate joint pain and body aches. He had spasms since day one. After two weeks, he developed swollen toe looked like a bunyon, then it moved up to the ankle then it moved up to the knee being swollen. The patient was sent to the imagining center. He had following imaging tests done, bilateral Lower extremity Doppler Exam. On 30-APR-2021, he was recommended to go to the emergency room (ER) and was admitted. He was diagnosed with blood clot and stayed overnight. He was prescribed on Xarelto (rivaroxaban) 15 mg twice a day (BID), titrating to 20 mg once a day. The patient was hospitalised for 2 days. He got another follow up on 14-MAY-2021, gave him another prescription for blood thinner to be on for two months. On 18-MAY-2021, he was given tramadol 7 pills for spams which had helped with his pain and currently patient was feeling horrible. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from joint pain, body aches, toe swelling, knee swelling/ ankle swelling, spams all over body, and blood clot, and the outcome of feeling horrible was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20210540030- Covid-19 vaccine ad26.cov2.s- A 54 yearold male presents with Blood clot, Body aches, Toe swelling, Knee swellng /Ankle swelling, Spasms all over body, feeling horrible. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20210540030- Covid-19 vaccine ad26.cov2.s-Joint pain. This event(s) is labeled per RSI and is therefore considered potentially related.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: 2,0
Labordaten: Test Date: 20210430; Test Name: Doppler scan; Result Unstructured Data: Not provided
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1344412

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MI
Alter: 60,0
Geschlecht: F
Eingang: 24.05.2021
Impfdatum: 08.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Abdominal discomfort Dizziness Dizziness postural Electric shock sensation Feeling abnormal Hypertension Laboratory test normal Mobility decreased Vertigo

Symptomtext

I woke up at 5am and when I sat up, I slumped over. I sat up again, stayed for 30 sec, went to the bathroom and when I came back, I experienced severe dizziness. For the next 4 hours, I couldn't move my head and would get a zing right up the back of my neck. When I tried to sit up again, I got really sick to my stomach. After 8 hours, I started feeling better and was able to sleep on either side, but not on my back. When I was on my back everything would start spinning again. By the afternoon of the next day, I was feeling better, but was afraid to move my head too much because I didn't want everything to start up again, so I went to the doctor. My BP was high, so he had me lay on the table. He turned my head and set it off again, so I was miserable again for the next 10 hours. After that, I felt better and was able to get up and function.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Electric shock sensation
Hospital-Tage: -
Labordaten: Lab work - everything was okay
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1342212

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: SC
Alter: 24,0
Geschlecht: M
Eingang: 23.05.2021
Impfdatum: 22.05.2021
Beginn: 22.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

he fainted

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: -
Andere Medikamente: unknown
Allergien: nkda
Vorherige Impfungen: -

VAERS 1341211

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: PA
Alter: 50,0
Geschlecht: M
Eingang: 22.05.2021
Impfdatum: 01.05.2021
Beginn: 04.05.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bell's palsy Musculoskeletal stiffness

Symptomtext

TWO TO THREE DAYS AFTER SHOT 5/2-5/3 PT HAD STIFF/ CRICK IN NECK FELT LIKE IT NEEDED TO VBE CRACKED BUT COULDNT CRACK IT.. ONE WEEK AFTER INJECTION 5/8 PT DEVELOPED BELLS PALSEY ON LEFT SIDE OF FACE PT STILL HAS BELLS PALSELY PT WAS SEEN BY HIS PHYSICIAN AND WAS ADVISED TO REPORT ADVERSE EVENT(S) TO PHARMACY TO REPORT TO VAERS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: NONE KNOWN
Allergien: NONE KNOWN
Vorherige Impfungen: -

VAERS 1336524

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: OH
Alter: 20,0
Geschlecht: M
Eingang: 21.05.2021
Impfdatum: 21.05.2021
Beginn: 21.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Loss of consciousness Presyncope

Symptomtext

5 minutes after vaccination patient had sign and symptoms of Vasovagal reaction. Patient felt dizziness, passed out. Patient was given apple juice, salty snack, bottle of water.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Assesed BP 105/78 immediately after event. Assessed BP 20 minutes later sitting and standing 126/84, 134/78 respectively. O2 sat 99 %
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1334385

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: IL
Alter: 70,0
Geschlecht: F
Eingang: 20.05.2021
Impfdatum: 06.05.2021
Beginn: 06.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Abdominal pain upper Diarrhoea Fatigue Loss of consciousness Radius fracture X-ray abnormal

Symptomtext

Passed out on a walk and broke my arm falling on the concrete. Have had stomach pains and diarrhea off and on since getting the shot.. very tired

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Xrays of my right arm on May 6th,2021. Showed broken radial head
Aktuelle Erkrankungen: No
Vorgeschichte: Neurophy in my feet
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1333212

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: CA
Alter: 34,0
Geschlecht: M
Eingang: 20.05.2021
Impfdatum: 16.05.2021
Beginn: 16.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt

Anxiety Balance disorder Condition aggravated Dizziness Fall Flushing Heart rate increased Hypotension Loss of consciousness Syncope

Symptomtext

While waiting for 15-mins monitoring after getting Johnson&Johnson covid vaccine, he fainted and fell off the chair. Pharmacy staff rushed to his aid and he regained consciousness within a minute. He said he was feeling flushed and dizzy. He said he was having too much anxiety and has had fainting issue with vaccinations/MRI in the past. His blood pressure was low with high heart rate. We called 911 and paramedics came immediately. He was still unstable so the paramedics took him for further evaluation

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1332238

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CA
Alter: 46,0
Geschlecht: M
Eingang: 19.05.2021
Impfdatum: 19.05.2021
Beginn: 19.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Balance disorder Cold sweat Immediate post-injection reaction Impaired driving ability Presyncope

Symptomtext

3 minutes after injection patient started to stand up to get pharmacist's attention and pharmacist looked over at patient and noticed patient was clammy and looking like he was going to fall over. Pharmacist told patient to sit back down and immediately grabbed e-kit and headed to patient's side. Patient was clammy (like just got out of shower). At 3:45 PM BP was 128/63 and PR was 44. At 3:50 PM BP was 92/56 and PR 51, at this point RPh decided it was more than a vaso-vagal reaction and administered the epinephrine injection at 3:51 PM - EMS was called. At 3:52 PM BP was 130/76 and PR 59, 3:55 PM 134/86 PR 66, 3:58 PM BP was 148/83 and PR 68 at 3:59 PM EMS arrived and patient declined them taking him to hospital via ambulance due to no insurance. He had pharmacist escort him to his car so he could get his cell phone and back to pharmacy so he could call his son to pick him up and take him to the hospital. Unknown if patient ended up going to hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: no
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: no
Vorherige Impfungen: -

VAERS 1331136

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CA
Alter: 52,0
Geschlecht: F
Eingang: 19.05.2021
Impfdatum: 12.04.2021
Beginn: 14.04.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Cardiovascular evaluation Cerebellar stroke Echocardiogram Magnetic resonance imaging abnormal Vertebral artery occlusion Vertigo

Symptomtext

Developed symptoms of Vertigo 2 days post vaccine, diagnosed with cerebellar stroke secondary to vertebral artery occlusion on 5/12/21. She had extensive work up which was normal following diagnosis.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebellar stroke
Hospital-Tage: 5,0
Labordaten: MRI showing vertebral artery occlusion Cardiac work up normal TEE normal
Aktuelle Erkrankungen: Restless leg syndrome
Vorgeschichte: Restless leg syndrome
Andere Medikamente: Ropinarole Armour thyroid Wellbutrin Metformin Zofran Trazodone
Allergien: Bactrim
Vorherige Impfungen: -

VAERS 1330114

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: MI
Alter: 30,0
Geschlecht: M
Eingang: 19.05.2021
Impfdatum: 18.05.2021
Beginn: 18.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Seizure Syncope Vomiting

Symptomtext

Roughly 5-10 minutes after receiving the vaccine, patient fainted and began seizing for about 30 seconds. 911 was called, but patient came too and denied ambulance. Patient then vomited a couple minutes after. Patient reported he had not eaten anything and he was given orange juice and water. Patient waited another 30 minutes and reported feeling better. denied any further medical treatment.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: N/a
Aktuelle Erkrankungen: none reported
Vorgeschichte: none reported
Andere Medikamente: unknown
Allergien: amoxicillin
Vorherige Impfungen: -

VAERS 1329985

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: PA
Alter: 36,0
Geschlecht: M
Eingang: 19.05.2021
Impfdatum: 19.05.2021
Beginn: 19.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Anxiety Bradycardia Feeling cold Hyperhidrosis Loss of consciousness Pain in extremity Pallor

Symptomtext

Patient anxious complained of arm pain with injection and approximately 3 minutes later patient had loss of consciousness for approximately 2 minutes. BP low normal 108/60. Patient pale, diaphoretic and cool to touch, Patient assisted to stretcher and on monitor and found to be bradycardic HR as low as 38 . CODE team arrived and within 5 minutes patient back to baseline

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Patient taken to ED via stretcher with code team to be monitored
Aktuelle Erkrankungen: none
Vorgeschichte: PTSD
Andere Medikamente: clondine, adderal, duloxetine
Allergien: none
Vorherige Impfungen: -

VAERS 1328524

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CA
Alter: 30,0
Geschlecht: M
Eingang: 18.05.2021
Impfdatum: 18.05.2021
Beginn: 18.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Blood glucose Blood pressure decreased Dizziness Electrocardiogram Hyperhidrosis Loss of consciousness Pallor

Symptomtext

PT WAS SEATED, WAITING FOR 15 MINUTE MONITORING PERIOD POST VACCINE ADMINISTRATION. FELT DIZZY. REMAINED SEATED BUT PASSED OUT FOR A FEW SECONDS. CALLED 911. CAME TO, WAS ABLE TO TALK AND BREATHE BUT WAS SWEATY AND DIZZY AND PALE. SAT ON FLOOR SO HE WOULDN'T SLIDE OFF CHAIR IN CASE HAPPENED AGAIN. PARAMEDICS CAME, MONITORED BP, BLOOD SUGAR, EKG. HE HAD LOW BP BUT IT CAME BACK TO NORMAL IN FEW MINUTES. PARAMEDICS DETERMINED HE WAS OK TO GO HOME, DIDN'T NEED TO GO TO HOSPITAL

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: BP MONITORING, BLOOD SUGAR, EKG ON 5/18/21
Aktuelle Erkrankungen: NKA
Vorgeschichte: NKA
Andere Medikamente: NKA
Allergien: NKA
Vorherige Impfungen: SAID HAPPENED WHEN YOUNGER AT DR OFFICE, DON'T KNOW WHAT KIND, BUT HE DIDN'T INDICATE THIS TO US BEFOREHAND ON FORM

VAERS 1327790

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NY
Alter: 20,0
Geschlecht: M
Eingang: 18.05.2021
Impfdatum: 18.05.2021
Beginn: 18.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Fatigue Feeling cold Feeling hot Hyperhidrosis Loss of consciousness Syncope

Symptomtext

pt had vasovagal syncope, dizzy, passed out, sweating, hot and cold. 911 was called. Put ice on pt's neck, spoke to pt to keep awake, blood pressure taken, EMS took all vitals and blood sugar and EKG all normal. pt allowed to leave pharmacy with ride home from girlfriend. followed up with pt 1 hour later by phone, pt is feeling ok but tired.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: no know drug allergies
Vorherige Impfungen: -

VAERS 1327568

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: PA
Alter: 22,0
Geschlecht: M
Eingang: 18.05.2021
Impfdatum: 15.05.2021
Beginn: 15.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Malaise Presyncope

Symptomtext

Sequence of Events re Incident * Patient made his appointment via on- line scheduler * Patient came in, filled out his paperwork, made no mention of previous vaccine issue on paperwork * I performed the usual screening of patient, and when I asked him about any previous reactions to immunizations he stated that he had an ?issue with a TdaP shot 4 years ago and passed out in doctor?s office for several minutes.? He stated the MD told him that ?he had several other issues with the shot so the MD said it was a ?bad batch??. * I made sure that the patient was comfortable about getting the Covid shot and he agreed that he was fine to get it. At that time the patient did not seem overly nervous about receiving the shot. * I administered the shot to the patient and he went directly to the seats next to the pharmacy. I asked him to stay there because he had a past issue with another vaccine. * Approximately 2-3 minutes later, the patient came back, looked troubled and said he didn?t feel well and was feeling the same way as the other shot. I brought him back into the pharmacy immunization room, sat him down and put his head between his knees. I did a quick check on him to be sure he was breathing OK and that there was no apparent allergic reaction. * After a minute I brought his head back up and put patient into regular seated position. At no point did he completely lose consciousness or faint. I asked him at that point if he wanted me to call an ambulance or a family member and he declined. He sat there in the chair for approximately 15 minutes- part of the time his head was in his hands, part of the time looking at his phone. He asked for a glass of water and I got him one (he had completely drank it by the time he left). I kept checking on him and it seemed like every time he saw me check on him he put down his phone and put his head in his hands again. He could have been embarrassed by the situation, unsure though. I tried to make him as comfortable as possible. * After 15-20 minutes I asked him if he wanted me to call someone and he said at that point he wasn?t sure he wanted to drive home so he would call his mother to pick him up, which he did. * I sat down with him for a couple of minutes and explained that this was called a vasovagal response and was quite common (I even empathized with him by explaining that I have the same response when I get blood drawn at the doctor?s office). He seemed to feel a little better after I explained it to him. * His mother came in 15 minutes later and I brought her back as well. She explained the same thing happened at the MD office 4 years ago and that it was the Meningitis shot, not Tdap. I explained to them going forward that it would probably be best to get his immunizations at the doctor?s office so that he could lay down after the shot and they agreed. * He and his mother then walked out of the immunization room and left the building. He left under his own power and without assistance from his mother. I gave him a business card and asked him to call me on Sunday to let me know that he was feeling ok.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: -
Allergien: No Known Drug Allergies
Vorherige Impfungen: Patient said 4 years prior he received a Tdap shot and "passed out for several minutes" but he asked the doctor about it at the

VAERS 1327350

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MI
Alter: 70,0
Geschlecht: M
Eingang: 18.05.2021
Impfdatum: 05.04.2021
Beginn: 18.05.2021
Tage bis Beginn: 43,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Thrombosis

Symptomtext

Blood Clot right leg after flight.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: Patient being treated.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None known
Allergien: None Known
Vorherige Impfungen: -

VAERS 1326701

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MA
Alter: 27,0
Geschlecht: F
Eingang: 18.05.2021
Impfdatum: 06.04.2021
Beginn: 06.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

Patient mailed letter stating she fainted after receiving vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1325260

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: SC
Alter: 35,0
Geschlecht: M
Eingang: 17.05.2021
Impfdatum: 17.05.2021
Beginn: 17.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Seizure

Symptomtext

Patient experienced a seizure about 5 minutes after receiving the vaccine. No history of seizure activity ever.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None Reported
Vorgeschichte: Reports None
Andere Medikamente: -
Allergien: NO
Vorherige Impfungen: -

VAERS 1324164

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: CA
Alter: 58,0
Geschlecht: F
Eingang: 17.05.2021
Impfdatum: 17.05.2021
Beginn: 17.05.2021
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Syncope

Symptomtext

Patient immediately felt dizzy and fainted a few minutes after getting the vaccine. She had to lay down on the ground to prevent falling.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: -
Andere Medikamente: Humira
Allergien: none
Vorherige Impfungen: -

VAERS 1321357

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: TX
Alter: 79,0
Geschlecht: F
Eingang: 15.05.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Fatigue Feeling abnormal Nausea Pulmonary thrombosis Sluggishness Thrombosis

Symptomtext

after getting the vaccine in morning, later that same evening patient felt sluggish, nauseaus, tired. Daughter finally convinced patient to see a doctor. Md prescribed her a cough medication. She still felt bad for another 2-3 weeks, so she finally went to the emergency room where she diagnosed with blood clots in the legs and the lungs. She staying in hospital approx. 4-5 days before being released.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary thrombosis
Hospital-Tage: 5,0
Labordaten: unknown
Aktuelle Erkrankungen: unknown, none listed on her form and does not get medications at our location
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: none
Vorherige Impfungen: -

VAERS 1318243

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NC
Alter: 37,0
Geschlecht: F
Eingang: 14.05.2021
Impfdatum: 14.05.2021
Beginn: 14.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Fall Loss of consciousness Paraesthesia

Symptomtext

Patient received Janssen vaccine on 5/14/21 around 3:35pm. After receiving her vaccine, she did not remain seated and fell to the floor immediately upon standing. She was unconscious but still breathing and regained consciousness about 30-45 seconds after her partner and I went to her. She was alert and was able to question what happened. She said she felt "tingly" and nothing else. She remained on the floor until EMT arrived. She was taken to a local hospital after vitals were taken by EMT unit.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Patient reported none
Vorgeschichte: Patient reported none
Andere Medikamente: Patient did not report any medications at time of vaccination
Allergien: Patient reported none
Vorherige Impfungen: -

VAERS 1317525

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CA
Alter: 49,0
Geschlecht: F
Eingang: 14.05.2021
Impfdatum: 02.04.2021
Beginn: 23.04.2021
Tage bis Beginn: 21,0
Dosis: UNK
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Deep vein thrombosis Laboratory test normal Pain in extremity Ultrasound scan

Symptomtext

(4/23/21) Symptoms included intermittent (R) lower leg pain. After 3days, started myself on Aspirin which seemed to improve Sx somewhat. Stopped the Aspirin. Then learned of the link of J&J Vaccines to blood clots. Called my primary physician (5/6/21) who suggested testing to r/o DVT. (5/7) Venous ultrasound confirmed a DVT/ blood clot in (R) lower leg. Was then sent directly to ER for further exam and initiation of anti-coagulation therapy. Started on Eliquis starter pack: Initially 10mg BID, then 5mg BID.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: -
Labordaten: Venous ultrasound (5/7/21)- Positive for "occlusive thrombus within the right peroneal vein." Lab draw in ER (5/7/21) all wnl.
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: Necon birth control, Multivitamin, nasal spray (Fluticasone/ Azelastine HCL)
Allergien: none
Vorherige Impfungen: -

VAERS 1317151

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CA
Alter: 61,0
Geschlecht: M
Eingang: 14.05.2021
Impfdatum: 03.04.2021
Beginn: 15.04.2021
Tage bis Beginn: 12,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Abdominal pain Dizziness Dyspnoea Faeces discoloured Fatigue Gait disturbance Head injury Headache Impaired work ability Loss of consciousness Myalgia Oxygen saturation Peripheral coldness Tinnitus

Symptomtext

For the first two weeks, there was only mild headache and fatigue. But on day 12 (or 13) following the shot, my husband had severe abdominal pain and black, tarry poop. He passed out on the toilet in the middle of the night and hit his head, woke up in a puddle of blood (from hitting his head) . He was severely lightheaded, short of breath, could not walk. He had to crawl back to bed. He continued to have severe lightheadedness, shortness of breath, muscle aches, abdominal pain, and also ringing in his ears. He called me early Saturday morning and told me what happened and that he called out from work. (We do not live together. He is 280 miles away because of his job.) That man has called out sick only one time since I've met him in 1998; so when he told me he did not go to work, I knew it had to be really bad. I drove up there ASAP the same day, and I took the pulse oximeter with me. His oxygen levels were all over the place. They were usually better (like high 70s to low 80s) while he was lying down. When he would sit up or stand up, the number would plummet, reading so low I thought he was going to die. One time his finger was so cold that it took me 4 tries to get a reading. It read at 55, but I realize that might be because his finger was too cold.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: None. My stubborn donkey of a husband refuses to go to the doctor. I'm just letting you know because I think you should know.
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: daily multivitamin
Allergien: octopus
Vorherige Impfungen: -

VAERS 1314960

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NY
Alter: 29,0
Geschlecht: F
Eingang: 13.05.2021
Impfdatum: 13.05.2021
Beginn: 13.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Electrocardiogram normal Fall Hyperhidrosis Loss of consciousness

Symptomtext

About 5-10 minutes after the patient received the vaccine, she lost consciousness and fell off her chair. She regained consciousness and I had her lay on the ground on her back. Her blood pressure was 88/69, heart rate was 86 and she was sweating a lot. EMS came and took her blood pressure again and it was 110/80. She went to the hospital for further observation and they did an EKG and said everything was normal, and now she is feeling okay.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1314170

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: AL
Alter: 32,0
Geschlecht: M
Eingang: 13.05.2021
Impfdatum: 11.05.2021
Beginn: 11.05.2021
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Confusional state Feeling hot Hyperhidrosis Loss of consciousness Pallor Speech disorder

Symptomtext

Patient began sweating profusely approximately 10 minutes after his vaccine. He went to his parent's car and asked his father to turn on the air conditioning as he was hot. he then passed out in the back seat of the car. His mother came inside and asked for assistance. I grabbed an epi-pen and ran outside to the car. Patient was breathing and had a pulse rate of 64. He aroused shortly after I began asking him if he could hear me and asked if he could tell me his name. He was pale (notably his lips were quite pale) and confused. He could not say his name but could nod appropriately to questions when asked. We immediately called EMS for assistance. They arrived within 4-5 minutes and transported the patient to hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Unknown
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 1311041

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CA
Alter: 56,0
Geschlecht: F
Eingang: 12.05.2021
Impfdatum: 06.04.2021
Beginn: 08.05.2021
Tage bis Beginn: 32,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 pneumonia Cough Hypoxia Intensive care Pyrexia SARS-CoV-2 test positive

Symptomtext

In spite of being immunized against COVID-19, patient presented to emergency room after developing non-productive cough, fever, and hypoxia. Diagnosed with COVID pneumonia and admitted to ICU.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: -
Labordaten: COVID PCR positive: 5/11/2021, Nasopharyngeal swab sent to Lab for genetic sequencing of variant strains.
Aktuelle Erkrankungen: Atrial Fibrillation
Vorgeschichte: Morbid Obesity
Andere Medikamente: None
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 1218171

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: PR
Alter: 47,0
Geschlecht: F
Eingang: 12.05.2021
Impfdatum: -
Beginn: 05.04.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Abdominal pain upper Anticoagulant therapy Cerebral thrombosis Chills Computerised tomogram head abnormal Full blood count Headache Abdominal pain Blood count abnormal Body temperature Cavernous sinus thrombosis Nausea Pyrexia Computerised tomogram Fibrin D dimer Fibrin D dimer increased Magnetic resonance imaging head abnormal Computerised tomogram head

Symptomtext

NAUSEA; ABDOMINAL PAIN; PERSISTENT HEADACHE; FEVER; CHILLS; BODY ACHES; COMPUTERISED TOMOGRAM HEAD ABNORMAL; FIBRIN D DIMER INCREASED; MAGNETIC RESONANCE IMAGING HEAD ABNORMAL; FULL BLOOD COUNT; VENOGRAM ABNORMAL; VENOUS THROMBOTIC CAVERN SINUS; THROMBOCYTOPENIA; PLATELET COUNT DECREASED; This spontaneous report received from a patient via a Regulatory Authority VAERS (Vaccine Adverse Event Reporting System), VAERS identification number: 1238777, 1218171, and concerned a 47-year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included aspirin allergy, hypertension, migraine. The patient never had an adverse event following any previous vaccine. On 31-MAR-2021 (also reported as 21-MAR-2021), the patient received COVID-19 Vaccine Ad26.COV2.S (suspension for injection, intramuscular, batch number: 042A21A) dose was not reported, administered in left arm for prophylactic vaccination. The concomitant medications included losartan, metoprolol tartrate, amlodipine besilate, withania somnifera root, lithium orotate, ergocalciferol, and unspecified natural pills. On "30-MAR-2021," the patient experienced nausea, abdominal pain, persistent headache, fever and was hospitalized (dates unspecified). On 05-APR-2021, the patient was hospitalized for venous thrombotic cavern sinus and thrombocytopenia 25,000, computerized tomogram head abnormal, fibrin d-dimer increased, magnetic resonance imaging head abnormal, developed platelet count decreased, venogram abnormal, and full blood count. It was reported that on 06-APR-2021, the patient started having nausea and stomach pain. On 08-APR-2021, the patient had a fever (100 degrees Fahrenheit), chills, body aches, and headaches. On 09-APR-2021, the headache got intense and no more fever. On an unspecified date, the patient kept having intense headache and went to the Emergency Room (ER). A complete blood count (CBC) showed low platelets level (25, 000 units, normal range not specified) and the patient was admitted to the hospital the morning after. A head computerized tomogram (CT) was negative. On an unspecified date, intense headache came back and a head CT scan was performed with positive result. Another CT scan with the contrast and a magnetic resonance imaging (MRI) the day after confirmed the positive result for a blood clot in the head. The patient was transferred to the Intensive Care Unit (ICU) for 5 days, then transferred to regular room for 2 days. The patient was diagnosed with vaccine-induced immune thrombotic thrombocytopenia (VIITT) and released with rivaroxaban 20 mg and methylprednisolone 4 mg treatment with follow-up in a week. The patient also had scheduled appointment with a neurologist and a hematologist. The patient was hospitalized (dates unspecified) for 12 days. The action taken with COVID-19 Vaccine Ad26.COV2.S was not applicable. The patient had not recovered from cavernous sinus thrombosis, thrombocytopenia, nausea, abdominal pain, persistent headache, chills, body aches; the patient recovered from fever on 09-APR-2021; and the outcome was not reported for computerized tomogram head abnormal, fibrin d dimer increased, magnetic resonance imaging head abnormal, platelet count decreased, venogram abnormal, and full blood count. This report was serious (Life Threatening, Hospitalization Caused / Prolonged). This case was a duplicate of Adverse Event Report (AER) case numbers 20210506021 and 20210500191. Upon review, it was determined that AER Number 20210500191 was nullified in error. All relevant information will now be submitted under this case (Adverse Event Report Case Number, 20210520237).; Sender's Comments: V0: This case obtained via VAERS (VAERS ID 1238777 & 1218171) concerns a 47-year-old female who experienced life-threatening cavernous sinus thrombosis with thrombocytopenia approximately 5 days after receiving the Janssen Covid-19 vaccine. Concurrent conditions include hypertension & migraine. Concomitant medications include losartan, metoprolol, amlodipine, withania somnifera root, lithium, ergocalciferol, and unspecified natural pills. After vaccination, the patient experienced nausea, abdominal pain, persistent headache, and fever and was hospitalized. Initial CT of head was negative. Repeat CT of head with contrast & MRI/MRV were abnormal and positive for thrombosis of cavernous sinus. Labs showed low platelet count (25,000) & elevated D dimer (unspecified). She was diagnosed with vaccine-induced immune thrombotic thrombocytopenia and after a total of 12 days, was discharged with rivaroxaban 20 mg and methylprednisolone 4 mg as corrective treatment with follow up in a week. She has scheduled appointments with a neurologist and a hematologist. Based on evolving knowledge of Thrombosis with Thrombocytopenia Syndrome (TTS, per definition), the low platelet count and temporal relationship to vaccination (Criteria level 1), the events are assessed to have a plausible relationship with vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cavernous sinus thrombosis
Hospital-Tage: -
Labordaten: Test Date: 202104; Test Name: Venogram; Result Unstructured Data: Abnormal; Test Date: 202104; Test Name: Head CT; Result Unstructured Data: positive; Test Date: 202104; Test Name: Head CT; Result Unstructured Data: negative; Test Date: 202104; Test Name: Head CT; Result Unstructured Data: positive result for blood clot; Test Date: 202104; Test Name: Head MRI; Result Unstructured Data: positive result for blood clot; Test Date: 202104; Test Name: Fibrin D dimer increased; Result Unstructured Data: Elevated; Test Date: 20210408; Test Name: Body temperature; Result Unstructured Data: 100 F; Test Date: 20210408; Test Name: Platelet count; Result Unstructured Data: 25,000; Test Date: 20210408; Test Name: Complete blood count; Result Unstructured Data: low platelet level
Aktuelle Erkrankungen: Drug allergy; Hypertension; Migraine
Vorgeschichte: Comments: The patient never had an adverse event following any previous vaccine.
Andere Medikamente: LOSARTAN; LOPRESSOR; NORVASC; ASHWAGANDHA [WITHANIA SOMNIFERA ROOT]; LITHIUM ORORATE 20; VITAMIN D [ERGOCALCIFEROL]
Allergien: -
Vorherige Impfungen: -

VAERS 1218171

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: PR
Alter: 47,0
Geschlecht: F
Eingang: 12.05.2021
Impfdatum: -
Beginn: 05.04.2021
Tage bis Beginn: -
Dosis: N/A
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Abdominal pain upper Anticoagulant therapy Cerebral thrombosis Chills Computerised tomogram head abnormal Full blood count Headache Abdominal pain Blood count abnormal Body temperature Cavernous sinus thrombosis Nausea Pyrexia Computerised tomogram Fibrin D dimer Fibrin D dimer increased Magnetic resonance imaging head abnormal Computerised tomogram head

Symptomtext

NAUSEA; ABDOMINAL PAIN; PERSISTENT HEADACHE; FEVER; CHILLS; BODY ACHES; COMPUTERISED TOMOGRAM HEAD ABNORMAL; FIBRIN D DIMER INCREASED; MAGNETIC RESONANCE IMAGING HEAD ABNORMAL; FULL BLOOD COUNT; VENOGRAM ABNORMAL; VENOUS THROMBOTIC CAVERN SINUS; THROMBOCYTOPENIA; PLATELET COUNT DECREASED; This spontaneous report received from a patient via a Regulatory Authority VAERS (Vaccine Adverse Event Reporting System), VAERS identification number: 1238777, 1218171, and concerned a 47-year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included aspirin allergy, hypertension, migraine. The patient never had an adverse event following any previous vaccine. On 31-MAR-2021 (also reported as 21-MAR-2021), the patient received COVID-19 Vaccine Ad26.COV2.S (suspension for injection, intramuscular, batch number: 042A21A) dose was not reported, administered in left arm for prophylactic vaccination. The concomitant medications included losartan, metoprolol tartrate, amlodipine besilate, withania somnifera root, lithium orotate, ergocalciferol, and unspecified natural pills. On "30-MAR-2021," the patient experienced nausea, abdominal pain, persistent headache, fever and was hospitalized (dates unspecified). On 05-APR-2021, the patient was hospitalized for venous thrombotic cavern sinus and thrombocytopenia 25,000, computerized tomogram head abnormal, fibrin d-dimer increased, magnetic resonance imaging head abnormal, developed platelet count decreased, venogram abnormal, and full blood count. It was reported that on 06-APR-2021, the patient started having nausea and stomach pain. On 08-APR-2021, the patient had a fever (100 degrees Fahrenheit), chills, body aches, and headaches. On 09-APR-2021, the headache got intense and no more fever. On an unspecified date, the patient kept having intense headache and went to the Emergency Room (ER). A complete blood count (CBC) showed low platelets level (25, 000 units, normal range not specified) and the patient was admitted to the hospital the morning after. A head computerized tomogram (CT) was negative. On an unspecified date, intense headache came back and a head CT scan was performed with positive result. Another CT scan with the contrast and a magnetic resonance imaging (MRI) the day after confirmed the positive result for a blood clot in the head. The patient was transferred to the Intensive Care Unit (ICU) for 5 days, then transferred to regular room for 2 days. The patient was diagnosed with vaccine-induced immune thrombotic thrombocytopenia (VIITT) and released with rivaroxaban 20 mg and methylprednisolone 4 mg treatment with follow-up in a week. The patient also had scheduled appointment with a neurologist and a hematologist. The patient was hospitalized (dates unspecified) for 12 days. The action taken with COVID-19 Vaccine Ad26.COV2.S was not applicable. The patient had not recovered from cavernous sinus thrombosis, thrombocytopenia, nausea, abdominal pain, persistent headache, chills, body aches; the patient recovered from fever on 09-APR-2021; and the outcome was not reported for computerized tomogram head abnormal, fibrin d dimer increased, magnetic resonance imaging head abnormal, platelet count decreased, venogram abnormal, and full blood count. This report was serious (Life Threatening, Hospitalization Caused / Prolonged). This case was a duplicate of Adverse Event Report (AER) case numbers 20210506021 and 20210500191. Upon review, it was determined that AER Number 20210500191 was nullified in error. All relevant information will now be submitted under this case (Adverse Event Report Case Number, 20210520237).; Sender's Comments: V0: This case obtained via VAERS (VAERS ID 1238777 & 1218171) concerns a 47-year-old female who experienced life-threatening cavernous sinus thrombosis with thrombocytopenia approximately 5 days after receiving the Janssen Covid-19 vaccine. Concurrent conditions include hypertension & migraine. Concomitant medications include losartan, metoprolol, amlodipine, withania somnifera root, lithium, ergocalciferol, and unspecified natural pills. After vaccination, the patient experienced nausea, abdominal pain, persistent headache, and fever and was hospitalized. Initial CT of head was negative. Repeat CT of head with contrast & MRI/MRV were abnormal and positive for thrombosis of cavernous sinus. Labs showed low platelet count (25,000) & elevated D dimer (unspecified). She was diagnosed with vaccine-induced immune thrombotic thrombocytopenia and after a total of 12 days, was discharged with rivaroxaban 20 mg and methylprednisolone 4 mg as corrective treatment with follow up in a week. She has scheduled appointments with a neurologist and a hematologist. Based on evolving knowledge of Thrombosis with Thrombocytopenia Syndrome (TTS, per definition), the low platelet count and temporal relationship to vaccination (Criteria level 1), the events are assessed to have a plausible relationship with vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cavernous sinus thrombosis
Hospital-Tage: -
Labordaten: Test Date: 202104; Test Name: Venogram; Result Unstructured Data: Abnormal; Test Date: 202104; Test Name: Head CT; Result Unstructured Data: positive; Test Date: 202104; Test Name: Head CT; Result Unstructured Data: negative; Test Date: 202104; Test Name: Head CT; Result Unstructured Data: positive result for blood clot; Test Date: 202104; Test Name: Head MRI; Result Unstructured Data: positive result for blood clot; Test Date: 202104; Test Name: Fibrin D dimer increased; Result Unstructured Data: Elevated; Test Date: 20210408; Test Name: Body temperature; Result Unstructured Data: 100 F; Test Date: 20210408; Test Name: Platelet count; Result Unstructured Data: 25,000; Test Date: 20210408; Test Name: Complete blood count; Result Unstructured Data: low platelet level
Aktuelle Erkrankungen: Drug allergy; Hypertension; Migraine
Vorgeschichte: Comments: The patient never had an adverse event following any previous vaccine.
Andere Medikamente: LOSARTAN; LOPRESSOR; NORVASC; ASHWAGANDHA [WITHANIA SOMNIFERA ROOT]; LITHIUM ORORATE 20; VITAMIN D [ERGOCALCIFEROL]
Allergien: -
Vorherige Impfungen: -

VAERS 1307658

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: PA
Alter: 53,0
Geschlecht: F
Eingang: 11.05.2021
Impfdatum: 09.04.2021
Beginn: 22.04.2021
Tage bis Beginn: 13,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Deep vein thrombosis Erythema Localised oedema Pain in extremity Peripheral swelling Skin warm Synovial cyst Ultrasound Doppler abnormal

Symptomtext

4/29/2021 1. Localized edema 2. H/O factor V Leiden mutation 3. History of deep vein thrombosis (DVT) of lower extremity - patient had Johnson and John vaccine on 4/9/2021. She then developed bilateral leg pain with calf swelling, redness, and warmth about 1 week ago. Patient has a history of DVT and factor V Leiden mutation. She has previously been treated with Eliquis for DVT. Patient concerned for repeat DVT. Recommended bilateral venous dopplers. - VAS US Doppler Venous Lower Extremity Left; Future - VAS US Doppler Venous Lower Extremity Right; Future . Acute deep vein thrombosis (DVT) of calf muscle vein of left lower extremity (HCC) 5. H/O factor V Leiden mutation - patient diagnosed with a new DVT on 4/29/2021. She is currently anticoagulated with Eliquis 5mg 1 tablet BID with plan to continue anticoagulation for at least 6 months. Patient follows with hematology

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: -
Labordaten: Bilateral venous doppler lower extremities. No evidence of DVT in the RLE within the limits of this study. Non-occlusive left popliteal DVT - age indeterminate. Left calf DVT involving with soleus and gastrocnemius veins. Bilateral calf superficial vein thrombosis involving the GSV's. Bilateral popliteal fossa Baker's cysts. Compared to 2017 study, left popliteal DVT was present.
Aktuelle Erkrankungen: -
Vorgeschichte: Essential hypertension, GE reflux, Vit D deficiency, Morbid obesity, Hypothyroidism, Psoriatic Arthritis, Factor V Leiden Mutation, Dyslipidemia, Impaired fasting glucose, History of DVT
Andere Medikamente: Medication Sig Dispense Refill ? cholecalciferol, vitamin D3, (VITAMIN D3) 2,000 unit cap capsule Take 2,000 Units by mouth daily. ? famotidine (PEPCID) 40 MG tablet 1 tablet 2 (two) times a day. ? glucos sul 2KCl/msm/chond/C/Mn (GL
Allergien: Scallops
Vorherige Impfungen: -

VAERS 1307322

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: FL
Alter: 24,0
Geschlecht: M
Eingang: 11.05.2021
Impfdatum: 11.05.2021
Beginn: 11.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

patient fainted immediately after receiving the shot

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1307306

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: AZ
Alter: 36,0
Geschlecht: F
Eingang: 11.05.2021
Impfdatum: 11.05.2021
Beginn: 11.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Loss of consciousness Syncope

Symptomtext

PATIENT FAINTED SHORTLY AFTER THE INJECTION, BUT THEN REGAINED CONSCIOUSNESS SHORTLY AFTER I ATTENDED TO HER BY SITTING HER UP AND CALLING 911. I WAS READY TO ADMINISTER CPR AND EPI.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: NONE
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: NONE
Allergien: ALLERGY TO CATS, OUTGROWN SINCE YOUNG.
Vorherige Impfungen: -

VAERS 1274268

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: SC
Alter: 58,0
Geschlecht: F
Eingang: 11.05.2021
Impfdatum: 30.04.2021
Beginn: 30.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Electrocardiogram Full blood count Loss of consciousness Metabolic function test Vomiting Syncope

Symptomtext

Loss of consciousness, vomiting.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: CBC and differential, Comprehensive metabolic panel, EKG.
Aktuelle Erkrankungen: None
Vorgeschichte: Hypothyroidism
Andere Medikamente: Levothyroxine
Allergien: Erythromycin causes hives
Vorherige Impfungen: -

VAERS 1304697

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: CO
Alter: 33,0
Geschlecht: M
Eingang: 10.05.2021
Impfdatum: 10.05.2021
Beginn: 10.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Disorientation Hyperhidrosis Syncope

Symptomtext

A few minutes after administration the patient went to leave the room where he got his vaccine. He stood up turned to ask another question about the vaccine and then fainted. He was out for about 15 seconds. He awoke disoriented and sweaty. I gave him water and some glucose tablets. He said he felt fine after that. i have called to follow with him and he says he fells fine

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: HIV positive
Andere Medikamente: biktarvy
Allergien: No know allergies
Vorherige Impfungen: -

VAERS 1302766

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: SC
Alter: 19,0
Geschlecht: M
Eingang: 10.05.2021
Impfdatum: 10.05.2021
Beginn: 10.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Cold sweat Dyskinesia Fall Pallor Seizure like phenomena

Symptomtext

Starting within two minutes of receiving Janssen vaccine patient became pale in color, clammy, and started exhibiting seizure like activity (jerking). Patient fell out of his chair and onto the floor. Patient does not remember incident, stated he only remembers looking at his phone then becoming alert again to people surrounding him. Patient was assessed by pharmacist immediately and EMS was called at 9:35 am. Vitals were taken by pharmacist at 9:37 am. Patient was re-assessed upon arrival of EMS.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure like phenomena
Hospital-Tage: -
Labordaten: Blood Pressure: 151/108 Pulse: 81 bpm
Aktuelle Erkrankungen: NONE DISCLOSED
Vorgeschichte: NONE DISCLOSED
Andere Medikamente: UNKNOWN
Allergien: NONE
Vorherige Impfungen: -

VAERS 1302037

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CO
Alter: 31,0
Geschlecht: F
Eingang: 10.05.2021
Impfdatum: 09.05.2021
Beginn: 09.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Syncope Unresponsive to stimuli

Symptomtext

Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Additional Details: Patient experienced lightheadedness, then passed out for about 20 seconds at around noon on 05/09/2021. Patient has recovered. Paramedics were called. Patient refused to go with paramedics.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1302035

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CO
Alter: 18,0
Geschlecht: M
Eingang: 10.05.2021
Impfdatum: 07.05.2021
Beginn: 07.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Blindness transient Chills Dizziness Haemodynamic test normal Hypotension Loss of consciousness Nausea Syncope Unresponsive to stimuli Visual impairment

Symptomtext

Systemic: Chills-Mild, Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Hypotension-Medium, Systemic: Nausea-Mild, Systemic: Visual Changes/Disturbances-Mild, Additional Details: DURING SYNCOPE EPISODE, PATIENT STATED HE "COULDN'T SEE". VISION RETURNED AFTER LESS THAN 1 MINUTE. PATIENT WAS UNCONCIOUS FOR LESS THAN 30 SECONDS. AFTER LAYING DOWN FOR 1 MINUTE, I RETURNED PATIENT TO CHAIR AND MONITORED BLOOD PRESSURE. PATIENT WAS HYPOTENSIVE FOR 20 MINUTES. PATIENT BECAME HEMODYANMICALLY STABLE AFTER 20 MINUTES USING 4 SEPERATE READINGS 5 MINUTES APART EACH. PATIENT'S FATHER ACCOMPANIED PATIENT AND OPTED TO TAKE HIM HOME AFTER HE WAS STABLE.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1300159

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: PA
Alter: 43,0
Geschlecht: M
Eingang: 08.05.2021
Impfdatum: 08.05.2021
Beginn: 08.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Hypotension Immediate post-injection reaction Nausea Pain Syncope Tremor

Symptomtext

PT COMPLAINED OF INTENSE PAIN IMMEDIATELY AFTER INJECTING, THEN NAUSOUSNESS, THEN WANTED TO STAND, AS I WAS PREVENTING HIM FROM STANDING HE BEGAN TO SHAKE AND THEN WENT LIMP, I USED SMELLING SALTS AND HE CAME TO, HE WAITED IN PHARMACY HIS BP WAS LOW, WE GAVE WATER AND AFTER ABOUT AN HOUR HE WAS ABLE TO WALK OUT ON HIS OWN

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE LISTED
Andere Medikamente: NOT KNOWN
Allergien: NO
Vorherige Impfungen: -

VAERS 1296632

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: GA
Alter: 29,0
Geschlecht: M
Eingang: 07.05.2021
Impfdatum: 07.05.2021
Beginn: 07.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fear of injection Loss of consciousness

Symptomtext

Patient received Janssen Covid-19 vaccination at 04:24pm on 05/07/2021 and was counselled to remain in the patient's waiting area per protocol. At approximately 04:32pm a patient in line to pick up their prescription alerted pharmacy staff that someone just slumped over in the chair. 911 was called immediately but pt. stated he did not need them as he did not want to pay and declined EpiPen which was made available to him. He verbalized that it might be "mental"?? and it usually happens to him when he "gets blood". He remained under observation and stated that he felt better. At approximately 04:54pm patient departed from the pharmacy area.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1296531

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CA
Alter: 18,0
Geschlecht: M
Eingang: 07.05.2021
Impfdatum: 07.05.2021
Beginn: 07.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Loss of consciousness Pallor

Symptomtext

Pt entered vaccination site and stated "I always pass out when I get a shot." Pt was vaccinated while lying on 3 chairs with father, several nurses, and site-lead present. Approximately three minutes after injection, Pt stated that he was feeling dizzy, became pale, and lost consciousness for approximately 45 seconds. Once he regained consciousness, Pt denied any pain or other discomfort. Pt stated that he would like to remain lying down "for a few minutes; it helps me feel better." Pt was held in post-vac for a total of 30 minute. He stated that his symptoms had resolved and left site with father, escorted to vehicle by nurse.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 1295644

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: FL
Alter: 43,0
Geschlecht: M
Eingang: 07.05.2021
Impfdatum: 09.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Computerised tomogram Dialysis device insertion Headache Hypoaesthesia Immunoglobulin therapy Lumbar puncture Paralysis Plasmapheresis X-ray

Symptomtext

on 4/10/21 headache, feet felt numb, continued to get worse until almost total paralysis of body. He is still currently in hospital getting treatments. ,

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paralysis
Hospital-Tage: -
Labordaten: CT scans, spinal tap, xrays, IVIG x10 bags, dialysis port in neck, Plasma Phersis
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: lithium, Invega, Lisinopril, Seroquel, omeprazole, lexaprole
Allergien: haldol
Vorherige Impfungen: -

VAERS 1292009

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NC
Alter: 47,0
Geschlecht: M
Eingang: 06.05.2021
Impfdatum: 04.05.2021
Beginn: 04.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Loss of consciousness Seizure Tremor

Symptomtext

Patient experienced a seizure episode immediately after I administered his COVID-19 vaccine. I administered the vaccine at 10:22 AM and a few seconds later Patient started to shake and toss his head back. I immediately called 911/paramedics after his wife and I helped him to lay to his side. His seizure episode lasted about 2 or 3 minutes. He quickly regained consciousness and became fully responsive before the paramedics arrived.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: The paramedics assessed his vitals when they arrived. Patient stated that he "felt fine" and he chose not to leave with the paramedics. I have not been made aware of any specific laboratory results or any other medical tests that may have been performed at this date and time.
Aktuelle Erkrankungen: A history of seizures/epilepsy per the Patient Vaccine Consent Form
Vorgeschichte: A history of seizures/epilepsy per the Patient Vaccine Consent Form
Andere Medikamente: Although patient stated that "his seizures were under control," due to the medication he takes, no specific medications were disclosed at the time of his visit. Patient is does not get any of his prescriptions filled at clinic. He only sche
Allergien: None per the Patient Vaccine Consent Form
Vorherige Impfungen: -

VAERS 1288974

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: FL
Alter: 81,0
Geschlecht: M
Eingang: 05.05.2021
Impfdatum: 09.04.2021
Beginn: 16.04.2021
Tage bis Beginn: 7,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Contusion Dizziness Ear pain Headache Loss of consciousness Oropharyngeal pain

Symptomtext

1 WEEK AFTER VACCINATION- EXPERIENCED HEAD ACHES , SORE THROAT AND EAR ACHES. AROUND 2 WEEKS- PATIENT. FELT DIZZY AND PASSED OUT. STILL HAS SOME BRUISING IN THE ARM NEAR BICEPS.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: WAS TESTED IN A HOSPITAL AND RELEASED WITH NO MAJOR COMPLICATIONS.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1288886

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: FL
Alter: 37,0
Geschlecht: M
Eingang: 05.05.2021
Impfdatum: 04.05.2021
Beginn: 04.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Confusional state Dizziness Dyspnoea Fall Fatigue Flushing Headache Hyperhidrosis Lethargy Loss of consciousness Seizure Skin discolouration Syncope Tremor Unresponsive to stimuli

Symptomtext

Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Confusion-Mild, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Mild, Systemic: Headache-Mild, Systemic: Seizure-Mild, Systemic: Shakiness-Medium, Additional Details: About 5 minutes after the shot, the patient lost conciousness, fell face forward on the ground. Face appeared grey, was unresponsive, but was making grunting sounds. His body appeared to be shaking lightly, possible seizure, was not responsive. Oral benadryl was not possible at this point. Turned patient on back/side in order to adminster the epipen. Patient quickly became alert and responded. No injection site reaction. Paramedics arrived shortly to check vitals and transfer him

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1285965

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: ID
Alter: 30,0
Geschlecht: M
Eingang: 04.05.2021
Impfdatum: 04.05.2021
Beginn: 04.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Loss of consciousness

Symptomtext

He felt dizzy and passed out for about a minute. Paramedics observed him for an hour, checked BP and pulse frequently. He said he has a history of syncope after any injection or needle stick. He was escorted out to his ride, said he's fine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: BP and pulse taken by paramedics every 10 minutes
Aktuelle Erkrankungen: -
Vorgeschichte: Needle phobia, has history of syncope after needle injection or blood draw
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: didn't disclose

VAERS 1285414

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MA
Alter: 22,0
Geschlecht: F
Eingang: 04.05.2021
Impfdatum: 07.04.2021
Beginn: 26.04.2021
Tage bis Beginn: 19,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Blood test normal Chest X-ray normal Computerised tomogram head Pyrexia Seizure

Symptomtext

Case had Covid-19 dx on 3/18/21. No SXS. Had Janssen vaccine administered on 4/7/21. Approx 2 wks later c/o fevers and a seizure on 4/26/2021. Was eval in medical facility then at another for seizure. Her fever was 102.7 about 1 hr prior to her seizure.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: All blood tests, chest film, and head CT were normal.
Aktuelle Erkrankungen: Covid-19 DX 3/18/2021 with positive Ag
Vorgeschichte: none
Andere Medikamente: Fiber and probiotic supplements, OCP
Allergien: none
Vorherige Impfungen: -

VAERS 1188381

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: TX
Alter: 45,0
Geschlecht: M
Eingang: 04.05.2021
Impfdatum: 03.04.2021
Beginn: 03.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Anxiety Arthralgia Asthenia Chills Dizziness Aphasia Cough Dyspnoea Fatigue Heart rate increased Hypersomnia Migraine Hyperhidrosis Loss of personal independence in daily activities Myalgia Nausea Pyrexia Somnolence

Symptomtext

Started with nausea, then it followed. Migrane, unable to talk, unable been awake ,I even fainted I don't know for how long but when I woke up was on the floor and sweating, chills, fever, shortness of breath, tireness, muscle pain and cough. Did not go to the doctor or hospital, I have no insurance. Even until today I still have a light cough and shortness of breath. All this stopped me from going to work for 2 weeks, and unenployment did not pay.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: no
Vorgeschichte: no
Andere Medikamente: no
Allergien: no
Vorherige Impfungen: -

VAERS 1284439

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: AK
Alter: 28,0
Geschlecht: M
Eingang: 03.05.2021
Impfdatum: 03.05.2021
Beginn: 03.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Eye movement disorder Syncope

Symptomtext

Patient fainted 4 minutes after vaccine given. Patient was able to talk but described "eyes in back of head". Blood pressure reading taken 132/76 pulse 72 then 128/82 pulse 85.Patient was responsive to our questions sitting on floor for 5 minutes. We then we observed him for and additional 15 minutes in our waiting area before he left.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 1283764

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: SC
Alter: 38,0
Geschlecht: F
Eingang: 03.05.2021
Impfdatum: 03.05.2021
Beginn: 03.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Dizziness Loss of consciousness Seizure Unresponsive to stimuli

Symptomtext

Patient received dose in right arm with no complications. However, about 1-2 minutes after vaccination patient reported feeling lightheaded. As I was instructing her to remain seated, she passed out and was unresponsive. She appeared to be having a seizure immediately after that lasted about 1 minute. Once this episode passed, she became responsive and could talk. EMS arrived and took over.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none known
Vorgeschichte: none known
Andere Medikamente: not available
Allergien: none
Vorherige Impfungen: -

VAERS 1283108

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CA
Alter: 53,0
Geschlecht: F
Eingang: 03.05.2021
Impfdatum: 02.04.2021
Beginn: 08.04.2021
Tage bis Beginn: 6,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Facial paralysis Headache Lacrimation increased Pain Rash

Symptomtext

4/2/21 She experienced headache, body ache watery eyes, 4/8/21 face and neck rash, mouth shifted to the left hand side, headache (allergy was gone). then 4/10/21 went to urgent care md prescribed prednisone 20mg 2 tab daily for 3 days then 1 tablet daily for 4 days pt did not mention to md of covid vaccine

Weitere VAERSDATA-Felder

Praegender Schweregrund: Facial paralysis
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: -
Vorgeschichte: high blood pressure
Andere Medikamente: tylenol 325mg
Allergien: none
Vorherige Impfungen: -

VAERS 1282756

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: LA
Alter: 39,0
Geschlecht: M
Eingang: 03.05.2021
Impfdatum: 03.05.2021
Beginn: 03.05.2021
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Deafness Hyperhidrosis Presyncope Tinnitus Tunnel vision Visual impairment

Symptomtext

Almost vasovagal syncope. Vaccine administered at 11:00. Vasovagal symptoms present at 11:03. Profuse sweating, decreased ability to see (tunnel vision), ringing in the ears (subsequent hearing loss). Fainting did not present, and symptoms completely subsided at 11:08.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: hypercholesterolemia
Andere Medikamente: atorvastatin (40mg x1/day)
Allergien: -
Vorherige Impfungen: -

VAERS 1276531

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: OR
Alter: 44,0
Geschlecht: M
Eingang: 01.05.2021
Impfdatum: -
Beginn: 01.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Asthma Dizziness Dyspnoea Fatigue Hot flush Hyperhidrosis Loss of consciousness Pain in extremity Somnolence

Symptomtext

SHORTNESS OF BREATH; ASTHMA ATTACK; DIZZINESS; EXPERIENCING HOT FLASHES; SORE ARM; SWEATING; PASSING OUT RIGHT AFTER VACCINATION; SLEEPY; LOW ENERGY; WEAKNESS; TIRED; This spontaneous report received from a patient concerned a 44 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included codeine allergy, penicillin allergy, anxiety, smoker, and alcohol user. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 042A21A expiry: UNKNOWN) dose was not reported, administered on 12-APR-2021 on right arm for prophylactic vaccination. Concomitant medications included clonazepam for anxiety, and ibuprofen for pain/ and inflammation. On 12-APR-2021, after 5 minutes, the patient started feeling dizzy and passed out. He woke up as nurse pulling his chest hair and nurse was about to give him adrenaline shot. The patient was for his vitals until restabilized and was asked to walk around for sometime. The patient had sore arm. The patient was at facility for 2 hours. On 12-APR-2021, at night, he woke up sweating and experiencing hot flashes as if med going through his body. On 16-APR-2021, the patient was not breathing well at night and woke up with an asthma attack which lasted for about 3 hours and the whole next day. He visited clinic for asthma attack and was prescribed with medicines. He had a week and half of low energy. On 27-APR-2021, the patient stated that he was still feeling sleepy, dizzy and tired sometimes. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from passing out right after vaccination on 12-APR-2021, experiencing hot flashes, shortness of breath, asthma attack, and sweating, and sore arm on 19-APR-2021, and had not recovered from dizziness, weakness, sleepy, tired, and half of low energy. This report was serious (Other Medically Important Condition).; Sender's Comments: 20210453787-COVID vaccine-loss of consciousness. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Alcohol use (Occasionally); Anxiety; Drug allergy; Penicillin allergy; Smoker (Occasionally)
Vorgeschichte: Comments: Unknown
Andere Medikamente: CLONAZEPAM; IBUPROFEN
Allergien: -
Vorherige Impfungen: -

VAERS 1276413

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: IN
Alter: 43,0
Geschlecht: F
Eingang: 01.05.2021
Impfdatum: -
Beginn: 17.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Bronchitis COVID-19 SARS-CoV-2 test Thrombosis

Symptomtext

COVID-19; BRONCHITIS; This spontaneous report received from a consumer (patient's husband) concerned a 43 year old female. The patient's height, and weight were not reported. The patient was not pregnant at the time of report. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: 042A21A, and expiry: 21-JUN-2021) dose was not reported, administered at Left Deltoid on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the patient was given a dose of the vaccine and she did not show up. On next day 10-APR-2021, she started shivering very badly and was feverish. On 11-APR-2021, the patient also had a headache. On 12-APR-2021, all symptoms gone. The next day on 13-APR-2021 when she got up she had chest tightness and went to doctor due to fever, chills, headache resumed. Since that day was the clot information in the news and they did testing for clot stuff which was all negative. Also the patient diagnosed with bronchitis. After the 13th she had 'on/off' days of experiencing symptoms. On 16-APR-2021, she tested for covid-19 via 'non-rapid' test and the results of test came on the 17th were positive for covid-19 (diarrhea, vomiting, chest tightness, shivering, chills, headache, feverish and nausea). On 17-APR-2021, she developed diarrhea and vomiting. By the 19-APR-2021, they went to the hospital where she received unspecified fluids and pain pills for the fever and to calm her down. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the bronchitis and covid-19 was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0- 20210443606 - Covid-19 vaccine ad26.cov2.s-Covid 19. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: Test Date: 20210413; Test Name: Clot blood; Result Unstructured Data: Negative; Test Date: 20210416; Test Name: COVID-19 PCR test; Result Unstructured Data: POSITIVE
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient was not pregnant at the time of report.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1274762

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: MN
Alter: 42,0
Geschlecht: F
Eingang: 30.04.2021
Impfdatum: 29.04.2021
Beginn: 29.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope Vomiting

Symptomtext

Fainted approximately 2 minutes after injection. Woke up approximately 1 minute later and immediately vomited.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension (treated)
Andere Medikamente: Lisinopril, xyzal, atorvastatin, lexapro, nuvaring, biotin, multivitamin
Allergien: None
Vorherige Impfungen: -

VAERS 1273974

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: IL
Alter: 23,0
Geschlecht: F
Eingang: 30.04.2021
Impfdatum: 30.04.2021
Beginn: 30.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Fall Loss of consciousness Secretion discharge Seizure Vital signs measurement Syncope

Symptomtext

Fainted and fell onto ground 5 min after receiving vaccine. 911 was called, I turned down the ambulance and had family take me to the hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: No diagnosed chronic illness
Andere Medikamente: Lexapro, hydroxizine Neither were taken within 24 hours of the vaccine.
Allergien: None
Vorherige Impfungen: -

VAERS 1273086

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: OH
Alter: 48,0
Geschlecht: F
Eingang: 30.04.2021
Impfdatum: 31.03.2021
Beginn: 09.04.2021
Tage bis Beginn: 9,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Amnesia Blood thyroid stimulating hormone Electric shock sensation Full blood count normal Lipids normal Metabolic function test Thyroxine normal Visual impairment

Symptomtext

Patient reports sudden change in vision and "zapping " sensation in brain as well as short term memory loss that started within 1 week of vaccination and is progressively worsening

Weitere VAERSDATA-Felder

Praegender Schweregrund: Electric shock sensation
Hospital-Tage: -
Labordaten: CBC, CMP, Lipid and TSH w/ reflext T4 all normal
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: None
Allergien: none
Vorherige Impfungen: -

VAERS 1246983

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: FL
Alter: 58,0
Geschlecht: M
Eingang: 30.04.2021
Impfdatum: 05.04.2021
Beginn: 16.04.2021
Tage bis Beginn: 11,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Activated partial thromboplastin time prolonged Anticoagulant therapy Cerebral venous sinus thrombosis Deep vein thrombosis Haematocrit decreased Chills Computerised tomogram Diarrhoea Feeling abnormal Haemoglobin decreased International normalised ratio normal Jugular vein thrombosis Peripheral swelling Platelet count normal Influenza like illness Nausea Pyrexia Thrombosis

Symptomtext

Patient received his dose of COVID-19 Janssen vaccine on 4/5/21. Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine. On 4/16/21 patient began to have swelling in his neck to his hand and presented to the ER. Patient reports having recent tooth surgery complication and thinks the appearance of swelling occurred on same side and occurred around same time. Patient was diagnosed with a DVT of the internal jugular, subclavian vein and given a dose of lovenox. Patient had personal matters to attend to and left AMA before full treatment and disease workup. Patient presented the next day on 4/17/21 to MC to receive further care. The swelling had worsened overnight. Labs showed normal platelet count and no thrombocytopenia. Ultrasound confirmed a near-occlusive right internal jugular and subclavian DVT. An asymptomatic cerebral venous thrombosis, with thrombosis in the right sigmoid sinus and partial thrombosis of the right transverse sinus was also noted on imaging. MC notes state usual cause for upper extremity DVT does not apply to patient - no trauma or evidence of cancer. Patient suffered no significant events during hospitalization. Clot was further treated with Argatroban during stay and patient was d/c on 4/20/21 with Apixaban to treat the DVT with plans to follow up with vascular surgery for surgery after clots are resolved in several weeks

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: 3,0
Labordaten: All labs 4/17/21 @1422 APTT 45 PT 11 INR 1 Heparin Anti-Xa unfractionated 0.10 WBC 6.5 RBC 4.44 Hgb 13.1 Hct 39.1 PLT count 257
Aktuelle Erkrankungen: none
Vorgeschichte: Comorbidities include obesity, HTN, HLD, sleep apnea, chronic knee/back pain
Andere Medikamente: albuterol inhaler, aspirin, atorvastatin, cholecalciferol, fluticasone, HCTZ, metformin, mometasone furorate inhaler, omeprazole, sertraline, tadalafil, tramadol, trazodone, zolpidem
Allergien: sulfamethoxazole/trimethoprim, lisinopril, alprostadil
Vorherige Impfungen: -

VAERS 1246983

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: FL
Alter: 58,0
Geschlecht: M
Eingang: 30.04.2021
Impfdatum: 05.04.2021
Beginn: 16.04.2021
Tage bis Beginn: 11,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Activated partial thromboplastin time prolonged Anticoagulant therapy Cerebral venous sinus thrombosis Deep vein thrombosis Haematocrit decreased Chills Computerised tomogram Diarrhoea Feeling abnormal Haemoglobin decreased International normalised ratio normal Jugular vein thrombosis Peripheral swelling Platelet count normal Influenza like illness Nausea Pyrexia Thrombosis

Symptomtext

Patient received his dose of COVID-19 Janssen vaccine on 4/5/21. Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine. On 4/16/21 patient began to have swelling in his neck to his hand and presented to the ER. Patient reports having recent tooth surgery complication and thinks the appearance of swelling occurred on same side and occurred around same time. Patient was diagnosed with a DVT of the internal jugular, subclavian vein and given a dose of lovenox. Patient had personal matters to attend to and left AMA before full treatment and disease workup. Patient presented the next day on 4/17/21 to MC to receive further care. The swelling had worsened overnight. Labs showed normal platelet count and no thrombocytopenia. Ultrasound confirmed a near-occlusive right internal jugular and subclavian DVT. An asymptomatic cerebral venous thrombosis, with thrombosis in the right sigmoid sinus and partial thrombosis of the right transverse sinus was also noted on imaging. MC notes state usual cause for upper extremity DVT does not apply to patient - no trauma or evidence of cancer. Patient suffered no significant events during hospitalization. Clot was further treated with Argatroban during stay and patient was d/c on 4/20/21 with Apixaban to treat the DVT with plans to follow up with vascular surgery for surgery after clots are resolved in several weeks

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: 3,0
Labordaten: All labs 4/17/21 @1422 APTT 45 PT 11 INR 1 Heparin Anti-Xa unfractionated 0.10 WBC 6.5 RBC 4.44 Hgb 13.1 Hct 39.1 PLT count 257
Aktuelle Erkrankungen: none
Vorgeschichte: Comorbidities include obesity, HTN, HLD, sleep apnea, chronic knee/back pain
Andere Medikamente: albuterol inhaler, aspirin, atorvastatin, cholecalciferol, fluticasone, HCTZ, metformin, mometasone furorate inhaler, omeprazole, sertraline, tadalafil, tramadol, trazodone, zolpidem
Allergien: sulfamethoxazole/trimethoprim, lisinopril, alprostadil
Vorherige Impfungen: -

VAERS 1164014

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: IL
Alter: 31,0
Geschlecht: M
Eingang: 30.04.2021
Impfdatum: 02.04.2021
Beginn: 02.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Dizziness Hyperhidrosis Loss of consciousness Syncope Headache

Symptomtext

fainting following injection

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: 1,0
Labordaten: severe headaches 10 days post vaccination leading to hospitalization
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: n/a
Allergien: n/a
Vorherige Impfungen: -

VAERS 1271930

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MA
Alter: 50,0
Geschlecht: M
Eingang: 29.04.2021
Impfdatum: 01.04.2021
Beginn: 22.04.2021
Tage bis Beginn: 21,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Anticoagulant therapy Back pain Chest pain Computerised tomogram thorax abnormal Dizziness Dyspnoea Haemoptysis Nephrolithiasis Pain Pulmonary thrombosis Thrombosis Ultrasound Doppler abnormal

Symptomtext

starting have shortness of breath/difficulty breathing and back and chest pain. light headed, pain unbearable. Saturday April 23rd Went to er was treated for kidney stones but they could only find one small one, Was sent home with pain medication. Shortness of breath persisted as did bloody cough and pain in chest and all over. Went back to the er on 4/28 as pain was unbearable (chest pain) once given a cat scan and diagnosed with blood clots in my lungs and then an ultra sound and found a blood clot in my leg (just above knee). It is thought that I was mis-diagnosed on the original trip to the er with kidney stones. I have been put on blood thinners and pain medication and will be following up with my doctor.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary thrombosis
Hospital-Tage: 1,0
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: lisinopril 10 mlg
Allergien: none
Vorherige Impfungen: -

VAERS 1271104

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NJ
Alter: 52,0
Geschlecht: M
Eingang: 29.04.2021
Impfdatum: 07.04.2021
Beginn: 14.04.2021
Tage bis Beginn: 7,0
Dosis: 1
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Abdominal pain Cerebral venous sinus thrombosis Chest discomfort Computerised tomogram abdomen normal Computerised tomogram head normal Facial paralysis Head discomfort Headache Hypoaesthesia Immediate post-injection reaction Induration Magnetic resonance imaging head normal Platelet count normal Transverse sinus thrombosis Venogram abnormal

Symptomtext

Immediately after the injection patient felt a pressure like and felt a ball on the back of his head left side that resolved within a day. Within a week from vaccine patient started having a headache on and off with feeling of like his brain is swelling on the left side. Within another week patient experienced abdominal pain and chest pressure. went to a hospital CT abdomen was negative. On 4/28 patient had a severe headache followed by numbness to left face and left facial droop. 911 was called patient was code stroke in ED.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral venous sinus thrombosis
Hospital-Tage: -
Labordaten: 4/28 CTH negative 4/28 MRI Brain negative 4/29 MRV Brain Venous sinus thrombosis left transverse sinus also suggested medially extending to the sigmoid sinus 4/28 Platelets 221, 4/29 177
Aktuelle Erkrankungen: None
Vorgeschichte: HTN DM controlled by diet H/O IV drug abuse 15 years ago heroin
Andere Medikamente: Methadone 50mg daily Metrololol Tartrate 100mg daily Remeron 15mg daily
Allergien: None
Vorherige Impfungen: -

VAERS 1268347

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: AK
Alter: 35,0
Geschlecht: F
Eingang: 28.04.2021
Impfdatum: 28.04.2021
Beginn: 28.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Hypotension Syncope

Symptomtext

Low blood pressure caused a syncopal event. Blood pressure was taken and reported stable within 5 minutes. EMT on scene recommends going to be checked out by higher level of medical care.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 1267116

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: IN
Alter: 48,0
Geschlecht: F
Eingang: 28.04.2021
Impfdatum: 26.04.2021
Beginn: 27.04.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Body temperature increased Chills Fatigue Headache Hyperhidrosis Injection site pain Pain Sleep disorder Syncope Tremor

Symptomtext

Received shot in upper right arm and it was painful. My arm grew more painful throughout the day. I became very tired as the day went on. Went to bed for the evening, Monday 4/26/2021 and woke up at 1:50am on Tuesday morning, 4/27/2021 in full body sweats, dripping with sweat. So weak I couldn't get up or lift my head. My husband took my temperature which was 103. Massive headaches, full body aches and pains, chills which made my body shake uncontrollably. My whole body hurt. Could not get up to use the restroom, tried and fainted back into the bed. Heart felt like it was beating out of my chest. My husband wanted to call 911 but I didn't want to. Felt like I had COVID again.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: Did not seek medical treatment.
Aktuelle Erkrankungen: Period Menorrhagia
Vorgeschichte: Anemia Menorrhagia Mitral Valve Disorder Tricuspid Valve Disorder
Andere Medikamente: Pantroprazole 40MG once daily D3 2000IU 50mcg once daily B12 1000mcg once daily Ibuprofen 800mg twice daily
Allergien: Prednisone
Vorherige Impfungen: -

VAERS 1266906

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CT
Alter: 30,0
Geschlecht: F
Eingang: 28.04.2021
Impfdatum: 28.04.2021
Beginn: 28.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Dizziness Dyskinesia Electrocardiogram Extremity contracture Hypotension Hypotonia Laboratory test Loss of consciousness Pallor Seizure Syncope Urinary incontinence

Symptomtext

at 4/28/21 patient was vaccinated w/ Jessen vaccine and soon became pale and observed to became flaccid and pass out. pt's HR was 50, sat02 99% and BP 70/40. Pt soon observed with BLUE contracting and BLLE adducting followed by urine incontinence. Pt did not fall and was sitting in her chair the entire episode that lasted for approximately 40-60sec. Pt awake and continued to have hypotension, dizziness reported. EMS contacted and pt transferred to local ER for evaluation of suspected syncope and seizure s/p vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: on 4/28/21 pt Seen at ER. routine labs, ECG completed and pt given 1L N.S. bolus. VSS and pt discharged on 4/28/21 at 1230pm for syncope and instructed to f/u with neurology r/t seizure concerns
Aktuelle Erkrankungen: none reported
Vorgeschichte: non reported
Andere Medikamente: other: pt reported undergoing IVF treatments
Allergien: none reported
Vorherige Impfungen: -

VAERS 1232609

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: WI
Alter: 38,0
Geschlecht: M
Eingang: 28.04.2021
Impfdatum: 12.04.2021
Beginn: 17.04.2021
Tage bis Beginn: 5,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Arthralgia Blood test Confusional state Fatigue Joint swelling Fibrin D dimer increased Ultrasound scan Venous thrombosis limb Pain in extremity Peripheral swelling Ultrasound scan abnormal

Symptomtext

Venous thrombosis of proximal greater saphenous vein

Weitere VAERSDATA-Felder

Praegender Schweregrund: Venous thrombosis limb
Hospital-Tage: -
Labordaten: Ultrasound, elevater d-dimer
Aktuelle Erkrankungen: -
Vorgeschichte: BMI 34
Andere Medikamente: Omeprazole
Allergien: none
Vorherige Impfungen: -

VAERS 1265409

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: OH
Alter: 44,0
Geschlecht: M
Eingang: 27.04.2021
Impfdatum: 11.04.2021
Beginn: 25.04.2021
Tage bis Beginn: 14,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Computerised tomogram normal Joint dislocation Magnetic resonance imaging Mental status changes Seizure

Symptomtext

Patient reports seizures on 4/25/2021 requiring 911 call, ambulance, and hospitalization stay. Patient mental status changed to violent and resulted in a dislocated shoulder when hospitalized. Patient has no history of seizures or violent behavior.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: 3,0
Labordaten: To date, normal CAT scan, waiting on MRI results, and is scheduled for EEG.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1265163

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CA
Alter: 31,0
Geschlecht: F
Eingang: 27.04.2021
Impfdatum: 03.04.2021
Beginn: 17.04.2021
Tage bis Beginn: 14,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Back pain Chest pain Dyspnoea Lung disorder Pain in extremity Thrombosis

Symptomtext

Blood clot in each lung, chest pain, labored breathing, leg pain and upper back pain.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: Don't have details
Aktuelle Erkrankungen: NA
Vorgeschichte: NA
Andere Medikamente: NA
Allergien: NA
Vorherige Impfungen: -

VAERS 1263472

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: PA
Alter: 76,0
Geschlecht: F
Eingang: 27.04.2021
Impfdatum: 03.04.2021
Beginn: 05.04.2021
Tage bis Beginn: 2,0
Dosis: N/A
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Thrombosis

Symptomtext

patient had a blood clot 2 days after receiving the J & J vaccine; she was hospitalized and released. We just learned of this when the patient was in to pick up a Rx--we are unsure if this was already recorded by the hospital that treated her--we were advised by our market manager to submit just in case they didn't submit at the hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: unknown
Aktuelle Erkrankungen: unknown
Vorgeschichte: high blood pressure, underactive thyroid, high cholestrol, anxiety, atherosclerotic heart disease
Andere Medikamente: buspirone, imdur, lipitor, levothyroxine, metoprolol, furosemide, pantoprazole, plavix, lisinopril
Allergien: unknown
Vorherige Impfungen: -

VAERS 1262401

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: PA
Alter: 63,0
Geschlecht: F
Eingang: 27.04.2021
Impfdatum: 10.04.2021
Beginn: 18.04.2021
Tage bis Beginn: 8,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Deep vein thrombosis Injection site mass Injection site pain Movement disorder Pain Thrombosis Ultrasound Doppler

Symptomtext

Throbbing pain at injection site and entire arm. Unable to move up without assistance. Pain grew more and more intense. Went to urgent care on unspecified date. NP examined me and discovered a lump in my arm. Both the lump and the vaccination site hurt when she pressed on them. She prescribed presdone and gave me a work order for a vascular ultrasound to be performed on my left arm. I went on unspecified date for the scan. It was discovered that a DVT blood clot had formed in my brachial vein in the left arm. I was then prescribed eliquis, 20 mg a day for 7 days and told not to take the predesone. NP called my pcp, his office immediately called me and asked me to come in as they are concerned about the high dosage of the eliquis.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: -
Labordaten: Vascular ultra sound down on left arm, covid vaccine arm.
Aktuelle Erkrankungen: -
Vorgeschichte: Diabetes 2
Andere Medikamente: atenolol-chlorthalidone 100-25 alprazolam 1-3 mg for sleep only Januvia 50 mg
Allergien: sulfa drugs metformin certain high blood pressure medicine, in medical charts, name unknown at the time
Vorherige Impfungen: -

VAERS 1261322

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: -
Alter: 46,0
Geschlecht: F
Eingang: 27.04.2021
Impfdatum: -
Beginn: 11.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood test Computerised tomogram Electrocardiogram Ischaemic stroke Magnetic resonance imaging Monoparesis Muscular weakness Thrombosis Ultrasound Doppler Ultrasound scan

Symptomtext

CLOT BLOOD; ACUTE ISCHEMIC STROKE IN LEFT FRONTAL LOBE; PARTIAL LOSS OF USE IN RIGHT LEG; MUSCLE WEAKNESS; This spontaneous report received from a patient concerned a 46 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included amoxicillin and flexeril allergy, and migraine. The patient experienced drug allergy when treated with cyclobenzaprine hydrochloride. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 042A21A, and batch number: 042A21A expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 11:30 on left arm for prophylactic vaccination. Concomitant medications included ascorbic acid, ascorbic acid/ergocalciferol/folic acid/nicotinamide/panthenol/retinol/riboflavin/thiamine hydrochloride, ergocalciferol, iron, and withania somnifera. Approximately three days after the vaccine, on 11-APR-2021 08:20, the patient experienced clot blood. Which caused an acute ischemic stroke in left frontal lobe resulting in partial loss of use in right leg and muscle weakness. The patient had a blood test, CT scan, Carotid artery ultrasound, diagnostic ultrasound, electrocardiogram (EKG) and an MRI, results are unknown. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from clot blood, acute ischemic stroke in left frontal lobe, muscle weakness, and partial loss of use in right leg. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: This is a report of a 46 year old, female patient who experienced a blood clot that caused an acute ischemic stroke in the left fontal lobe 3 days after receiving the covid-19 vaccine ad26.cov.2. Patient's height and weight were not reported. Patient has migraine and allergies to amoxicillin, flexeril and cyclobenzapine hydrochloride. Concomitant medications included ascorbic acid, ascorbic acid/ ergocalciferol/folic acid/ nicotinamide/ panthenol/retinol/ riboflavin/ thiamine hydrochloride, ergocalciferol, iron, and withania somnifera. Smoking history, drug abuse and alcohol intake were not reported. Three (3) days after receiving the vaccine, patient was noted to have a blood clot (unspecified area) that caused an acute ischemic stroke in the left frontal lobe, resulting in muscle weakness and partial loss of use of the right leg. Patient had blood tests done as well as CT Scan, carotid artery ultrasound, electrocardiogram and MRI but the results were not reported. The information provided precludes a meaningful medical assessment. Additional information requested.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Ischaemic stroke
Hospital-Tage: -
Labordaten: Test Name: EKG; Result Unstructured Data: Unknown; Test Name: CT scan; Result Unstructured Data: Unknown; Test Name: MRI; Result Unstructured Data: unknown; Test Name: Carotid artery ultrasound; Result Unstructured Data: Unknown; Test Name: Blood test; Result Unstructured Data: Unknown; Test Name: Diagnostic ultrasound; Result Unstructured Data: Unknown
Aktuelle Erkrankungen: Allergic reaction to antibiotics; Migraine
Vorgeschichte: Comments: Unknown
Andere Medikamente: VITAMIN D [ERGOCALCIFEROL]; ASHWAGANDHA [WITHANIA SOMNIFERA]; VITAMIN C [ASCORBIC ACID]; IRON; MULTIVITAMINS [ASCORBIC ACID;ERGOCALCIFEROL;FOLIC ACID;NICOTINAMIDE;PANTHENOL;RETINOL;RIBOFLAVIN;THI
Allergien: -
Vorherige Impfungen: -

VAERS 1192048

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MA
Alter: 58,0
Geschlecht: F
Eingang: 27.04.2021
Impfdatum: -
Beginn: 09.04.2021
Tage bis Beginn: -
Dosis: N/A
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Dizziness Erythema Exophthalmos Loss of consciousness Malaise Electrocardiogram Feeling hot Hyperhidrosis Nausea Mobility decreased Staring Unresponsive to stimuli

Symptomtext

FEELING HOT; SWEATY; NAUSEA; This spontaneous report received from a patient concerned a 58 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included high blood pressure, and severe anaphylactic to penicillin. The patient experienced rash when treated with cefalexin, and headache and vomiting when treated with erythromycin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A and expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the subject experienced feeling hot. On 09-APR-2021, the subject experienced sweaty. On 09-APR-2021, the subject experienced nausea. Laboratory data included: EKG (NR: not provided) Unknown. Treatment medications (dates unspecified) included: epinephrine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from feeling hot, sweaty, and nausea on 11-APR-2021. This report was non-serious.; Sender's Comments: V0: Medical assessment comment is not required as per standard procedure as case assessed as non-serious.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Test Date: 20210409; Test Name: EKG; Result Unstructured Data: Unknown
Aktuelle Erkrankungen: Blood pressure high; Penicillin allergy
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1192048

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MA
Alter: 58,0
Geschlecht: F
Eingang: 27.04.2021
Impfdatum: -
Beginn: 09.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Dizziness Erythema Exophthalmos Loss of consciousness Malaise Electrocardiogram Feeling hot Hyperhidrosis Nausea Mobility decreased Staring Unresponsive to stimuli

Symptomtext

FEELING HOT; SWEATY; NAUSEA; This spontaneous report received from a patient concerned a 58 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included high blood pressure, and severe anaphylactic to penicillin. The patient experienced rash when treated with cefalexin, and headache and vomiting when treated with erythromycin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A and expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the subject experienced feeling hot. On 09-APR-2021, the subject experienced sweaty. On 09-APR-2021, the subject experienced nausea. Laboratory data included: EKG (NR: not provided) Unknown. Treatment medications (dates unspecified) included: epinephrine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from feeling hot, sweaty, and nausea on 11-APR-2021. This report was non-serious.; Sender's Comments: V0: Medical assessment comment is not required as per standard procedure as case assessed as non-serious.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Test Date: 20210409; Test Name: EKG; Result Unstructured Data: Unknown
Aktuelle Erkrankungen: Blood pressure high; Penicillin allergy
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1260371

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CA
Alter: 62,0
Geschlecht: M
Eingang: 26.04.2021
Impfdatum: 01.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 9,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Angiotensin converting enzyme Antibody test Antinuclear antibody negative Back pain Bacterial test negative Bell's palsy Borrelia test negative CSF glucose increased CSF protein increased CSF red blood cell count positive CSF white blood cell count increased Constipation Dysarthria Dysphagia Epstein-Barr virus test negative Facet joint syndrome Facial paralysis Facial paresis

Symptomtext

Patient states he received J&J vaccine on 4/1; on 4/10 he had nonradiating persistent low back pain. A few days after that (on 4/13) he felt numbness and pain in his legs, in addition to ?decreased sensation in his inner thighs. These sensations were migratory and intermittent. Also noted in his upper extremities as well. He also had issues with temperature sensation in his lower extremities. On 4/14 he had slight haziness in vision while driving which resolved after 30-60min and has not recurred. He also had slight difficulty walking. On 4/15 he had an appointment with his PMD; had L-spine XR which revealed moderate lower lumbar facet arthritis, and was thought that change in sensation was likely d/t radiculopathy - was prescribed ibuprofen, muscle relaxant, oxycodone (took oxy x1, ibuprofen for a few days). Since then he has also had intermittent stabbing pains in various parts of his body which resolved spontaneously. On 4/17-4/18 his back pain resolved. On 4/18 at 4:30am he woke up with R-sided facial weakness. He has not had focal weakness aside from the face. Was seen in ED that morning for this R-sided facial droop involving the forehead, diagnosed with Bell's palsy and given prednisone/valacyclovir. Yesterday 4/19 around mid-day he started having L-sided facial weakness and slurred speech. This has progressed since yesterday. Reports ability to swallow, though a little difficult d/t cheek weakness. Low back pain has returned as well. Does report constipation and possible poor bladder emptying for the last few days. He was seen by a Doctor and referred to ED to rule out AIDP and other diseases after J&J vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: 6,0
Labordaten: Lyme neg, ANA<1:40, M. Pneumoniae Ab 0.44 (H), GQ1 Ab pending, RF neg, EBV neg, ACE pending CSF: protein 136, glucose 96, RBC 84, WBC 46 (1N, 74L, 22M, 1E, 2B), gram stain many WBC rare RBC, bacterial cx neg, HSV 1/2 pcr neg, OCB neg, VZV pcr neg, lyme pending, meningoencephalitis panel pending, WNV pending, 4/20/21 MRI c-spine w/w/out contrast No spinal canal stenosis. No focal cervical spinal cord abnormality or abnormal enhancement. 4/20/21 MRI T-spine w/w/out contrast No convincing spinal cord abnormality. No abnormal enhancement.. 4/20/21 MRI L-spine w/w/out contrast Degenerative changes without high-grade spinal canal or foraminal stenosis at any lumbar level. No clumping or abnormal enhancement of the nerve roots of the cauda equina. 4/20/21 MRI brain w/w/out contrast No acute infarction, intracranial hemorrhage or mass effect. Abnormal enhancement of the bilateral facial nerves. This is a nonspecific finding and can be seen in the setting of Guillain-Barre syndrome, Lyme disease, sarcoidosis/other granulomatous processes, meningitis, leukemia, carcinomatosis as well as other intracranial processes. Recommend comparison with CSF studies. Incidental left sphenoid wing meningioma. No vasogenic edema in the adjacent left temporal lobe.
Aktuelle Erkrankungen: Denies any illnesses at time of vaccination or in the preceding month
Vorgeschichte: hypertension, chronic HSV in suppression for 30 years, ADHD, GERD
Andere Medikamente: amphetamine-dextroamphetamine, amlodipine, benazepril, simvastatin, valacyclovir
Allergien: None
Vorherige Impfungen: -

VAERS 1258089

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: VA
Alter: 33,0
Geschlecht: F
Eingang: 26.04.2021
Impfdatum: 10.04.2021
Beginn: 22.04.2021
Tage bis Beginn: 12,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Deep vein thrombosis Pain in extremity Peripheral swelling Ultrasound Doppler

Symptomtext

Client complained of pain and swelling in right calf area 2 -3 days before going to ER , at ER. Doppler study confirmed popliteal DVT

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: -
Labordaten: Doppler study 04252021
Aktuelle Erkrankungen: None stated
Vorgeschichte: GERD
Andere Medikamente: Tylenol OTC
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1220558

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CA
Alter: 62,0
Geschlecht: M
Eingang: 26.04.2021
Impfdatum: 08.04.2021
Beginn: 12.04.2021
Tage bis Beginn: 4,0
Dosis: UNK
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Abdominal pain upper Chest X-ray Chills Computerised tomogram head Confusional state Amnesia Electrocardiogram Full blood count Headache Fracture Laboratory test Magnetic resonance imaging abnormal Pain Retching Magnetic resonance imaging Metabolic function test Nausea Seizure

Symptomtext

4/9 thru 4/12, body aches, chills. 4/12 0400 throwing up stomach pain from dry heaving throughout the day, confusion starting at 6pm on 4/12. Seizure on 4/12 at 8 pm. 911, ambulance. to Hospital Seizure so severe caused a Fracture in the Right Scapula. MRI on 4/15 showed a venous thrombosis partial occlusion in the brain.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: 4/12, labs, chest x-ray, shoulder x-ray, 4/13 CT head, and Adomnal MRI with contrast. 4/ 15 Head MRI with contrast
Aktuelle Erkrankungen: none
Vorgeschichte: controlled hypertension
Andere Medikamente: Flomax 0.4mg, lipitor 40mg, lisinopril 20mg, melatonin 5mg, red rice yeast 600mg, CoQ10 30mg
Allergien: none
Vorherige Impfungen: -

VAERS 1251620

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: IL
Alter: 73,0
Geschlecht: F
Eingang: 24.04.2021
Impfdatum: 05.04.2021
Beginn: 08.04.2021
Tage bis Beginn: 3,0
Dosis: UNK
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Arthralgia Blood test Groin pain Pain in extremity Thrombosis Ultrasound scan

Symptomtext

Severe pain in left thigh groin & knee area. Went to ER, confirmed blood clot. Sent home w/blood thinners - Xarelto

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: Ultra Sound in ER Blood Work
Aktuelle Erkrankungen: Stage 3 kidney disease
Vorgeschichte: Kidney disease
Andere Medikamente: Tylenol
Allergien: none
Vorherige Impfungen: -

VAERS 1251424

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: OK
Alter: 44,0
Geschlecht: M
Eingang: 24.04.2021
Impfdatum: 10.04.2021
Beginn: 22.04.2021
Tage bis Beginn: 12,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Bell's palsy Dyskinesia Speech disorder

Symptomtext

Bell's Palsy on right side of face developed 4/22/21. Pt thought he was having a stroke and went to the ER. Doctor gave him B12 to inject 2 doses. Worsening 4/24/21 and having a lot of trouble speaking and eating/drinking.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: high blood pressure
Andere Medikamente: metoprolol er 100mg, losartan 100mg, cymbalta 60mg
Allergien: none
Vorherige Impfungen: -

VAERS 1249253

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CA
Alter: 43,0
Geschlecht: M
Eingang: 23.04.2021
Impfdatum: -
Beginn: 06.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Productive cough Seizure Vomiting

Symptomtext

INCREASED SEIZURES; THREW UP; INCREASED PHLEGM / INCREASED COUGHING; This spontaneous report received from a parent concerned a 43 years old white Hispanic or Latino male. The patient's height, and weight were not reported. The patient's past medical history included cerebral palsy, mental retardation, and epilepsy, and concurrent conditions included seizures, cough, and phlegm. Patient had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: UNKNOWN) dose was not reported, 1 total administered on 06-APR-2021 on right deltoid for prophylactic vaccination. No concomitant medications were reported. On 06-APR-2021, the patient experienced increased phlegm / increased coughing. On 07-APR-2021, the patient experienced increased seizures. On the same day, he experienced threw up. The patient usually had a cough and phlegm. On the following day of vaccination, the patient's amount of phlegm and cough was increased and he throw-up and had 2 seizures. On 08-Apr-2021, the patient had 10 seizures. The patient regularly had seizures but the number per day increased after vaccination. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from increased seizures on 09-APR-2021, and threw up on 07-APR-2021, and had not recovered from increased phlegm / increased coughing. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210428761-covid-19 vaccine ad26.cov2.s-increased seizures. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Cough; Phlegm; Seizures
Vorgeschichte: Medical History/Concurrent Conditions: Cerebral palsy; Epilepsy; Mental retardation; Comments: The patient had no known drug allergies.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1249198

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: IN
Alter: -
Geschlecht: F
Eingang: 23.04.2021
Impfdatum: -
Beginn: 10.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Generalised tonic-clonic seizure Injection site mass Injection site warmth Pain Tenderness

Symptomtext

2X GRAND MAL SEIZURE; TENDER; SORE; LUMP AT INJECTION SITE; INJECTION SITE FELT HOT; This spontaneous report received from a patient concerned a white, not hispanic or latino female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included seizure which was under control with medications. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A,expiry: UNKNOWN) dose was not reported,1 total administered on 07-APR-2021 in left arm for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021, the patient experienced tender, sore, lump at injection site, injection site felt hot to touch. On 11-APR-2021, the patient had two grand mal seizure and and had to visit an emergency room/hospital. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from lump at injection site, and injection site felt hot on 11-APR-2021, was recovering from tender, and sore, and the outcome of 2x grand mal seizure was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210424069- covid-19 vaccine ad26.cov2.s -2x grand mal seizure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY

Weitere VAERSDATA-Felder

Praegender Schweregrund: Generalised tonic-clonic seizure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Seizure (Patient have not had seizure for 2 years after she started taking her medication)
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1247663

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CA
Alter: 55,0
Geschlecht: F
Eingang: 23.04.2021
Impfdatum: 06.04.2021
Beginn: 06.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood test Dyspnoea Headache Loss of consciousness Photophobia Somnolence

Symptomtext

4/6/ 21 within hours of the vaccine: extreme sleepiness as if I had been drugged , excruciating headache for hours but I could not open my eyes or full wake up, trouble breathing, but could not open my eyes or fully wake up. 4/6/ 21 5pm awake but very groggy headache is not as bad. Took an alleve which helped but the headache did not go away. 4/7-4/12 bad headache exacerbated by going outdoors in sunlight. persistent grogginess every morning. very difficult to wake up. I run several days a week was able to complete 4 miles no problem . but headaches would be worse being outside in daylight. 4/13 I read news of headaches and clotting rx so I saw my Dr. did blood work and scheduled for MRI. blood work /platelets came back WNL . MRI was cost prohibitive for me so I cancelled MRI would follow up with MRI if headaches worsened and or developed other symptoms. 4/13-4/21 Persistent , annoying headache but improving somewhat. Still have difficulty waking up in the am. 4/22 First day that headache mostly was not present. Difficulty waking up in the am still. 4/17

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: 4/13/2021 blood work in prep for MRI all WNL I think? MRI scheduled for 4/15/21 I declined due to costs and to see if symptoms would improve or worsen.
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: Estrogen 4mg/gm cream 2 pumps a day testosterone 3mg/gm cream 2 pumps a day progesterone 100mg tab 1 a day
Allergien: penicillin
Vorherige Impfungen: -

VAERS 1246269

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CA
Alter: 46,0
Geschlecht: F
Eingang: 23.04.2021
Impfdatum: 05.04.2021
Beginn: 05.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Blood glucose normal Electrocardiogram Hyperhidrosis Muscle spasms Seizure Loss of consciousness Mydriasis Tremor Syncope Urine analysis

Symptomtext

I?m writing this as a former, trained healthcare professional (physical therapist). 30sec-after injection I raised my left (injected) arm and my deltoid/bicep had a sudden hard spasm. I told my husband (who was in the middle of getting his shot) and the administrator that I was passing out. I blacked out. They ran over. They said 5 minutes passed in which my eyes were wide open and dilated. I suddenly began profuse sweating and convulsions/ severe full body shaking. They could not keep me lucid, and called 911. Paramedics came and got a systolic BP of 36 (I?m unaware of the diastolic BP) with blood sugar at 111 ish. I could not form words and kept going in and out of consciousness. I was transported by ambulance to the ER. A few minutes into the ambulance ride I was able to form words, and vitals stared to return. I?ve passed out a few times and this WAS NOT a normal episode of syncope.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: 4/5/21 (immediately following): EKG, urine
Aktuelle Erkrankungen: None
Vorgeschichte: Osteoarthritis
Andere Medikamente: None
Allergien: Kefflex
Vorherige Impfungen: -

VAERS 1243319

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MI
Alter: 44,0
Geschlecht: F
Eingang: 22.04.2021
Impfdatum: 08.04.2021
Beginn: 08.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Abdominal pain Computerised tomogram normal Diarrhoea Dizziness Dysstasia Electrocardiogram normal Fall Feeling abnormal Full blood count normal Injury Loss of consciousness Loss of personal independence in daily activities Malaise Mobility decreased Nausea

Symptomtext

A few hours after the vaccine I felt really bad. I had severe diarreah and abdominal pains which caused me to go to the ER d/t abdominal pain. I was so severly sick, in bed and couldnt hardly move. On Sat I was being transported to the hospital when I got super nauseaed so my husband pulled over and I passed out and went unconscious and fell out the car onto the ground. EMT was called and transported me to the hospital when a CT Scan and EKG was performed. I was given IV fluids, monitored and released after some time. Over the next few days I felt absolutely awful. On 4/15 I had a phone F/U visit with my PCP. I still havent felt to myself to date and had to go back to the ER last night because I was so nauseaed and dizzy I couldnt stand or do anything and I am still having the diarreah also

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: CT Scan-normal EKG-normal CBC-normal
Aktuelle Erkrankungen: diarreah
Vorgeschichte: Cynkipi, Ruptured Aneruysm, TIAs
Andere Medikamente: no
Allergien: Depacko, Clinminicine, SSRI drugs, latex
Vorherige Impfungen: -

VAERS 1240924

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: GA
Alter: 73,0
Geschlecht: F
Eingang: 22.04.2021
Impfdatum: -
Beginn: 07.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Bell's palsy Epistaxis

Symptomtext

BLOODY NOSE; BELL'S PALSY; This spontaneous report received from a patient concerned a 73 year old female patient. The patient's height, and weight were not reported. The patient's past medical history included carotid surgery on 12-MAR-2021. The patient received vaccination with JANSSEN COVID-19 VACCINE (covid-19 vaccine ad26.cov2.s) (suspension for injection, route of admin intramuscular, batch number: 042A21A, expiry: UNKNOWN) dose was not reported, administered to left arm on 02-APR-2021 for prophylactic vaccination. Concomitant medications included clopidogrel bisulfate for blood thinner. The patient reported no other symptoms or side effects after the vaccine. Around 07-APR-2021, patient started getting Bell's palsy and went to the Emergency Room (ER) because she thought she was having a stroke. The patient was diagnosed with Bell's palsy. The patient followed up with primary care provided on 12-APR-2021. Patient's Bell's palsy was not recovered completely but was almost gone. The patient had bloody nose on 13-APR-2021 and went to urgent care. The patient was told not to worry about it and 'it will probably never happen again'. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from bleeding from nose, and was recovering from bell's palsy. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: This 73-year-old female patient experienced medically important Bell's palsy 5 days after receiving JANSSEN COVID-19 VACCINE (covid-19 vaccine ad26.cov2.s) intramuscularly to left arm for prophylactic vaccination. The patient's had carotid surgery 21 days prior to the vaccination. Concomitant medications included clopidogrel bisulphate. The patient reported no other symptoms after the vaccination. She started to get Bell's palsy symptoms 5 days post vaccination and visited emergency room. She was diagnosed with Bell's palsy. Details of symptoms, diagnosis, treatment were not reported. She followed up with primary care provider 10 days post vaccination and was seen with Bell's palsy "almost gone". She was recovering from Bell's palsy. The patient experienced non-serious bloody nose the next day and had recovered. Although information is limited, as there is no confirmatory epidemiologic/biologic evidence that vaccinations cause/contribute to the development of Bell's palsy, and the most common causes include viral infection and diabetes, the event is assessed to have an indeterminate causal association to immunization, per WHO causality classification for adverse events following immunization. Company causality for Bell's Palsy is considered not related to JANSSEN COVID-19 VACCINE. Additional information has been requested for further assessment.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Arterial operation NOS
Andere Medikamente: PLAVIX
Allergien: -
Vorherige Impfungen: -

VAERS 1238670

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: PA
Alter: 18,0
Geschlecht: F
Eingang: 21.04.2021
Impfdatum: 11.04.2021
Beginn: 11.04.2021
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Hyperhidrosis Loss of consciousness Visual impairment

Symptomtext

Patient was nervous and shortly after injection reported that she had vision changes and got diaphoretic. While assisting the pt into a reclining position she briefly lost consciousness; total duration 3-5 seconds. She regained consciousness immediately once she was flat and her feet were elevated. I monitored her blood several times and it was normal. Over the course of 30-40 minutes she recovered and left the pharmacy.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none known
Vorgeschichte: none known
Andere Medikamente: none known
Allergien: none reported
Vorherige Impfungen: -

VAERS 1237936

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CO
Alter: 46,0
Geschlecht: F
Eingang: 21.04.2021
Impfdatum: 08.04.2021
Beginn: 13.04.2021
Tage bis Beginn: 5,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test Chest pain Dyspnoea Pain in extremity Thrombosis

Symptomtext

Blood clot in right arm , SOB, CHEST PAIN, arm pain,

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: blood work, imaging, medications
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: tylenol 650 mg
Allergien: sulfa
Vorherige Impfungen: -

VAERS 1237716

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CT
Alter: 41,0
Geschlecht: F
Eingang: 21.04.2021
Impfdatum: 10.04.2021
Beginn: 18.04.2021
Tage bis Beginn: 8,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Back pain Computerised tomogram Dizziness Dysarthria Energy increased Facial paralysis Fatigue Feeling abnormal Full blood count Headache Hemiparesis Magnetic resonance imaging Nausea Neck pain Pain in extremity Urine analysis

Symptomtext

4/10 - sore arm, no other symptoms 4/11 - headache 8/10, brain fog, nausea, dizziness, 7/10 neck and back pain, 8/10 exhaustion 4/12-4/17 - low grade headache 3-4/10 4/19 - 8/10 headache, 8/10 exhaustion, extreme weakness on right-side, rapid onset of stroke-like symptoms (Est 815am) to right side (face droop with impaired slurred slow speech, right arm, right leg immobility) facial symptoms resolved quickly (less than 1 minute), complete speech impairment lasting 2-3 minutes, partial speech impairment sustaining through to mid-day, complete right side weakness lasting 3-5 minutes before total resolve and intermittent R-side weakness after transport to hospital. Arrived at Emergency department about 930/10am, most symptoms subsided by time of admission - slowed speech persisted to mid-day. Discharged at 4pm to home. 4/19 - 6/10 exhaustion through most of the day 4/20-4-21 unusually high level of energy 4/21 - back pain and low grade headache return 3/10 4/22 - back pain more intense 4/10, intermittent headache 3/10 - report to CDC 4/26 - scheduled follow up appointment with Neurology

Weitere VAERSDATA-Felder

Praegender Schweregrund: Facial paralysis
Hospital-Tage: -
Labordaten: CT Scan with contrast CBC Urinalysis MRI all tests run on 4/18 with no s/s of stroke.
Aktuelle Erkrankungen: None
Vorgeschichte: Lyme disease
Andere Medikamente: Amoxicillin, Zoloft
Allergien: Sulfa-antibiotics
Vorherige Impfungen: -

VAERS 1236105

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NJ
Alter: 33,0
Geschlecht: F
Eingang: 21.04.2021
Impfdatum: -
Beginn: 03.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood test Chest X-ray Chills Computerised tomogram head Facial bones fracture Fall Feeding disorder Lip injury Loss of consciousness Pyrexia SARS-CoV-2 test Vertigo

Symptomtext

BLACKED OUT; VERTIGO AGGRAVATED; BROKEN NOSE; FALL; BUSTED LIPS; COULD NOT EAT ANYTHING; CHILLS; FEVER; This spontaneous report received from a patient concerned a 33 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included vertigo, non-alcohol user, and non-smoker. The patient was not pregnant at the time of reporting. The patient had no known drug allergies and no history of drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: 21-JUN-2021) dose was not reported, 1 total, administered on right arm on 03-APR-2021 13:30 for prophylactic vaccination. Concomitant medications included meclozine hydrochloride for vertigo. On 03-APR-2021, 15 minutes after vaccination the patient felt dizzy. On the same evening, the patient experienced fever, vomiting, sweating, dizziness and chills. On 04-APR-2021, the patient could not eat anything and experienced black out and fell from which the patient experienced busted lips and broken nose. The patient was taken to the emergency room and was hospitalized on 04-APR-2021. During hospitalization the patient had blood test and chest X-ray which was normal and COVID-19 virus test was negative. At the hospital the patient was diagnosed with aggravated vertigo due to vaccination but according to the patient it was not her vertigo since she did not get her usual vertigo symptoms before blacking out (dizziness, room spinning, or feeling like about to fall). The duration of hospitalization was 1 day. On 07-APR-2021, the patient went back to the hospital to follow-up and the patient's physician ran tests for blood work and computed tomography (CT) scan of her head with no abnormal findings. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the blacked out, vertigo aggravated, broken nose, fall, busted lips, could not eat anything, chills and fever was not reported. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition).; Sender's Comments: V0: 20210423964-covid-19 vaccine ad26.cov2.s -Vertigo aggravated. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY VO:20210423964-covid-19 vaccine ad26.cov2.s-broken nose, black out. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: 1,0
Labordaten: Test Date: 20210404; Test Name: Blood test; Result Unstructured Data: Normal; Test Date: 20210404; Test Name: Chest X-ray; Result Unstructured Data: Normal; Test Date: 20210404; Test Name: COVID-19 virus test; Result Unstructured Data: Negative; Test Date: 20210407; Test Name: Blood test; Result Unstructured Data: Normal; Test Date: 20210407; Test Name: Head CT; Result Unstructured Data: Normal
Aktuelle Erkrankungen: Abstains from alcohol; Non-smoker; Vertigo
Vorgeschichte: Comments: The patient was not pregnant at the time of reporting. The patient had no known drug allergies and no history of drug abuse or illicit drug usage.
Andere Medikamente: MECLIZINE HYDROCHLORIDE
Allergien: -
Vorherige Impfungen: -

VAERS 1192883

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: PA
Alter: 46,0
Geschlecht: F
Eingang: 21.04.2021
Impfdatum: -
Beginn: 05.04.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: ID / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Abdominal discomfort Blood glucose Blood magnesium Body temperature Body temperature increased Cold sweat Dizziness Dyspnoea Chills Differential white blood cell count Electrocardiogram Fatigue Fibrin D dimer Full blood count Glomerular filtration rate Headache Glomerular filtration rate normal Liver function test normal

Symptomtext

SHORTNESS OF BREATH; HEART PALPITATIONS; SEVERE DIZZINESS; STOMACH UPSET; NAUSEA; HEADACHE; FAINTED; FEELING UNWELL; CLAMMY CHILLS; TEMPERATURE RAISED A LITTLE; GENERAL FATIGUE; NIGHT SWEATS AND WAKE UP FROM SLEEP; DRY HEAVING; This spontaneous report received from a patient concerned a 46 year old female. The patient's height, and weight were not reported. The patient's past medical history included possible COVID-19 infection in FEB-2020 (not confirmed). The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: UNKNOWN) dose was not reported, 1 total, administered on left deltoid muscle on 05-APR-2021 13:00 for prophylactic vaccination. No concomitant medications were reported. On 05-APR-2021, the patient was fainted for about 5 minutes after vaccination and about 8 hours later, she experienced dry heaving, clammy chills, night sweats and wake up from sleep, feeling unwell, temperature raised a little, general fatigue and headache. It was reporter that, the clammy chills subsided by 07-APR-2021 after patient took Tylenol (paracetamol), but then later reported that it was still ongoing. On 09-APR-2021, the patient experienced severe dizziness, more temperature raising, further nausea and stomach upset. On 10-APR-2021, the patient experienced shortness of breath, heart palpitations, increased nausea and stomach upset. It was reported that the patient had visited emergency room at hospital at around 2 PM on the same day for shortness of breath, heart palpitations, increased nausea and stomach upset, dry heaving and temperature increase. The symptoms that were ongoing included the night sweats which wake from sleep, nausea and stomach upset and other symptoms were resolved. On 10-APR-2021, the patient's normal laboratory data included complete blood count (CBC), differential white blood cell count, electrocardiogram, fragment D dimer, glomerular filtration rate, glucose, liver function test, magnesium, metabolic function test, NT-proBNP, and troponin T. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fainted on 05-APR-2021, severe dizziness, shortness of breath, heart palpitations, dry heaving, feeling unwell, and temperature raised a little on APR-2021, and general fatigue, and headache on 07-APR-2021, and had not recovered from clammy chills, nausea, stomach upset, and night sweats and wake up from sleep. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210420859 - covid-19 vaccine ad26.cov2.s - fainted. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: Test Date: 20210405; Test Name: Body temperature; Result Unstructured Data: Raised; Test Date: 20210409; Test Name: Body temperature; Result Unstructured Data: Raised; Test Date: 20210410; Test Name: CBC; Result Unstructured Data: Normal; Test Date: 20210410; Test Name: Metabolic function test; Result Unstructured Data: Normal; Test Date: 20210410; Test Name: NT-proBNP; Result Unstructured Data: Normal; Test Date: 20210410; Test Name: Liver function test; Result Unstructured Data: Normal; Test Date: 20210410; Test Name: Troponin T; Result Unstructured Data: Normal; Test Date: 20210410; Test Name: Differential white blood cell count; Result Unstructured Data: Normal; Test Date: 20210410; Test Name: Glomerular filtration rate; Result Unstructured Data: Normal; Test Date: 20210410; Test Name: Glucose; Result Unstructured Data: Normal; Test Date: 20210410; Test Name: Electrocardiogram; Result Unstructured Data: Normal; Test Date: 20210410; Test Name: Fragment D dimer; Result Unstructured Data: Normal; Test Date: 20210410; Test Name: Magnesium; Result Unstructured Data: Normal
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: COVID-19
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1192883

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: PA
Alter: 46,0
Geschlecht: F
Eingang: 21.04.2021
Impfdatum: -
Beginn: 05.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Abdominal discomfort Blood glucose Blood magnesium Body temperature Body temperature increased Cold sweat Dizziness Dyspnoea Chills Differential white blood cell count Electrocardiogram Fatigue Fibrin D dimer Full blood count Glomerular filtration rate Headache Glomerular filtration rate normal Liver function test normal

Symptomtext

SHORTNESS OF BREATH; HEART PALPITATIONS; SEVERE DIZZINESS; STOMACH UPSET; NAUSEA; HEADACHE; FAINTED; FEELING UNWELL; CLAMMY CHILLS; TEMPERATURE RAISED A LITTLE; GENERAL FATIGUE; NIGHT SWEATS AND WAKE UP FROM SLEEP; DRY HEAVING; This spontaneous report received from a patient concerned a 46 year old female. The patient's height, and weight were not reported. The patient's past medical history included possible COVID-19 infection in FEB-2020 (not confirmed). The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: UNKNOWN) dose was not reported, 1 total, administered on left deltoid muscle on 05-APR-2021 13:00 for prophylactic vaccination. No concomitant medications were reported. On 05-APR-2021, the patient was fainted for about 5 minutes after vaccination and about 8 hours later, she experienced dry heaving, clammy chills, night sweats and wake up from sleep, feeling unwell, temperature raised a little, general fatigue and headache. It was reporter that, the clammy chills subsided by 07-APR-2021 after patient took Tylenol (paracetamol), but then later reported that it was still ongoing. On 09-APR-2021, the patient experienced severe dizziness, more temperature raising, further nausea and stomach upset. On 10-APR-2021, the patient experienced shortness of breath, heart palpitations, increased nausea and stomach upset. It was reported that the patient had visited emergency room at hospital at around 2 PM on the same day for shortness of breath, heart palpitations, increased nausea and stomach upset, dry heaving and temperature increase. The symptoms that were ongoing included the night sweats which wake from sleep, nausea and stomach upset and other symptoms were resolved. On 10-APR-2021, the patient's normal laboratory data included complete blood count (CBC), differential white blood cell count, electrocardiogram, fragment D dimer, glomerular filtration rate, glucose, liver function test, magnesium, metabolic function test, NT-proBNP, and troponin T. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fainted on 05-APR-2021, severe dizziness, shortness of breath, heart palpitations, dry heaving, feeling unwell, and temperature raised a little on APR-2021, and general fatigue, and headache on 07-APR-2021, and had not recovered from clammy chills, nausea, stomach upset, and night sweats and wake up from sleep. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210420859 - covid-19 vaccine ad26.cov2.s - fainted. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: Test Date: 20210405; Test Name: Body temperature; Result Unstructured Data: Raised; Test Date: 20210409; Test Name: Body temperature; Result Unstructured Data: Raised; Test Date: 20210410; Test Name: CBC; Result Unstructured Data: Normal; Test Date: 20210410; Test Name: Metabolic function test; Result Unstructured Data: Normal; Test Date: 20210410; Test Name: NT-proBNP; Result Unstructured Data: Normal; Test Date: 20210410; Test Name: Liver function test; Result Unstructured Data: Normal; Test Date: 20210410; Test Name: Troponin T; Result Unstructured Data: Normal; Test Date: 20210410; Test Name: Differential white blood cell count; Result Unstructured Data: Normal; Test Date: 20210410; Test Name: Glomerular filtration rate; Result Unstructured Data: Normal; Test Date: 20210410; Test Name: Glucose; Result Unstructured Data: Normal; Test Date: 20210410; Test Name: Electrocardiogram; Result Unstructured Data: Normal; Test Date: 20210410; Test Name: Fragment D dimer; Result Unstructured Data: Normal; Test Date: 20210410; Test Name: Magnesium; Result Unstructured Data: Normal
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: COVID-19
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 941980

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: IN
Alter: -
Geschlecht: F
Eingang: 21.04.2021
Impfdatum: -
Beginn: 12.04.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Anaphylactic reaction Blood potassium decreased Dysphagia Electrocardiogram normal Inappropriate schedule of product administration Interchange of vaccine products Discomfort Eye swelling Injection site erythema Injection site pruritus Lip pruritus Rash erythematous Thirst Paraesthesia oral Pruritus Swelling White blood cell count

Symptomtext

POST-INJECTION ANAPHYLAXIS; This spontaneous report received from a patient concerned an adult female. The patient's weight, height, and medical history were not reported. The patient was not pregnant at the time of report. The patient was previously treated with Pfizer covid-19 vaccine in Jan-2021 for prophylactic vaccination and experienced anaphylactic reaction. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 12-APR-2021 to left deltoid for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 12-APR-2021, the patient experienced anaphylaxis within 5 minutes of injection. Use of epipen was required to maintain airway while ambulance was route to vaccination location. The patient had questionable COVID-19 immunity as a result despite two vaccinations. Treatment medications (dates unspecified) included: prednisone. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from post-injection anaphylaxis on 12-APR-2021. This report was serious (Life Threatening).; Sender's Comments: v0 An adult female patient (age unspecified) the past medical history remarkable for anaphylactic reaction to Pfizer covid-19 vaccine experienced anaphylactic reaction 5 minutes after the Janssen COVID-19 Vaccine Ad26.COV2 was administered. Use of EpiPen was required to maintain airway. Given the close temporal relationship and history of anaphylaxis to the other vaccine the event is considered related.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1234132

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NY
Alter: 43,0
Geschlecht: M
Eingang: 20.04.2021
Impfdatum: 01.04.2021
Beginn: 15.04.2021
Tage bis Beginn: 14,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Laboratory test Thrombosis

Symptomtext

Blood clot in left leg , Found out on April 15 2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: Thursday , April 15th 2021, patient had lab test and found out about the clot.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1215528

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: MI
Alter: 34,0
Geschlecht: F
Eingang: 20.04.2021
Impfdatum: 08.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Arthralgia Chills Fatigue Immediate post-injection reaction Injection site mass Blood pressure increased Breast mass Breast pain Headache Injection site induration Nausea Pain Paraesthesia Peripheral swelling Pyrexia Nodule Pain in extremity Shoulder injury related to vaccine administration

Symptomtext

4/10/21 Patient presented to Urgent Care with Arm Pain (left arm painful and tingly since COVID shot 4/8; now pain is different and there is a lump on her forearm she can feel). 4/13/21 Contacted the office to schedule an appointment regarding worsening symptoms. Scheduled appointment. 4/14/21 cont. Seen in office by PA for: 1. Left arm pain - tender nodule L forearm, will get US due to recent birth, Johnson and Johnson vaccine, FH of DVT, to r/o DVT causing the lump, await results. Symptomatic care in the interim, may use warm compresses. - USV VENOUS UPPER EXTREMITY DUPLEX LEFT; Future 2. Paresthesia of left arm - site of reported injection and superficial induration 1.5cm from acromion process, suspect SIRVA due to sit of administration of vaccine, recommend symptomatic care with warm compresses, gentle massage if benefit noted, pt is breastfeeding so recommend local care at this time, consider PT, pt declines at this time as she will be on vacation next week. Discussed possible cortisone injection but deferred due to recent COVID vaccine 6 days ago, pt agrees as there is some recommendation to avoid steroids in close proximity to vaccinations to avoid blunting the immune response 3. Family history of DVT - see #1 4/15/21 After speaking with the DVT clinic Dr contacted the patient and recommended she take an 81mg low dose daily aspirin, until symptoms resolve, around one month. And repeating venus duplex in 7-10 days. Determined she would go prior to her leaving for her trip as she planned to be out-of-town during that time frame. (Per provider result notes.) 4/16/21 Patient was seen in emergency department for: Patient presents for evaluation of multiple concerns. Following the Johnson & Johnson COVID-19 vaccine she was recently diagnosed with superficial thrombophlebitis in the left forearm by ultrasound, has been taking aspirin and symptoms have not worsened. Left upper extremity exam is quite reassuring today, I see no clinical evidence for DVT and she is neurovascular intact. I did not feel that repeat ultrasound was necessary at this time, but she does have this scheduled next week so I advised her to keep that appointment. She has a very slight headache which has been present since the day she received the vaccine, currently 2/10 without vision or other neurologic concerns. No abdominal pain. I have low clinical suspicion for CVST or PVT at this time. Advised return if she develops worsening headache or new neurologic symptoms. Patient complained of new onset left lower lateral breast pain and lump starting today. She is currently breastfeeding and notes decreased milk production today. She does have a tender fullness on exam but no redness or visible swelling, she is nontoxic and well-appearing without fever. She has history of mastitis in the past, but she states her PCP recommended she be evaluated for possible blood clot in the breast. Advised the patient that I have very little concern for that at this time, if anything it would be superficial and not amenable to anticoagulation but I did not feel that imaging was necessary at this time. I will cover her with antibiotics for lactational mastitis, she has cephalosporin allergy but states she had formal testing for penicillin allergy and tolerated this well so I prescribed Augmentin. She will use a warm compress and continue nursing, I did recommend she start on the right side to initiate let down on the left. 4/20/21 patient was seen in the office for: Patient presents for follow up of recent ED visit. She was seen here last week for left arm pain/nodule/paresthesa following her Johnson & Johnson vaccine. She also reported a slight headache that was present since day of vaccine. An US was performed and showed a left cephalic vein thrombus of LUE. She was advised to start ASA 81mg daily for the next month and get repeat US in 7-10 days. She then called in with left breast pain/swelling and was directed to the ED for evaluation of possible blood clot. She does have hx of mastitis several weeks ago. The ED did not pursue additional imagining of breast, they told her it was likely lactational mastitis and they did prescribe augmentin and warm compresses for this. Today, patient presents states he feels "a lot better". Regarding the left breast lump, redness, swelling she states this has completely resolved. She did not start the augmentin as she was worried about this potentially causing thrush for her daughter; she explains she had mastitis 7-8 weeks ago and was on antibiotics and then her and her daughter continually passed thrush back/forth to eachother 3x so she was hoping to avoid this. She did treat with frequent feeding/pupming, and warm compresses and symptoms resolved. She was told to see us for elevated blood pressure in the ER, per review of EMR and her DC papers, her blood pressure in the ED was 130/75. Today her blood pressure is 122/78. Regarding her left arm symptoms, she states the numbness/tingling has nearly resolved; she will occasionally get a very mild tingling in her 4th/5th fingers that resolves after a few seconds. She denies pain or swelling of the arm. She no longer can palpate the clot and thinks that it is gone. She no longer feels swelling or tenderness in her left axilla. She stopped the ASA and started motrin/warm compresses as was advised by the ED. Her mild headache continues since the vaccine but is somewhat improved. She denies worsening or severe headache; denies vision changes, dizziness, lightheadedness, speech difficulty, etc. Phone encounter also from 4/20/21: Phone call placed to DVT clinic to get their guidance as Dr had talked with them last week. Reached RN, who reviewed with Dr. After review of patient's history/chart/growth of superficial clot, Dr recommended that patient not travel as planned and continue on 81mg ASA daily. They would like us to place a referral so they can see her later this week or early next week. They also want us to place order for repeat US either this coming Friday or Monday and they will coordinate to get this done at their office/same time as appointment. I did place phone call to patient to discuss and give their advice. They had just left this morning by car. I reviewed Dr advice to not travel and she will discuss with her husband if they are going to run around or not. She was agreeable to continuing on the 81mg ASA Daily and repeat US/visit with DVT clinic in 5-7 days as recommended.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Venous thrombosis
Hospital-Tage: -
Labordaten: 4/14/21 USV Venous Upper Extremity Duplex Left, see continuation page for results. 4/14/21 USV Venus Upper Extremity Duplex Left, Impression: 1. There is no deep venous thrombosis in the visualized deep veins of the left upper extremity. 2. Short segment superficial venous thrombus in the cephalic vein in the left forearm 4/19/21 USV Venus Upper Extremity Duplex Left, Left Cephalic Vein: Short segment of thrombosis continues at the mid forearm. Measuring 15 mm in length, previously 12 mm. ADDITIONAL FINDINGS: Normal cardiac pulsatility is present in the subclavian veins. _____________________ Impression There is no sonographic evidence for deep venous thrombosis in the visualized deep veins of the left upper extremity. Short segment of superficial thrombophlebitis continues at the left cephalic vein within the forearm.
Aktuelle Erkrankungen: Unknown- reported to urgent care on 4/10/21...that she'd had fatigue and sligth body aches prior to getting the vaccine. (Neg COVID-19 PCR test 4/10/21)
Vorgeschichte: CIN
Andere Medikamente: Unknown
Allergien: Ancef {Cefazolin}- anaphylaxis
Vorherige Impfungen: -

VAERS 1215528

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MI
Alter: 34,0
Geschlecht: F
Eingang: 20.04.2021
Impfdatum: 08.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: UN / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Arthralgia Chills Fatigue Immediate post-injection reaction Injection site mass Blood pressure increased Breast mass Breast pain Headache Injection site induration Nausea Pain Paraesthesia Peripheral swelling Pyrexia Nodule Pain in extremity Shoulder injury related to vaccine administration

Symptomtext

4/10/21 Patient presented to Urgent Care with Arm Pain (left arm painful and tingly since COVID shot 4/8; now pain is different and there is a lump on her forearm she can feel). 4/13/21 Contacted the office to schedule an appointment regarding worsening symptoms. Scheduled appointment. 4/14/21 cont. Seen in office by PA for: 1. Left arm pain - tender nodule L forearm, will get US due to recent birth, Johnson and Johnson vaccine, FH of DVT, to r/o DVT causing the lump, await results. Symptomatic care in the interim, may use warm compresses. - USV VENOUS UPPER EXTREMITY DUPLEX LEFT; Future 2. Paresthesia of left arm - site of reported injection and superficial induration 1.5cm from acromion process, suspect SIRVA due to sit of administration of vaccine, recommend symptomatic care with warm compresses, gentle massage if benefit noted, pt is breastfeeding so recommend local care at this time, consider PT, pt declines at this time as she will be on vacation next week. Discussed possible cortisone injection but deferred due to recent COVID vaccine 6 days ago, pt agrees as there is some recommendation to avoid steroids in close proximity to vaccinations to avoid blunting the immune response 3. Family history of DVT - see #1 4/15/21 After speaking with the DVT clinic Dr contacted the patient and recommended she take an 81mg low dose daily aspirin, until symptoms resolve, around one month. And repeating venus duplex in 7-10 days. Determined she would go prior to her leaving for her trip as she planned to be out-of-town during that time frame. (Per provider result notes.) 4/16/21 Patient was seen in emergency department for: Patient presents for evaluation of multiple concerns. Following the Johnson & Johnson COVID-19 vaccine she was recently diagnosed with superficial thrombophlebitis in the left forearm by ultrasound, has been taking aspirin and symptoms have not worsened. Left upper extremity exam is quite reassuring today, I see no clinical evidence for DVT and she is neurovascular intact. I did not feel that repeat ultrasound was necessary at this time, but she does have this scheduled next week so I advised her to keep that appointment. She has a very slight headache which has been present since the day she received the vaccine, currently 2/10 without vision or other neurologic concerns. No abdominal pain. I have low clinical suspicion for CVST or PVT at this time. Advised return if she develops worsening headache or new neurologic symptoms. Patient complained of new onset left lower lateral breast pain and lump starting today. She is currently breastfeeding and notes decreased milk production today. She does have a tender fullness on exam but no redness or visible swelling, she is nontoxic and well-appearing without fever. She has history of mastitis in the past, but she states her PCP recommended she be evaluated for possible blood clot in the breast. Advised the patient that I have very little concern for that at this time, if anything it would be superficial and not amenable to anticoagulation but I did not feel that imaging was necessary at this time. I will cover her with antibiotics for lactational mastitis, she has cephalosporin allergy but states she had formal testing for penicillin allergy and tolerated this well so I prescribed Augmentin. She will use a warm compress and continue nursing, I did recommend she start on the right side to initiate let down on the left. 4/20/21 patient was seen in the office for: Patient presents for follow up of recent ED visit. She was seen here last week for left arm pain/nodule/paresthesa following her Johnson & Johnson vaccine. She also reported a slight headache that was present since day of vaccine. An US was performed and showed a left cephalic vein thrombus of LUE. She was advised to start ASA 81mg daily for the next month and get repeat US in 7-10 days. She then called in with left breast pain/swelling and was directed to the ED for evaluation of possible blood clot. She does have hx of mastitis several weeks ago. The ED did not pursue additional imagining of breast, they told her it was likely lactational mastitis and they did prescribe augmentin and warm compresses for this. Today, patient presents states he feels "a lot better". Regarding the left breast lump, redness, swelling she states this has completely resolved. She did not start the augmentin as she was worried about this potentially causing thrush for her daughter; she explains she had mastitis 7-8 weeks ago and was on antibiotics and then her and her daughter continually passed thrush back/forth to eachother 3x so she was hoping to avoid this. She did treat with frequent feeding/pupming, and warm compresses and symptoms resolved. She was told to see us for elevated blood pressure in the ER, per review of EMR and her DC papers, her blood pressure in the ED was 130/75. Today her blood pressure is 122/78. Regarding her left arm symptoms, she states the numbness/tingling has nearly resolved; she will occasionally get a very mild tingling in her 4th/5th fingers that resolves after a few seconds. She denies pain or swelling of the arm. She no longer can palpate the clot and thinks that it is gone. She no longer feels swelling or tenderness in her left axilla. She stopped the ASA and started motrin/warm compresses as was advised by the ED. Her mild headache continues since the vaccine but is somewhat improved. She denies worsening or severe headache; denies vision changes, dizziness, lightheadedness, speech difficulty, etc. Phone encounter also from 4/20/21: Phone call placed to DVT clinic to get their guidance as Dr had talked with them last week. Reached RN, who reviewed with Dr. After review of patient's history/chart/growth of superficial clot, Dr recommended that patient not travel as planned and continue on 81mg ASA daily. They would like us to place a referral so they can see her later this week or early next week. They also want us to place order for repeat US either this coming Friday or Monday and they will coordinate to get this done at their office/same time as appointment. I did place phone call to patient to discuss and give their advice. They had just left this morning by car. I reviewed Dr advice to not travel and she will discuss with her husband if they are going to run around or not. She was agreeable to continuing on the 81mg ASA Daily and repeat US/visit with DVT clinic in 5-7 days as recommended.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Venous thrombosis
Hospital-Tage: -
Labordaten: 4/14/21 USV Venous Upper Extremity Duplex Left, see continuation page for results. 4/14/21 USV Venus Upper Extremity Duplex Left, Impression: 1. There is no deep venous thrombosis in the visualized deep veins of the left upper extremity. 2. Short segment superficial venous thrombus in the cephalic vein in the left forearm 4/19/21 USV Venus Upper Extremity Duplex Left, Left Cephalic Vein: Short segment of thrombosis continues at the mid forearm. Measuring 15 mm in length, previously 12 mm. ADDITIONAL FINDINGS: Normal cardiac pulsatility is present in the subclavian veins. _____________________ Impression There is no sonographic evidence for deep venous thrombosis in the visualized deep veins of the left upper extremity. Short segment of superficial thrombophlebitis continues at the left cephalic vein within the forearm.
Aktuelle Erkrankungen: Unknown- reported to urgent care on 4/10/21...that she'd had fatigue and sligth body aches prior to getting the vaccine. (Neg COVID-19 PCR test 4/10/21)
Vorgeschichte: CIN
Andere Medikamente: Unknown
Allergien: Ancef {Cefazolin}- anaphylaxis
Vorherige Impfungen: -

VAERS 1178391

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: -
Alter: -
Geschlecht: M
Eingang: 20.04.2021
Impfdatum: -
Beginn: 06.04.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accident Loss of consciousness Deafness unilateral Paraesthesia Road traffic accident Deafness Dizziness Feeling hot Heart rate increased Injection site pain Pain

Symptomtext

UNCONSCIOUS WHILE DRIVING BACK HOME; ACCIDENT; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry: Unknown) dose was not reported, frequency 1 total administered on 06-APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 06-APR-2021, after vaccination, the patient waited in the vaccine facility for 15 minutes and left. While driving back to home, the patient became unconscious and had an accident. Customer confirmed that the patient was alive but customer was extremely disappointed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the unconscious while driving back home and accident was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0- 20210420258-covid-19 vaccine ad26.cov2.s -Unconscious while driving back home. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1178391

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: -
Alter: -
Geschlecht: M
Eingang: 20.04.2021
Impfdatum: -
Beginn: 06.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accident Loss of consciousness Deafness unilateral Paraesthesia Road traffic accident Deafness Dizziness Feeling hot Heart rate increased Injection site pain Pain

Symptomtext

UNCONSCIOUS WHILE DRIVING BACK HOME; ACCIDENT; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry: Unknown) dose was not reported, frequency 1 total administered on 06-APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 06-APR-2021, after vaccination, the patient waited in the vaccine facility for 15 minutes and left. While driving back to home, the patient became unconscious and had an accident. Customer confirmed that the patient was alive but customer was extremely disappointed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the unconscious while driving back home and accident was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0- 20210420258-covid-19 vaccine ad26.cov2.s -Unconscious while driving back home. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1231260

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: TX
Alter: 38,0
Geschlecht: F
Eingang: 19.04.2021
Impfdatum: 06.04.2021
Beginn: 17.04.2021
Tage bis Beginn: 11,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Cerebral venous sinus thrombosis

Symptomtext

I was contacted by physician assistant who informed us that patient was at HCF being treated for clotting believed to be secondary to having received the Janssen Covid19 vaccination. He said that she was diagnosed as having a focal dural venous thrombosis in the superior sagittal sinus and was being treated with Eliquis. He requested that we report this event to VAERS.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral venous sinus thrombosis
Hospital-Tage: -
Labordaten: Unknown
Aktuelle Erkrankungen: Nothing reported
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1229848

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: WA
Alter: 32,0
Geschlecht: F
Eingang: 19.04.2021
Impfdatum: 09.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Angiocardiogram Blood pressure increased Chest X-ray Diarrhoea Dyspnoea Electrocardiogram Fibrin D dimer increased Headache Nausea Pulmonary oedema Pyrexia Tachycardia White blood cell count increased

Symptomtext

Severe headache, nausea, diarrhea, tachycardia, shortness of breath, fluid in lower lobes of lungs, elevated O BNP, high temperature >103. Blood pressure increased

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary oedema
Hospital-Tage: -
Labordaten: 4/17/2021 WBC > 12,000 CT Angio Chest scan eKG Chest X-ray D-Dimer elevated
Aktuelle Erkrankungen: Na
Vorgeschichte: Na
Andere Medikamente: Na
Allergien: Sulfa / erythromycin/ lactose
Vorherige Impfungen: -

VAERS 1229680

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MO
Alter: 46,0
Geschlecht: F
Eingang: 19.04.2021
Impfdatum: 06.04.2021
Beginn: 07.04.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Ear pain Headache Heavy menstrual bleeding Polymenorrhoea Thrombosis

Symptomtext

Received Janssen vaccine 4/6. Started menstrual cycle 12 hours after vaccine even though had just completed last cycle 1 week prior. Normally cycles are 28-30 days apart. They have not been quite as regular since Covid and has had some shorter periods between normal cycles. After the vaccine bleeding was heavier than normal with large clots but by end of last week had changed color and looked like it was ending. Today had no discharge upon awakening but again has a small amount of bright blood. Of course, there is concern for coagulopathy related to the vaccination. No leg pain, no shortness of breath. Has had HA off and on since had Covid but no worse now than in previous weeks. Left ear pain has been painful since Covid but now has pain in both ears when that occurs. Quit taking ibuprofen last week for discomfort and switched to Tylenol.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: CBC TSH PT/PTT to be drawn today
Aktuelle Erkrankungen: None
Vorgeschichte: Past history of Covid Pneumonia
Andere Medikamente: Tylenol and Ibuprofen
Allergien: Percocet leads to severe vomiting
Vorherige Impfungen: -

VAERS 1228882

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: FL
Alter: 72,0
Geschlecht: F
Eingang: 19.04.2021
Impfdatum: 10.04.2021
Beginn: 11.04.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Dizziness Heart rate decreased Loss of consciousness Pallor Presyncope Vomiting

Symptomtext

This is a spouse. Medical Center do not have this patient's medical record and is reporting the reaction on her behalf based on available information. Patient reported she was having brunch 4/11/21 am and started feeling very dizzy (was dining outside) and her son informed her that she was very pale. Her stomach started to rumble and threw up. Son called the ambulance due to "low pulse" and "loss of consciousness". She was treated at ER with iv fluids and anti-nausea medicine and was discharged that day (4/11/21) around 1pm with diagnosis of "Vagal Response". She recalled being in the ambulance around 4/11@11:10am.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: need to obtain from patient.
Aktuelle Erkrankungen: endoscopy 3/31/21 which she reported"fungus growing in throat"
Vorgeschichte: chronic cough, acid reflux
Andere Medikamente: per patient: see last box (additional items) Prescriptions taken at time of vaccine as per patient: 1) pantoprazole 40mg 2) fluoxetine 10mg 3) atorvastatin 20mg 4) aspirin 81mg 5) mometasone nasal spray 6) fluoxetine 10mg 7) mvi 8) calcium
Allergien: Scallops
Vorherige Impfungen: -

VAERS 1228533

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: TX
Alter: 43,0
Geschlecht: M
Eingang: 19.04.2021
Impfdatum: 08.04.2021
Beginn: 08.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Loss of consciousness

Symptomtext

Prior to receiving dose of the Janssen Cov-19 vaccine, the patient expressed that he had a fear of needles. The vaccine was admistered and the patient was asked to stay seated in the waiting area after the injection. After a few minutes the patient passed out while seated and was moved to being seated on the floor by staff. The patient was given water and his blood pressure was monitored periodically for the next hour before releasing the patient.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: BP monitored by pharmacist
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1216146

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: IA
Alter: 32,0
Geschlecht: F
Eingang: 19.04.2021
Impfdatum: 08.04.2021
Beginn: 08.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Alanine aminotransferase normal Albumin globulin ratio Anion gap Aspartate aminotransferase normal Basophil count normal Anticoagulant therapy Fatigue Headache Pain Pain in extremity Basophil percentage Blood albumin normal Blood alkaline phosphatase normal Blood bilirubin normal Blood calcium decreased Blood chloride normal Blood creatinine normal Blood glucose normal

Symptomtext

patient had the vaccine at 11:30 am then she had symptoms of Headache , Body ache , sore arm , tired in the evening. she called her dr they told her she should be fine as long as the symptoms within the 48 hrs after the shot. The patient still have the headache after the 48 hrs. she call the dr and the dr suggest her to go to ER . ER sent her to clinic and she diagnosed with blood clot in brain and they put Heparin then Aspirin 81 mg the patient left clinic and start back to work on the 19th

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral venous sinus thrombosis
Hospital-Tage: 1,0
Labordaten: no info
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: Metformin Synthroid Bromocriptine Terbinafine Vit D3 Prenatal Aspirin 81mg ( started after the incident )
Allergien: Coconut codeine
Vorherige Impfungen: -

VAERS 1216146

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: IA
Alter: 32,0
Geschlecht: F
Eingang: 19.04.2021
Impfdatum: 08.04.2021
Beginn: 08.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Alanine aminotransferase normal Albumin globulin ratio Anion gap Aspartate aminotransferase normal Basophil count normal Anticoagulant therapy Fatigue Headache Pain Pain in extremity Basophil percentage Blood albumin normal Blood alkaline phosphatase normal Blood bilirubin normal Blood calcium decreased Blood chloride normal Blood creatinine normal Blood glucose normal

Symptomtext

patient had the vaccine at 11:30 am then she had symptoms of Headache , Body ache , sore arm , tired in the evening. she called her dr they told her she should be fine as long as the symptoms within the 48 hrs after the shot. The patient still have the headache after the 48 hrs. she call the dr and the dr suggest her to go to ER . ER sent her to clinic and she diagnosed with blood clot in brain and they put Heparin then Aspirin 81 mg the patient left clinic and start back to work on the 19th

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral venous sinus thrombosis
Hospital-Tage: 1,0
Labordaten: no info
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: Metformin Synthroid Bromocriptine Terbinafine Vit D3 Prenatal Aspirin 81mg ( started after the incident )
Allergien: Coconut codeine
Vorherige Impfungen: -

VAERS 1222849

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CA
Alter: 52,0
Geschlecht: F
Eingang: 17.04.2021
Impfdatum: 02.04.2021
Beginn: 03.04.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chest pain Chills Dyspepsia Headache Pain Pyrexia Syncope

Symptomtext

Fever, chills, horrible headache, overall pain, faint, but then 2 hours of awful heartburn. It went away on day 2 and some heart pain returned on day 3 and hasn't returned.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: No
Vorgeschichte: Hypothyroid
Andere Medikamente: Thyroid medication
Allergien: No
Vorherige Impfungen: -

VAERS 1216662

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CA
Alter: 50,0
Geschlecht: F
Eingang: 16.04.2021
Impfdatum: 08.04.2021
Beginn: 08.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Bradyphrenia Diarrhoea Dizziness Feeling cold Hyperhidrosis Hypertrophy of tongue papillae Injection site pain Migraine Pyrexia Syncope

Symptomtext

APPROXIMATELY 3 HOURS AFTER VACCINATION THE PATIENT EXPERIENCED A SLIGHT FEVER, CHILLS, SWEATS, AND AN EXTREME MIGRAINE HEADACHE. SHE TOOK TYLENOL FOR HER SYMPTOMS. OVER THE NEXT 2 DAYS THESE SYMPTOMS IMPROVED BUT SHE DEVELOPED A RASH WITH BUMPS ON HER TONGUE, DIZZINESS, AND SLOW COGNITION WHICH LASTED ABOUT 2 DAYS. SHE WAS FINE FOR 24-48 HOURS WHEN ALL THE PREVIOUSLY MENTIONED SYMPTOMS RETURNED BUT EVEN MORE PRONOUNCED AND SHE HAD EXPLOSIVE DIARRHEA WITH INCREASED PAIN AT THE INJECTION SITE. AT SOME POINT DURING ALL THIS SHE VISITED HER MAIN PHARMACY AND AS SHE WAS TELLING THE PHARMACIST ABOUT HER SYMPTOMS SHE FAINTED AND WOKE TO EMS AND WAS TRANSPORTED TO THE HOSPITAL. THE ER DID NOT FIND ANY REASON FOR HER FAINTING. SHE WAS HYDRATED AND THINKS IT WAS ANXIETY BROUGHT ON BY HER EXPERIENCE. SHE CALLED ME TODAY 4/15/21 TO TELL ME ABOUT HER SYMPTOMS AND EXPERIENCE. SHE STATED THAT SHE HAD A NEW SYMPTOM OF A SHARP PAIN IN HER BACK SO I STRONGLY SUGGESTED SHE GO BACK TO ER TO CONTINUE TESTING IN CASE THE PAIN WAS SOMEHOW RELATED TO THE VACCINE INCIDENT. SHE SAID SHE WOULD GO TO URGENT CARE IF SHE FELT THE PAIN WAS BAD ENOUGH.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: UNKNOWN
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: PATIENT DID NOT WANT TO DISCLOSE THIS INFORMATION
Allergien: N/A
Vorherige Impfungen: -

VAERS 1215787

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NY
Alter: 38,0
Geschlecht: U
Eingang: 16.04.2021
Impfdatum: -
Beginn: 06.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Back pain Blood pressure measurement Chills Diarrhoea Dyspnoea Headache Hypotension Loss of consciousness

Symptomtext

PASSED OUT; LOW BLOOD PRESSURE; DIFFICULTY BREATHING; DIARRHEA; BACK PAIN; CHILLS; HEADACHE; This spontaneous report received from a patient concerned a 38 year old of unspecified sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A) dose was not reported, frequency once total, administered on 06-APR-2021 on left deltoid for prophylactic vaccination. No concomitant medications were reported. On 06-APR-2021, Laboratory data included: Blood pressure (NR: not provided) low. The patient experienced side effects of chills, back pain, felt passed out, low blood pressure, headaches and diarrhea. The patient had difficulty breathing and went to emergency room stable at the time of reporting. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from passed out, low blood pressure, difficulty breathing, diarrhea, and chills on 06-APR-2021, and had not recovered from back pain, and headache. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210414531-JANSSEN COVID-19 VACCINE Ad26.COV2.S- Passed out. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Test Date: 20210406; Test Name: Blood pressure; Result Unstructured Data: Low
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1215777

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MO
Alter: 50,0
Geschlecht: M
Eingang: 16.04.2021
Impfdatum: -
Beginn: 06.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cough Headache Heart rate Heart rate increased Loss of consciousness Paraesthesia Tinnitus

Symptomtext

BLACKED OUT; RAPID/STRONG HEARTBEAT; TINGLING ARMS AND LEGS; COUGH; WHITE NOISE IN EARS; HEADACHE; This spontaneous report received from a patient concerned 50 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: 042A21A, and expiry: unknown) dose was not reported, administered on 06-APR-2021 at about 8:30 on left deltoid for prophylactic vaccination. No concomitant medications were reported. On 06-APR-2021, after about 5 minutes of vaccination, the patient experienced 'white noise' in ears, vision changes, had a visual aura (a pattern around side of vision and moved to front of vision) and blacked out only for few minutes. He blacked out in the pharmacy but was not sure for how long. On 06-APR-2021, the patient felt a little dizzy, experienced headache, and tingling in arms and legs (reported as ''arms and legs felt like they were gone''). On the same day, he also had a rapid/strong heartbeat for a while that made him cough and it went away after about 45 minutes. The strong heart beat had come and gone throughout the day. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from blacked out and cough, and the outcome of white noise in ears, tingling arms and legs, rapid/strong heartbeat, and headache was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210411724 - Covid-19 vaccine ad26.cov2.s- BLACKED OUT. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Test Date: 20210406; Test Name: Heart rate; Result Unstructured Data: rapid hearbeat
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1216418

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: TN
Alter: 68,0
Geschlecht: M
Eingang: 15.04.2021
Impfdatum: 03.04.2021
Beginn: 12.04.2021
Tage bis Beginn: 9,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Catheterisation cardiac abnormal Chest discomfort Electrocardiogram Fatigue Headache Pericarditis SARS-CoV-2 test negative

Symptomtext

Severe headache with fatigue started 04/12/2021. 04/14/2021 tightening in chest. went to local urgent care clinic for rapid test and treatment. EKG done also. Showed abnormal.,sent to local ER. Diagnosed with possible STEMI. Ems ride to north cath lab. Heart cath diagnosis of Pericarditis.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: -
Labordaten: Rapid test x 2 negative abnormal ekg, heart cath diagnosis pericarditis. All on 04/15/2021
Aktuelle Erkrankungen: None
Vorgeschichte: Diabetes, HTN
Andere Medikamente: Aspirin, atorvastatin, carvedilol,telamisartan, finisteride, humalog insulin, hctz, Allegra, fish oil, b complex, vit D, folic acid
Allergien: PCN
Vorherige Impfungen: Loss of consciousness, 66,flu vaccine

VAERS 1216052

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NY
Alter: 34,0
Geschlecht: F
Eingang: 15.04.2021
Impfdatum: 31.03.2021
Beginn: 31.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Balance disorder Chest pain Chills Fatigue Feeling abnormal Gait disturbance Headache Hyperhidrosis Menstrual disorder Myalgia Nasal congestion Pain Pyrexia Thrombosis

Symptomtext

Approximately 5 hours after the vaccine I developed a very bad headache followed by chills, sweats, congestion, chest pain, body pain, muscle pain, fatigue and fever. The muscle pain and weakness was so bad I would loose balance when walking. I then started to menstruate clots, not my normal cycle timing, which lasted about 2 days. The clots subsided but I am still bleeding today. I was in bed for 4 days with severe immune response symptoms. After those symptoms subsided the fatigue was so extreme it was hard to function.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: PCOS
Andere Medikamente: Spironolactone, metformin, birth control, vitamin d , vitamin b
Allergien: None
Vorherige Impfungen: -

VAERS 1215117

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 042A21A

schwer

Staat: MI
Alter: 34,0
Geschlecht: M
Eingang: 15.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fall Head injury Loss of consciousness

Symptomtext

patient fell over while sitting on chair in observation area. He landed head first with head facing right. He lost consciousness for 5-10 seconds. CLient was rolled onto his back when he regained consciousness. Client was aproppriate with responding to questions. Vitals taken and assisted back to chair. Reclining.Two abrasions noted on right side of face near eye from glasses. Small amount of blood noted in mouth following incident. small abrasion and bump on head top/right.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Client declined further medical attention
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: nka
Vorherige Impfungen: -

VAERS 1214980

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: OK
Alter: 67,0
Geschlecht: F
Eingang: 15.04.2021
Impfdatum: 12.04.2021
Beginn: 12.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Altered visual depth perception Arthralgia Aura Blood test normal Cardiac imaging procedure abnormal Chest X-ray normal Chest pain Computerised tomogram abnormal Dizziness Dysgeusia Electrocardiogram normal Feeling abnormal Heart rate irregular Myocardial necrosis marker normal Nausea Pain in extremity Paraesthesia Parosmia

Symptomtext

Strange odor a few minutes after injection, followed by bitter taste, then nausea and spaciness. Dizzyness, with vision looking 2D and flat by 15 minutes. Told Pharmacist, of spaciness who said stay as long as I wanted. Left at 30 minute point, still spacy and nauseous. Spaciness ended by an hour with nausea off and on. Chest pain - began around 7pm, continued to expand in area of chest, sharp stabbing pain later, pain from just above left elbow to hand and tingling of fingers, pain lower left leg and tingling of left foot. Irregular heart rate at different times. Checked into emergency room at 11:00. IV inserted, placed on continual heart and oxygen monitors, EKGs, chest X-rays (2), blood tests (3). Admitted to hospital sometime during the night. Given IV medications to counteract IV contrast allergy. These medications caused full body shakes, eyesight auras and extreme nausea with gagging. Heart CT taken with IV contrast. Discharged around 3:00 PM.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: 1,0
Labordaten: 4/12-13/21 EKGs, chest X-rays and blood tests normal, cardiac enzyme tests showed no heart attack. 4/13/21 Heart CT showed inflammation of the pericardium. The Cardiologist said it m was caused by the Covid 19 immunization. I was placed on colchicine for 2 weeks. I was given follow-up appointments with my primary care physician and the cardiologist. These are results my husband and I were told during my hospital stay but I do not yet have the documentation in hand.
Aktuelle Erkrankungen: ear infection diagnosed and treated almost 4 weeks before Simvastatin, Diazepam, Cephalexin, Tetracycline. Latex. Contrast Dye (esp. iodine ones), vaccines. Cleaners, insect sprays Paint fumes, Shellfish.
Vorgeschichte: paralyzed vocal cord, hypothyroidism, hypertension
Andere Medikamente: Synthroid, Xanax, Aspirin, Atenolol, Amlodipine, Omeprazole,
Allergien: Penicillins, Erythromycin, Oxycodone Acetaminophen, Niacin, Gabapentine, Simvastatin, Fluticasone Propionate
Vorherige Impfungen: Tetanus hives, vomiting age 32

VAERS 1214372

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MI
Alter: 18,0
Geschlecht: M
Eingang: 15.04.2021
Impfdatum: 10.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Loss of consciousness

Symptomtext

patient rolled to side, after he regained consciousness, moved to a reclining chair, Vitals taken and juice given PO. Held him for about 25 min. Orthostatic BP taken. patient stated he felt fine, vitals good, no dizziness prior to discharge home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: none reported
Vorherige Impfungen: -

VAERS 1212666

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: PR
Alter: 21,0
Geschlecht: F
Eingang: 15.04.2021
Impfdatum: 31.03.2021
Beginn: 01.04.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Computerised tomogram Haematology test Laboratory test Palpitations Pregnancy test Pyrexia Seizure Urine analysis

Symptomtext

SYMPTOMS PRESENTED: SEIZURES, PALPITATIONS, FEVER, PULSE IN 125-130 FOR SEVERAL HOURS EVEN WHEN I WAS RESTING, BLOOD PRESSURE 86/66

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: CT SCAN LABORATORY TEST HEMATOLOGY CHEMISTRY LAB TEST URINE TEST PREGNANCY TEST
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: NONE
Allergien: NONE
Vorherige Impfungen: -

VAERS 1212002

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MD
Alter: 30,0
Geschlecht: F
Eingang: 15.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Anxiety Decreased appetite Fatigue Hypersomnia Injection site erythema Pain Pain in extremity Platelet count normal Restless legs syndrome Seizure like phenomena Vomiting

Symptomtext

my daughter, 30 year old, on disability with POTS, MCAS, EDS, dysautonomia, received the JJ COVID vaccine at 1:30 PM on 4/9/2021.. She started vomiting 20 minutes after the vaccine was administered and the pharmacist said it was because she was anxious and has not eaten much. We went home, she was very tired and slept most of the afternoon. At 6 PM she started vomiting again. It continued till 10:30 PM when she could not drink anything. We went to the hospital where she exhibited what looked like a seizure in the waiting room and was admitted to the hospital for observation. Discharged 4/10/2021 evening. 4/11/2021 exhibited restless leg syndrome, could not sit, lay down, whole body aches. 4/12/2021 extremely sore arm, could not move it without pain. Area of injection looks read but not hot and no swelling.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure like phenomena
Hospital-Tage: 1,0
Labordaten: please contact the physician or hospital for details. We were not provided a list of blood work. We did ask about platelets and were told the level was "normal"
Aktuelle Erkrankungen: POTS, MCAS, EDS, chronic fatigue, dysautonomia
Vorgeschichte: POTS, MCAS, EDS, chronic fatigue, dysautonomia
Andere Medikamente: Yaz- birht control vitamin B12 vitamin D salt pills multivitamins one a day
Allergien: penicillin amoxicillin fentanyl Sudafed dilaudid
Vorherige Impfungen: flu vaccine

VAERS 1210695

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: UT
Alter: 19,0
Geschlecht: F
Eingang: 14.04.2021
Impfdatum: 02.04.2021
Beginn: 02.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Nausea Presyncope

Symptomtext

pt experienced weakness, nausea, and near syncopal episodes within 10 minutes of receiving vaccine. Symptoms resolved within minutes, pt was monitored in clinic for an additional 30 minutes with stable vitals and no further episodes. Pt left clinic in good condition, brother drover her home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: oral contraceptives (ortho cyclen)
Allergien: Advil
Vorherige Impfungen: -

VAERS 1210459

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: TX
Alter: 29,0
Geschlecht: F
Eingang: 14.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Deafness Seizure Syncope

Symptomtext

patient fainted, loss of hearing in ear, had a brief seizure

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: n/a
Allergien: n/a
Vorherige Impfungen: -

VAERS 1210256

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CA
Alter: 43,0
Geschlecht: F
Eingang: 14.04.2021
Impfdatum: 05.04.2021
Beginn: 05.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood pressure fluctuation Diarrhoea Dyspnoea Flushing Headache Hot flush Hypertension Loss of consciousness Lymphadenopathy Mobility decreased Muscle spasms Nausea Pain Pyrexia Swollen tongue Tremor Urticaria Vision blurred

Symptomtext

Day 1 - Immediate small hives all over body for 1 hour, flush, fever, shaking, nausea, then hives lef. Day 1 evening - Fever 103, blurry eyes, severe headache, swollen tongue, severe pain all over, all major surgery sites spasming, vomit and diarrhea , hard to breath and blackout. Day 2 - Fever, eyes blurry, Blood pressure spike, headache severe, tongue swollen, severe hives, vomit, and diarrhea, cannot move body, pain increased tenfold Day 3 - Worse than day 2, hives are severe and can barely move body, Blood pressure spike, off to the ER. They admitted me and gave me different combos of steroids, pain killer, lorazepam, etc. to figure out the right combination to keep me steady. Day 4 - evening I was able to go on home care with the correct combination of medication. If my numbers don't stay steady I would have had to go back. During the rest of this time - Severe pain throughout body, fever, shortness of breath. The hives are now just my my skin flushing. Heat flashes. My fever has just gone down to normal degrees today. My Blood Pressure has gone from 175/111 back and forth to normal. My headache is still there and body pain. Hives are now just flushed skin. Swollen Lymph nodes in throat. No more vomit or diarrhea.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: 2,0
Labordaten: Medical Records
Aktuelle Erkrankungen: Idiopathic Chronic Urticaria
Vorgeschichte: Several ongoing unrelated surgeries
Andere Medikamente: Epi-Pen, Vitamin D, Zinc, Multivitamin
Allergien: Diphenhydramine, Loratadine, Cetirizine Hydrochloride, Clindamycin, Meloxicam, Pennsaid, Penicillin, Beef/Lamb/Goat/Mutton, Hand Sanitizer/Perfume
Vorherige Impfungen: -

VAERS 1210142

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: TX
Alter: 20,0
Geschlecht: F
Eingang: 14.04.2021
Impfdatum: 07.04.2021
Beginn: 14.04.2021
Tage bis Beginn: 7,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Fall Injection site reaction Peripheral embolism Seizure

Symptomtext

Patient was working and fell on the job due to what was perceived to be a seizure. Paramedics were called, and patient was taken to the emergency room. Initial reports from the hospital are that patient has clotting in the arm around the injection site. Patient is still at the hospital at the time of this report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Peripheral embolism
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1209395

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A 21A

schwer

Staat: MD
Alter: 68,0
Geschlecht: M
Eingang: 14.04.2021
Impfdatum: 06.04.2021
Beginn: 13.04.2021
Tage bis Beginn: 7,0
Dosis: UNK
Route/Site: SYR / UN

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Chest pain Computerised tomogram abnormal Mechanical ventilation Pulmonary oedema X-ray abnormal

Symptomtext

Developed chest pains, Rehabilitation Center moved to hospital on 4/13/2021. Took a turn for the worse in the evening of 4/13/2021. Hospital found fluid on lung x ray. He was placed on ventilator overnight preformed CT Scan the afternoon of 4/14 and discovered several bloods clots In right lung. Patient still in hospital under sedation and on ventilator. Hospital has started him on Heparin.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary oedema
Hospital-Tage: 2,0
Labordaten: X-RAY- RT LUNG CLEAR IN THE MORNING OF 4/13, EVENING OF 4/13 DISCOVERED RT LUNG FILLED WITH FLUID CT SCAN- ON THE AFTERNOON OF 4/14 FOUND SEVERAL BLOOD CLOTS PRESENT IN RIGHT LUNG
Aktuelle Erkrankungen: HEART FAILURE PERFORATED BOWEL SURGERY (4 WEEKS AGO)
Vorgeschichte: HEART FAILURE
Andere Medikamente: VAST PRESCRIPTIONS FOR HEART FAILURE, CHANGING AS HE JUST CAME OUT OF HOSPITAL 4 WEEKS AGO FUE TO NEEDING SURGERY FOR A PERFORATED BOWEL.
Allergien: N/A
Vorherige Impfungen: -

VAERS 1209101

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: OH
Alter: 26,0
Geschlecht: M
Eingang: 14.04.2021
Impfdatum: 06.04.2021
Beginn: 07.04.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chills Headache Loss of consciousness Nausea Pain Pyrexia Seizure Vomiting

Symptomtext

Within 12 hours of injection: Body aches, fever, severe chills ( convulsions ), headache, nausea, threw up three times, passed out.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1209063

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MA
Alter: 28,0
Geschlecht: M
Eingang: 14.04.2021
Impfdatum: 08.04.2021
Beginn: 08.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Flushing Hyperhidrosis Syncope Unresponsive to stimuli

Symptomtext

Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Additional Details: while observing the patient after administering the vaccine, he temporarily fainted. He came to immediately and felt better within the following 5 minutes.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1208891

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NJ
Alter: 54,0
Geschlecht: F
Eingang: 14.04.2021
Impfdatum: 03.04.2021
Beginn: 08.04.2021
Tage bis Beginn: 5,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Haemorrhoids thrombosed Intensive care Rectal haemorrhage Rectal polypectomy Syncope Transfusion Vomiting

Symptomtext

Hemmoriged and passed many clots from my reared. Lost a lot of blood. Fainted and threw up. Was in ICU for 2 nights. Had 2 blood transfusions. They clamped area where polyp was removed on March 30th.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: 3,0
Labordaten: Entered the hospital on April 8, 2021 and was released on April 10, 2021
Aktuelle Erkrankungen: March 30th...endoscopy and colonoscopy
Vorgeschichte: High blood pressure, cholesterol, Esophagitis, Asthma, Chronic anemia
Andere Medikamente: Amlodipine 5MG, Montelukast 10 MG, Atorvastatin 20 MG, Hydrocloroth-iazide 12.5 MG, Pantoprazole 40 Mg, Latanaprost (one drop in each eye daily), Elderberry gummies, Multi vitamin, and Alprazolam .5 MG as needed.
Allergien: Cinnamon
Vorherige Impfungen: 3 flu shots, pneumonia followed all 3 times

VAERS 1207953

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21a

schwer

Staat: FL
Alter: 23,0
Geschlecht: M
Eingang: 14.04.2021
Impfdatum: 10.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Cold sweat Loss of consciousness Nausea

Symptomtext

Pt received the vaccine sat in our waiting area and then passed out a couple minutes after receiving the vaccine. He came to in a minute or so. We called 911 and the paramedics came and took him to the local hospital. Per his report he had not had anything to eat that day and when he came to he felt nauseated and clammy.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1207537

UNKNOWN MANUFACTURER · COVID19 (COVID19 (UNKNOWN)) · Charge 042A21A

schwer

Staat: NY
Alter: 40,0
Geschlecht: F
Eingang: 14.04.2021
Impfdatum: 31.03.2021
Beginn: 31.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Dizziness Dyspnoea Electrocardiogram Laboratory test Palpitations Syncope X-ray

Symptomtext

Dizziness about 3-4hrs after injection Heart rate between 114-138 about 6hrs after injection to 4/5 Fainting about 14-16hrs after injection Extreme SOB and palpitations upon exertion about 6hrs after injection to present

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: 4/1/2021 - Lab work, EKG, X-ray
Aktuelle Erkrankungen: N/A - no other illnesses at time of vaccination or up to one month prior
Vorgeschichte: N/A - no chronic or long standing health conditions
Andere Medikamente: Zoloft
Allergien: NKA
Vorherige Impfungen: -

VAERS 1207185

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NC
Alter: 26,0
Geschlecht: F
Eingang: 14.04.2021
Impfdatum: 08.04.2021
Beginn: 08.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Loss of consciousness

Symptomtext

passed out

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: all shots make patient pass out

VAERS 1206995

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: WI
Alter: 25,0
Geschlecht: F
Eingang: 14.04.2021
Impfdatum: 08.04.2021
Beginn: 08.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Paraesthesia Syncope

Symptomtext

Systemic: Fainting / Unresponsive-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium, Systemic: Weakness-Medium, Additional Details: Patient fainted briefly and was weak and had tingling in both arms and hands-tried hydration and fan cooled air circulation-revived within 10-15 min-kept for observation for 30 -45 minutes and had mother pick her up so she didnt drive

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1205704

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MI
Alter: 39,0
Geschlecht: F
Eingang: 13.04.2021
Impfdatum: 03.04.2021
Beginn: 07.04.2021
Tage bis Beginn: 4,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood test Burning sensation Computerised tomogram normal Dizziness Electrocardiogram normal Electroencephalogram normal Hyperhidrosis Hypoaesthesia Loss of consciousness Magnetic resonance imaging normal Nasal discomfort Nausea Seizure Urine analysis

Symptomtext

Right side nose burning, numbness in face. Severe sweating, nausea, dizziness. Passing out. 4 episodes over 2 hours 3 with black out. Hospital diagnosed with seizure disorder even though mri, eeg, ekg, and ct showed no seizure activitity.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: 2,0
Labordaten: Blood, urine, eeg, ekg, mri and ct
Aktuelle Erkrankungen: -
Vorgeschichte: Thyroid
Andere Medikamente: Levothyroxine Celexa
Allergien: Penicillin cecolr sulfa ammoxocillian erithromycin biaxin
Vorherige Impfungen: -

VAERS 1205086

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: VA
Alter: 62,0
Geschlecht: F
Eingang: 13.04.2021
Impfdatum: 07.04.2021
Beginn: 12.04.2021
Tage bis Beginn: 5,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Organ failure Thrombosis

Symptomtext

Patient's husband called to report that his wife was in the hospital due to a blood clot that formed in her leg. He stated that she was having organ failure. Patient is currently being treated at a local hospital for blood clots that were moving and affecting her organs.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: 2,0
Labordaten: n/a
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a - the patient does not fill her prescriptions at our pharmacy. She only came in for the vaccine. I do not know her health conditions or history.
Andere Medikamente: n/a
Allergien: cipro, clindamycin, erythromycin, morphine, penicillin, tramadol, Levaquin, dilaudid, benadryl
Vorherige Impfungen: -

VAERS 1204875

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CA
Alter: 36,0
Geschlecht: F
Eingang: 13.04.2021
Impfdatum: 10.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dizziness Fall Syncope Vital signs measurement

Symptomtext

Patient got dizzy and fainted and fall down the chair. She did come back alert within a minute. Patient said that she fainted once time before when she got her blood draw. She admitted that she did not eat anything in the morning before the vaccine appointment. We did call 911 and the firemen responded within 5-10 minutes and verified that all her vitals signs are normal . Patient declined to go to the hospital. We have patient sit on the floor, drink some water and eat some Skittles and she did reported she was feeling better. We had patient call her family to pick her up.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1204833

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: PA
Alter: 39,0
Geschlecht: F
Eingang: 13.04.2021
Impfdatum: 05.04.2021
Beginn: 06.04.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site induration Injection site pain Injection site thrombosis

Symptomtext

Blood clot at injection site in left arm. Place where I was injected still hurts and feels like there is a bullet lodged under my skin when I touch my arm. The pain isn't as severe as it was last week but the blood clot is still there under my skin.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site thrombosis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Amlodipine and fluticasone
Allergien: N/A
Vorherige Impfungen: -

VAERS 1203671

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: ID
Alter: 18,0
Geschlecht: M
Eingang: 13.04.2021
Impfdatum: 10.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chills Headache Influenza like illness Myalgia Pyrexia Syncope

Symptomtext

Patient had fever/chills/sore muscles. Patient reports going to take shower to help with flu-like symptoms and fainting in the shower. Patient's parents helped patient and had him hydrate. He has recovered now, with a lingering Head Ache.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1203347

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: FL
Alter: 82,0
Geschlecht: M
Eingang: 13.04.2021
Impfdatum: 25.03.2021
Beginn: 28.03.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Fatigue Seizure Syncope

Symptomtext

PATIENT WAS ADMINISTERED THE JANSSEN COVID VACCINE AT APPROXIMATELY 10:30AM. IMMEDIATELY FOLLOWING REMOVAL OF NEEDLE AFTER INJECTION, THE PATIENT APPEARED TO FAINT FALLING FORWARD IN HIS OWN LAP. AFTER ABOUT 15 TO 30 SECONDS, HE REGAINED CONSCIOUS. WE ASSESSED THE PATIENT TO ASK IF HE HAD EVER EXPERIENCED FAINTING BEFORE OR SPECIFICALLY DURING VACCINATION. HE HAD NO PREVIOUS EPISODES. WE QUICKLY OFFERED THE PATIENT SOME WATER AND CRACKERS WHILE HE REMAINED SEATED. THE PATIENT FELL FORWARD AGAIN AND APPEARED TO BE CONVULSING. ONCE HE STABILIZED, MY PARTNER STEPPED AWAY TO RETRIEVE WATER, AND THE PATIENT ONCE AGAIN FELL FORWARD AND BEGAN CONVULSING. ONCE HE STABILIZED, HE DRANK SOME WATER AND ATE SOME CRACKERS. HE MENTIONED THAT HE FELT EXTREMELY TIRED. WE INSISTED TO CALL THE PARAMEDICS FOR HELP,BUT HE DECLINED SAYING THAT HE WAS OK AND MAYBE THE NEEDLE TRIGGERED THE EVENT. AFTER WE OBSERVED THE PATIENT FOR 30 MINUTES AND HE ASSURED US HE WAS IN STABLE CONDITION, HE LEFT WITH HIS GIRLFRIEND. PATIENT WAS CALLED TWICE AFTER THE EVENT TO FOLLOW-UP BUT WE HAVE NOT HAD SUCCESS IN FOLLOW-UP.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: UNKNOWN
Aktuelle Erkrankungen: None
Vorgeschichte: Excellent health
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1201796

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: AZ
Alter: 22,0
Geschlecht: M
Eingang: 13.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cold sweat Feeling cold Hyperhidrosis Oxygen saturation Syncope

Symptomtext

Patient fainted while sitting in chair. Started sweating profusely, felt clammy and cold. Elevated legs, checked pulse and pulse oximeter. Was awake and talking within a couple minutes. Gave him cold water and crackers and he was feeling much better. Paramedics arrived and confirmed all was good.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Pre-Diabetic
Andere Medikamente: Unknown
Allergien: None
Vorherige Impfungen: -

VAERS 1201297

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: OH
Alter: 26,0
Geschlecht: F
Eingang: 13.04.2021
Impfdatum: 09.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain Blood test Computerised tomogram Dyspnoea Headache Seizure

Symptomtext

Severe abdominal pain, headache, supposed seizures, labored breathing

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: 1,0
Labordaten: CT Scan, blood panel
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: Wellbutrin 300mg
Allergien: n/a
Vorherige Impfungen: -

VAERS 1201220

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21a

schwer

Staat: AZ
Alter: 41,0
Geschlecht: F
Eingang: 13.04.2021
Impfdatum: 08.04.2021
Beginn: 08.04.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Loss of consciousness

Symptomtext

pt was under observation while she was seated on a chair and she became unconscious briefly

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: 911 arrived and checked with her
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none mentioned by patient
Allergien: none
Vorherige Impfungen: -

VAERS 1200961

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NH
Alter: 23,0
Geschlecht: M
Eingang: 13.04.2021
Impfdatum: 12.04.2021
Beginn: 12.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

Patient fainted

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1200956

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CT
Alter: 47,0
Geschlecht: F
Eingang: 13.04.2021
Impfdatum: 01.04.2021
Beginn: 03.04.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Abdominal pain Abdominal pain upper Chills Diarrhoea Headache Hyperhidrosis Miliaria Pain Paraesthesia Presyncope Tremor Vomiting

Symptomtext

55 hrs after vaccination, I was doubled over with severe abdominal pain. Continuous waves of severe pain. Shortly after severe pain started, tremors/teeth chattering chills even under seven heavy blankets, lasted for hours. Headache (which had been there since 6 hrs after vaccination). Pain was so severe that I was getting ready to go to ER and then vomited. Felt a tad better only to vomit again three hours later, body in a pool of sweat but no fever. Aches, tingling hot prickly sensation running from toes to head, almost passed out. Diarreah every hour after second vomit, stomach pain started to subside then but never went away completely until 3 days after.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: Urgent care asked for CT Scan if pain didn't subside in two days.
Aktuelle Erkrankungen: none
Vorgeschichte: -
Andere Medikamente: Lisinopril 10 mg, Vit D sublinguial
Allergien: Penicillin, Amoxicillin, Eurythromycin
Vorherige Impfungen: -

VAERS 1171428

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: TX
Alter: 43,0
Geschlecht: M
Eingang: 13.04.2021
Impfdatum: 06.04.2021
Beginn: 06.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Asthenia Electrocardiogram normal Feeling abnormal Full blood count normal Headache Hyperhidrosis Loss of consciousness Myalgia Syncope Urine analysis normal Malaise Nausea Physical examination Seizure

Symptomtext

Sweating profusely, passed out 2 times in 15 min at Walgreens. Diagnosed vaso Vega syncope after a day In the hospital. Was told ?it just happens? 1 week later still weak, foggy head, headache, muscle aches

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: 1,0
Labordaten: CBC/ekg/urinalysis all normal
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Zyrtec
Allergien: None
Vorherige Impfungen: -

VAERS 1171428

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: TX
Alter: 43,0
Geschlecht: M
Eingang: 13.04.2021
Impfdatum: 06.04.2021
Beginn: 06.04.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Asthenia Electrocardiogram normal Feeling abnormal Full blood count normal Headache Hyperhidrosis Loss of consciousness Myalgia Syncope Urine analysis normal Malaise Nausea Physical examination Seizure

Symptomtext

Sweating profusely, passed out 2 times in 15 min at Walgreens. Diagnosed vaso Vega syncope after a day In the hospital. Was told ?it just happens? 1 week later still weak, foggy head, headache, muscle aches

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: 1,0
Labordaten: CBC/ekg/urinalysis all normal
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Zyrtec
Allergien: None
Vorherige Impfungen: -

VAERS 1199521

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: TN
Alter: 19,0
Geschlecht: F
Eingang: 12.04.2021
Impfdatum: 09.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Chills Head injury Headache Irritability Loss of consciousness Nausea Pain Pyrexia

Symptomtext

Patient passed out/syncopal episode with head injury approximately 16 hours after getting vaccine per patient. Patient states she had a headache, fever, body aches, chills approximately 7 hours the vaccine. Patient sustained a head injury/possible concussion with nausea, head pain, irritability after syncopal episode.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Patient sent to ER for further evaluation on 4/12/2021
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Multivitamin, Loratadine 10 mg
Allergien: Codeine, Clindamycin, Seasonal allergies
Vorherige Impfungen: -

VAERS 1199491

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: VA
Alter: 28,0
Geschlecht: F
Eingang: 12.04.2021
Impfdatum: 10.04.2021
Beginn: 11.04.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Electrocardiogram normal Syncope

Symptomtext

I received the vaccine at 1:30pm on April 10, 2021. The next morning at 10am, I fainted.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: I went to urgent care and they took an EKG. Everything came back normal.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: Penicillin, Sulfa, Supprex, Alcohol
Vorherige Impfungen: -

VAERS 1199396

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NV
Alter: 40,0
Geschlecht: M
Eingang: 12.04.2021
Impfdatum: 10.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Loss of consciousness Paraesthesia

Symptomtext

Ten minutes after the vaccination, pt passed out and came right back. He said he was fine except his hands were tingling. We called 911 and they took him for the vital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1199377

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NV
Alter: 25,0
Geschlecht: F
Eingang: 12.04.2021
Impfdatum: 10.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blindness Dizziness Loss of consciousness Nausea Vomiting

Symptomtext

Approximately ten minutes after the vaccination, she passed out for a few seconds and came back. She experienced lightheadedness, loss of vision, nausea, and vomiting. We called 911 and they took her vital. Ten minutes later, she was fine and drove home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: No
Vorgeschichte: She has low blood pressure (at borderline)
Andere Medikamente: n/a
Allergien: NO
Vorherige Impfungen: -

VAERS 1199253

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: TN
Alter: 34,0
Geschlecht: M
Eingang: 12.04.2021
Impfdatum: 12.04.2021
Beginn: 12.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Feeling abnormal Immediate post-injection reaction Syncope

Symptomtext

Pt fainted immediately after injection, regained consciousness after about 15 seconds. Reported feeling uneasy and weak for 20-30 minutes following injection. Provided supportive care with water. Pt was able to leave on his own after about 45 minutes.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: Reported fainting with vaccines in the past

VAERS 1199077

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CA
Alter: 19,0
Geschlecht: M
Eingang: 12.04.2021
Impfdatum: 12.04.2021
Beginn: 12.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Feeling abnormal Syncope

Symptomtext

While patient was waiting out the 15 min, he states he felt weird and went to let his father know. Upon getting up and leaving waiting area, pt. fainted but was quickly alert and able to speak. Patients father did state the patient has a needle aversion and has experienced this situation in the past.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: no known
Vorgeschichte: no known
Andere Medikamente: unknown
Allergien: no known
Vorherige Impfungen: patients father stated this has happened in the past

VAERS 1198088

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: OH
Alter: 23,0
Geschlecht: M
Eingang: 12.04.2021
Impfdatum: 12.04.2021
Beginn: 12.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Loss of consciousness Seizure

Symptomtext

AFTER RECEIVING THE IMMUNIZATION, PATIENT SLOWLY MOVED FROM THE CHAIR TO THE CORNER OF WALL AND SAID HE FELT FAINT. HE BECAME UNSCONSCIOUS FOR A FEW SECONDS AND WHEN HE BECAME ALERT, BEGAN CONVULSING. WE CALLED THE PARAMEDICS. WHEN THEY ARRIVED, THE PATIENT REFUSED TREATMENT.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: UNKNOWN
Vorgeschichte: UNKNOWN
Andere Medikamente: UNKNOWN
Allergien: UNKNOWN
Vorherige Impfungen: -

VAERS 1197637

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: PA
Alter: 28,0
Geschlecht: M
Eingang: 12.04.2021
Impfdatum: 10.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

PATIENT FAINTED AFTER LEAVING IMMUNIZATION ROOM

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: NONE
Allergien: NONE
Vorherige Impfungen: -

VAERS 1197500

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NY
Alter: 44,0
Geschlecht: M
Eingang: 12.04.2021
Impfdatum: -
Beginn: 02.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dehydration Influenza Injection site pain Loss of consciousness

Symptomtext

SYNCOPE/PASSED OUT FOR A COUPLE OF HOURS; SEVERELY DEHYDRATED; FLU; INJECTION SITE WAS SORE; This spontaneous report received from a pharmacist concerned a 44 year old The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: 06-JUN-2021) dose was not reported, frequency 1 total administered on 02-APR-2021 to right arm for prophylactic vaccination. No concomitant medications were reported. On 02-APR-2021, the patient was severely dehydrated a couple of hours after receiving the vaccine, syncope/passed out for a couple of hours (unsure how long), and injection site was sore. On same day, it felt like the patient had the flu, which was described as chills, fever and the patient's throat being sore at the same time. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from syncope/passed out for a couple of hours, severely dehydrated, injection site was sore, and felt like patient had the flu on 04-APR-2021. This report was serious (Other Medically Important Condition).; Sender's Comments: V0;20210411188-covid-19 vaccine ad26.cov2. s-syncope/passed out, severely dehydrated. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Unknown
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1196363

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: FL
Alter: 24,0
Geschlecht: F
Eingang: 12.04.2021
Impfdatum: 10.04.2021
Beginn: 12.04.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Syncope Urticaria

Symptomtext

Patient fainted shortly after receiving dose on 4/10. Patient did respond shortly afterwards and was given juice and a ice pack. Continued to monitor for some 30 plus minutes prior to releasing. Called patient around 5PM same day, patient sounded great and was doing well. Note: Patient has a history of fainting upon vaccine admin. but did not indicate to provider prior to administering vaccine. Patent called at moms request on 4/12 at 9:54 am and indicated she noted upon waking 2 hives in crevasse of arm which spread to all over body. Advised patient to call MD office for guidance and speak to live person. Spoke to doctor's office whom indicated they would address hives condition and then advise provider this provider.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: known at this time
Aktuelle Erkrankungen: None known
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: None
Vorherige Impfungen: -

VAERS 1190660

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: TX
Alter: 57,0
Geschlecht: F
Eingang: 12.04.2021
Impfdatum: 10.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Chest discomfort Dizziness Loss of consciousness Dyspnoea

Symptomtext

light headed, couldn't breathe, hospital trip

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: iv
Aktuelle Erkrankungen: -
Vorgeschichte: seizures
Andere Medikamente: gabapentin, levetiratam
Allergien: sulfa, morphine, robaxin, plavix, baclofen, vitalopran, cymbalta, latex
Vorherige Impfungen: -

VAERS 1168029

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NJ
Alter: 30,0
Geschlecht: F
Eingang: 12.04.2021
Impfdatum: -
Beginn: 04.04.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Body temperature Chills Hyperhidrosis Nausea Feeding disorder Hangover Pyrexia Seizure Vomiting Water pollution

Symptomtext

WOKE UP IN SWEATS; VOMITING; CONVULSIONS; NAUSEA; FELT VERY WEAK; CHILLS AND COULD NOT GET WARM; FEVER; This spontaneous report received from a patient concerned a 30 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included non-smoker, and low body temperature, and other pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: UNKNOWN) dose was not reported,1 total, administered on 03-APR-2021 16:00 to left arm for prophylactic vaccination. No concomitant medications were reported. On 04-APR-2021, the patient started experiencing side effects. On 04-APR-2021 at 2:00 the patient had convulsions, chills and could not get warm. At same time the patient started to get nausea and it was bad at 2:15 or 2:30. The patient also had vomiting from 2:30 to 5:30. During this time the patient had body temperature ranging in between 99-100.3F. On 04-APR-2021 at 6:00, the patient woke up in sweats. Nausea continued throughout the day. On 04-APR-2021 at 16:00, the patient took Zofran and nausea completely stopped. The body temperature remained at 99 F till 19:00. On 05- APR -2021 since 10:00 the patient finally able to eat and drink, still the patient feels very weak. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from convulsions, woke up in sweats, and nausea on 04-APR-2021, vomiting on 04-APR-2021 05:30, and fever on 05-APR-2021, had not recovered from felt very weak, and the outcome of chills and could not get warm was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210409520-covid-19 vaccine ad26.cov2.s-convulsions. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: Test Date: 20210404; Test Name: Body temperature; Result Unstructured Data: 99 F; Comments: Temperature remained at 99 until Sunday at 19:00.; Test Date: 20210404; Test Name: Body temperature; Result Unstructured Data: 99-100.3 F; Comments: Temperature was 99-100.3F during 2:30 to 5:30.
Aktuelle Erkrankungen: Body temperature decreased; Non-smoker
Vorgeschichte: Comments: The patient had no known allergies.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1168029

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NJ
Alter: 30,0
Geschlecht: F
Eingang: 12.04.2021
Impfdatum: -
Beginn: 04.04.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Body temperature Chills Hyperhidrosis Nausea Feeding disorder Hangover Pyrexia Seizure Vomiting Water pollution

Symptomtext

WOKE UP IN SWEATS; VOMITING; CONVULSIONS; NAUSEA; FELT VERY WEAK; CHILLS AND COULD NOT GET WARM; FEVER; This spontaneous report received from a patient concerned a 30 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included non-smoker, and low body temperature, and other pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: UNKNOWN) dose was not reported,1 total, administered on 03-APR-2021 16:00 to left arm for prophylactic vaccination. No concomitant medications were reported. On 04-APR-2021, the patient started experiencing side effects. On 04-APR-2021 at 2:00 the patient had convulsions, chills and could not get warm. At same time the patient started to get nausea and it was bad at 2:15 or 2:30. The patient also had vomiting from 2:30 to 5:30. During this time the patient had body temperature ranging in between 99-100.3F. On 04-APR-2021 at 6:00, the patient woke up in sweats. Nausea continued throughout the day. On 04-APR-2021 at 16:00, the patient took Zofran and nausea completely stopped. The body temperature remained at 99 F till 19:00. On 05- APR -2021 since 10:00 the patient finally able to eat and drink, still the patient feels very weak. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from convulsions, woke up in sweats, and nausea on 04-APR-2021, vomiting on 04-APR-2021 05:30, and fever on 05-APR-2021, had not recovered from felt very weak, and the outcome of chills and could not get warm was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210409520-covid-19 vaccine ad26.cov2.s-convulsions. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: Test Date: 20210404; Test Name: Body temperature; Result Unstructured Data: 99 F; Comments: Temperature remained at 99 until Sunday at 19:00.; Test Date: 20210404; Test Name: Body temperature; Result Unstructured Data: 99-100.3 F; Comments: Temperature was 99-100.3F during 2:30 to 5:30.
Aktuelle Erkrankungen: Body temperature decreased; Non-smoker
Vorgeschichte: Comments: The patient had no known allergies.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1195229

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: IN
Alter: 56,0
Geschlecht: F
Eingang: 11.04.2021
Impfdatum: 06.04.2021
Beginn: 06.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Myalgia Pain Syncope Vomiting

Symptomtext

Night of and night after experienced body muscle aches; 3 days after had fainting spell and vomitting

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: Multiple vitamin; requip; zoloft
Allergien: none
Vorherige Impfungen: -

VAERS 1194599

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: OH
Alter: 45,0
Geschlecht: M
Eingang: 11.04.2021
Impfdatum: 11.04.2021
Beginn: 11.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Loss of consciousness

Symptomtext

Patient passed out, opened ammonia salt within 2 minutes, pt lost responsiveness after 7 minutes, gave Epipen, called EMS. Patient observed for additional 15 minutes, BP and HR stable per EMS review.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1194579

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MA
Alter: 24,0
Geschlecht: M
Eingang: 11.04.2021
Impfdatum: 07.04.2021
Beginn: 07.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Dizziness Foaming at mouth Loss of consciousness Malaise Pallor Syncope Tonic clonic movements

Symptomtext

Patient received the vaccine and was asked to wait in the observation area afterwards. He approached the counter a few minutes later to report he wasn't feeling well. As he was speaking with the technician he became very pale, reported lightheadedness and fainted with loss of consciousness. The technician reported that he witnessed convulsive type tonic movements concentrated in the neck and upper-arms more than the abdomen or legs. He also reported foaming at the mouth and following each event which repeated 3 times in less then 15 minutes, he woke with confusion and no memory of where he was. EMS arrived after 15 minutes and transported the patient to the ED for evaluation. Upon follow up with the patient the next day, he reported that the ED found nothing on his medical exam and he had worked a 10 hour shift prior to receiving the vaccine and had had nothing to eat or drink.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: unknown
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -

VAERS 1194503

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: OH
Alter: 31,0
Geschlecht: M
Eingang: 11.04.2021
Impfdatum: 11.04.2021
Beginn: 11.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Hypotension Loss of consciousness Unresponsive to stimuli

Symptomtext

Patient passed out in sitting position 5 minutes after receiving vaccine, opened ammonia salts at 1:40pm, but patient became unresponsive by 1:48, administered EpiPen in right thigh. EMS contacted - HR of 54, BP too low to calculate. MD/hospital referral.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1194456

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MA
Alter: 39,0
Geschlecht: F
Eingang: 11.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Confusional state Cyanosis Disorientation Loss of consciousness Malaise Pallor Tremor

Symptomtext

After the immunization was administered to the patient, she was asked to have a seat in the waiting area for observation. A few minutes after she sat, she told her husband who was seated with her she didn't feel well (he did not inform us). The technician observing her noticed she passed out and reported to the pharmacist (myself). I designated a team member to call 911 and ran out to the patient. She was extremely pale and her lips were blue. With the assistance of her husband I laid her on the floor, had him elevate her feet and checked for pulse and breathing. I couldn't immediately find her pulse but within 30 seconds she began to come to. She appeared to tremor a few times as she came to and her color began to return. She was extremely confused and did not know where she was upon awakening. EMS arrived on the scene approximately 10-15 minutes after the event. They did standard patient evaluation which was unremarkable and proceeded to bring her to the local ED, According to the patient, the ED visit yielded nothing and they said "she couldn't be more healthy". One note, that was revealed in conversation with the patient while waiting for EMS to arrive is that the patient had very little to eat or drink prior to being administered the vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -

VAERS 1193142

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NJ
Alter: 46,0
Geschlecht: M
Eingang: 11.04.2021
Impfdatum: 10.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Cognitive disorder Dizziness Fall Feeling hot Hyperhidrosis Muscle rigidity Seizure like phenomena Tremor

Symptomtext

Seizure-like episode. Patient was seated when his body went rigid and he lost postural control and started to slide sideways. His body was shaking slightly and his eyes were open but there was no cognitive awareness. This lasted no more than 90 seconds and then patient came to abruptly and reoriented himself on the chair before I had the opportunity to get him to the floor. Patient then stated that he was lightheaded, warm and sweaty. EMT had been called and upon assessment of the patient transported him to the ER.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure like phenomena
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: NKA
Vorherige Impfungen: -

VAERS 1192699

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MD
Alter: 26,0
Geschlecht: F
Eingang: 11.04.2021
Impfdatum: 07.04.2021
Beginn: 07.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Hyperhidrosis Nausea Palpitations Presyncope

Symptomtext

Nearly immediate after administration of vaccine- stood up to move to a waiting chair & experienced dizziness to the point of near syncope, heart pounding, nausea, sweating- pharmacy brought juice and watched me. Drank juice but was disoriented enough to spill a bit- sat for about 30 minutes until symptoms cleared up enough to walk around and got a ride home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: N/a
Aktuelle Erkrankungen: N/a
Vorgeschichte: Anxiety, depression, blood sugar crashes, history of dizziness (suspected hypoglycemia), GERD
Andere Medikamente: Citalopram, fluvoxamine
Allergien: Pollen
Vorherige Impfungen: -

VAERS 1192591

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: OR
Alter: 49,0
Geschlecht: M
Eingang: 10.04.2021
Impfdatum: 08.04.2021
Beginn: 08.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: UN / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Differential white blood cell count Dizziness Electrocardiogram Full blood count Metabolic function test Nausea Syncope

Symptomtext

Nausea, dizziness, syncope

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: EKG, CBC, basic metabolic panel, white blood cell differential
Aktuelle Erkrankungen: N/a
Vorgeschichte: Htn
Andere Medikamente: Lisinopril, lorazepam, claratin
Allergien: N/a
Vorherige Impfungen: -

VAERS 1192355

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: AK
Alter: 32,0
Geschlecht: M
Eingang: 10.04.2021
Impfdatum: 10.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Feeling hot Loss of consciousness Pallor Thirst

Symptomtext

2-3 Minutes after receiving the vaccine, the patient was seated in the waiting area for his 15 minute wait time. We heard a crash and the yell of his wife and 3 children. Found the patient laying on his back on the ground. Patient was breathing, but non responsive to tapping and shouting. 911 was called. Patient regained consciousness after about 15-30 seconds. He complained of being hot, thirsty, having to go to the bathroom and feeling out of it. He appeared pale. We did record a BP of 95/57. He remained conscious until EMT's arrived. He was attended to and taken to the ER by emergency personal.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Don't know
Aktuelle Erkrankungen: none
Vorgeschichte: not aware of any
Andere Medikamente: Unkown
Allergien: None reported
Vorherige Impfungen: -

VAERS 1192351

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: CA
Alter: 54,0
Geschlecht: F
Eingang: 10.04.2021
Impfdatum: 10.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

patient fainted less than a minute after injection. She regained consciousness and were taking care by fire department crews . Other wise doing fine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: N/A
Allergien: none
Vorherige Impfungen: -

VAERS 1191654

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: -
Alter: 37,0
Geschlecht: M
Eingang: 10.04.2021
Impfdatum: 08.04.2021
Beginn: 08.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Blood pressure measurement Chills Dizziness Syncope Tinnitus

Symptomtext

Patient had syncope, dizziness, ringing of ears, chills. BP 144/92 P73 RR17. Given water and recovered, discharged home in stable condition

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1191590

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: WI
Alter: 20,0
Geschlecht: F
Eingang: 10.04.2021
Impfdatum: 10.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

Fainted but responded when I talked to her. Had her lie on floor. Gave cold compress and cold water to drink. She stayed awake from then on. We sat her up and had her wait until she felt better. Waited here 30 minutes after vaccine and felt ok when she left.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1191509

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: OK
Alter: 52,0
Geschlecht: M
Eingang: 10.04.2021
Impfdatum: 10.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Presyncope

Symptomtext

vagal response 1 minute after vaccination,

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: n/a
Allergien: -
Vorherige Impfungen: -

VAERS 1191485

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: SC
Alter: 46,0
Geschlecht: F
Eingang: 10.04.2021
Impfdatum: 10.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Dizziness Hyperhidrosis Loss of consciousness

Symptomtext

Patient started to feel light headed and sweaty approximately 5 minutes after receiving her vaccine. She lost consciousness for a few seconds and was weak and light headed after regaining consciousness.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: Junel FE 1/20, Emgality 120mg/ml
Allergien: -
Vorherige Impfungen: -

VAERS 1191316

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: SC
Alter: 23,0
Geschlecht: F
Eingang: 10.04.2021
Impfdatum: 08.04.2021
Beginn: 08.04.2021
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chills Dizziness Pyrexia Syncope

Symptomtext

Patient fainted shortly after getting the Janssen vaccine. She felt faint and let us know so we laid her down elevated her legs, and she fell out for a few seconds she continued to have a strong pulse. We gave her an ice pack and water after she came back and had her lay down for 10 more minutes. I checked with her a few days later she said she had fever and chills 8 hours after the vaccine but felt better.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: n/a
Allergien: n/a
Vorherige Impfungen: -

VAERS 1191265

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: -
Alter: 26,0
Geschlecht: M
Eingang: 10.04.2021
Impfdatum: 10.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Dizziness Head injury Headache Nausea Syncope Vomiting

Symptomtext

Patient fainted from sitting position and hit forehead. Had symptoms of nausea, HA, and laid down for 15 minutes. Drank OJ, ate chips upon sitting and laid back down due to dizziness. Patient sat up, vomited, and continued symptoms of headache. Stayed in observation for an hour and felt better enough to go home with friend. Recommended patient visit medical provider if no improvement or worsening of symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1191200

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: -
Alter: 29,0
Geschlecht: M
Eingang: 10.04.2021
Impfdatum: 10.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dizziness Headache Nausea Syncope Vomiting

Symptomtext

Patient fainted from sitting on chair, felt nauseous, dizzy, and lightheaded 5 minutes after receiving vaccine. Felt dizzy for an additional 15 minutes and laid supine. Patient drank juice, ate a salty snack, and sat up. Continued to feel lightheaded, laid down for additional 15 minutes. Patient vomited, complains of headache and nausea. Symptoms continued for an additional 45 minutes before patient felt comfortable to leave with friend.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1191131

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NJ
Alter: 57,0
Geschlecht: F
Eingang: 10.04.2021
Impfdatum: 10.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Asthenia Disorientation Dizziness Hyperhidrosis Hypoaesthesia Lethargy Pallor Paraesthesia Presyncope Speech disorder Vital signs measurement Vomiting

Symptomtext

Patient said she felt like she was going to pass out. Was advised to sit down immediately. Patients breathing was fine, but she was extremely lethargic/limp. Was coherent but slow to answer questions, excessively sweating and pale, small amount of vomit. At one point, patient said that she did not know where she was. Said that her fingers felt numb and tingly (could not pick up water or orange juice...we had to put water and juice to her lips to drink). She said that she needed to lay down. Per patient she had oatmeal with very little sugar for breakfast and coffee. Believe the reaction was a vasovagal response.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: Emt was called they checked her blood pressure, which at that point was very normal. The EMT took her to the hospital.
Aktuelle Erkrankungen: per patient none besides recent dental work
Vorgeschichte: none per patient to emt
Andere Medikamente: unknown
Allergien: nka
Vorherige Impfungen: -

VAERS 1190357

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: -
Alter: -
Geschlecht: U
Eingang: 10.04.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dyskinesia Loss of consciousness Tremor

Symptomtext

During the observation period the patient lost consciousness for a short period. The patient was sitting in a chair and dropped her phone. She exhibited a mild fencing response and her hand trembled until she regained consciousness. Patient stated she has passed out from needles in the past.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1190234

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: SC
Alter: 39,0
Geschlecht: M
Eingang: 10.04.2021
Impfdatum: 06.04.2021
Beginn: 06.04.2021
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Hyperhidrosis Pallor Syncope

Symptomtext

Patient fainted about 3-4 minutes after receiving the vaccine. Patient was very pale and sweaty. We laid the patient down and gave him an ice pack and water. He quickly came back and felt better within 5-10 minutes.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: n/a
Allergien: n/a
Vorherige Impfungen: -

VAERS 1190115

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: IN
Alter: 19,0
Geschlecht: F
Eingang: 10.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Immediate post-injection reaction Syncope

Symptomtext

Patient fainted immediately after vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1189715

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: WI
Alter: 30,0
Geschlecht: M
Eingang: 10.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Impaired work ability Syncope Unresponsive to stimuli

Symptomtext

Systemic: Fainting / Unresponsive-Mild, Additional Details: patient was given J and J \r\nCOVID vaccine. patient was seated when patient fainted. patient came to right away and was instructed to lay flat and elevate feet. patient started fo feel better. bp 100/80. Pt was monitored for 30min. Further BP was also 100/80. Pt was instructed to take it easy tonight and leave early from target shift and to seek medical care if any further fainting or symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1189708

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: WI
Alter: 33,0
Geschlecht: F
Eingang: 10.04.2021
Impfdatum: 07.04.2021
Beginn: 07.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Dizziness Syncope Tremor Unresponsive to stimuli

Symptomtext

Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Shakiness-Medium, Systemic: Weakness-Medium

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1189598

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: OK
Alter: 47,0
Geschlecht: F
Eingang: 10.04.2021
Impfdatum: 07.04.2021
Beginn: 07.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Dizziness Fall Feeling abnormal Feeling cold Headache Illness Injection site pain Myalgia Nausea Pain Pain in extremity Pyrexia Syncope

Symptomtext

Around five hours after shot I felt what I would describe as brain fog and light headache, by the evening I was aching, chilling and had 101 fever. Aches in my muscles and joints as if I had Rocky mountain spotted fever again. That is what the side effects reminded me of. This went on for over 48 hours. I have never been so sick. Very nauseous by next day. Also fell to the floor from nearly passing out the following morning. Took a minute for the light headed To pass. Arm pain still today. It was very scary and seemed to be a very serious reaction. Friday after noon finally started feeling better. The other strange part of this is that my daughter and best friend and I received the shot together in the same lot number and every one of us was deathly ill with the same symptoms. I am the only one with the fainting spells. Still feel fatigued today. And shoulders and left arm injection site still sore and achy.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: Did not go to hospital or doctor.
Aktuelle Erkrankungen: None
Vorgeschichte: Asthma induced allergies occasionally
Andere Medikamente: Dexilant Singulair
Allergien: Latex allergies, allergies to cats, allergies to latex enzyme type foods.
Vorherige Impfungen: -

VAERS 1188455

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: AK
Alter: 55,0
Geschlecht: F
Eingang: 10.04.2021
Impfdatum: 02.04.2021
Beginn: 02.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dizziness Dysstasia Headache Hypotension Loss of consciousness Nausea

Symptomtext

Severe headache onset one minute after vaccine administered-reported to nurse. Lasted 8 hours, by 1 week daily but less severe. Nausea and dizziness began 15 minutes after dosage and has lasted seven days so far. Passed out and needed help standing twice during week. Low blood pressures 88/62, HR 42. Symptoms continue presently.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Fibromyalgia, Erythema Nodosum, orthopedic arthritis, degenerative disc disease
Andere Medikamente: Trazodone, Lyrica, Methadone, Lorazepam, Naproxen Sodium, Vitamin B-12 via injection, Vitamin D, Advil Dual Action
Allergien: Shellfish, both consumed and inhaled vapors resulting in Anaphylaxis Naltrexone Hydrocodone Penicillin
Vorherige Impfungen: -

VAERS 1187506

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NC
Alter: 34,0
Geschlecht: F
Eingang: 10.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Chills Dizziness Loss of consciousness Hot flush Hyperhidrosis Vision blurred

Symptomtext

Around 5.5 hours after I got the shot my blood sugar bottomed out. I had a hot flash, started sweating and my vision went blurry. I couldn?t walk 3 feet without having to sit with my head between my knees. I passed out in a 5 foot walk but luckily i sat down on my couch as it was happening. I?m not diabetic, haven?t ever been hypoglycemic. Ibuprofen and food after about 2 or 3 hours is a must.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: N/A after eating I felt much better.
Aktuelle Erkrankungen: N/A
Vorgeschichte: Anxiety, ADHD, Hypertension- controlled.
Andere Medikamente: Famotidine OTC, Vyvanse 40mg PO QD, Lisinopril 20 mg PO QD, Zoloft 100mg PO QD.
Allergien: N/A
Vorherige Impfungen: -

VAERS 1188340

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: AK
Alter: 18,0
Geschlecht: F
Eingang: 09.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Condition aggravated Dizziness Fatigue Loss of consciousness Snoring Tremor

Symptomtext

RIGHT AFTER THE SHOT, THE PATIENT SAID THAT SHE FELT LIGHT HEADED AND TIRED. SHE STARTED TO SHAKE AND SLUMPED OVER AGAINST HER FATHER THAT WAS NEXT TO HER. SHE STARTED TO SNORE, WOKE UP AND THEN PASSED OUT AGAIN. HER FATHER SAID THAT SHE REACTS TO SHOTS THIS WAY. SHE DID NOT RECEIVE ANY TREATMENT. SHE WAS IN THE PHARMACY FOR A TOTAL OF 25 MINUTES.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: LATEX
Vorherige Impfungen: SEE ABOVE STATEMENT

VAERS 1187529

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CA
Alter: 33,0
Geschlecht: M
Eingang: 09.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

Fainting

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1187422

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: OH
Alter: 41,0
Geschlecht: M
Eingang: 09.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Immediate post-injection reaction Loss of consciousness

Symptomtext

PATIENT WAS SEATED AND GIVEN VACCINE AND PASSED OUT IMMEDIATELY. PATIENT REGAINED CONSCIOUSNESS A FEW MOMENTS LATER. PATIENT WAS MOVED TO THE FLOOR IN SUPINE POSITION WITH LEGS ELEVATED. PATIENT STAYED CONCIOUS AND RECOVERED IN 20-25 MINUTES. BLOOD PRESSURE WAS 122/78, PATIENT REMAINED AWAKE AND ALERT. PATIENT LEFT STORE UNDER HIS OWN POWER WITH HIS SPOUSE.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1187287

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: IA
Alter: 32,0
Geschlecht: F
Eingang: 09.04.2021
Impfdatum: 06.04.2021
Beginn: 06.04.2021
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Dizziness Dyspnoea Headache Nausea Pain Pyrexia Syncope

Symptomtext

within 5 minutes of immunization: syncope, nausea later that day: feeling winded, lessened syncope and nausea overnight: fever 103 F, chills, body aches, headache continuing through today: occasional, mild lightheadedness, nausea and feeling winded

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: none known
Vorherige Impfungen: -

VAERS 1187039

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: CA
Alter: 20,0
Geschlecht: F
Eingang: 09.04.2021
Impfdatum: 08.04.2021
Beginn: 08.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Headache Limb injury Malaise Syncope

Symptomtext

pt stated that 4 hours after vaccine on 4/8/21 she fainted while at home and hit her arm. She stated that she believes she did not eat enough. She said that after eating and drinking electrolytes she felt better. AS of 4/9/21 she states she has a headache and feels icky. pt stated she did not receive any medical attention

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: unknown
Allergien: no
Vorherige Impfungen: -

VAERS 1186736

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NY
Alter: 60,0
Geschlecht: F
Eingang: 09.04.2021
Impfdatum: 06.04.2021
Beginn: 06.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

patient fainted 40 seconds, regained complete alertness

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none reported
Vorgeschichte: hx of syncope with needles/shots/blood draw
Andere Medikamente: unknown
Allergien: none reported
Vorherige Impfungen: unknown

VAERS 1186652

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: MI
Alter: 32,0
Geschlecht: M
Eingang: 09.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

Patient started fainting a few minutes after the Janssen vaccine was injected. Patient started fainting in while he was seated. He wasn't very responsive but his eyes were open. Patient stated that he has a panic attack to the injection of the needle and has had similar reactions in the past from other injections.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 1186318

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: TN
Alter: 22,0
Geschlecht: M
Eingang: 09.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

Immediate brief episode of syncope without hitting head or injury. Full recovery after 30 minutes of observation

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: BP 140/90, HR 90, O2 sat 98%
Aktuelle Erkrankungen: No
Vorgeschichte: Hyperlipidemia
Andere Medikamente: "Statin"
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1186302

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: PA
Alter: 24,0
Geschlecht: M
Eingang: 09.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

Syncope

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1186224

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: CO
Alter: 35,0
Geschlecht: F
Eingang: 09.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Confusional state Dizziness Loss of consciousness

Symptomtext

Patient was waiting after vaccine in 15 minute required post vaccine period and started to become dizzy. She waved us down and we went out to assist her. Patient lost consciousness for about 30 seconds, then regained consciousness with confusion. We gave the patient water, ibuprofen, and a snack. We had her wait in the pharmacy for 50 minutes after the incident. She was feeling much better upon leaving.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1186192

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: CA
Alter: 28,0
Geschlecht: F
Eingang: 09.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

FAINTING REACTION SYNCOPE - PATEINT REPORTS OF PREVIOUS HISTORY OF FAINTING REACTION TO NEEDLE PRICKS IN THE PAST. PATIENT WAS STABLE ABD MONITORED FOR MORE THAN 30 MINUTS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: n/a
Allergien: penicillin
Vorherige Impfungen: -

VAERS 1185959

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: NC
Alter: 25,0
Geschlecht: F
Eingang: 09.04.2021
Impfdatum: 07.04.2021
Beginn: 07.04.2021
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Fall Loss of consciousness

Symptomtext

BEFORE VACCINE ADMINISTRATION, PATIENT STATED THAT HE HAS A PHOBIA TOWARDS RECEIVING SHOTS. ALMOST IMMEDIATELY AFTER VACCINE, PATIENT REPORTING FEELING LIGHT-HEADED. HE SAT DOWN IN A CHAIR FOR 5 MORE MINUTES. ONE PATIENT TRIED TO GATHER HIMSELF AND WALK TO THE PHARMACY EXIT, HE PASSED OUT AND FELL FORWARD INTO THE ARMS OF THE PHARMACIST MANAGER AND VACCINATOR. HE WAS AGAIN PROVIDED WITH A CHAIR, SOME WATER, AND A COLD TOWEL. HE RECOVERED ABOUT 15 MINUTES LATER.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: NONE
Aktuelle Erkrankungen: UNKNOWN
Vorgeschichte: UNKNOWN
Andere Medikamente: UNKNOWN
Allergien: NONE LISTED
Vorherige Impfungen: -

VAERS 1185909

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: -
Alter: 39,0
Geschlecht: F
Eingang: 09.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Seizure Syncope

Symptomtext

PATIENT FAINTED AND HAD A 20SEC SEIZURE SEVERAL MINUTES AFTER RECIEVING VACCINE. PATIENT HAD EXTREME ANXIETY ABOUT BEING VACCINATED BEFORE HAND AS WELL AS HAD NOT EATEN DAY OF. PATIENT SYMPTOMS SUBSIDED AND HSOPITLIZATION WAS NOT REQUIRED.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NO
Vorgeschichte: NO
Andere Medikamente: -
Allergien: PCN
Vorherige Impfungen: -

VAERS 1185899

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: MA
Alter: 19,0
Geschlecht: M
Eingang: 09.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Syncope Unresponsive to stimuli

Symptomtext

Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Medium

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1185892

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042a21a

schwer

Staat: PA
Alter: 23,0
Geschlecht: F
Eingang: 09.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Impaired driving ability Loss of consciousness Nausea

Symptomtext

patient experienced a wave of nausea, light-headedness, and briefly lost consciousness during vaccination. When she lost consciousness, I supported her weight and she remained in the chair for approx 15 seconds until she regained consciousness. I had two technicians to assist in calling a code white and documenting the event. At 10:43 am, patient lost consciousness and regained 15 seconds later. Once I knew the patient was stable enough to support her own weight, i held her hands to make sure she was not going to lose consciuosness again. I administered an ice pack and a cool towel at 10:45 am. Code white was responded to by associates from AP and manager. I observed the patient for 15 minutes, and AP associate observed for another 15 minutes for a total of 30 minutes. The patient recovered fully and had a friend drive her home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: syncope, details unknown

VAERS 1185306

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 042A21A

schwer

Staat: TN
Alter: 21,0
Geschlecht: M
Eingang: 09.04.2021
Impfdatum: 09.04.2021
Beginn: 09.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Immediate post-injection reaction Syncope Vital signs measurement

Symptomtext

Immediate brief episode of syncope without hitting head or injury. Monitored for 30 minutes with full recovery.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: 136/92, O2 sat 99%, HR 76 138/80, O2 sat 98%, HR 88 at discharge
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: None
Allergien: NKDA
Vorherige Impfungen: -